0000047217-24-000024.txt : 20240228 0000047217-24-000024.hdr.sgml : 20240228 20240228172733 ACCESSION NUMBER: 0000047217-24-000024 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 108 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HP INC CENTRAL INDEX KEY: 0000047217 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER & OFFICE EQUIPMENT [3570] ORGANIZATION NAME: 06 Technology IRS NUMBER: 941081436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-04423 FILM NUMBER: 24697246 BUSINESS ADDRESS: STREET 1: 1501 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6508571501 MAIL ADDRESS: STREET 1: 1501 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: HEWLETT PACKARD CO DATE OF NAME CHANGE: 19920703 10-Q 1 hpq-20240131.htm 10-Q hpq-20240131
0000047217false10/312024Q1http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrentP2Dhttp://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrentP2DP2D00000472172023-11-012024-01-3100000472172024-01-31xbrli:shares0000047217us-gaap:ProductMember2023-11-012024-01-31iso4217:USD0000047217us-gaap:ProductMember2022-11-012023-01-310000047217us-gaap:ServiceMember2023-11-012024-01-310000047217us-gaap:ServiceMember2022-11-012023-01-3100000472172022-11-012023-01-31iso4217:USDxbrli:shares00000472172023-10-3100000472172022-10-3100000472172023-01-310000047217us-gaap:CommonStockMember2023-10-310000047217us-gaap:AdditionalPaidInCapitalMember2023-10-310000047217us-gaap:RetainedEarningsMember2023-10-310000047217us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-310000047217us-gaap:RetainedEarningsMember2023-11-012024-01-310000047217us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-11-012024-01-310000047217us-gaap:CommonStockMember2023-11-012024-01-310000047217us-gaap:AdditionalPaidInCapitalMember2023-11-012024-01-310000047217us-gaap:CommonStockMember2024-01-310000047217us-gaap:AdditionalPaidInCapitalMember2024-01-310000047217us-gaap:RetainedEarningsMember2024-01-310000047217us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-310000047217us-gaap:CommonStockMember2022-10-310000047217us-gaap:AdditionalPaidInCapitalMember2022-10-310000047217us-gaap:RetainedEarningsMember2022-10-310000047217us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-310000047217us-gaap:RetainedEarningsMember2022-11-012023-01-310000047217us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-11-012023-01-310000047217us-gaap:CommonStockMember2022-11-012023-01-310000047217us-gaap:AdditionalPaidInCapitalMember2022-11-012023-01-310000047217us-gaap:CommonStockMember2023-01-310000047217us-gaap:AdditionalPaidInCapitalMember2023-01-310000047217us-gaap:RetainedEarningsMember2023-01-310000047217us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-31hpq:segment0000047217hpq:PersonalSystemsMemberhpq:CommercialPSMemberus-gaap:OperatingSegmentsMember2023-11-012024-01-310000047217hpq:PersonalSystemsMemberhpq:CommercialPSMemberus-gaap:OperatingSegmentsMember2022-11-012023-01-310000047217hpq:ConsumerPSMemberhpq:PersonalSystemsMemberus-gaap:OperatingSegmentsMember2023-11-012024-01-310000047217hpq:ConsumerPSMemberhpq:PersonalSystemsMemberus-gaap:OperatingSegmentsMember2022-11-012023-01-310000047217hpq:PersonalSystemsMemberus-gaap:OperatingSegmentsMember2023-11-012024-01-310000047217hpq:PersonalSystemsMemberus-gaap:OperatingSegmentsMember2022-11-012023-01-310000047217hpq:PrintingMemberhpq:SuppliesMemberus-gaap:OperatingSegmentsMember2023-11-012024-01-310000047217hpq:PrintingMemberhpq:SuppliesMemberus-gaap:OperatingSegmentsMember2022-11-012023-01-310000047217hpq:PrintingMemberus-gaap:OperatingSegmentsMemberhpq:CommercialPrintingMember2023-11-012024-01-310000047217hpq:PrintingMemberus-gaap:OperatingSegmentsMemberhpq:CommercialPrintingMember2022-11-012023-01-310000047217hpq:PrintingMemberus-gaap:OperatingSegmentsMemberhpq:ConsumerPrintingMember2023-11-012024-01-310000047217hpq:PrintingMemberus-gaap:OperatingSegmentsMemberhpq:ConsumerPrintingMember2022-11-012023-01-310000047217hpq:PrintingMemberus-gaap:OperatingSegmentsMember2023-11-012024-01-310000047217hpq:PrintingMemberus-gaap:OperatingSegmentsMember2022-11-012023-01-310000047217hpq:CorporateInvestmentsMemberus-gaap:OperatingSegmentsMember2023-11-012024-01-310000047217hpq:CorporateInvestmentsMemberus-gaap:OperatingSegmentsMember2022-11-012023-01-310000047217us-gaap:OperatingSegmentsMember2023-11-012024-01-310000047217us-gaap:OperatingSegmentsMember2022-11-012023-01-310000047217us-gaap:MaterialReconcilingItemsMember2023-11-012024-01-310000047217us-gaap:MaterialReconcilingItemsMember2022-11-012023-01-310000047217us-gaap:CorporateNonSegmentMember2023-11-012024-01-310000047217us-gaap:CorporateNonSegmentMember2022-11-012023-01-310000047217hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMemberhpq:Fiscal2023RestructuringPlanMember2023-10-310000047217hpq:NonLaborMemberhpq:Fiscal2023RestructuringPlanMember2023-10-310000047217hpq:OtherPlanMember2023-10-310000047217hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMemberhpq:Fiscal2023RestructuringPlanMember2023-11-012024-01-310000047217hpq:NonLaborMemberhpq:Fiscal2023RestructuringPlanMember2023-11-012024-01-310000047217hpq:OtherPlanMember2023-11-012024-01-310000047217hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMemberhpq:Fiscal2023RestructuringPlanMember2024-01-310000047217hpq:NonLaborMemberhpq:Fiscal2023RestructuringPlanMember2024-01-310000047217hpq:OtherPlanMember2024-01-310000047217hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMemberhpq:Fiscal2023RestructuringPlanMember2022-10-310000047217hpq:NonLaborMemberhpq:Fiscal2023RestructuringPlanMember2022-10-310000047217hpq:OtherPlanMember2022-10-310000047217hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMemberhpq:Fiscal2023RestructuringPlanMember2022-11-012023-01-310000047217hpq:NonLaborMemberhpq:Fiscal2023RestructuringPlanMember2022-11-012023-01-310000047217hpq:OtherPlanMember2022-11-012023-01-310000047217hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMemberhpq:Fiscal2023RestructuringPlanMember2023-01-310000047217hpq:NonLaborMemberhpq:Fiscal2023RestructuringPlanMember2023-01-310000047217hpq:OtherPlanMember2023-01-310000047217hpq:Fiscal2023PlanMembersrt:MinimumMember2022-11-182022-11-18hpq:employee0000047217hpq:Fiscal2023PlanMembersrt:MaximumMember2022-11-182022-11-180000047217hpq:Fiscal2023PlanMemberhpq:LaborAndNonLaborActionsMember2022-11-180000047217hpq:LaborCostsMemberhpq:Fiscal2023PlanMember2022-11-180000047217country:USus-gaap:PensionPlansDefinedBenefitMember2023-11-012024-01-310000047217country:USus-gaap:PensionPlansDefinedBenefitMember2022-11-012023-01-310000047217us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-11-012024-01-310000047217us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-11-012023-01-310000047217us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-11-012024-01-310000047217us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-11-012023-01-310000047217us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-310000047217country:USus-gaap:PensionPlansDefinedBenefitMember2024-01-310000047217us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-3100000472172023-01-012023-01-310000047217hpq:Fiscal2023RestructuringPlanMemberus-gaap:SpecialTerminationBenefitsMember2022-11-012023-10-31xbrli:purehpq:country0000047217us-gaap:LandBuildingsAndImprovementsMember2024-01-310000047217us-gaap:LandBuildingsAndImprovementsMember2023-10-310000047217us-gaap:MachineryAndEquipmentMember2024-01-310000047217us-gaap:MachineryAndEquipmentMember2023-10-310000047217srt:AmericasMember2023-11-012024-01-310000047217srt:AmericasMember2022-11-012023-01-310000047217us-gaap:EMEAMember2023-11-012024-01-310000047217us-gaap:EMEAMember2022-11-012023-01-310000047217srt:AsiaPacificMember2023-11-012024-01-310000047217srt:AsiaPacificMember2022-11-012023-01-3100000472172024-02-012024-01-3100000472172025-02-012024-01-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2024-01-310000047217us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2024-01-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2024-01-310000047217us-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2024-01-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2023-10-310000047217us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2023-10-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2023-10-310000047217us-gaap:FairValueMeasurementsRecurringMemberhpq:FinancialInstitutionInstrumentMember2023-10-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:OtherContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:OtherContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:OtherContractMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:OtherContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:OtherContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:OtherContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:OtherContractMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:OtherContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-01-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:FairValueMeasurementsRecurringMember2024-01-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-10-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueMeasurementsRecurringMember2023-10-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2024-01-310000047217us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2024-01-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2024-01-310000047217us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2024-01-310000047217us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2023-10-310000047217us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2023-10-310000047217us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2023-10-310000047217us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2023-10-310000047217us-gaap:CorporateDebtSecuritiesMember2024-01-310000047217us-gaap:CorporateDebtSecuritiesMember2023-10-310000047217us-gaap:USTreasuryAndGovernmentMember2024-01-310000047217us-gaap:USTreasuryAndGovernmentMember2023-10-310000047217hpq:FinancialInstitutionInstrumentMember2024-01-310000047217hpq:FinancialInstitutionInstrumentMember2023-10-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMember2024-01-310000047217hpq:MarketableEquitySecuritiesandMutualFundsMember2023-10-310000047217us-gaap:OtherNoncurrentAssetsMember2024-01-310000047217us-gaap:OtherNoncurrentAssetsMember2023-10-310000047217us-gaap:CashFlowHedgingMember2023-11-012024-01-310000047217us-gaap:OtherCurrentAssetsMember2024-01-310000047217us-gaap:OtherCurrentLiabilitiesMember2024-01-310000047217us-gaap:OtherNoncurrentLiabilitiesMember2024-01-310000047217us-gaap:OtherCurrentAssetsMember2023-10-310000047217us-gaap:OtherCurrentLiabilitiesMember2023-10-310000047217us-gaap:OtherNoncurrentLiabilitiesMember2023-10-310000047217us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-01-310000047217us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueHedgingMember2024-01-310000047217us-gaap:InterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-01-310000047217us-gaap:InterestRateContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-01-310000047217us-gaap:InterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-01-310000047217us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2023-10-310000047217us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueHedgingMember2023-10-310000047217us-gaap:InterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2023-10-310000047217us-gaap:InterestRateContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2023-10-310000047217us-gaap:InterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2023-10-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-10-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-01-310000047217us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000047217us-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-10-310000047217us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2024-01-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2024-01-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2024-01-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-10-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2023-10-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2023-10-310000047217us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2023-10-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-10-310000047217us-gaap:NondesignatedMemberus-gaap:OtherContractMember2024-01-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:OtherContractMember2024-01-310000047217us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:OtherContractMember2024-01-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:OtherContractMember2024-01-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:OtherContractMember2024-01-310000047217us-gaap:NondesignatedMemberus-gaap:OtherContractMember2023-10-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:OtherContractMember2023-10-310000047217us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:OtherContractMember2023-10-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:OtherContractMember2023-10-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:OtherContractMember2023-10-310000047217us-gaap:NondesignatedMember2024-01-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2024-01-310000047217us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2024-01-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2024-01-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-01-310000047217us-gaap:NondesignatedMember2023-10-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2023-10-310000047217us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2023-10-310000047217us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2023-10-310000047217us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-10-310000047217us-gaap:InterestRateContractMemberhpq:InterestAndOtherIncomeExpenseMember2023-11-012024-01-310000047217us-gaap:InterestRateContractMemberhpq:InterestAndOtherIncomeExpenseMember2022-11-012023-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-11-012024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-11-012023-01-310000047217us-gaap:CashFlowHedgingMember2022-11-012023-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:SalesMember2023-11-012024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:SalesMember2022-11-012023-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2023-11-012024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2022-11-012023-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:OperatingExpenseMember2023-11-012024-01-310000047217us-gaap:CashFlowHedgingMemberus-gaap:OperatingExpenseMember2022-11-012023-01-310000047217us-gaap:CashFlowHedgingMemberhpq:InterestAndOtherExpenseNetMember2023-11-012024-01-310000047217us-gaap:CashFlowHedgingMemberhpq:InterestAndOtherExpenseNetMember2022-11-012023-01-310000047217us-gaap:ForeignExchangeContractMemberhpq:InterestAndOtherIncomeExpenseMember2023-11-012024-01-310000047217us-gaap:ForeignExchangeContractMemberhpq:InterestAndOtherIncomeExpenseMember2022-11-012023-01-310000047217us-gaap:OtherContractMemberhpq:InterestAndOtherIncomeExpenseMember2023-11-012024-01-310000047217us-gaap:OtherContractMemberhpq:InterestAndOtherIncomeExpenseMember2022-11-012023-01-310000047217us-gaap:CommercialPaperMember2024-01-310000047217us-gaap:CommercialPaperMember2023-10-310000047217hpq:NotesPayableToBanksLinesOfCreditAndOtherNotesPayablesMember2024-01-310000047217hpq:NotesPayableToBanksLinesOfCreditAndOtherNotesPayablesMember2023-10-310000047217hpq:USDollarGlobalNotesDueSeptember2041Member2024-01-310000047217hpq:USDollarGlobalNotesDueSeptember2041Member2023-10-310000047217hpq:USDollarGlobalNotesDueJune2025Member2024-01-310000047217hpq:USDollarGlobalNotesDueJune2025Member2023-10-310000047217hpq:USDollarGlobalNotesDueJune2027Member2024-01-310000047217hpq:USDollarGlobalNotesDueJune2027Member2023-10-310000047217hpq:USDollarGlobalNotesDueJune2030Member2024-01-310000047217hpq:USDollarGlobalNotesDueJune2030Member2023-10-310000047217hpq:USDollarGlobalNotesDueJune2026Member2024-01-310000047217hpq:USDollarGlobalNotesDueJune2026Member2023-10-310000047217hpq:USDollarGlobalNotesDueJune2031Member2024-01-310000047217hpq:USDollarGlobalNotesDueJune2031Member2023-10-310000047217hpq:USDollarGlobalNotesDueApril2029Member2024-01-310000047217hpq:USDollarGlobalNotesDueApril2029Member2023-10-310000047217hpq:USDollarGlobalNotesDueApril2032Member2024-01-310000047217hpq:USDollarGlobalNotesDueApril2032Member2023-10-310000047217hpq:USDollarGlobalNotesDueJanuary2028Member2024-01-310000047217hpq:USDollarGlobalNotesDueJanuary2028Member2023-10-310000047217hpq:USDollarGlobalNotesDueJanuary2033Member2024-01-310000047217hpq:USDollarGlobalNotesDueJanuary2033Member2023-10-310000047217hpq:USDollarGlobalNotesDueMarch2029Member2024-01-310000047217hpq:USDollarGlobalNotesDueMarch2029Member2023-10-310000047217hpq:USDollarGlobalNotesMember2024-01-310000047217hpq:USDollarGlobalNotesMember2023-10-310000047217srt:MinimumMemberhpq:OtherLongTermDebtMember2024-01-310000047217srt:MaximumMemberhpq:OtherLongTermDebtMember2024-01-310000047217hpq:OtherLongTermDebtMember2024-01-310000047217hpq:OtherLongTermDebtMember2023-10-310000047217us-gaap:CommercialPaperMember2024-01-310000047217us-gaap:RevolvingCreditFacilityMember2024-01-310000047217us-gaap:RevolvingCreditFacilityMemberhpq:A364DayRevolvingCreditFacilityMember2023-03-310000047217us-gaap:RevolvingCreditFacilityMemberhpq:A364DayRevolvingCreditFacilityMember2023-03-312023-03-310000047217us-gaap:LineOfCreditMember2024-01-310000047217us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-11-012024-01-310000047217us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-11-012023-01-310000047217us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-11-012024-01-310000047217us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-11-012023-01-310000047217us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-11-012024-01-310000047217us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-11-012023-01-310000047217us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-11-012024-01-310000047217us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-11-012023-01-310000047217hpq:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossAndNetPriorServiceCostCreditMember2023-11-012024-01-310000047217hpq:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossAndNetPriorServiceCostCreditMember2022-11-012023-01-310000047217hpq:AccumulatedDefinedBenefitPlansAdjustmentCurtailmentsSettlementsAndOtherMember2023-11-012024-01-310000047217hpq:AccumulatedDefinedBenefitPlansAdjustmentCurtailmentsSettlementsAndOtherMember2022-11-012023-01-310000047217us-gaap:AccumulatedTranslationAdjustmentMember2023-11-012024-01-310000047217us-gaap:AccumulatedTranslationAdjustmentMember2022-11-012023-01-310000047217us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-10-310000047217us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-10-310000047217us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-10-310000047217us-gaap:AccumulatedTranslationAdjustmentMember2023-10-310000047217us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-310000047217us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-310000047217us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-310000047217us-gaap:AccumulatedTranslationAdjustmentMember2024-01-310000047217hpq:Forsythetal.vs.HPInc.andHewlettPackardEnterpriseMember2016-08-182016-08-18hpq:age0000047217hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember2010-04-302010-05-100000047217hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember2012-04-110000047217hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember2012-12-112012-12-110000047217hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember2012-04-200000047217hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember2012-04-212012-04-210000047217hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember2013-01-242013-01-240000047217hpq:PhilipsPatentLitigationMember2020-09-012020-09-30hpq:patent0000047217hpq:PhilipsPatentLitigationMember2020-10-012020-10-310000047217hpq:CaltechPatentLitigationMember2021-03-192021-03-190000047217hpq:DynamicSecurityLitigationMember2020-12-012022-04-30hpq:claim0000047217hpq:DynamicSecurityLitigationMember2024-01-012024-01-310000047217hpq:AcquisitionOfAutonomyMemberhpq:AutonomyRelatedLegalMattersMember2015-04-172015-04-17hpq:subsidiary0000047217hpq:AcquisitionOfAutonomyMemberhpq:AutonomyRelatedLegalMattersMember2015-10-012015-10-010000047217hpq:MessrsLynchMemberhpq:AcquisitionOfAutonomyMemberhpq:AutonomyRelatedLegalMattersMember2015-10-012015-10-010000047217hpq:NokiaPatentLitigationMember2023-10-312023-10-310000047217hpq:NokiaPatentLitigationU.S.InternationalTradeCommissionMember2023-10-312023-10-310000047217hpq:NokiaPatentLitigationMember2023-11-012023-11-300000047217country:BRhpq:NokiaPatentLitigationMember2023-11-012023-11-300000047217srt:EuropeMemberhpq:R2SemiconductorLitigationMember2022-11-012022-11-300000047217hpq:AccessAdvancePatentPoolUnifiedPatentCourtMember2024-01-31hpq:member0000047217hpq:AccessAdvancePatentPoolUnifiedPatentCourtMemberhpq:DusseldorfGermanyMember2023-11-012024-01-31hpq:affiliate0000047217hpq:AccessAdvancePatentPoolUnifiedPatentCourtMemberhpq:MunichGermanyMember2023-11-012024-01-31
Use these links to rapidly review the document
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________
FORM 10-Q
(Mark One) 
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
January 31, 2024
Or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to            
Commission file number
1-4423
_________________________________________
HP INC.
(Exact name of registrant as specified in its charter)
Delaware94-1081436
(State or other jurisdiction of
incorporation or organization)
(I.R.S. employer
identification no.)
1501 Page Mill Road94304
Palo Alto,California(Zip code)
(Address of principal executive offices)
(650) 857-1501
(Registrant’s telephone number, including area code)
_______________________________________
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.01 per shareHPQNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer  ☐ Smaller reporting company ☐
                                 Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares of HP Inc. common stock outstanding as of January 31, 2024 was 980,731,959 shares.



HP INC. AND SUBSIDIARIES
Form 10-Q
For the Quarterly Period ended January 31, 2024
Table of Contents
In this report on Form 10-Q, for all periods presented, “we”, “us”, “our”, the “company”, the “Company”, “HP” and “HP Inc.” refer to HP Inc. (formerly Hewlett-Packard Company) and its consolidated subsidiaries.

2
Forward-Looking Statements
This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of Part I, contains forward-looking statements based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, they could affect the business and results of operations of HP Inc. and its consolidated subsidiaries (“HP”) which may differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including, but not limited to, any statements regarding the impact of the COVID-19 pandemic; projections of net revenue, margins, expenses, effective tax rates, net earnings, net earnings per share, cash flows, benefit plan funding, deferred taxes, share repurchases, foreign currency exchange rates or other financial items; any projections of the amount, timing or impact of cost savings or restructuring and other charges, planned structural cost reductions and productivity initiatives; any statements of the plans, strategies and objectives of management for future operations, including, but not limited to, our business model and transformation, our sustainability goals, our go-to-market strategy, the execution of restructuring plans and any resulting cost savings (including the Fiscal 2023 Plan (as defined below)), net revenue or profitability improvements or other financial impacts; any statements concerning the expected development, demand, performance, market share or competitive performance relating to products or services; any statements concerning potential supply constraints, component shortages, manufacturing disruptions or logistics challenges; any statements regarding current or future macroeconomic trends or events and the impact of those trends and events on HP and its financial performance; any statements regarding pending investigations, claims, disputes or other litigation matters; any statements of expectation or belief as to the timing and expected benefits of acquisitions and other business combination and investment transactions (including the acquisition of Plantronics, Inc. (“Poly”)); and any statements of assumptions underlying any of the foregoing. Forward-looking statements can also generally be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” and similar terms. Risks, uncertainties and assumptions that could affect our business and results of operations include factors relating to the impact of macroeconomic and geopolitical trends, changes and events, including the Russian invasion of Ukraine, tension across the Taiwan Strait, the Israel-Hamas conflict, other hostilities in the Middle East and the regional and global ramifications of these events; volatility in global capital markets and foreign currency, increases in benchmark interest rates, the effects of inflation and instability of financial institutions; risks associated with HP’s international operations; the effects of global pandemics, such as COVID-19, or other public health crises; the execution and performance of contracts by HP and its suppliers, customers, clients and partners, including logistical challenges with respect to such execution and performance; changes in estimates and assumptions HP makes in connection with the preparation of its financial statements; the need to manage (and reliance on) third-party suppliers, including with respect to supply constraints and component shortages, and the need to manage HP’s global, multi-tier distribution network and potential misuse of pricing programs by HP’s channel partners, adapt to new or changing marketplaces and effectively deliver HP’s services; HP’s ability to execute on its strategic plans, including the previously announced initiatives, business model changes and transformation; execution of planned structural cost reductions and productivity initiatives; HP’s ability to complete any contemplated share repurchases, other capital return programs or other strategic transactions; the competitive pressures faced by HP’s businesses; successfully innovating, developing and executing HP’s go-to-market strategy, including online, omnichannel and contractual sales, in an evolving distribution, reseller and customer landscape; the development and transition of new products and services and the enhancement of existing products and services to meet evolving customer needs and respond to emerging technological trends, including artificial intelligence; successfully competing and maintaining the value proposition of HP’s products, including supplies and services; challenges to HP’s ability to accurately forecast inventories, demand and pricing, which may be due to HP’s multi-tiered channel, sales of HP’s products to unauthorized resellers or unauthorized resale of HP’s products or our uneven sales cycle; integration and other risks associated with business combination and investment transactions; the results of our restructuring plans (including the Fiscal 2023 Plan), including estimates and assumptions related to the cost (including any possible disruption of HP’s business) and the anticipated benefits of our restructuring plans; the protection of HP’s intellectual property assets, including intellectual property licensed from third parties; the hiring and retention of key employees; disruptions in operations from system security risks, data protection breaches, cyberattacks, extreme weather conditions or other effects of climate change, and other natural or manmade disasters or catastrophic events; the impact of changes to federal, state, local and foreign laws and regulations, including environmental regulations and tax laws; our aspirations related to environmental, social and governance matters; potential impacts, liabilities and costs from pending or potential investigations, claims and disputes; our use of artificial intelligence; the effectiveness of our internal control over financial reporting; and other risks that are described herein, as well as the risks discussed in Item 1A “Risk Factors” of Part I in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023 and that are otherwise described or updated from time to time in HP’s other filings with the Securities and Exchange Commission (the “SEC”). HP’s Fiscal 2023 Plan includes HP's efforts to take advantage of future growth opportunities, including but not limited to, investments to drive growth, investments in our people, improving product mix, driving structural cost savings and other productivity measures. Structural cost savings represent gross reductions in costs driven by operational efficiency, digital transformation, and portfolio optimization. These initiatives include but are not limited to workforce reductions, platform simplification, programs consolidation and productivity measures undertaken by HP, which HP expects to be sustainable in the
3
longer-term. These structural cost savings are net of any new recurring costs resulting from these initiatives and exclude one-time investments to generate such savings. HP’s expectations on the longer-term sustainability of such structural cost savings are based on its current business operations and market dynamics and could be significantly impacted by various factors, including but not limited to HP’s evolving business models, future investment decisions, market environment and technology landscape. The forward-looking statements in this report are made as of the date of this filing and HP assumes no obligation and does not intend to update these forward-looking statements.
4
Part I. Financial Information

ITEM 1. Financial Statements and Supplementary Data.
Index
 Page
    

5
HP INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Earnings
(Unaudited)
 Three months ended January 31
 20242023
 In millions, except per share amounts
Net revenue:
Products
$12,419 $13,044 
Services766 754 
Total net revenue13,185 13,798 
Cost of net revenue:
Products
9,871 10,589 
Services426 422 
Total cost of net revenue10,297 11,011 
Gross margin2,888 2,787 
Research and development399 403 
Selling, general and administrative1,383 1,331 
Restructuring and other charges63 141 
Acquisition and divestiture charges27 84 
Amortization of intangible assets81 85 
Total operating expenses1,953 2,044 
Earnings from operations935 743 
Interest and other, net(142)(181)
Earnings before taxes793 562 
Provision for taxes(171)(93)
Net earnings$622 $469 
Net earnings per share:
Basic$0.63 $0.47 
Diluted$0.62 $0.47 
Weighted-average shares used to compute net earnings per share:
Basic995 989 
Diluted1,002 996 
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.

6
HP INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Comprehensive Income
(Unaudited)
 Three months ended January 31
 20242023
 In millions
Net earnings$622 $469 
Other comprehensive loss before taxes:
Change in unrealized components of available-for-sale debt securities:
Unrealized gains arising during the period4 4 
Change in unrealized components of cash flow hedges:
Unrealized losses arising during the period(162)(623)
Gains reclassified into earnings(159)(334)
(321)(957)
Change in unrealized components of defined benefit plans:
Losses arising during the period(10)(1)
Amortization of actuarial loss and prior service benefit2 — 
Curtailments, settlements and other— 1 
(8)— 
Change in cumulative translation adjustment20 29 
Other comprehensive loss before taxes(305)(924)
Benefit from taxes70 183 
Other comprehensive loss, net of taxes(235)(741)
Comprehensive income (loss)$387 $(272)
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
7
HP INC. AND SUBSIDIARIES
Consolidated Condensed Balance Sheets
(Unaudited)
 As of
 January 31, 2024October 31, 2023
 
In millions, except par value
ASSETS  
Current assets:  
Cash, cash equivalents and restricted cash$2,417 $3,232 
Accounts receivable, net of allowance for credit losses of $84 and $93, respectively
3,804 4,237 
Inventory6,928 6,862 
Other current assets3,709 3,646 
Total current assets16,858 17,977 
Property, plant and equipment, net2,807 2,827 
Goodwill8,610 8,591 
Other non-current assets7,571 7,609 
Total assets$35,846 $37,004 
LIABILITIES AND STOCKHOLDERS’ DEFICIT  
Current liabilities:  
Notes payable and short-term borrowings$359 $230 
Accounts payable13,255 14,046 
Other current liabilities10,243 10,212 
Total current liabilities23,857 24,488 
Long-term debt9,301 9,254 
Other non-current liabilities4,328 4,331 
Stockholders’ deficit:  
Preferred stock, $0.01 par value (300 shares authorized; none issued)
— — 
Common stock, $0.01 par value (9,600 shares authorized; 980 and 989 shares issued and outstanding at January 31, 2024 and October 31, 2023, respectively)
10 10 
Additional paid-in capital1,579 1,505 
Accumulated deficit(2,771)(2,361)
Accumulated other comprehensive loss(458)(223)
Total stockholders’ deficit(1,640)(1,069)
Total liabilities and stockholders’ deficit$35,846 $37,004 
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
8
HP INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Cash Flows
(Unaudited)
 Three months ended January 31
 20242023
In millions
Cash flows from operating activities:  
Net earnings$622 $469 
Adjustments to reconcile net earnings to net cash provided by operating activities:  
Depreciation and amortization205 209 
Stock-based compensation expense177 167 
Restructuring and other charges63 141 
Deferred taxes on earnings(5)(140)
Other, net(20)4 
Changes in operating assets and liabilities, net of acquisitions:  
Accounts receivable446 244 
Inventory(47)230 
Accounts payable(744)(1,731)
Net investment in leases(62)(16)
Taxes on earnings49 220 
Restructuring and other(87)(92)
Other assets and liabilities(476)279 
Net cash provided by (used in) operating activities
121 (16)
Cash flows from investing activities:  
Investment in property, plant and equipment, net(158)(192)
Purchases of available-for-sale securities and other investments— (4)
Maturities and sales of available-for-sale securities and other investments— 1 
Collateral posted for derivative instruments
(70)(240)
Net cash used in investing activities(228)(435)
Cash flows from financing activities:  
Proceeds from short-term borrowings with original maturities less than 90 days, net100 200 
Proceeds from debt, net of issuance costs92 52 
Payment of debt and associated costs(49)(539)
Stock-based award activities and others(76)(79)
Repurchase of common stock(500)(100)
Cash dividends paid(275)(259)
Collateral returned for derivative instruments
— (200)
Net cash used in financing activities(708)(925)
Decrease in cash, cash equivalents and restricted cash(815)(1,376)
Cash, cash equivalents and restricted cash at beginning of period3,232 3,145 
Cash, cash equivalents and restricted cash at end of period$2,417 $1,769 
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.
9
HP INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Stockholders’ Deficit
(Unaudited)
 Common StockAdditional
Paid-in Capital		 Accumulated
Other
Comprehensive Loss 		 Total Stockholders’ Deficit
Number of SharesPar ValueAccumulated Deficit
 In millions, except number of shares in thousands
Balance at October 31, 2023
988,782 $10 $1,505 $(2,361)$(223)$(1,069)
Net earnings— — — 622 — 622 
Other comprehensive loss, net of taxes— — — — (235)(235)
Comprehensive income— — — — — 387 
Issuance of common stock in connection with employee stock plans and other8,677 — (76)— — (76)
Repurchases of common stock (Note 10)(17,062)— (27)(487)— (514)
Cash dividends ($0.55 per common share)
— — — (545)— (545)
Stock-based compensation expense— — 177 — — 177 
Balance at January 31, 2024
980,397 $10 $1,579 $(2,771)$(458)$(1,640)

 Common StockAdditional
Paid-in Capital		 Accumulated
Other
Comprehensive Income (Loss) 		 Total Stockholders’ Deficit
Number of SharesPar ValueAccumulated Deficit
 In millions, except number of shares in thousands
Balance at October 31, 2022
979,869 $10 $1,172 $(4,492)$285 $(3,025)
Net earnings— — — 469 — 469 
Other comprehensive loss, net of taxes— — — — (741)(741)
Comprehensive loss— — — — — (272)
Issuance of common stock in connection with employee stock plans and other8,844 — (79)— — (79)
Repurchases of common stock (Note 10)(3,624)— (4)(96)— (100)
Cash dividends ($0.53 per common share)
— — — (518)— (518)
Stock-based compensation expense— — 167 — — 167 
Balance at January 31, 2023
985,089 $10 $1,256 $(4,637)$(456)$(3,827)
The accompanying notes are an integral part of these Consolidated Condensed Financial Statements.

10
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)
Note 1: Basis of Presentation
Basis of Presentation
The accompanying Consolidated Condensed Financial Statements of HP and its wholly-owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2023 in HP’s Annual Report on Form 10-K, filed on December 18, 2023. The Consolidated Condensed Balance Sheet for October 31, 2023 was derived from audited financial statements.
Principles of Consolidation
The Consolidated Condensed Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.
Reclassifications
HP has reclassified certain prior-year amounts to conform to the current-year presentation.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates.
Recently Adopted Accounting Pronouncements
In September 2022, the Financial Accounting Standards Board (“FASB”) issued guidance that enhances the transparency about the use of supplier finance programs. Under the new guidance, companies that use a supplier finance program in connection with the purchase of goods or services are required to disclose information about those programs to allow users of financial statements to understand the nature, activity during the period, changes from period to period, and potential magnitude. HP adopted this guidance in the first quarter of fiscal year 2024, except for the disclosure on roll forward information which will be adopted in fiscal year 2025, in line with the effective adoption dates prescribed by the FASB. See Note 6, “Supplementary Financial Information,” for additional disclosure related to HP’s supplier finance programs.
Recently Issued Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In November 2023, the FASB issued guidance that updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2025 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.

11
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Note 2: Segment Information
HP’s operations are organized into three reportable segments: Personal Systems, Printing, and Corporate Investments.
Personal Systems offers commercial and consumer desktops and notebooks, detachables and convertibles, workstations, thin clients, commercial mobility devices, retail point-of-sale (“POS”) systems, displays, hybrid systems, software, solutions and services. Personal Systems includes support and deployment, configurations and extended warranty services and maintains multi-operating system and multi-architecture strategies using Microsoft Windows and Google Chrome operating systems, and predominantly use processors from Intel Corporation (“Intel”) and Advanced Micro Devices, Inc. (“AMD”).
Personal Systems groups its global business capabilities into the following business units when reporting business performance:
•Commercial PS consists of devices and accessories, including workstations, thin clients, mobility devices and hybrid systems, for use by enterprise, public sector (which includes education), and small- and medium-sized business (“SMB”) customers. HP offers a range of services and solutions to commercial customers to help them manage the lifecycle of their personal computers (“PCs”) and mobility installed base. 
•Consumer PS consists of devices, accessories and services which are optimized for consumer usage, focusing on gaming, learning and working remotely, consuming multi-media for entertainment, managing personal life activities, sharing information, and staying connected informed and secure.
Printing offers consumer and commercial printer hardware, supplies, services and solutions. Printing is also focused on Graphics and 3D Printing and Personalization in the commercial and industrial markets. Our global business capabilities within Printing are described below:
•Office Printing Solutions delivers HP’s office printers, supplies, services, and solutions to SMBs, public sector and large enterprises. It also includes Original Equipment Manufacturer (“OEM”) hardware and solutions.
•Home Printing Solutions delivers innovative printing products, supplies, services and solutions for the home and home business.
•Graphics Solutions delivers large-format, commercial and industrial solutions and supplies to print service providers and packaging converters through a wide portfolio of printers and presses (HP DesignJet, HP Latex, HP Indigo and HP PageWide Web Presses).
•3D Printing & Personalization offers a portfolio of additive manufacturing solutions and supplies to help customers succeed in their additive and digital manufacturing journey. HP offers complete solutions in collaboration with an ecosystem of partners.
Printing groups its global business capabilities into the following business units when reporting business performance:
•Commercial Printing consists of office printing solutions, graphics solutions and 3D printing and personalization, excluding supplies;
•Consumer Printing consists of home printing solutions, excluding supplies; and
•Supplies comprises a set of highly innovative consumable products, ranging from ink and laser cartridges to media, graphics supplies and 3D printing and digital manufacturing supplies, for recurring use in consumer and commercial hardware.
Corporate Investments includes certain business incubation and investment projects.
HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges and amortization of intangible assets.
12
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Segment Operating Results and the reconciliation to HP consolidated results were as follows:
 Three months ended January 31
 20242023
In millions
Net revenue:
Commercial PS$6,045 $6,382 
Consumer PS2,764 2,803 
Personal Systems8,809 9,185 
Supplies2,863 2,857 
Commercial Printing1,227 1,388 
Consumer Printing285 367 
Printing4,375 4,612 
Corporate Investments2 1 
Total segment net revenue13,186 13,798 
Other(1)— 
Total net revenue$13,185 $13,798 
Earnings before taxes:
Personal Systems$537 $475 
Printing872 870 
Corporate Investments(37)(33)
Total segment earnings from operations1,372 1,312 
Corporate and unallocated costs and other(89)(92)
Stock-based compensation expense(177)(167)
Restructuring and other charges(63)(141)
Acquisition and divestiture charges(27)(84)
Amortization of intangible assets(81)(85)
Interest and other, net(142)(181)
Total earnings before taxes$793 $562 
Realignment
Effective at the beginning of its first quarter of fiscal year 2024, HP realigned its business unit financial reporting more closely with its customer market segmentation. The realignment resulted in the transfer of LaserJet printers net revenues from Consumer Printing to Commercial Printing. HP reflected this change to its business unit information in prior reporting periods on an as-if basis which resulted in the reclassification of net revenues from Consumer Printing to Commercial Printing. The reporting change had no impact to previously reported segment net revenue, consolidated net revenue, earnings from operations, net earnings or net earnings per share (“EPS”).
13
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)
Note 3: Restructuring and Other Charges
Summary of Restructuring Plans
HP’s restructuring activities summarized by plan were as follows:
Fiscal 2023 Plan
Severance and EERNon-labor
Other prior-year plans(1)
Total
In millions
Accrued balance as of October 31, 2023$88 $18 $2 $108 
Charges43 2 3 48 
Cash payments(63)(6)(3)(72)
Non-cash and other adjustments2 — (2)— 
Accrued balance as of January 31, 2024$70 $14 $— $84 
Total costs incurred to date as of January 31, 2024$445 $43 $869 $1,357 
Reflected in Consolidated Condensed Balance Sheets
Other current liabilities$70 $3 $— $73 
Other non-current liabilities$— $11 $— $11 
Accrued balance as of October 31, 2022$— $— $32 $32 
Charges122 9 — 131 
Cash payments(53)(4)(25)(82)
Non-cash and other adjustments(2)(5)1 (6)
Accrued balance as of January 31, 2023$67 $— $8 $75 
(1)     Primarily includes the fiscal 2020 plan along with other legacy plans, all of which are substantially complete. HP does not expect any further material activity associated with these plans.
Fiscal 2023 Plan
On November 18, 2022, HP’s Board of Directors approved the Future Ready Plan (the “Fiscal 2023 Plan”) intended to enable digital transformation, portfolio optimization and operational efficiency which HP expects will be implemented through fiscal year 2025. HP expects to reduce global headcount by approximately 4,000 to 6,000 employees. HP estimates that it will incur pre-tax charges of approximately $1.0 billion of which approximately $0.7 billion primarily in labor costs related to workforce reductions and the remaining costs will relate to non-labor actions and other charges.
Other charges
Other charges include non-recurring costs, including those as a result of information technology rationalization efforts and transformation program management costs, and are distinct from ongoing operational costs. These costs primarily relate to third-party professional services and other non-recurring costs. For the three months ended January 31, 2024, HP incurred $15 million of other charges. For the three months ended January 31, 2023, HP incurred $10 million of other charges.
14
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)
Note 4: Retirement and Post-Retirement Benefit Plans
The components of HP’s pension and post-retirement benefit (credit) cost recognized in the Consolidated Condensed Statements of Earnings were as follows:
 Three months ended January 31
 U.S. Defined Benefit PlansNon-U.S. Defined Benefit PlansPost- Retirement Benefit Plans
 202420232024202320242023
 In millions
Service cost$— $— $9 $9 $— $— 
Interest cost57 54 12 10 4 4 
Expected return on plan assets(61)(65)(13)(13)(4)(3)
Amortization and deferrals:
Actuarial loss (gain)7 5 — 1 (4)(4)
Prior service cost (credit)— — 2 1 (3)(3)
Net periodic benefit (credit) cost3 (6)10 8 (7)(6)
Settlement loss — — — 1 — — 
Total periodic benefit (credit) cost$3 $(6)$10 $9 $(7)$(6)
Employer Contributions and Funding Policy
HP’s policy is to fund its pension plans so that it makes at least the minimum contribution required by local government, funding and taxing authorities.
During fiscal year 2024, HP anticipates making contributions of approximately $45 million to its non-U.S. pension plans, approximately $31 million to its U.S. non-qualified plan participants and approximately $3 million to cover benefit claims under HP’s post-retirement benefit plans. During the three months ended January 31, 2024, HP contributed $11 million to its non-U.S. pension plans, paid $6 million to cover benefit payments to U.S. non-qualified plan participants and paid $2 million to cover benefit claims under HP’s post-retirement benefit plans.
HP’s pension and other post-retirement benefit costs and obligations depend on various assumptions. Differences between expected and actual returns on investments and changes in discount rates and other actuarial assumptions are reflected as unrecognized gains or losses, and such gains or losses are amortized to earnings in future periods. A deterioration in the funded status of a plan could result in a need for additional contributions or an increase in net pension and post-retirement benefit costs in future periods. Actuarial gains or losses are determined at the measurement date and amortized over the remaining service life for active plans or the life expectancy of plan participants for frozen plans.
Retirement Incentive Program
As part of the Fiscal 2023 Plan, HP announced a voluntary EER program for its U.S. employees in January 2023. Voluntary participation in the EER program was limited to employees at least 55 years old with 10 or more years of service at HP. Employees accepted into the EER program left HP on dates ranging from March 15, 2023 to October 31, 2023. The U.S. defined benefit pension plan was amended to provide that the EER benefit was to be paid from the plan for eligible electing EER participants. The retirement incentive benefit was calculated as a lump sum based on years of service at HP at the time of retirement, ranging from 20 to 52 weeks of pay. As a result of this retirement incentive, HP recognized a special termination benefit (“STB”) expense of $105 million for the year ended October 31, 2023 as a restructuring charge. This expense is the present value of all additional benefits that HP will distribute from the pension plan assets.
All employees participating in the EER program were offered the opportunity to continue health care coverage at the active employee contribution rates for up to 36 months following retirement, but not beyond age 65 when Medicare is available. In addition, HP provided up to $12,000 in employer credits under the Retirement Medical Savings Account program. HP recognized an additional STB expense of $34 million as restructuring and other charges for the year ended October 31, 2023 for the health care incentives.

15
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)
Note 5: Taxes on Earnings
Provision for Taxes
HP’s effective tax rate was 21.6% and 16.6% for the three months ended January 31, 2024 and 2023, respectively. The difference between the U.S. federal statutory tax rate of 21% and HP’s effective tax rate for the three months ended January 31, 2023 was primarily due to tax effects of favorable tax rates associated with certain earnings from HP's operations in lower-tax jurisdictions throughout the world.
During the three months ended January 31, 2023, HP recorded $56 million of net income tax benefits related to discrete items in the provision for taxes. These amounts included $30 million of income tax benefits related to restructuring charges, $14 million related to acquisition charges and $12 million of other net tax benefits. During the three months ended January 31, 2023, excess tax benefits associated with stock options, restricted stock units and performance-adjusted restricted stock units were immaterial.
Uncertain Tax Positions
As of January 31, 2024, the amount of gross unrecognized tax benefits was $1.2 billion, of which up to $828 million would affect HP’s effective tax rate if realized. Total gross unrecognized tax benefits increased by $20 million for the three months ended January 31, 2024. HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Consolidated Condensed Statements of Earnings. As of January 31, 2024 and 2023, HP had accrued $105 million and $73 million, respectively, for interest and penalties.
HP engages in continuous discussions and negotiations with taxing authorities regarding tax matters in various jurisdictions. HP expects complete resolution of certain tax years with various tax authorities within the next 12 months. HP believes it is reasonably possible that its existing gross unrecognized tax benefits may be reduced by $39 million within the next 12 months, affecting HP’s effective tax rate if realized.
HP is subject to income tax in the United States and approximately 60 other countries and is subject to routine corporate income tax audits in many of these jurisdictions. In addition, HP is subject to numerous ongoing audits by federal, state and foreign tax authorities. The Internal Revenue Service (“IRS”) is conducting an audit of HP’s 2018 and 2019 income tax returns.
16
HP INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Earnings (Continued)
(Unaudited)
Note 6: Supplementary Financial Information

Cash, cash equivalents and restricted cash
 As of
 January 31, 2024October 31, 2023
 In millions
Cash and cash equivalents$2,263 $3,107 
Restricted cash(1)
154 125 
$2,417 $3,232 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Accounts Receivable
The allowance for credit losses related to accounts receivable and changes were as follows:
 Three months ended January 31, 2024
 In millions
Balance at beginning of period$93 
Benefit of allowance for credit losses(6)
Deductions, net of recoveries(3)
Balance at end of period$84 
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Condensed Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Condensed Balance Sheets. The recourse obligations as of January 31, 2024 and October 31, 2023 were not material.
The following is a summary of the activity under these arrangements:
Three months ended January 31
 2024 2023
 In millions
Balance at beginning of period(1)
$141 $185 
Trade receivables sold3,298 3,679 
Cash receipts(3,232)(3,753)
Foreign currency and other5 17 
Balance at end of period(1)
$212 $128 
(1)    Amounts outstanding from third parties reported in Accounts receivable in the Consolidated Condensed Balance Sheets.

17
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)
Inventory
 As of
 January 31, 2024October 31, 2023
 In millions
Finished goods$3,603 $3,930 
Purchased parts and fabricated assemblies3,325 2,932 
$6,928 $6,862 

Other Current Assets
 As of
 January 31, 2024October 31, 2023
 In millions
Supplier and other receivables$1,419 $1,349 
Prepaid and other current assets1,376 1,445 
Value-added taxes receivable914 852 
$3,709 $3,646 

Property, Plant and Equipment, Net
 As of
 January 31, 2024October 31, 2023
 In millions
Land, buildings and leasehold improvements$2,348 $2,332 
Machinery and equipment, including equipment held for lease5,452 5,384 
7,800 7,716 
Accumulated depreciation(4,993)(4,889)
$2,807 $2,827 

Other Non-Current Assets
 As of
 January 31, 2024October 31, 2023
 In millions
Deferred tax assets$3,230 $3,155 
Intangible assets1,519 1,593 
Right-of-use assets1,165 1,188 
Deposits and prepaid412 427 
Prepaid pension and post-retirement benefit assets395 393 
Other850 853 
$7,571 $7,609 

18
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)
Other Current Liabilities
 As of
 January 31, 2024October 31, 2023
 In millions
Sales and marketing programs$2,920 $3,053 
Deferred revenue1,424 1,424 
Other accrued taxes1,071 994 
Employee compensation and benefit648 1,046 
Warranty572 569 
Operating lease liabilities459 430 
Tax liability282 217 
Other2,867 2,479 
$10,243 $10,212 

Other Non-Current Liabilities
 As of
 January 31, 2024October 31, 2023
In millions
Deferred revenue$1,373 $1,324 
Tax liability926 904 
Operating lease liabilities815 825 
Pension, post-retirement, and post-employment liabilities546 546 
Deferred tax liability31 44 
Other637 688 
$4,328 $4,331 

Interest and Other, Net
 Three months ended January 31
 2024 2023
 In millions
Interest expense on borrowings$(116)$(143)
Factoring costs(40)(32)
Loss on extinguishment of debt— (8)
Non-operating retirement-related credits4 11 
Other, net10 (9)
$(142)$(181)

19
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)
Net Revenue by Region
Three months ended January 31
 2024 2023
 In millions
Americas$5,408 $5,747 
Europe, Middle East and Africa4,668 4,636 
Asia-Pacific and Japan3,109 3,415 
Total net revenue$13,185 $13,798 
Value of Remaining Performance Obligations
As of January 31, 2024, the estimated value of transaction price allocated to remaining performance obligations was $3.8 billion. HP expects to recognize approximately $1.7 billion of the unearned amount in next 12 months and $2.1 billion thereafter.
HP has elected the practical expedients and accordingly does not disclose the aggregate amount of the transaction price allocated to remaining performance obligations if:
•the contract has an original expected duration of one year or less; or
•the revenue from the performance obligation is recognized over time on an as-invoiced basis when the amount corresponds directly with the value to the customer; or
•the portion of the transaction price that is variable in nature is allocated entirely to a wholly unsatisfied performance obligation.
The remaining performance obligations are subject to change and may be affected by various factors, such as termination of contracts, contract modifications and adjustment for currency.
Contract Liabilities
As of January 31, 2024 and October 31, 2023, HP’s contract liabilities balances were $2.8 billion and $2.7 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Consolidated Condensed Balance Sheets.
The increase in the contract liabilities balance for the three months ended January 31, 2024, was primarily driven by sales of fixed-price support and maintenance services, partially offset by $0.5 billion of revenue recognized that was included in the contract liabilities balance as of October 31, 2023.
Supplier Finance Programs
HP facilitates voluntary supplier finance programs to provide certain suppliers the opportunity to sell their right to HP’s payment obligations to participating financial institutions. Under this program, HP agrees to pay the participating financial institutions the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Participation by suppliers in these programs have no impact on the payment terms and amounts due from HP. HP does not have an economic interest in a supplier's participation in the program and is not a party to the agreement between the supplier and the financial institutions. In connection with these programs, HP does not pledge assets or other forms of guarantees as security for the committed payment to the participating financial institutions. HP pays a monthly service fee to a third-party administrator that provides the supplier finance platform and related support. HP and the participating financial institutions may terminate the agreement upon at least 30 days notice. As of January 31, 2024 and October 31, 2023, HP had $5.3 billion and $6.6 billion respectively, in obligations outstanding (i.e., unpaid invoices) that were confirmed as valid under the supplier finance programs. Of the amounts confirmed as valid under the program and outstanding, the amounts owed to participating financial institutions were $0.7 billion and $0.9 billion as of January 31, 2024 and October 31, 2023, respectively. These obligations are included within the Accounts payable line item of HP’s Consolidated Condensed Balance Sheet.

20
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)
Note 7: Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
Fair Value Hierarchy
HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
Level 3—Unobservable inputs for the asset or liability.
The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.
    The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:
 As of January 31, 2024As of October 31, 2023
 Fair Value Measured UsingFair Value Measured Using
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
 In millions
Assets:        
Cash Equivalents:        
Corporate debt$— $502 $— $502 $— $589 $— $589 
Government debt(1)
1,029 — — 1,029 1,900 — — 1,900 
Available-for-Sale Investments:
Financial institution instruments— 3 — 3 — 3 — 3 
Marketable securities and mutual funds
43 49 — 92 33 45 — 78 
Derivative Instruments:     
Foreign currency contracts— 212 — 212 — 489 — 489 
Other derivatives— 2 — 2 — — — — 
Total assets$1,072 $768 $— $1,840 $1,933 $1,126 $— $3,059 
Liabilities:        
Derivative Instruments:        
Interest rate contracts$— $43 $— $43 $— $58 $— $58 
Foreign currency contracts— 248 — 248 — 212 — 212 
Other derivatives— — — — — 2 — 2 
Total liabilities$— $291 $— $291 $— $272 $— $272 
(1)    Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds. Money market funds invested in government debt and traded in active markets are included in Level 1.
21
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Valuation Techniques
Cash Equivalents and Investments: HP holds time deposits, money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.
Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 8, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.
Other Fair Value Disclosures
Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Consolidated Condensed Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $9.3 billion as compared to its carrying amount of $9.7 billion at January 31, 2024. The fair value of HP’s short- and long-term debt was $8.5 billion as compared to its carrying value of $9.5 billion at October 31, 2023. If measured at fair value in the Consolidated Condensed Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.
Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Consolidated Condensed Balance Sheets, the carrying amounts approximate fair value due to their short maturities. If measured at fair value in the Consolidated Condensed Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.
Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Consolidated Condensed Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.

22
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Note 8: Financial Instruments
Cash Equivalents and Available-for-Sale Investments
 As of January 31, 2024As of October 31, 2023
 CostGross Unrealized GainGross Unrealized LossFair ValueCostGross Unrealized GainGross Unrealized LossFair Value
 In millions
Cash Equivalents:        
Corporate debt$502 $— $— $502 $589 $— $— $589 
Government debt1,029 — — 1,029 1,900 — — 1,900 
Total cash equivalents1,531 — — 1,531 2,489 — — 2,489 
Available-for-Sale Investments:     
Financial institution instruments3 — — 3 3 — — 3 
Marketable securities and mutual funds
40 52 — 92 40 38 — 78 
Total available-for-sale investments43 52 — 95 43 38 — 81 
Total cash equivalents and available-for-sale investments$1,574 $52 $— $1,626 $2,532 $38 $— $2,570 
All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of January 31, 2024 and October 31, 2023, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.
Contractual maturities of investments in available-for-sale debt securities were as follows:
 As of January 31, 2024
 Amortized CostFair Value
 In millions
Due in one year$3 $3 
Non-marketable equity securities in privately held companies are included in Other non-current assets in the Consolidated Condensed Balance Sheets. These amounted to $108 million and $111 million as of January 31, 2024 and October 31, 2023, respectively.
HP determines credit losses on cash equivalents and available-for-sale debt securities at the individual security level. All instruments are considered investment grade. No credit-related or noncredit-related impairment losses were recorded for the three months ended January 31, 2024.
Derivative Instruments
HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets.
23
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates from contractually established thresholds. The Company includes gross collateral posted and received in other current assets and other current liabilities in the Consolidated Condensed Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $119 million and $91 million as of January 31, 2024 and as of October 31, 2023, respectively, all of which were fully collateralized within two business days.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of January 31, 2024 and October 31, 2023.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts, option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted net revenue, cost of revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
During the three months ended January 31, 2024 and 2023, no portion of the hedging instruments’ gain or loss was excluded from the assessment of effectiveness for fair value and cash flow hedges.
Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:
24
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

 As of January 31, 2024As of October 31, 2023
 Outstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current LiabilitiesOutstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current Liabilities
 In millions
Derivatives designated as hedging instruments     
Fair value hedges:     
Interest rate contracts$750 $— $— $— $43 $750 $— $— $— $58 
Cash flow hedges:
Foreign currency contracts15,282 173 28 182 59 15,278 410 70 147 52 
Total derivatives designated as hedging instruments16,032 173 28 182 102 16,028 410 70 147 110 
Derivatives not designated as hedging instruments    
Foreign currency contracts3,926 11 — 7 — 4,446 9 — 13 — 
Other derivatives130 2 — — — 125 — — 2 — 
Total derivatives not designated as hedging instruments4,056 13 — 7 — 4,571 9 — 15 — 
Total derivatives$20,088 $186 $28 $189 $102 $20,599 $419 $70 $162 $110 
Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of January 31, 2024 and October 31, 2023, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Condensed Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
 Gross Amount
Recognized		Gross Amount
Offset		Net Amount
Presented		Derivatives
Financial
Collateral		 Net Amount
 In millions
As of January 31, 2024       
Derivative assets$214 $— $214 $170 $40 (1)$4 
Derivative liabilities$291 $— $291 $170 $109 (2)$12 
As of October 31, 2023       
Derivative assets$489 $— $489 $178 $291 (1)$20 
Derivative liabilities$272 $— $272 $178 $89 (2)$5 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Effect of Derivative Instruments in the Consolidated Condensed Statements of Earnings
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:
25
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Derivative InstrumentHedged ItemLocationYearTotal amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recordedGain/(loss) recognized in earnings on derivative instrumentsGain/(loss) recognized in earnings on hedged item
In millions
Three months ended January 31
Interest rate contractFixed-rate debtInterest and other, net2024$(142)$15 $(15)
2023$(181)$14 $(14)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:
Three months ended January 31
20242023
In millions
Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:
Foreign currency contracts$(162)$(623)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
Total amounts of income/(expense) line items in the statement of financial performance in which the effects of cash flow hedges are recordedGain/(loss) reclassified from Accumulated 
other comprehensive (loss) income into earnings
Three months ended January 31Three months ended January 31
2024202320242023
In millions
Net revenue$13,185 $13,798 $199 $386 
Cost of revenue(10,297)(11,011)(40)(54)
Operating expenses(1,953)(2,044)(3)(1)
Interest and other, net(142)(181)3 3 
Total$159 $334 
As of January 31, 2024, HP expects to reclassify an estimated accumulated other comprehensive loss of $33 million, net of taxes, to earnings within the next twelve months associated with cash flow hedges along with the earnings effects of the related forecasted transactions. The amounts ultimately reclassified into earnings could be different from the amounts previously included in Accumulated other comprehensive (loss) income based on the change of market rate, and therefore could have different impact on earnings.
26
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Condensed Statements of Earnings as follows:
Gain/(loss) recognized in earnings on derivative instrument
 Three months ended January 31
 Location20242023
  In millions
Foreign currency contractsInterest and other, net$1 $(44)
Other derivativesInterest and other, net4 6 
Total $5 $(38)

27
HP INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Earnings (Continued)
(Unaudited)
Note 9: Borrowings
Notes Payable and Short-Term Borrowings
 As of January 31, 2024As of October 31, 2023
 Amount
Outstanding		Weighted-Average
Interest Rate		Amount
Outstanding		Weighted-Average
Interest Rate
 In millions
Commercial Paper$100 5.5 %$— — %
Current portion of long-term debt193 5.9 %179 6.0 %
Notes payable to banks, lines of credit and other66 1.2 %51 1.0 %
$359  $230  
Long-Term Debt
 As of
 January 31, 2024October 31, 2023
 In millions
U.S. Dollar Global Notes(1)
  
$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041
$1,199 $1,199 
$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025
1,149 1,149 
$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027
999 999 
$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030
503 503 
$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026
521 521 
$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031(2)
997 997 
$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029
999 999 
$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032
676 676 
$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028
899 899 
$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033
1,097 1,097 
$500 issued at par at a price of 100% at 4.75%, due March 2029
3 3 
9,042 9,042 
Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030
549 506 
Fair value adjustment related to hedged debt(43)(58)
Unamortized debt issuance cost(54)(57)
Current portion of long-term debt(193)(179)
Total long-term debt$9,301 $9,254 
(1)HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.
(2)HP allocated an amount equal to the net proceeds to finance or refinance, in whole or in part, environmentally and socially responsible eligible projects in the following eight areas: renewable energy; green buildings; energy efficiency; clean transportation; pollution prevention and control; eco-efficient and/or circular economy products, production technologies and processes; environmentally sustainable management of living natural resources and land use; and socioeconomic advancement and empowerment.

As disclosed in Note 8, “Financial Instruments,” HP uses interest rate swaps to mitigate some of the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates. Interest rates shown in the table of long-term debt have not been adjusted to reflect the impact of any interest rate swaps.
Commercial Paper
As of January 31, 2024, HP maintained a U.S. commercial paper program for the issuance of U.S. dollar-denominated commercial paper up to a maximum aggregate principal amount of $6.0 billion. The principal amount outstanding under this program and certain short-term borrowings at any time cannot exceed a $6.0 billion authorization by HP’s Board of Directors.

28
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Credit Facilities
As of January 31, 2024, HP maintained a $5.0 billion sustainability-linked senior unsecured committed revolving credit facility, which HP entered into in May 2021, and a $1.0 billion senior unsecured committed 364-day revolving credit facility, which HP entered into in March 2023. Commitments under the $5.0 billion revolving credit facility will be available until May 26, 2026 and commitments under the $1.0 billion 364-day revolving credit facility will be available until March 19, 2024. Commitment fees, interest rates and other terms of borrowing under the revolving credit facilities vary based on HP’s external credit ratings and, for the $5.0 billion facility, certain sustainability metrics. Funds borrowed under the revolving credit facilities may be used for general corporate purposes.
As of January 31, 2024, HP was in compliance with the covenants in the credit agreements governing the revolving credit facilities.
Available Borrowing Resources
As of January 31, 2024, HP had available borrowing resources of $1.0 billion from uncommitted lines of credit in addition to the full capacity of the revolving credit facilities.

29
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Note 10: Stockholders’ Deficit
Share Repurchase Program
HP’s share repurchase program authorizes both open market and private repurchase transactions. During the three months ended January 31, 2024, HP executed share repurchases of 17.1 million shares and settled total shares for $0.5 billion. Share repurchases executed during the three months ended January 31, 2024 included 0.3 million shares settled in February 2024. During the three months ended January 31, 2023, HP executed share repurchases of 3.6 million shares and settled total shares for $0.1 billion.
The shares repurchased during the three months ended January 31, 2024 and 2023 were all open market repurchase transactions. As of January 31, 2024, HP had approximately $1.5 billion remaining under the share repurchase authorizations approved by HP’s Board of Directors.

Taxes related to Other Comprehensive Income (Loss)
 Three months ended January 31
 20242023
 In millions
Tax effect on change in unrealized components of available-for-sale debt securities:  
Tax provision on unrealized gains arising during the period$— $(1)
Tax effect on change in unrealized components of cash flow hedges: 
Tax benefit on unrealized losses arising during the period36 106 
Tax provision on gains reclassified into earnings32 78 
68 184 
Tax effect on change in unrealized components of defined benefit plans:  
Tax benefit on losses arising during the period2 — 
2 — 
Tax benefit on other comprehensive loss$70 $183 

30
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Changes and reclassifications related to Other Comprehensive Loss, net of taxes
 Three months ended January 31
 20242023
 In millions
Other comprehensive loss, net of taxes:
Change in unrealized components of available-for-sale debt securities:
Unrealized gains arising during the period$4 $3 
Change in unrealized components of cash flow hedges:
Unrealized losses arising during the period(126)(517)
Gains reclassified into earnings(127)(256)
(253)(773)
Change in unrealized components of defined benefit plans:
Losses arising during the period(8)(1)
Amortization of actuarial loss and prior service benefit(1)
2 — 
Curtailments, settlements and other— 1 
(6)— 
Change in cumulative translation adjustment20 29 
Other comprehensive loss, net of taxes$(235)$(741)
(1)These components are included in the computation of net pension and post-retirement benefit (credit) charges in Note 4, “Retirement and Post-Retirement Benefit Plans”.

The components of Accumulated other comprehensive loss, net of taxes and changes were as follows:
 Three months ended January 31, 2024
 Net unrealized
gains (losses) on
available-for-sale debt
securities		Net unrealized gains (losses) on cash
flow hedges		Unrealized
components
of defined
benefit plans		Change in cumulative
translation
adjustment		Accumulated
other
comprehensive loss
 In millions
Balance at beginning of period$7 $230 $(437)$(23)$(223)
Other comprehensive gains (losses) before reclassifications4 (126)(8)20 (110)
Reclassifications of gain into earnings— (127)2 — (125)
Balance at end of period$11 $(23)$(443)$(3)$(458)

31
HP INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Earnings (Continued)
(Unaudited)
Note 11: Earnings Per Share
HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.
A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:
 Three months ended January 31
 20242023
 In millions, except per share amounts
Numerator:
Net earnings$622 $469 
Denominator:
Weighted-average shares used to compute basic net EPS995 989 
Dilutive effect of employee stock plans7 7 
Weighted-average shares used to compute diluted net EPS1,002 996 
Net earnings per share:
Basic$0.63 $0.47 
Diluted$0.62 $0.47 
Anti-dilutive weighted-average stock-based compensation awards(1)
6 7 
(1)HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent unrecognized compensation cost.

Note 12: Litigation and Contingencies
HP is involved in lawsuits, claims, investigations and proceedings, including those identified below, consisting of IP, commercial, securities, employment, employee benefits and environmental matters that arise in the ordinary course of business. HP accrues a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. HP believes it has recorded adequate provisions for any such matters and, as of January 31, 2024, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.
Litigation, Proceedings and Investigations
Copyright Levies.  Proceedings are ongoing or have been concluded involving HP in certain European countries, challenging the imposition or the modification of levies regimes upon IT equipment (such as PCs or printers) or the restrictions to exonerate the application of private copying levies on devices purchased by business users. The levies are generally based upon the number of products sold and the per-product amounts of the levies, which vary. Some European countries are expected to implement legislation to introduce or extend existing levy schemes to digital devices. HP, other companies and various industry associations have opposed the extension of levies to the digital product and certain requirements for business sales exemptions and have advocated alternative models of compensation to rights holders.
32
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Based on the exemption of levies on business sales and industry opposition to increasing levies to digital products, HP’s assessments of the merits of various proceedings and HP’s estimates of the number of units impacted and the amounts of the levies, HP has accrued amounts that it believes are adequate to address the ongoing disputes.
Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise. This is a purported class and collective action filed on August 18, 2016 in the United States District Court, Northern District of California, against HP and Hewlett Packard Enterprise (“HPE”) alleging the defendants violated federal and state law by terminating older workers and replacing them with younger workers. In their most recent complaint, plaintiffs seek to represent (1) a putative nationwide federal Age Discrimination in Employment Act (ADEA) collective comprised of all former HP Inc. employees 40 years of age and older who had their employment terminated under a WFR plan in or after 2014 or 2015, depending on state law; and (2) a putative Rule 23 class under California law comprised of all former HP Inc. employees 40 years of age and older who had their employment terminated in California under a WFR plan in or after 2012. Excluded from the putative collective and class are employees who (a) signed a Waiver and General Release Agreement at termination, or (b) signed an Agreement to Arbitrate Claims. Similar claims are pending against HPE. Because the court granted plaintiffs’ motion for preliminary certification of the putative nationwide ADEA collectives, a third-party administrator notified eligible former employees of their right to opt into the ADEA collective. This opt-in period closed on February 15, 2022. Plaintiffs seek monetary damages, punitive damages, and other relief. In June 2023, the parties reached an agreement in principle to resolve this matter. The parties have finalized a settlement agreement, and the court preliminarily approved it on October 26, 2023. The Court has set the Final Approval Hearing for March 28, 2024.
India Directorate of Revenue Intelligence Proceedings. On April 30 and May 10, 2010, the India Directorate of Revenue Intelligence (the “DRI”) issued show cause notices to Hewlett-Packard India Sales Private Limited (“HP India”), a subsidiary of HP, seven HP India employees and one former HP India employee alleging that HP India underpaid customs duties while importing products and spare parts into India and seeking to recover an aggregate of approximately $370 million, plus penalties and interest. Prior to the issuance of the notices, HP India deposited approximately $16 million with the DRI and agreed to post a provisional bond in exchange for the DRI’s agreement to not seize HP India products and spare parts or interrupt business by HP India.
On April 11, 2012, the Bangalore Commissioner of Customs issued an order on the products-related notice affirming certain duties and penalties against HP India and the named individuals of approximately $386 million, of which HP India had already deposited $9 million. On December 11, 2012, HP India voluntarily deposited an additional $10 million in connection with the products-related notice. The differential duty demand is subject to interest. On April 20, 2012, the Commissioner issued an order on the parts-related notice affirming certain duties and penalties against HP India and certain of the named individuals of approximately $17 million, of which HP India had already deposited $7 million. After the order, HP India deposited an additional $3 million in connection with the parts-related notice so as to avoid certain penalties.
HP India filed appeals of the Commissioner’s orders before the Customs, Excise and Service Tax Appellate Tribunal (the “Customs Tribunal”) along with applications for waiver of the pre-deposit of remaining demand amounts as a condition for hearing the appeals. The Customs Department has also filed cross-appeals before the Customs Tribunal. On January 24, 2013, the Customs Tribunal ordered HP India to deposit an additional $24 million against the products order, which HP India deposited in March 2013. On February 7, 2014, the Customs Tribunal granted HP India’s application for extension of the stay of deposit until disposal of the appeals. On October 27, 2014, the Customs Tribunal commenced hearings on the cross-appeals of the Commissioner’s orders and rejected HP India’s request to remand the matter to the Commissioner on procedural grounds. The Customs Tribunal cancelled hearings to reconvene in 2015, 2016 and January 2019. On January 20, 2021, the Customs Tribunal held a virtual hearing during which the judge allowed HP’s application for a physical hearing on the merits as soon as practicable, which will be scheduled when physical hearings resume at court. Pursuant to the separation and distribution agreement, Hewlett Packard Enterprise has agreed to indemnify HP in part, based on the extent to which any liability arises from the products and spare parts of Hewlett Packard Enterprise’s businesses.
Philips Patent Litigation. In September 2020, Koninklijke Philips N.V. and Philips North America LLC (collectively, “Philips”) filed a complaint against HP for patent infringement in federal court for the District of Delaware and filed a companion complaint with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP and 8 other sets of respondents. Both complaints allege that certain digital video-capable devices and components thereof infringe four of Philips’ patents. In October 2020, the ITC instituted an investigation, and Philips later withdrew two of the four patents. On March 23, 2022, the ITC rendered a final determination that no violation of Section 337 has occurred. Philips did not appeal and elected to resume litigation with its case in federal court. Philips seeks unspecified damages and an injunction against HP, and the prior stay has been lifted. On August 10, 2023, HP filed a motion for summary judgment of indefiniteness for all asserted claims.
33
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Caltech Patent Litigation. On November 11, 2020, the California Institute of Technology (“Caltech”) filed a complaint against HP for patent infringement in the federal court for the Western District of Texas. On March 19, 2021, Caltech filed an amendment to this same complaint. The complaint as amended alleges infringement of five of Caltech’s patents, U.S. Patent Nos. 7,116,710; 7,421,032; 7,716,552; 7,916,781; and 8,284,833. The accused products are HP commercial and consumer PCs as well as wireless printers that comply with the IEEE 802.11n, 802.11ac, and/or 802.11ax standards. Caltech seeks unspecified damages and other relief. In August 2021, the court stayed the case pending the decision in related cases brought by Caltech against Apple and Broadcom. On November 6, 2023, the court issued an order maintaining the stay of all discovery and deadlines pending discovery relating to whether Caltech has standing to bring suit with respect to the asserted patents and the court’s resolution of that issue. A hearing concerning Caltech’s standing is scheduled for May 2024.
York County on behalf of the County of York Retirement Fund v. HP Inc., et al., and related proceedings. On November 5, 2020, York County, on behalf of the County of York Retirement Fund, filed a putative class action complaint against HP, Dion Weisler, and Catherine Lesjak in federal court in the Northern District of California. The court appointed Maryland Electrical Industry Pension Fund as Lead Plaintiff. Lead Plaintiff filed a consolidated complaint, which additionally names as defendants Enrique Lores and Richard Bailey. The complaint alleges, among other things, that from November 5, 2015 to June 21, 2016, HP and the named current and former officers violated Sections 10(b) and 20(a) of the Exchange Act by concealing material information and making false statements about HP’s printing supplies business. Plaintiffs seek compensatory damages and other relief. HP and the named officers filed a motion to dismiss the complaint for failure to state a claim upon which relief can be granted. On March 3, 2022, the court granted the motion to dismiss with prejudice. Plaintiffs appealed the decision. On April 11, 2023, the appellate court reversed the district court’s decision and remanded the case to the district court for further proceedings consistent with the appellate opinion, including consideration of HP’s other arguments for dismissal. On June 27, 2023, the district court issued an order setting the briefing schedule for a renewed motion to dismiss. On May 17, 2021, stockholder Scott Franklin filed a derivative complaint against certain current and former officers and directors in federal court in the District of Delaware. Plaintiff purports to bring the action on behalf of HP, which he has named as a nominal defendant, and he makes substantially the same factual allegations as in the York County securities complaint, bringing claims for breach of fiduciary duty and violations of securities laws. The derivative plaintiff seeks compensatory damages, governance reforms, and other relief. By court order following stipulations by the parties, the case was transferred to the Northern District of California, and the case was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. On January 13, 2022, stockholder Gerald Lovoi filed a derivative complaint in federal court in the Northern District of California against the same current and former officers and directors named in the Franklin action. The complaint alleges the same basic claims based on the same alleged conduct as the Franklin action and seeks similar relief. By stipulation of the parties, the Lovoi action was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. Both derivative actions will remain stayed while the district court considers on remand HP’s other arguments for dismissal.
34
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Legal Proceedings re Authentication of Supplies. Since 2016, HP has from time to time been named in civil litigation, or been the subject of government investigations, involving supplies authentication protocols used in certain HP printers in multiple geographies, including but not limited to the United States, Italy, Israel, the Netherlands, Australia and New Zealand. The supplies authentication protocols are often referred to as Dynamic Security. The core allegations in these proceedings claim misleading or inadequate consumer notifications and permissions pertaining to the use of Dynamic Security, the installation of firmware updates, or the potential inability of cartridges with clone chips or circuitry to work in HP printers with Dynamic Security. Plaintiffs base or have based their claims on various legal theories, including but not limited to unfair competition, computer trespass, and similar statutory claims. Among other relief, Plaintiffs have sought or seek money damages and in certain cases have or may seek injunctive relief against the use or operation of Dynamic Security or relief requiring interoperability. If HP is not successful in its defense of these cases or investigations, it could be subject to damages, penalties, significant settlement demands, or injunctive relief that may be costly or may disrupt operations. Certain of these proceedings in Italy, the Netherlands, Israel, Australia and New Zealand have been resolved, have concluded, or have concluded subject only to HP’s pending appeal. Civil litigation filed by Digital Revolution B.V. (trading as 123Inkt) against HP Nederlands B.V., et al. (Netherlands) in March 2020, including its competition claim, remains pending. Both parties have appealed. In addition, two putative class actions have been filed against HP in federal court in California, in December 2020, April 2022, and one in federal court in Illinois, in January 2024, arising out of the use of Dynamic Security firmware updates in HP Laserjet printers, in HP Inkjet printers, and in both, respectively. Plaintiffs in these cases seek compensatory damages, restitution, injunctive relief against alleged unfair and anticompetitive business practices, and other relief. In the case directed to Laserjet printers, plaintiffs filed a motion for class certification, and, on December 8, 2023, the court entered an order denying in full plaintiffs’ request to certify a damages class and granting certification of a narrowed injunctive relief class composed of those who did not see HP’s disclosures. In its order, the court declined at this juncture to resolve the merits of the sufficiency of HP’s disclosures. The other cases are in their early stages.
Autonomy-Related Legal Proceedings.
As the result of an internal investigation, HP obtained information about certain accounting improprieties, disclosure failures and misrepresentations at Autonomy that occurred before and in connection with its 2011 acquisition of Autonomy. On April 17, 2015, four former HP subsidiaries that became subsidiaries of Hewlett Packard Enterprise at the time of the Separation (Autonomy Corporation Limited, Hewlett Packard Vision BV, Autonomy Systems, Limited, and Autonomy, Inc.) initiated civil proceedings in the U.K. High Court of Justice against two members of Autonomy’s former management, Michael Lynch and Sushovan Hussain, for breach of their fiduciary duties in causing Autonomy group companies to engage in improper transactions and accounting practices. The claims seek more than $5 billion in damages. Messrs. Lynch and Hussain filed defenses and Mr. Lynch filed a counterclaim seeking $160 million in damages for alleged misstatements regarding Lynch. Trial concluded in January 2020. On May 17, 2022, the court issued its final judgment, finding that HP succeeded on substantially all claims and that Messrs. Lynch and Hussein engaged in fraud, and dismissing Mr. Lynch’s counterclaim. The court deferred its damages ruling to a later, separate judgment to be issued after further proceedings, which began on February 12, 2024, but indicated that damages awarded may be substantially less than is claimed. Litigation is unpredictable, and there can be no assurance that HP will recover damages or as to how any award of damages will compare with the amount claimed. The amount ultimately awarded, if any, would be recorded in the period received. No adjustment has been recorded in the financial statements in relation to this potential award. Pursuant to the terms of the separation and distribution agreement, HP and Hewlett Packard Enterprise will share equally in any recovery. In addition, Messrs. Hussein and Lynch, and Stephen Chamberlain, former VP of Finance of Autonomy, were each indicted on federal criminal charges in the Northern District of California. On April 30, 2018, a jury found Mr. Hussein guilty of conspiracy to commit wire fraud, securities fraud, and multiple counts of wire fraud, and that judgment was affirmed on appeal in August 2020. Messrs. Lynch and Chamberlain are set to face trial on charges of conspiracy to commit wire fraud, and multiple counts of wire fraud on March 18, 2024. HP is continuing to cooperate with the ongoing enforcement actions.
35
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Nokia Patent Litigation. On October 31, 2023, Nokia filed a complaint for patent infringement against HP in federal court for the District of Delaware asserting ten patents and filed two companion complaints with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP, asserting seven of the ten patents asserted in the federal court case. The complaints allege that HP products that are compliant with certain video coding technology standards, including Advanced Video Coding (H.264) or High Efficiency Video Coding (H.265) standards, infringe Nokia’s patents. In November 2023, the ITC instituted investigations on Nokia’s complaints. On December 11, 2023, HP filed counterclaims against Nokia in the Delaware action, including claims that Nokia violated its commitments to license standard-essential patents on fair, reasonable, and non-discriminatory (“FRAND”) terms, and seeking a court determination of the proper FRAND rate. Nokia’s patent litigation against HP also includes a lawsuit filed in November 2023 against HP and six of its subsidiaries in the European Unified Patent Court in Germany, 2 lawsuits filed in November 2023 but served in January 2024 against HP and its German subsidiary in state court in Munich, Germany, and a lawsuit filed on December 1, 2023, against a subsidiary, HP Brasil Indústria e Comércio de Equipamentos Eletrônicos Ltda. (“HP Brazil”), in the state court in Rio de Janeiro in Brazil. In Brazil, Nokia alleged that HP’s products contain “skip mode” technology compatible with H.264 video standards that infringes one of Nokia’s Brazilian patents. On December 4, 2023, before HP had received service of the lawsuit, the court granted Nokia an ex parte preliminary injunction against HP Brazil’s commercialization of such products in Brazil. HP has appealed the injunction and asked the appellate court to suspend its enforcement. If the court does not do so, the injunction in Brazil will take effect and remain in place unless overturned on appeal, until the state court revokes or modifies it, or the case is resolved. If HP is not successful in its defenses, it may be subject to injunctions, orders to recall products in Germany and other EU countries, or licensing demands to avoid potential disruptions to its business. On January 31, 2024, HP Brazil filed the non-infringement defense and a patent nullity action against Nokia. Given the procedural posture and nature of these cases, including proceedings that are in their early stages and have significant factual and legal issues to be resolved, HP is unable to make a reasonable estimate of the potential loss or range of losses that may arise from these matters.
R2 Semiconductor Litigation. In November 2022, R2 Semiconductor, Inc. (“R2”) filed a lawsuit in the Dusseldorf Regional Court in Germany against Intel Deutschland GmbH, HP Deutschland GmbH and certain other Intel customers. R2 asserts one European patent is infringed by HP’s products that contain certain Intel processors. R2 seeks an injunction prohibiting the sale of the alleged infringing products. Intel is indemnifying HP subject to certain limitations in the parties’ agreement. The Dusseldorf Regional Court conducted a trial on December 7, 2023 and issued an adverse judgment on February 7, 2024. The Court’s judgment imposes an injunction prohibiting sales of the accused products in Germany, an order to stop all other infringing actions, and an order to issue a communication to commercial customers recalling the relevant products sold since March 5, 2020, which could take effect upon notice of R2’s payment of the required sureties and remain in place unless stayed or overturned on appeal or the parties reach an agreement. On February 8, 2024, HP filed an appeal and request for a stay of the judgment pending appeal. Given the procedural posture, the nature of the case, and the relationship with Intel, HP is unable to make a reasonable estimate of the potential loss or range of losses that might arise from this lawsuit and that would not be indemnifiable by Intel.
Litigation with Access Advance Patent Pool regarding video codecs. Access Advance LLC (“Access Advance”) is an independent licensing administrator formed to license allegedly essential patents for standards-based video codecs, which it licenses through various licensing pools. In late 2023, members of Access Advance’s HEVC Advance patent pool launched a patent litigation campaign against HP in Germany and Europe. To date, three pool members, Dolby, Mitsubishi Electric (“Mitsubishi”) and Konikijke Philips N.V. (“Philips”) have each filed patent infringement lawsuits against HP and various affiliates. Specifically, Dolby filed a lawsuit against HP and 14 affiliates in the new Unified Patent Court (UPC) in Düsseldorf, and Mitsubishi and Philips each filed a lawsuit against HP and two affiliates in the State Court in Munich, Germany. The complaints allege that HP products that are compliant with the High Efficiency Video Coding (H.265) standard infringe the pool members' respective patents, seek an injunction, and allege that HP has failed to act as a willing licensee of HEVC essential patents based on HP's negotiations with Access Advance. If HP is not successful in its defenses in these suits, it may be subject to injunctions, recall orders, and claims for damages or face licensing demands to avoid potential disruptions to its business. Given the procedural posture and nature of these cases, which are in their early stages and have significant factual and legal issues to be resolved, HP is unable to make a reasonable estimate of the potential loss or range of losses that may arise from these matters.
Environmental
    HP is, and may become a party to, proceedings brought by U.S., state, or other governmental entities or private third parties under federal, state, local, or foreign environmental laws, including the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), known as “Superfund,” or state laws similar to CERCLA. HP is also conducting environmental investigations or remediation at several current or former operating sites and former disposal sites pursuant to administrative orders or consent agreements with environmental agencies.
36
HP INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements (Continued)
(Unaudited)

Note 13: Guarantees, Indemnifications and Warranties
Guarantees
In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.
Cross-Indemnifications with Hewlett Packard Enterprise
On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 12, “Litigation and Contingencies”.
Indemnifications  
In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.
HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.
Warranties
HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.
HP’s aggregate product warranty liabilities and changes were as follows:
 Three months ended January 31, 2024
 In millions
Balance at beginning of period$706 
Accruals for warranties issued183 
Adjustments related to pre-existing warranties (including changes in estimates)19 
Settlements made (in cash or in kind)(229)
Balance at end of period$679 

37
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
HP INC. AND SUBSIDIARIES
Management’s Discussion and Analysis of
Financial Condition and Results of Operations

The discussion of financial condition and results of our operations that follows provides information that will assist the reader in understanding our Consolidated Condensed Financial Statements, the changes in certain key items in those financial statements from year to year, and the primary factors that accounted for those changes, as well as how certain accounting principles, policies and estimates affect our Consolidated Condensed Financial Statements. This discussion should be read in conjunction with our Consolidated Condensed Financial Statements and the related notes that appear elsewhere in this document.
OVERVIEW
We are a leading global provider of personal computing and other digital access devices, imaging and printing products, and related technologies, solutions, and services. We sell to individual consumers, SMBs and large enterprises, including customers in the government, health, and education sectors.
We have three reportable segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment offers commercial and consumer desktops and notebooks, detachables and convertibles, workstations, thin clients, commercial mobility devices, retail POS systems, displays, hybrid systems, software, solutions, and services. The Printing segment provides consumer and commercial printer hardware, supplies, solutions and services. Corporate Investments include certain business incubation and investment projects.
•In Personal Systems, our long-term strategic focus is on:
◦profitable growth through innovation, market segmentation and simplification of our portfolio
◦enhanced innovation in multi-operating systems, multi-architecture, geography, customer segments and other key attributes;
◦investing in endpoint services and solutions. We are focused on services, including Device as a Service, as the market shifts to contractual solutions, and accelerating in attractive adjacencies such as hybrid systems; and
◦driving innovation to enable productivity and collaboration with PCs becoming essential for hybrid work, learning and play.
We believe that we are well positioned due to our competitive product lineup along with our recent acquisitions enhancing our portfolio of hybrid systems and remote-computing solutions.
•In Printing, our long-term strategic focus is on:
◦offering innovative printing solutions and contractual solutions to serve consumers, SMBs and large enterprises through our Instant Ink Services, HP+ and Managed Print Services solutions;
◦providing digital printing solutions for industrial graphics segments and applications including commercial publishing, labels, packaging, and textiles; and
◦expanding our footprint in 3D printing across digital manufacturing and strategic applications.
Certain aspects of our business are identified as key growth areas, and we are committed to growing these at a rate faster than our core business with accretive margins in the longer term. The key growth areas are comprised of;
•Hybrid Systems: Video conferencing solutions, cameras, headsets, voice, and related software capabilities
•Gaming: Gaming PCs, HyperX and gaming accessories
•Workforce Solutions: Managed services (Managed Print Service and Device-as-a-Service), digital services and lifecycle services
•Consumer Subscriptions: Instant Ink, other consumer subscriptions and consumer digital services
•Industrial Graphics: Large Format Industrial, Page Wide Press (PWP), Indigo and Page Wide Industrial packaging solutions and supplies
38
•3D & Personalization: Portfolio of additive manufacturing solutions and supplies including end-to-end solutions such as molded fiber, footwear and orthotics
We believe our ability to innovate will help us gain momentum in growth areas like hybrid systems and gaming, and we see significant opportunities to drive greater recurring revenues across Personal Systems and Printing. Our Workforce Solutions organization drives integration across our commercial services, software and security portfolio. We continue to build on strong portfolios like Instant Ink to grow our Consumer Subscription business. In Industrial Graphics, we are driving the shift from analog to digital in segments like labels and packaging. In 3D and Personalization, we are creating end-to-end solutions that we believe can capture more value with our differentiated technology.
We continue to experience challenges that are representative of the trends and uncertainties that may affect our industry, generally, and our business and financial results, specifically, and we expect these challenges to continue in the short-term. One set of challenges relates to the current macroeconomic environment and the adverse impact on demand for certain of our products. A second set of challenges relates to changes in the competitive landscape. Our primary competitors are exerting competitive pressure in targeted areas and are entering new markets, our emerging competitors are introducing new technologies and business models, and our alliance partners in some businesses are increasingly becoming our competitors in others. A third set of challenges relates to business model changes and our go-to-market execution in an evolving distribution and reseller landscape, with increasing online and omnichannel presence. Additional challenges we face at the segment level are set forth below.
•    In Personal Systems, we face challenges with a competitive pricing environment and demand softness.
•    In Printing, we face challenges from our competitors with a favorable foreign currency environment and non-original supplies (which includes imitation, refill, or remanufactured alternatives). We also obtain many Printing components from single source suppliers due to technology, availability, price, quality, or other considerations.
To address these challenges, we continue to pursue innovation with a view towards developing new products and services aligned with generating market demand and meeting the needs of our customers and partners. In addition, we continue to work on improving our operations and adapting our business models, with a particular focus on enhancing our end-to-end processes, analytics, efficiencies and simplification of our product portfolio. We also continue to work on optimizing our sales coverage models, aligning our sales incentives with our strategic goals, improving channel execution and inventory, production and backlog management, strengthening our capabilities in our areas of strategic focus, effective cost management, strengthening our pricing strategy, and developing and capitalizing on market opportunities.
Macroeconomic Environment
Our business and financial performance depend significantly on worldwide economic conditions. We face global macroeconomic challenges such as ongoing geopolitical conflicts (including the Russian invasion of Ukraine, tensions across the Taiwan Strait, the Israel-Hamas conflict and other hostilities in the Middle East), uncertainty in the markets, volatility in exchange rates, inflationary trends and evolving dynamics in the global trade environment. We also experience seasonality in the sale of our products and services which may be affected by general economic conditions.
During the three months ended January 31, 2024, we experienced continued market uncertainty, overall demand weakness due to cautious commercial spending on information technology hardware, reduced discretionary consumer spending and a competitive pricing environment across both Personal Systems and Printing, and we anticipate these trends to persist in the short-term. These market pressures created new and different demand dynamics which adversely impacted certain regional markets, specifically China. Despite the overall macroeconomic challenges, in Personal Systems we outperformed the market in units while maintaining profitability and in Printing we continue to execute on our strategy of optimizing the geographic and product mix. Our revenue declines continued to slow sequentially, consistent with the stabilizing trends we expected heading into the year.
We are exposed to fluctuations in foreign currency exchange rates. We have a large global presence, with more than 65% of our net revenue coming from outside the United States. As a result, our financial results can be, and particularly in recent periods have been, impacted by fluctuations in foreign currency exchange rates. While the foreign currency fluctuations were favorable to our financial results in Q1’24, we expect these fluctuations to have a minimal impact to our financial results in fiscal 2024.
For a further discussion of trends, uncertainties and other factors that could impact our operating results, see the section entitled “Risk Factors” in Item 1A of Part I in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.
39
Transformation Update
In November 2022, we announced our Future Ready Plan (the “Fiscal 2023 Plan”) to become a more digitally enabled company, focus investments on key growth opportunities and simplify our operating model. The Fiscal 2023 Plan is expected to run through end of fiscal year 2025. The three key elements of our Fiscal 2023 Plan are digital transformation, portfolio optimization, and operational efficiency. We are on track to achieve our gross annual run-rate structural cost savings target for fiscal year 2024 as well as the overall goal exiting fiscal year 2025.
We enhanced our digital capabilities in Workforce Solutions and continued to leverage AI to positively impact both our products and solutions. Additionally, we are reducing portfolio complexity, improving continuity of supply, and increasing our forecast accuracy across our business to drive reduction in our cost of sales and operating expenses. We also continued to reduce our structural cost through headcount reductions and are on track to achieve our overall headcount reduction goal. We expect to continue to invest some of the savings into our growth areas and our people.
See “Risk Factors—We may not achieve some or all of the expected benefits of our restructuring plans and our restructuring may adversely affect our business” in Item 1A of Part I in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. For more information on our Fiscal 2023 Plan, see Note 3, “Restructuring and Other Charges,” to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES
MD&A is based on our Consolidated Condensed Financial Statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, net revenue and expenses, and the disclosure of contingent liabilities. Management believes that there have been no significant changes during the three months ended January 31, 2024 to the items that we disclosed as our critical accounting policies and estimates in MD&A in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

ACCOUNTING PRONOUNCEMENTS
For a summary of recent accounting pronouncements applicable to our Consolidated Condensed Financial Statements see Note 1, “Basis of Presentation”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.

RESULTS OF OPERATIONS
Revenue from our international operations has historically represented, and we expect will continue to represent, a majority of our overall net revenue. As a result, our net revenue growth has been impacted, and we expect it will continue to be impacted, by fluctuations in foreign currency exchange rates. In order to provide a framework for assessing performance excluding the impact of foreign currency fluctuations, we supplement the year-over-year percentage change in net revenue with the year-over-year percentage change in net revenue on a constant currency basis, which excludes the effect of foreign currency exchange fluctuations calculated by translating current period revenues using monthly exchange rates from the comparative period and excluding any hedging impact recognized in the current period, and without adjusting for any repricing or demand impacts from changes in foreign currency exchange rates. This information is provided so that net revenue can be viewed with and without the effect of fluctuations in foreign currency exchange rates, which is consistent with how management evaluates our net revenue results and trends, as management does not believe that the excluded items are reflective of ongoing operating results. The constant currency measures are provided in addition to, and not as a substitute for, the year-over-year percentage change in net revenue on a GAAP basis. Other companies may calculate and define similarly labeled items differently, which may limit the usefulness of this measure for comparative purposes.
40
Results of operations in dollars and as a percentage of net revenue were as follows:
 Three months ended January 31
 20242023
 Dollars% of Net RevenueDollars% of Net Revenue
 Dollars in millions
Net revenue:
Products
$12,419 94.2 %$13,044 94.5 %
Services766 5.8 %754 5.5 %
Total net revenue13,185 100.0 %13,798 100.0 %
Cost of net revenue:
Products(1)
9,871 79.5 %10,589 81.2 %
Services(2)
426 55.6 %422 56.0 %
Total cost of net revenue10,297 78.1 %11,011 79.8 %
Gross Margin2,888 21.9 %2,787 20.2 %
Research and development399 3.0 %403 2.9 %
Selling, general and administrative1,383 10.5 %1,331 9.7 %
Restructuring and other charges63 0.5 %141 1.0 %
Acquisition and divestiture charges27 0.2 %84 0.6 %
Amortization of intangible assets81 0.6 %85 0.6 %
Total operating expenses1,953 14.8 %2,044 14.8 %
Earnings from operations935 7.1 %743 5.4 %
Interest and other, net(142)(1.1)%(181)(1.3)%
Earnings before taxes793 6.0 %562 4.1 %
Provision for taxes(171)(1.3)%(93)(0.7)%
Net earnings$622 4.7 %$469 3.4 %
    
(1)Products cost of net revenue as a percentage of net revenue is calculated as a percentage of product net revenue.
(2)Services cost of net revenue as a percentage of net revenue is calculated as a percentage of services net revenue.
Net Revenue
Products net revenue includes revenue from the sale of hardware, supplies, subscriptions and software licenses. Services net revenue includes revenue from our service offerings and support on hardware devices. For the three months ended January 31, 2024, net revenue decreased 4.4% (decreased 4.9% on a constant currency basis) as compared to the prior-year period. U.S. net revenue decreased 7.0% to $4.4 billion, and net revenue from international operations decreased 3.1% to $8.8 billion. The decrease in net revenue was primarily driven by demand softness and competitive pricing in products, partially offset by favorable foreign currency impacts while services increased nominally.
A detailed discussion of the factors contributing to the changes in segment net revenue is included in “Segment Information” below.
41
Gross Margin
For the three months ended January 31, 2024, gross margin increased by 1.7 percentage points primarily driven by products gross margin due to lower commodity and logistics costs, favorable foreign currency impacts and cost savings, partially offset by competitive pricing while services gross margin increased nominally.
A detailed discussion of the factors contributing to the changes in segment gross margins is included under “Segment Information” below.
Operating Expenses
Research and Development (“R&D”)
R&D expense decreased 1.0% for the three months ended January 31, 2024, primarily due to lower variable compensation and disciplined cost management, partially offset by higher R&D partner funding received in the prior period.
Selling, General and Administrative (“SG&A”)
SG&A expense increased 3.9% for the three months ended January 31, 2024 primarily due to higher go-to market initiatives, partially offset by lower variable compensation and disciplined cost management including Future Ready transformation savings.
Restructuring and Other Charges
Restructuring and other charges for the three months ended January 31, 2024 primarily relate to the Fiscal 2023 Plan. For more information, see Note 3, “Restructuring and other charges”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
Acquisition and Divestiture Charges
Acquisition and divestiture charges primarily include direct third-party professional and legal fees, integration and divestiture-related costs, non-cash adjustments to the fair value of certain acquired assets, such as inventory, and certain compensation charges related to cash settlement of restricted stock units and performance-based restricted stock units from acquisitions. Acquisition and divestiture charges for the three months ended January 31, 2024 decreased by $57 million primarily due to the fiscal year 2022 Poly acquisition and continuing integration progress.
Amortization of Intangible Assets
Amortization of intangible assets for the three months ended January 31, 2024 primarily relate to intangible assets resulting from prior acquisitions and remained flat.
Interest and Other, Net
Interest and other, net expense decreased $39 million for the three months ended January 31, 2024 primarily due to lower interest expense on debt.
Provision for Taxes
HP’s effective tax rate was 21.6% for the three months ended January 31, 2024, which did not materially differ from the U.S. federal statutory tax rate of 21%.
In December 2021, the Organization for Economic Cooperation and Development (“OECD”) enacted model rules for a new global minimum tax framework (“BEPS Pillar Two”), and various governments around the world have enacted, or are in the process of enacting, legislation on this. We are in the process of assessing the tax effects of Pillar Two legislation for when it comes into effect, and we plan to treat the tax as a period cost. Due to the complexities in applying the legislation, the quantitative impact of the enacted or substantively enacted legislation is not yet reasonably estimable.

42
Segment Information
During the first quarter of fiscal year 2024, HP realigned its business unit financial reporting more closely with its customer market segmentation. A description of the products and services for each segment and the business unit realignment can be found in Note 2, “Segment Information” to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference. Future changes to this organizational structure may result in changes to the segments disclosed.
Personal Systems
 Three months ended January 31
 20242023% Change
 Dollars in millions
Net revenue$8,809$9,185(4.1)%
Earnings from operations$537$47513.1 %
Earnings from operations as a % of net revenue6.1 %5.2 % 

The components of net revenue and the weighted net revenue change by business unit were as follows:
 Three months ended January 31
 Net Revenue
Weighted Net Revenue Change(1)
 20242023
 Dollars in millionsPercentage Points
Commercial PS$6,045 $6,382 (3.7)
Consumer PS2,764 2,803 (0.4)
Total Personal Systems$8,809 $9,185 (4.1)
(1)Weighted Net Revenue Change Percentage Points measures contribution of each business unit towards overall segment revenue growth. It is calculated by dividing the change in revenue of each business unit from the prior-year period by total segment revenue for the prior-year period.
Three months ended January 31, 2024 compared with three months ended January 31, 2023
Personal Systems net revenue decreased 4.1% (decreased 4.9% on a constant currency basis) for the three months ended January 31, 2024. The net revenue decrease was primarily due to a decline in average selling price (“ASPs”) by 7.5%, offset by a 5.1% increase in commercial and consumer client PCs unit volume as we outperformed the market in units while maintaining profitability. The decline in ASPs is primarily due to competitive pricing and unfavorable mix shifts, partially offset by favorable currency impacts. Consequently, Commercial PS net revenue decreased 5.3% primarily due to a 5.1% decline in ASPs, partially offset by a 1.9% increase in units and Consumer PS net revenue decreased 1.4% primarily due to a 10.4% decline in ASPs, partially offset by a 9.8% increase in units.
Personal Systems earnings from operations as a percentage of net revenue increased by 0.9 percentage points. The increase was primarily driven by an increase in gross margin, partially offset by an increase in operating expenses as a percentage of revenue. Gross margin increased primarily due to lower commodity and logistics costs, favorable foreign currency impacts and cost savings, partially offset by competitive pricing. Operating expenses as a percentage of revenue increased due to higher go-to market initiatives and higher R&D partner funding received in the prior year, partially offset by lower variable compensation and disciplined cost management including Future Ready transformation savings.
43
Printing
 Three months ended January 31
 20242023% Change
 Dollars in millions
Net revenue$4,375$4,612(5.1)%
Earnings from operations$872$8700.2 %
Earnings from operations as a % of net revenue19.9 %18.9 % 
    
The components of net revenue and the weighted net revenue change by business unit were as follows:
 Three months ended January 31
 Net Revenue
Weighted Net Revenue Change(1)
 20242023
 Dollars in millionsPercentage Points
Supplies$2,863 $2,857 0.1 
Commercial1,227 1,388 (3.5)
Consumer285 367 (1.7)
Total Printing$4,375 $4,612 (5.1)
(1)Weighted Net Revenue Change Percentage Points measures contribution of each business unit towards overall segment revenue growth. It is calculated by dividing the change in revenue of each business unit from the prior-year period by total segment revenue for the prior-year period.
Three months ended January 31, 2024 compared with three months ended January 31, 2023
Printing net revenue decreased 5.1% (decreased 4.8% on a constant currency basis) for the three months ended January 31, 2024. The decrease in net revenue was driven by Commercial Printing and Consumer Printing, while Supplies net revenue increased nominally. Printer unit volume decreased 16.5% primarily due to demand softness and Print hardware ASPs decreased 2.8% primarily due to competitive pricing and unfavorable mix shifts.
Net revenue for Commercial Printing decreased by 11.6% primarily due to a 18.3% decrease in printer unit volume due to demand softness, partially offset by a 1.0% increase in ASPs. The increase in ASPs was primarily driven by mix shifts, partially offset by competitive pricing.
Net revenue for Consumer Printing decreased 22.3%, primarily due to a 9.0% decrease in ASPs and 15.4% decrease in printer unit volume. The decrease in printer unit volume was primarily due to demand softness and the decrease in ASPs was primarily driven by competitive pricing, partially offset by favorable mix shifts.
Printing earnings from operations as a percentage of net revenue increased by 1.0 percentage point, primarily due to a increase in gross margin, partially offset by higher operating expenses as a percentage of revenue. The increase in gross margin is primarily due to lower printer unit volume, lower commodity and logistics costs, as well as cost savings. Operating expenses as a percentage of revenue increased primarily due to go-to market initiatives, partially offset by lower variable compensation and disciplined cost management including Future Ready transformation savings.
Corporate Investments
The loss from operations in Corporate Investments for the three months ended January 31, 2024 was primarily due to expenses associated with our incubation projects and investments in digital enablement.
44
LIQUIDITY AND CAPITAL RESOURCES
We use cash generated by operations as our primary source of liquidity. We believe that current cash, cash flow from operating activities, new borrowings, available commercial paper authorization and the credit facilities will be sufficient to meet HP’s operating cash requirements, planned capital expenditures, interest and principal payments on all borrowings, pension and post-retirement funding requirements, authorized share repurchases and annual dividend payments for the foreseeable future. Additionally, if suitable acquisition opportunities arise, the Company may obtain all or a portion of the required financing through additional borrowings. While our access to capital markets may be constrained and our cost of borrowing may increase under certain business, market and economic conditions, our access to a variety of funding sources to meet our liquidity needs is designed to facilitate continued access to capital resources under all such conditions. Our liquidity is subject to various risks including the risks identified in the section entitled “Risk Factors” in Item 1A of Part I in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023 and the market risks identified in the section entitled “Quantitative and Qualitative Disclosures about Market Risk” in Item 3 of Part I of this report.
Amounts held outside of the U.S. are generally utilized to support non-U.S. liquidity needs and may from time to time be distributed to the U.S. Repatriations of amounts held outside the U.S. generally will not be taxable from a U.S. federal tax perspective but may be subject to state income or foreign withholding tax upon repatriation. As we evaluate the future cash needs of our operations, we may revise the amount of foreign earnings considered to be permanently reinvested in our foreign subsidiaries and how to utilize such funds, including reducing our gross debt level, or other uses.
Liquidity
Our cash, cash equivalents and restricted cash and total debt were as follows: 
 As of
 January 31, 2024October 31, 2023
 In millions
Cash and cash equivalents$2,263 $3,107 
Restricted cash$154 $125 
Total debt$9,660 $9,484 

Our key cash flow metrics were as follows:
 Three months ended January 31
 20242023
 In millions
Net cash provided by (used in) operating activities
$121 $(16)
Net cash used in investing activities(228)(435)
Net cash used in financing activities(708)(925)
Net decrease in cash, cash equivalents and restricted cash
$(815)$(1,376)
Operating Activities
Compared to the corresponding period in fiscal year 2023, net cash provided by operating activities increased by $0.1 billion for the three months ended January 31, 2024, primarily due to higher net earnings and favorable working capital impacts, partially offset by amounts collected and held on behalf of a third party for trade receivables previously sold and higher variable compensation payout in the current period for fiscal year 2023.
45
Key Working Capital Metrics
Management utilizes current cash conversion cycle information to manage our working capital level. Our working capital metrics and cash conversion cycle impacts were as follows:
 As ofAs of
 January 31, 2024October 31, 2023ChangeJanuary 31, 2023October 31, 2022ChangeY/Y Change
Days of sales outstanding in accounts receivable (“DSO”)26 28 (2)28 28 — (2)
Days of supply in inventory (“DOS”)61 57 4 60 57 3 1 
Days of purchases outstanding in accounts payable (“DPO”)(116)(117)1 (110)(114)4 (6)
Cash conversion cycle(29)(32)3 (22)(29)7 (7)
January 31, 2024 as compared to January 31, 2023
The cash conversion cycle is the sum of days of DSO and DOS less DPO. Items which may cause the cash conversion cycle in a particular period to differ from historical trends include, but are not limited to, changes in business mix, changes in payment terms and timing, timing and extent of receivables factoring, seasonal trends and the timing of revenue recognition and inventory purchases within the period.
DSO measures the average number of days our receivables are outstanding. DSO is calculated by dividing ending accounts receivable, net of allowance for credit losses, by a 90-day average net revenue. The decrease in DSO was primarily driven by favorable revenue linearity and improved collections.
DOS measures the average number of days from procurement to sale of our product. DOS is calculated by dividing ending inventory by a 90-day average cost of goods sold. The increase in DOS is primarily due to strategic buys in Personal Systems and higher in-transit sea shipments, offset by inventory reduction in Print.
DPO measures the average number of days our accounts payable balances are outstanding. DPO is calculated by dividing ending accounts payable by a 90-day average cost of goods sold. The increase in DPO was primarily driven by favorable payment terms with vendors.
Investing Activities
Compared to the corresponding period in fiscal year 2023, net cash used in investing decreased by $0.2 billion for the three months ended January 31, 2024, primarily due to lower collateral posted for derivative instruments.
Financing Activities
Compared to the corresponding period in fiscal year 2023, net cash used in financing activities decreased by $0.2 billion for the three months ended January 31, 2024, primarily due the lower net payment of debt of $0.4 billion and collateral returned for derivative instruments of $0.2 billion in the prior period, partially offset by a $0.4 billion increase in share repurchases.
Share Repurchases and Dividends
During the three months ended January 31, 2024, HP returned $0.8 billion to the shareholders in the form of cash dividends of $0.3 billion and share repurchases of $0.5 billion. As of January 31, 2024, HP had approximately $1.5 billion remaining under the share repurchase authorizations approved by HP’s Board of Directors.
For more information on our share repurchases, see Note 10, “Stockholders’ Deficit”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
Capital Resources
Debt Levels
We maintain debt levels that we establish through consideration of a number of factors, including cash flow expectations, cash requirements for operations, investment plans (including acquisitions), share repurchase activities, our cost of capital and targeted capital structure as well as credit rating considerations. Depending on these factors, we may, from time to time, incur additional indebtedness or repay or refinance existing indebtedness. Outstanding borrowings increased to $9.7 billion as of January 31, 2024 as compared to $9.5 billion as of October 31, 2023, bearing weighted-average interest rates of 4.2% for both January 31, 2024 and October 31, 2023.
46
Our weighted-average interest rate reflects the effective rate on our borrowings prevailing during the period and reflects the effect of interest rate swaps. For more information on our interest rate swaps, see Note 8, “Financial Instruments”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
As of January 31, 2024, we maintained a 5-year sustainability-linked senior unsecured committed revolving credit facility with aggregate lending commitments of $5.0 billion which will be available until May 26, 2026. In March 2023, we also entered into a $1.0 billion senior unsecured committed revolving credit facility with a 364-day maturity. Funds borrowed under the revolving credit facilities may be used for general corporate purposes.
Available Borrowing Resources
As of January 31, 2024, we had available borrowing resources of $1.0 billion from uncommitted lines of credit in addition to the full capacity of the revolving credit facilities.
For more information on our borrowings, see Note 9, “Borrowings”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
Credit Ratings
Our credit risk is evaluated by major independent rating agencies based upon publicly available information as well as information they obtain during our ongoing discussions. While we currently do not have any rating downgrade triggers that would accelerate the maturity of a material amount of our debt, a downgrade from our current credit rating may increase the cost of borrowing under our credit facility, reduce market capacity for our commercial paper, require the posting of additional collateral under some of our derivative contracts and may have a negative impact on our liquidity and capital position and our contractual business going forward, depending on the extent of such downgrade. We can access alternative sources of funding, including drawdowns under our credit facilities, if necessary, to offset potential reductions in the market capacity for our commercial paper.

47
CONTRACTUAL AND OTHER OBLIGATIONS
Retirement and Post-Retirement Benefit Plan Contributions
As of January 31, 2024, we anticipate making contributions for the remainder of fiscal year 2024 of approximately $34 million to our non-U.S. pension plans, $25 million to cover benefit payments to U.S. non-qualified pension plan participants and $1 million to cover benefit claims for our post-retirement benefit plans. Our policy is to fund our pension plans so that we meet the minimum contribution required by local government, funding and taxing authorities. For more information on our retirement and post-retirement benefit plans, see Note 4, “Retirement and Post-Retirement Benefit Plans”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
Cost Savings Plan
As a result of our approved restructuring plans, we expect to make future cash payments of approximately $0.4 billion. We expect to make future cash payments of $0.2 billion in fiscal year 2024 with remaining cash payments through fiscal year 2025. For more information on our restructuring activities that are part of our cost improvements, see Note 3, “Restructuring and Other Charges”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
Uncertain Tax Positions
As of January 31, 2024, we had approximately $943 million of recorded liabilities and related interest and penalties pertaining to uncertain tax positions. We are unable to make a reasonable estimate as to when cash settlement with the tax authorities might occur due to the uncertainties related to these tax matters. Payments of these obligations would result from settlements with taxing authorities. For more information on our uncertain tax positions, see Note 5, “Taxes on Earnings”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.
Off-balance sheet arrangements
As part of our ongoing business, we have not participated in transactions that generate material relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. For more information on our third-party short-term financing arrangements, see Note 6, “Supplementary Financial Information”, to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.

48
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
For quantitative and qualitative disclosures about market risk affecting HP, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. Our exposure to market risk has not changed materially since October 31, 2023.

Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, our disclosure controls and procedures were not effective due to the material weakness in our internal control over financial reporting described below.
Material Weakness
As previously reported in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2023, we previously identified a material weakness in internal control over financial reporting. The material weakness resulted from undue reliance on information generated from certain software solutions affecting net revenue without effectively designed information technology general controls (“ITGCs”), specifically around user access and change management. Information generated from these software solutions is used by management in accounting for net revenue, including estimating variable consideration, and certain of these software solutions are used in the processing of revenue-related transactions.
This material weakness did not result in any errors. While this material weakness did not result in a material misstatement of our financial statements, there is a reasonable possibility that it could have resulted in a material misstatement in the Company's annual or interim consolidated financial statements that would not be detected. Accordingly, we determined that it constituted a material weakness.
With respect to the material weakness above, management, under the oversight of the Audit Committee, is in the process of designing appropriate ITGCs specific to the impacted software solutions. While we have taken steps to implement our remediation plan, the material weakness will not be considered remediated until the enhanced controls operate for a sufficient period of time and management has concluded, through testing, that the related controls are effective. The Company will monitor the effectiveness of its remediation plan and refine its remediation plan as appropriate.
Changes in Internal Control over Financial Reporting
As described above, we are taking steps to remediate the material weakness in our internal control over financial reporting. Other than in connection with the remediation process described above, no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended January 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
49
PART II. OTHER INFORMATION

Item 1. Legal Proceedings.
Information with respect to this item may be found in Note 12, “Litigation and Contingencies” to the Consolidated Condensed Financial Statements in Item 1 of Part I of this report, which is incorporated herein by reference.

Item 1A. Risk Factors.
Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023, which could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common and capital stock. There have been no material changes in our risk factors since our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

50
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Recent Sales of Unregistered Securities
There were no unregistered sales of equity securities during the period covered by this report.
Issuer Purchases of Equity Securities
The table below provides information regarding the Company’s share repurchases during the three months ended January 31, 2024.
PeriodTotal
Number
of Shares
Purchased		Average
Price Paid
per Share		Total Number of
Shares Purchased as
Part of Publicly
Announced Plans
or Programs		Approximate Dollar
Value of Shares
that May Yet Be
Purchased under the
Plans or Programs
 In thousands, except per share amounts
November 2023— $— — $2,034,564 
December 20233,667 $30.30 3,667 $1,923,463 
January 202413,082 $29.73 13,082 $1,534,564 
Total16,749  16,749  
The Company’s share repurchase program, which does not have a specific expiration date, authorizes repurchases in the open market or in private transactions. On February 22, 2020, HP’s Board of Directors increased HP’s remaining share repurchase authorization to $15.0 billion in total. All share repurchases settled in the first quarter of fiscal year 2024 were open market transactions. As of January 31, 2024, HP had approximately $1.5 billion remaining under the share repurchase authorizations. From time-to-time HP may repurchase shares opportunistically and to offset the dilution created by shares issued under employee stock plans.

Item 3. Defaults Upon Senior Securities.
None.

Item 4. Mine Safety Disclosures.
Not applicable.

Item 5. Other Information.
Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the three months ended January 31, 2024, no such plans or other arrangements were adopted or terminated.

Item 6. Exhibits.
The Exhibit Index beginning on page 52 of this report sets forth a list of exhibits.

51
HP INC. AND SUBSIDIARIES
EXHIBIT INDEX


Exhibit
Number		 Incorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
2(a)8-K001-044232.1November 5, 2015
2(b)8-K001-044232.2November 5, 2015
2(c)8-K001-044232.4November 5, 2015
3(a)10-Q001-044233(a)June 12, 1998
3(b)10-Q001-044233(b)March 16, 2001
52
Exhibit
Number		Incorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
3(c)8-K001-044233.2October 22, 2015
3(d)8-K001-044233.1April 7, 2016
3(e)10-K001-044233(e)December 18, 2023
3(f)8-K001-044233.1February 20, 2020
4(a)S-3333-2151164.1December 15, 2016
4(b)S-3333-2151164.2December 15, 2016
4(c)Form of Registrant’s 4.375% Global Note due September 15, 2021 and 6.000% Global Note due September 15, 2041 and form of related Officers’ Certificate.8-K001-04423
4.4, 4.5 and 4.6
September 19, 2011
4(d)Form of Registrant’s 4.650% Global Note due December 9, 2021 and related Officers’ Certificate.8-K001-04423
4.3 and 4.4
December 12, 2011
4(e)Form of Registrant’s 4.050% Global Note due September 15, 2022 and related Officers’ Certificate.8-K001-04423
4.2 and 4.3
March 12, 2012
4(f)8-A/A001-044234.1June 23, 2006
4(g)10-Q001-044234(j)June 5, 2018
4(h)10-K001-044234(h)December 18, 2023
4(i)8-K001-044234.1June 17, 2020
4(j)Form of 2.200% notes due 2025 and related Officers’ Certificate.8-K001-04423June 17, 2020
4(k)Form of 3.000% notes due 2027 and related Officers’ Certificate.8-K001-04423
4.3 and 4.5
June 17, 2020
4(l)Form of 3.400% notes due 2030 and related Officers’ Certificate.8-K001-04423
4.4 and 4.5
June 17, 2020
4(m)8-K001-044234.2June 21, 2021
4(n)8-K001-044234.3June 21, 2021
4(o)
Form of 4.000% notes due 2029 and related Officers’ Certificate.
8-K001-04423
4.2 and 4.4
March 31, 2022
4(p)
Form of 4.200% notes due 2032 and related Officers’ Certificate.
8-K001-04423
4.3 and 4.4
March 31, 2022
4(q)
Form of 4.750% notes due 2028 and related Officers’ Certificate.
8-K001-04423
4.2 and 4.4
June 21, 2022
4(r)
Form of 5.500% notes due 2033 and related Officers’ Certificate.
8-K001-04423
4.3 and 4.4
June 21, 2022
4(s)8-K001-044234.2September 7, 2022
53
Exhibit
Number		 Incorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
10(a)S-8333-1142534.1April 7, 2004
10(b)8-K001-0442310.2September 21, 2006
10(c)8-K001-0442399.3November 23, 2005
10(d)8-K001-0442310.2January 24, 2008
10(e)10-Q001-0442310(o)(o)March 10, 2008
10(f)10-Q001-0442310(p)(p)March 10, 2008
10(g)10-Q001-0442310(u)(u)June 6, 2008
10(h)10-Q001-0442310(b)(b)(b)March 10, 2009
10(i)10-K001-0442310(i)(i)(i)December 15, 2010
10(j)10-K001-0442310(j)(j)(j)December 15, 2010
10(k)10-K001-0442310(k)(k)(k)December 15, 2010
10(1)8-K001-0442310.2March 21, 2013
10(m)10-Q001-0442310(v)(v)March 11, 2014
10(n)10-Q001-0442310(w)(w)March 11, 2014
10(o)10-Q001-0442310(x)(x)March 11, 2014
10(p)10-Q001-0442310(a)(a)(a)March 11, 2014
10(q)10-Q001-0442310(b)(b)(b)March 11, 2014
10(r)10-Q001-0442310(e)(e)(e)March 11, 2015
10(s)10-Q001-0442310(f)(f)(f)March 11, 2015
10(t)10-Q001-0442310(i)(i)(i)March 11, 2015
10(u) 10-K 001-04423 10(e)(e)(e) December 16, 2015
10(v) 10-K 001-04423 10(f)(f)(f) December 16, 2015
10(w) 10-K 001-04423 10(g)(g)(g) December 16, 2015

54
Exhibit
Number		 Incorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
10(x) 10-K/A001-04423 10(n)(n) December 15, 2017
10(y) 10-Q 001-04423 10(p)(p) March 5, 2020
10(z) 10-Q 001-04423 10(p)(p) March 3, 2016
10(a)(a)10-Q001-0442310(w)(w)March 2, 2017
10(b)(b)10-Q001-0442310(x)(x)
March 2, 2017
10(c)(c)10-Q001-0442310(y)(y)
March 2, 2017
10(d)(d)10-Q001-0442310(b)(b)(b)March 1, 2018
10(e)(e)10-Q001-0442310(c)(c)(c)March 1, 2018
10(f)(f)10-Q001-0442310(e)(e)(e)March 1, 2018
10(g)(g)10-Q001-0442310(f)(f)(f)March 1, 2018
10(h)(h)10-K001-0442310(g)(g)(g)December 13, 2018
10(i)(i)10-K001-0442310(h)(h)(h)December 13, 2018
10(j)(j)10-Q001-0442310(j)(j)(j)March 5, 2019
10(k)(k) 10-Q001-0442310(k)(k)(k)March 5, 2019
10(l)(l) 10-Q001-0442310(l)(l)(l)August 29, 2019
10(m)(m) 10-K001-0442310(m)(m)(m)December 12, 2019
10(n)(n) 10-K001-0442310(n)(n)(n)December 12, 2019





55
Exhibit
Number		  Incorporated by Reference
 Exhibit Description Form File No. Exhibit(s) Filing Date
10(o)(o) 10-Q 001-04423 10(m)(m)(m) March 5, 2020
10(p)(p) 10-Q 001-04423 10(n)(n)(n) March 5, 2020
10(q)(q) 10-Q 001-04423 10(o)(o)(o) March 5, 2020
10(r)(r) 10-Q 001-04423 10(p)(p)(p) March 5, 2020
10(s)(s) 10-Q 001-04423 10(q)(q)(q) March 5, 2020
10(t)(t) 10-Q001-0442310(r)(r)(r)June 5, 2020
10(u)(u) 10-Q001-0442310(s)(s)(s)June 5, 2020
10(v)(v)10-Q001-0442310(t)(t)(t)June 5, 2020
10(w)(w)10-K001-0442310(x)(x)(x)December 10, 2020
10(x)(x)10-K001-0442310(y)(y)(y)December 10, 2020
10(y)(y)10-Q001-0442310(x)(x)(x)March 5, 2021
10(z)(z)10-Q001-0442310(y)(y)(y)March 5, 2021
10(a)(a)(a)10-Q001-0442310(z)(z)(z)March 5, 2021
10(b)(b)(b)10-Q001-0442310(a)(a)(a)(a)March 5, 2021
10(c)(c)(c)10-Q001-0442310(b)(b)(b)(b)March 5, 2021
10(d)(d)(d)10-Q001-0442310(c)(c)(c)(c)March 5, 2021
10(e)(e)(e)10-Q001-0442310(d)(d)(d)(d)March 5, 2021
10(f)(f)(f)10-Q001-0442310(e)(e)(e)(e)March 5, 2021







56
Exhibit
Number		  Incorporated by Reference
 Exhibit Description Form File No. Exhibit(s) Filing Date
10(g)(g)(g)10-Q001-0442310(f)(f)(f)(f)March 5, 2021
10(h)(h)(h)8-K001-0442310.1June 1, 2021
10(i)(i)(i)10-Q001-0442310(j)(j)(j)September 3, 2021
10(j)(j)(j)10-Q001-0442310(j)(j)(j)March 7, 2022
10(k)(k)(k)10-Q001-0442310(k)(k)(k)March 7, 2022
10(l)(l)(l)10-Q001-0442310(l)(l)(l)March 7, 2022
10(m)(m)(m)10-Q001-0442310(m)(m)(m)March 7, 2022
10(n)(n)(n)10-Q001-0442310(n)(n)(n)March 7, 2022
10(o)(o)(o)10-Q001-0442310(o)(o)(o)March 7, 2022
10(p)(p)(p)8-K001-0442310.1April 22, 2022
10(q)(q)(q)8-K001-0442310.1August 26, 2022
10(r)(r)(r)S-8333-2671514.4August 29, 2022
10(s)(s)(s)S-8333-2671514.5August 29, 2022
10(t)(t)(t)10-K001-0442310(t)(t)(t)December 6, 2022
10(u)(u)(u)10-Q001-0442310(u)(u)(u)March 1, 2023
10(v)(v)(v)10-Q001-0442310(v)(v)(v)March 1, 2023
10(w)(w)(w)10-Q001-0442310(w)(w)(w)March 1, 2023
10(x)(x)(x)10-Q001-0442310(x)(x)(x)March 1, 2023
10(y)(y)(y)10-Q001-0442310(y)(y)(y)March 1, 2023
10(z)(z)(z)10-Q001-0442310(z)(z)(z)March 1, 2023
57
10(a)(a)(a)(a)10-Q001-0442310(a)(a)(a)(a)March 1, 2023
10(b)(b)(b)(b)10-Q001-0442310(b)(b)(b)(b)March 1, 2023
10(c)(c)(c)(c)10-Q001-0442310(c)(c)(c)(c)March 1, 2023
10(d)(d)(d)(d)
2023 Amendment to the HP Inc. Cash Account Restoration Plan.*
10-Q001-0442310(d)(d)(d)(d)May 31, 2023
10(e)(e)(e)(e)
Third Amendment to the HP Inc. Excess Benefit Plan.*
10-Q001-0442310(e)(e)(e)(e)May 31, 2023
10(f)(f)(f)(f)
10(g)(g)(g)(g)
10(h)(h)(h)(h)
10(i)(i)(i)(i)
10(j)(j)(j)(j)
10(k)(k)(k)(k)
10(l)(l)(l)(l)
31.1
31.2     
32     
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.†        
101.SCH Inline XBRL Taxonomy Extension Schema Document.†        
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.†        
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.†        
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.†        
58
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.†        
104The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended January 31, 2024, formatted in Inline XBRL (included within the Exhibit 101 attachments).†


*    Indicates management contract or compensatory plan, contract or arrangement.
**    Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Registration S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the SEC upon request.
†    Filed herewith.
††    Furnished herewith.

The registrant agrees to furnish to the Commission supplementally upon request a copy of (1) any instrument with respect to long-term debt not filed herewith as to which the total amount of securities authorized thereunder does not exceed 10% of the total assets of the registrant and its subsidiaries on a consolidated basis and (2) any omitted schedules to any material agreements set forth above.


59
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 HP INC.
/s/ TIMOTHY BROWN
 
Timothy Brown
Interim Chief Financial Officer
(Principal Financial Officer and
Authorized Signatory)
Date: February 28, 2024

60
 EX-10.(F)(F)(F)(F) 2 hpq-standardrsuagreementfy.htm EX-10.(F)(F)(F)(F) Document
Exhibit 10(f)(f)(f)(f)
image_03.jpg


GRANT AGREEMENT for use from November 1, 2023


Name:
fld_NAME_AC
Employee ID:
fld_EMPLID
    
Grant Date:
expGRANT_DATE
Grant ID:
fld_GRANT_NBR
Amount:
0
Plan:
fld_DESCR
Vesting Schedule:
fld_HTMLAREA1

Restricted Stock Units

    THIS GRANT AGREEMENT, as of the Grant Date noted above between HP Inc., a Delaware Corporation (“Company”), and the employee named above (“Employee”), is entered into as follows:

    WHEREAS, the continued participation of the Employee is considered by the Company to be important for the Company's continued growth; and

    WHEREAS, in order to give the Employee an incentive to continue in the employ of the Company (or its Affiliates or Subsidiaries), to accept ancillary agreements designed to protect the legitimate business interests of the Company that are made a condition of this grant and to participate in the affairs of the Company, the HR and Compensation Committee of the Board of Directors of the Company or its delegates (“Committee”) has determined that the Employee shall be granted restricted stock units representing hypothetical shares of the Company’s common stock (“RSUs”), with each RSU equal in value to one share of the Company’s $0.01 par value common stock (“Share”), subject to the restrictions stated below and in accordance with the terms and conditions of the plan named above (“Plan”), a copy of which can be found on the Long-term Incentives website along with a copy of the related prospectus. The Plan and the related prospectus also can be obtained by written or telephonic request to the Company Secretary. Unless otherwise defined in this Grant Agreement, any capitalized terms in this Grant Agreement shall have the meaning ascribed to such terms in the Plan.

    THEREFORE, the parties agree as follows:

1.Grant of Restricted Stock Units.
Subject to the terms and conditions of this Grant Agreement and of the Plan, the Company hereby grants to the Employee the number of RSUs set forth above.

2.Vesting Schedule.
The interest of the Employee in the RSUs shall vest according to the vesting schedule set forth above, or if earlier, in accordance with Section 8 or 9, below, except to the extent a severance plan applicable to the Employee provides otherwise. Unless the provisions of Section 8 or 9 apply, the Employee must remain in the employ of the Company, any Subsidiary or Affiliate on a continuous basis through the close of business on the applicable Vesting Date, as set forth above, and the Employee must be in compliance with the requirements and conditions provided for in the Plan and this Grant Agreement for the interest of the Employee in the RSUs to become fully vested on that date.

3.Benefit Upon Settlement.
Within 75 days of each Vesting Date set forth on the above vesting schedule or, if earlier, a vesting event pursuant to Section 8 or 9 below, the Company shall deliver or pay, as applicable, to the Employee (or the Employee’s guardian, estate or beneficiary in the event of Section 8 or 9) Shares or a combination of cash and Shares, as the Company determines in its sole discretion, with a value equal to:

(a)    the number of RSUs that have become vested as of such vesting date or vesting event, as applicable, multiplied by the Fair Market Value of a Share on the date on which such RSUs vested; plus
(b)    a dividend equivalent payment credited in the form of additional RSUs for each ordinary cash dividend the Company pays on its Shares and for which the record date occurs between the grant date and the date the RSUs are settled, determined by:
(1)multiplying the per share cash dividend paid by the Company on its Shares by the total number of RSUs that are outstanding as of the record date for the dividend; and
1


(2)dividing the amount determined in (1) above by the Fair Market Value of a Share on the dividend payment date to determine the number of additional whole and fractional RSUs to be credited to the Employee;
provided, however, that if any aggregated dividend equivalent payments in Section (b)(2) above to be delivered in Shares result in a payment of a fractional Share, such fractional Share shall be rounded up to the next whole Share.

Notwithstanding the foregoing, the Company may, in its sole discretion, settle the RSUs in the form of a cash payment to the extent settlement in Shares: (i) is prohibited under local law; (ii) would require the Employee, the Company and/or any Subsidiary or Affiliate to obtain the approval of any governmental and/or regulatory body in the Employee's country; (iii) would result in adverse tax consequences for the Employee, the Company or any Subsidiary or Affiliate; or (iv) is administratively burdensome. Alternatively, the Company may, in its sole discretion, settle the RSUs in the form of Shares but require the Employee to sell such Shares immediately or within a specified period of time following the Employee’s termination of employment (in which case the Employee expressly authorizes the Company to issue sales instructions on the Employee's behalf).

4.Restrictions.
Except as otherwise provided for in this Grant Agreement, the RSUs or rights granted hereunder may not be sold, pledged or otherwise transferred. The period of time between the Grant Date and the date the RSUs become fully vested pursuant to Section 2 is referred to herein as the “Restriction Period.”
5.Custody of Restricted Stock Units.
The RSUs subject hereto shall be recorded in an account with the Plan broker in the name of the Employee. Upon termination of the Restriction Period, if the Company determines, in its sole discretion, to deliver Shares pursuant to Section 3 above, such Shares shall be released into the Employee’s account; provided, however, that a portion of such Shares shall be surrendered in payment of Tax-Related Items, as defined and in accordance with Section 12 below, unless the Company, in its sole discretion, establishes alternative procedures for the payment of Tax-Related Items.

6.No Stockholder Rights.
RSUs represent hypothetical Shares. Until Shares are delivered to the Employee pursuant to the terms of this Grant Agreement, the Employee shall not be entitled to any of the rights or benefits generally accorded to stockholders, including, without limitation, the receipt of dividends.

7.Termination of Employment.
Except as otherwise provided for in this Grant Agreement or in the Plan or as otherwise determined by the Company in its sole discretion, if the Employee's employment with the Company, any Subsidiary or Affiliate is terminated at any time for any reason prior to the lapse of the Restriction Period, all unvested RSUs granted hereunder shall be forfeited by the Employee, except to the extent a severance plan applicable to the Employee provides otherwise.

For purposes of this Grant Agreement, the Employee's employment or service will be considered terminated as of the date the Employee is no longer actively providing services to the Company, any Subsidiary or Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any) and will not be extended by any notice period (e.g., the Employee's period of employment or service would not include any contractual notice period or any period of “garden leave” or similar period mandated under the employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when the Employee's employment or service is terminated for purposes of this Grant Agreement (including whether the Employee may still be considered to be providing service while on a leave of absence).

8.Disability or Retirement of the Employee.
If the Employee’s employment is terminated prior to the end of the Restriction Period by reason of the Employee’s Total and Permanent Disability or retirement in accordance with the applicable retirement policy, all RSUs shall immediately vest including any amounts for dividend equivalent payments on RSUs that vest at termination. The Company’s obligation to vest the RSUs under this paragraph is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company, and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the RSU remains outstanding.

9.Death of the Employee.
In the event that termination of employment prior to the end of the Restriction Period is due to the death of the Employee, all unvested RSUs shall immediately vest including any amounts for dividend equivalent payments on such vested RSUs.

10.Termination for Cause.
Upon termination of the Employee’s employment for Cause (as defined in the Plan), then all unvested RSUs shall be forfeited by the Employee on the date of the Employee’s termination, except to the extent a severance plan applicable to the Employee provides otherwise. Such forfeiture shall occur regardless of whether the Employee has satisfied any applicable age and service requirements for retirement.

11.Section 409A.
The following provisions apply to the extent the Employee is subject to taxation in the U.S. Payments made pursuant to the Plan and this Grant Agreement are intended to comply with or qualify for an exemption from Section 409A of the Code (“Section 409A”). The Company reserves the right, to the extent the Company deems necessary or advisable in its sole discretion, to unilaterally amend or modify the Plan and/or this Grant Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, including any amendments or actions that would result in the reduction of benefits payable under this Grant Agreement, as the Company determines are necessary or appropriate to ensure that all RSUs and dividend equivalent payments are made in a manner that qualifies for an exemption from, or complies with, Section 409A or mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Section 409A: provided however, that the Company makes no representations that the RSUs or dividend equivalents will be exempt from
2


any taxes, interest, and/or penalties that may apply under Section 409A and makes no undertaking to preclude Section 409A from applying to this RSU. For the avoidance of doubt, the Employee hereby acknowledges and agrees that neither the Company nor any Affiliate or Subsidiary will have any liability to the Employee or any other party if any amounts payable under this Grant Agreement are not exempt from, or compliant with, Section 409A, or for any action taken by the Company with respect thereto. Any payments under this Grant Agreement, the settlement of which is triggered by a "separation from service" (within the meaning of Section 409A) of a "specified employee" (as defined under Section 409A), shall be made on a date that is the earlier of (a) the Employee’s death or (b) the later of the specified settlement date and the date which is six months after the date of the Employee’s separation from service.

12.Taxes.
(a)The Employee shall be liable for any and all taxes, including income tax, social insurance, fringe benefit tax, payroll tax, payment on account, employer taxes or other tax-related items related to the Employee’s participation in the Plan and legally applicable to or otherwise recoverable from the Employee by the Company and/or, if different, the Employee’s employer (the “Employer”) whether incurred at grant, vesting, sale, prior to vesting or at any other time (“Tax-Related Items”). In the event that the Company or the Employer (which, for purposes of this Section 12, shall include a former employer) is required, allowed or permitted to withhold taxes as a result of the grant or vesting of RSUs or the issuance or subsequent sale of Shares acquired pursuant to such RSUs, or due upon receipt of dividend equivalent payments or dividends, the Employee shall surrender a sufficient number of whole Shares, make a cash payment or make adequate arrangements satisfactory to the Company and/or the Employer to withhold such taxes from Employee’s wages or other cash compensation paid to the Employee by the Company and/or the Employer at the election of the Company, in its sole discretion, or, if permissible under local law, the Company may sell or arrange for the sale of Shares that Employee acquires as necessary to cover all Tax-Related Items that the Company or the Employer has to withhold or that are legally recoverable from the Employee (such as fringe benefit tax) at the time the restrictions on the RSUs lapse, unless the Company, in its sole discretion, has established alternative procedures for such payment. However, with respect to any RSUs subject to Section 409A, the Employer shall limit the surrender of Shares to the minimum number of Shares permitted to avoid a prohibited acceleration under Section 409A. The Employee will receive a cash refund for any fraction of a surrendered Share or Shares in excess of any and all Tax-Related Items. To the extent that any surrender of Shares or payment of cash or alternative procedure for such payment is insufficient, the Employee authorizes the Company, its Affiliates and Subsidiaries, which are qualified to deduct tax at source, to deduct from the Employee’s compensation all Tax-Related Items. The Employee agrees to pay any Tax-Related Items that cannot be satisfied from wages or other cash compensation, to the extent permitted by Applicable Law.

(b)Regardless of any action the Company or the Employer takes with respect to any or all Tax-Related Items, the Employee acknowledges and agrees that the ultimate liability for all Tax-Related Items is and remains the Employee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Employee further acknowledges that the Company and/or the Employer: (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of RSUs or dividend equivalents, including, but not limited to, the grant, vesting or settlement of RSUs or dividend equivalents, the subsequent delivery of Shares and/or cash upon settlement of such RSUs or the subsequent sale of any Shares acquired pursuant to such RSUs and receipt of any dividends or dividend equivalent payments; and (ii) notwithstanding Section 11, do not commit to and are under no obligation to structure the terms or any aspect of this grant of RSUs and/or dividend equivalents to reduce or eliminate the Employee’s liability for Tax-Related Items or to achieve any particular tax result. Further, if the Employee has become subject to tax in more than one jurisdiction, the Employee acknowledges that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(c)Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Employee’s jurisdiction(s), in which case the Employee will receive a refund of any over-withheld amount in cash and will have no entitlement to the Share equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Employee is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.

(d)The Employee shall pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Employee’s participation in the Plan or the Employee’s receipt of RSUs that cannot be satisfied by the means previously described. The Company may refuse to deliver the benefit described in Section 3 if the Employee fails to comply with the Employee’s obligations in connection with the Tax-Related Items.

(e)The Employee consents and agrees that in the event the RSUs or the dividend equivalents become subject to an employer tax that is legally permitted to be recovered from the Employee, as may be determined by the Company and/or the Employer at their sole discretion, and whether or not the Employee’s employment with the Company and/or the Employer is continuing at the time such tax becomes recoverable, the Employee will assume any liability for any such taxes that may be payable by the Company and/or the Employer in connection with the RSUs and dividend equivalents. Further, the Employee agrees that the Company and/or the Employer may collect any such taxes from the Employee by any of the means set forth in this Section 12. The Employee further agrees to execute any other consents or elections required to accomplish the above, promptly upon request of the Company.

13.Data Privacy Consent.
(a)The Employee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Employee’s personal data as described in this Grant Agreement and any other materials by and among, as applicable, the Company, its Subsidiaries or Affiliates, and the Employer for the exclusive purpose of implementing, administering and managing the Employee’s participation in the Plan.

(b)The Employee understands that the Company, its Subsidiaries and Affiliates, and the Employer may hold certain personal information about the Employee, including, but not limited to, name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency, status, job title, any shares of stock or directorships held in the Company, details of all RSUs, options or any other entitlement to shares of stock granted, canceled, purchased, exercised, vested, unvested or
3


outstanding in the Employee’s favor (“Data”) for the exclusive purpose of implementing, managing and administering the Plan.

(c)The Employee understands that Data may be transferred to Merrill Lynch and any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Employee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Employee’s country. The Company is committed to protecting the privacy of Data in such cases. The Employee understands that by contract both with the Company and/or any of its Subsidiaries or Affiliates and with Merrill Lynch and/or the Company’s other vendors, the people and companies that have access to the Employee’s Data are bound to handle such Data in a manner consistent with the Company’s privacy policy and law. The Company periodically performs due diligence and audits on its vendors in accordance with good commercial practices to ensure their capabilities and compliance with those commitments. The Employee further understands that Data will be held only as long as is necessary to implement, administer and manage the Employee’s participation in the Plan.

(d)The Employee understands that if the Employee resides outside the United States, the Employee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Employee’s local human resources representative. Further, the Employee understands that the Employee is providing the consents herein on a purely voluntary basis. If the Employee does not consent, or if the Employee later seeks to revoke the Employee’s consent, the Employee's employment status or service with the Company or the Employee’s Employer will not be affected; the only consequence of refusing or withdrawing the Employee’s consent is that the Company would not be able to grant the Employee RSUs or other equity awards or administer and manage the Employee’s participation in the Plan. Therefore, the Employee understands that refusing or withdrawing the Employee’s consent may affect the Employee’s ability to participate in the Plan. For more information on the consequences of the Employee’s refusal to consent or withdrawal of consent, the Employee understands that the Employee may contact the Employee’s local human resources representative.

(e)Further, the Employee understands that the Company may rely on a different legal basis for the processing and/or transfer of Data in the future and/or request that the Employee provide another data privacy consent. If applicable and upon request of the Company or a Subsidiary or Affiliate, the Employee agrees to provide an executed data privacy consent or acknowledgement (or any other consents, acknowledgements or agreements) to the Company or a Subsidiary or Affiliate that the Company and/or a Subsidiary or Affiliate may deem necessary to obtain under the data privacy laws in the Employee’s country of employment, either now or in the future. The Employee understands that the Employee may be unable to participate in the Plan if the Employee fails to execute any such acknowledgement, agreement or consent requested by the Company and/or a Subsidiary or Affiliate.

By electronically accepting RSUs on the Merrill Lynch website, the Employee is declaring that the Employee agrees with the data processing practices described in this Section 13 and that the Employee consents to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned therein for the purposes described therein.

14.Plan Information.
The Employee agrees to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with Applicable Laws outside the United States, from the Long-term Incentives website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the investor relations section of the Company's website at https://investor.hp.com/home/default.aspx. The Employee acknowledges that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Company Secretary. The Employee hereby consents to receive any documents related to current or future participation in the Plan by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

15.Acknowledgment and Waiver.
The Employee understands, acknowledges and agrees that:

(a)except as provided in Sections 8 and 9, the vesting of the RSUs is earned only by continuing employment with the Company or one of its Subsidiaries or Affiliates and that being hired and granted RSUs will not result in the RSUs vesting;

(b)this Grant Agreement and its incorporated documents reflect all agreements on its subject matters and the Employee is not accepting this Grant Agreement based on any promises, representations or inducements other than those reflected in this Grant Agreement;

(c)all good faith decisions and interpretations of the Committee regarding the Plan and RSUs granted under the Plan are binding, conclusive and final;

(d)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time;
(e)the grant of RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs or other awards, or benefits in lieu of RSUs, even if Shares or RSUs have been granted in the past;

(f)all decisions with respect to future grants, if any, will be at the sole discretion of the Company;

(g)the Employee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with the ability of the Employer to terminate the Employee’s employment relationship at any time and it is expressly agreed and understood that employment is terminable at the will of either party;

(h)the Employee is voluntarily participating in the Plan;
4


(i)RSUs and their resulting benefits are extraordinary items that are outside the scope of the Employee’s employment contract, if any;

(j)RSUs and their resulting benefits are not intended to replace any pension rights or compensation;

(k)RSUs and their resulting benefits are not part of normal or expected compensation or salary for any purposes, including, but not limited to calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

(l)unless otherwise agreed by the Company, the RSUs and their resulting benefits are not granted as consideration for, or in connection with, the service the Employee may provide as a director of a Subsidiary or Affiliate;

(m)this grant of RSUs will not be interpreted to form an employment contract or relationship with the Company, and furthermore, this grant of RSUs will not be interpreted to form an employment contract with any Subsidiary or Affiliate;

(n)the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(o)no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from (i) termination of Employee’s employment (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any), and/or (ii) the application of any recoupment policy or any recovery or clawback policy otherwise required by law, and in consideration of the grant of the RSUs to which the Employee is otherwise not entitled, the Employee agrees not to institute any claim against the Company, the Employer or any other Subsidiary or Affiliate and releases the Company, the Employer and any other Subsidiary and Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Employee shall be deemed irrevocably to have agreed not to pursue such claim and to have agreed to execute any and all documents necessary to request dismissal or withdrawal of such claims;

(p)the Company, the Employer or any other Subsidiary or Affiliate will not be liable for any foreign exchange rate fluctuation between the Employee’s local currency and the United States dollar that may affect the value of the RSUs or any amounts due to the Employee pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement;

(q)if the Company determines that the Employee has engaged in misconduct prohibited by Applicable Law or any applicable policy of the Company, as in effect from time to time, or the Company is required to make recovery from the Employee under Applicable Law or a Company policy adopted to comply with applicable legal requirements, then the Company may, in its sole discretion, to the extent it determines appropriate, (i) recover from the Employee the proceeds from RSUs vested up to three years prior to the Employee’s termination of employment or any time thereafter, (ii) cancel the Employee’s outstanding RSUs, and (iii) take any other action it deems to be required and appropriate; and

(r)the delivery of any documents related to the Plan or Awards granted under the Plan, including the Plan, this Grant Agreement, the Plan prospectus and any reports of the Company generally provided to the Company’s stockholders, may be made by electronic delivery. Such means of electronic delivery may include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via electronic mail or other such means of electronic delivery specified by the Company. The Employee may receive from the Company a paper copy of any documents delivered electronically at no cost to the Employee by contacting the Company in writing in accordance with Section 18(k). If the attempted electronic delivery of any document fails, the Employee will be provided with a paper copy of such document. The Employee may revoke the Employee’s consent to the electronic delivery of documents or may change the electronic mail address to which such documents are to be delivered (if the Employee has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised electronic mail address in accordance with Section 18(k). The Employee is not required to consent to the electronic delivery of documents.

16.No Advice Regarding Grant.
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Employee’s participation in the Plan, or the Employee’s acquisition or sale of the underlying Shares. The Employee is hereby advised to consult with the Employee’s own personal tax, legal and financial advisors regarding the Employee’s participation in the Plan before taking any action related to the Plan.

17.Additional Eligibility Requirements Permitted.
In addition to any other eligibility criteria provided for in the Plan, the Company may require that the Employee execute a separate document agreeing to the terms of a current arbitration agreement and/or a current ARCIPD, each in a form acceptable to the Company and/or that the Employee be in compliance with the ARCIPD throughout the entire Restriction Period and through the date the RSU is to be granted or settled. If such separate documents are required by the Company and the Employee does not accept them within 75 days of the Grant Date or such other date as of which the Company shall require in its discretion, this RSU shall be canceled and the Employee shall have no further rights under this Grant Agreement.

18.Miscellaneous.
(a)The Company shall not be required to treat as owner of RSUs and any associated benefits hereunder, any transferee to whom such RSUs or benefits shall have been transferred in violation of any of the provisions of this Grant Agreement.

(b)The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Grant Agreement.

(c)The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Employee with respect to the subject matter hereof, other than the terms of any severance plan applicable to the Employee that provides more favorable vesting. Notwithstanding the foregoing, nothing in the Plan or this Grant Agreement shall affect the validity or interpretation of any duly authorized written agreement between the Company and the
5


Employee under which an award properly granted under and pursuant to the Plan serves as any part of the consideration furnished to the Employee, including, without limitation, any agreement that imposes restrictions during or after employment regarding confidential information and proprietary developments. This Grant Agreement is governed by the laws of the state of Delaware without regard to its conflict of law provisions.

(d)If the Employee has received this or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

(e)The provisions of this Grant Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

(f)Notwithstanding Section 18(e), the Company’s obligations under this Grant Agreement and the Employee’s agreement to the terms of an arbitration agreement and/or an ARCIPD, if any, are mutually dependent. In the event that the Employee breaches the arbitration agreement or the Employee’s ARCIPD is breached or found not to be binding upon the Employee for any reason by a court of law, then the Company will have no further obligation or duty to perform under the Plan or this Grant Agreement.

(g)A waiver by the Company of a breach of any provision of this Grant Agreement shall not operate or be construed as a waiver of any other provision of this Grant Agreement, or of any subsequent breach by the Employee or any other Participant.

(h)The Employee acknowledges that, depending on the Employee or broker’s country of residence or where the Company Shares are listed, the Employee may be subject to insider trading restrictions and/or market abuse laws, which may affect the Employee's ability to acquire, sell or otherwise dispose of Shares or rights to Shares during times the Employee is considered to have “inside information” regarding the Company (as defined by the laws in the Employee’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Employee placed before the Employee possessed inside information. Furthermore, the Employee cold be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Employee acknowledges that it is the Employee’s responsibility to comply with any applicable restrictions and that the Employee should to consult the Employee’s personal advisor on this matter.

(i)Notwithstanding any provisions in this Grant Agreement, for any Employee who resides and/or works in a country other than the United States, the grant of the RSUs shall be subject to any additional terms and conditions set forth in the Appendix to this Grant Agreement for the Employee’s country of employment (account of residence, if different), if any. Moreover, if the Employee relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to the Employee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal, regulatory, tax or administrative reasons. The Appendix, if any, constitutes part of this Grant Agreement.

(j)The Company reserves the right to impose other requirements on the Employee’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Employee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

(k)All RSUs granted and/or Shares issued under this Grant Agreement are subject to claw back under the Company policy as in effect from time to time.

(l)Any notice required or permitted hereunder to the Employee shall be given in writing and shall be deemed effectively given upon delivery to the Employee at the address then on file with the Company.

(m)Any notice to be given under the terms of this Grant Agreement to the Company will be addressed in care of Attn: Global Equity at HP Inc., 1501 Page Mill Road, Palo Alto, California 94304, USA.

(n)The Employee acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect the Employee’s ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends or dividend equivalent payments) in a brokerage or bank account outside the Employee's country. The Employee may be required to report such accounts, assets or transactions to the tax or other authorities in the Employee’s country. The Employee also may be required to repatriate sale proceeds or other funds received as a result of the Employee's participation in the Plan to the Employee’s country through a designated bank or broker within a certain time after receipt. The Employee acknowledges that it is the Employee’s responsibility to be compliant with such regulations, and the Employee is advised to consult the Employee’s personal legal advisor for any details.

19.Forfeitures and Recoupment.
(a)Recoupment Policy. The RSUs granted hereunder, any Shares issued pursuant to the RSUs and any proceeds therefrom shall be subject to and remain subject to any incentive compensation clawback or recoupment policy of the Company (i) currently in effect, (ii) as may be adopted by the Company to comply with applicable law and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, including, without limitation, pursuant to Section 10D of the Exchange Act, Rule 10D-1 thereunder and Section 303A.14 of the New York Stock Exchange Listed Company Manual) or (iii) as may be adopted by the Company to facilitate the Company’s objectives related to eliminating or reducing fraud, misconduct, wrongdoing, or violations of law by an employee or other service provider or related to improving the Company’s governance practices or similar considerations and, in each case, as may be amended from time to time (the “Policy”), with the provisions contained in such Policy deemed incorporated into this Grant Agreement without Employee’s additional or separate consent.

(b)Recoupment Authorization. For purposes of the foregoing, the Employee expressly and explicitly authorizes the Company to issue instructions, on the Employee's behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to this RSU to re-convey, transfer or otherwise return such Shares
6


and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Grant Agreement and the Policy conflict, the terms of the Policy shall prevail.


HP Inc.


Enrique Lores
CEO and President




    Kristen Ludgate
Chief People Officer



RETAIN THIS GRANT AGREEMENT FOR YOUR RECORDS

Important Note: Your grant is subject to the terms and conditions of this Grant Agreement, including any Appendix for your country of employment, and to the Company obtaining all necessary government approvals. If you have questions regarding your grant, please contact global.equity@hp.com.

7

 EX-10.(G)(G)(G)(G) 3 hpq-retentionrsuagreementf.htm EX-10.(G)(G)(G)(G) Document
Exhibit 10(g)(g)(g)(g)
image_06.jpg


RETENTION GRANT AGREEMENT for use from November 1, 2023


Name:
fld_NAME_AC
Employee ID:
fld_EMPLID
    
Grant Date:
expGRANT_DATE
Grant ID:
fld_GRANT_NBR
Amount:
0
Plan:
fld_DESCR
Vesting Schedule:
fld_HTMLAREA1

Restricted Stock Units

    THIS GRANT AGREEMENT, as of the Grant Date noted above between HP Inc., a Delaware Corporation (“Company”), and the employee named above (“Employee”), is entered into as follows:

    WHEREAS, the continued participation of the Employee is considered by the Company to be important for the Company's continued growth; and

    WHEREAS, in order to give the Employee an incentive to continue in the employ of the Company (or its Affiliates or Subsidiaries), to accept ancillary agreements designed to protect the legitimate business interests of the Company that are made a condition of this grant and to participate in the affairs of the Company, the HR and Compensation Committee of the Board of Directors of the Company or its delegates (“Committee”) has determined that the Employee shall be granted restricted stock units representing hypothetical shares of the Company’s common stock (“RSUs”), with each RSU equal in value to one share of the Company’s $0.01 par value common stock (“Share”), subject to the restrictions stated below and in accordance with the terms and conditions of the plan named above (“Plan”), a copy of which can be found on the Long-term Incentives website along with a copy of the related prospectus. The Plan and the related prospectus also can be obtained by written or telephonic request to the Company Secretary. Unless otherwise defined in this Grant Agreement, any capitalized terms in this Grant Agreement shall have the meaning ascribed to such terms in the Plan.

    THEREFORE, the parties agree as follows:

1.Grant of Restricted Stock Units.
Subject to the terms and conditions of this Grant Agreement and of the Plan, the Company hereby grants to the Employee the number of RSUs set forth above.

2.Vesting Schedule.
The interest of the Employee in the RSUs shall vest according to the vesting schedule set forth above, or if earlier, in accordance with Section 8 or 9, below, except to the extent a severance plan applicable to the Employee provides otherwise. Unless the provisions of Section 8 or 9 apply, the Employee must remain in the employ of the Company, any Subsidiary or Affiliate on a continuous basis through the close of business on the applicable Vesting Date, as set forth above, and the Employee must be in compliance with the requirements and conditions provided for in the Plan and this Grant Agreement for the interest of the Employee in the RSUs to become fully vested on that date.

3.Benefit Upon Settlement.
Within 75 days of each Vesting Date set forth on the above vesting schedule or, if earlier, a vesting event pursuant to Section 8 or 9 below, the Company shall deliver or pay, as applicable, to the Employee (or the Employee’s guardian, estate or beneficiary in the event of Section 8 or 9) Shares or a combination of cash and Shares, as the Company determines in its sole discretion, with a value equal to:

(a)    the number of RSUs that have become vested as of such vesting date or vesting event, as applicable, multiplied by the Fair Market Value of a Share on the date on which such RSUs vested; plus
(b)    a dividend equivalent payment credited in the form of additional RSUs for each ordinary cash dividend the Company pays on its Shares and for which the record date occurs between the grant date and the date the RSUs are settled, determined by:
(1)multiplying the per share cash dividend paid by the Company on its Shares by the total number of RSUs that are outstanding as of the record date for the dividend; and
1


(2)dividing the amount determined in (1) above by the Fair Market Value of a Share on the dividend payment date to determine the number of additional whole and fractional RSUs to be credited to the Employee;
provided, however, that if any aggregated dividend equivalent payments in Section (b)(2) above to be delivered in Shares result in a payment of a fractional Share, such fractional Share shall be rounded up to the next whole Share.

Notwithstanding the foregoing, the Company may, in its sole discretion, settle the RSUs in the form of a cash payment to the extent settlement in Shares: (i) is prohibited under local law; (ii) would require the Employee, the Company and/or any Subsidiary or Affiliate to obtain the approval of any governmental and/or regulatory body in the Employee's country; (iii) would result in adverse tax consequences for the Employee, the Company or any Subsidiary or Affiliate; or (iv) is administratively burdensome. Alternatively, the Company may, in its sole discretion, settle the RSUs in the form of Shares but require the Employee to sell such Shares immediately or within a specified period of time following the Employee’s termination of employment (in which case the Employee expressly authorizes the Company to issue sales instructions on the Employee's behalf).

4.Restrictions.
Except as otherwise provided for in this Grant Agreement, the RSUs or rights granted hereunder may not be sold, pledged or otherwise transferred. The period of time between the Grant Date and the date the RSUs become fully vested pursuant to Section 2 is referred to herein as the “Restriction Period.”
5.Custody of Restricted Stock Units.
The RSUs subject hereto shall be recorded in an account with the Plan broker in the name of the Employee. Upon termination of the Restriction Period, if the Company determines, in its sole discretion, to deliver Shares pursuant to Section 3 above, such Shares shall be released into the Employee’s account; provided, however, that a portion of such Shares shall be surrendered in payment of Tax-Related Items, as defined and in accordance with Section 12 below, unless the Company, in its sole discretion, establishes alternative procedures for the payment of Tax-Related Items.

6.No Stockholder Rights.
RSUs represent hypothetical Shares. Until Shares are delivered to the Employee pursuant to the terms of this Grant Agreement, the Employee shall not be entitled to any of the rights or benefits generally accorded to stockholders, including, without limitation, the receipt of dividends.

7.Termination of Employment.
Except as otherwise provided for in this Grant Agreement or in the Plan or as otherwise determined by the Company in its sole discretion, if the Employee's employment with the Company, any Subsidiary or Affiliate is terminated at any time for any reason prior to the lapse of the Restriction Period, all unvested RSUs granted hereunder shall be forfeited by the Employee, except to the extent a severance plan applicable to the Employee provides otherwise.

For purposes of this Grant Agreement, the Employee's employment or service will be considered terminated as of the date the Employee is no longer actively providing services to the Company, any Subsidiary or Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any) and will not be extended by any notice period (e.g., the Employee's period of employment or service would not include any contractual notice period or any period of “garden leave” or similar period mandated under the employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when the Employee's employment or service is terminated for purposes of this Grant Agreement (including whether the Employee may still be considered to be providing service while on a leave of absence).

8.Disability of the Employee.
If the Employee’s employment is terminated prior to the end of the Restriction Period by reason of the Employee’s Total and Permanent Disability, all RSUs shall immediately vest including any amounts for dividend equivalent payments on RSUs that vest at termination. The Company’s obligation to vest the RSUs under this paragraph is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company, and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the RSU remains outstanding.

9.Death of the Employee.
In the event that termination of employment prior to the end of the Restriction Period is due to the death of the Employee, all unvested RSUs shall immediately vest including any amounts for dividend equivalent payments on such vested RSUs.

10.Termination for Cause.
Upon termination of the Employee’s employment for Cause (as defined in the Plan), then all unvested RSUs shall be forfeited by the Employee on the date of the Employee’s termination, except to the extent a severance plan applicable to the Employee provides otherwise. Such forfeiture shall occur regardless of whether the Employee has satisfied any applicable age and service requirements for retirement.

11.Section 409A.
The following provisions apply to the extent the Employee is subject to taxation in the U.S. Payments made pursuant to the Plan and this Grant Agreement are intended to comply with or qualify for an exemption from Section 409A of the Code (“Section 409A”). The Company reserves the right, to the extent the Company deems necessary or advisable in its sole discretion, to unilaterally amend or modify the Plan and/or this Grant Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, including any amendments or actions that would result in the reduction of benefits payable under this Grant Agreement, as the Company determines are necessary or appropriate to ensure that all RSUs and dividend equivalent payments are made in a manner that qualifies for an exemption from, or complies with, Section 409A or mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Section 409A: provided however, that the Company makes no representations that the RSUs or dividend equivalents will be exempt from
2


any taxes, interest, and/or penalties that may apply under Section 409A and makes no undertaking to preclude Section 409A from applying to this RSU. For the avoidance of doubt, the Employee hereby acknowledges and agrees that neither the Company nor any Affiliate or Subsidiary will have any liability to the Employee or any other party if any amounts payable under this Grant Agreement are not exempt from, or compliant with, Section 409A, or for any action taken by the Company with respect thereto. Any payments under this Grant Agreement, the settlement of which is triggered by a "separation from service" (within the meaning of Section 409A) of a "specified employee" (as defined under Section 409A), shall be made on a date that is the earlier of (a) the Employee’s death or (b) the later of the specified settlement date and the date which is six months after the date of the Employee’s separation from service.

12.Taxes.
(a)The Employee shall be liable for any and all taxes, including income tax, social insurance, fringe benefit tax, payroll tax, payment on account, employer taxes or other tax-related items related to the Employee’s participation in the Plan and legally applicable to or otherwise recoverable from the Employee by the Company and/or, if different, the Employee’s employer (the “Employer”) whether incurred at grant, vesting, sale, prior to vesting or at any other time (“Tax-Related Items”). In the event that the Company or the Employer (which, for purposes of this Section 12, shall include a former employer) is required, allowed or permitted to withhold taxes as a result of the grant or vesting of RSUs or the issuance or subsequent sale of Shares acquired pursuant to such RSUs, or due upon receipt of dividend equivalent payments or dividends, the Employee shall surrender a sufficient number of whole Shares, make a cash payment or make adequate arrangements satisfactory to the Company and/or the Employer to withhold such taxes from Employee’s wages or other cash compensation paid to the Employee by the Company and/or the Employer at the election of the Company, in its sole discretion, or, if permissible under local law, the Company may sell or arrange for the sale of Shares that Employee acquires as necessary to cover all Tax-Related Items that the Company or the Employer has to withhold or that are legally recoverable from the Employee (such as fringe benefit tax) at the time the restrictions on the RSUs lapse, unless the Company, in its sole discretion, has established alternative procedures for such payment. However, with respect to any RSUs subject to Section 409A, the Employer shall limit the surrender of Shares to the minimum number of Shares permitted to avoid a prohibited acceleration under Section 409A. The Employee will receive a cash refund for any fraction of a surrendered Share or Shares in excess of any and all Tax-Related Items. To the extent that any surrender of Shares or payment of cash or alternative procedure for such payment is insufficient, the Employee authorizes the Company, its Affiliates and Subsidiaries, which are qualified to deduct tax at source, to deduct from the Employee’s compensation all Tax-Related Items. The Employee agrees to pay any Tax-Related Items that cannot be satisfied from wages or other cash compensation, to the extent permitted by Applicable Law.

(b)Regardless of any action the Company or the Employer takes with respect to any or all Tax-Related Items, the Employee acknowledges and agrees that the ultimate liability for all Tax-Related Items is and remains the Employee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Employee further acknowledges that the Company and/or the Employer: (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of RSUs or dividend equivalents, including, but not limited to, the grant, vesting or settlement of RSUs or dividend equivalents, the subsequent delivery of Shares and/or cash upon settlement of such RSUs or the subsequent sale of any Shares acquired pursuant to such RSUs and receipt of any dividends or dividend equivalent payments; and (ii) notwithstanding Section 11, do not commit to and are under no obligation to structure the terms or any aspect of this grant of RSUs and/or dividend equivalents to reduce or eliminate the Employee’s liability for Tax-Related Items or to achieve any particular tax result. Further, if the Employee has become subject to tax in more than one jurisdiction, the Employee acknowledges that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(c)Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Employee’s jurisdiction(s), in which case the Employee will receive a refund of any over-withheld amount in cash and will have no entitlement to the Share equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Employee is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.

(d)The Employee shall pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Employee’s participation in the Plan or the Employee’s receipt of RSUs that cannot be satisfied by the means previously described. The Company may refuse to deliver the benefit described in Section 3 if the Employee fails to comply with the Employee’s obligations in connection with the Tax-Related Items.

(e)The Employee consents and agrees that in the event the RSUs or the dividend equivalents become subject to an employer tax that is legally permitted to be recovered from the Employee, as may be determined by the Company and/or the Employer at their sole discretion, and whether or not the Employee’s employment with the Company and/or the Employer is continuing at the time such tax becomes recoverable, the Employee will assume any liability for any such taxes that may be payable by the Company and/or the Employer in connection with the RSUs and dividend equivalents. Further, the Employee agrees that the Company and/or the Employer may collect any such taxes from the Employee by any of the means set forth in this Section 12. The Employee further agrees to execute any other consents or elections required to accomplish the above, promptly upon request of the Company.

13.Data Privacy Consent.
(a)The Employee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Employee’s personal data as described in this Grant Agreement and any other materials by and among, as applicable, the Company, its Subsidiaries or Affiliates, and the Employer for the exclusive purpose of implementing, administering and managing the Employee’s participation in the Plan.

(b)The Employee understands that the Company, its Subsidiaries and Affiliates, and the Employer may hold certain personal information about the Employee, including, but not limited to, name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency, status, job title, any shares of stock or directorships held in the Company, details of all RSUs, options or any other entitlement to shares of stock granted, canceled, purchased, exercised, vested, unvested or
3


outstanding in the Employee’s favor (“Data”) for the exclusive purpose of implementing, managing and administering the Plan.

(c)The Employee understands that Data may be transferred to Merrill Lynch and any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Employee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Employee’s country. The Company is committed to protecting the privacy of Data in such cases. The Employee understands that by contract both with the Company and/or any of its Subsidiaries or Affiliates and with Merrill Lynch and/or the Company’s other vendors, the people and companies that have access to the Employee’s Data are bound to handle such Data in a manner consistent with the Company’s privacy policy and law. The Company periodically performs due diligence and audits on its vendors in accordance with good commercial practices to ensure their capabilities and compliance with those commitments. The Employee further understands that Data will be held only as long as is necessary to implement, administer and manage the Employee’s participation in the Plan.

(d)The Employee understands that if the Employee resides outside the United States, the Employee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Employee’s local human resources representative. Further, the Employee understands that the Employee is providing the consents herein on a purely voluntary basis. If the Employee does not consent, or if the Employee later seeks to revoke the Employee’s consent, the Employee's employment status or service with the Company or the Employee’s Employer will not be affected; the only consequence of refusing or withdrawing the Employee’s consent is that the Company would not be able to grant the Employee RSUs or other equity awards or administer and manage the Employee’s participation in the Plan. Therefore, the Employee understands that refusing or withdrawing the Employee’s consent may affect the Employee’s ability to participate in the Plan. For more information on the consequences of the Employee’s refusal to consent or withdrawal of consent, the Employee understands that the Employee may contact the Employee’s local human resources representative.

(e)Further, the Employee understands that the Company may rely on a different legal basis for the processing and/or transfer of Data in the future and/or request that the Employee provide another data privacy consent. If applicable and upon request of the Company or a Subsidiary or Affiliate, the Employee agrees to provide an executed data privacy consent or acknowledgement (or any other consents, acknowledgements or agreements) to the Company or a Subsidiary or Affiliate that the Company and/or a Subsidiary or Affiliate may deem necessary to obtain under the data privacy laws in the Employee’s country of employment, either now or in the future. The Employee understands that the Employee may be unable to participate in the Plan if the Employee fails to execute any such acknowledgement, agreement or consent requested by the Company and/or a Subsidiary or Affiliate.

By electronically accepting RSUs on the Merrill Lynch website, the Employee is declaring that the Employee agrees with the data processing practices described in this Section 13 and that the Employee consents to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned therein for the purposes described therein.

14.Plan Information.
The Employee agrees to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with Applicable Laws outside the United States, from the Long-term Incentives website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the investor relations section of the Company's website at https://investor.hp.com/home/default.aspx. The Employee acknowledges that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Company Secretary. The Employee hereby consents to receive any documents related to current or future participation in the Plan by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

15.Acknowledgment and Waiver.
The Employee understands, acknowledges and agrees that:

(a)except as provided in Sections 8 and 9, the vesting of the RSUs is earned only by continuing employment with the Company or one of its Subsidiaries or Affiliates and that being hired and granted RSUs will not result in the RSUs vesting;

(b)this Grant Agreement and its incorporated documents reflect all agreements on its subject matters and the Employee is not accepting this Grant Agreement based on any promises, representations or inducements other than those reflected in this Grant Agreement;

(c)all good faith decisions and interpretations of the Committee regarding the Plan and RSUs granted under the Plan are binding, conclusive and final;

(d)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time;
(e)the grant of RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs or other awards, or benefits in lieu of RSUs, even if Shares or RSUs have been granted in the past;

(f)all decisions with respect to future grants, if any, will be at the sole discretion of the Company;

(g)the Employee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with the ability of the Employer to terminate the Employee’s employment relationship at any time and it is expressly agreed and understood that employment is terminable at the will of either party;

(h)the Employee is voluntarily participating in the Plan;
4


(i)RSUs and their resulting benefits are extraordinary items that are outside the scope of the Employee’s employment contract, if any;

(j)RSUs and their resulting benefits are not intended to replace any pension rights or compensation;

(k)RSUs and their resulting benefits are not part of normal or expected compensation or salary for any purposes, including, but not limited to calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

(l)unless otherwise agreed by the Company, the RSUs and their resulting benefits are not granted as consideration for, or in connection with, the service the Employee may provide as a director of a Subsidiary or Affiliate;

(m)this grant of RSUs will not be interpreted to form an employment contract or relationship with the Company, and furthermore, this grant of RSUs will not be interpreted to form an employment contract with any Subsidiary or Affiliate;

(n)the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(o)no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from (i) termination of Employee’s employment (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any), and/or (ii) the application of any recoupment policy or any recovery or clawback policy otherwise required by law, and in consideration of the grant of the RSUs to which the Employee is otherwise not entitled, the Employee agrees not to institute any claim against the Company, the Employer or any other Subsidiary or Affiliate and releases the Company, the Employer and any other Subsidiary and Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Employee shall be deemed irrevocably to have agreed not to pursue such claim and to have agreed to execute any and all documents necessary to request dismissal or withdrawal of such claims;

(p)the Company, the Employer or any other Subsidiary or Affiliate will not be liable for any foreign exchange rate fluctuation between the Employee’s local currency and the United States dollar that may affect the value of the RSUs or any amounts due to the Employee pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement;

(q)if the Company determines that the Employee has engaged in misconduct prohibited by Applicable Law or any applicable policy of the Company, as in effect from time to time, or the Company is required to make recovery from the Employee under Applicable Law or a Company policy adopted to comply with applicable legal requirements, then the Company may, in its sole discretion, to the extent it determines appropriate, (i) recover from the Employee the proceeds from RSUs vested up to three years prior to the Employee’s termination of employment or any time thereafter, (ii) cancel the Employee’s outstanding RSUs, and (iii) take any other action it deems to be required and appropriate; and

(r)the delivery of any documents related to the Plan or Awards granted under the Plan, including the Plan, this Grant Agreement, the Plan prospectus and any reports of the Company generally provided to the Company’s stockholders, may be made by electronic delivery. Such means of electronic delivery may include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via electronic mail or other such means of electronic delivery specified by the Company. The Employee may receive from the Company a paper copy of any documents delivered electronically at no cost to the Employee by contacting the Company in writing in accordance with Section 18(k). If the attempted electronic delivery of any document fails, the Employee will be provided with a paper copy of such document. The Employee may revoke the Employee’s consent to the electronic delivery of documents or may change the electronic mail address to which such documents are to be delivered (if the Employee has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised electronic mail address in accordance with Section 18(k). The Employee is not required to consent to the electronic delivery of documents.

16.No Advice Regarding Grant.
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Employee’s participation in the Plan, or the Employee’s acquisition or sale of the underlying Shares. The Employee is hereby advised to consult with the Employee’s own personal tax, legal and financial advisors regarding the Employee’s participation in the Plan before taking any action related to the Plan.

17.Additional Eligibility Requirements Permitted.
In addition to any other eligibility criteria provided for in the Plan, the Company may require that the Employee execute a separate document agreeing to the terms of a current arbitration agreement and/or a current ARCIPD, each in a form acceptable to the Company and/or that the Employee be in compliance with the ARCIPD throughout the entire Restriction Period and through the date the RSU is to be granted or settled. If such separate documents are required by the Company and the Employee does not accept them within 75 days of the Grant Date or such other date as of which the Company shall require in its discretion, this RSU shall be canceled and the Employee shall have no further rights under this Grant Agreement.

18.Miscellaneous.
(a)The Company shall not be required to treat as owner of RSUs and any associated benefits hereunder, any transferee to whom such RSUs or benefits shall have been transferred in violation of any of the provisions of this Grant Agreement.

(b)The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Grant Agreement.

(c)The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Employee with respect to the subject matter hereof, other than the terms of any severance plan applicable to the Employee that provides more favorable vesting. Notwithstanding the foregoing, nothing in the Plan or this Grant Agreement shall affect the validity or interpretation of any duly authorized written agreement between the Company and the
5


Employee under which an award properly granted under and pursuant to the Plan serves as any part of the consideration furnished to the Employee, including, without limitation, any agreement that imposes restrictions during or after employment regarding confidential information and proprietary developments. This Grant Agreement is governed by the laws of the state of Delaware without regard to its conflict of law provisions.

(d)If the Employee has received this or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

(e)The provisions of this Grant Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

(f)Notwithstanding Section 18(e), the Company’s obligations under this Grant Agreement and the Employee’s agreement to the terms of an arbitration agreement and/or an ARCIPD, if any, are mutually dependent. In the event that the Employee breaches the arbitration agreement or the Employee’s ARCIPD is breached or found not to be binding upon the Employee for any reason by a court of law, then the Company will have no further obligation or duty to perform under the Plan or this Grant Agreement.

(g)A waiver by the Company of a breach of any provision of this Grant Agreement shall not operate or be construed as a waiver of any other provision of this Grant Agreement, or of any subsequent breach by the Employee or any other Participant.

(h)The Employee acknowledges that, depending on the Employee or broker’s country of residence or where the Company Shares are listed, the Employee may be subject to insider trading restrictions and/or market abuse laws, which may affect the Employee's ability to acquire, sell or otherwise dispose of Shares or rights to Shares during times the Employee is considered to have “inside information” regarding the Company (as defined by the laws in the Employee’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Employee placed before the Employee possessed inside information. Furthermore, the Employee cold be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Employee acknowledges that it is the Employee’s responsibility to comply with any applicable restrictions and that the Employee should to consult the Employee’s personal advisor on this matter.

(i)Notwithstanding any provisions in this Grant Agreement, for any Employee who resides and/or works in a country other than the United States, the grant of the RSUs shall be subject to any additional terms and conditions set forth in the Appendix to this Grant Agreement for the Employee’s country of employment (account of residence, if different), if any. Moreover, if the Employee relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to the Employee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal, regulatory, tax or administrative reasons. The Appendix, if any, constitutes part of this Grant Agreement.

(j)The Company reserves the right to impose other requirements on the Employee’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Employee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

(k)All RSUs granted and/or Shares issued under this Grant Agreement are subject to claw back under the Company policy as in effect from time to time.

(l)Any notice required or permitted hereunder to the Employee shall be given in writing and shall be deemed effectively given upon delivery to the Employee at the address then on file with the Company.

(m)Any notice to be given under the terms of this Grant Agreement to the Company will be addressed in care of Attn: Global Equity at HP Inc., 1501 Page Mill Road, Palo Alto, California 94304, USA.

(n)The Employee acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect the Employee’s ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends or dividend equivalent payments) in a brokerage or bank account outside the Employee's country. The Employee may be required to report such accounts, assets or transactions to the tax or other authorities in the Employee’s country. The Employee also may be required to repatriate sale proceeds or other funds received as a result of the Employee's participation in the Plan to the Employee’s country through a designated bank or broker within a certain time after receipt. The Employee acknowledges that it is the Employee’s responsibility to be compliant with such regulations, and the Employee is advised to consult the Employee’s personal legal advisor for any details.

19.Forfeitures and Recoupment.
(a)Recoupment Policy. The RSUs granted hereunder, any Shares issued pursuant to the RSUs and any proceeds therefrom shall be subject to and remain subject to any incentive compensation clawback or recoupment policy of the Company (i) currently in effect, (ii) as may be adopted by the Company to comply with applicable law and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, including, without limitation, pursuant to Section 10D of the Exchange Act, Rule 10D-1 thereunder and Section 303A.14 of the New York Stock Exchange Listed Company Manual) or (iii) as may be adopted by the Company to facilitate the Company’s objectives related to eliminating or reducing fraud, misconduct, wrongdoing, or violations of law by an employee or other service provider or related to improving the Company’s governance practices or similar considerations and, in each case, as may be amended from time to time (the “Policy”), with the provisions contained in such Policy deemed incorporated into this Grant Agreement without Employee’s additional or separate consent.

(b)Recoupment Authorization. For purposes of the foregoing, the Employee expressly and explicitly authorizes the Company to issue instructions, on the Employee's behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to this RSU to re-convey, transfer or otherwise return such Shares
6


and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Grant Agreement and the Policy conflict, the terms of the Policy shall prevail.


HP Inc.


Enrique Lores
CEO and President




    Kristen Ludgate
Chief People Officer



RETAIN THIS GRANT AGREEMENT FOR YOUR RECORDS

Important Note: Your grant is subject to the terms and conditions of this Grant Agreement, including any Appendix for your country of employment, and to the Company obtaining all necessary government approvals. If you have questions regarding your grant, please contact global.equity@hp.com.
7

 EX-10.(H)(H)(H)(H) 4 hpq-standardnqsoagreementf.htm EX-10.(H)(H)(H)(H) Document
Exhibit 10(h)(h)(h)(h)
image_0.jpg
GRANT AGREEMENT for use from November 1, 2023


Name:

Fld_NAME_AC

Employee ID:

Fld_EMPLID

Grant Date:
expGRANT_DATE
Grant ID:
Fld_GRANT_NBR
Grant Price:
$fld_NAME1_AC
Amount:
0
Plan:
Fld_DESCR
Vesting Schedule:
Fld_HTMLAREA1

Non-Qualified Stock Option

    THIS GRANT AGREEMENT, as of the Grant Date noted above between HP Inc., a Delaware corporation (“Company”), and the employee named above (“Employee”), is entered into as follows:

    WHEREAS, the continued participation of the Employee is considered by the Company to be important for the Company's continued growth; and

WHEREAS, in order to give the Employee an incentive to continue in the employ of the Company (or its Affiliates or Subsidiaries), to accept ancillary agreements designed to protect the legitimate business interests of the Company that are made a condition of this grant and to participate in the affairs of the Company, the HR and Compensation Committee of the Board of Directors of the Company or its delegates (“Committee”) has determined that the Employee shall be granted a non-qualified stock option to purchase the number of shares stated above of its $0.01 par value voting Common Stock (“Shares”) upon the terms and conditions set forth herein and in accordance with the terms and conditions of the Plan named above, a copy of which can be found on the Long-term Incentives website along with a copy of the related prospectus. The Plan and the related prospectus can also be obtained by written or telephonic request to the Company Secretary. Unless otherwise defined in this Grant Agreement, any capitalized terms in this Grant Agreement shall have the meaning ascribed to such terms in the Plan.

THEREFORE, the parties agree as follows:
1.Grant of Stock Options.
This non-qualified Stock Option is granted under and pursuant to the Plan and is subject to each and all of the provisions thereof.
2.Grant Price.
The Grant Price is the price per Share set forth above.            
3.Restrictions on Transfer.
This Stock Option is not transferable by the Employee otherwise than by will or the laws of descent and distribution, and is exercisable only by the Employee during the Employee’s lifetime. This Stock Option may not be transferred, assigned, pledged or hypothecated by the Employee during the Employee’s lifetime, whether by operation of law or otherwise, and is not subject to execution, attachment or similar process.
4.Vesting Schedule.
This Stock Option will vest and become exercisable according to the vesting schedule set forth above except as otherwise provided in this Grant Agreement and except to the extent a severance plan applicable to the Employee provides otherwise, subject to the Employee’s compliance with the terms and conditions of the Plan and this Grant Agreement.
5.Expiration Date.
This Stock Option will expire on the 10th anniversary of the Grant Date set forth above ("Expiration Date"), unless sooner terminated or canceled in accordance with the provisions of the Plan and this Grant Agreement. The Employee must exercise this Stock Option, if at all, on a day the New York Stock Exchange is open for trading and on or before the Expiration Date. The Employee shall be solely responsible for exercising this Stock Option, if at all, prior to its Expiration Date. The Company shall have no obligation to notify the Employee of this Stock Option’s expiration.

6.Method of Exercise.
This Stock Option, to the extent it is then vested and exercisable, may be exercised through a broker designated by the Company or by any other method the Committee has approved; provided, however, that no such exercise shall be with respect to fewer than twenty-five (25) Shares or the remaining Shares covered by the Stock Option if less than twenty-five. The exercise must be accompanied by the payment of the full Grant Price of such Shares and any Tax-Related Items withholding. Payment may be in cash or Shares or a combination thereof to the extent permissible under Applicable Law, or through a broker-assisted cashless exercise; provided, however, that any payment in Shares shall be in strict compliance with all procedural rules established by the Committee.
1

7.Termination of Employment.
Except as otherwise provided for in this Grant Agreement or in the Plan or as otherwise determined by the Company in its sole discretion, all unvested Shares shall be forfeited by the Employee as of the date of termination and the Employee may exercise the Stock Option, to the extent that it is then vested, within three months after the date of the Employee’s termination (but in no event later than the Expiration Date), except to the extent a severance plan applicable to the Employee provides otherwise.

For purposes of this Grant Agreement, the Employee's employment or service will be considered terminated as of the date the Employee is no longer actively providing services to the Company, any Subsidiary or Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any) and will not be extended by any notice period (e.g., the Employee's period of employment or service would not include any contractual notice period or any period of “garden leave” or similar period mandated under the employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when the Employee's employment or service is terminated for purposes of this Grant Agreement (including whether the Employee may still be considered to be providing service while on a leave of absence).
8.Death of Employee.
Notwithstanding the provisions of Section 4 of this Grant Agreement, in the event of the Employee's death this Stock Option shall vest in full and the Employee’s legal representative or designated beneficiary shall have the right to exercise all or a portion of the Employee's rights under this Grant Agreement within one year after the death of the Employee, and shall be bound by the provisions of the Plan. In all cases, however, this Stock Option will expire no later than the Expiration Date.
9.Disability or Retirement of the Employee.
Notwithstanding the provisions of Section 4 of this Grant Agreement, in the event of the Employee’s termination due to retirement in accordance with the applicable retirement policy, or Permanent and Total Disability, this Stock Option shall vest in full and the Employee may exercise the Employee’s rights under this Grant Agreement within three years from the date of termination. In all cases, however, this Stock Option will expire no later than the Expiration Date. The Company’s obligation to vest the Stock Option under this paragraph is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company and any-post employment period during which the Stock Option remains outstanding and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the Stock Option remains outstanding.

10.Termination for Cause.
Upon termination of the Employee’s employment for Cause (as defined in the Plan), then, except as provided in Section 17(a), all unvested Shares shall be forfeited by the Employee and the Employee may exercise the Stock Option, to the extent that it is then vested, before the New York Stock Exchange closes on the date of the Employee’s termination, except to the extent a severance plan applicable to the Employee provides otherwise. Such forfeiture shall occur regardless of whether the Employee has satisfied any applicable age and service requirements for retirement.

11.Taxes.
(a) The Employee shall be liable for any and all taxes, including income tax, social insurance, fringe benefit tax, payroll tax, payment on account, employer taxes, or other tax-related items related to the Employee’s participation in the Plan and legally applicable to or otherwise recoverable from the Employee by the Company and/or, if different, the Employee’s employer (the “Employer”) whether incurred at grant, vesting, exercise, sale, prior to vesting or at any other time (“Tax-Related Items”). In the event that the Company or the Employer (which, for purposes of this Section 11, shall include a form employer) is required, allowed or permitted to withhold taxes as a result of the grant, vesting or exercise of the Stock Options, or subsequent sale of Shares acquired pursuant to such Stock Options, the Employee shall make a cash payment or make adequate arrangements satisfactory to the Company and/or the Employer to withhold such taxes from Employee’s wages or other cash compensation paid to the Employee by the Company and/or the Employer at the election of the Company, in its sole discretion, or, if permissible under Applicable Law, the Company may sell or arrange for the sale of Shares that Employee acquires as necessary to cover all applicable required withholding Tax-Related Items that are legally recoverable from the Employee at the time of the tax withholding event, unless the Company, in its sole discretion, has established alternative procedures for such payment. To the extent that any surrender of Shares or payment of cash or alternative procedure for such payment is insufficient, the Employee authorizes the Company, its Affiliates and Subsidiaries, which are qualified to deduct tax at source, to deduct from the Employee’s compensation all Tax-Related Items. The Employee agrees to pay any Tax-Related Items that cannot be satisfied from wages or other cash compensation, to the extent permitted by Applicable Law.

(b)Regardless of any action the Company or the Employer takes with respect to any or all Tax-Related Items, the Employee acknowledges and agrees that the ultimate liability for all Tax-Related Items is and remains the Employee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Employee further acknowledges that the Company and/or the Employer: (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of Stock Options, including, but not limited to, the grant, vesting, exercise or settlement of the Stock Options, the subsequent issuance of Shares and/or cash upon settlement of such Stock Options or the subsequent sale of any Shares acquired pursuant to such Stock Options and receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms or any aspect of this grant of Stock Options to reduce or eliminate the Employee’s liability for Tax-Related Items or to achieve any particular tax result. Further, if the Employee has become subject to tax in more than one jurisdiction, the Employee acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(c)Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Employee’s jurisdiction(s), in which case the Employee will receive a refund of any over-withheld amount in cash and will have no entitlement to the Share equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Employee is deemed to have been issued the full number of shares of Common Stock subject to the exercised Stock Options, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.

(d)The Employee shall pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Employee’s participation in the Plan or the Employee’s receipt,
2

vesting or exercise of Stock Options or subsequent sale of the Shares acquired on exercise, or at any other time, that cannot be satisfied by the means previously described. The Company may refuse to deliver the benefit described herein if the Employee fails to comply with the Employee’s obligations in connection with the Tax-Related Items.

(e)In accepting the Stock Option, the Employee consents and agrees that in the event the Stock Option becomes subject to an Employer tax that is legally permitted to be recovered from the Employee, as may be determined by the Company and/or the Employer at their sole discretion, and whether or not the Employee’s employment with the Company and/or the Employer is continuing at the time such tax becomes recoverable, the Employee will assume any liability for any such taxes that may be payable by the Company and/or the Employer in connection with the Stock Option. Further, by accepting the Stock Option, the Employee agrees that the Company and/or the Employer may collect any such taxes from the Employee by any of the means set forth in this Section 11. The Employee further agrees to execute any other consents or elections required to accomplish the above promptly upon request of the Company.

12.Acknowledgement and Waiver.
By accepting this Stock Option, the Employee acknowledges, understands and agrees that:

(a)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time;

(b)the grant of Stock Options is voluntary and occasional and does not create any contractual or other right to receive future grants of Stock Options, or benefits in lieu of Stock Options, even if Stock Options have been granted repeatedly in the past;

(c)all decisions with respect to future grants, if any, will be at the sole discretion of the Company;

(d)the Employee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with the ability of the Employer to terminate the Employee’s employment relationship at any time and it is expressly agreed and understood that employment is terminable at the will of either party, insofar as permitted by Applicable Law;
(e)the Employee is participating voluntarily in the Plan;

(f)Stock Options and their resulting benefits are not intended to replace any pension rights or compensation;

(g)Stock Options and their resulting benefits are not part of normal or expected compensation or salary for any purposes, including, but not limited to calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments insofar as permitted by Applicable Law and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Employer or any Subsidiary or Affiliate;

(h)unless otherwise agreed with the Company, the Stock Options and the Shares subject to the Stock Options, and the income and value of same, are not granted as consideration for, or in connection with, the service the Employee may provide as a director of any Subsidiary or Affiliate;

(i)this grant of Stock Options will not be interpreted to form an employment contract or relationship with the Company, and furthermore, this Stock Option will not be interpreted to form an employment contract with the Employer or any Subsidiary or Affiliate;

(j)the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(k)no claim or entitlement to compensation or damages shall arise from forfeiture of the Stock Options ore recoupment of any Shares acquired under the Plan resulting from (i) termination of Employee’s employment by the Company or the Employer (for any reason whatsoever and whether or not in breach of local labor laws), and/or (ii) the application of any recoupment policy or any recovery or clawback policy otherwise required by law, and in consideration of the grant of the Stock Options to which the Employee is otherwise not entitled, the Employee agrees not to institute any claim against the Company or the Employer and releases the Company and the Employer from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Employee shall be deemed irrevocably to have agreed not to pursue such claim and to have agreed to execute any and all documents necessary to request dismissal or withdrawal of such claims;

(l)notwithstanding any terms or conditions of the Plan to the contrary, in the event of termination of the Employee’s employment (whether or not in breach of local labor laws), the Employee’s right to exercise or otherwise to receive benefits under this Grant Agreement after termination of employment, if any, will be measured by the date of termination of Employee’s active employment and will not be extended by any notice period mandated under local law (e.g., active employment would not include a period of “garden leave” or similar period pursuant to local law); the Committee shall have the exclusive discretion to determine when the Employee is no longer actively employed for purposes of the Stock Options;

(m)neither the Company, the Employer, nor any Subsidiary or Affiliate will be liable for any foreign exchange rate fluctuation between the Employee’s local currency and the United States dollar that may affect the value of the Stock Options or any amounts due to the Employee pursuant to the settlement of the Stock Options or the subsequent sale of any Shares acquired upon settlement; and

(n)if the Company determines that the Employee has engaged in misconduct prohibited by Applicable Law or any applicable policy of the Company, as in effect from time to time, or the Company is required to make recovery from the Employee under Applicable Law or a Company policy adopted to comply with applicable legal requirements, then the Company may, in its sole discretion, to the extent it determines appropriate and to the extent permitted under Applicable Law, (a) recover from the Employee the proceeds from Stock Options exercised up to three years prior to the Employee’s termination of employment or any time thereafter, (b) cancel the Employee’s outstanding Stock Options whether or not vested, and (c) take any other action required or permitted by Applicable Law.

13.Data Privacy Consent.

3

(a)The Employee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Employee’s personal data as described in this Grant Agreement and any other materials by and among, as applicable, the Company, its Subsidiaries or Affiliates, and the Employer for the exclusive purpose of implementing, administering and managing the Employee’s participation in the Plan.

(b)The Employee understands that the Company, its Subsidiaries and Affiliates, and the Employer may hold certain personal information about the Employee, including, but not limited to, name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency, status, job title, any shares of stock or directorships held in the Company, details of all restricted stock units, Stock Options or any other entitlement to shares of stock granted, canceled, purchased, exercised, vested, unvested or outstanding in the Employee’s favor (“Data”) for the exclusive purpose of implementing, managing and administering the Plan.

(c)The Employee understands that Data may be transferred to Merrill Lynch and any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Employee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Employee’s country. The Company is committed to protecting the privacy of Data in such cases. The Employee understands that by contract both with the Company and/or any of its Subsidiaries or Affiliates and with Merrill Lynch and/or the Company’s other vendors, the people and companies that have access to the Employee’s Data are bound to handle such Data in a manner consistent with the Company’s privacy policy and law. The Company periodically performs due diligence and audits on its vendors in accordance with good commercial practices to ensure their capabilities and compliance with those commitments. The Employee further understands that Data will be held only as long as is necessary to implement, administer and manage the Employee’s participation in the Plan.

(d)The Employee understands that if the Employee resides outside the United States, the Employee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Employee’s local human resources representative. Further, the Employee understands that the Employee is providing the consents herein on a purely voluntary basis. If the Employee does not consent, or if the Employee later seeks to revoke the Employee’s consent, the Employee's employment status or service with the Company or the Employee’s Employer will not be affected; the only consequence of refusing or withdrawing the Employee’s consent is that the Company would not be able to grant the Employee Stock Units or other equity awards or administer and manage the Employee’s participation in the Plan. Therefore, the Employee understands that refusing or withdrawing the Employee’s consent may affect the Employee’s ability to participate in the Plan. For more information on the consequences of the Employee’s refusal to consent or withdrawal of consent, the Employee understands that the Employee may contact the Employee’s local human resources representative.

(e)Further, the Employee understands that the Company may rely on a different legal basis for the processing and/or transfer of Data in the future and/or request that the Employee provide another data privacy consent. If applicable and upon request of the Company or a Subsidiary or Affiliate, the Employee agrees to provide an executed data privacy consent or acknowledgement (or any other consents, acknowledgements or agreements) to the Company or a Subsidiary or Affiliate that the Company and/or a Subsidiary or Affiliate may deem necessary to obtain under the data privacy laws in the Employee’s country of employment, either now or in the future. The Employee understands that the Employee may be unable to participate in the Plan if the Employee fails to execute any such acknowledgement, agreement or consent requested by the Company and/or a Subsidiary or Affiliate.

By electronically accepting Stock Units on the Merrill Lynch website, the Employee is declaring that the Employee agrees with the data processing practices described in this Section 12 and that the Employee consents to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned therein for the purposes described therein.

14.No Advice Regarding Grant.
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Employee’s participation in the Plan, or the Employee’s acquisition or sale of the underlying Shares. The Employee is hereby advised to consult with the Employee’s own personal tax, legal and financial advisors regarding the Employee’s participation in the Plan before taking any action related to the Plan.

15.Plan Information.
The Employee agrees to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with laws outside the United States, from the Long-term Incentives website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the investor relations section of the Company's website. The Employee acknowledges that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Company Secretary. The Employee hereby consents to receive any documents related to current or future participation in the Plan by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.

16.Additional Eligibility Requirements Permitted.
In addition to any other eligibility criteria provided for in the Plan, the Company may require that the Employee execute a separate document agreeing to the terms of a current arbitration agreement and/or a current ARCIPD, each in a form acceptable to the Company and/or that the Employee be in compliance with the ARCIPD throughout the entire exercise period. If such separate documents are required by the Company and the Employee does not accept them within 75 days of the Grant Date set forth above or such other date as of which the Company shall require in its discretion, this Stock Option shall be canceled and the Employee shall have no further rights under this Grant Agreement.

17.Miscellaneous.
(a)The Plan is incorporated herein by reference. The Plan and this Grant Agreement, including the Appendix, constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Employee with respect to the subject matter hereof, other than the terms of any severance plan applicable to the Employee that provides more favorable vesting or extended post-termination exercise periods, and may not be modified adversely to the Employee's interest except by means of a writing signed by the Company and the Employee. Notwithstanding the foregoing, nothing in the Plan or this Grant Agreement shall affect the validity or
4

interpretation of any duly authorized written agreement between the Company and the Employee under which an award properly granted under and pursuant to the Plan serves as any part of the consideration furnished to the Employee. This Grant Agreement is governed by the laws of the state of Delaware without regard to its conflict of law provisions.

(b)If the Employee has received this or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

(c)The provisions of this Grant Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

(d)Notwithstanding Section 17(c), the Company’s obligations under this Grant Agreement and the Employee’s agreement to the terms of an arbitration agreement and/or an ARCIPD, if any, are mutually dependent. In the event that the Employee breaches the arbitration agreement or the Employee’s ARCIPD is breached or found not to be binding upon the Employee for any reason by a court of law, then the Company will have no further obligation or duty to perform under the Plan or this Grant Agreement.

(e)The Employee acknowledges that, depending on the Employee or broker’s country of residence or where the Company Shares are listed, the Employee may be subject to insider trading restrictions and/or market abuse laws, which may affect the Employee's ability to acquire, sell or otherwise dispose of Shares or rights to Shares during times the Employee is considered to have “inside information” regarding the Company (as defined by the laws in the Employee’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Employee placed before the Employee possessed inside information. Furthermore, the Employee cold be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Employee acknowledges that it is the Employee’s responsibility to comply with any applicable restrictions and that the Employee should to consult the Employee’s personal advisor on this matter.

(f)Notwithstanding any provisions in this Grant Agreement, the grant of the Stock Options shall be subject to any additional terms and conditions set forth in the Appendix to this Grant Agreement for the Employee’s country. Moreover, if the Employee relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to the Employee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan. The Appendix constitutes part of this Grant Agreement.

(g)The Company reserves the right to impose other requirements on the Employee’s participation in the Plan, on the Stock Options and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Employee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

(h)A waiver by the Company of a breach of any provision of this Grant Agreement shall not operate or be construed as a waiver of any other provision of this Grant Agreement, or of any subsequent breach by the Employee or any other employee participating in the Plan.

(i)The Company shall not be required to treat as owner of Stock Options, or to provide any associated benefits hereunder, any transferee to whom such Stock Options or benefits shall have been transferred in violation of any of the provisions of this Grant Agreement.

(j)The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Grant Agreement.

(k)All rights granted and/or Shares issued under this Grant Agreement are subject to claw back under the Company policy as in effect from time to time.

(l)Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon delivery to the Employee at his address then on file with the Company.

18.Forfeitures and Recoupment.
(a)Recoupment Policy. The Stock Options granted hereunder, any Shares issued pursuant to the Stock Options and any proceeds therefrom shall be subject to and remain subject to any incentive compensation clawback or recoupment policy of the Company (i) currently in effect, (ii) as may be adopted by the Company to comply with applicable law and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, including, without limitation, pursuant to Section 10D of the Exchange Act, Rule 10D-1 thereunder and Section 303A.14 of the New York Stock Exchange Listed Company Manual) or (iii) as may be adopted by the Company to facilitate the Company’s objectives related to eliminating or reducing fraud, misconduct, wrongdoing, or violations of law by an employee or other service provider or related to improving the Company’s governance practices or similar considerations and, in each case, as may be amended from time to time (the “Policy”), with the provisions contained in such Policy deemed incorporated into this Grant Agreement without Employee’s additional or separate consent.

(b)Recoupment Authorization. For purposes of the foregoing, the Employee expressly and explicitly authorizes the Company to issue instructions, on the Employee's behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to this Stock Option to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Grant Agreement and the Policy conflict, the terms of the Policy shall prevail.

HP INC.


Enrique Lores
CEO and President

5


Kristen Ludgate
Chief People Officer


RETAIN THIS GRANT AGREEMENT FOR YOUR RECORDS

Important Note: Your grant is subject to the terms and conditions of this Grant Agreement, including any Appendix for your country of employment, and to the Company obtaining all necessary government approvals. If you have questions regarding your grant, please contact global.equity@hp.com.

6
 EX-10.(I)(I)(I)(I) 5 hpq-retentionnqsoagreement.htm EX-10.(I)(I)(I)(I) Document
Exhibit 10(i)(i)(i)(i)
image_05.jpg
RETENTION GRANT AGREEMENT for use from November 1, 2023


Name:

Fld_NAME_AC

Employee ID:

Fld_EMPLID

Grant Date:
expGRANT_DATE
Grant ID:
Fld_GRANT_NBR
Grant Price:
$fld_NAME1_AC
Amount:
0
Plan:
Fld_DESCR
Vesting Schedule:
Fld_HTMLAREA1

Non-Qualified Stock Option

    THIS GRANT AGREEMENT, as of the Grant Date noted above between HP Inc., a Delaware corporation (“Company”), and the employee named above (“Employee”), is entered into as follows:

    WHEREAS, the continued participation of the Employee is considered by the Company to be important for the Company's continued growth; and

WHEREAS, in order to give the Employee an incentive to continue in the employ of the Company (or its Affiliates or Subsidiaries), to accept ancillary agreements designed to protect the legitimate business interests of the Company that are made a condition of this grant and to participate in the affairs of the Company, the HR and Compensation Committee of the Board of Directors of the Company or its delegates (“Committee”) has determined that the Employee shall be granted a non-qualified stock option to purchase the number of shares stated above of its $0.01 par value voting Common Stock (“Shares”) upon the terms and conditions set forth herein and in accordance with the terms and conditions of the Plan named above, a copy of which can be found on the Long-term Incentives website along with a copy of the related prospectus. The Plan and the related prospectus can also be obtained by written or telephonic request to the Company Secretary. Unless otherwise defined in this Grant Agreement, any capitalized terms in this Grant Agreement shall have the meaning ascribed to such terms in the Plan.

THEREFORE, the parties agree as follows:
1.Grant of Stock Options.
This non-qualified Stock Option is granted under and pursuant to the Plan and is subject to each and all of the provisions thereof.
2.Grant Price.
The Grant Price is the price per Share set forth above.            
3.Restrictions on Transfer.
This Stock Option is not transferable by the Employee otherwise than by will or the laws of descent and distribution, and is exercisable only by the Employee during the Employee’s lifetime. This Stock Option may not be transferred, assigned, pledged or hypothecated by the Employee during the Employee’s lifetime, whether by operation of law or otherwise, and is not subject to execution, attachment or similar process.
4.Vesting Schedule.
This Stock Option will vest and become exercisable according to the vesting schedule set forth above except as otherwise provided in this Grant Agreement and except to the extent a severance plan applicable to the Employee provides otherwise, subject to the Employee’s compliance with the terms and conditions of the Plan and this Grant Agreement.
5.Expiration Date.
This Stock Option will expire on the 10th anniversary of the Grant Date set forth above ("Expiration Date"), unless sooner terminated or canceled in accordance with the provisions of the Plan and this Grant Agreement. The Employee must exercise this Stock Option, if at all, on a day the New York Stock Exchange is open for trading and on or before the Expiration Date. The Employee shall be solely responsible for exercising this Stock Option, if at all, prior to its Expiration Date. The Company shall have no obligation to notify the Employee of this Stock Option’s expiration.

6.Method of Exercise.
This Stock Option, to the extent it is then vested and exercisable, may be exercised through a broker designated by the Company or by any other method the Committee has approved; provided, however, that no such exercise shall be with respect to fewer than twenty-five (25) Shares or the remaining Shares covered by the Stock Option if less than twenty-five. The exercise must be accompanied by the payment of the full Grant Price of such Shares and any Tax-Related Items withholding. Payment may be in cash or Shares or a combination thereof to the extent permissible under Applicable Law, or through a broker-assisted cashless exercise; provided, however, that any payment in Shares shall be in strict compliance with all procedural rules established by the Committee.
1

7.Termination of Employment.
Except as otherwise provided for in this Grant Agreement or in the Plan or as otherwise determined by the Company in its sole discretion, all unvested Shares shall be forfeited by the Employee as of the date of termination and the Employee may exercise the Stock Option, to the extent that it is then vested, within three months after the date of the Employee’s termination (but in no event later than the Expiration Date), except to the extent a severance plan applicable to the Employee provides otherwise.

For purposes of this Grant Agreement, the Employee's employment or service will be considered terminated as of the date the Employee is no longer actively providing services to the Company, any Subsidiary or Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any) and will not be extended by any notice period (e.g., the Employee's period of employment or service would not include any contractual notice period or any period of “garden leave” or similar period mandated under the employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when the Employee's employment or service is terminated for purposes of this Grant Agreement (including whether the Employee may still be considered to be providing service while on a leave of absence).
8.Death of Employee.
Notwithstanding the provisions of Section 4 of this Grant Agreement, in the event of the Employee's death this Stock Option shall vest in full and the Employee’s legal representative or designated beneficiary shall have the right to exercise all or a portion of the Employee's rights under this Grant Agreement within one year after the death of the Employee, and shall be bound by the provisions of the Plan. In all cases, however, this Stock Option will expire no later than the Expiration Date.
9.Disability of the Employee.
Notwithstanding the provisions of Section 4 of this Grant Agreement, in the event of the Employee’s termination due to Permanent and Total Disability, this Stock Option shall vest in full and the Employee may exercise the Employee’s rights under this Grant Agreement within three years from the date of termination. In all cases, however, this Stock Option will expire no later than the Expiration Date. The Company’s obligation to vest the Stock Option under this paragraph is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company and any-post employment period during which the Stock Option remains outstanding and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the Stock Option remains outstanding.

10.Termination for Cause.
Upon termination of the Employee’s employment for Cause (as defined in the Plan), then, except as provided in Section 17(a), all unvested Shares shall be forfeited by the Employee and the Employee may exercise the Stock Option, to the extent that it is then vested, before the New York Stock Exchange closes on the date of the Employee’s termination, except to the extent a severance plan applicable to the Employee provides otherwise. Such forfeiture shall occur regardless of whether the Employee has satisfied any applicable age and service requirements for retirement.

11.Taxes.
(a) The Employee shall be liable for any and all taxes, including income tax, social insurance, fringe benefit tax, payroll tax, payment on account, employer taxes, or other tax-related items related to the Employee’s participation in the Plan and legally applicable to or otherwise recoverable from the Employee by the Company and/or, if different, the Employee’s employer (the “Employer”) whether incurred at grant, vesting, exercise, sale, prior to vesting or at any other time (“Tax-Related Items”). In the event that the Company or the Employer (which, for purposes of this Section 11, shall include a form employer) is required, allowed or permitted to withhold taxes as a result of the grant, vesting or exercise of the Stock Options, or subsequent sale of Shares acquired pursuant to such Stock Options, the Employee shall make a cash payment or make adequate arrangements satisfactory to the Company and/or the Employer to withhold such taxes from Employee’s wages or other cash compensation paid to the Employee by the Company and/or the Employer at the election of the Company, in its sole discretion, or, if permissible under Applicable Law, the Company may sell or arrange for the sale of Shares that Employee acquires as necessary to cover all applicable required withholding Tax-Related Items that are legally recoverable from the Employee at the time of the tax withholding event, unless the Company, in its sole discretion, has established alternative procedures for such payment. To the extent that any surrender of Shares or payment of cash or alternative procedure for such payment is insufficient, the Employee authorizes the Company, its Affiliates and Subsidiaries, which are qualified to deduct tax at source, to deduct from the Employee’s compensation all Tax-Related Items. The Employee agrees to pay any Tax-Related Items that cannot be satisfied from wages or other cash compensation, to the extent permitted by Applicable Law.

(b)Regardless of any action the Company or the Employer takes with respect to any or all Tax-Related Items, the Employee acknowledges and agrees that the ultimate liability for all Tax-Related Items is and remains the Employee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Employee further acknowledges that the Company and/or the Employer: (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of Stock Options, including, but not limited to, the grant, vesting, exercise or settlement of the Stock Options, the subsequent issuance of Shares and/or cash upon settlement of such Stock Options or the subsequent sale of any Shares acquired pursuant to such Stock Options and receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms or any aspect of this grant of Stock Options to reduce or eliminate the Employee’s liability for Tax-Related Items or to achieve any particular tax result. Further, if the Employee has become subject to tax in more than one jurisdiction, the Employee acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(c)Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Employee’s jurisdiction(s), in which case the Employee will receive a refund of any over-withheld amount in cash and will have no entitlement to the Share equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Employee is deemed to have been issued the full number of shares of Common Stock subject to the exercised Stock Options, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.

(d)The Employee shall pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Employee’s participation in the Plan or the Employee’s receipt,
2

vesting or exercise of Stock Options or subsequent sale of the Shares acquired on exercise, or at any other time, that cannot be satisfied by the means previously described. The Company may refuse to deliver the benefit described herein if the Employee fails to comply with the Employee’s obligations in connection with the Tax-Related Items.

(e)In accepting the Stock Option, the Employee consents and agrees that in the event the Stock Option becomes subject to an Employer tax that is legally permitted to be recovered from the Employee, as may be determined by the Company and/or the Employer at their sole discretion, and whether or not the Employee’s employment with the Company and/or the Employer is continuing at the time such tax becomes recoverable, the Employee will assume any liability for any such taxes that may be payable by the Company and/or the Employer in connection with the Stock Option. Further, by accepting the Stock Option, the Employee agrees that the Company and/or the Employer may collect any such taxes from the Employee by any of the means set forth in this Section 11. The Employee further agrees to execute any other consents or elections required to accomplish the above promptly upon request of the Company.

12.Acknowledgement and Waiver.
By accepting this Stock Option, the Employee acknowledges, understands and agrees that:

(a)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time;

(b)the grant of Stock Options is voluntary and occasional and does not create any contractual or other right to receive future grants of Stock Options, or benefits in lieu of Stock Options, even if Stock Options have been granted repeatedly in the past;

(c)all decisions with respect to future grants, if any, will be at the sole discretion of the Company;

(d)the Employee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with the ability of the Employer to terminate the Employee’s employment relationship at any time and it is expressly agreed and understood that employment is terminable at the will of either party, insofar as permitted by Applicable Law;
(e)the Employee is participating voluntarily in the Plan;

(f)Stock Options and their resulting benefits are not intended to replace any pension rights or compensation;

(g)Stock Options and their resulting benefits are not part of normal or expected compensation or salary for any purposes, including, but not limited to calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments insofar as permitted by Applicable Law and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Employer or any Subsidiary or Affiliate;

(h)unless otherwise agreed with the Company, the Stock Options and the Shares subject to the Stock Options, and the income and value of same, are not granted as consideration for, or in connection with, the service the Employee may provide as a director of any Subsidiary or Affiliate;

(i)this grant of Stock Options will not be interpreted to form an employment contract or relationship with the Company, and furthermore, this Stock Option will not be interpreted to form an employment contract with the Employer or any Subsidiary or Affiliate;

(j)the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(k)no claim or entitlement to compensation or damages shall arise from forfeiture of the Stock Options ore recoupment of any Shares acquired under the Plan resulting from (i) termination of Employee’s employment by the Company or the Employer (for any reason whatsoever and whether or not in breach of local labor laws), and/or (ii) the application of any recoupment policy or any recovery or clawback policy otherwise required by law, and in consideration of the grant of the Stock Options to which the Employee is otherwise not entitled, the Employee agrees not to institute any claim against the Company or the Employer and releases the Company and the Employer from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Employee shall be deemed irrevocably to have agreed not to pursue such claim and to have agreed to execute any and all documents necessary to request dismissal or withdrawal of such claims;

(l)notwithstanding any terms or conditions of the Plan to the contrary, in the event of termination of the Employee’s employment (whether or not in breach of local labor laws), the Employee’s right to exercise or otherwise to receive benefits under this Grant Agreement after termination of employment, if any, will be measured by the date of termination of Employee’s active employment and will not be extended by any notice period mandated under local law (e.g., active employment would not include a period of “garden leave” or similar period pursuant to local law); the Committee shall have the exclusive discretion to determine when the Employee is no longer actively employed for purposes of the Stock Options;

(m)neither the Company, the Employer, nor any Subsidiary or Affiliate will be liable for any foreign exchange rate fluctuation between the Employee’s local currency and the United States dollar that may affect the value of the Stock Options or any amounts due to the Employee pursuant to the settlement of the Stock Options or the subsequent sale of any Shares acquired upon settlement; and

(n)if the Company determines that the Employee has engaged in misconduct prohibited by Applicable Law or any applicable policy of the Company, as in effect from time to time, or the Company is required to make recovery from the Employee under Applicable Law or a Company policy adopted to comply with applicable legal requirements, then the Company may, in its sole discretion, to the extent it determines appropriate and to the extent permitted under Applicable Law, (a) recover from the Employee the proceeds from Stock Options exercised up to three years prior to the Employee’s termination of employment or any time thereafter, (b) cancel the Employee’s outstanding Stock Options whether or not vested, and (c) take any other action required or permitted by Applicable Law.

13.Data Privacy Consent.

3

(a)The Employee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Employee’s personal data as described in this Grant Agreement and any other materials by and among, as applicable, the Company, its Subsidiaries or Affiliates, and the Employer for the exclusive purpose of implementing, administering and managing the Employee’s participation in the Plan.

(b)The Employee understands that the Company, its Subsidiaries and Affiliates, and the Employer may hold certain personal information about the Employee, including, but not limited to, name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency, status, job title, any shares of stock or directorships held in the Company, details of all restricted stock units, Stock Options or any other entitlement to shares of stock granted, canceled, purchased, exercised, vested, unvested or outstanding in the Employee’s favor (“Data”) for the exclusive purpose of implementing, managing and administering the Plan.

(c)The Employee understands that Data may be transferred to Merrill Lynch and any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Employee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Employee’s country. The Company is committed to protecting the privacy of Data in such cases. The Employee understands that by contract both with the Company and/or any of its Subsidiaries or Affiliates and with Merrill Lynch and/or the Company’s other vendors, the people and companies that have access to the Employee’s Data are bound to handle such Data in a manner consistent with the Company’s privacy policy and law. The Company periodically performs due diligence and audits on its vendors in accordance with good commercial practices to ensure their capabilities and compliance with those commitments. The Employee further understands that Data will be held only as long as is necessary to implement, administer and manage the Employee’s participation in the Plan.

(d)The Employee understands that if the Employee resides outside the United States, the Employee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Employee’s local human resources representative. Further, the Employee understands that the Employee is providing the consents herein on a purely voluntary basis. If the Employee does not consent, or if the Employee later seeks to revoke the Employee’s consent, the Employee's employment status or service with the Company or the Employee’s Employer will not be affected; the only consequence of refusing or withdrawing the Employee’s consent is that the Company would not be able to grant the Employee Stock Units or other equity awards or administer and manage the Employee’s participation in the Plan. Therefore, the Employee understands that refusing or withdrawing the Employee’s consent may affect the Employee’s ability to participate in the Plan. For more information on the consequences of the Employee’s refusal to consent or withdrawal of consent, the Employee understands that the Employee may contact the Employee’s local human resources representative.

(e)Further, the Employee understands that the Company may rely on a different legal basis for the processing and/or transfer of Data in the future and/or request that the Employee provide another data privacy consent. If applicable and upon request of the Company or a Subsidiary or Affiliate, the Employee agrees to provide an executed data privacy consent or acknowledgement (or any other consents, acknowledgements or agreements) to the Company or a Subsidiary or Affiliate that the Company and/or a Subsidiary or Affiliate may deem necessary to obtain under the data privacy laws in the Employee’s country of employment, either now or in the future. The Employee understands that the Employee may be unable to participate in the Plan if the Employee fails to execute any such acknowledgement, agreement or consent requested by the Company and/or a Subsidiary or Affiliate.

By electronically accepting Stock Units on the Merrill Lynch website, the Employee is declaring that the Employee agrees with the data processing practices described in this Section 12 and that the Employee consents to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned therein for the purposes described therein.

14.No Advice Regarding Grant.
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Employee’s participation in the Plan, or the Employee’s acquisition or sale of the underlying Shares. The Employee is hereby advised to consult with the Employee’s own personal tax, legal and financial advisors regarding the Employee’s participation in the Plan before taking any action related to the Plan.

15.Plan Information.
The Employee agrees to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with laws outside the United States, from the Long-term Incentives website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the investor relations section of the Company's website. The Employee acknowledges that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Company Secretary. The Employee hereby consents to receive any documents related to current or future participation in the Plan by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.

16.Additional Eligibility Requirements Permitted.
In addition to any other eligibility criteria provided for in the Plan, the Company may require that the Employee execute a separate document agreeing to the terms of a current arbitration agreement and/or a current ARCIPD, each in a form acceptable to the Company and/or that the Employee be in compliance with the ARCIPD throughout the entire exercise period. If such separate documents are required by the Company and the Employee does not accept them within 75 days of the Grant Date set forth above or such other date as of which the Company shall require in its discretion, this Stock Option shall be canceled and the Employee shall have no further rights under this Grant Agreement.

17.Miscellaneous.
(a)The Plan is incorporated herein by reference. The Plan and this Grant Agreement, including the Appendix, constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Employee with respect to the subject matter hereof, other than the terms of any severance plan applicable to the Employee that provides more favorable vesting or extended post-termination exercise periods, and may not be modified adversely to the Employee's interest except by means of a writing signed by the Company and the Employee. Notwithstanding the foregoing, nothing in the Plan or this Grant Agreement shall affect the validity or
4

interpretation of any duly authorized written agreement between the Company and the Employee under which an award properly granted under and pursuant to the Plan serves as any part of the consideration furnished to the Employee. This Grant Agreement is governed by the laws of the state of Delaware without regard to its conflict of law provisions.

(b)If the Employee has received this or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

(c)The provisions of this Grant Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

(d)Notwithstanding Section 17(c), the Company’s obligations under this Grant Agreement and the Employee’s agreement to the terms of an arbitration agreement and/or an ARCIPD, if any, are mutually dependent. In the event that the Employee breaches the arbitration agreement or the Employee’s ARCIPD is breached or found not to be binding upon the Employee for any reason by a court of law, then the Company will have no further obligation or duty to perform under the Plan or this Grant Agreement.

(e)The Employee acknowledges that, depending on the Employee or broker’s country of residence or where the Company Shares are listed, the Employee may be subject to insider trading restrictions and/or market abuse laws, which may affect the Employee's ability to acquire, sell or otherwise dispose of Shares or rights to Shares during times the Employee is considered to have “inside information” regarding the Company (as defined by the laws in the Employee’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Employee placed before the Employee possessed inside information. Furthermore, the Employee cold be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Employee acknowledges that it is the Employee’s responsibility to comply with any applicable restrictions and that the Employee should to consult the Employee’s personal advisor on this matter.

(f)Notwithstanding any provisions in this Grant Agreement, the grant of the Stock Options shall be subject to any additional terms and conditions set forth in the Appendix to this Grant Agreement for the Employee’s country. Moreover, if the Employee relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to the Employee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan. The Appendix constitutes part of this Grant Agreement.

(g)The Company reserves the right to impose other requirements on the Employee’s participation in the Plan, on the Stock Options and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Employee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

(h)A waiver by the Company of a breach of any provision of this Grant Agreement shall not operate or be construed as a waiver of any other provision of this Grant Agreement, or of any subsequent breach by the Employee or any other employee participating in the Plan.

(i)The Company shall not be required to treat as owner of Stock Options, or to provide any associated benefits hereunder, any transferee to whom such Stock Options or benefits shall have been transferred in violation of any of the provisions of this Grant Agreement.

(j)The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Grant Agreement.

(k)All rights granted and/or Shares issued under this Grant Agreement are subject to claw back under the Company policy as in effect from time to time.

(l)Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon delivery to the Employee at his address then on file with the Company.

18.Forfeitures and Recoupment.
(a)Recoupment Policy. The Stock Options granted hereunder, any Shares issued pursuant to the Stock Options and any proceeds therefrom shall be subject to and remain subject to any incentive compensation clawback or recoupment policy of the Company (i) currently in effect, (ii) as may be adopted by the Company to comply with applicable law and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, including, without limitation, pursuant to Section 10D of the Exchange Act, Rule 10D-1 thereunder and Section 303A.14 of the New York Stock Exchange Listed Company Manual) or (iii) as may be adopted by the Company to facilitate the Company’s objectives related to eliminating or reducing fraud, misconduct, wrongdoing, or violations of law by an employee or other service provider or related to improving the Company’s governance practices or similar considerations and, in each case, as may be amended from time to time (the “Policy”), with the provisions contained in such Policy deemed incorporated into this Grant Agreement without Employee’s additional or separate consent.

(b)Recoupment Authorization. For purposes of the foregoing, the Employee expressly and explicitly authorizes the Company to issue instructions, on the Employee's behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to this Stock Option to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Grant Agreement and the Policy conflict, the terms of the Policy shall prevail.

HP INC.


Enrique Lores
CEO and President

5


Kristen Ludgate
Chief People Officer


RETAIN THIS GRANT AGREEMENT FOR YOUR RECORDS

Important Note: Your grant is subject to the terms and conditions of this Grant Agreement, including any Appendix for your country of employment, and to the Company obtaining all necessary government approvals. If you have questions regarding your grant, please contact global.equity@hp.com.

6
 EX-10.(J)(J)(J)(J) 6 hpq-fy24parsuagreementjanu.htm EX-10.(J)(J)(J)(J) Document
image_0b.jpg Exhibit 10(j)(j)(j)(j)

GRANT AGREEMENT for use from November 1, 2023

Name:fld_NAME_ACEmployee ID:fld_EMPLID


Grant Date:

expGRANT_DATE
Grant ID:fld_GRANT_NBR
Target Amount:0
Plan:fld_DESCR

Performance-Adjusted Restricted Stock Units
GRANT SUMMARY
Target Amount
0 Shares
Performance Period1 November 2023 – 31 October 2026
Year 1 EPS1 November 2023 – 31 October 2024
Year 2 EPS1 November 2024 – 31 October 2025
Year 3 EPS1 November 2025 – 31 October 2026
3-year TSR1 November 2023 – 31 October 2026
3-year KGA1 November 2023 – 31 October 2026






    




THIS PERFORMANCE-ADJUSTED RESTRICTED STOCK UNITS GRANT AGREEMENT (this “Grant Agreement”), as of the Grant Date noted above between HP Inc., a Delaware Corporation (“Company”), and the employee named above (“Employee”), is entered into as follows:

WHEREAS, the continued participation of the Employee is considered by the Company to be important for the Company's continued growth; and

    WHEREAS, in order to give the Employee an incentive to continue in the employ of the Company (or its Affiliates or Subsidiaries), to accept ancillary agreements designed to protect the legitimate business interests of the Company that are made a condition of this grant and to participate in the affairs of the Company, the HR and Compensation Committee of the Board of Directors of the Company or its delegates (“Committee”) has determined that the Employee shall be granted performance-adjusted restricted stock units (“PARSUs”) representing hypothetical shares of the Company’s common stock (the “Grant”) and dividend equivalents. The target amount stated above reflects the target number of PARSUs that may be granted to Employee (the “Target Amount”). The number of PARSUs achieved will be determined and paid out at the end of the Performance Period. Each PARSU will be equal in value to one share of the Company’s $0.01 par value common stock (“Share”), subject to the restrictions stated below and in accordance with the terms and conditions of the plan named above (“Plan”), a copy of which can be found on the Long-term Incentives website along with a copy of the related prospectus. The Plan and the related prospectus also can be obtained by written or telephonic request to the Company Secretary. Unless otherwise defined in this Grant Agreement, any capitalized terms in this Grant Agreement shall have the meaning ascribed to such terms in the Plan.

    THEREFORE, the parties agree as follows:

1.Grant of Performance-Adjusted Restricted Stock Units.


Subject to the terms and conditions of this Grant Agreement and of the Plan, the Company hereby grants to the Employee PARSUs together with dividend equivalent units, as set forth below.


2.Performance Criteria and Performance Periods.

The goals associated with the PARSUs shall be established by the Committee and will be communicated separately to the Employee by the Company. Shares delivered at the end of the Performance Period with respect to the PARSUs will range from 0% to 300% of the Target Amount of PARSUs (excluding the effect of dividend equivalents) based upon the Company’s performance against the earnings per share (“EPS”), relative total shareholder return (“TSR”), as compared to S&P 500 performance, and key growth areas revenue (“KGA”) goals, as certified by the Committee. No PARSUs will vest if performance is below minimum levels.

Exhibit A provides more details on the relative TSR calculation.

3.Crediting of Units.
(a)The final payout of PARSUs will be determined based on the attainment level of the performance criteria, which are comprised of (i) EPS goals, as adjusted by (ii) relative TSR goals, and (iii) KGA revenue goals, which will be applied in accordance with the adjustments made to the Target Amount of units as set forth below in Sections 3(b) and 3(c). The total number of PARSUs that will become eligible to be paid out will be the sum of the Adjusted EPS Units (as further adjusted pursuant to Section 3(b)(ii)) and the Adjusted KGA Units, as defined below in Sections 3(b) and 3(c).
    In no case may the total number of PARSUs exceed 300% of the Target Amount, excluding the effect of dividend equivalents.

(b)A number of PARSUs equal to 80% of the Target Amount of units will be adjusted as described in Section 3(b)(i) and (ii) below.

i)Adjustments Based on EPS Goals. The Target Amount of units will initially be adjusted based upon performance against the average of the yearly EPS goals, as certified by the Committee (the “Adjusted EPS Units”). Each year’s EPS goals will result in the following adjustment: 0% if performance is below the threshold level, 25% if performance is at the threshold level, 50% if performance is at the below target level, 100% if performance is at the target level, 200% if performance is at the above target level, and 300% if performance is at or above the maximum level. For performance that falls among any of the attainment levels between the threshold level and the maximum level, a proportionate percentage will be applied based on straight-line interpolation between the attainment levels. At the end of the Performance Period each individual year’s EPS performance will be added together and then divided by three to determine the average EPS performance for the Performance Period, which will then be applied to the Target Amount of units to determine the EPS payout. By way of example, if Year 1 EPS performance is at below target level, Year 2 EPS performance is at the above target level, and Year 3 EPS performance is at the above target level, the EPS payout would be 150% (the sum of 50%, 200%, and 200%, divided by 3). Accordingly, the Adjusted EPS Units would be equal to 150% of the Target Amount of units.

ii)Adjustments Based on TSR Goals. After the end of the 3-year Performance Period, the Adjusted EPS Units will be further adjusted based upon performance against the TSR goal for the Performance Period, as certified by the Committee as follows: if relative TSR performance is in the bottom quartile (lower than 25th percentile), the percentage by which the Adjusted EPS Units will be adjusted will be reduced by 50% (but not below 0% of target) (using the example above, 150%-50% = 100%); if relative TSR is in the top quartile (higher than 75th percentile), the percentage by which the Adjusted EPS Units will be adjusted will be increased by 50% (capped at 300% of target performance) (using the example above, 150%+50% = 200%); if relative TSR performance is in the second or third quartile (from 25th percentile to 75th percentile), no additional adjustment will be made to the Adjusted EPS Units (using the example above, Adjusted EPS Units will be at 150%).

(c)A number of PARSUs equal to 20% of the Target Amount of units will be adjusted based on KGA Revenue Goals. After the end of the 3-year Performance Period, a number of PARSUs equal to 20% of the Target Amount of units will be adjusted based upon performance against the KGA revenue goals, as certified by the Committee (the “Adjusted KGA Units”), as follows: 0% if performance is below the threshold level, 25% if performance is at the threshold level, 50% if performance is at the below target level, 100% if performance is at the target level, 200% if performance is at the above target level, and 300% if performance is at or above the maximum level. For performance that falls among any of the attainment levels between the threshold level and the maximum level, a proportionate percentage will be applied based on straight-line interpolation between the attainment levels.

(d)Service Requirement. Notwithstanding (a) through (c) above, the Employee must be employed on the last U.S. business day of the Performance Period to be credited with any PARSUs.
4.Payout of Performance-Adjusted Restricted Stock Units and Dividend Equivalents.

Except as otherwise provided in Sections 9 through 12 below, following the Committee's certification (if applicable) at the end of the Performance Period that the goals associated with the PARSUs have been met and that the terms and conditions set forth in this Grant Agreement have been fulfilled (and in any event within 75 days of the last day of the Performance Period), the Company shall deliver to the Employee's account (or the Employee’s estate or beneficiary or legal guardian in the event of Sections 9 through 11 below, as applicable) a number of Shares equal to the following:

(a)    a number of Shares corresponding to the number of PARSUs that have become vested pursuant to Section 3 (and Section 9 through 11, as applicable); plus

2

(b)    a dividend equivalent payment credited in the form of additional PARSUs for each ordinary cash dividend the Company pays on its Shares and for which the record date occurs between the grant date and the date the PARSUs are settled, determined by:

(1)multiplying the per share cash dividend paid by the Company on its Shares by the total number the number of PARSUs that became vested as determined in Section 3 as of the record date for the dividend; and
(2)dividing the amount determined in (1) above by the Fair Market Value of a Share on the dividend payment date to determine the number of additional whole and fractional PARSUs to be credited to the Employee;
provided, however, that if any aggregated dividend equivalent payments in Section (b)(2) above result in a payment of a fractional Share, such fractional Share shall be rounded up to the nearest whole Share.

Notwithstanding the foregoing, the Company may, in its sole discretion, settle the PARSUs in the form of a cash payment to the extent settlement in Shares: (i) is prohibited under local law; (ii) would require the Employee, the Company and/or any Subsidiary or Affiliate to obtain the approval of any governmental and/or regulatory body in the Employee's country; (iii) would result in adverse tax consequences for the Employee, the Company or any Subsidiary or Affiliate; or (iv) is administratively burdensome. Alternatively, the Company may, in its sole discretion, settle the PARSUs in the form of Shares but require the Employee to sell such Shares immediately or within a specified period of time following the Employee’s termination of employment (in which case the Employee expressly authorizes the Company to issue sales instructions on the Employee's behalf).

5.Restrictions.

Except as otherwise provided for in this Grant Agreement, the PARSUs or rights granted hereunder may not be sold, pledged or otherwise transferred.

6.Custody of Performance-Adjusted Restricted Stock Units.

The PARSUs subject hereto shall be held in a restricted book entry account in the name of the Employee. Upon completion of the Performance Period, any Shares deliverable pursuant to Section 4 above shall be released into an unrestricted brokerage account in the name of the Employee; provided, however, that a portion of such Shares shall be surrendered in payment of Tax-Related Items in accordance with Section 14 below, unless the Company, in its sole discretion, establishes alternative procedures for the payment of such taxes. Any Shares not deliverable pursuant to Section 4 above shall be forfeited from the Employee's account.

7.No Stockholder Rights.

PARSUs represent hypothetical Shares. Until Shares are delivered to the Employee pursuant to the terms of this Grant Agreement, the Employee shall not be entitled to any of the rights or benefits generally accorded to stockholders, including, without limitation, the receipt of dividends.

8.Termination of Employment.

If the Employee's employment with the Company, or any Subsidiary or Affiliate, is terminated prior to the last U.S. business day of the Performance Period for any reason other than death, retirement or Total and Permanent Disability, all unvested PARSUs granted hereunder shall be forfeited by the Employee, except to the extent a severance plan applicable to the Employee provides otherwise, subject to the terms and conditions of this Grant Agreement.

For purposes of this Grant Agreement, the Employee's employment or service will be considered terminated as of the date he or she is no longer actively providing services to the Company or any Subsidiary or Affiliate. The Committee shall have the exclusive discretion to determine when the Employee's employment or service is terminated for purposes of this Grant Agreement (including whether the Employee may still be considered to be providing service while on a leave of absence).

9.Benefit in Event of Death of the Employee.

In the event that termination of employment is due to the death of the Employee, all unvested PARSUs shall vest immediately based on deemed attainment of the performance criteria at target levels, or based on actual performance as determined in accordance with Sections 3(a) through (c) for a termination occurring after the completion of a performance period, including any Shares representing dividend equivalent payments calculated in accordance with Section 4(b), except that the calculation will be based on the number of PARSUs that vest in accordance with this Section 9, and any such Shares representing the vested PARSUs and dividend equivalent payments shall be delivered within 75 days of vesting.

10.Retirement of the Employee.

If the Employee’s termination is due to retirement in accordance with an applicable retirement policy, a pro rata portion of the PARSUs shall vest at the end of the 36-month Performance Period based on actual performance as determined in accordance with Sections 3(a) through (c). Pro rata vesting shall be based on the number of full months elapsed from the beginning of the performance period to the date of the Employee’s termination due to retirement. The Company’s obligation to deliver the amounts that vest pursuant to this Section 10 is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company and
3

any-post employment period during which the PARSU remains outstanding, and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the PARSU remains outstanding.
11.Total and Permanent Disability of the Employee.

In the event that termination of employment is due to the Total and Permanent Disability of the Employee, all unvested PARSUs shall vest immediately based on deemed attainment of the performance criteria at target levels, or based on actual performance as determined in accordance with Sections 3(a) through (c) for a termination occurring after the completion of a performance period, including any Shares representing dividend equivalent payments calculated in accordance with Section 4(b), except that the calculation will be based on the number of PARSUs that vest in accordance with this Section 11, and any such Shares representing the vested PARSUs and dividend equivalent payments shall be delivered within 75 days of vesting. The Company’s obligation to deliver the amounts that vest pursuant to this Section 11 is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company and any-post employment period during which the PARSU remains outstanding and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the PARSU remains outstanding.

12.Termination for Cause.

Upon termination of the Employee’s employment for Cause (as defined in the Plan), then all unvested PARSUs shall be forfeited by the Employee on the date of the Employee’s termination, except to the extent a severance plan applicable to the Employee provides otherwise. Such forfeiture shall occur regardless of whether the Employee has satisfied any applicable age and service requirements for retirement.

13.Section 409A.

The following provisions apply to the extent the Employee is subject to taxation in the U.S. Payments made pursuant to this Plan and this Grant Agreement are intended to comply with or qualify for an exemption from Section 409A of the Code (“Section 409A”). The Company reserves the right, to the extent the Company deems necessary or advisable in its sole discretion, to unilaterally amend or modify the Plan and/or this Grant Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, including any amendments or actions that would result in the reduction of benefits payable under this Grant Agreement, as the Company determines are necessary or appropriate to ensure that all PARSUs and dividend equivalent payments are made in a manner that qualifies for an exemption from, or complies with, Section 409A or mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Section 409A; provided however, that the Company makes no representations that the PARSUs or the dividend equivalents will be exempt from any taxes, interest, and/or penalties that may apply under Section 409A and makes no undertaking to preclude Section 409A from applying to the PARSUs or the dividend equivalents. For the avoidance of doubt, the Employee hereby acknowledges and agrees that neither the Company nor any Affiliate or Subsidiary will have any liability to the Employee or any other party if any amounts payable under this Grant Agreement are not exempt from, or compliant with, Section 409A, or for any action taken by the Company with respect thereto. Any PARSUs or dividend equivalents that are considered non-qualified deferred compensation subject to Section 409A (“NQDC”) and the settlement of which is triggered by “separation from service” (within the meaning of Section 409A) of a “specified employee” (as defined under Section 409A) shall be made on a date that is the earliest of (a) the Employee’s death, (b) the specified settlement date, and (c) the date which is one day following six months after the date of the Employee’s separation from service. If the PARSUs or dividend equivalents are considered NQDC and the payment period contemplated in Sections 10 or 11 crosses a calendar year, the PARSUs or dividend equivalents shall be paid in the second calendar year.

14.Taxes.

(a)The Employee shall be liable for any and all taxes, including income tax, social insurance, fringe benefit tax, payroll tax, payment on account, employer taxes or other tax-related items related to the Employee’s participation in the Plan and legally applicable to or otherwise recoverable from the Employee by the Company and/or, if different, the Employee’s employer (the “Employer”) whether incurred at grant, vesting, sale, prior to vesting or at any other time (“Tax-Related Items”). In the event that the Company or the Employer (which, for purposes of this Section 14, shall include a former employer) is required, allowed or permitted to withhold taxes as a result of the grant or vesting of PARSUs (including dividend equivalents) or the issuance or subsequent sale of Shares acquired pursuant to such PARSUs, or due upon receipt of dividend equivalent payments or dividends, the Employee shall surrender a sufficient number of whole Shares, make a cash payment or make adequate arrangements satisfactory to the Company and/or the Employer to withhold such taxes from the Employee’s wages or other cash compensation paid to the Employee by the Company and/or the Employer at the election of the Company, in its sole discretion, or, if permissible under local law, the Company may sell or arrange for the sale of Shares that Employee acquires as necessary to cover all Tax-Related Items that the Company or the Employer has to withhold or that are legally recoverable from the Employee (such as fringe benefit tax) at the time the restrictions on the PARSUs lapse, unless the Company, in its sole discretion, has established alternative procedures for such payment. However, with respect to any PARSUs subject to Section 409A, the Employer shall limit the surrender of Shares to the minimum number of Shares permitted to avoid a prohibited acceleration under Section 409A. The Employee will receive a cash refund for any fraction of a surrendered Share or Shares in excess of any and all Tax-Related Items. To the extent that any surrender of Shares or payment of cash or alternative procedure for such payment is insufficient, the Employee authorizes the Company, its Affiliates and Subsidiaries, which are qualified to deduct tax at source, to deduct from the Employee’s compensation all Tax-Related Items. The Employee agrees to pay any Tax-Related Items that cannot be satisfied from wages or other cash compensation, to the extent permitted by Applicable Law.

4

The Company and/or the Employer may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case the Employee will receive a refund of any over-withheld amount in cash and will have no entitlement to the Share equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Employee is deemed to have been issued the full number of Shares subject to the vested PARSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Employee’s participation in the Plan.

(b)Regardless of any action the Company or the Employer takes with respect to any or all Tax-Related Items, the Employee acknowledges and agrees that the ultimate liability for all Tax-Related Items is and remains the Employee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Employee further acknowledges that the Company and/or the Employer: (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of PARSUs or dividend equivalents, including, but not limited to, the grant, vesting or settlement of PARSUs or dividend equivalents, the subsequent delivery of Shares and/or cash upon settlement of such PARSUs or the subsequent sale of any Shares acquired pursuant to such PARSUs and receipt of any dividends or dividend equivalent payments; and (ii) notwithstanding Section 13, do not commit to and are under no obligation to structure the terms or any aspect of this grant of PARSUs and/or dividend equivalents to reduce or eliminate the Employee’s liability for Tax-Related Items or to achieve any particular tax result. Further, if the Employee has become subject to tax in more than one jurisdiction, the Employee acknowledges that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction. The Employee shall pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Employee’s participation in the Plan or the Employee’s receipt of PARSUs that cannot be satisfied by the means previously described. The Company may refuse to deliver the benefit described in Section 4 if the Employee fails to comply with the Employee’s obligations in connection with the Tax-Related Items.

(c)In accepting the PARSUs, the Employee consents and agrees that in the event the PARSUs or the dividend equivalents become subject to an employer tax that is legally permitted to be recovered from the Employee, as may be determined by the Company and/or the Employer at their sole discretion, and whether or not the Employee’s employment with the Company and/or the Employer is continuing at the time such tax becomes recoverable, the Employee will assume any liability for any such taxes that may be payable by the Company and/or the Employer in connection with the PARSUs and dividend equivalents. Further, by accepting the PARSUs, the Employee agrees that the Company and/or the Employer may collect any such taxes from the Employee by any of the means set forth in this Section 14. The Employee further agrees to execute any other consents or elections required to accomplish the above, promptly upon request of the Company.

1.Data Privacy Consent.

(a)The Employee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Employee’s personal data as described in this Grant Agreement and any other materials by and among, as applicable, the Company, its Subsidiaries or Affiliates, and the Employer for the exclusive purpose of implementing, administering and managing the Employee’s participation in the Plan.

(b)The Employee understands that the Company, its Subsidiaries or Affiliates, and the Employer may hold certain personal information about the Employee, including, but not limited to, name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency, status, job title, any shares of stock or directorships held in the Company, details of all PARSUs, options or any other entitlement to shares of stock granted, canceled, purchased, exercised, vested, unvested or outstanding in the Employee’s favor (“Data”) for the exclusive purpose of implementing, managing and administering the Plan.

(c)The Employee understands that Data may be transferred to Merrill Lynch and any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Employee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Employee’s country. The Company is committed to protecting the privacy of Data in such cases. The Employee understands that by contract both with the Company and/or any of its Subsidiaries or Affiliates and with Merrill Lynch and/or the Company’s other vendors, the people and companies that have access to the Employee’s Data are bound to handle such Data in a manner consistent with the Company's privacy policy and law. The Company periodically performs due diligence and audits on its vendors in accordance with good commercial practices to ensure their capabilities and compliance with those commitments. The Employee further understands that Data will be held only as long as is necessary to implement, administer and manage the Employee’s participation in the Plan.

(d)The Employee understands that if he or she resides outside the United States, the Employee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, the Employee understands that he or she is providing the consents herein on a purely voluntary basis. If the Employee does not consent, or if the Employee later seeks to revoke his or her consent, the Employee's employment status or service with the Company or his or her Employer will not be affected; the only consequence of refusing or withdrawing the Employee’s consent is that the Company would not be able to grant the Employee PARSUs or other equity awards or administer and manage the Employee’s participation in the Plan. Therefore, the Employee understands that refusing or withdrawing his or her consent may affect the Employee’s ability to participate in the Plan. For more information on the consequences of the Employee’s refusal to consent or withdrawal of consent, the Employee understands that he or she may contact the Employee’s local human resources representative.

(e)Further, the Employee understands that the Company may rely on a different legal basis for the processing and/or transfer of Data in the future and/or request that the Employee provide another data privacy consent. If applicable and upon request of the Company or a Subsidiary or Affiliate, the Employee agrees to provide an executed data privacy consent or
5

acknowledgement (or any other consents, acknowledgements or agreements) to the Company or a Subsidiary or Affiliate that the Company and/or a Subsidiary or Affiliate may deem necessary to obtain under the data privacy laws in the Employee’s country of employment, either now or in the future. The Employee understands that he or she may be unable to participate in the Plan if he or she fails to execute any such acknowledgement, agreement or consent requested by the Company and/or a Subsidiary or Affiliate.

By electronically accepting PARSUs on the Merrill Lynch website, the Employee is declaring that the Employee agrees with the data processing practices described in this Section 15 and that the Employee consents to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned therein for the purposes described therein.

15.Plan Information.

The Employee agrees to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with Applicable Laws outside the United States, from the Long-term Incentives website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the investor relations section of the Company's website. The Employee acknowledges that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Company Secretary. The Employee hereby consents to receive any documents related to current or future participation in the Plan by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

16.Acknowledgment and Waiver.

By accepting this grant of PARSUs and any Shares, the Employee understands, acknowledges and agrees that:

(a)this Grant Agreement and its incorporated documents reflect all agreements on its subject matters and the Employee is not accepting this Grant Agreement based on any promises, representations or inducements other than those reflected in this Grant Agreement;

(b)all good faith decisions and interpretations of the Committee regarding the Plan and PARSUs granted under the Plan are binding, conclusive and final;

(c)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time;
(d)the grant of PARSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of PARSUs or other awards, or benefits in lieu of PARSUs, even if Shares or PARSUs have been granted in the past;

(e)all decisions with respect to future grants, if any, will be at the sole discretion of the Company;

(f)the Employee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with the ability of the Employer to terminate the Employee’s employment relationship at any time and it is expressly agreed and understood that employment is terminable at the will of either party;

(g)the Employee is voluntarily participating in the Plan;
(h)PARSUs and their resulting benefits are extraordinary items that are outside the scope of the Employee’s employment contract, if any;

(i)PARSUs and their resulting benefits are not intended to replace any pension rights or compensation;

(j)PARSUs and their resulting benefits are not part of normal or expected compensation or salary for any purposes, including, but not limited to calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

(k)unless otherwise agreed by the Company, the PARSUs and their resulting benefits are not granted as consideration for, or in connection with, the service the Employee may provide as a director of Subsidiary or Affiliate;

(l)this grant of PARSUs will not be interpreted to form an employment contract or relationship with the Company, and furthermore, this grant of PARSUs will not be interpreted to form an employment contract with any Subsidiary or Affiliate;

(m)the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(n)no claim or entitlement to compensation or damages shall arise from forfeiture of the PARSUs resulting from termination of Employee’s employment (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any), and in consideration of the grant of the PARSUs to which the Employee is otherwise not entitled, the Employee irrevocably agrees never to institute any claim against the Company, the Employer or any other Subsidiary or Affiliate and releases the Company, the Employer and any other Subsidiary and Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in
6

the Plan, the Employee shall be deemed irrevocably to have agreed not to pursue such claim and to have agreed to execute any and all documents necessary to request dismissal or withdrawal of such claims;

(o)the Company, the Employer or any other Subsidiary or Affiliate will not be liable for any foreign exchange rate fluctuation between the Employee’s local currency and the United States dollar that may affect the value of the PARSUs or any amounts due to the Employee pursuant to the settlement of the PARSUs or the subsequent sale of any Shares acquired upon settlement;

(p)if the Company's performance is below minimum levels as set forth in this Grant Agreement, no PARSUs or dividend equivalents will vest and no Shares will be delivered to the Employee;

(q)if the Company determines that the Employee has engaged in misconduct prohibited by Applicable Law or any applicable policy of the Company, as in effect from time to time, or the Company is required to make recovery from the Employee under Applicable Law or a Company policy adopted to comply with applicable legal requirements, then the Company may, in its sole discretion, to the extent it determines appropriate, (i) recover from the Employee the proceeds from PARSUs vested up to three (3) years prior to the Employee’s termination of employment or any time thereafter, (ii) cancel the Employee’s outstanding PARSUs, and (iii) take any other action it deems to be required and appropriate; and

(r)the delivery of any documents related to the Plan or Awards granted under the Plan, including the Plan, this Grant Agreement, the Plan prospectus and any reports of the Company generally provided to the Company’s stockholders, may be made by electronic delivery. Such means of electronic delivery may include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via electronic mail or other such means of electronic delivery specified by the Company. The Employee may receive from the Company a paper copy of any documents delivered electronically at no cost to the Employee by contacting the Company in writing in accordance with Section 21(l). If the attempted electronic delivery of any document fails, the Employee will be provided with a paper copy of such document. The Employee may revoke his or her consent to the electronic delivery of documents or may change the electronic mail address to which such documents are to be delivered (if the Employee has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised electronic mail address in accordance with Section 21(l). The Employee is not required to consent to the electronic delivery of documents.
17.No Advice Regarding Grant.
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Employee’s participation in the Plan, or the Employee’s acquisition or sale of the underlying Shares. The Employee is hereby advised to consult with his or her personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.
18.Additional Eligibility Requirements Permitted.

In addition to any other eligibility criteria provided for in the Plan, the Company may require that the Employee execute a separate document agreeing to the terms of a current arbitration agreement and/or a current ARCIPD, each in a form acceptable to the Company and/or that the Employee be in compliance with the ARCIPD throughout the entire Performance Period. If such separate documents are required by the Company and the Employee does not accept them within 75 days of the Grant Date or such other date as of which the Company shall require in its discretion, the PARSUs shall be canceled, and the Employee shall have no further rights under this Grant Agreement.

19.Insider Trading Policy.

The Employee acknowledges and understands that, depending on his or her broker's country of residence or where the Company shares are listed, the Employee may be subject to insider trading restrictions and/or market abuse laws which may affect the Employee’s ability to accept, acquire, purchase, sell or otherwise dispose of Shares or, rights to Shares during such times when the Employee is considered to have “inside information” regarding the Company as defined in the laws or regulations in the Employee’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Employee placed before he or she possessed inside information. Furthermore, the Employee could be prohibited from (a) disclosing the inside information to any third party (other than on a “need to know” basis) and (b) “tipping” third parties or causing them otherwise to buy or sell securities. The Employee understands that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Employee acknowledges that it is his or her responsibility to comply with such regulations; therefore, he or she should consult with the Employee’s personal advisor on this matter.    

20.Miscellaneous.

(a)The Company shall not be required to treat as owner of PARSUs and any associated benefits hereunder any transferee to whom such PARSUs or benefits shall have been transferred in violation of any of the provisions of this Grant Agreement.

(b)The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Grant Agreement.

(c)The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Employee with respect to the subject matter hereof, other than the terms of any severance plan applicable to the Employee that provides more favorable vesting. Notwithstanding the foregoing, nothing in the Plan or this Grant Agreement shall affect the validity or interpretation of any duly authorized written agreement between the Company and the
7

Employee under which an award properly granted under and pursuant to the Plan serves as any part of the consideration furnished to the Employee, including without limitation, any agreement that imposes restrictions during or after employment regarding confidential information and proprietary developments. This Grant Agreement is governed by the laws of the state of Delaware without regard to its conflict of law provisions.

(d)If the Employee has received this or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

(e)The provisions of this Grant Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

(f)Notwithstanding Section 21(e), the Company’s obligations under this Grant Agreement and the Employee’s agreement to the terms of an arbitration agreement and/or an ARCIPD, if any, are mutually dependent. If the Employee breaches the arbitration agreement or the Employee’s ARCIPD is breached or found not to be binding upon the Employee for any reason by a court of law, then the Company will have no further obligation or duty to perform under the Plan or this Grant Agreement.

(g)A waiver by the Company of a breach of any provision of this Grant Agreement shall not operate or be construed as a waiver of any other provision of this Grant Agreement, or of any subsequent breach by the Employee or any other Awardee.

(h)Notwithstanding any provisions in this Grant Agreement, the grant of the PARSUs shall be subject to any special terms and conditions set forth in the Appendix to this Grant Agreement for the Employee’s country of employment (and country of residence, if different), if any. Moreover, if the Employee relocates to one of the countries included in the Appendix, the special terms and conditions for such country will apply to the Employee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal, regulatory, tax or administrative reasons. The Appendix, if any, constitutes part of this Grant Agreement.

(i)The Company reserves the right to impose other requirements on the Employee’s participation in the Plan, on the PARSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Employee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
(j)All rights granted and/or Shares issued under this Grant Agreement are subject to claw back under the Company policy as in effect from time to time.

(k)Any notice required or permitted hereunder to the Employee shall be given in writing and shall be deemed effectively given upon delivery to the Employee at the address then on file with the Company.

(l)Any notice to be given under the terms of this Grant Agreement to the Company will be addressed in care of Attn: Global Equity at HP Inc., 1501 Page Mill, Palo Alto, California 94304, USA.

(m)The Employee acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect his or her ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends or dividend equivalent payments) in a brokerage or bank account outside the Employee's country. The Employee may be required to report such accounts, assets or transactions to the tax or other authorities in his or her country. The Employee also may be required to repatriate sale proceeds or other funds received as a result of the Employee's participation in the Plan to his or her country through a designated bank or broker within a certain time after receipt. The Employee acknowledges that it is his or her responsibility to be compliant with such regulations, and the Employee is advised to consult his or her personal legal advisor for any details.

21.Forfeitures and Recoupment.

(a)Recoupment Policy. The RSUs granted hereunder, any Shares issued pursuant to the PARSUs and any proceeds therefrom shall be subject to and remain subject to any incentive compensation clawback or recoupment policy of the Company (i) currently in effect, (ii) as may be adopted by the Company to comply with applicable law and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, including, without limitation, pursuant to Section 10D of the Exchange Act, Rule 10D-1 thereunder and Section 303A.14 of the New York Stock Exchange Listed Company Manual) or (iii) as may be adopted by the Company to facilitate the Company’s objectives related to eliminating or reducing fraud, misconduct, wrongdoing, or violations of law by an employee or other service provider or related to improving the Company’s governance practices or similar considerations and, in each case, as may be amended from time to time (the “Policy”), with the provisions contained in such Policy deemed incorporated into this Grant Agreement without Employee’s additional or separate consent.

(b)Recoupment Authorization. For purposes of the foregoing, the Employee expressly and explicitly authorizes the Company to issue instructions, on the Employee's behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to this RSU to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Grant Agreement and the Policy conflict, the terms of the Policy shall prevail.

8

HP Inc.


Enrique Lores
CEO and President



Kristen Ludgate
Chief People Officer



RETAIN THIS GRANT AGREEMENT FOR YOUR RECORDS

Important Note: Your grant is subject to the terms and conditions of this Grant Agreement and to the Company obtaining all necessary government approvals. If you have questions regarding your grant, please contact global.equity@hp.com.

9

Exhibit A

TOTAL SHAREHOLDER RETURN (TSR) CALCULATION

PEER GROUP

The peer group consists of the companies that are included in the Standard & Poor’s (“S&P”) 500 index, with at least three months of trading history, at the beginning of the Performance Period on November 1, 2023 (“TSR Peer Group”, each a “Peer Company”).

(a)If a Peer Company is removed from the S&P 500 index during the Performance Period but remains a publicly traded company, then such company will remain in the TSR Peer Group.
(b)In the event of a bankruptcy, liquidation or delisting of a Peer Company at any time during the Performance Period, such company shall remain a Peer Company and be assigned a TSR of negative one hundred percent (-100%). Delisting shall mean that a company ceases to be publicly traded on a national securities exchange as a result of any involuntary failure to meet the listing requirements of such national securities exchange, but shall not include delisting as a result of any voluntary going-private or similar transaction.
(c)If a Peer Company is acquired by another company, including through a management buy-out or going-private transaction, and the Peer Company is not the surviving entity or is otherwise no longer publicly traded after the transaction, then the acquired Peer Company will be removed from the TSR Peer Group for the entire Performance Period; provided, however, that if the acquired Peer Company became bankrupt or became delisted prior to its acquisition it shall be treated as provided in paragraph (b) above.
(d)If a Peer Company spins off a portion of its business in a manner which results in the Peer Company and the spin-off company both being publicly traded, the Peer Company will remain in the TSR Peer Group, and the spin-off company’s value will be included in the Peer Company’s TSR calculation as a “special dividend” and reinvested in the Peer Company’s stock.
(e)If a Peer Company acquires another company, and the Peer Company continues to be the surviving entity after the transaction, then the acquiring Peer Company will remain in the TSR Peer Group for the Performance Period.
(f)If the Company’s or any Peer Company’s stock splits (or if there are other similar subdivisions, consolidations or changes in such company’s stock or capitalization), such company’s TSR performance will be adjusted for the stock split so as not to give an advantage or disadvantage to such company by comparison to other companies in the TSR Peer Group.

The Committee shall have the authority, or delegate such authority, to make all determinations regarding the adjustment of the TSR goal, including, but not limited to, the extent of achievement, and any adjustments to the calculation of TSR or the treatment of Peer Companies, as necessary or appropriate.

TSR CALCULATION

The final payout of PARSUs will be determined based on the formula set forth in Section 3(a) of the Grant Agreement. The TSR Goal is based upon the Company’s TSR ranking relative to the TSR Peer Group for the Performance Period.

Company’s Relative TSR Performance RankPayout Modifier or Adjustment
<25th percentile
of the TSR Peer Group
-50% to the final 3-year average EPS performance
25th to 75th percentile
of the TSR Peer Group
No adjustment to the final 3-year average EPS performance
>75th percentile
of the TSR Peer Group
+50% to the final 3-year average EPS performance

The TSR shall be calculated as follows, where:
•“Beginning Stock Price” shall mean the average closing stock price in the calendar month prior to the start of the Performance Period (October 2023)
•“Ending Stock Price” shall mean the average closing stock price in the last calendar month of the Performance Period (October 2026)
•“Reinvested Dividends” shall mean the dividends paid with respect to an ex-dividend date that occurs beginning from the date when the Beginning Stock Price is measured through the end of the Performance Period (whether or not the dividend payment date occurs during such period), which shall be deemed to have been reinvested in the underlying common shares.

TSR = Ending Stock Price – Beginning Stock Price + Reinvested Dividends
                                Beginning Stock Price

10
 EX-10.(K)(K)(K)(K) 7 hpq-standardpolyrsuagreeme.htm EX-10.(K)(K)(K)(K) Document
Exhibit 10(k)(k)(k)(k)
image_0a.jpg


GRANT AGREEMENT for use from December 1, 2023


Name:
fld_NAME_AC
Employee ID:
fld_EMPLID
    
Grant Date:
expGRANT_DATE
Grant ID:
fld_GRANT_NBR
Amount:
0
Plan:Plantronics, Inc. 2003 Stock Plan
Vesting Schedule:
fld_HTMLAREA1

Restricted Stock Units

    THIS GRANT AGREEMENT, as of the Grant Date noted above between HP Inc., a Delaware Corporation (“Company”), and the employee named above (“Employee”), is entered into as follows:

    WHEREAS, the continued participation of the Employee is considered by the Company to be important for the Company's continued growth; and

    WHEREAS, in order to give the Employee an incentive to continue in the employ of the Company (or its Subsidiaries), to accept ancillary agreements designed to protect the legitimate business interests of the Company that are made a condition of this grant and to participate in the affairs of the Company, the HR and Compensation Committee of the Board of Directors of the Company or its delegates (“Committee”) has determined that the Employee shall be granted restricted stock units representing hypothetical shares of the Company’s common stock (“RSUs”), with each RSU equal in value to one share of the Company’s $0.01 par value common stock (“Share”), subject to the restrictions stated below and in accordance with the terms and conditions of the plan named above (“Plan”), a copy of which can be found on the Long-term Incentives website along with a copy of the related prospectus. The Plan and the related prospectus also can be obtained by written or telephonic request to the Company Secretary. Unless otherwise defined in this Grant Agreement, any capitalized terms in this Grant Agreement shall have the meaning ascribed to such terms in the Plan.

    THEREFORE, the parties agree as follows:

1.Grant of Restricted Stock Units.
Subject to the terms and conditions of this Grant Agreement and of the Plan, the Company hereby grants to the Employee the number of RSUs set forth above.

2.Vesting Schedule.
The interest of the Employee in the RSUs shall vest according to the vesting schedule set forth above, or if earlier, in accordance with Section 8 or 9, below, except to the extent a severance plan applicable to the Employee provides otherwise. Unless the provisions of Section 8 or 9 apply, the Employee must remain in the employ of the Company or any Subsidiary on a continuous basis through the close of business on the applicable Vesting Date, as set forth above, and the Employee must be in compliance with the requirements and conditions provided for in the Plan and this Grant Agreement for the interest of the Employee in the RSUs to become fully vested on that date.

3.Benefit Upon Settlement.
Within 75 days of each Vesting Date set forth on the above vesting schedule or, if earlier, a vesting event pursuant to Section 8 or 9 below, the Company shall deliver or pay, as applicable, to the Employee (or the Employee’s guardian, estate or beneficiary in the event of Section 8 or 9) Shares or a combination of cash and Shares, as the Company determines in its sole discretion, with a value equal to:

(a)    the number of RSUs that have become vested as of such vesting date or vesting event, as applicable, multiplied by the Fair Market Value of a Share on the date on which such RSUs vested; plus
(b)    a dividend equivalent payment credited in the form of additional RSUs for each ordinary cash dividend the Company pays on its Shares and for which the record date occurs between the grant date and the date the RSUs are settled, determined by:
(1)multiplying the per share cash dividend paid by the Company on its Shares by the total number of RSUs that are outstanding as of the record date for the dividend; and
(2)dividing the amount determined in (1) above by the Fair Market Value of a Share on the dividend payment date to determine the number of additional whole and fractional RSUs to be credited to the Employee;
1


provided, however, that if any aggregated dividend equivalent payments in Section (b)(2) above to be delivered in Shares result in a payment of a fractional Share, such fractional Share shall be rounded up to the next whole Share.

Notwithstanding the foregoing, the Company may, in its sole discretion, settle the RSUs in the form of a cash payment to the extent settlement in Shares: (i) is prohibited under local law; (ii) would require the Employee, the Company and/or any Subsidiary to obtain the approval of any governmental and/or regulatory body in the Employee's country; (iii) would result in adverse tax consequences for the Employee, the Company or any Subsidiary; or (iv) is administratively burdensome. Alternatively, the Company may, in its sole discretion, settle the RSUs in the form of Shares but require the Employee to sell such Shares immediately or within a specified period of time following the Employee’s termination of employment (in which case the Employee expressly authorizes the Company to issue sales instructions on the Employee's behalf).

4.Restrictions.
Except as otherwise provided for in this Grant Agreement, the RSUs or rights granted hereunder may not be sold, pledged or otherwise transferred. The period of time between the Grant Date and the date the RSUs become fully vested pursuant to Section 2 is referred to herein as the “Restriction Period.”
5.Custody of Restricted Stock Units.
The RSUs subject hereto shall be recorded in an account with the Plan broker in the name of the Employee. Upon termination of the Restriction Period, if the Company determines, in its sole discretion, to deliver Shares pursuant to Section 3 above, such Shares shall be released into the Employee’s account; provided, however, that a portion of such Shares shall be surrendered in payment of Tax-Related Items, as defined and in accordance with Section 12 below, unless the Company, in its sole discretion, establishes alternative procedures for the payment of Tax-Related Items.

6.No Stockholder Rights.
RSUs represent hypothetical Shares. Until Shares are delivered to the Employee pursuant to the terms of this Grant Agreement, the Employee shall not be entitled to any of the rights or benefits generally accorded to stockholders, including, without limitation, the receipt of dividends.

7.Termination of Employment.
Except as otherwise provided for in this Grant Agreement or in the Plan or as otherwise determined by the Company in its sole discretion, if the Employee's employment with the Company or any Subsidiary is terminated at any time for any reason prior to the lapse of the Restriction Period, all unvested RSUs granted hereunder shall be forfeited by the Employee, except to the extent a severance plan applicable to the Employee provides otherwise.

For purposes of this Grant Agreement, the Employee's employment or service will be considered terminated as of the date the Employee is no longer actively providing services to the Company, any Subsidiary (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any) and will not be extended by any notice period (e.g., the Employee's period of employment or service would not include any contractual notice period or any period of “garden leave” or similar period mandated under the employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when the Employee's employment or service is terminated for purposes of this Grant Agreement (including whether the Employee may still be considered to be providing service while on a leave of absence).

8.Disability or Retirement of the Employee.
If the Employee’s employment is terminated prior to the end of the Restriction Period by reason of the Employee’s Disability or retirement in accordance with the applicable retirement policy, all RSUs shall immediately vest including any amounts for dividend equivalent payments on RSUs that vest at termination. The Company’s obligation to vest the RSUs under this paragraph is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company, and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the RSU remains outstanding.

9.Death of the Employee.
In the event that termination of employment prior to the end of the Restriction Period is due to the death of the Employee, all unvested RSUs shall immediately vest including any amounts for dividend equivalent payments on such vested RSUs.

10.Termination for Cause.
Upon termination of the Employee’s employment for Cause, then all unvested RSUs shall be forfeited by the Employee on the date of the Employee’s termination, except to the extent a severance plan applicable to the Employee provides otherwise. Such forfeiture shall occur regardless of whether the Employee has satisfied any applicable age and service requirements for retirement. For the purpose of this Grant Agreement, “Cause” shall mean, unless otherwise defined in an agreement to which the Employee is a party with the Company or a Subsidiary, the occurrence of any of the following: (i) the Employee’s conviction of, or plea of guilty or nolo contendere to, a felony under Applicable Law; (ii) the Employee’s willful and deliberate failure in the performance of the Employee’s duties in any material respect; (iii) the Employee’s willful misconduct that results in material harm to the Company or a Subsidiary; or (iv) the Employee’s material violation of the Company’s ethics and compliance program, code of conduct or other material policy of the Company.

11.Section 409A.
The following provisions apply to the extent the Employee is subject to taxation in the U.S. Payments made pursuant to the Plan and this Grant Agreement are intended to comply with or qualify for an exemption from Section 409A of the Code (“Section 409A”). The Company reserves the right, to the extent the Company deems necessary or advisable in its sole discretion, to unilaterally amend or modify the Plan and/or this Grant Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, including any amendments or actions that would result in the reduction of benefits payable under this Grant Agreement, as the Company determines are necessary or appropriate to ensure that all RSUs and dividend equivalent payments are made in a manner that qualifies for an exemption from, or complies with, Section
2


409A or mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Section 409A: provided however, that the Company makes no representations that the RSUs or dividend equivalents will be exempt from any taxes, interest, and/or penalties that may apply under Section 409A and makes no undertaking to preclude Section 409A from applying to this RSU. For the avoidance of doubt, the Employee hereby acknowledges and agrees that neither the Company nor any Subsidiary will have any liability to the Employee or any other party if any amounts payable under this Grant Agreement are not exempt from, or compliant with, Section 409A, or for any action taken by the Company with respect thereto. Any payments under this Grant Agreement, the settlement of which is triggered by a "separation from service" (within the meaning of Section 409A) of a "specified employee" (as defined under Section 409A), shall be made on a date that is the earlier of (a) the Employee’s death or (b) the later of the specified settlement date and the date which is six months after the date of the Employee’s separation from service.

12.Taxes.
(a)The Employee shall be liable for any and all taxes, including income tax, social insurance, fringe benefit tax, payroll tax, payment on account, employer taxes or other tax-related items related to the Employee’s participation in the Plan and legally applicable to or otherwise recoverable from the Employee by the Company and/or, if different, the Employee’s employer (the “Employer”) whether incurred at grant, vesting, sale, prior to vesting or at any other time (“Tax-Related Items”). In the event that the Company or the Employer (which, for purposes of this Section 12, shall include a former employer) is required, allowed or permitted to withhold taxes as a result of the grant or vesting of RSUs or the issuance or subsequent sale of Shares acquired pursuant to such RSUs, or due upon receipt of dividend equivalent payments or dividends, the Employee shall surrender a sufficient number of whole Shares, make a cash payment or make adequate arrangements satisfactory to the Company and/or the Employer to withhold such taxes from Employee’s wages or other cash compensation paid to the Employee by the Company and/or the Employer at the election of the Company, in its sole discretion, or, if permissible under local law, the Company may sell or arrange for the sale of Shares that Employee acquires as necessary to cover all Tax-Related Items that the Company or the Employer has to withhold or that are legally recoverable from the Employee (such as fringe benefit tax) at the time the restrictions on the RSUs lapse, unless the Company, in its sole discretion, has established alternative procedures for such payment. However, with respect to any RSUs subject to Section 409A, the Employer shall limit the surrender of Shares to the minimum number of Shares permitted to avoid a prohibited acceleration under Section 409A. The Employee will receive a cash refund for any fraction of a surrendered Share or Shares in excess of any and all Tax-Related Items. To the extent that any surrender of Shares or payment of cash or alternative procedure for such payment is insufficient, the Employee authorizes the Company and its Subsidiaries, which are qualified to deduct tax at source, to deduct from the Employee’s compensation all Tax-Related Items. The Employee agrees to pay any Tax-Related Items that cannot be satisfied from wages or other cash compensation, to the extent permitted by Applicable Law.

(b)Regardless of any action the Company or the Employer takes with respect to any or all Tax-Related Items, the Employee acknowledges and agrees that the ultimate liability for all Tax-Related Items is and remains the Employee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Employee further acknowledges that the Company and/or the Employer: (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of RSUs or dividend equivalents, including, but not limited to, the grant, vesting or settlement of RSUs or dividend equivalents, the subsequent delivery of Shares and/or cash upon settlement of such RSUs or the subsequent sale of any Shares acquired pursuant to such RSUs and receipt of any dividends or dividend equivalent payments; and (ii) notwithstanding Section 11, do not commit to and are under no obligation to structure the terms or any aspect of this grant of RSUs and/or dividend equivalents to reduce or eliminate the Employee’s liability for Tax-Related Items or to achieve any particular tax result. Further, if the Employee has become subject to tax in more than one jurisdiction, the Employee acknowledges that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(c)Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Employee’s jurisdiction(s), in which case the Employee will receive a refund of any over-withheld amount in cash and will have no entitlement to the Share equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Employee is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.

(d)The Employee shall pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Employee’s participation in the Plan or the Employee’s receipt of RSUs that cannot be satisfied by the means previously described. The Company may refuse to deliver the benefit described in Section 3 if the Employee fails to comply with the Employee’s obligations in connection with the Tax-Related Items.

(e)The Employee consents and agrees that in the event the RSUs or the dividend equivalents become subject to an employer tax that is legally permitted to be recovered from the Employee, as may be determined by the Company and/or the Employer at their sole discretion, and whether or not the Employee’s employment with the Company and/or the Employer is continuing at the time such tax becomes recoverable, the Employee will assume any liability for any such taxes that may be payable by the Company and/or the Employer in connection with the RSUs and dividend equivalents. Further, the Employee agrees that the Company and/or the Employer may collect any such taxes from the Employee by any of the means set forth in this Section 12. The Employee further agrees to execute any other consents or elections required to accomplish the above, promptly upon request of the Company.

13.Data Privacy Consent.
(a)The Employee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Employee’s personal data as described in this Grant Agreement and any other materials by and among, as applicable, the Company, its Subsidiaries, and the Employer for the exclusive purpose of implementing, administering and managing the Employee’s participation in the Plan.

(b)The Employee understands that the Company, its Subsidiaries, and the Employer may hold certain personal information about the Employee, including, but not limited to, name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency, status, job title, any shares of stock or directorships held in the Company, details of all RSUs, options or
3


any other entitlement to shares of stock granted, canceled, purchased, exercised, vested, unvested or outstanding in the Employee’s favor (“Data”) for the exclusive purpose of implementing, managing and administering the Plan.

(c)The Employee understands that Data may be transferred to Merrill Lynch and any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Employee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Employee’s country. The Company is committed to protecting the privacy of Data in such cases. The Employee understands that by contract both with the Company and/or any of its Subsidiaries and with Merrill Lynch and/or the Company’s other vendors, the people and companies that have access to the Employee’s Data are bound to handle such Data in a manner consistent with the Company’s privacy policy and law. The Company periodically performs due diligence and audits on its vendors in accordance with good commercial practices to ensure their capabilities and compliance with those commitments. The Employee further understands that Data will be held only as long as is necessary to implement, administer and manage the Employee’s participation in the Plan.

(d)The Employee understands that if the Employee resides outside the United States, the Employee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Employee's local human resources representative. Further, the Employee understands that the Employee is providing the consents herein on a purely voluntary basis. If the Employee does not consent, or if the Employee later seeks to revoke the Employee's consent, the Employee's employment status or service with the Company or the Employee's Employer will not be affected; the only consequence of refusing or withdrawing the Employee’s consent is that the Company would not be able to grant the Employee RSUs or other equity awards or administer and manage the Employee’s participation in the Plan. Therefore, the Employee understands that refusing or withdrawing the Employee's consent may affect the Employee’s ability to participate in the Plan. For more information on the consequences of the Employee’s refusal to consent or withdrawal of consent, the Employee understands that the Employee may contact the Employee's local human resources representative.

(e)Further, the Employee understands that the Company may rely on a different legal basis for the processing and/or transfer of Data in the future and/or request that the Employee provide another data privacy consent. If applicable and upon request of the Company or a Subsidiary, the Employee agrees to provide an executed data privacy consent or acknowledgement (or any other consents, acknowledgements or agreements) to the Company or a Subsidiary that the Company and/or a Subsidiary may deem necessary to obtain under the data privacy laws in the Employee’s country of employment, either now or in the future. The Employee understands that the Employee may be unable to participate in the Plan if the Employee fails to execute any such acknowledgement, agreement or consent requested by the Company and/or a Subsidiary.

By electronically accepting RSUs on the Merrill Lynch website, the Employee is declaring that the Employee agrees with the data processing practices described in this Section 13 and that the Employee consents to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned therein for the purposes described therein.

14.Plan Information.
The Employee agrees to receive copies of the Plan, [the Plan prospectus] and other Plan information, including information prepared to comply with Applicable Laws outside the United States, from the Long-term Incentives website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the investor relations section of the Company's website at https://investor.hp.com/home/default.aspx. The Employee acknowledges that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Company Secretary. The Employee hereby consents to receive any documents related to current or future participation in the Plan by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

15.Acknowledgment and Waiver.
The Employee understands, acknowledges and agrees that:

(a)except as provided in Sections 8 and 9, the vesting of the RSUs is earned only by continuing employment with the Company or one of its Subsidiaries and that being hired and granted RSUs will not result in the RSUs vesting;

(b)this Grant Agreement and its incorporated documents reflect all agreements on its subject matters and the Employee is not accepting this Grant Agreement based on any promises, representations or inducements other than those reflected in this Grant Agreement;

(c)all good faith decisions and interpretations of the Committee regarding the Plan and RSUs granted under the Plan are binding, conclusive and final;

(d)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time;
(e)the grant of RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs or other awards, or benefits in lieu of RSUs, even if Shares or RSUs have been granted in the past;

(f)all decisions with respect to future grants, if any, will be at the sole discretion of the Company;

(g)the Employee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with the ability of the Employer to terminate the Employee’s employment relationship at any time and it is expressly agreed and understood that employment is terminable at the will of either party;

(h)the Employee is voluntarily participating in the Plan;
4


(i)RSUs and their resulting benefits are extraordinary items that are outside the scope of the Employee’s employment contract, if any;

(j)RSUs and their resulting benefits are not intended to replace any pension rights or compensation;

(k)RSUs and their resulting benefits are not part of normal or expected compensation or salary for any purposes, including, but not limited to calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

(l)unless otherwise agreed by the Company, the RSUs and their resulting benefits are not granted as consideration for, or in connection with, the service the Employee may provide as a director of a Subsidiary;

(m)this grant of RSUs will not be interpreted to form an employment contract or relationship with the Company, and furthermore, this grant of RSUs will not be interpreted to form an employment contract with any Subsidiary;

(n)the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(o)no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from (i) termination of Employee’s employment (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any), and/or (ii) the application of any recoupment policy or any recovery or clawback policy otherwise required by law, and in consideration of the grant of the RSUs to which the Employee is otherwise not entitled, the Employee agrees not to institute any claim against the Company, the Employer or any other Subsidiary and releases the Company, the Employer and any other Subsidiary from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Employee shall be deemed irrevocably to have agreed not to pursue such claim and to have agreed to execute any and all documents necessary to request dismissal or withdrawal of such claims;

(p)the Company, the Employer or any other Subsidiary will not be liable for any foreign exchange rate fluctuation between the Employee’s local currency and the United States dollar that may affect the value of the RSUs or any amounts due to the Employee pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement;

(q)if the Company determines that the Employee has engaged in misconduct prohibited by Applicable Law or any applicable policy of the Company, as in effect from time to time, or the Company is required to make recovery from the Employee under Applicable Law or a Company policy adopted to comply with applicable legal requirements, then the Company may, in its sole discretion, to the extent it determines appropriate, (i) recover from the Employee the proceeds from RSUs vested up to three years prior to the Employee’s termination of employment or any time thereafter, (ii) cancel the Employee’s outstanding RSUs, and (iii) take any other action it deems to be required and appropriate; and

(r)the delivery of any documents related to the Plan or Awards granted under the Plan, including the Plan, this Grant Agreement, the Plan prospectus and any reports of the Company generally provided to the Company’s stockholders, may be made by electronic delivery. Such means of electronic delivery may include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via electronic mail or other such means of electronic delivery specified by the Company. The Employee may receive from the Company a paper copy of any documents delivered electronically at no cost to the Employee by contacting the Company in writing in accordance with Section 18(k). If the attempted electronic delivery of any document fails, the Employee will be provided with a paper copy of such document. The Employee may revoke the Employee's consent to the electronic delivery of documents or may change the electronic mail address to which such documents are to be delivered (if the Employee has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised electronic mail address in accordance with Section 18(k). The Employee is not required to consent to the electronic delivery of documents.

16.No Advice Regarding Grant.
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Employee’s participation in the Plan, or the Employee’s acquisition or sale of the underlying Shares. The Employee is hereby advised to consult with the Employee's own personal tax, legal and financial advisors regarding the Employee's participation in the Plan before taking any action related to the Plan.

17.Additional Eligibility Requirements Permitted.
In addition to any other eligibility criteria provided for in the Plan, the Company may require that the Employee execute a separate document agreeing to the terms of a current arbitration agreement and/or a current ARCIPD, each in a form acceptable to the Company and/or that the Employee be in compliance with the ARCIPD throughout the entire Restriction Period and through the date the RSU is to be granted or settled. If such separate documents are required by the Company and the Employee does not accept them within 75 days of the Grant Date or such other date as of which the Company shall require in its discretion, this RSU shall be canceled and the Employee shall have no further rights under this Grant Agreement.

18.Miscellaneous.
(a)The Company shall not be required to treat as owner of RSUs and any associated benefits hereunder, any transferee to whom such RSUs or benefits shall have been transferred in violation of any of the provisions of this Grant Agreement.

(b)The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Grant Agreement.

(c)The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Employee with respect to the subject matter hereof, other than the terms of any severance plan applicable to the Employee that provides more favorable vesting. Notwithstanding the foregoing, nothing in the Plan or this Grant Agreement shall affect the validity or interpretation of any duly authorized written agreement between the Company and the
5


Employee under which an award properly granted under and pursuant to the Plan serves as any part of the consideration furnished to the Employee, including, without limitation, any agreement that imposes restrictions during or after employment regarding confidential information and proprietary developments. This Grant Agreement is governed by the laws of the state of Delaware without regard to its conflict of law provisions.

(d)If the Employee has received this or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

(e)The provisions of this Grant Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

(f)Notwithstanding Section 18(e), the Company’s obligations under this Grant Agreement and the Employee’s agreement to the terms of an arbitration agreement and/or an ARCIPD, if any, are mutually dependent. In the event that the Employee breaches the arbitration agreement or the Employee’s ARCIPD is breached or found not to be binding upon the Employee for any reason by a court of law, then the Company will have no further obligation or duty to perform under the Plan or this Grant Agreement.

(g)A waiver by the Company of a breach of any provision of this Grant Agreement shall not operate or be construed as a waiver of any other provision of this Grant Agreement, or of any subsequent breach by the Employee or any other Participant.

(h)The Employee acknowledges that, depending on the Employee or broker’s country of residence or where the Company Shares are listed, the Employee may be subject to insider trading restrictions and/or market abuse laws, which may affect the Employee's ability to acquire, sell or otherwise dispose of Shares or rights to Shares during times the Employee is considered to have “inside information” regarding the Company (as defined by the laws in the Employee’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Employee placed before the Employee possessed inside information. Furthermore, the Employee cold be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Employee acknowledges that it is the Employee's responsibility to comply with any applicable restrictions and that the Employee should to consult the Employee's personal advisor on this matter.

(i)Notwithstanding any provisions in this Grant Agreement, for any Employee who resides and/or works in a country other than the United States, the grant of the RSUs shall be subject to any additional terms and conditions set forth in the Appendix to this Grant Agreement for the Employee’s country of employment (account of residence, if different), if any. Moreover, if the Employee relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to the Employee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal, regulatory, tax or administrative reasons. The Appendix, if any, constitutes part of this Grant Agreement.

(j)The Company reserves the right to impose other requirements on the Employee’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Employee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

(k)All RSUs granted and/or Shares issued under this Grant Agreement are subject to claw back under the Company policy as in effect from time to time.

(l)Any notice required or permitted hereunder to the Employee shall be given in writing and shall be deemed effectively given upon delivery to the Employee at the address then on file with the Company.

(m)Any notice to be given under the terms of this Grant Agreement to the Company will be addressed in care of Attn: Global Equity at HP Inc., 1501 Page Mill Road, Palo Alto, California 94304, USA.

(n)The Employee acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect the Employee's ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends or dividend equivalent payments) in a brokerage or bank account outside the Employee's country. The Employee may be required to report such accounts, assets or transactions to the tax or other authorities in the Employee's country. The Employee also may be required to repatriate sale proceeds or other funds received as a result of the Employee's participation in the Plan to the Employee's country through a designated bank or broker within a certain time after receipt. The Employee acknowledges that it is the Employee's responsibility to be compliant with such regulations, and the Employee is advised to consult the Employee's personal legal advisor for any details.

19.Forfeitures and Recoupment.
(a)Recoupment Policy. The RSUs granted hereunder, any Shares issued pursuant to the RSUs and any proceeds therefrom shall be subject to and remain subject to any incentive compensation clawback or recoupment policy of the Company (i) currently in effect, (ii) as may be adopted by the Company to comply with applicable law and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, including, without limitation, pursuant to Section 10D of the Exchange Act, Rule 10D-1 thereunder and Section 303A.14 of the New York Stock Exchange Listed Company Manual) or (iii) as may be adopted by the Company to facilitate the Company’s objectives related to eliminating or reducing fraud, misconduct, wrongdoing, or violations of law by an employee or other service provider or related to improving the Company’s governance practices or similar considerations and, in each case, as may be amended from time to time (the “Policy”), with the provisions contained in such Policy deemed incorporated into this Grant Agreement without Employee’s additional or separate consent.

(b)Recoupment Authorization. For purposes of the foregoing, the Employee expressly and explicitly authorizes the Company to issue instructions, on the Employee's behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to this RSU to re-convey, transfer or otherwise return such Shares
6


and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Grant Agreement and the Policy conflict, the terms of the Policy shall prevail.


HP Inc.


Enrique Lores
CEO and President




    Kristen Ludgate
Chief People Officer



RETAIN THIS GRANT AGREEMENT FOR YOUR RECORDS

Important Note: Your grant is subject to the terms and conditions of this Grant Agreement, including any Appendix for your country of employment, and to the Company obtaining all necessary government approvals. If you have questions regarding your grant, please contact global.equity@hp.com.
7

 EX-10.(L)(L)(L)(L) 8 hpq-retentionpolyrsuagreem.htm EX-10.(L)(L)(L)(L) Document
Exhibit 10(l)(l)(l)(l)
image_02.jpg


RETENTION GRANT AGREEMENT for use from December 1, 2023


Name:
fld_NAME_AC
Employee ID:
fld_EMPLID
    
Grant Date:
expGRANT_DATE
Grant ID:
fld_GRANT_NBR
Amount:
0
Plan:Plantronics, Inc. 2003 Stock Plan
Vesting Schedule:
fld_HTMLAREA1

Restricted Stock Units

    THIS GRANT AGREEMENT, as of the Grant Date noted above between HP Inc., a Delaware Corporation (“Company”), and the employee named above (“Employee”), is entered into as follows:

    WHEREAS, the continued participation of the Employee is considered by the Company to be important for the Company's continued growth; and

    WHEREAS, in order to give the Employee an incentive to continue in the employ of the Company (or its Subsidiaries), to accept ancillary agreements designed to protect the legitimate business interests of the Company that are made a condition of this grant and to participate in the affairs of the Company, the HR and Compensation Committee of the Board of Directors of the Company or its delegates (“Committee”) has determined that the Employee shall be granted restricted stock units representing hypothetical shares of the Company’s common stock (“RSUs”), with each RSU equal in value to one share of the Company’s $0.01 par value common stock (“Share”), subject to the restrictions stated below and in accordance with the terms and conditions of the plan named above (“Plan”), a copy of which can be found on the Long-term Incentives website along with a copy of the related prospectus. The Plan and the related prospectus also can be obtained by written or telephonic request to the Company Secretary. Unless otherwise defined in this Grant Agreement, any capitalized terms in this Grant Agreement shall have the meaning ascribed to such terms in the Plan.

    THEREFORE, the parties agree as follows:

1.Grant of Restricted Stock Units.
Subject to the terms and conditions of this Grant Agreement and of the Plan, the Company hereby grants to the Employee the number of RSUs set forth above.

2.Vesting Schedule.
The interest of the Employee in the RSUs shall vest according to the vesting schedule set forth above, or if earlier, in accordance with Section 8 or 9, below, except to the extent a severance plan applicable to the Employee provides otherwise. Unless the provisions of Section 8 or 9 apply, the Employee must remain in the employ of the Company or any Subsidiary on a continuous basis through the close of business on the applicable Vesting Date, as set forth above, and the Employee must be in compliance with the requirements and conditions provided for in the Plan and this Grant Agreement for the interest of the Employee in the RSUs to become fully vested on that date.

3.Benefit Upon Settlement.
Within 75 days of each Vesting Date set forth on the above vesting schedule or, if earlier, a vesting event pursuant to Section 8 or 9 below, the Company shall deliver or pay, as applicable, to the Employee (or the Employee’s guardian, estate or beneficiary in the event of Section 8 or 9) Shares or a combination of cash and Shares, as the Company determines in its sole discretion, with a value equal to:

(a)    the number of RSUs that have become vested as of such vesting date or vesting event, as applicable, multiplied by the Fair Market Value of a Share on the date on which such RSUs vested; plus
(b)    a dividend equivalent payment credited in the form of additional RSUs for each ordinary cash dividend the Company pays on its Shares and for which the record date occurs between the grant date and the date the RSUs are settled, determined by:
(1)multiplying the per share cash dividend paid by the Company on its Shares by the total number of RSUs that are outstanding as of the record date for the dividend; and
(2)dividing the amount determined in (1) above by the Fair Market Value of a Share on the dividend payment date to determine the number of additional whole and fractional RSUs to be credited to the Employee;
1


provided, however, that if any aggregated dividend equivalent payments in Section (b)(2) above to be delivered in Shares result in a payment of a fractional Share, such fractional Share shall be rounded up to the next whole Share.

Notwithstanding the foregoing, the Company may, in its sole discretion, settle the RSUs in the form of a cash payment to the extent settlement in Shares: (i) is prohibited under local law; (ii) would require the Employee, the Company and/or any Subsidiary to obtain the approval of any governmental and/or regulatory body in the Employee's country; (iii) would result in adverse tax consequences for the Employee, the Company or any Subsidiary; or (iv) is administratively burdensome. Alternatively, the Company may, in its sole discretion, settle the RSUs in the form of Shares but require the Employee to sell such Shares immediately or within a specified period of time following the Employee’s termination of employment (in which case the Employee expressly authorizes the Company to issue sales instructions on the Employee's behalf).

4.Restrictions.
Except as otherwise provided for in this Grant Agreement, the RSUs or rights granted hereunder may not be sold, pledged or otherwise transferred. The period of time between the Grant Date and the date the RSUs become fully vested pursuant to Section 2 is referred to herein as the “Restriction Period.”
5.Custody of Restricted Stock Units.
The RSUs subject hereto shall be recorded in an account with the Plan broker in the name of the Employee. Upon termination of the Restriction Period, if the Company determines, in its sole discretion, to deliver Shares pursuant to Section 3 above, such Shares shall be released into the Employee’s account; provided, however, that a portion of such Shares shall be surrendered in payment of Tax-Related Items, as defined and in accordance with Section 12 below, unless the Company, in its sole discretion, establishes alternative procedures for the payment of Tax-Related Items.

6.No Stockholder Rights.
RSUs represent hypothetical Shares. Until Shares are delivered to the Employee pursuant to the terms of this Grant Agreement, the Employee shall not be entitled to any of the rights or benefits generally accorded to stockholders, including, without limitation, the receipt of dividends.

7.Termination of Employment.
Except as otherwise provided for in this Grant Agreement or in the Plan or as otherwise determined by the Company in its sole discretion, if the Employee's employment with the Company or any Subsidiary is terminated at any time for any reason prior to the lapse of the Restriction Period, all unvested RSUs granted hereunder shall be forfeited by the Employee, except to the extent a severance plan applicable to the Employee provides otherwise.

For purposes of this Grant Agreement, the Employee's employment or service will be considered terminated as of the date the Employee is no longer actively providing services to the Company, any Subsidiary (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any) and will not be extended by any notice period (e.g., the Employee's period of employment or service would not include any contractual notice period or any period of “garden leave” or similar period mandated under the employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when the Employee's employment or service is terminated for purposes of this Grant Agreement (including whether the Employee may still be considered to be providing service while on a leave of absence).

8.Disability of the Employee.
If the Employee’s employment is terminated prior to the end of the Restriction Period by reason of the Employee’s Disability, all RSUs shall immediately vest including any amounts for dividend equivalent payments on RSUs that vest at termination. The Company’s obligation to vest the RSUs under this paragraph is subject to the condition that (i) the Employee shall have executed a current Agreement Regarding Confidential Information and Proprietary Developments (“ARCIPD”) that is satisfactory to the Company no later than the date immediately prior to the date of the Employee’s termination of employment, (ii) the Employee has not engaged in any conduct that creates a conflict of interest in the opinion of the Company during the Employee’s active employment with the Company, and (iii) the Employee is in compliance with any-post employment restrictions in the ARCIPD during the period in which the RSU remains outstanding.

9.Death of the Employee.
In the event that termination of employment prior to the end of the Restriction Period is due to the death of the Employee, all unvested RSUs shall immediately vest including any amounts for dividend equivalent payments on such vested RSUs.

10.Termination for Cause.
Upon termination of the Employee’s employment for Cause, then all unvested RSUs shall be forfeited by the Employee on the date of the Employee’s termination, except to the extent a severance plan applicable to the Employee provides otherwise. Such forfeiture shall occur regardless of whether the Employee has satisfied any applicable age and service requirements for retirement. For the purpose of this Grant Agreement, “Cause” shall mean, unless otherwise defined in an agreement to which the Employee is a party with the Company or a Subsidiary, the occurrence of any of the following: (i) the Employee’s conviction of, or plea of guilty or nolo contendere to, a felony under Applicable Law; (ii) the Employee’s willful and deliberate failure in the performance of the Employee’s duties in any material respect; (iii) the Employee’s willful misconduct that results in material harm to the Company or a Subsidiary; or (iv) the Employee’s material violation of the Company’s ethics and compliance program, code of conduct or other material policy of the Company.

11.Section 409A.
The following provisions apply to the extent the Employee is subject to taxation in the U.S. Payments made pursuant to the Plan and this Grant Agreement are intended to comply with or qualify for an exemption from Section 409A of the Code (“Section 409A”). The Company reserves the right, to the extent the Company deems necessary or advisable in its sole discretion, to unilaterally amend or modify the Plan and/or this Grant Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, including any amendments or actions that would result in the reduction of benefits payable under this Grant Agreement, as the Company determines are necessary or appropriate to ensure that all RSUs and dividend equivalent payments are made in a manner that qualifies for an exemption from, or complies with, Section
2


409A or mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Section 409A: provided however, that the Company makes no representations that the RSUs or dividend equivalents will be exempt from any taxes, interest, and/or penalties that may apply under Section 409A and makes no undertaking to preclude Section 409A from applying to this RSU. For the avoidance of doubt, the Employee hereby acknowledges and agrees that neither the Company nor any Subsidiary will have any liability to the Employee or any other party if any amounts payable under this Grant Agreement are not exempt from, or compliant with, Section 409A, or for any action taken by the Company with respect thereto. Any payments under this Grant Agreement, the settlement of which is triggered by a "separation from service" (within the meaning of Section 409A) of a "specified employee" (as defined under Section 409A), shall be made on a date that is the earlier of (a) the Employee’s death or (b) the later of the specified settlement date and the date which is six months after the date of the Employee’s separation from service.

12.Taxes.
(a)The Employee shall be liable for any and all taxes, including income tax, social insurance, fringe benefit tax, payroll tax, payment on account, employer taxes or other tax-related items related to the Employee’s participation in the Plan and legally applicable to or otherwise recoverable from the Employee by the Company and/or, if different, the Employee’s employer (the “Employer”) whether incurred at grant, vesting, sale, prior to vesting or at any other time (“Tax-Related Items”). In the event that the Company or the Employer (which, for purposes of this Section 12, shall include a former employer) is required, allowed or permitted to withhold taxes as a result of the grant or vesting of RSUs or the issuance or subsequent sale of Shares acquired pursuant to such RSUs, or due upon receipt of dividend equivalent payments or dividends, the Employee shall surrender a sufficient number of whole Shares, make a cash payment or make adequate arrangements satisfactory to the Company and/or the Employer to withhold such taxes from Employee’s wages or other cash compensation paid to the Employee by the Company and/or the Employer at the election of the Company, in its sole discretion, or, if permissible under local law, the Company may sell or arrange for the sale of Shares that Employee acquires as necessary to cover all Tax-Related Items that the Company or the Employer has to withhold or that are legally recoverable from the Employee (such as fringe benefit tax) at the time the restrictions on the RSUs lapse, unless the Company, in its sole discretion, has established alternative procedures for such payment. However, with respect to any RSUs subject to Section 409A, the Employer shall limit the surrender of Shares to the minimum number of Shares permitted to avoid a prohibited acceleration under Section 409A. The Employee will receive a cash refund for any fraction of a surrendered Share or Shares in excess of any and all Tax-Related Items. To the extent that any surrender of Shares or payment of cash or alternative procedure for such payment is insufficient, the Employee authorizes the Company and its Subsidiaries, which are qualified to deduct tax at source, to deduct from the Employee’s compensation all Tax-Related Items. The Employee agrees to pay any Tax-Related Items that cannot be satisfied from wages or other cash compensation, to the extent permitted by Applicable Law.

(b)Regardless of any action the Company or the Employer takes with respect to any or all Tax-Related Items, the Employee acknowledges and agrees that the ultimate liability for all Tax-Related Items is and remains the Employee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Employee further acknowledges that the Company and/or the Employer: (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of RSUs or dividend equivalents, including, but not limited to, the grant, vesting or settlement of RSUs or dividend equivalents, the subsequent delivery of Shares and/or cash upon settlement of such RSUs or the subsequent sale of any Shares acquired pursuant to such RSUs and receipt of any dividends or dividend equivalent payments; and (ii) notwithstanding Section 11, do not commit to and are under no obligation to structure the terms or any aspect of this grant of RSUs and/or dividend equivalents to reduce or eliminate the Employee’s liability for Tax-Related Items or to achieve any particular tax result. Further, if the Employee has become subject to tax in more than one jurisdiction, the Employee acknowledges that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(c)Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Employee’s jurisdiction(s), in which case the Employee will receive a refund of any over-withheld amount in cash and will have no entitlement to the Share equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Employee is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.

(d)The Employee shall pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Employee’s participation in the Plan or the Employee’s receipt of RSUs that cannot be satisfied by the means previously described. The Company may refuse to deliver the benefit described in Section 3 if the Employee fails to comply with the Employee’s obligations in connection with the Tax-Related Items.

(e)The Employee consents and agrees that in the event the RSUs or the dividend equivalents become subject to an employer tax that is legally permitted to be recovered from the Employee, as may be determined by the Company and/or the Employer at their sole discretion, and whether or not the Employee’s employment with the Company and/or the Employer is continuing at the time such tax becomes recoverable, the Employee will assume any liability for any such taxes that may be payable by the Company and/or the Employer in connection with the RSUs and dividend equivalents. Further, the Employee agrees that the Company and/or the Employer may collect any such taxes from the Employee by any of the means set forth in this Section 12. The Employee further agrees to execute any other consents or elections required to accomplish the above, promptly upon request of the Company.

13.Data Privacy Consent.
(a)The Employee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Employee’s personal data as described in this Grant Agreement and any other materials by and among, as applicable, the Company, its Subsidiaries, and the Employer for the exclusive purpose of implementing, administering and managing the Employee’s participation in the Plan.

(b)The Employee understands that the Company, its Subsidiaries, and the Employer may hold certain personal information about the Employee, including, but not limited to, name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency, status, job title, any shares of stock or directorships held in the Company, details of all RSUs, options or
3


any other entitlement to shares of stock granted, canceled, purchased, exercised, vested, unvested or outstanding in the Employee’s favor (“Data”) for the exclusive purpose of implementing, managing and administering the Plan.

(c)The Employee understands that Data may be transferred to Merrill Lynch and any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Employee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Employee’s country. The Company is committed to protecting the privacy of Data in such cases. The Employee understands that by contract both with the Company and/or any of its Subsidiaries and with Merrill Lynch and/or the Company’s other vendors, the people and companies that have access to the Employee’s Data are bound to handle such Data in a manner consistent with the Company’s privacy policy and law. The Company periodically performs due diligence and audits on its vendors in accordance with good commercial practices to ensure their capabilities and compliance with those commitments. The Employee further understands that Data will be held only as long as is necessary to implement, administer and manage the Employee’s participation in the Plan.

(d)The Employee understands that if the Employee resides outside the United States, the Employee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Employee's local human resources representative. Further, the Employee understands that the Employee is providing the consents herein on a purely voluntary basis. If the Employee does not consent, or if the Employee later seeks to revoke the Employee's consent, the Employee's employment status or service with the Company or the Employee's Employer will not be affected; the only consequence of refusing or withdrawing the Employee’s consent is that the Company would not be able to grant the Employee RSUs or other equity awards or administer and manage the Employee’s participation in the Plan. Therefore, the Employee understands that refusing or withdrawing the Employee's consent may affect the Employee’s ability to participate in the Plan. For more information on the consequences of the Employee’s refusal to consent or withdrawal of consent, the Employee understands that the Employee may contact the Employee's local human resources representative.

(e)Further, the Employee understands that the Company may rely on a different legal basis for the processing and/or transfer of Data in the future and/or request that the Employee provide another data privacy consent. If applicable and upon request of the Company or a Subsidiary, the Employee agrees to provide an executed data privacy consent or acknowledgement (or any other consents, acknowledgements or agreements) to the Company or a Subsidiary that the Company and/or a Subsidiary may deem necessary to obtain under the data privacy laws in the Employee’s country of employment, either now or in the future. The Employee understands that the Employee may be unable to participate in the Plan if the Employee fails to execute any such acknowledgement, agreement or consent requested by the Company and/or a Subsidiary.

By electronically accepting RSUs on the Merrill Lynch website, the Employee is declaring that the Employee agrees with the data processing practices described in this Section 13 and that the Employee consents to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned therein for the purposes described therein.

14.Plan Information.
The Employee agrees to receive copies of the Plan, [the Plan prospectus] and other Plan information, including information prepared to comply with Applicable Laws outside the United States, from the Long-term Incentives website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the investor relations section of the Company's website at https://investor.hp.com/home/default.aspx. The Employee acknowledges that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Company Secretary. The Employee hereby consents to receive any documents related to current or future participation in the Plan by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

15.Acknowledgment and Waiver.
The Employee understands, acknowledges and agrees that:

(a)except as provided in Sections 8 and 9, the vesting of the RSUs is earned only by continuing employment with the Company or one of its Subsidiaries and that being hired and granted RSUs will not result in the RSUs vesting;

(b)this Grant Agreement and its incorporated documents reflect all agreements on its subject matters and the Employee is not accepting this Grant Agreement based on any promises, representations or inducements other than those reflected in this Grant Agreement;

(c)all good faith decisions and interpretations of the Committee regarding the Plan and RSUs granted under the Plan are binding, conclusive and final;

(d)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time;
(e)the grant of RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs or other awards, or benefits in lieu of RSUs, even if Shares or RSUs have been granted in the past;

(f)all decisions with respect to future grants, if any, will be at the sole discretion of the Company;

(g)the Employee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with the ability of the Employer to terminate the Employee’s employment relationship at any time and it is expressly agreed and understood that employment is terminable at the will of either party;

(h)the Employee is voluntarily participating in the Plan;
4


(i)RSUs and their resulting benefits are extraordinary items that are outside the scope of the Employee’s employment contract, if any;

(j)RSUs and their resulting benefits are not intended to replace any pension rights or compensation;

(k)RSUs and their resulting benefits are not part of normal or expected compensation or salary for any purposes, including, but not limited to calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

(l)unless otherwise agreed by the Company, the RSUs and their resulting benefits are not granted as consideration for, or in connection with, the service the Employee may provide as a director of a Subsidiary;

(m)this grant of RSUs will not be interpreted to form an employment contract or relationship with the Company, and furthermore, this grant of RSUs will not be interpreted to form an employment contract with any Subsidiary;

(n)the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(o)no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from (i) termination of Employee’s employment (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Employee is employed or retained or the terms of the Employee's employment or service agreement, if any), and/or (ii) the application of any recoupment policy or any recovery or clawback policy otherwise required by law, and in consideration of the grant of the RSUs to which the Employee is otherwise not entitled, the Employee agrees not to institute any claim against the Company, the Employer or any other Subsidiary and releases the Company, the Employer and any other Subsidiary from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Employee shall be deemed irrevocably to have agreed not to pursue such claim and to have agreed to execute any and all documents necessary to request dismissal or withdrawal of such claims;

(p)the Company, the Employer or any other Subsidiary will not be liable for any foreign exchange rate fluctuation between the Employee’s local currency and the United States dollar that may affect the value of the RSUs or any amounts due to the Employee pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement;

(q)if the Company determines that the Employee has engaged in misconduct prohibited by Applicable Law or any applicable policy of the Company, as in effect from time to time, or the Company is required to make recovery from the Employee under Applicable Law or a Company policy adopted to comply with applicable legal requirements, then the Company may, in its sole discretion, to the extent it determines appropriate, (i) recover from the Employee the proceeds from RSUs vested up to three years prior to the Employee’s termination of employment or any time thereafter, (ii) cancel the Employee’s outstanding RSUs, and (iii) take any other action it deems to be required and appropriate; and

(r)the delivery of any documents related to the Plan or Awards granted under the Plan, including the Plan, this Grant Agreement, the Plan prospectus and any reports of the Company generally provided to the Company’s stockholders, may be made by electronic delivery. Such means of electronic delivery may include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via electronic mail or other such means of electronic delivery specified by the Company. The Employee may receive from the Company a paper copy of any documents delivered electronically at no cost to the Employee by contacting the Company in writing in accordance with Section 18(k). If the attempted electronic delivery of any document fails, the Employee will be provided with a paper copy of such document. The Employee may revoke the Employee's consent to the electronic delivery of documents or may change the electronic mail address to which such documents are to be delivered (if the Employee has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised electronic mail address in accordance with Section 18(k). The Employee is not required to consent to the electronic delivery of documents.

16.No Advice Regarding Grant.
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Employee’s participation in the Plan, or the Employee’s acquisition or sale of the underlying Shares. The Employee is hereby advised to consult with the Employee's own personal tax, legal and financial advisors regarding the Employee's participation in the Plan before taking any action related to the Plan.

17.Additional Eligibility Requirements Permitted.
In addition to any other eligibility criteria provided for in the Plan, the Company may require that the Employee execute a separate document agreeing to the terms of a current arbitration agreement and/or a current ARCIPD, each in a form acceptable to the Company and/or that the Employee be in compliance with the ARCIPD throughout the entire Restriction Period and through the date the RSU is to be granted or settled. If such separate documents are required by the Company and the Employee does not accept them within 75 days of the Grant Date or such other date as of which the Company shall require in its discretion, this RSU shall be canceled and the Employee shall have no further rights under this Grant Agreement.

18.Miscellaneous.
(a)The Company shall not be required to treat as owner of RSUs and any associated benefits hereunder, any transferee to whom such RSUs or benefits shall have been transferred in violation of any of the provisions of this Grant Agreement.

(b)The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Grant Agreement.

(c)The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Employee with respect to the subject matter hereof, other than the terms of any severance plan applicable to the Employee that provides more favorable vesting. Notwithstanding the foregoing, nothing in the Plan or this Grant Agreement shall affect the validity or interpretation of any duly authorized written agreement between the Company and the
5


Employee under which an award properly granted under and pursuant to the Plan serves as any part of the consideration furnished to the Employee, including, without limitation, any agreement that imposes restrictions during or after employment regarding confidential information and proprietary developments. This Grant Agreement is governed by the laws of the state of Delaware without regard to its conflict of law provisions.

(d)If the Employee has received this or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

(e)The provisions of this Grant Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

(f)Notwithstanding Section 18(e), the Company’s obligations under this Grant Agreement and the Employee’s agreement to the terms of an arbitration agreement and/or an ARCIPD, if any, are mutually dependent. In the event that the Employee breaches the arbitration agreement or the Employee’s ARCIPD is breached or found not to be binding upon the Employee for any reason by a court of law, then the Company will have no further obligation or duty to perform under the Plan or this Grant Agreement.

(g)A waiver by the Company of a breach of any provision of this Grant Agreement shall not operate or be construed as a waiver of any other provision of this Grant Agreement, or of any subsequent breach by the Employee or any other Participant.

(h)The Employee acknowledges that, depending on the Employee or broker’s country of residence or where the Company Shares are listed, the Employee may be subject to insider trading restrictions and/or market abuse laws, which may affect the Employee's ability to acquire, sell or otherwise dispose of Shares or rights to Shares during times the Employee is considered to have “inside information” regarding the Company (as defined by the laws in the Employee’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Employee placed before the Employee possessed inside information. Furthermore, the Employee cold be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Employee acknowledges that it is the Employee's responsibility to comply with any applicable restrictions and that the Employee should to consult the Employee's personal advisor on this matter.

(i)Notwithstanding any provisions in this Grant Agreement, for any Employee who resides and/or works in a country other than the United States, the grant of the RSUs shall be subject to any additional terms and conditions set forth in the Appendix to this Grant Agreement for the Employee’s country of employment (account of residence, if different), if any. Moreover, if the Employee relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to the Employee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal, regulatory, tax or administrative reasons. The Appendix, if any, constitutes part of this Grant Agreement.

(j)The Company reserves the right to impose other requirements on the Employee’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Employee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

(k)All RSUs granted and/or Shares issued under this Grant Agreement are subject to claw back under the Company policy as in effect from time to time.

(l)Any notice required or permitted hereunder to the Employee shall be given in writing and shall be deemed effectively given upon delivery to the Employee at the address then on file with the Company.

(m)Any notice to be given under the terms of this Grant Agreement to the Company will be addressed in care of Attn: Global Equity at HP Inc., 1501 Page Mill Road, Palo Alto, California 94304, USA.

(n)The Employee acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect the Employee's ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends or dividend equivalent payments) in a brokerage or bank account outside the Employee's country. The Employee may be required to report such accounts, assets or transactions to the tax or other authorities in the Employee's country. The Employee also may be required to repatriate sale proceeds or other funds received as a result of the Employee's participation in the Plan to the Employee's country through a designated bank or broker within a certain time after receipt. The Employee acknowledges that it is the Employee's responsibility to be compliant with such regulations, and the Employee is advised to consult the Employee's personal legal advisor for any details.

19.Forfeitures and Recoupment.
(a)Recoupment Policy. The RSUs granted hereunder, any Shares issued pursuant to the RSUs and any proceeds therefrom shall be subject to and remain subject to any incentive compensation clawback or recoupment policy of the Company (i) currently in effect, (ii) as may be adopted by the Company to comply with applicable law and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, including, without limitation, pursuant to Section 10D of the Exchange Act, Rule 10D-1 thereunder and Section 303A.14 of the New York Stock Exchange Listed Company Manual) or (iii) as may be adopted by the Company to facilitate the Company’s objectives related to eliminating or reducing fraud, misconduct, wrongdoing, or violations of law by an employee or other service provider or related to improving the Company’s governance practices or similar considerations and, in each case, as may be amended from time to time (the “Policy”), with the provisions contained in such Policy deemed incorporated into this Grant Agreement without Employee’s additional or separate consent.

(b)Recoupment Authorization. For purposes of the foregoing, the Employee expressly and explicitly authorizes the Company to issue instructions, on the Employee's behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to this RSU to re-convey, transfer or otherwise return such Shares
6


and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Grant Agreement and the Policy conflict, the terms of the Policy shall prevail.


HP Inc.


Enrique Lores
CEO and President




    Kristen Ludgate
Chief People Officer



RETAIN THIS GRANT AGREEMENT FOR YOUR RECORDS

Important Note: Your grant is subject to the terms and conditions of this Grant Agreement, including any Appendix for your country of employment, and to the Company obtaining all necessary government approvals. If you have questions regarding your grant, please contact global.equity@hp.com.
7

 EX-31.1 9 hp-13124xexhibit311q124.htm EX-31.1 Document


Exhibit 31.1
CERTIFICATION
I, Enrique Lores, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of HP Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: February 28, 2024
  /s/ ENRIQUE LORES
Enrique Lores
President and Chief Executive Officer


 EX-31.2 10 hp-13124xexhibit312q124.htm EX-31.2 Document


Exhibit 31.2
CERTIFICATION
I, Timothy J. Brown, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of HP Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: February 28, 2024
/s/ TIMOTHY J. BROWN
  
Timothy J. Brown
Interim Chief Financial Officer
(Principal Financial Officer)


 EX-32 11 hp-13124xexhibit32q124.htm EX-32 Document




Exhibit 32

CERTIFICATION
OF
CHIEF EXECUTIVE OFFICER
AND
CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Enrique Lores, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of HP Inc. for the first quarter ended January 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of HP Inc.
February 28, 2024
/s/ ENRIQUE LORES
  By: 
Enrique Lores
President and Chief Executive Officer
________________________________________________________________________________________________________________________
I, Timothy J. Brown, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of HP Inc. for the first quarter ended January 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of HP Inc.
February 28, 2024
/s/ TIMOTHY J. BROWN
  By: 
Timothy J. Brown
Interim Chief Financial Officer
________________________________________________________________________________________________________________________


 EX-101.SCH 12 hpq-20240131.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Consolidated Condensed Statements of Earnings (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Condensed Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Restructuring and Other Charges link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Retirement and Post-Retirement Benefit Plans link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Taxes on Earnings link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Supplementary Financial Information link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Fair Value link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Borrowings link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Litigation and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Guarantees, Indemnifications and Warranties link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Restructuring and Other Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Retirement and Post-Retirement Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Supplementary Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Fair Value (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Stockholders' Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Guarantees, Indemnifications and Warranties (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Restructuring and Other Charges - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Retirement and Post-Retirement Benefit Plans - Schedule of Components of Pension and Post-Retirement Benefit (Credit) (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Retirement and Post-Retirement Benefit Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Taxes on Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Supplementary Financial Information - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Supplementary Financial Information - Schedule of Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Supplementary Financial Information - Schedule of Other Non-Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Supplementary Financial Information - Schedule of Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Supplementary Financial Information - Schedule of Interest and Other, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Supplementary Financial Information - Schedule of Net Revenue by Region (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Supplementary Financial Information - Contract Liabilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Fair Value - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Financial Instruments - Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Borrowings - Schedule of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Borrowings - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Stockholders' Deficit - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Stockholders' Deficit - Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Stockholders' Deficit - Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - Litigation and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - Guarantees, Indemnifications and Warranties (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 13 hpq-20240131_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 14 hpq-20240131_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 15 hpq-20240131_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Gross Unrealized Loss Cash And Cash Equivalents, Gross Unrealized Losses Cash And Cash Equivalents, Gross Unrealized Losses Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Corporate Investments Corporate Investments [Member] Business reporting segment that includes HP Labs and certain business incubation projects. Pay vs Performance Disclosure [Line Items] Other Non-Current Liabilities Other Noncurrent Liabilities [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Restructuring and other charges Increase (Decrease) in Restructuring and Other Increase (Decrease) in Restructuring and Other Maximum borrowing capacity under credit facility Line of Credit Facility, Maximum Borrowing Capacity Research and development Research and Development Expense Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent All Award Types Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Remaining performance obligations period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period India Directorate of Revenue Intelligence Proceedings India Directorate Of Revenue Intelligence Proceedings [Member] Proceedings alleging the underpayment of customs duties to the India Directorate of Revenue. Employer Contributions and Funding Policy Pension and Other Postretirement Plans, Policy [Policy Text Block] Borrowings Debt Disclosure [Text Block] Other Current Liabilities Other Current Liabilities [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Dynamic Security Litigation Dynamic Security Litigation [Member] Dynamic Security Litigation Revolving Credit Facility Revolving Credit Facility [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Schedule of Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings Derivatives Not Designated as Hedging Instruments [Table Text Block] Corporate debt Corporate Debt Securities [Member] Interest and other, net Interest and other, net Interest and other, net Nonoperating Income (Expense) Additional amount deposited against products-related show cause notice Additional Deposit Against Products Related Show Cause Notice The amount of additional deposit made with the Commissioner of Customs in connection with the products-related show cause notice. Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] $900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028 U.S. Dollar Global Notes , Due January 2028 [Member] U.S. Dollar Global Notes , Due January 2028 Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Number of current employees Loss Contingency, Number of Defendants, Current Employee Loss Contingency, Number of Defendants, Current Employee Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Stockholders' Deficit Equity [Text Block] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] $1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029 U.S. Dollar Global Notes, Due April 2029 [Member] U.S. Dollar Global Notes, Due April 2029 Geographical [Axis] Geographical [Axis] Non-U.S. Foreign Plan [Member] Taxes on Earnings Income Tax Disclosure [Text Block] Settlements made (in cash or in kind) Standard and Extended Product Warranty Accrual, Decrease for Payments Accruals for warranties issued Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Net revenue: Segment Reporting Information, Operating Income (Loss) [Abstract] Cost Debt Securities, Available-For-Sale, Excluding Accrued Interest And Equity Securities, FV-NI, Amortized Cost Debt Securities, Available-For-Sale, Excluding Accrued Interest And Equity Securities, FV-NI, Amortized Cost Collateral returned for derivative instruments Payment For Collateral Returned For Derivative Instruments Payment For Collateral Returned For Derivative Instruments Total cash equivalents and available-for-sale investments, gross unrealized loss Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Loss, before Tax Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Loss, before Tax Cash receipts Cash Receipts The aggregate amount of cash receipts under revolving financing receivables arrangements facilities during the reporting period. Current liabilities: Liabilities, Current [Abstract] Preferred stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.01 par value (300 shares authorized; none issued) Preferred Stock, Value, Issued Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Purchased parts and fabricated assemblies Inventory, Work in Process and Raw Materials, Net of Reserves Cash dividends paid Payments of Ordinary Dividends, Common Stock Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Diluted (usd per share) Earnings Per Share, Diluted Gross Amount Recognized Derivative Liability, Subject to Master Netting Arrangement, before Offset Factoring costs Factoring Costs Factoring Costs PEO Total Compensation Amount PEO Total Compensation Amount Guarantees, Indemnifications and Warranties Guarantees [Text Block] Hedging Relationship [Axis] Hedging Relationship [Axis] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounts receivable, net of allowance for credit losses of $84 and $93, respectively Accounts Receivable, after Allowance for Credit Loss, Current $1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032 U.S. Dollar Global Notes , Due April 2032 [Member] U.S. Dollar Global Notes , Due April 2032 Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Credit Facilities Line of Credit [Member] Patents withdrawn Loss Contingency, Patents Withdrawn Loss Contingency, Patents Withdrawn Schedule of Components of Pension and Post-Retirement Benefit (Credit) Schedule of Net Benefit Costs [Table Text Block] Marketable securities and mutual funds Marketable Equity Securities and Mutual Funds [Member] Marketable Equity Securities and Mutual Funds [Member] Weighted-Average Interest Rate Debt Instrument, Interest Rate, Weighted Average Interest Rate [Abstract] Debt Instrument, Interest Rate, Weighted Average Interest Rate [Abstract] Debt securities, fair value Debt Securities, Available-for-Sale, Excluding Accrued Interest Litigation Case [Axis] Litigation Case [Axis] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Printing Printing [Member] Business reporting segment that provides consumer and commercial printer hardware, printing supplies, printing media and scanning devices. Trading Symbol Trading Symbol Restructuring Plan [Domain] Restructuring Plan [Domain] Minimum age of plaintiff Loss Contingency, Minimum Age of Plaintiff Loss Contingency, Minimum Age of Plaintiff Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Available-for-Sale Investments: Investments, Fair Value Disclosure Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] R2 Semiconductor Litigation R2 Semiconductor Litigation [Member] R2 Semiconductor Litigation Net earnings Net earnings Net earnings Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Total cash equivalents and available-for-sale investments, fair value Cash Equivalents and Available For Sale Securities, Fair Value, Excluding Accrued Interest Cash Equivalents and Available For Sale Securities, Fair Value, Excluding Accrued Interest Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Machinery and equipment, including equipment held for lease Machinery and Equipment [Member] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Carrying value, short- and long-term debt Debt and Lease Obligation LIABILITIES AND STOCKHOLDERS’ DEFICIT Liabilities and Equity [Abstract] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Stockholders’ deficit: Equity, Attributable to Parent [Abstract] Gains (losses) reclassified into earnings Reclassifications of gain into earnings Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Debt securities, gross unrealized loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Other Other Assets, Miscellaneous, Noncurrent Contract liability Contract with Customer, Liability Change in unrealized components of cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent Unrealized losses arising during the period Gain/(loss) recognized in Accumulated other comprehensive loss on derivative Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Schedule of Reconciliation of the Number of Shares Used for Basic and Diluted Net EPS Calculations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Service cost Defined Benefit Plan, Service Cost Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Restructuring and other Increase (Decrease) in Restructuring Reserve Executive Category: Executive Category [Axis] Deposits and prepaid Deposits Assets, Noncurrent Foreign currency contracts Foreign Exchange Contract [Member] Level 1 Fair Value, Inputs, Level 1 [Member] Name Measure Name Name Forgone Recovery, Individual Name Tax benefits related to restructuring charges Income Tax Reconciliation Restructuring Charges Income Tax Reconciliation Restructuring Charges Autonomy Acquisition Of Autonomy [Member] Represents the information pertaining to the acquisition of Autonomy Corporation by the entity. Goodwill Goodwill Schedule of Property, Plant and Equipment, Net Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Schedule of Reconciliation of Revenue from Segment Operating Results to HP Consolidated Results Reconciliation of Revenue from Segments to Consolidated [Table Text Block] Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Adjustments related to pre-existing warranties (including changes in estimates) Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Outstanding Gross Notional Derivative, Notional Amount Obligations outstanding Supplier Finance Program, Obligation Balance at beginning of period Balance at end of period Receivables Sold but Not Collected from Third Party Represents the amount of receivables sold to the third party, but not collected by the third party from customer under revolving financing receivables arrangements. Cash dividends per share (usd per share) Common Stock, Dividends, Per Share, Declared Amount Outstanding Debt, Current [Abstract] Measurement Frequency [Axis] Measurement Frequency [Axis] Nokia Patent Litigation, U.S. International Trade Commission Nokia Patent Litigation, U.S. International Trade Commission [Member] Nokia Patent Litigation, U.S. International Trade Commission Operating lease liabilities Operating Lease, Liability, Noncurrent Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities Investments Classified by Contractual Maturity Date [Table Text Block] Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Restricted cash Restricted Cash and Cash Equivalents, Current Retirement Plan Type [Domain] Retirement Plan Type [Domain] Accounts payable Increase (Decrease) in Accounts Payable, Trade Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Revolving credit facility, term Debt Instrument, Term 364-Day Revolving Credit Facility 364-Day Revolving Credit Facility [Member] 364-Day Revolving Credit Facility Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Health care coverage extension, enhanced early retirement program, period Health Care Coverage Extension, Enhanced Early Retirement Program, Period Health Care Coverage Extension, Enhanced Early Retirement Program, Period Retirement Benefits [Abstract] Retirement Benefits [Abstract] Other Other Sundry Liabilities, Noncurrent Line of Credit Facility [Table] Line of Credit Facility [Table] Income Statement Location [Axis] Income Statement Location [Axis] Schedule of Long-Term Debt Schedule of Long-Term Debt Instruments [Table Text Block] Transfers and Servicing Trade Receivables Policy Transfers and Servicing of Financial Assets, Policy [Policy Text Block] Litigation and Contingencies Commitments and Contingencies, Policy [Policy Text Block] Severance and EER Employee Severance And Enhanced Early Retirement Program [Member] Europe Europe [Member] Cash Equivalents and Available-for-Sale Investments Cash and Cash Equivalents, Policy [Policy Text Block] Total net revenue Net revenue Revenues Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Interest expense on borrowings Interest Expense, Debt Proceeds from debt, net of issuance costs Proceeds from Debt, Net of Issuance Costs Notes Payable and Short-Term Borrowings Short-Term Debt [Line Items] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Financial Collateral Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset Inventory Increase (Decrease) in Inventories Domestic Plan Domestic Plan [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Accrued balance, beginning of the period Accrued balance, end of the period Restructuring Reserve Acquisition and divestiture charges Acquisition and divestiture charges Business Combination, Acquisition Related Costs Award Type Award Type [Axis] Anti-dilutive weighted-average stock-based compensation awards (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Quarterly Report Document Quarterly Report Other non-current liabilities Restructuring Reserve, Noncurrent Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Hedging Designation [Axis] Hedging Designation [Axis] Property, plant and equipment, gross Property, Plant and Equipment, Gross Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Likelihood of no resolution period Income Tax Examination Likelihood of No Resolution Period The period of likelihood that the uncertain tax position will not be resolved. Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Trading Arrangement: Trading Arrangement [Axis] Special Termination Benefits Special Termination Benefits [Member] Contributions to benefit plans Defined Benefit Plan, Plan Assets, Contributions by Employer Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Derivatives, Fair Value Derivatives, Fair Value [Line Items] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Commercial Printing Commercial Printing [Member] A business unit within the Printing group business segment that is classified as Commercial. Available-for-Sale Investments: Debt Securities, Available-for-Sale [Abstract] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Tax effects related to acquisition and divestiture charges Effective Income Tax Rate Reconciliation, Business Combination, Amount Effective Income Tax Rate Reconciliation, Business Combination, Amount Net periodic benefit (credit) cost Defined Benefit Plan Net Periodic Benefit Cost before Settlements and Curtailments The total amount of net periodic benefit cost (credit) for defined benefit plans for the period, before gain or loss due to settlements or curtailments. Derivative liabilities Offsetting Derivative Liabilities [Abstract] Change in cumulative translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent Number of former employee Loss Contingency, Number of Defendants, Former Employee Loss Contingency, Number of Defendants, Former Employee Operating lease liabilities Operating Lease, Liability, Current Tax provision on unrealized gains arising during the period Unrealized gains arising during the period Net unrealized gains (losses) on available-for-sale debt securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Warranty Product Warranty Accrual, Current Change in unrealized components of available-for-sale debt securities: OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax [Abstract] Amortization of intangible assets Amortization of intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Unrealized gains (losses) arising during the period Other comprehensive gains (losses) before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Intangible assets Finite-Lived Intangible Assets, Net Property, Plant and Equipment, Net Property, Plant and Equipment [Line Items] Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Equity securities, gross unrealized loss Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Liabilities Offsetting Liabilities [Table Text Block] Taxes on earnings Increase (Decrease) in Income Taxes Payable Counterparty Name [Domain] Counterparty Name [Domain] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Fair value, short- and long-term debt Debt Instrument, Fair Value Disclosure Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Maturities and sales of available-for-sale securities and other investments Proceeds from Sale, Maturity and Collection of Investments Gross margin Gross Profit Current portion of long-term debt Long-Term Debt and Lease Obligation, Current Deferred revenue Contract with Customer, Liability, Current Amortization and deferrals: Defined Benefit Plan Amortization and Deferrals [Abstract] Security Exchange Name Security Exchange Name Long-term debt Long-Term Debt Gross Unrealized Loss Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, Before Tax Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, Before Tax Total assets Assets, Fair Value Disclosure Selling, general and administrative Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Change in cumulative translation adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Non-Marketable Equity Securities Investments Investment, Policy [Policy Text Block] Derivatives Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Pension, post-retirement, and post-employment liabilities Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Total operating expenses Operating expenses Costs and Expenses Settlement loss Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Maximum Maximum [Member] Total costs incurred to date Restructuring and Related Cost, Cost Incurred to Date Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Cost Cash Equivalents, at Carrying Value Document Type Document Type Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Tabular List, Table Tabular List [Table Text Block] Tax benefit on losses arising during the period Losses arising during the period Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Financial institution instruments Financial Institution Instrument [Member] Financial Institution Instrument Europe, Middle East and Africa EMEA [Member] Entity Address, Address Line One Entity Address, Address Line One Changes in aggregated product warranty liabilities Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Other, net Other Noncash Income (Expense) Eligible age with twenty years of service for enhanced early retirement program Eligible Age with Ten Years of Service for Enhanced Early Retirement Program Eligible Age with Ten Years of Service for Enhanced Early Retirement Program Business Acquisition [Axis] Business Acquisition [Axis] Tax liability Taxes Payable, Current Other countries with income tax jurisdiction Other Countries with Income Tax Jurisdiction Number Represents the number of other countries in which the entity is subject to income taxes. Autonomy-Related Legal Matters Autonomy Related Legal Matters [Member] The risk of loss associated with the autonomy related legal matters. $1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033 U.S. Dollar Global Notes , Due January 2033 [Member] U.S. Dollar Global Notes , Due January 2033 Balance at beginning of period Balance at end of period Accounts Receivable, Allowance for Credit Loss, Current Other current liabilities Other accrued liabilities Other Liabilities, Current Income Statement [Abstract] Income Statement [Abstract] Cost of net revenue: Costs and Expenses [Abstract] Value-added taxes receivable Value Added Tax Receivable, Current Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Debt securities, cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash Equivalents: Fair Value Cash and Cash Equivalents, Fair Value Disclosure Schedule of Restructuring Activities by Plan Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Tax benefit (provision) on unrealized (losses) gains arising during the period Other Comprehensive Income (Loss) before Reclassifications, Tax Fair Value Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI Derivative Instruments: Derivative instruments, liabilities Net Amount Presented Derivative Liability Fiscal 2023 Plan Fiscal 2023 Plan [Member] Fiscal 2023 Plan Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Operating Segments Operating Segments [Member] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Issuance of common stock in connection with employee stock plans and other Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other current assets Other current assets Other Assets, Current Equity securities, gross unrealized gain Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Financial Instruments Financial Instruments Disclosure [Text Block] Collateral posted for derivative instruments Collateral Posted For Derivatives Collateral Posted For Derivatives Amortization of actuarial loss and prior service benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax Entity Tax Identification Number Entity Tax Identification Number Inventory Inventory Inventory, Net Purchases of available-for-sale securities and other investments Payments to Acquire Marketable Securities Additional amount deposited against product order Additional Deposit Against Product Order The amount of additional deposit made with the Customs Tribunal in connection with the product order. Statistical Measurement [Axis] Statistical Measurement [Axis] Trade receivables sold Trade Receivables Sold The aggregate face amount of accounts receivable that were sold to third party under revolving financing receivables arrangements during the reporting period. Balance Sheet Location [Domain] Balance Sheet Location [Domain] Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Trade Receivables Sold and Cash Received [Roll Forward] Trade Receivables Sold and Cash Received [Roll Forward] No definition available. Fair value of derivatives with credit contingent features in a net liability position Derivative, Net Liability Position, Aggregate Fair Value Offsetting [Abstract] Gross Unrealized Gain Cash And Cash Equivalents, Gross Unrealized Gains Cash And Cash Equivalents, Gross Unrealized Gains Duties and penalties under show cause notices Duties, Penalties Affirmed under Show Cause Notices The aggregate amount of duties and penalties that the Commissioner of Customs is seeking to have HP India and the other named individuals pay under the products and parts show cause notices. Total Shareholder Return Amount Total Shareholder Return Amount Repurchase of common stock Payment in connection with repurchases of shares Payments for Repurchase of Common Stock Products Product [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Segments [Domain] Segments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Other accrued taxes Taxes Payable Other than Income Current Carrying value as of the balance sheet date of obligations incurred and payable for taxes other than income tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Corporate and unallocated costs and other Segment Reporting Information Corporate and Unallocated Costs, Gains and Eliminations Amount of reconciling item for corporate and unallocated costs, gains and eliminations. Schedule of Interest and Other, Net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Consolidation Items [Domain] Consolidation Items [Domain] Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Face amount of debt instrument Debt Instrument, Face Amount Derivatives Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Change in unrealized components of defined benefit plans: Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax [Abstract] Current assets: Assets, Current [Abstract] Issuance rate (percent) Debt Instrument, Rate At Issuance Debt Instrument, Rate At Issuance Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Derivative Instruments Derivatives, Policy [Policy Text Block] Labor Costs Labor Costs [Member] Labor Costs Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Net earnings per share: Earnings Per Share, Basic [Abstract] Interest cost Defined Benefit Plan, Interest Cost PEO PEO [Member] Penalties and interest accrued Income Tax Examination, Penalties and Interest Accrued Schedule of Taxes Related to Other Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Retirement and Post-Retirement Benefit Plans Retirement Benefits [Text Block] Components of accumulated other comprehensive income, net of taxes Accumulated Other Comprehensive Income (Loss) [Line Items] Gross Amount Recognized Derivative Asset, Subject to Master Netting Arrangement, before Offset Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Change in cumulative translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Schedule of Trade Receivables Sold and Cash Received Schedule Of Trade Receivables Sold And Cash Received [Table Text Block] Schedule Of Trade Receivables Sold And Cash Received Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Equity securities, fair value Equity Securities, FV-NI, Current Net earnings, basic Net Income (Loss) Available to Common Stockholders, Basic Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Gains reclassified into earnings Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Debt Instrument [Axis] Debt Instrument [Axis] Repurchases of common stock (Note 10) Stock Repurchased and Retired During Period, Value Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective tax rate (percent) Effective Income Tax Rate Reconciliation, Percent Number of subsidiaries Number Of Subsidiaries Represents the number of subsidiaries. Credit Facility [Axis] Credit Facility [Axis] Gross Unrealized Gain Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, Before Tax Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, Before Tax Unrealized gains arising during the period OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Foreign currency and other Foreign currency and other The aggregate amount of FX and other under revolving financing receivables arrangements facilities during the reporting period. Services Service [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Other derivatives Other Contract [Member] Consumer Printing Consumer Printing [Member] Consumer Printing Period to collateralize Derivative, Period to Collateralize Derivative, Period to Collateralize Accumulated Other Comprehensive Income (Loss) Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Brazil BRAZIL Pre-tax effect of derivative instruments in cash flow hedging relationships Effect of Cash Flow Hedges on Results of Operations [Abstract] Measurement Frequency [Domain] Measurement Frequency [Domain] All Executive Categories All Executive Categories [Member] Deferred revenue Contract with Customer, Liability, Noncurrent Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Supplier and other receivables Nontrade Receivables, Current Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Unrealized components of defined benefit plans Change in unrealized components of defined benefit plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Labor and Non-Labor Actions Labor And Non-Labor Actions [Member] Labor And Non-Labor Actions Number of reportable segments Number of Reportable Segments Net earnings per share: Earnings Per Share [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Gain/(loss) recognized in earnings on hedged item Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Reasonably possible decrease in existing unrecognized tax benefits within the next 12 months Decrease in Unrecognized Tax Benefits is Reasonably Possible Benefit from taxes Tax benefit on other comprehensive loss Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Litigation and Contingencies Legal Matters and Contingencies [Text Block] Commercial paper and notes payable to banks, lines of credit and other Short-Term Debt, Weighted Average Interest Rate, at Point in Time Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Change in unrealized components of defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent Tax liability Taxes Payable Noncurrent Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Segment Information Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Schedule of Notes Payable and Short-Term Borrowings Schedule of Short-Term Debt [Table Text Block] Other comprehensive loss before taxes: Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Total periodic benefit (credit) cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) All Individuals All Individuals [Member] Cost method and other equity investments Equity Securities, Cost Method and Other Equity Investments Equity Securities, Cost Method and Other Equity Investments Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise Forsyth, et al. vs. HP Inc. and Hewlett Packard Enterprise [Member] Forsyth, et al. vs. HP Inc. and Hewlett Packard Enterprise [Member] Litigation Case [Domain] Litigation Case [Domain] Other, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Restructuring Type [Axis] Restructuring Type [Axis] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Statement [Table] Statement [Table] Subsegments [Domain] Subsegments [Domain] Current Fiscal Year End Date Current Fiscal Year End Date Net Earnings Per Share Earnings Per Share, Policy [Policy Text Block] U.S. Dollar Global Notes U S Dollar Global Notes [Member] Corporate debt securities denominated in U.S. dollars. Gain/(loss) recognized in earnings on derivative instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Unrecognized tax benefits Unrecognized Tax Benefits PEO Name PEO Name Asia-Pacific and Japan Asia Pacific [Member] Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Government debt US Treasury and Government [Member] Post-Retirement Benefit Plans Other Postretirement Benefits Plan [Member] Amount deposited under show cause notice prior to order Amount Deposited under Products Show Cause Notice Represents amount deposited under the products and parts show cause notices. Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Munich, Germany Munich, Germany [Member] Munich, Germany Total cash equivalents and available-for-sale investments, gross unrealized gain Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Gain, before Tax Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Gain, before Tax Non-operating retirement-related credits Non-operating Retirement Related Credits Non-operating Retirement Related Credits Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Losses arising during the period Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Other Other Accrued Liabilities, Current Prior service cost (credit) Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Corporate and unallocated costs and other Corporate, Non-Segment [Member] Other assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Depreciation and amortization Depreciation, Depletion and Amortization Interest rate (percent) Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Balance at beginning of period Balance at end of period Standard and Extended Product Warranty Accrual Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders’ deficit Balance at beginning of period Balance at end of period Equity, Attributable to Parent Commercial Paper Commercial Paper [Member] Consolidation Items [Axis] Consolidation Items [Axis] Unrecognized tax benefits that would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041 U.S. Dollar Global Notes, Due September 2041 [Member] Corporate debt securities issued at discount to par pursuant to a 2009 Shelf Registration which is denominated in U.S. dollars and due in September 2041. Schedule of Cash Equivalents and Available For Sale Investments [Table] Schedule of Cash Equivalents and Available For Sale Investments [Table] Schedule of the cash equivalents and available-for-sale investments. Revenue recognized Contract with Customer, Liability, Revenue Recognized Payment terms offered by HP Supplier Finance Program, Payment Timing, Period Subsegments [Axis] Subsegments [Axis] Net unrealized gains (losses) on cash flow hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Earnings before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Mr. Lynch Messrs Lynch [Member] Represents information on Messrs Lynch Fair Value Fair Value Measurement, Policy [Policy Text Block] Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Restructuring and Other Charges Restructuring and Related Activities Disclosure [Text Block] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] New claims filed Loss Contingency, New Claims Filed, Number Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Operating expenses Operating Expense [Member] Entity Emerging Growth Company Entity Emerging Growth Company Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Unamortized debt issuance cost Debt Issuance Costs, Net Fair Value Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract] Guarantees [Abstract] Guarantees [Abstract] Investment in property, plant and equipment, net Payments to Acquire Productive Assets Other Non-Current Assets Other Noncurrent Assets [Member] Schedule of Aggregate Product Warranty Liabilities and Changes Schedule of Product Warranty Liability [Table Text Block] Net investment in leases Increase (Decrease) In Net Investment In Leases Increase (Decrease) In Net Investment In Leases Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Schedule of Cash Equivalents and Available-for-Sale Investments Schedule of Cash Equivalents and Available For Sale Investments Reconciliation [Table Text Block] Tabular disclosure of the reconciliation of cash equivalents and available-for-sale securities from cost basis to fair value. Unrecognized increase in tax benefits change Unrecognized Tax Benefits, Period Increase (Decrease) Fiscal 2023 Plan Fiscal 2023 Restructuring Plan [Member] Fiscal 2020 Restructuring Plan [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Caltech Patent Litigation Caltech Patent Litigation [Member] Caltech Patent Litigation Available borrowing resources Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030 Other Long Term Debt [Member] Other Long Term Debt [Member] Title Trading Arrangement, Individual Title Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Schedule of Net Revenue by Region Revenue from External Customers by Geographic Areas [Table Text Block] Consumer PS Consumer PS [Member] Consumer PS Common Stock Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Earnings Per Share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Expected positions to be eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Investments, All Other Investments [Abstract] Investments, All Other Investments [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Current portion of long-term debt Debt, Weighted Average Interest Rate Geographical [Domain] Geographical [Domain] Total amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recorded Gain (Loss) on Fair Value Hedges Recognized in Earnings Sales and marketing programs Accrued Marketing Costs, Current Commercial PS Commercial PS [Member] Commercial PS Minimum Minimum [Member] Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Weighted-average shares used to compute net earnings per share: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Stock-based award activities and others Net (Payments) Proceeds Related To Stock Based Award Activities Net (Payments) Proceeds Related To Stock Based Award Activities Exercise Price Award Exercise Price Gain/(loss) recognized in earnings on derivative instrument Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Loss Contingency, Number Of Patent Pool Members Loss Contingency, Number Of Patent Pool Members Loss Contingency, Number Of Patent Pool Members Reflected in Consolidated Condensed Balance Sheets Restructuring Reserve [Abstract] Loss expected to be reclassified from AOCI into earnings in next 12 months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Amounts owed to participating financial institutions Supplier Finance Program, Obligation, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Cash dividends Dividends, Common Stock, Cash ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Interest and other, net Interest And Other Expense, Net [Member] Interest And Other Expense, Net Total liabilities Liabilities, Fair Value Disclosure Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Gross Amounts Not Offset Derivative Liability [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Other Current Assets Other Current Assets [Member] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Prepaid pension and post-retirement benefit assets Prepaid Pension And Post-retirement Benefit Asset, Non Current Prepaid Pension And Post-retirement Benefit Asset, Non Current $500 issued at par at a price of 100% at 4.75%, due March 2029 U.S. Dollar Global Notes , Due March 2029 [Member] U.S. Dollar Global Notes , Due March 2029 Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Retirement Plan Type [Axis] Retirement Plan Type [Axis] Accumulated Deficit Retained Earnings [Member] Current portion of long-term debt Long-Term Debt, Current Maturities Guarantees, Indemnifications and Warranties Guarantees, Indemnifications and Warranties Policies [Policy Text Block] Total cash equivalents and available-for-sale investments, cost Cash Equivalents and Available For Sale Securities, Amortized Cost Basis, Excluding Accrued Interest Cash Equivalents and Available For Sale Securities, Amortized Cost Basis, Excluding Accrued Interest Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Schedule of Reconciliation of Operating Profit (Loss) from Segment Operating Results to HP Consolidated Results Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Total liabilities and stockholders’ deficit Liabilities and Equity Other non-current assets Other non-current assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Right-of-use assets Operating Lease, Right-of-Use Asset Basic (usd per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Non-cash and other adjustments Restructuring Reserve, Accrual Adjustment Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Number of members Number Of Members Represents number of members. Deferred tax assets Deferred Tax Assets, Net Net Amount Derivative Liability, Including Not Subject To Master Netting Arrangement, After Offset And Deduction, Net Derivative Liability, Including Not Subject To Master Netting Arrangement, After Offset And Deduction, Net Net earnings, diluted Net Income (Loss) Available to Common Stockholders, Diluted Estimated pre-tax charges Restructuring and Related Cost, Expected Cost Arrangement Duration Trading Arrangement Duration Schedule of Other Non-Current Assets Schedule of Other Assets, Noncurrent [Table Text Block] Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Supplementary Financial Information Supplemental Balance Sheet Disclosures [Text Block] Charges Restructuring and other charges Restructuring Charges Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Share repurchase authorization remaining Stock Repurchase Program, Remaining Authorized Repurchase Amount Termination Date Trading Arrangement Termination Date Income tax reconciliation other discrete items tax charges (credits) Income Tax Reconciliation Other Discrete Items Tax Charges (Credits) Income Tax Reconciliation Other Discrete Items Tax Charges (Credits) Common stock, shares authorized (in shares) Common Stock, Shares Authorized Americas Americas [Member] Land, buildings and leasehold improvements Land, Buildings and Improvements [Member] Commercial Paper Short-Term Debt Debt securities, gross unrealized gain Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Financial assets and liabilities measured at fair value on a recurring basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Deductions, net of recoveries Allowance for Doubtful Accounts Receivable, Deductions, Net of Recoveries Amount of deductions of receivables doubtful of collection, net of recoveries that were previously charged off. Derivative Instrument [Axis] Derivative Instrument [Axis] Number of affiliates Number Of Affiliates Number Of Affiliates Supplies Supplies [Member] A business unit within the Printing group business segment that provides supplies. Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Due in one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One All Adjustments to Compensation All Adjustments to Compensation [Member] Tax effects on reclassification into earnings Reclassification from AOCI, Current Period, Tax Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Common stock, $0.01 par value (9,600 shares authorized; 980 and 989 shares issued and outstanding at January 31, 2024 and October 31, 2023, respectively) Common Stock, Value, Outstanding Award Timing Disclosures [Line Items] Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income Schedule Of Derivative Instruments, Effect On Other Comprehensive Income (Loss), Pre-Tax [Table Text Block] Schedule Of Derivative Instruments, Effect On Other Comprehensive Income (Loss), Pre-Tax $1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027 U.S. Dollar Global Notes, Due June 2027 [Member] U.S. Dollar Global Notes, Due June 2027 Compensation Amount Outstanding Recovery Compensation Amount Foreign currency maturity Maximum Length of Time, Foreign Currency Cash Flow Hedge Financial Collateral Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset Benefit of allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Change in unrealized components of cash flow hedges: Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract] Düsseldorf, Germany Düsseldorf, Germany [Member] Düsseldorf, Germany Derivative Instruments: Derivative instruments, assets Net Amount Presented Derivative Asset Deferred taxes on earnings Deferred Income Tax Expense (Benefit) Restructuring Plan [Axis] Restructuring Plan [Axis] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Maximum retirement medical savings account employer credits Maximum Retirement Medical Savings Account Employer Credits Maximum Retirement Medical Savings Account Employer Credits Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Segment Reporting Information, Revenue for Reportable Segment [Abstract] Segment Reporting Information, Revenue for Reportable Segment [Abstract] Prepaid and other current assets Prepaid Expense and Other Assets, Current Taxes on Earnings Income Tax, Policy [Policy Text Block] Notes payable and short-term borrowings Notes payable to banks, lines of credit and other Debt, Current Notes payable to banks, lines of credit and other Notes Payable To Banks Lines Of Credit And Other Notes Payables [Member] Obligation related to notes payable to banks, lines of credit and other debt. Insider Trading Arrangements [Line Items] Components of accumulated other comprehensive income, net of taxes AOCI Attributable to Parent, Net of Tax [Roll Forward] Allowance for credit loss Accounts Receivable, Allowance for Credit Loss Anticipated contributions Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year Other current liabilities Restructuring Reserve, Current Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Issuance of common stock in connection with employee stock plans and other (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Dilutive effect of employee stock plans (shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Adjustment to Compensation, Amount Adjustment to Compensation Amount Cost of revenue Cost of Sales [Member] Payment of debt and associated costs Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030 Other Borrowings Cash payments Payments for Restructuring Document Period End Date Document Period End Date Curtailments, settlements and other Accumulated Defined Benefit Plans Adjustment Curtailments Settlements And Other [Member] Accumulated other comprehensive income (loss) related to curtailment, settlement and other components of pension and other postretirement defined benefit plans. Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Fair value adjustment related to hedged debt Debt Instrument, Change In Fair Value Of Hedged Debt Debt Instrument, Change In Fair Value Of Hedged Debt Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Net revenue Sales [Member] Entity Central Index Key Entity Central Index Key Curtailments, settlements and other Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax Liabilities: Liabilities, Fair Value Disclosure [Abstract] Segment Information Segment Reporting Information [Line Items] Stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Provision for taxes Income Tax Expense (Benefit) Finished goods Inventory, Finished Goods, Net of Reserves Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Employee compensation and benefit Employee-related Liabilities, Current Fair Value Fair Value Disclosures [Text Block] Name Trading Arrangement, Individual Name Cash Equivalents: Cash and Cash Equivalents [Abstract] Personal Systems Personal Systems [Member] Business reporting segment that provides commercial PCs, consumer PCs, workstations, handheld computing devices, calculators and other related accessories, software and services for the commercial and consumer markets. Other comprehensive loss, net of taxes Other comprehensive loss, net of taxes Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Amendment Flag Amendment Flag Non-labor Non-Labor [Member] Non-Labor [Member] Gross Amount Offset Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Fair value hedges Fair Value Hedging [Member] Actuarial loss (gain) Defined Benefit Plan, Amortization of Gain (Loss) Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Amortization of actuarial loss and prior service benefit Accumulated Defined Benefit Plans Adjustment Actuarial Gain Loss And Net Prior Service Cost Credit [Member] Accumulated other comprehensive income (loss) related to actuarial gain (loss) and prior period cost (credit) components of pension and other postretirement defined benefit plans. Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Shares settled (in shares) Stock Repurchases Executed During Period Settlement In Subsequent Period, Shares Stock Repurchases Executed During Period Settlement In Subsequent Period, Shares Other prior-year plans Other Plan [Member] Other Plan [Member] Due in one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Assets: Assets, Fair Value Disclosure [Abstract] Credit Facility [Domain] Credit Facility [Domain] Repurchases of common stock (in shares) Repurchases of common stock (shares) Stock Repurchased and Retired During Period, Shares Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Net Amount Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Aggregate damages sought Loss Contingency, Damages Sought, Value Long-term debt Total long-term debt Long-Term Debt, Excluding Current Maturities Philips Patent Litigation Philips Patent Litigation [Member] Philips Patent Litigation Deferred tax liability Deferred Tax Liabilities, Net Diluted (in shares) Weighted-average shares used to compute diluted net EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Additional amount deposited against parts-related show cause notice Additional Deposit Against Parts Related Show Cause Notice The amount of additional deposit made with the Commissioner of Customs in connection with the parts-related show cause notice. Interest rate contracts Interest Rate Contract [Member] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Gross Amounts Not Offset Derivative Asset [Abstract] Schedule of Other Non-Current Liabilities Other Noncurrent Liabilities [Table Text Block] Restructuring and other charges Restructuring and other charges Restructuring and Other Charges Restructuring and Other Charges Derivative assets Offsetting Derivative Assets [Abstract] Company Selected Measure Amount Company Selected Measure Amount Loss contingency deposit to prevent interruption of business Loss Contingency, Deposit to Prevent Interruption of Business The amount deposited by the entity to prevent interruption of business. Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-in Capital Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Access Advance Patent Pool, Unified Patent Court Access Advance Patent Pool, Unified Patent Court [Member] Access Advance Patent Pool, Unified Patent Court Litigation and Contingencies Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Discount to par (percent) Debt Instrument, Discount Rate at Issuance The discount to par at which a debt instrument was issued. U.S. UNITED STATES Fair Value Measured on a Recurring Basis Fair Value, Recurring [Member] Other Segment Reconciling Items [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Schedule of Other Current Liabilities Other Current Liabilities [Table Text Block] Other non-current liabilities Other non-current liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Remaining performance obligations Revenue, Remaining Performance Obligation, Amount $850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030 U.S. Dollar Global Notes, Due June 2030 [Member] U.S. Dollar Global Notes, Due June 2030 Tax effects related to other tax benefits Effective Income Tax Rate Reconciliation, Other Tax Benefits, Amount Effective Income Tax Rate Reconciliation, Other Tax Benefits, Amount Other comprehensive loss before taxes Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent Cash flow hedges Cash Flow Hedging [Member] Defined Benefit Plans Pension Plan [Member] Segment Information Segment Reporting Disclosure [Text Block] $1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025 U.S. Dollar Global Notes, Due June 2025 [Member] U.S. Dollar Global Notes, Due June 2025 Decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Equity securities, cost Equity Securities, FV-NI, Cost Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Assets Offsetting Assets [Table Text Block] Proceeds from short-term borrowings with original maturities less than 90 days, net Proceeds from Short-Term Debt, Maturing in Three Months or Less $1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031 U.S. Dollar Global Notes, Due June 2031 [Member] U.S. Dollar Global Notes, Due June 2031 Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Gross Amount Offset Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Long-term debt Debt Instrument [Line Items] Basic (in shares) Weighted-average shares used to compute basic net EPS (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Earnings from operations Total segment earnings from operations Operating Income (Loss) Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Nokia Patent Litigation Nokia Patent Litigation [Member] Nokia Patent Litigation Total cost of net revenue Cost of revenue Cost of Revenue $1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026 U.S. Dollar Global Notes, Due June 2026 [Member] U.S. Dollar Global Notes, Due June 2026 Cash equivalents and available-for-sale investments Schedule of Cash Equivalents and Available For Sale Investments [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Statement Statement [Line Items] Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes Schedule of Allowance for Doubtful Accounts Receivable Current Rollforward [Table Text Block] Tabular disclosure of the change in allowance for doubtful accounts - accounts receivable during the period. Offsetting of Derivatives Instruments Derivatives, Offsetting Fair Value Amounts, Policy [Policy Text Block] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Interest and other, net Interest And Other Income Expense [Member] Primary financial statement caption encompassing interest and other income or expense, net. Type of Restructuring [Domain] Type of Restructuring [Domain] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Other charges Other Restructuring Costs EX-101.PRE 16 hpq-20240131_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 17 image_0.jpg begin 644 image_0.jpg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�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image_02.jpg begin 644 image_02.jpg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�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image_03.jpg begin 644 image_03.jpg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�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image_05.jpg begin 644 image_05.jpg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�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image_06.jpg begin 644 image_06.jpg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�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image_0a.jpg begin 644 image_0a.jpg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�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image_0b.jpg begin 644 image_0b.jpg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�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htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover Page
 3 Months Ended
Jan. 31, 2024
shares
Cover [Abstract]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Jan. 31, 2024
Document Transition Report false
Entity File Number 1-4423
Entity Registrant Name HP INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 94-1081436
Entity Address, Address Line One 1501 Page Mill Road
Entity Address, City or Town Palo Alto,
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94304
City Area Code 650
Local Phone Number 857-1501
Title of 12(b) Security Common stock, par value $0.01 per share
Trading Symbol HPQ
Security Exchange Name NYSE
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 980,731,959
Entity Central Index Key 0000047217
Amendment Flag false
Current Fiscal Year End Date --10-31
Document Fiscal Year Focus 2024
Document Fiscal Period Focus Q1
XML 25 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Condensed Statements of Earnings (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Total net revenue $ 13,185 $ 13,798
Cost of net revenue:    
Total cost of net revenue 10,297 11,011
Gross margin 2,888 2,787
Research and development 399 403
Selling, general and administrative 1,383 1,331
Restructuring and other charges 63 141
Acquisition and divestiture charges 27 84
Amortization of intangible assets 81 85
Total operating expenses 1,953 2,044
Earnings from operations 935 743
Interest and other, net (142) (181)
Earnings before taxes 793 562
Provision for taxes (171) (93)
Net earnings $ 622 $ 469
Net earnings per share:    
Basic (usd per share) $ 0.63 $ 0.47
Diluted (usd per share) $ 0.62 $ 0.47
Weighted-average shares used to compute net earnings per share:    
Basic (in shares) 995 989
Diluted (in shares) 1,002 996
Products    
Total net revenue $ 12,419 $ 13,044
Cost of net revenue:    
Total cost of net revenue 9,871 10,589
Services    
Total net revenue 766 754
Cost of net revenue:    
Total cost of net revenue $ 426 $ 422
XML 26 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Condensed Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net earnings $ 622 $ 469
Change in unrealized components of available-for-sale debt securities:    
Unrealized gains arising during the period 4 4
Change in unrealized components of cash flow hedges:    
Unrealized losses arising during the period (162) (623)
Gains reclassified into earnings (159) (334)
Change in unrealized components of cash flow hedges (321) (957)
Change in unrealized components of defined benefit plans:    
Losses arising during the period (10) (1)
Amortization of actuarial loss and prior service benefit 2 0
Curtailments, settlements and other 0 1
Change in unrealized components of defined benefit plans (8) 0
Change in cumulative translation adjustment 20 29
Other comprehensive loss before taxes (305) (924)
Benefit from taxes 70 183
Other comprehensive loss, net of taxes (235) (741)
Comprehensive income (loss) $ 387 $ (272)
XML 27 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Condensed Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Current assets:    
Cash, cash equivalents and restricted cash $ 2,417 $ 3,232
Accounts receivable, net of allowance for credit losses of $84 and $93, respectively 3,804 4,237
Inventory 6,928 6,862
Other current assets 3,709 3,646
Total current assets 16,858 17,977
Property, plant and equipment, net 2,807 2,827
Goodwill 8,610 8,591
Other non-current assets 7,571 7,609
Total assets 35,846 37,004
Current liabilities:    
Notes payable and short-term borrowings 359 230
Accounts payable 13,255 14,046
Other current liabilities 10,243 10,212
Total current liabilities 23,857 24,488
Long-term debt 9,301 9,254
Other non-current liabilities 4,328 4,331
Stockholders’ deficit:    
Preferred stock, $0.01 par value (300 shares authorized; none issued) 0 0
Common stock, $0.01 par value (9,600 shares authorized; 980 and 989 shares issued and outstanding at January 31, 2024 and October 31, 2023, respectively) 10 10
Additional paid-in capital 1,579 1,505
Accumulated deficit (2,771) (2,361)
Accumulated other comprehensive loss (458) (223)
Total stockholders’ deficit (1,640) (1,069)
Total liabilities and stockholders’ deficit $ 35,846 $ 37,004
XML 28 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Statement of Financial Position [Abstract]    
Allowance for credit loss $ 84 $ 93
Preferred stock, par value (usd per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 300,000,000 300,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 9,600,000,000 9,600,000,000
Common stock, shares issued (in shares) 980,000,000 989,000,000
Common stock, shares outstanding (in shares) 980,000,000 989,000,000
XML 29 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Cash flows from operating activities:    
Net earnings $ 622 $ 469
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 205 209
Stock-based compensation expense 177 167
Restructuring and other charges 63 141
Deferred taxes on earnings (5) (140)
Other, net (20) 4
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 446 244
Inventory (47) 230
Accounts payable (744) (1,731)
Net investment in leases (62) (16)
Taxes on earnings 49 220
Restructuring and other (87) (92)
Other assets and liabilities (476) 279
Net cash provided by (used in) operating activities 121 (16)
Cash flows from investing activities:    
Investment in property, plant and equipment, net (158) (192)
Purchases of available-for-sale securities and other investments 0 (4)
Maturities and sales of available-for-sale securities and other investments 0 1
Collateral posted for derivative instruments (70) (240)
Net cash used in investing activities (228) (435)
Cash flows from financing activities:    
Proceeds from short-term borrowings with original maturities less than 90 days, net 100 200
Proceeds from debt, net of issuance costs 92 52
Payment of debt and associated costs (49) (539)
Stock-based award activities and others (76) (79)
Repurchase of common stock (500) (100)
Cash dividends paid (275) (259)
Collateral returned for derivative instruments 0 (200)
Net cash used in financing activities (708) (925)
Decrease in cash, cash equivalents and restricted cash (815) (1,376)
Cash, cash equivalents and restricted cash at beginning of period 3,232 3,145
Cash, cash equivalents and restricted cash at end of period $ 2,417 $ 1,769
XML 30 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Oct. 31, 2022   979,869      
Balance at beginning of period at Oct. 31, 2022 $ (3,025) $ 10 $ 1,172 $ (4,492) $ 285
Increase (Decrease) in Stockholders' Equity          
Net earnings 469     469  
Other comprehensive loss, net of taxes (741)       (741)
Comprehensive income (loss) (272)        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,844      
Issuance of common stock in connection with employee stock plans and other $ (79)   (79)    
Repurchases of common stock (in shares) (3,600) (3,624)      
Repurchases of common stock (Note 10) $ (100)   (4) (96)  
Cash dividends (518)     (518)  
Stock-based compensation expense 167   167    
Balance (in shares) at Jan. 31, 2023   985,089      
Balance at end of period at Jan. 31, 2023 $ (3,827) $ 10 1,256 (4,637) (456)
Balance (in shares) at Oct. 31, 2023 989,000 988,782      
Balance at beginning of period at Oct. 31, 2023 $ (1,069) $ 10 1,505 (2,361) (223)
Increase (Decrease) in Stockholders' Equity          
Net earnings 622     622  
Other comprehensive loss, net of taxes (235)       (235)
Comprehensive income (loss) 387        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,677      
Issuance of common stock in connection with employee stock plans and other $ (76)   (76)    
Repurchases of common stock (in shares) (17,100) (17,062)      
Repurchases of common stock (Note 10) $ (514)   (27) (487)  
Cash dividends (545)     (545)  
Stock-based compensation expense $ 177   177    
Balance (in shares) at Jan. 31, 2024 980,000 980,397      
Balance at end of period at Jan. 31, 2024 $ (1,640) $ 10 $ 1,579 $ (2,771) $ (458)
XML 31 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) (Parenthetical) - $ / shares
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Cash dividends per share (usd per share) $ 0.55 $ 0.53
XML 32 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Basis of Presentation
 3 Months Ended
Jan. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation
Basis of Presentation
The accompanying Consolidated Condensed Financial Statements of HP and its wholly-owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2023 in HP’s Annual Report on Form 10-K, filed on December 18, 2023. The Consolidated Condensed Balance Sheet for October 31, 2023 was derived from audited financial statements.
Principles of Consolidation
The Consolidated Condensed Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.
Reclassifications
HP has reclassified certain prior-year amounts to conform to the current-year presentation.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates.
Recently Adopted Accounting Pronouncements
In September 2022, the Financial Accounting Standards Board (“FASB”) issued guidance that enhances the transparency about the use of supplier finance programs. Under the new guidance, companies that use a supplier finance program in connection with the purchase of goods or services are required to disclose information about those programs to allow users of financial statements to understand the nature, activity during the period, changes from period to period, and potential magnitude. HP adopted this guidance in the first quarter of fiscal year 2024, except for the disclosure on roll forward information which will be adopted in fiscal year 2025, in line with the effective adoption dates prescribed by the FASB. See Note 6, “Supplementary Financial Information,” for additional disclosure related to HP’s supplier finance programs.
Recently Issued Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In November 2023, the FASB issued guidance that updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2025 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
XML 33 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information
 3 Months Ended
Jan. 31, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
HP’s operations are organized into three reportable segments: Personal Systems, Printing, and Corporate Investments.
Personal Systems offers commercial and consumer desktops and notebooks, detachables and convertibles, workstations, thin clients, commercial mobility devices, retail point-of-sale (“POS”) systems, displays, hybrid systems, software, solutions and services. Personal Systems includes support and deployment, configurations and extended warranty services and maintains multi-operating system and multi-architecture strategies using Microsoft Windows and Google Chrome operating systems, and predominantly use processors from Intel Corporation (“Intel”) and Advanced Micro Devices, Inc. (“AMD”).
Personal Systems groups its global business capabilities into the following business units when reporting business performance:
•Commercial PS consists of devices and accessories, including workstations, thin clients, mobility devices and hybrid systems, for use by enterprise, public sector (which includes education), and small- and medium-sized business (“SMB”) customers. HP offers a range of services and solutions to commercial customers to help them manage the lifecycle of their personal computers (“PCs”) and mobility installed base. 
•Consumer PS consists of devices, accessories and services which are optimized for consumer usage, focusing on gaming, learning and working remotely, consuming multi-media for entertainment, managing personal life activities, sharing information, and staying connected informed and secure.
Printing offers consumer and commercial printer hardware, supplies, services and solutions. Printing is also focused on Graphics and 3D Printing and Personalization in the commercial and industrial markets. Our global business capabilities within Printing are described below:
•Office Printing Solutions delivers HP’s office printers, supplies, services, and solutions to SMBs, public sector and large enterprises. It also includes Original Equipment Manufacturer (“OEM”) hardware and solutions.
•Home Printing Solutions delivers innovative printing products, supplies, services and solutions for the home and home business.
•Graphics Solutions delivers large-format, commercial and industrial solutions and supplies to print service providers and packaging converters through a wide portfolio of printers and presses (HP DesignJet, HP Latex, HP Indigo and HP PageWide Web Presses).
•3D Printing & Personalization offers a portfolio of additive manufacturing solutions and supplies to help customers succeed in their additive and digital manufacturing journey. HP offers complete solutions in collaboration with an ecosystem of partners.
Printing groups its global business capabilities into the following business units when reporting business performance:
•Commercial Printing consists of office printing solutions, graphics solutions and 3D printing and personalization, excluding supplies;
•Consumer Printing consists of home printing solutions, excluding supplies; and
•Supplies comprises a set of highly innovative consumable products, ranging from ink and laser cartridges to media, graphics supplies and 3D printing and digital manufacturing supplies, for recurring use in consumer and commercial hardware.
Corporate Investments includes certain business incubation and investment projects.
HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges and amortization of intangible assets.
Segment Operating Results and the reconciliation to HP consolidated results were as follows:
 Three months ended January 31
 20242023
In millions
Net revenue:
Commercial PS$6,045 $6,382 
Consumer PS2,764 2,803 
Personal Systems8,809 9,185 
Supplies2,863 2,857 
Commercial Printing1,227 1,388 
Consumer Printing285 367 
Printing4,375 4,612 
Corporate Investments2 1 
Total segment net revenue13,186 13,798 
Other(1)— 
Total net revenue$13,185 $13,798 
Earnings before taxes:
Personal Systems$537 $475 
Printing872 870 
Corporate Investments(37)(33)
Total segment earnings from operations1,372 1,312 
Corporate and unallocated costs and other(89)(92)
Stock-based compensation expense(177)(167)
Restructuring and other charges(63)(141)
Acquisition and divestiture charges(27)(84)
Amortization of intangible assets(81)(85)
Interest and other, net(142)(181)
Total earnings before taxes$793 $562 
Realignment
Effective at the beginning of its first quarter of fiscal year 2024, HP realigned its business unit financial reporting more closely with its customer market segmentation. The realignment resulted in the transfer of LaserJet printers net revenues from Consumer Printing to Commercial Printing. HP reflected this change to its business unit information in prior reporting periods on an as-if basis which resulted in the reclassification of net revenues from Consumer Printing to Commercial Printing. The reporting change had no impact to previously reported segment net revenue, consolidated net revenue, earnings from operations, net earnings or net earnings per share (“EPS”).
XML 34 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring and Other Charges
 3 Months Ended
Jan. 31, 2024
Restructuring and Related Activities [Abstract]  
Restructuring and Other Charges Restructuring and Other Charges
Summary of Restructuring Plans
HP’s restructuring activities summarized by plan were as follows:
Fiscal 2023 Plan
Severance and EERNon-labor
Other prior-year plans(1)
Total
In millions
Accrued balance as of October 31, 2023$88 $18 $2 $108 
Charges43 2 3 48 
Cash payments(63)(6)(3)(72)
Non-cash and other adjustments2 — (2)— 
Accrued balance as of January 31, 2024$70 $14 $— $84 
Total costs incurred to date as of January 31, 2024$445 $43 $869 $1,357 
Reflected in Consolidated Condensed Balance Sheets
Other current liabilities$70 $3 $— $73 
Other non-current liabilities$— $11 $— $11 
Accrued balance as of October 31, 2022$— $— $32 $32 
Charges122 9 — 131 
Cash payments(53)(4)(25)(82)
Non-cash and other adjustments(2)(5)1 (6)
Accrued balance as of January 31, 2023$67 $— $8 $75 
(1)     Primarily includes the fiscal 2020 plan along with other legacy plans, all of which are substantially complete. HP does not expect any further material activity associated with these plans.
Fiscal 2023 Plan
On November 18, 2022, HP’s Board of Directors approved the Future Ready Plan (the “Fiscal 2023 Plan”) intended to enable digital transformation, portfolio optimization and operational efficiency which HP expects will be implemented through fiscal year 2025. HP expects to reduce global headcount by approximately 4,000 to 6,000 employees. HP estimates that it will incur pre-tax charges of approximately $1.0 billion of which approximately $0.7 billion primarily in labor costs related to workforce reductions and the remaining costs will relate to non-labor actions and other charges.
Other charges
Other charges include non-recurring costs, including those as a result of information technology rationalization efforts and transformation program management costs, and are distinct from ongoing operational costs. These costs primarily relate to third-party professional services and other non-recurring costs. For the three months ended January 31, 2024, HP incurred $15 million of other charges. For the three months ended January 31, 2023, HP incurred $10 million of other charges.
XML 35 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
Retirement and Post-Retirement Benefit Plans
 3 Months Ended
Jan. 31, 2024
Retirement Benefits [Abstract]  
Retirement and Post-Retirement Benefit Plans Retirement and Post-Retirement Benefit Plans
The components of HP’s pension and post-retirement benefit (credit) cost recognized in the Consolidated Condensed Statements of Earnings were as follows:
 Three months ended January 31
 U.S. Defined Benefit PlansNon-U.S. Defined Benefit PlansPost- Retirement Benefit Plans
 202420232024202320242023
 In millions
Service cost$— $— $9 $9 $— $— 
Interest cost57 54 12 10 4 4 
Expected return on plan assets(61)(65)(13)(13)(4)(3)
Amortization and deferrals:
Actuarial loss (gain)7 5 — 1 (4)(4)
Prior service cost (credit)— — 2 1 (3)(3)
Net periodic benefit (credit) cost3 (6)10 8 (7)(6)
Settlement loss — — — 1 — — 
Total periodic benefit (credit) cost$3 $(6)$10 $9 $(7)$(6)
Employer Contributions and Funding Policy
HP’s policy is to fund its pension plans so that it makes at least the minimum contribution required by local government, funding and taxing authorities.
During fiscal year 2024, HP anticipates making contributions of approximately $45 million to its non-U.S. pension plans, approximately $31 million to its U.S. non-qualified plan participants and approximately $3 million to cover benefit claims under HP’s post-retirement benefit plans. During the three months ended January 31, 2024, HP contributed $11 million to its non-U.S. pension plans, paid $6 million to cover benefit payments to U.S. non-qualified plan participants and paid $2 million to cover benefit claims under HP’s post-retirement benefit plans.
HP’s pension and other post-retirement benefit costs and obligations depend on various assumptions. Differences between expected and actual returns on investments and changes in discount rates and other actuarial assumptions are reflected as unrecognized gains or losses, and such gains or losses are amortized to earnings in future periods. A deterioration in the funded status of a plan could result in a need for additional contributions or an increase in net pension and post-retirement benefit costs in future periods. Actuarial gains or losses are determined at the measurement date and amortized over the remaining service life for active plans or the life expectancy of plan participants for frozen plans.
Retirement Incentive Program
As part of the Fiscal 2023 Plan, HP announced a voluntary EER program for its U.S. employees in January 2023. Voluntary participation in the EER program was limited to employees at least 55 years old with 10 or more years of service at HP. Employees accepted into the EER program left HP on dates ranging from March 15, 2023 to October 31, 2023. The U.S. defined benefit pension plan was amended to provide that the EER benefit was to be paid from the plan for eligible electing EER participants. The retirement incentive benefit was calculated as a lump sum based on years of service at HP at the time of retirement, ranging from 20 to 52 weeks of pay. As a result of this retirement incentive, HP recognized a special termination benefit (“STB”) expense of $105 million for the year ended October 31, 2023 as a restructuring charge. This expense is the present value of all additional benefits that HP will distribute from the pension plan assets.
All employees participating in the EER program were offered the opportunity to continue health care coverage at the active employee contribution rates for up to 36 months following retirement, but not beyond age 65 when Medicare is available. In addition, HP provided up to $12,000 in employer credits under the Retirement Medical Savings Account program. HP recognized an additional STB expense of $34 million as restructuring and other charges for the year ended October 31, 2023 for the health care incentives.
XML 36 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Taxes on Earnings
 3 Months Ended
Jan. 31, 2024
Income Tax Disclosure [Abstract]  
Taxes on Earnings Taxes on Earnings
Provision for Taxes
HP’s effective tax rate was 21.6% and 16.6% for the three months ended January 31, 2024 and 2023, respectively. The difference between the U.S. federal statutory tax rate of 21% and HP’s effective tax rate for the three months ended January 31, 2023 was primarily due to tax effects of favorable tax rates associated with certain earnings from HP's operations in lower-tax jurisdictions throughout the world.
During the three months ended January 31, 2023, HP recorded $56 million of net income tax benefits related to discrete items in the provision for taxes. These amounts included $30 million of income tax benefits related to restructuring charges, $14 million related to acquisition charges and $12 million of other net tax benefits. During the three months ended January 31, 2023, excess tax benefits associated with stock options, restricted stock units and performance-adjusted restricted stock units were immaterial.
Uncertain Tax Positions
As of January 31, 2024, the amount of gross unrecognized tax benefits was $1.2 billion, of which up to $828 million would affect HP’s effective tax rate if realized. Total gross unrecognized tax benefits increased by $20 million for the three months ended January 31, 2024. HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Consolidated Condensed Statements of Earnings. As of January 31, 2024 and 2023, HP had accrued $105 million and $73 million, respectively, for interest and penalties.
HP engages in continuous discussions and negotiations with taxing authorities regarding tax matters in various jurisdictions. HP expects complete resolution of certain tax years with various tax authorities within the next 12 months. HP believes it is reasonably possible that its existing gross unrecognized tax benefits may be reduced by $39 million within the next 12 months, affecting HP’s effective tax rate if realized.
HP is subject to income tax in the United States and approximately 60 other countries and is subject to routine corporate income tax audits in many of these jurisdictions. In addition, HP is subject to numerous ongoing audits by federal, state and foreign tax authorities. The Internal Revenue Service (“IRS”) is conducting an audit of HP’s 2018 and 2019 income tax returns.
XML 37 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information
 3 Months Ended
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplementary Financial Information Supplementary Financial Information
Cash, cash equivalents and restricted cash
 As of
 January 31, 2024October 31, 2023
 In millions
Cash and cash equivalents$2,263 $3,107 
Restricted cash(1)
154 125 
$2,417 $3,232 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Accounts Receivable
The allowance for credit losses related to accounts receivable and changes were as follows:
 Three months ended January 31, 2024
 In millions
Balance at beginning of period$93 
Benefit of allowance for credit losses(6)
Deductions, net of recoveries(3)
Balance at end of period$84 
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Condensed Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Condensed Balance Sheets. The recourse obligations as of January 31, 2024 and October 31, 2023 were not material.
The following is a summary of the activity under these arrangements:
Three months ended January 31
 2024 2023
 In millions
Balance at beginning of period(1)
$141 $185 
Trade receivables sold3,298 3,679 
Cash receipts(3,232)(3,753)
Foreign currency and other5 17 
Balance at end of period(1)
$212 $128 
(1)    Amounts outstanding from third parties reported in Accounts receivable in the Consolidated Condensed Balance Sheets.
Inventory
 As of
 January 31, 2024October 31, 2023
 In millions
Finished goods$3,603 $3,930 
Purchased parts and fabricated assemblies3,325 2,932 
$6,928 $6,862 

Other Current Assets
 As of
 January 31, 2024October 31, 2023
 In millions
Supplier and other receivables$1,419 $1,349 
Prepaid and other current assets1,376 1,445 
Value-added taxes receivable914 852 
$3,709 $3,646 

Property, Plant and Equipment, Net
 As of
 January 31, 2024October 31, 2023
 In millions
Land, buildings and leasehold improvements$2,348 $2,332 
Machinery and equipment, including equipment held for lease5,452 5,384 
7,800 7,716 
Accumulated depreciation(4,993)(4,889)
$2,807 $2,827 

Other Non-Current Assets
 As of
 January 31, 2024October 31, 2023
 In millions
Deferred tax assets$3,230 $3,155 
Intangible assets1,519 1,593 
Right-of-use assets1,165 1,188 
Deposits and prepaid412 427 
Prepaid pension and post-retirement benefit assets395 393 
Other850 853 
$7,571 $7,609 
Other Current Liabilities
 As of
 January 31, 2024October 31, 2023
 In millions
Sales and marketing programs$2,920 $3,053 
Deferred revenue1,424 1,424 
Other accrued taxes1,071 994 
Employee compensation and benefit648 1,046 
Warranty572 569 
Operating lease liabilities459 430 
Tax liability282 217 
Other2,867 2,479 
$10,243 $10,212 

Other Non-Current Liabilities
 As of
 January 31, 2024October 31, 2023
In millions
Deferred revenue$1,373 $1,324 
Tax liability926 904 
Operating lease liabilities815 825 
Pension, post-retirement, and post-employment liabilities546 546 
Deferred tax liability31 44 
Other637 688 
$4,328 $4,331 

Interest and Other, Net
 Three months ended January 31
 2024 2023
 In millions
Interest expense on borrowings$(116)$(143)
Factoring costs(40)(32)
Loss on extinguishment of debt— (8)
Non-operating retirement-related credits4 11 
Other, net10 (9)
$(142)$(181)
Net Revenue by Region
Three months ended January 31
 2024 2023
 In millions
Americas$5,408 $5,747 
Europe, Middle East and Africa4,668 4,636 
Asia-Pacific and Japan3,109 3,415 
Total net revenue$13,185 $13,798 
Value of Remaining Performance Obligations
As of January 31, 2024, the estimated value of transaction price allocated to remaining performance obligations was $3.8 billion. HP expects to recognize approximately $1.7 billion of the unearned amount in next 12 months and $2.1 billion thereafter.
HP has elected the practical expedients and accordingly does not disclose the aggregate amount of the transaction price allocated to remaining performance obligations if:
•the contract has an original expected duration of one year or less; or
•the revenue from the performance obligation is recognized over time on an as-invoiced basis when the amount corresponds directly with the value to the customer; or
•the portion of the transaction price that is variable in nature is allocated entirely to a wholly unsatisfied performance obligation.
The remaining performance obligations are subject to change and may be affected by various factors, such as termination of contracts, contract modifications and adjustment for currency.
Contract Liabilities
As of January 31, 2024 and October 31, 2023, HP’s contract liabilities balances were $2.8 billion and $2.7 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Consolidated Condensed Balance Sheets.
The increase in the contract liabilities balance for the three months ended January 31, 2024, was primarily driven by sales of fixed-price support and maintenance services, partially offset by $0.5 billion of revenue recognized that was included in the contract liabilities balance as of October 31, 2023.
Supplier Finance Programs
HP facilitates voluntary supplier finance programs to provide certain suppliers the opportunity to sell their right to HP’s payment obligations to participating financial institutions. Under this program, HP agrees to pay the participating financial institutions the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Participation by suppliers in these programs have no impact on the payment terms and amounts due from HP. HP does not have an economic interest in a supplier's participation in the program and is not a party to the agreement between the supplier and the financial institutions. In connection with these programs, HP does not pledge assets or other forms of guarantees as security for the committed payment to the participating financial institutions. HP pays a monthly service fee to a third-party administrator that provides the supplier finance platform and related support. HP and the participating financial institutions may terminate the agreement upon at least 30 days notice. As of January 31, 2024 and October 31, 2023, HP had $5.3 billion and $6.6 billion respectively, in obligations outstanding (i.e., unpaid invoices) that were confirmed as valid under the supplier finance programs. Of the amounts confirmed as valid under the program and outstanding, the amounts owed to participating financial institutions were $0.7 billion and $0.9 billion as of January 31, 2024 and October 31, 2023, respectively. These obligations are included within the Accounts payable line item of HP’s Consolidated Condensed Balance Sheet.
XML 38 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value
 3 Months Ended
Jan. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
Fair Value Hierarchy
HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
Level 3—Unobservable inputs for the asset or liability.
The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.
    The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:
 As of January 31, 2024As of October 31, 2023
 Fair Value Measured UsingFair Value Measured Using
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
 In millions
Assets:        
Cash Equivalents:        
Corporate debt$— $502 $— $502 $— $589 $— $589 
Government debt(1)
1,029 — — 1,029 1,900 — — 1,900 
Available-for-Sale Investments:
Financial institution instruments— 3 — 3 — 3 — 3 
Marketable securities and mutual funds
43 49 — 92 33 45 — 78 
Derivative Instruments:     
Foreign currency contracts— 212 — 212 — 489 — 489 
Other derivatives— 2 — 2 — — — — 
Total assets$1,072 $768 $— $1,840 $1,933 $1,126 $— $3,059 
Liabilities:        
Derivative Instruments:        
Interest rate contracts$— $43 $— $43 $— $58 $— $58 
Foreign currency contracts— 248 — 248 — 212 — 212 
Other derivatives— — — — — 2 — 2 
Total liabilities$— $291 $— $291 $— $272 $— $272 
(1)    Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds. Money market funds invested in government debt and traded in active markets are included in Level 1.
Valuation Techniques
Cash Equivalents and Investments: HP holds time deposits, money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.
Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 8, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.
Other Fair Value Disclosures
Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Consolidated Condensed Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $9.3 billion as compared to its carrying amount of $9.7 billion at January 31, 2024. The fair value of HP’s short- and long-term debt was $8.5 billion as compared to its carrying value of $9.5 billion at October 31, 2023. If measured at fair value in the Consolidated Condensed Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.
Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Consolidated Condensed Balance Sheets, the carrying amounts approximate fair value due to their short maturities. If measured at fair value in the Consolidated Condensed Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.
Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Consolidated Condensed Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.
XML 39 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments
 3 Months Ended
Jan. 31, 2024
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
Cash Equivalents and Available-for-Sale Investments
 As of January 31, 2024As of October 31, 2023
 CostGross Unrealized GainGross Unrealized LossFair ValueCostGross Unrealized GainGross Unrealized LossFair Value
 In millions
Cash Equivalents:        
Corporate debt$502 $— $— $502 $589 $— $— $589 
Government debt1,029 — — 1,029 1,900 — — 1,900 
Total cash equivalents1,531 — — 1,531 2,489 — — 2,489 
Available-for-Sale Investments:     
Financial institution instruments3 — — 3 3 — — 3 
Marketable securities and mutual funds
40 52 — 92 40 38 — 78 
Total available-for-sale investments43 52 — 95 43 38 — 81 
Total cash equivalents and available-for-sale investments$1,574 $52 $— $1,626 $2,532 $38 $— $2,570 
All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of January 31, 2024 and October 31, 2023, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.
Contractual maturities of investments in available-for-sale debt securities were as follows:
 As of January 31, 2024
 Amortized CostFair Value
 In millions
Due in one year$3 $3 
Non-marketable equity securities in privately held companies are included in Other non-current assets in the Consolidated Condensed Balance Sheets. These amounted to $108 million and $111 million as of January 31, 2024 and October 31, 2023, respectively.
HP determines credit losses on cash equivalents and available-for-sale debt securities at the individual security level. All instruments are considered investment grade. No credit-related or noncredit-related impairment losses were recorded for the three months ended January 31, 2024.
Derivative Instruments
HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates from contractually established thresholds. The Company includes gross collateral posted and received in other current assets and other current liabilities in the Consolidated Condensed Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $119 million and $91 million as of January 31, 2024 and as of October 31, 2023, respectively, all of which were fully collateralized within two business days.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of January 31, 2024 and October 31, 2023.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts, option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted net revenue, cost of revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
During the three months ended January 31, 2024 and 2023, no portion of the hedging instruments’ gain or loss was excluded from the assessment of effectiveness for fair value and cash flow hedges.
Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:
 As of January 31, 2024As of October 31, 2023
 Outstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current LiabilitiesOutstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current Liabilities
 In millions
Derivatives designated as hedging instruments     
Fair value hedges:     
Interest rate contracts$750 $— $— $— $43 $750 $— $— $— $58 
Cash flow hedges:
Foreign currency contracts15,282 173 28 182 59 15,278 410 70 147 52 
Total derivatives designated as hedging instruments16,032 173 28 182 102 16,028 410 70 147 110 
Derivatives not designated as hedging instruments    
Foreign currency contracts3,926 11 — 7 — 4,446 9 — 13 — 
Other derivatives130 2 — — — 125 — — 2 — 
Total derivatives not designated as hedging instruments4,056 13 — 7 — 4,571 9 — 15 — 
Total derivatives$20,088 $186 $28 $189 $102 $20,599 $419 $70 $162 $110 
Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of January 31, 2024 and October 31, 2023, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Condensed Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
 Gross Amount
Recognized		Gross Amount
Offset		Net Amount
Presented		Derivatives
Financial
Collateral		 Net Amount
 In millions
As of January 31, 2024       
Derivative assets$214 $— $214 $170 $40 (1)$4 
Derivative liabilities$291 $— $291 $170 $109 (2)$12 
As of October 31, 2023       
Derivative assets$489 $— $489 $178 $291 (1)$20 
Derivative liabilities$272 $— $272 $178 $89 (2)$5 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Effect of Derivative Instruments in the Consolidated Condensed Statements of Earnings
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:
Derivative InstrumentHedged ItemLocationYearTotal amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recordedGain/(loss) recognized in earnings on derivative instrumentsGain/(loss) recognized in earnings on hedged item
In millions
Three months ended January 31
Interest rate contractFixed-rate debtInterest and other, net2024$(142)$15 $(15)
2023$(181)$14 $(14)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:
Three months ended January 31
20242023
In millions
Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:
Foreign currency contracts$(162)$(623)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
Total amounts of income/(expense) line items in the statement of financial performance in which the effects of cash flow hedges are recordedGain/(loss) reclassified from Accumulated 
other comprehensive (loss) income into earnings
Three months ended January 31Three months ended January 31
2024202320242023
In millions
Net revenue$13,185 $13,798 $199 $386 
Cost of revenue(10,297)(11,011)(40)(54)
Operating expenses(1,953)(2,044)(3)(1)
Interest and other, net(142)(181)3 3 
Total$159 $334 
As of January 31, 2024, HP expects to reclassify an estimated accumulated other comprehensive loss of $33 million, net of taxes, to earnings within the next twelve months associated with cash flow hedges along with the earnings effects of the related forecasted transactions. The amounts ultimately reclassified into earnings could be different from the amounts previously included in Accumulated other comprehensive (loss) income based on the change of market rate, and therefore could have different impact on earnings.
The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Condensed Statements of Earnings as follows:
Gain/(loss) recognized in earnings on derivative instrument
 Three months ended January 31
 Location20242023
  In millions
Foreign currency contractsInterest and other, net$1 $(44)
Other derivativesInterest and other, net4 6 
Total $5 $(38)
XML 40 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Borrowings
 3 Months Ended
Jan. 31, 2024
Debt Disclosure [Abstract]  
Borrowings Borrowings
Notes Payable and Short-Term Borrowings
 As of January 31, 2024As of October 31, 2023
 Amount
Outstanding		Weighted-Average
Interest Rate		Amount
Outstanding		Weighted-Average
Interest Rate
 In millions
Commercial Paper$100 5.5 %$— — %
Current portion of long-term debt193 5.9 %179 6.0 %
Notes payable to banks, lines of credit and other66 1.2 %51 1.0 %
$359  $230  
Long-Term Debt
 As of
 January 31, 2024October 31, 2023
 In millions
U.S. Dollar Global Notes(1)
  
$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041
$1,199 $1,199 
$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025
1,149 1,149 
$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027
999 999 
$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030
503 503 
$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026
521 521 
$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031(2)
997 997 
$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029
999 999 
$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032
676 676 
$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028
899 899 
$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033
1,097 1,097 
$500 issued at par at a price of 100% at 4.75%, due March 2029
3 3 
9,042 9,042 
Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030
549 506 
Fair value adjustment related to hedged debt(43)(58)
Unamortized debt issuance cost(54)(57)
Current portion of long-term debt(193)(179)
Total long-term debt$9,301 $9,254 
(1)HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.
(2)HP allocated an amount equal to the net proceeds to finance or refinance, in whole or in part, environmentally and socially responsible eligible projects in the following eight areas: renewable energy; green buildings; energy efficiency; clean transportation; pollution prevention and control; eco-efficient and/or circular economy products, production technologies and processes; environmentally sustainable management of living natural resources and land use; and socioeconomic advancement and empowerment.

As disclosed in Note 8, “Financial Instruments,” HP uses interest rate swaps to mitigate some of the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates. Interest rates shown in the table of long-term debt have not been adjusted to reflect the impact of any interest rate swaps.
Commercial Paper
As of January 31, 2024, HP maintained a U.S. commercial paper program for the issuance of U.S. dollar-denominated commercial paper up to a maximum aggregate principal amount of $6.0 billion. The principal amount outstanding under this program and certain short-term borrowings at any time cannot exceed a $6.0 billion authorization by HP’s Board of Directors.
Credit Facilities
As of January 31, 2024, HP maintained a $5.0 billion sustainability-linked senior unsecured committed revolving credit facility, which HP entered into in May 2021, and a $1.0 billion senior unsecured committed 364-day revolving credit facility, which HP entered into in March 2023. Commitments under the $5.0 billion revolving credit facility will be available until May 26, 2026 and commitments under the $1.0 billion 364-day revolving credit facility will be available until March 19, 2024. Commitment fees, interest rates and other terms of borrowing under the revolving credit facilities vary based on HP’s external credit ratings and, for the $5.0 billion facility, certain sustainability metrics. Funds borrowed under the revolving credit facilities may be used for general corporate purposes.
As of January 31, 2024, HP was in compliance with the covenants in the credit agreements governing the revolving credit facilities.
Available Borrowing Resources
As of January 31, 2024, HP had available borrowing resources of $1.0 billion from uncommitted lines of credit in addition to the full capacity of the revolving credit facilities.
XML 41 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Deficit
 3 Months Ended
Jan. 31, 2024
Stockholders' Equity Note [Abstract]  
Stockholders' Deficit Stockholders’ Deficit
Share Repurchase Program
HP’s share repurchase program authorizes both open market and private repurchase transactions. During the three months ended January 31, 2024, HP executed share repurchases of 17.1 million shares and settled total shares for $0.5 billion. Share repurchases executed during the three months ended January 31, 2024 included 0.3 million shares settled in February 2024. During the three months ended January 31, 2023, HP executed share repurchases of 3.6 million shares and settled total shares for $0.1 billion.
The shares repurchased during the three months ended January 31, 2024 and 2023 were all open market repurchase transactions. As of January 31, 2024, HP had approximately $1.5 billion remaining under the share repurchase authorizations approved by HP’s Board of Directors.

Taxes related to Other Comprehensive Income (Loss)
 Three months ended January 31
 20242023
 In millions
Tax effect on change in unrealized components of available-for-sale debt securities:  
Tax provision on unrealized gains arising during the period$— $(1)
Tax effect on change in unrealized components of cash flow hedges: 
Tax benefit on unrealized losses arising during the period36 106 
Tax provision on gains reclassified into earnings32 78 
68 184 
Tax effect on change in unrealized components of defined benefit plans:  
Tax benefit on losses arising during the period2 — 
2 — 
Tax benefit on other comprehensive loss$70 $183 
Changes and reclassifications related to Other Comprehensive Loss, net of taxes
 Three months ended January 31
 20242023
 In millions
Other comprehensive loss, net of taxes:
Change in unrealized components of available-for-sale debt securities:
Unrealized gains arising during the period$4 $3 
Change in unrealized components of cash flow hedges:
Unrealized losses arising during the period(126)(517)
Gains reclassified into earnings(127)(256)
(253)(773)
Change in unrealized components of defined benefit plans:
Losses arising during the period(8)(1)
Amortization of actuarial loss and prior service benefit(1)
2 — 
Curtailments, settlements and other— 1 
(6)— 
Change in cumulative translation adjustment20 29 
Other comprehensive loss, net of taxes$(235)$(741)
(1)These components are included in the computation of net pension and post-retirement benefit (credit) charges in Note 4, “Retirement and Post-Retirement Benefit Plans”.

The components of Accumulated other comprehensive loss, net of taxes and changes were as follows:
 Three months ended January 31, 2024
 Net unrealized
gains (losses) on
available-for-sale debt
securities		Net unrealized gains (losses) on cash
flow hedges		Unrealized
components
of defined
benefit plans		Change in cumulative
translation
adjustment		Accumulated
other
comprehensive loss
 In millions
Balance at beginning of period$7 $230 $(437)$(23)$(223)
Other comprehensive gains (losses) before reclassifications4 (126)(8)20 (110)
Reclassifications of gain into earnings— (127)2 — (125)
Balance at end of period$11 $(23)$(443)$(3)$(458)
XML 42 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share
 3 Months Ended
Jan. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.
A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:
 Three months ended January 31
 20242023
 In millions, except per share amounts
Numerator:
Net earnings$622 $469 
Denominator:
Weighted-average shares used to compute basic net EPS995 989 
Dilutive effect of employee stock plans7 7 
Weighted-average shares used to compute diluted net EPS1,002 996 
Net earnings per share:
Basic$0.63 $0.47 
Diluted$0.62 $0.47 
Anti-dilutive weighted-average stock-based compensation awards(1)
6 7 
(1)HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent unrecognized compensation cost.
XML 43 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Litigation and Contingencies
 3 Months Ended
Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Litigation and Contingencies Litigation and Contingencies
HP is involved in lawsuits, claims, investigations and proceedings, including those identified below, consisting of IP, commercial, securities, employment, employee benefits and environmental matters that arise in the ordinary course of business. HP accrues a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. HP believes it has recorded adequate provisions for any such matters and, as of January 31, 2024, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.
Litigation, Proceedings and Investigations
Copyright Levies.  Proceedings are ongoing or have been concluded involving HP in certain European countries, challenging the imposition or the modification of levies regimes upon IT equipment (such as PCs or printers) or the restrictions to exonerate the application of private copying levies on devices purchased by business users. The levies are generally based upon the number of products sold and the per-product amounts of the levies, which vary. Some European countries are expected to implement legislation to introduce or extend existing levy schemes to digital devices. HP, other companies and various industry associations have opposed the extension of levies to the digital product and certain requirements for business sales exemptions and have advocated alternative models of compensation to rights holders.
Based on the exemption of levies on business sales and industry opposition to increasing levies to digital products, HP’s assessments of the merits of various proceedings and HP’s estimates of the number of units impacted and the amounts of the levies, HP has accrued amounts that it believes are adequate to address the ongoing disputes.
Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise. This is a purported class and collective action filed on August 18, 2016 in the United States District Court, Northern District of California, against HP and Hewlett Packard Enterprise (“HPE”) alleging the defendants violated federal and state law by terminating older workers and replacing them with younger workers. In their most recent complaint, plaintiffs seek to represent (1) a putative nationwide federal Age Discrimination in Employment Act (ADEA) collective comprised of all former HP Inc. employees 40 years of age and older who had their employment terminated under a WFR plan in or after 2014 or 2015, depending on state law; and (2) a putative Rule 23 class under California law comprised of all former HP Inc. employees 40 years of age and older who had their employment terminated in California under a WFR plan in or after 2012. Excluded from the putative collective and class are employees who (a) signed a Waiver and General Release Agreement at termination, or (b) signed an Agreement to Arbitrate Claims. Similar claims are pending against HPE. Because the court granted plaintiffs’ motion for preliminary certification of the putative nationwide ADEA collectives, a third-party administrator notified eligible former employees of their right to opt into the ADEA collective. This opt-in period closed on February 15, 2022. Plaintiffs seek monetary damages, punitive damages, and other relief. In June 2023, the parties reached an agreement in principle to resolve this matter. The parties have finalized a settlement agreement, and the court preliminarily approved it on October 26, 2023. The Court has set the Final Approval Hearing for March 28, 2024.
India Directorate of Revenue Intelligence Proceedings. On April 30 and May 10, 2010, the India Directorate of Revenue Intelligence (the “DRI”) issued show cause notices to Hewlett-Packard India Sales Private Limited (“HP India”), a subsidiary of HP, seven HP India employees and one former HP India employee alleging that HP India underpaid customs duties while importing products and spare parts into India and seeking to recover an aggregate of approximately $370 million, plus penalties and interest. Prior to the issuance of the notices, HP India deposited approximately $16 million with the DRI and agreed to post a provisional bond in exchange for the DRI’s agreement to not seize HP India products and spare parts or interrupt business by HP India.
On April 11, 2012, the Bangalore Commissioner of Customs issued an order on the products-related notice affirming certain duties and penalties against HP India and the named individuals of approximately $386 million, of which HP India had already deposited $9 million. On December 11, 2012, HP India voluntarily deposited an additional $10 million in connection with the products-related notice. The differential duty demand is subject to interest. On April 20, 2012, the Commissioner issued an order on the parts-related notice affirming certain duties and penalties against HP India and certain of the named individuals of approximately $17 million, of which HP India had already deposited $7 million. After the order, HP India deposited an additional $3 million in connection with the parts-related notice so as to avoid certain penalties.
HP India filed appeals of the Commissioner’s orders before the Customs, Excise and Service Tax Appellate Tribunal (the “Customs Tribunal”) along with applications for waiver of the pre-deposit of remaining demand amounts as a condition for hearing the appeals. The Customs Department has also filed cross-appeals before the Customs Tribunal. On January 24, 2013, the Customs Tribunal ordered HP India to deposit an additional $24 million against the products order, which HP India deposited in March 2013. On February 7, 2014, the Customs Tribunal granted HP India’s application for extension of the stay of deposit until disposal of the appeals. On October 27, 2014, the Customs Tribunal commenced hearings on the cross-appeals of the Commissioner’s orders and rejected HP India’s request to remand the matter to the Commissioner on procedural grounds. The Customs Tribunal cancelled hearings to reconvene in 2015, 2016 and January 2019. On January 20, 2021, the Customs Tribunal held a virtual hearing during which the judge allowed HP’s application for a physical hearing on the merits as soon as practicable, which will be scheduled when physical hearings resume at court. Pursuant to the separation and distribution agreement, Hewlett Packard Enterprise has agreed to indemnify HP in part, based on the extent to which any liability arises from the products and spare parts of Hewlett Packard Enterprise’s businesses.
Philips Patent Litigation. In September 2020, Koninklijke Philips N.V. and Philips North America LLC (collectively, “Philips”) filed a complaint against HP for patent infringement in federal court for the District of Delaware and filed a companion complaint with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP and 8 other sets of respondents. Both complaints allege that certain digital video-capable devices and components thereof infringe four of Philips’ patents. In October 2020, the ITC instituted an investigation, and Philips later withdrew two of the four patents. On March 23, 2022, the ITC rendered a final determination that no violation of Section 337 has occurred. Philips did not appeal and elected to resume litigation with its case in federal court. Philips seeks unspecified damages and an injunction against HP, and the prior stay has been lifted. On August 10, 2023, HP filed a motion for summary judgment of indefiniteness for all asserted claims.
Caltech Patent Litigation. On November 11, 2020, the California Institute of Technology (“Caltech”) filed a complaint against HP for patent infringement in the federal court for the Western District of Texas. On March 19, 2021, Caltech filed an amendment to this same complaint. The complaint as amended alleges infringement of five of Caltech’s patents, U.S. Patent Nos. 7,116,710; 7,421,032; 7,716,552; 7,916,781; and 8,284,833. The accused products are HP commercial and consumer PCs as well as wireless printers that comply with the IEEE 802.11n, 802.11ac, and/or 802.11ax standards. Caltech seeks unspecified damages and other relief. In August 2021, the court stayed the case pending the decision in related cases brought by Caltech against Apple and Broadcom. On November 6, 2023, the court issued an order maintaining the stay of all discovery and deadlines pending discovery relating to whether Caltech has standing to bring suit with respect to the asserted patents and the court’s resolution of that issue. A hearing concerning Caltech’s standing is scheduled for May 2024.
York County on behalf of the County of York Retirement Fund v. HP Inc., et al., and related proceedings. On November 5, 2020, York County, on behalf of the County of York Retirement Fund, filed a putative class action complaint against HP, Dion Weisler, and Catherine Lesjak in federal court in the Northern District of California. The court appointed Maryland Electrical Industry Pension Fund as Lead Plaintiff. Lead Plaintiff filed a consolidated complaint, which additionally names as defendants Enrique Lores and Richard Bailey. The complaint alleges, among other things, that from November 5, 2015 to June 21, 2016, HP and the named current and former officers violated Sections 10(b) and 20(a) of the Exchange Act by concealing material information and making false statements about HP’s printing supplies business. Plaintiffs seek compensatory damages and other relief. HP and the named officers filed a motion to dismiss the complaint for failure to state a claim upon which relief can be granted. On March 3, 2022, the court granted the motion to dismiss with prejudice. Plaintiffs appealed the decision. On April 11, 2023, the appellate court reversed the district court’s decision and remanded the case to the district court for further proceedings consistent with the appellate opinion, including consideration of HP’s other arguments for dismissal. On June 27, 2023, the district court issued an order setting the briefing schedule for a renewed motion to dismiss. On May 17, 2021, stockholder Scott Franklin filed a derivative complaint against certain current and former officers and directors in federal court in the District of Delaware. Plaintiff purports to bring the action on behalf of HP, which he has named as a nominal defendant, and he makes substantially the same factual allegations as in the York County securities complaint, bringing claims for breach of fiduciary duty and violations of securities laws. The derivative plaintiff seeks compensatory damages, governance reforms, and other relief. By court order following stipulations by the parties, the case was transferred to the Northern District of California, and the case was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. On January 13, 2022, stockholder Gerald Lovoi filed a derivative complaint in federal court in the Northern District of California against the same current and former officers and directors named in the Franklin action. The complaint alleges the same basic claims based on the same alleged conduct as the Franklin action and seeks similar relief. By stipulation of the parties, the Lovoi action was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. Both derivative actions will remain stayed while the district court considers on remand HP’s other arguments for dismissal.
Legal Proceedings re Authentication of Supplies. Since 2016, HP has from time to time been named in civil litigation, or been the subject of government investigations, involving supplies authentication protocols used in certain HP printers in multiple geographies, including but not limited to the United States, Italy, Israel, the Netherlands, Australia and New Zealand. The supplies authentication protocols are often referred to as Dynamic Security. The core allegations in these proceedings claim misleading or inadequate consumer notifications and permissions pertaining to the use of Dynamic Security, the installation of firmware updates, or the potential inability of cartridges with clone chips or circuitry to work in HP printers with Dynamic Security. Plaintiffs base or have based their claims on various legal theories, including but not limited to unfair competition, computer trespass, and similar statutory claims. Among other relief, Plaintiffs have sought or seek money damages and in certain cases have or may seek injunctive relief against the use or operation of Dynamic Security or relief requiring interoperability. If HP is not successful in its defense of these cases or investigations, it could be subject to damages, penalties, significant settlement demands, or injunctive relief that may be costly or may disrupt operations. Certain of these proceedings in Italy, the Netherlands, Israel, Australia and New Zealand have been resolved, have concluded, or have concluded subject only to HP’s pending appeal. Civil litigation filed by Digital Revolution B.V. (trading as 123Inkt) against HP Nederlands B.V., et al. (Netherlands) in March 2020, including its competition claim, remains pending. Both parties have appealed. In addition, two putative class actions have been filed against HP in federal court in California, in December 2020, April 2022, and one in federal court in Illinois, in January 2024, arising out of the use of Dynamic Security firmware updates in HP Laserjet printers, in HP Inkjet printers, and in both, respectively. Plaintiffs in these cases seek compensatory damages, restitution, injunctive relief against alleged unfair and anticompetitive business practices, and other relief. In the case directed to Laserjet printers, plaintiffs filed a motion for class certification, and, on December 8, 2023, the court entered an order denying in full plaintiffs’ request to certify a damages class and granting certification of a narrowed injunctive relief class composed of those who did not see HP’s disclosures. In its order, the court declined at this juncture to resolve the merits of the sufficiency of HP’s disclosures. The other cases are in their early stages.
Autonomy-Related Legal Proceedings.
As the result of an internal investigation, HP obtained information about certain accounting improprieties, disclosure failures and misrepresentations at Autonomy that occurred before and in connection with its 2011 acquisition of Autonomy. On April 17, 2015, four former HP subsidiaries that became subsidiaries of Hewlett Packard Enterprise at the time of the Separation (Autonomy Corporation Limited, Hewlett Packard Vision BV, Autonomy Systems, Limited, and Autonomy, Inc.) initiated civil proceedings in the U.K. High Court of Justice against two members of Autonomy’s former management, Michael Lynch and Sushovan Hussain, for breach of their fiduciary duties in causing Autonomy group companies to engage in improper transactions and accounting practices. The claims seek more than $5 billion in damages. Messrs. Lynch and Hussain filed defenses and Mr. Lynch filed a counterclaim seeking $160 million in damages for alleged misstatements regarding Lynch. Trial concluded in January 2020. On May 17, 2022, the court issued its final judgment, finding that HP succeeded on substantially all claims and that Messrs. Lynch and Hussein engaged in fraud, and dismissing Mr. Lynch’s counterclaim. The court deferred its damages ruling to a later, separate judgment to be issued after further proceedings, which began on February 12, 2024, but indicated that damages awarded may be substantially less than is claimed. Litigation is unpredictable, and there can be no assurance that HP will recover damages or as to how any award of damages will compare with the amount claimed. The amount ultimately awarded, if any, would be recorded in the period received. No adjustment has been recorded in the financial statements in relation to this potential award. Pursuant to the terms of the separation and distribution agreement, HP and Hewlett Packard Enterprise will share equally in any recovery. In addition, Messrs. Hussein and Lynch, and Stephen Chamberlain, former VP of Finance of Autonomy, were each indicted on federal criminal charges in the Northern District of California. On April 30, 2018, a jury found Mr. Hussein guilty of conspiracy to commit wire fraud, securities fraud, and multiple counts of wire fraud, and that judgment was affirmed on appeal in August 2020. Messrs. Lynch and Chamberlain are set to face trial on charges of conspiracy to commit wire fraud, and multiple counts of wire fraud on March 18, 2024. HP is continuing to cooperate with the ongoing enforcement actions.
Nokia Patent Litigation. On October 31, 2023, Nokia filed a complaint for patent infringement against HP in federal court for the District of Delaware asserting ten patents and filed two companion complaints with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP, asserting seven of the ten patents asserted in the federal court case. The complaints allege that HP products that are compliant with certain video coding technology standards, including Advanced Video Coding (H.264) or High Efficiency Video Coding (H.265) standards, infringe Nokia’s patents. In November 2023, the ITC instituted investigations on Nokia’s complaints. On December 11, 2023, HP filed counterclaims against Nokia in the Delaware action, including claims that Nokia violated its commitments to license standard-essential patents on fair, reasonable, and non-discriminatory (“FRAND”) terms, and seeking a court determination of the proper FRAND rate. Nokia’s patent litigation against HP also includes a lawsuit filed in November 2023 against HP and six of its subsidiaries in the European Unified Patent Court in Germany, 2 lawsuits filed in November 2023 but served in January 2024 against HP and its German subsidiary in state court in Munich, Germany, and a lawsuit filed on December 1, 2023, against a subsidiary, HP Brasil Indústria e Comércio de Equipamentos Eletrônicos Ltda. (“HP Brazil”), in the state court in Rio de Janeiro in Brazil. In Brazil, Nokia alleged that HP’s products contain “skip mode” technology compatible with H.264 video standards that infringes one of Nokia’s Brazilian patents. On December 4, 2023, before HP had received service of the lawsuit, the court granted Nokia an ex parte preliminary injunction against HP Brazil’s commercialization of such products in Brazil. HP has appealed the injunction and asked the appellate court to suspend its enforcement. If the court does not do so, the injunction in Brazil will take effect and remain in place unless overturned on appeal, until the state court revokes or modifies it, or the case is resolved. If HP is not successful in its defenses, it may be subject to injunctions, orders to recall products in Germany and other EU countries, or licensing demands to avoid potential disruptions to its business. On January 31, 2024, HP Brazil filed the non-infringement defense and a patent nullity action against Nokia. Given the procedural posture and nature of these cases, including proceedings that are in their early stages and have significant factual and legal issues to be resolved, HP is unable to make a reasonable estimate of the potential loss or range of losses that may arise from these matters.
R2 Semiconductor Litigation. In November 2022, R2 Semiconductor, Inc. (“R2”) filed a lawsuit in the Dusseldorf Regional Court in Germany against Intel Deutschland GmbH, HP Deutschland GmbH and certain other Intel customers. R2 asserts one European patent is infringed by HP’s products that contain certain Intel processors. R2 seeks an injunction prohibiting the sale of the alleged infringing products. Intel is indemnifying HP subject to certain limitations in the parties’ agreement. The Dusseldorf Regional Court conducted a trial on December 7, 2023 and issued an adverse judgment on February 7, 2024. The Court’s judgment imposes an injunction prohibiting sales of the accused products in Germany, an order to stop all other infringing actions, and an order to issue a communication to commercial customers recalling the relevant products sold since March 5, 2020, which could take effect upon notice of R2’s payment of the required sureties and remain in place unless stayed or overturned on appeal or the parties reach an agreement. On February 8, 2024, HP filed an appeal and request for a stay of the judgment pending appeal. Given the procedural posture, the nature of the case, and the relationship with Intel, HP is unable to make a reasonable estimate of the potential loss or range of losses that might arise from this lawsuit and that would not be indemnifiable by Intel.
Litigation with Access Advance Patent Pool regarding video codecs. Access Advance LLC (“Access Advance”) is an independent licensing administrator formed to license allegedly essential patents for standards-based video codecs, which it licenses through various licensing pools. In late 2023, members of Access Advance’s HEVC Advance patent pool launched a patent litigation campaign against HP in Germany and Europe. To date, three pool members, Dolby, Mitsubishi Electric (“Mitsubishi”) and Konikijke Philips N.V. (“Philips”) have each filed patent infringement lawsuits against HP and various affiliates. Specifically, Dolby filed a lawsuit against HP and 14 affiliates in the new Unified Patent Court (UPC) in Düsseldorf, and Mitsubishi and Philips each filed a lawsuit against HP and two affiliates in the State Court in Munich, Germany. The complaints allege that HP products that are compliant with the High Efficiency Video Coding (H.265) standard infringe the pool members' respective patents, seek an injunction, and allege that HP has failed to act as a willing licensee of HEVC essential patents based on HP's negotiations with Access Advance. If HP is not successful in its defenses in these suits, it may be subject to injunctions, recall orders, and claims for damages or face licensing demands to avoid potential disruptions to its business. Given the procedural posture and nature of these cases, which are in their early stages and have significant factual and legal issues to be resolved, HP is unable to make a reasonable estimate of the potential loss or range of losses that may arise from these matters.
Environmental
    HP is, and may become a party to, proceedings brought by U.S., state, or other governmental entities or private third parties under federal, state, local, or foreign environmental laws, including the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), known as “Superfund,” or state laws similar to CERCLA. HP is also conducting environmental investigations or remediation at several current or former operating sites and former disposal sites pursuant to administrative orders or consent agreements with environmental agencies.
XML 44 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Guarantees, Indemnifications and Warranties
 3 Months Ended
Jan. 31, 2024
Guarantees [Abstract]  
Guarantees, Indemnifications and Warranties Guarantees, Indemnifications and Warranties
Guarantees
In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.
Cross-Indemnifications with Hewlett Packard Enterprise
On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 12, “Litigation and Contingencies”.
Indemnifications  
In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.
HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.
Warranties
HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.
HP’s aggregate product warranty liabilities and changes were as follows:
 Three months ended January 31, 2024
 In millions
Balance at beginning of period$706 
Accruals for warranties issued183 
Adjustments related to pre-existing warranties (including changes in estimates)19 
Settlements made (in cash or in kind)(229)
Balance at end of period$679 
XML 45 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Pay vs Performance Disclosure    
Net earnings $ 622 $ 469
XML 46 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended
Jan. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 47 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Basis of Presentation (Policies)
 3 Months Ended
Jan. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying Consolidated Condensed Financial Statements of HP and its wholly-owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2023 in HP’s Annual Report on Form 10-K, filed on December 18, 2023. The Consolidated Condensed Balance Sheet for October 31, 2023 was derived from audited financial statements.
Principles of Consolidation
Principles of Consolidation
The Consolidated Condensed Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.
Reclassifications
Reclassifications
HP has reclassified certain prior-year amounts to conform to the current-year presentation.
Use of Estimates
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Adopted Accounting Pronouncements
In September 2022, the Financial Accounting Standards Board (“FASB”) issued guidance that enhances the transparency about the use of supplier finance programs. Under the new guidance, companies that use a supplier finance program in connection with the purchase of goods or services are required to disclose information about those programs to allow users of financial statements to understand the nature, activity during the period, changes from period to period, and potential magnitude. HP adopted this guidance in the first quarter of fiscal year 2024, except for the disclosure on roll forward information which will be adopted in fiscal year 2025, in line with the effective adoption dates prescribed by the FASB. See Note 6, “Supplementary Financial Information,” for additional disclosure related to HP’s supplier finance programs.
Recently Issued Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In November 2023, the FASB issued guidance that updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2025 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
Segment Information
HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges and amortization of intangible assets.
Employer Contributions and Funding Policy
Employer Contributions and Funding Policy
HP’s policy is to fund its pension plans so that it makes at least the minimum contribution required by local government, funding and taxing authorities.
Taxes on Earnings HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Consolidated Condensed Statements of Earnings.
Transfers and Servicing Trade Receivables Policy
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Condensed Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Condensed Balance Sheets. The recourse obligations as of January 31, 2024 and October 31, 2023 were not material.
Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
Fair Value Hierarchy
HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
Level 3—Unobservable inputs for the asset or liability.
The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.
Valuation Techniques
Cash Equivalents and Investments: HP holds time deposits, money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.
Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 8, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.
Other Fair Value Disclosures
Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Consolidated Condensed Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $9.3 billion as compared to its carrying amount of $9.7 billion at January 31, 2024. The fair value of HP’s short- and long-term debt was $8.5 billion as compared to its carrying value of $9.5 billion at October 31, 2023. If measured at fair value in the Consolidated Condensed Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.
Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Consolidated Condensed Balance Sheets, the carrying amounts approximate fair value due to their short maturities. If measured at fair value in the Consolidated Condensed Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.
Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Consolidated Condensed Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.
Cash Equivalents and Available-for-Sale Investments All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents.
Non-Marketable Equity Securities Investments Non-marketable equity securities in privately held companies are included in Other non-current assets in the Consolidated Condensed Balance Sheets.
Derivative Instruments
Derivative Instruments
HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates from contractually established thresholds. The Company includes gross collateral posted and received in other current assets and other current liabilities in the Consolidated Condensed Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $119 million and $91 million as of January 31, 2024 and as of October 31, 2023, respectively, all of which were fully collateralized within two business days.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of January 31, 2024 and October 31, 2023.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts, option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted net revenue, cost of revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
Offsetting of Derivatives Instruments
Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements.
Net Earnings Per Share
HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.
Litigation and Contingencies
HP is involved in lawsuits, claims, investigations and proceedings, including those identified below, consisting of IP, commercial, securities, employment, employee benefits and environmental matters that arise in the ordinary course of business. HP accrues a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. HP believes it has recorded adequate provisions for any such matters and, as of January 31, 2024, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.
Guarantees, Indemnifications and Warranties
Guarantees
In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.
Cross-Indemnifications with Hewlett Packard Enterprise
On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 12, “Litigation and Contingencies”.
Indemnifications  
In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.
HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.
Warranties
HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.
XML 48 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information (Tables)
 3 Months Ended
Jan. 31, 2024
Segment Reporting [Abstract]  
Schedule of Reconciliation of Revenue from Segment Operating Results to HP Consolidated Results
Segment Operating Results and the reconciliation to HP consolidated results were as follows:
 Three months ended January 31
 20242023
In millions
Net revenue:
Commercial PS$6,045 $6,382 
Consumer PS2,764 2,803 
Personal Systems8,809 9,185 
Supplies2,863 2,857 
Commercial Printing1,227 1,388 
Consumer Printing285 367 
Printing4,375 4,612 
Corporate Investments2 1 
Total segment net revenue13,186 13,798 
Other(1)— 
Total net revenue$13,185 $13,798 
Earnings before taxes:
Personal Systems$537 $475 
Printing872 870 
Corporate Investments(37)(33)
Total segment earnings from operations1,372 1,312 
Corporate and unallocated costs and other(89)(92)
Stock-based compensation expense(177)(167)
Restructuring and other charges(63)(141)
Acquisition and divestiture charges(27)(84)
Amortization of intangible assets(81)(85)
Interest and other, net(142)(181)
Total earnings before taxes$793 $562 
Schedule of Reconciliation of Operating Profit (Loss) from Segment Operating Results to HP Consolidated Results
Segment Operating Results and the reconciliation to HP consolidated results were as follows:
 Three months ended January 31
 20242023
In millions
Net revenue:
Commercial PS$6,045 $6,382 
Consumer PS2,764 2,803 
Personal Systems8,809 9,185 
Supplies2,863 2,857 
Commercial Printing1,227 1,388 
Consumer Printing285 367 
Printing4,375 4,612 
Corporate Investments2 1 
Total segment net revenue13,186 13,798 
Other(1)— 
Total net revenue$13,185 $13,798 
Earnings before taxes:
Personal Systems$537 $475 
Printing872 870 
Corporate Investments(37)(33)
Total segment earnings from operations1,372 1,312 
Corporate and unallocated costs and other(89)(92)
Stock-based compensation expense(177)(167)
Restructuring and other charges(63)(141)
Acquisition and divestiture charges(27)(84)
Amortization of intangible assets(81)(85)
Interest and other, net(142)(181)
Total earnings before taxes$793 $562 
XML 49 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring and Other Charges (Tables)
 3 Months Ended
Jan. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Activities by Plan
HP’s restructuring activities summarized by plan were as follows:
Fiscal 2023 Plan
Severance and EERNon-labor
Other prior-year plans(1)
Total
In millions
Accrued balance as of October 31, 2023$88 $18 $2 $108 
Charges43 2 3 48 
Cash payments(63)(6)(3)(72)
Non-cash and other adjustments2 — (2)— 
Accrued balance as of January 31, 2024$70 $14 $— $84 
Total costs incurred to date as of January 31, 2024$445 $43 $869 $1,357 
Reflected in Consolidated Condensed Balance Sheets
Other current liabilities$70 $3 $— $73 
Other non-current liabilities$— $11 $— $11 
Accrued balance as of October 31, 2022$— $— $32 $32 
Charges122 9 — 131 
Cash payments(53)(4)(25)(82)
Non-cash and other adjustments(2)(5)1 (6)
Accrued balance as of January 31, 2023$67 $— $8 $75 
(1)     Primarily includes the fiscal 2020 plan along with other legacy plans, all of which are substantially complete. HP does not expect any further material activity associated with these plans.
XML 50 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Retirement and Post-Retirement Benefit Plans (Tables)
 3 Months Ended
Jan. 31, 2024
Retirement Benefits [Abstract]  
Schedule of Components of Pension and Post-Retirement Benefit (Credit)
The components of HP’s pension and post-retirement benefit (credit) cost recognized in the Consolidated Condensed Statements of Earnings were as follows:
 Three months ended January 31
 U.S. Defined Benefit PlansNon-U.S. Defined Benefit PlansPost- Retirement Benefit Plans
 202420232024202320242023
 In millions
Service cost$— $— $9 $9 $— $— 
Interest cost57 54 12 10 4 4 
Expected return on plan assets(61)(65)(13)(13)(4)(3)
Amortization and deferrals:
Actuarial loss (gain)7 5 — 1 (4)(4)
Prior service cost (credit)— — 2 1 (3)(3)
Net periodic benefit (credit) cost3 (6)10 8 (7)(6)
Settlement loss — — — 1 — — 
Total periodic benefit (credit) cost$3 $(6)$10 $9 $(7)$(6)
XML 51 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information (Tables)
 3 Months Ended
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents
Cash, cash equivalents and restricted cash
 As of
 January 31, 2024October 31, 2023
 In millions
Cash and cash equivalents$2,263 $3,107 
Restricted cash(1)
154 125 
$2,417 $3,232 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Schedule of Restricted Cash
Cash, cash equivalents and restricted cash
 As of
 January 31, 2024October 31, 2023
 In millions
Cash and cash equivalents$2,263 $3,107 
Restricted cash(1)
154 125 
$2,417 $3,232 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes
The allowance for credit losses related to accounts receivable and changes were as follows:
 Three months ended January 31, 2024
 In millions
Balance at beginning of period$93 
Benefit of allowance for credit losses(6)
Deductions, net of recoveries(3)
Balance at end of period$84 
Schedule of Trade Receivables Sold and Cash Received
The following is a summary of the activity under these arrangements:
Three months ended January 31
 2024 2023
 In millions
Balance at beginning of period(1)
$141 $185 
Trade receivables sold3,298 3,679 
Cash receipts(3,232)(3,753)
Foreign currency and other5 17 
Balance at end of period(1)
$212 $128 
(1)    Amounts outstanding from third parties reported in Accounts receivable in the Consolidated Condensed Balance Sheets.
Schedule of Inventory
Inventory
 As of
 January 31, 2024October 31, 2023
 In millions
Finished goods$3,603 $3,930 
Purchased parts and fabricated assemblies3,325 2,932 
$6,928 $6,862 
Schedule of Other Current Assets
Other Current Assets
 As of
 January 31, 2024October 31, 2023
 In millions
Supplier and other receivables$1,419 $1,349 
Prepaid and other current assets1,376 1,445 
Value-added taxes receivable914 852 
$3,709 $3,646 
Schedule of Property, Plant and Equipment, Net
Property, Plant and Equipment, Net
 As of
 January 31, 2024October 31, 2023
 In millions
Land, buildings and leasehold improvements$2,348 $2,332 
Machinery and equipment, including equipment held for lease5,452 5,384 
7,800 7,716 
Accumulated depreciation(4,993)(4,889)
$2,807 $2,827 
Schedule of Other Non-Current Assets
Other Non-Current Assets
 As of
 January 31, 2024October 31, 2023
 In millions
Deferred tax assets$3,230 $3,155 
Intangible assets1,519 1,593 
Right-of-use assets1,165 1,188 
Deposits and prepaid412 427 
Prepaid pension and post-retirement benefit assets395 393 
Other850 853 
$7,571 $7,609 
Schedule of Other Current Liabilities
Other Current Liabilities
 As of
 January 31, 2024October 31, 2023
 In millions
Sales and marketing programs$2,920 $3,053 
Deferred revenue1,424 1,424 
Other accrued taxes1,071 994 
Employee compensation and benefit648 1,046 
Warranty572 569 
Operating lease liabilities459 430 
Tax liability282 217 
Other2,867 2,479 
$10,243 $10,212 
Schedule of Other Non-Current Liabilities
Other Non-Current Liabilities
 As of
 January 31, 2024October 31, 2023
In millions
Deferred revenue$1,373 $1,324 
Tax liability926 904 
Operating lease liabilities815 825 
Pension, post-retirement, and post-employment liabilities546 546 
Deferred tax liability31 44 
Other637 688 
$4,328 $4,331 
Schedule of Interest and Other, Net
Interest and Other, Net
 Three months ended January 31
 2024 2023
 In millions
Interest expense on borrowings$(116)$(143)
Factoring costs(40)(32)
Loss on extinguishment of debt— (8)
Non-operating retirement-related credits4 11 
Other, net10 (9)
$(142)$(181)
Schedule of Net Revenue by Region
Net Revenue by Region
Three months ended January 31
 2024 2023
 In millions
Americas$5,408 $5,747 
Europe, Middle East and Africa4,668 4,636 
Asia-Pacific and Japan3,109 3,415 
Total net revenue$13,185 $13,798 
XML 52 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value (Tables)
 3 Months Ended
Jan. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:
 As of January 31, 2024As of October 31, 2023
 Fair Value Measured UsingFair Value Measured Using
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
 In millions
Assets:        
Cash Equivalents:        
Corporate debt$— $502 $— $502 $— $589 $— $589 
Government debt(1)
1,029 — — 1,029 1,900 — — 1,900 
Available-for-Sale Investments:
Financial institution instruments— 3 — 3 — 3 — 3 
Marketable securities and mutual funds
43 49 — 92 33 45 — 78 
Derivative Instruments:     
Foreign currency contracts— 212 — 212 — 489 — 489 
Other derivatives— 2 — 2 — — — — 
Total assets$1,072 $768 $— $1,840 $1,933 $1,126 $— $3,059 
Liabilities:        
Derivative Instruments:        
Interest rate contracts$— $43 $— $43 $— $58 $— $58 
Foreign currency contracts— 248 — 248 — 212 — 212 
Other derivatives— — — — — 2 — 2 
Total liabilities$— $291 $— $291 $— $272 $— $272 
(1)    Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds. Money market funds invested in government debt and traded in active markets are included in Level 1.
XML 53 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments (Tables)
 3 Months Ended
Jan. 31, 2024
Investments, All Other Investments [Abstract]  
Schedule of Cash Equivalents and Available-for-Sale Investments
Cash Equivalents and Available-for-Sale Investments
 As of January 31, 2024As of October 31, 2023
 CostGross Unrealized GainGross Unrealized LossFair ValueCostGross Unrealized GainGross Unrealized LossFair Value
 In millions
Cash Equivalents:        
Corporate debt$502 $— $— $502 $589 $— $— $589 
Government debt1,029 — — 1,029 1,900 — — 1,900 
Total cash equivalents1,531 — — 1,531 2,489 — — 2,489 
Available-for-Sale Investments:     
Financial institution instruments3 — — 3 3 — — 3 
Marketable securities and mutual funds
40 52 — 92 40 38 — 78 
Total available-for-sale investments43 52 — 95 43 38 — 81 
Total cash equivalents and available-for-sale investments$1,574 $52 $— $1,626 $2,532 $38 $— $2,570 
Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities
Contractual maturities of investments in available-for-sale debt securities were as follows:
 As of January 31, 2024
 Amortized CostFair Value
 In millions
Due in one year$3 $3 
Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:
 As of January 31, 2024As of October 31, 2023
 Outstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current LiabilitiesOutstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current Liabilities
 In millions
Derivatives designated as hedging instruments     
Fair value hedges:     
Interest rate contracts$750 $— $— $— $43 $750 $— $— $— $58 
Cash flow hedges:
Foreign currency contracts15,282 173 28 182 59 15,278 410 70 147 52 
Total derivatives designated as hedging instruments16,032 173 28 182 102 16,028 410 70 147 110 
Derivatives not designated as hedging instruments    
Foreign currency contracts3,926 11 — 7 — 4,446 9 — 13 — 
Other derivatives130 2 — — — 125 — — 2 — 
Total derivatives not designated as hedging instruments4,056 13 — 7 — 4,571 9 — 15 — 
Total derivatives$20,088 $186 $28 $189 $102 $20,599 $419 $70 $162 $110 
Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Assets As of January 31, 2024 and October 31, 2023, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Condensed Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
 Gross Amount
Recognized		Gross Amount
Offset		Net Amount
Presented		Derivatives
Financial
Collateral		 Net Amount
 In millions
As of January 31, 2024       
Derivative assets$214 $— $214 $170 $40 (1)$4 
Derivative liabilities$291 $— $291 $170 $109 (2)$12 
As of October 31, 2023       
Derivative assets$489 $— $489 $178 $291 (1)$20 
Derivative liabilities$272 $— $272 $178 $89 (2)$5 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Liabilities As of January 31, 2024 and October 31, 2023, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Condensed Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
 Gross Amount
Recognized		Gross Amount
Offset		Net Amount
Presented		Derivatives
Financial
Collateral		 Net Amount
 In millions
As of January 31, 2024       
Derivative assets$214 $— $214 $170 $40 (1)$4 
Derivative liabilities$291 $— $291 $170 $109 (2)$12 
As of October 31, 2023       
Derivative assets$489 $— $489 $178 $291 (1)$20 
Derivative liabilities$272 $— $272 $178 $89 (2)$5 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:
Derivative InstrumentHedged ItemLocationYearTotal amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recordedGain/(loss) recognized in earnings on derivative instrumentsGain/(loss) recognized in earnings on hedged item
In millions
Three months ended January 31
Interest rate contractFixed-rate debtInterest and other, net2024$(142)$15 $(15)
2023$(181)$14 $(14)
Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income
The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:
Three months ended January 31
20242023
In millions
Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:
Foreign currency contracts$(162)$(623)
Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings
The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
Total amounts of income/(expense) line items in the statement of financial performance in which the effects of cash flow hedges are recordedGain/(loss) reclassified from Accumulated 
other comprehensive (loss) income into earnings
Three months ended January 31Three months ended January 31
2024202320242023
In millions
Net revenue$13,185 $13,798 $199 $386 
Cost of revenue(10,297)(11,011)(40)(54)
Operating expenses(1,953)(2,044)(3)(1)
Interest and other, net(142)(181)3 3 
Total$159 $334 
Schedule of Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings
The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Condensed Statements of Earnings as follows:
Gain/(loss) recognized in earnings on derivative instrument
 Three months ended January 31
 Location20242023
  In millions
Foreign currency contractsInterest and other, net$1 $(44)
Other derivativesInterest and other, net4 6 
Total $5 $(38)
XML 54 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Borrowings (Tables)
 3 Months Ended
Jan. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Notes Payable and Short-Term Borrowings
Notes Payable and Short-Term Borrowings
 As of January 31, 2024As of October 31, 2023
 Amount
Outstanding		Weighted-Average
Interest Rate		Amount
Outstanding		Weighted-Average
Interest Rate
 In millions
Commercial Paper$100 5.5 %$— — %
Current portion of long-term debt193 5.9 %179 6.0 %
Notes payable to banks, lines of credit and other66 1.2 %51 1.0 %
$359  $230  
Schedule of Long-Term Debt
Long-Term Debt
 As of
 January 31, 2024October 31, 2023
 In millions
U.S. Dollar Global Notes(1)
  
$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041
$1,199 $1,199 
$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025
1,149 1,149 
$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027
999 999 
$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030
503 503 
$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026
521 521 
$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031(2)
997 997 
$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029
999 999 
$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032
676 676 
$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028
899 899 
$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033
1,097 1,097 
$500 issued at par at a price of 100% at 4.75%, due March 2029
3 3 
9,042 9,042 
Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030
549 506 
Fair value adjustment related to hedged debt(43)(58)
Unamortized debt issuance cost(54)(57)
Current portion of long-term debt(193)(179)
Total long-term debt$9,301 $9,254 
(1)HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.
(2)HP allocated an amount equal to the net proceeds to finance or refinance, in whole or in part, environmentally and socially responsible eligible projects in the following eight areas: renewable energy; green buildings; energy efficiency; clean transportation; pollution prevention and control; eco-efficient and/or circular economy products, production technologies and processes; environmentally sustainable management of living natural resources and land use; and socioeconomic advancement and empowerment.
XML 55 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Deficit (Tables)
 3 Months Ended
Jan. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Taxes Related to Other Comprehensive Income (Loss)
Taxes related to Other Comprehensive Income (Loss)
 Three months ended January 31
 20242023
 In millions
Tax effect on change in unrealized components of available-for-sale debt securities:  
Tax provision on unrealized gains arising during the period$— $(1)
Tax effect on change in unrealized components of cash flow hedges: 
Tax benefit on unrealized losses arising during the period36 106 
Tax provision on gains reclassified into earnings32 78 
68 184 
Tax effect on change in unrealized components of defined benefit plans:  
Tax benefit on losses arising during the period2 — 
2 — 
Tax benefit on other comprehensive loss$70 $183 
Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes
Changes and reclassifications related to Other Comprehensive Loss, net of taxes
 Three months ended January 31
 20242023
 In millions
Other comprehensive loss, net of taxes:
Change in unrealized components of available-for-sale debt securities:
Unrealized gains arising during the period$4 $3 
Change in unrealized components of cash flow hedges:
Unrealized losses arising during the period(126)(517)
Gains reclassified into earnings(127)(256)
(253)(773)
Change in unrealized components of defined benefit plans:
Losses arising during the period(8)(1)
Amortization of actuarial loss and prior service benefit(1)
2 — 
Curtailments, settlements and other— 1 
(6)— 
Change in cumulative translation adjustment20 29 
Other comprehensive loss, net of taxes$(235)$(741)
(1)These components are included in the computation of net pension and post-retirement benefit (credit) charges in Note 4, “Retirement and Post-Retirement Benefit Plans”.
Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes
The components of Accumulated other comprehensive loss, net of taxes and changes were as follows:
 Three months ended January 31, 2024
 Net unrealized
gains (losses) on
available-for-sale debt
securities		Net unrealized gains (losses) on cash
flow hedges		Unrealized
components
of defined
benefit plans		Change in cumulative
translation
adjustment		Accumulated
other
comprehensive loss
 In millions
Balance at beginning of period$7 $230 $(437)$(23)$(223)
Other comprehensive gains (losses) before reclassifications4 (126)(8)20 (110)
Reclassifications of gain into earnings— (127)2 — (125)
Balance at end of period$11 $(23)$(443)$(3)$(458)
XML 56 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share (Tables)
 3 Months Ended
Jan. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Reconciliation of the Number of Shares Used for Basic and Diluted Net EPS Calculations
A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:
 Three months ended January 31
 20242023
 In millions, except per share amounts
Numerator:
Net earnings$622 $469 
Denominator:
Weighted-average shares used to compute basic net EPS995 989 
Dilutive effect of employee stock plans7 7 
Weighted-average shares used to compute diluted net EPS1,002 996 
Net earnings per share:
Basic$0.63 $0.47 
Diluted$0.62 $0.47 
Anti-dilutive weighted-average stock-based compensation awards(1)
6 7 
(1)HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent unrecognized compensation cost.
XML 57 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Guarantees, Indemnifications and Warranties (Tables)
 3 Months Ended
Jan. 31, 2024
Guarantees [Abstract]  
Schedule of Aggregate Product Warranty Liabilities and Changes
HP’s aggregate product warranty liabilities and changes were as follows:
 Three months ended January 31, 2024
 In millions
Balance at beginning of period$706 
Accruals for warranties issued183 
Adjustments related to pre-existing warranties (including changes in estimates)19 
Settlements made (in cash or in kind)(229)
Balance at end of period$679 
XML 58 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information - Narrative (Details)
 3 Months Ended
Jan. 31, 2024
segment
Segment Reporting [Abstract]  
Number of reportable segments 3
XML 59 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Net revenue:    
Total net revenue $ 13,185 $ 13,798
Segment Reporting Information, Revenue for Reportable Segment [Abstract]    
Total segment earnings from operations 935 743
Restructuring and other charges (63) (141)
Acquisition and divestiture charges (27) (84)
Amortization of intangible assets (81) (85)
Interest and other, net (142) (181)
Earnings before taxes 793 562
Operating Segments    
Net revenue:    
Total net revenue 13,186 13,798
Segment Reporting Information, Revenue for Reportable Segment [Abstract]    
Total segment earnings from operations 1,372 1,312
Other    
Net revenue:    
Total net revenue (1) 0
Segment Reporting Information, Revenue for Reportable Segment [Abstract]    
Stock-based compensation expense (177) (167)
Restructuring and other charges (63) (141)
Acquisition and divestiture charges (27) (84)
Amortization of intangible assets (81) (85)
Interest and other, net (142) (181)
Corporate and unallocated costs and other    
Segment Reporting Information, Revenue for Reportable Segment [Abstract]    
Corporate and unallocated costs and other (89) (92)
Personal Systems | Operating Segments    
Net revenue:    
Total net revenue 8,809 9,185
Segment Reporting Information, Revenue for Reportable Segment [Abstract]    
Total segment earnings from operations 537 475
Printing | Operating Segments    
Net revenue:    
Total net revenue 4,375 4,612
Segment Reporting Information, Revenue for Reportable Segment [Abstract]    
Total segment earnings from operations 872 870
Corporate Investments | Operating Segments    
Net revenue:    
Total net revenue 2 1
Segment Reporting Information, Revenue for Reportable Segment [Abstract]    
Total segment earnings from operations (37) (33)
Commercial PS | Personal Systems | Operating Segments    
Net revenue:    
Total net revenue 6,045 6,382
Consumer PS | Personal Systems | Operating Segments    
Net revenue:    
Total net revenue 2,764 2,803
Supplies | Printing | Operating Segments    
Net revenue:    
Total net revenue 2,863 2,857
Commercial Printing | Printing | Operating Segments    
Net revenue:    
Total net revenue 1,227 1,388
Consumer Printing | Printing | Operating Segments    
Net revenue:    
Total net revenue $ 285 $ 367
XML 60 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Oct. 31, 2023
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period $ 108 $ 32 $ 32
Charges 48 131  
Cash payments (72) (82)  
Non-cash and other adjustments 0 (6)  
Accrued balance, end of the period 84 75 108
Total costs incurred to date 1,357    
Reflected in Consolidated Condensed Balance Sheets      
Other current liabilities 73    
Other non-current liabilities 11    
Fiscal 2023 Plan | Severance and EER      
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period 88 0 0
Charges 43 122  
Cash payments (63) (53)  
Non-cash and other adjustments 2 (2)  
Accrued balance, end of the period 70 67 88
Total costs incurred to date 445    
Reflected in Consolidated Condensed Balance Sheets      
Other current liabilities 70    
Other non-current liabilities 0    
Fiscal 2023 Plan | Non-labor      
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period 18 0 0
Charges 2 9  
Cash payments (6) (4)  
Non-cash and other adjustments 0 (5)  
Accrued balance, end of the period 14 0 18
Total costs incurred to date 43    
Reflected in Consolidated Condensed Balance Sheets      
Other current liabilities 3    
Other non-current liabilities 11    
Other prior-year plans      
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period 2 32 32
Charges 3 0  
Cash payments (3) (25)  
Non-cash and other adjustments (2) 1  
Accrued balance, end of the period 0 $ 8 $ 2
Total costs incurred to date 869    
Reflected in Consolidated Condensed Balance Sheets      
Other current liabilities 0    
Other non-current liabilities $ 0    
XML 61 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring and Other Charges - Narrative (Details)
employee in Thousands, $ in Millions
 3 Months Ended
Nov. 18, 2022
USD ($)
employee
Jan. 31, 2024
USD ($)
Jan. 31, 2023
USD ($)
Restructuring Cost and Reserve [Line Items]      
Other charges   $ 15 $ 10
Fiscal 2023 Plan | Labor and Non-Labor Actions      
Restructuring Cost and Reserve [Line Items]      
Estimated pre-tax charges $ 1,000    
Fiscal 2023 Plan | Labor Costs      
Restructuring Cost and Reserve [Line Items]      
Estimated pre-tax charges $ 700    
Minimum | Fiscal 2023 Plan      
Restructuring Cost and Reserve [Line Items]      
Expected positions to be eliminated | employee 4    
Maximum | Fiscal 2023 Plan      
Restructuring Cost and Reserve [Line Items]      
Expected positions to be eliminated | employee 6    
XML 62 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Retirement and Post-Retirement Benefit Plans - Schedule of Components of Pension and Post-Retirement Benefit (Credit) (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Post-Retirement Benefit Plans    
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 0 $ 0
Interest cost 4 4
Expected return on plan assets (4) (3)
Amortization and deferrals:    
Actuarial loss (gain) (4) (4)
Prior service cost (credit) (3) (3)
Net periodic benefit (credit) cost (7) (6)
Settlement loss 0 0
Total periodic benefit (credit) cost (7) (6)
U.S. | Defined Benefit Plans    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 0 0
Interest cost 57 54
Expected return on plan assets (61) (65)
Amortization and deferrals:    
Actuarial loss (gain) 7 5
Prior service cost (credit) 0 0
Net periodic benefit (credit) cost 3 (6)
Settlement loss 0 0
Total periodic benefit (credit) cost 3 (6)
Non-U.S. | Defined Benefit Plans    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 9 9
Interest cost 12 10
Expected return on plan assets (13) (13)
Amortization and deferrals:    
Actuarial loss (gain) 0 1
Prior service cost (credit) 2 1
Net periodic benefit (credit) cost 10 8
Settlement loss 0 1
Total periodic benefit (credit) cost $ 10 $ 9
XML 63 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Retirement and Post-Retirement Benefit Plans - Narrative (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Oct. 31, 2023
Defined Benefit Plan Disclosure [Line Items]        
Eligible age with twenty years of service for enhanced early retirement program 55 years      
Restructuring and other charges   $ 48,000 $ 131,000  
Health care coverage extension, enhanced early retirement program, period 36 months      
Maximum retirement medical savings account employer credits $ 12      
Other charges   15,000 $ 10,000  
Special Termination Benefits | Fiscal 2023 Plan        
Defined Benefit Plan Disclosure [Line Items]        
Restructuring and other charges       $ 105,000
Other charges       $ 34,000
Post-Retirement Benefit Plans        
Defined Benefit Plan Disclosure [Line Items]        
Anticipated contributions   3,000    
Contributions to benefit plans   2,000    
Non-U.S. | Defined Benefit Plans        
Defined Benefit Plan Disclosure [Line Items]        
Anticipated contributions   45,000    
Contributions to benefit plans   11,000    
U.S. | Defined Benefit Plans        
Defined Benefit Plan Disclosure [Line Items]        
Anticipated contributions   31,000    
Contributions to benefit plans   $ 6,000    
XML 64 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Taxes on Earnings (Details)
$ in Millions
 3 Months Ended
Jan. 31, 2024
USD ($)
country
Jan. 31, 2023
USD ($)
Income Tax Disclosure [Abstract]    
Effective tax rate (percent) 21.60% 16.60%
Income tax reconciliation other discrete items tax charges (credits)   $ (56)
Tax benefits related to restructuring charges   30
Tax effects related to acquisition and divestiture charges   14
Tax effects related to other tax benefits   12
Unrecognized tax benefits $ 1,200  
Unrecognized tax benefits that would impact effective tax rate 828  
Unrecognized increase in tax benefits change 20  
Penalties and interest accrued $ 105 $ 73
Likelihood of no resolution period 12 months  
Reasonably possible decrease in existing unrecognized tax benefits within the next 12 months $ 39  
Other countries with income tax jurisdiction | country 60  
XML 65 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Jan. 31, 2023
Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 2,263 $ 3,107    
Restricted cash 154 125    
Cash, cash equivalents and restricted cash $ 2,417 $ 3,232 $ 1,769 $ 3,145
XML 66 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details)
$ in Millions
 3 Months Ended
Jan. 31, 2024
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Balance at beginning of period $ 93
Benefit of allowance for credit losses (6)
Deductions, net of recoveries (3)
Balance at end of period $ 84
XML 67 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Trade Receivables Sold and Cash Received [Roll Forward]    
Balance at beginning of period $ 141 $ 185
Trade receivables sold 3,298 3,679
Cash receipts (3,232) (3,753)
Foreign currency and other 5 17
Balance at end of period $ 212 $ 128
XML 68 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Inventory (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Finished goods $ 3,603 $ 3,930
Purchased parts and fabricated assemblies 3,325 2,932
Inventory $ 6,928 $ 6,862
XML 69 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Other Current Assets (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Supplier and other receivables $ 1,419 $ 1,349
Prepaid and other current assets 1,376 1,445
Value-added taxes receivable 914 852
Other current assets $ 3,709 $ 3,646
XML 70 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Property, Plant and Equipment, Net    
Property, plant and equipment, gross $ 7,800 $ 7,716
Accumulated depreciation (4,993) (4,889)
Property, plant and equipment, net 2,807 2,827
Land, buildings and leasehold improvements    
Property, Plant and Equipment, Net    
Property, plant and equipment, gross 2,348 2,332
Machinery and equipment, including equipment held for lease    
Property, Plant and Equipment, Net    
Property, plant and equipment, gross $ 5,452 $ 5,384
XML 71 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Other Non-Current Assets (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Deferred tax assets $ 3,230 $ 3,155
Intangible assets 1,519 1,593
Right-of-use assets $ 1,165 $ 1,188
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other non-current assets Other non-current assets
Deposits and prepaid $ 412 $ 427
Prepaid pension and post-retirement benefit assets 395 393
Other 850 853
Other non-current assets $ 7,571 $ 7,609
XML 72 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Sales and marketing programs $ 2,920 $ 3,053
Deferred revenue 1,424 1,424
Other accrued taxes 1,071 994
Employee compensation and benefit 648 1,046
Warranty $ 572 $ 569
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other accrued liabilities Other accrued liabilities
Operating lease liabilities $ 459 $ 430
Tax liability 282 217
Other 2,867 2,479
Other accrued liabilities $ 10,243 $ 10,212
XML 73 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Deferred revenue $ 1,373 $ 1,324
Tax liability 926 904
Operating lease liabilities $ 815 $ 825
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities Other non-current liabilities
Pension, post-retirement, and post-employment liabilities $ 546 $ 546
Deferred tax liability 31 44
Other 637 688
Other non-current liabilities $ 4,328 $ 4,331
XML 74 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Interest and Other, Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Interest expense on borrowings $ (116) $ (143)
Factoring costs (40) (32)
Loss on extinguishment of debt 0 (8)
Non-operating retirement-related credits 4 11
Other, net 10 (9)
Interest and other, net $ (142) $ (181)
XML 75 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Schedule of Net Revenue by Region (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Disaggregation of Revenue [Line Items]    
Total net revenue $ 13,185 $ 13,798
Americas    
Disaggregation of Revenue [Line Items]    
Total net revenue 5,408 5,747
Europe, Middle East and Africa    
Disaggregation of Revenue [Line Items]    
Total net revenue 4,668 4,636
Asia-Pacific and Japan    
Disaggregation of Revenue [Line Items]    
Total net revenue $ 3,109 $ 3,415
XML 76 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details)
$ in Billions
Jan. 31, 2024
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Remaining performance obligations $ 3.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations 3.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01  
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Remaining performance obligations $ 1.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations period 12 months
Remaining performance obligations $ 1.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-02-01  
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Remaining performance obligations $ 2.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations period
Remaining performance obligations $ 2.1
XML 77 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Contract Liabilities (Narrative) (Details) - USD ($)
$ in Billions
 3 Months Ended
Jan. 31, 2024
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Contract liability $ 2.8 $ 2.7
Revenue recognized $ 0.5  
XML 78 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details) - USD ($)
$ in Billions
Jan. 31, 2024
Oct. 31, 2023
Offsetting [Abstract]    
Payment terms offered by HP 30 days  
Obligations outstanding $ 5.3 $ 6.6
Amounts owed to participating financial institutions $ 0.7 $ 0.9
XML 79 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Assets:    
Cash Equivalents: $ 1,531 $ 2,489
Derivative Instruments: 214 489
Liabilities:    
Derivative Instruments: 291 272
Fair Value Measured on a Recurring Basis    
Assets:    
Total assets 1,840 3,059
Liabilities:    
Total liabilities 291 272
Fair Value Measured on a Recurring Basis | Corporate debt    
Assets:    
Cash Equivalents: 502 589
Fair Value Measured on a Recurring Basis | Government debt    
Assets:    
Cash Equivalents: 1,029 1,900
Fair Value Measured on a Recurring Basis | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 3 3
Fair Value Measured on a Recurring Basis | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 92 78
Fair Value Measured on a Recurring Basis | Foreign currency contracts    
Assets:    
Derivative Instruments: 212 489
Liabilities:    
Derivative Instruments: 248 212
Fair Value Measured on a Recurring Basis | Other derivatives    
Assets:    
Derivative Instruments: 2 0
Liabilities:    
Derivative Instruments: 0 2
Fair Value Measured on a Recurring Basis | Interest rate contracts    
Liabilities:    
Derivative Instruments: 43 58
Fair Value Measured on a Recurring Basis | Level 1    
Assets:    
Total assets 1,072 1,933
Liabilities:    
Total liabilities 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Corporate debt    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Government debt    
Assets:    
Cash Equivalents: 1,029 1,900
Fair Value Measured on a Recurring Basis | Level 1 | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 43 33
Fair Value Measured on a Recurring Basis | Level 1 | Foreign currency contracts    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Other derivatives    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Interest rate contracts    
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 2    
Assets:    
Total assets 768 1,126
Liabilities:    
Total liabilities 291 272
Fair Value Measured on a Recurring Basis | Level 2 | Corporate debt    
Assets:    
Cash Equivalents: 502 589
Fair Value Measured on a Recurring Basis | Level 2 | Government debt    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 2 | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 3 3
Fair Value Measured on a Recurring Basis | Level 2 | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 49 45
Fair Value Measured on a Recurring Basis | Level 2 | Foreign currency contracts    
Assets:    
Derivative Instruments: 212 489
Liabilities:    
Derivative Instruments: 248 212
Fair Value Measured on a Recurring Basis | Level 2 | Other derivatives    
Assets:    
Derivative Instruments: 2 0
Liabilities:    
Derivative Instruments: 0 2
Fair Value Measured on a Recurring Basis | Level 2 | Interest rate contracts    
Liabilities:    
Derivative Instruments: 43 58
Fair Value Measured on a Recurring Basis | Level 3    
Assets:    
Total assets 0 0
Liabilities:    
Total liabilities 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Corporate debt    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Government debt    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Foreign currency contracts    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Other derivatives    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Interest rate contracts    
Liabilities:    
Derivative Instruments: $ 0 $ 0
XML 80 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value - Narrative (Details) - USD ($)
$ in Billions
Jan. 31, 2024
Oct. 31, 2023
Fair Value Disclosures [Abstract]    
Fair value, short- and long-term debt $ 9.3 $ 8.5
Carrying value, short- and long-term debt $ 9.7 $ 9.5
XML 81 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Cash Equivalents:    
Cost $ 1,531 $ 2,489
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,531 2,489
Available-for-Sale Investments:    
Cost 43 43
Gross Unrealized Gain 52 38
Gross Unrealized Loss 0 0
Fair Value 95 81
Total cash equivalents and available-for-sale investments, cost 1,574 2,532
Total cash equivalents and available-for-sale investments, gross unrealized gain 52 38
Total cash equivalents and available-for-sale investments, gross unrealized loss 0 0
Total cash equivalents and available-for-sale investments, fair value 1,626 2,570
Corporate debt    
Cash Equivalents:    
Cost 502 589
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 502 589
Government debt    
Cash Equivalents:    
Cost 1,029 1,900
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,029 1,900
Financial institution instruments    
Available-for-Sale Investments:    
Debt securities, cost 3 3
Debt securities, gross unrealized gain 0 0
Debt securities, gross unrealized loss 0 0
Debt securities, fair value 3 3
Marketable securities and mutual funds    
Available-for-Sale Investments:    
Equity securities, cost 40 40
Equity securities, gross unrealized gain 52 38
Equity securities, gross unrealized loss 0 0
Equity securities, fair value $ 92 $ 78
XML 82 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details)
$ in Millions
Jan. 31, 2024
USD ($)
Amortized Cost  
Due in one year $ 3
Fair Value  
Due in one year $ 3
XML 83 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Oct. 31, 2023
Derivatives, Fair Value    
Fair value of derivatives with credit contingent features in a net liability position $ 119 $ 91
Period to collateralize 2 days  
Loss expected to be reclassified from AOCI into earnings in next 12 months $ 33  
Cash flow hedges    
Derivatives, Fair Value    
Foreign currency maturity 12 months  
Other Non-Current Assets    
Derivatives, Fair Value    
Cost method and other equity investments $ 108 $ 111
XML 84 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Derivatives, Fair Value    
Outstanding Gross Notional $ 20,088 $ 20,599
Derivative instruments, assets 214 489
Derivative instruments, liabilities $ 291 $ 272
Other Current Assets    
Derivatives, Fair Value    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other current assets Other current assets
Derivative instruments, assets $ 186 $ 419
Other Non-Current Assets    
Derivatives, Fair Value    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other non-current assets Other non-current assets
Derivative instruments, assets $ 28 $ 70
Other Current Liabilities    
Derivatives, Fair Value    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Derivative instruments, liabilities $ 189 $ 162
Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities Other non-current liabilities
Derivative instruments, liabilities $ 102 $ 110
Derivatives designated as hedging instruments    
Derivatives, Fair Value    
Outstanding Gross Notional 16,032 16,028
Derivatives designated as hedging instruments | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 173 410
Derivatives designated as hedging instruments | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 28 70
Derivatives designated as hedging instruments | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 182 147
Derivatives designated as hedging instruments | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 102 110
Derivatives designated as hedging instruments | Fair value hedges | Interest rate contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 750 750
Derivatives designated as hedging instruments | Fair value hedges | Interest rate contracts | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives designated as hedging instruments | Fair value hedges | Interest rate contracts | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives designated as hedging instruments | Fair value hedges | Interest rate contracts | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives designated as hedging instruments | Fair value hedges | Interest rate contracts | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 43 58
Derivatives designated as hedging instruments | Cash flow hedges | Foreign currency contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 15,282 15,278
Derivatives designated as hedging instruments | Cash flow hedges | Foreign currency contracts | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 173 410
Derivatives designated as hedging instruments | Cash flow hedges | Foreign currency contracts | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 28 70
Derivatives designated as hedging instruments | Cash flow hedges | Foreign currency contracts | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 182 147
Derivatives designated as hedging instruments | Cash flow hedges | Foreign currency contracts | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 59 52
Derivatives not designated as hedging instruments    
Derivatives, Fair Value    
Outstanding Gross Notional 4,056 4,571
Derivatives not designated as hedging instruments | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 13 9
Derivatives not designated as hedging instruments | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 7 15
Derivatives not designated as hedging instruments | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives not designated as hedging instruments | Foreign currency contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 3,926 4,446
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 11 9
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 7 13
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives not designated as hedging instruments | Other derivatives    
Derivatives, Fair Value    
Outstanding Gross Notional 130 125
Derivatives not designated as hedging instruments | Other derivatives | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 2 0
Derivatives not designated as hedging instruments | Other derivatives | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Other derivatives | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 2
Derivatives not designated as hedging instruments | Other derivatives | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities $ 0 $ 0
XML 85 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Oct. 31, 2023
Derivative assets    
Gross Amount Recognized $ 214 $ 489
Gross Amount Offset 0 0
Net Amount Presented 214 489
Gross Amounts Not Offset    
Derivatives 170 178
Financial Collateral 40 291
Net Amount 4 20
Derivative liabilities    
Gross Amount Recognized 291 272
Gross Amount Offset 0 0
Net Amount Presented 291 272
Gross Amounts Not Offset    
Derivatives 170 178
Financial Collateral 109 89
Net Amount $ 12 $ 5
Period to collateralize 2 days  
XML 86 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details) - Interest rate contracts - Interest and other, net - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]    
Total amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recorded $ (142) $ (181)
Gain/(loss) recognized in earnings on derivative instruments 15 14
Gain/(loss) recognized in earnings on hedged item $ (15) $ (14)
XML 87 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]    
Gain/(loss) recognized in Accumulated other comprehensive loss on derivative $ (162) $ (623)
Foreign currency contracts | Cash flow hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain/(loss) recognized in Accumulated other comprehensive loss on derivative $ (162) $ (623)
XML 88 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Pre-tax effect of derivative instruments in cash flow hedging relationships    
Net revenue $ 13,185 $ 13,798
Cost of revenue (10,297) (11,011)
Operating expenses (1,953) (2,044)
Interest and other, net (142) (181)
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings 159 334
Cash flow hedges    
Pre-tax effect of derivative instruments in cash flow hedging relationships    
Net revenue 13,185 13,798
Cost of revenue (10,297) (11,011)
Operating expenses (1,953) (2,044)
Interest and other, net (142) (181)
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings 159 334
Cash flow hedges | Net revenue    
Pre-tax effect of derivative instruments in cash flow hedging relationships    
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings 199 386
Cash flow hedges | Cost of revenue    
Pre-tax effect of derivative instruments in cash flow hedging relationships    
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings (40) (54)
Cash flow hedges | Operating expenses    
Pre-tax effect of derivative instruments in cash flow hedging relationships    
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings (3) (1)
Cash flow hedges | Interest and other, net    
Pre-tax effect of derivative instruments in cash flow hedging relationships    
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings $ 3 $ 3
XML 89 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]    
Gain/(loss) recognized in earnings on derivative instrument $ 5 $ (38)
Interest and other, net | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain/(loss) recognized in earnings on derivative instrument 1 (44)
Interest and other, net | Other derivatives    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain/(loss) recognized in earnings on derivative instrument $ 4 $ 6
XML 90 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Amount Outstanding    
Current portion of long-term debt $ 193 $ 179
Notes payable to banks, lines of credit and other $ 359 $ 230
Weighted-Average Interest Rate    
Current portion of long-term debt 5.90% 6.00%
Commercial Paper    
Amount Outstanding    
Commercial Paper $ 100 $ 0
Weighted-Average Interest Rate    
Commercial paper and notes payable to banks, lines of credit and other 5.50% 0.00%
Notes payable to banks, lines of credit and other    
Amount Outstanding    
Notes payable to banks, lines of credit and other $ 66 $ 51
Weighted-Average Interest Rate    
Commercial paper and notes payable to banks, lines of credit and other 1.20% 1.00%
XML 91 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
Borrowings - Schedule of Long-Term Debt (Details) - USD ($)
Jan. 31, 2024
Oct. 31, 2023
Long-term debt    
Fair value adjustment related to hedged debt $ (43,000,000) $ (58,000,000)
Unamortized debt issuance cost (54,000,000) (57,000,000)
Current portion of long-term debt (193,000,000) (179,000,000)
Total long-term debt 9,301,000,000 9,254,000,000
U.S. Dollar Global Notes    
Long-term debt    
Long-term debt 9,042,000,000 9,042,000,000
$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041    
Long-term debt    
Long-term debt 1,199,000,000 1,199,000,000
Face amount of debt instrument $ 1,200,000,000  
Discount to par (percent) 99.863%  
Interest rate (percent) 6.00%  
$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025    
Long-term debt    
Long-term debt $ 1,149,000,000 1,149,000,000
Face amount of debt instrument $ 1,150,000,000  
Discount to par (percent) 99.769%  
Interest rate (percent) 2.20%  
$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027    
Long-term debt    
Long-term debt $ 999,000,000 999,000,000
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.718%  
Interest rate (percent) 3.00%  
$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030    
Long-term debt    
Long-term debt $ 503,000,000 503,000,000
Face amount of debt instrument $ 850,000,000  
Discount to par (percent) 99.79%  
Interest rate (percent) 3.40%  
$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026    
Long-term debt    
Long-term debt $ 521,000,000 521,000,000
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.808%  
Interest rate (percent) 1.45%  
$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031    
Long-term debt    
Long-term debt $ 997,000,000 997,000,000
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.573%  
Interest rate (percent) 2.65%  
$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029    
Long-term debt    
Long-term debt $ 999,000,000 999,000,000
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.767%  
Interest rate (percent) 4.00%  
$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032    
Long-term debt    
Long-term debt $ 676,000,000 676,000,000
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.966%  
Interest rate (percent) 4.20%  
$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028    
Long-term debt    
Long-term debt $ 899,000,000 899,000,000
Face amount of debt instrument $ 900,000,000  
Discount to par (percent) 99.841%  
Interest rate (percent) 4.75%  
$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033    
Long-term debt    
Long-term debt $ 1,097,000,000 1,097,000,000
Face amount of debt instrument $ 1,100,000,000  
Discount to par (percent) 99.725%  
Interest rate (percent) 5.50%  
$500 issued at par at a price of 100% at 4.75%, due March 2029    
Long-term debt    
Long-term debt $ 3,000,000 3,000,000
Face amount of debt instrument $ 500,000,000  
Issuance rate (percent) 100.00%  
Interest rate (percent) 4.75%  
Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030    
Long-term debt    
Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030 $ 549,000,000 $ 506,000,000
Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030 | Minimum    
Long-term debt    
Interest rate (percent) 1.58%  
Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030 | Maximum    
Long-term debt    
Interest rate (percent) 8.30%  
XML 92 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
Borrowings - Narrative (Details) - USD ($)
Mar. 31, 2023
Jan. 31, 2024
Commercial Paper    
Line of Credit Facility [Line Items]    
Maximum borrowing capacity under credit facility   $ 6,000,000,000
Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Maximum borrowing capacity under credit facility   5,000,000,000
Revolving Credit Facility | 364-Day Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Maximum borrowing capacity under credit facility $ 1,000,000,000  
Revolving credit facility, term 364 days  
Credit Facilities    
Line of Credit Facility [Line Items]    
Available borrowing resources   $ 1,000,000,000
XML 93 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Deficit - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Stockholders' Equity Note [Abstract]    
Repurchases of common stock (shares) 17.1 3.6
Payment in connection with repurchases of shares $ 500 $ 100
Shares settled (in shares) 0.3  
Share repurchase authorization remaining $ 1,500  
XML 94 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Components of accumulated other comprehensive income, net of taxes    
Tax benefit on other comprehensive loss $ 70 $ 183
Tax provision on unrealized gains arising during the period    
Components of accumulated other comprehensive income, net of taxes    
Tax benefit (provision) on unrealized (losses) gains arising during the period 0 (1)
Net unrealized gains (losses) on cash flow hedges    
Components of accumulated other comprehensive income, net of taxes    
Tax benefit (provision) on unrealized (losses) gains arising during the period 36 106
Tax effects on reclassification into earnings 32 78
Tax benefit on other comprehensive loss 68 184
Tax benefit on losses arising during the period    
Components of accumulated other comprehensive income, net of taxes    
Tax benefit (provision) on unrealized (losses) gains arising during the period 2 0
Unrealized components of defined benefit plans    
Components of accumulated other comprehensive income, net of taxes    
Tax benefit on other comprehensive loss $ 2 $ 0
XML 95 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Deficit - Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Unrealized gains (losses) arising during the period $ (110)  
Gains (losses) reclassified into earnings (125)  
Other comprehensive loss, net of taxes (235) $ (741)
Unrealized gains arising during the period    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Unrealized gains (losses) arising during the period 4 3
Gains (losses) reclassified into earnings 0  
Net unrealized gains (losses) on cash flow hedges    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Unrealized gains (losses) arising during the period (126) (517)
Gains (losses) reclassified into earnings (127) (256)
Other comprehensive loss, net of taxes (253) (773)
Losses arising during the period    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Unrealized gains (losses) arising during the period (8) (1)
Amortization of actuarial loss and prior service benefit    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Gains (losses) reclassified into earnings 2 0
Curtailments, settlements and other    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Gains (losses) reclassified into earnings 0 1
Change in unrealized components of defined benefit plans    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Unrealized gains (losses) arising during the period (8)  
Gains (losses) reclassified into earnings 2  
Other comprehensive loss, net of taxes (6) 0
Change in cumulative translation adjustment    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Unrealized gains (losses) arising during the period 20  
Gains (losses) reclassified into earnings 0  
Change in cumulative translation adjustment $ 20 $ 29
XML 96 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Deficit - Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Components of accumulated other comprehensive income, net of taxes    
Balance at beginning of period $ (1,069) $ (3,025)
Other comprehensive gains (losses) before reclassifications (110)  
Reclassifications of gain into earnings (125)  
Balance at end of period (1,640) (3,827)
Accumulated other comprehensive loss    
Components of accumulated other comprehensive income, net of taxes    
Balance at beginning of period (223) 285
Balance at end of period (458) (456)
Net unrealized gains (losses) on available-for-sale debt securities    
Components of accumulated other comprehensive income, net of taxes    
Balance at beginning of period 7  
Other comprehensive gains (losses) before reclassifications 4 3
Reclassifications of gain into earnings 0  
Balance at end of period 11  
Net unrealized gains (losses) on cash flow hedges    
Components of accumulated other comprehensive income, net of taxes    
Balance at beginning of period 230  
Other comprehensive gains (losses) before reclassifications (126) (517)
Reclassifications of gain into earnings (127) $ (256)
Balance at end of period (23)  
Unrealized components of defined benefit plans    
Components of accumulated other comprehensive income, net of taxes    
Balance at beginning of period (437)  
Other comprehensive gains (losses) before reclassifications (8)  
Reclassifications of gain into earnings 2  
Balance at end of period (443)  
Change in cumulative translation adjustment    
Components of accumulated other comprehensive income, net of taxes    
Balance at beginning of period (23)  
Other comprehensive gains (losses) before reclassifications 20  
Reclassifications of gain into earnings 0  
Balance at end of period $ (3)  
XML 97 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Numerator:    
Net earnings, basic $ 622 $ 469
Net earnings, diluted $ 622 $ 469
Denominator:    
Weighted-average shares used to compute basic net EPS (in shares) 995 989
Dilutive effect of employee stock plans (shares) 7 7
Weighted-average shares used to compute diluted net EPS (in shares) 1,002 996
Net earnings per share:    
Basic (usd per share) $ 0.63 $ 0.47
Diluted (usd per share) $ 0.62 $ 0.47
Anti-dilutive weighted-average stock-based compensation awards (shares) 6 7
XML 98 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
Litigation and Contingencies (Details)
$ in Millions
 1 Months Ended 3 Months Ended 17 Months Ended
Oct. 31, 2023
patent
claim
Mar. 19, 2021
patent
Aug. 18, 2016
age
Oct. 01, 2015
USD ($)
Apr. 17, 2015
subsidiary
employee
Jan. 24, 2013
USD ($)
Dec. 11, 2012
USD ($)
Apr. 21, 2012
USD ($)
May 10, 2010
USD ($)
employee
Jan. 31, 2024
member
claim
Nov. 30, 2023
claim
subsidiary
patent
Nov. 30, 2022
patent
Oct. 31, 2020
patent
Sep. 30, 2020
patent
Jan. 31, 2024
member
affiliate
Apr. 30, 2022
claim
Apr. 20, 2012
USD ($)
Apr. 11, 2012
USD ($)
Philips Patent Litigation                                    
Litigation and Contingencies                                    
Patents allegedly infringed | patent                           4        
Patents withdrawn | patent                         2          
Caltech Patent Litigation                                    
Litigation and Contingencies                                    
Patents allegedly infringed | patent   5                                
Dynamic Security Litigation                                    
Litigation and Contingencies                                    
New claims filed | claim                   1           2    
Nokia Patent Litigation                                    
Litigation and Contingencies                                    
Patents allegedly infringed | patent 10                                  
New claims filed | claim                     2              
Number of subsidiaries | subsidiary                     6              
Nokia Patent Litigation | Brazil                                    
Litigation and Contingencies                                    
Patents allegedly infringed | patent                     1              
Nokia Patent Litigation, U.S. International Trade Commission                                    
Litigation and Contingencies                                    
Patents allegedly infringed | patent 7                                  
New claims filed | claim 2                                  
R2 Semiconductor Litigation | Europe                                    
Litigation and Contingencies                                    
Patents allegedly infringed | patent                       1            
Access Advance Patent Pool, Unified Patent Court                                    
Litigation and Contingencies                                    
Loss Contingency, Number Of Patent Pool Members | member                   3         3      
Access Advance Patent Pool, Unified Patent Court | Düsseldorf, Germany                                    
Litigation and Contingencies                                    
Number of affiliates | affiliate                             14      
Access Advance Patent Pool, Unified Patent Court | Munich, Germany                                    
Litigation and Contingencies                                    
Number of affiliates | affiliate                             2      
Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise                                    
Litigation and Contingencies                                    
Minimum age of plaintiff | age     40                              
India Directorate of Revenue Intelligence Proceedings                                    
Litigation and Contingencies                                    
Number of current employees | employee                 7                  
Number of former employee | employee                 1                  
Aggregate damages sought                 $ 370                  
Loss contingency deposit to prevent interruption of business                 $ 16                  
Duties and penalties under show cause notices                                 $ 17 $ 386
Amount deposited under show cause notice prior to order                                 $ 7 $ 9
Additional amount deposited against products-related show cause notice             $ 10                      
Additional amount deposited against parts-related show cause notice               $ 3                    
Additional amount deposited against product order           $ 24                        
Autonomy-Related Legal Matters | Autonomy                                    
Litigation and Contingencies                                    
Aggregate damages sought       $ 5,000                            
Number of subsidiaries | subsidiary         4                          
Number of members | employee         2                          
Autonomy-Related Legal Matters | Autonomy | Mr. Lynch                                    
Litigation and Contingencies                                    
Aggregate damages sought       $ 160                            
XML 99 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
Guarantees, Indemnifications and Warranties (Details)
$ in Millions
 3 Months Ended
Jan. 31, 2024
USD ($)
Changes in aggregated product warranty liabilities  
Balance at beginning of period $ 706
Accruals for warranties issued 183
Adjustments related to pre-existing warranties (including changes in estimates) 19
Settlements made (in cash or in kind) (229)
Balance at end of period $ 679
EXCEL 101 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &V+7%@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !MBUQ8Q !B=>X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)OI\V**Z&;B^))07!!\1:2V=U@TX1DI-VW-XV[740?P&-F_GSS M#4RG@] ^XG/T 2-93%>3ZXR,%CJB(A]/>*,7?/B,?8$9#=BCPX$2M'4+3,X3 MPW'J.[@ 9AAA=.F[@&8AENJ?V-(!=DI.R2ZI<1SK<55R>8<6WIX>7\JZE1T2 MJ4%C_I6LH&/ #3M/?EW=W6\?F.0-OZX:7O';+>>"KT6S?I]=?_A=A)TW=F?_ ML?%94';PZR[D%U!+ P04 " !MBUQ8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M &V+7%CCE4;Q+ 4 #(5 8 >&PO=V]R:W-H965T&UL MC9AO;^HV%,:_BL6F:9-*DSC\[2@2I>V];&TO+=VF;MH+DQB(FL29[4#Y]CM. M(&%=.$E?E"3D//Q\;#_']F@GY+O:<*[)1Q3&ZKJUT3JYLBSE;7C$U*5(> S? MK(2,F(9;N;94(CGSLZ HM*AM]ZR(!7%K/,J>S>5X)%(=!C&?2Z+2*&)R?\-# ML;MN.:WC@Y=@O='F@34>)6S-%US_ELPEW%F%BA]$/%:!B(GDJ^O6Q+FZ<:D) MR-[X/> [=7)-3%.60KR;FYE_W;(-$0^YIXT$@X\MG_(P-$K \<]!M%7\I@D\ MO3ZJWV>-A\8LF>)3$?X1^'ISW1JTB,]7+ WUB]A]Y8<&=8V>)T*5_2>[_-U. MIT6\5&D1'8*!( KB_)-]'!)Q&F"?":"'@"P15OY#&>4MTVP\DF)'I'D;U,Q% MUM0L&N""V/3*0DOX-H X/9Z*+9=D#ATPLC3HF:>6=XB]R6/IF5B7/(I8;Q2Y MBWWN_S?> HX"AAYA;B@J^ N++XGK7!!JTPY1&R:Y0F3=HHUN)NNB;?QKLE1: MPBCXNZJEN4*G6L%,C2N5,(]?MV#L*RZWO#7^X3NG9_^,\'4*O@ZF/KX57@H# M79/7?5+9#7BX8[>?$8IN0=%M1O&<,JFY#/?DA2="ZBHB7$K+E"-$O8*HUXQH MSF4@?#/," SRRA3A2L7 RD86@M8OT/H-NTPR<*C,8,YG"]=:L5!AZ1H43 -4 MYR[6@=Z3^R#DY"F-EEQ6L> :3KO3H2X",RQ@ADU@7O@Z,+,.,O7$HLJ>PW6^ MSO-I-GN:7B)8CEWZG=T$;!9[0D)_,=-U%V2A85P1(_CTJQT15[^] MPR!/3-EI OG*/LC,AV$6K (O(T4ZMD9RV&D[]L#IN#V,D):$M GAQ/?!#]7% M\8(\P'OD6UR=.US2Z=I.5HG(8Q"&Y$4PK*8XI?L[J'G_#W5J[J"K7\4NKL3$ MY>8L%&02:G&!T97>[^#N_9FN&(ES*;9![%5G$M><3C"TLB XN(U_1IL+I5E( M_@R2\],#5QQV7!NS7ZAX%%^AU;0RD+ 0.[MX/PH.(RC+@X![^&FBH &)%'/KC\B>RX%XJ(5N56+C25$01> XL M0KWW"Y(P2;8L3#GYWKZ$J9K HBI;HV'49;UP<*.'0NH'\9HL]M%2A)6P=94" M6P71LD!0W,*/^2)W']Z&Q6!'YRI7C=#3VP*K!K2L!K11-9BF4IHE1[[.R'(% M7I&J2C1<\0U=5].R"M!&56 6PWHQWU^9!1H[HE:2X8HU9*7ITT:F;Q9#4-3! M4M="5DZ!&IT')F$$3#P/]I&P6.!^+HDQEM9/&UG_(F)0[FY2!5^KZM[$=>H6 MD+1T?-K(\>\B+M=F@'T!!;T!BXT2%E>G#Q>L12L-G^)^?4S6!C;P*! N4PM4 M&C_%/?LX*W./7.0>N<$%ZOK.+3W>Q:WY:*7W@3+5^XU#:<-VES5R;5A:MUVL>KNEV;NX-1<[ MRU.V>WA8Z0PU8C6[7;A>WY<]4AQWY>2Y<[KDR5];),99QH.RP3A'/;,GR M$ZWB:7$@.,F/P3C=;;Z^E4+3JJUD-*T& MY=F4>%XXS2DO)HMY=>]>+N:BU!DOV+U$JLQS*O^]99EXNIG@R;& M=#'?TC5[8/K+]E["U;3UDO*<%8J+ DFVNIF\Q]=W?C6@LOB'LR>U]QF94!Z% M^&8N/J8W$\\0L8PMM7%!X=^.W;$L,YZ XWOC=-(^TPS<__SB_; CFD2IV M)[*O/-6;FTD\02E;T3+3G\73'ZP):&;\+46FJK_HJ;'U)FA9*BWR9C 0Y+RH M_]/G9B+V!H ?^P#2#"#] <'( +\9X%>!UF156!^HIHNY%$](&FOP9CY4%TB;S>X37-L3 %:4Y@J[5EB[9S03.&,7DCDT6/_^$0^\7 M6PK.Y.P@X%D;\.R(A"R'8=NBKEW-]J?<(TG42XS%"GL8VQ,3MIRAD_-W*92" M T"N>6%#"P M_=COX=J,_)%<)RUO\MJ4:EDN=2F!NH(5>L,D6L)YNV;64S498(1]TJ$)#D9 ML=>IB.=$?;_\7G+%:V4V"P#F4FD.Z,R%VW@]7(D]7HM-'(SP[JD>=O/F0FK^ M'ZV 8MT:F M[9!DF-]DUE\$%BOB!6/3VJD:=LM:6RBLI,A?@,<* '^ D/A]<;,81<'(,8 [ M<<-.*5E\+#0#"='=GKHP1[Z5,A@ 7.* ]#%M5O'8KNHT";M%J9W.1P8%.T.: M/H\D?:@U43+(^=!H%I(1QDZ/L%N0[J78\:JH!T0'X5!S+G$TV#T6JV0LW9TR M8;E2KNHWUFCKOU$>]/N70TTS6H5C%0TI%,UXE:U M#SPK35]T!&?CJ.K+2M'):0%F; M;R&0JJP]NMK.Y>UP?CK])&[];%8;=*3UQ-@S.)3$).GKD;Q"V;[3I[A7 HAMCS!FO,HJM).(+8229Q2R8<\RF4HM;STSWTY+7R(]I MTFDN.:81?*4!;'P<--TDP/T>QF;FCY99I--<$IZE.R=.Z3XY,6?R=AATI^+$ MK>(G=>ADV#XF\:#_5M\?5>_Q>_< MU#\J?*I>>RF4L16X]*XB6"ZR?D]?7VBQK5YU/PJM15Y]W#":,FD,X/N5$/KE MPCR@_;5D\3]02P,$% @ ;8M<6 0-8;>F! 2A( !@ !X;"]W;W)K MDD9 M5PLGT7IWZ[HJ2DB*U8W8$0[_;(1,L8:AW+IJ)PF.11(I6E*9;_W!,F#@O'=XX3'^@VT6;"7$N>B'[>/4H8N965 MF*:$*RHXDF2S<.[\VU7@&85))C*?]&AE/4<%&5*B[14!@0IY<43OY1$G"B ';M"4"H$385AAT)8 M*H2YHP6RW*UW6./E7(H#DD8:K)F7G)M<&[RAW(3Q24OXEX*>7JX$5X+1&&L2 M(QC$$"%X>](P ='2"HD-S*>0(XD)WIZ@]SP2*4%OGSG.8@IZ5VB GI_>H;=O MKM ;1#EZH(Q!C-3YO;##7L5K)ZU_WJV5EI#=?]G8 M*ZP/[=;-DK]5.QR1A0.&%9%[XBR__<8?>]_97+^0L3,BAA41PS[KRU]AAR)8 MYMMF*]LMQ$,S=_2G^MLQP/*MDSF"-*EBCWOBL$LRWQ.1PQF%7 M9/0S+ :(RT[PXV+ >TP97C,R@$UTH# CL&VL-5(DRB35E*A;FT.C2T;N0L;. M*!I7%(U[(_=<$[.%,J$0EE1!&%$,[L-#)P3MB*0BMM%0V!Z=QJP1U3Z),\"3 M"O#D:V,:896@#90TE)!XVQ'!R24C>"%C9X1,*T*F7QI!)I0B_S.$TU: !OZX MN38M0F.S@]H".:MPSWIQ_YBGFR01PTK1#07\E&O1NX_,+&!'LP98BU 8=F2= M[]65U>N%^XJ\LQ9,SX(N\!LNV*1FHTF'#R?=@?^U:P=Z)E"*T9IP>--HQS"W M+Z#R6Q=:09>R=LY,4#,3]$;WEU>LG-+D>39ZS4C:A#KB6+<=?F\Q7]ZE0FKZ M&>>MLREBD TZM6=FA&O0"F)=6M,,>*"7:MD@7X74?X??6X%L2"0<_PTG%!,$*^QV)0]:U%MD M.EHXOZ[W?F_U7/YF:O"<$QD48 _M\(H8\#\X'J^FCY+U!+ P04 M" !MBUQ8[C6Y-X@% #*%0 & 'AL+W=OS7[R@Y MDFQ1B@ODBZV7YT[/'%SLA?RN-HQI]#//"G4]V6B]O9K/5;)A.5678LL* M>',O9$XUW,J'N=I*1M/**,_FQ'&">4YY,5DNJF4_GX M@65B?SW!DZ<'W_C#1IL'\^5B2Q_8+=-WVQL)=_/&2\IS5B@N"B39_?7D/;Y: MD< 85(A_.-NKSC4RH:R%^&YN/J?7$\/@=-)\ MTQAVKY^\_U8%#\&LJ6(KD?W+4[VYGD03E+)[6F;ZF]C_S@X!^<9?(C)5_:+] M >M,4%(J+?*#,3#(>5'_TY^'1'0,L#=@0 X&Y%P#]V#@5H'6S*JP/E)-EPLI M]D@:-'@S%U5N*FN(AA=F&&^UA+<<[/1R)0HE,IY2S5($-RF,$%Q]H!DM$H9N MC6.%WMP5M$PY8-ZB&;J[_8C>7+Q%%X@7Z O/,A@/M9AKH&.(>T0PJ4C5GH;:A1#*8KB@3 M,)C*O+Z(O"J\B]B=FABWK*H?V:,MP)J%W^4>.=Y)@'V01]S0'J#?!.B/!OBY MV,% "&EEY?<^&,0D.F%E 47!0-J#AE4PRNJKWC!(Z='ZL!$,^FD+G?B$H 44 M>(&=8-@0#$<)_BTTS5J7<;KF&=>7T* %6_IH=*-:@&HCI)YI)G.T%A(<\N+!/ERN9;A.*YL%1%QG8*A:R<-G M:MZ!N)5>7XNP2WS_E* %YCE#Q1>WHH7'5>M8'SISRLJUKU 8]G_N*5U+U;$C?S3 FR#>5X4#7!M50V/R]J?HGBH9V?*UE9]P'VM MBEVG5^,L*.(/%9%6T?"XI/6+\7/I["N5Y_9V,%:4.R0=K:#A>+3DW6J1?-^( M+&52O7X5$1R^,^T>3[BVE[Y1@?SETO="WHX[FU8WR;ANWD!OS&",H.29-$S1 MA7/I8"@I$L'>OV3HC>LX4 XI?!S14D-=Y/^Q])T978:X4B5T?M:.J"^?ISN! M4ITM:.JNGR?0B,$#3I4 MO2WEZ0Q:]H1N.51!*TW2I^"'ITIG13G^ -56H,FX0(/4E7F954<1AZ5IY=C7 MV1D)>SL[*\P-!@H):069/"O(#4M1*Y_(8=5NS-G6CE4]IY5V7WUG7J_YL*$( M<0=(MQ)-QB6ZECTU7 .MC/L:/,.!UYNV-I@3#.RA22O5Y!RI[FA*O6?[Q1B" M_CF$9:-M@UDVVO/.09LYY?Q"Y0,O%,K8/=@YER$D0=8'A_6-%MOJ[&TMM!9Y M=;EA%+@; +R_%[ I/=R8X[SF^';Y/U!+ P04 " !MBUQ8M5(;R1L# !: M"@ & 'AL+W=OCVZW>60B98PU2N;)5*@J,\*6&V MYSA].\&46\$XOS:3P5ADFE%.9A*I+$FP_'U#F-A,+-=ZN?! 5[$V%^Q@G.(5 MF1/]F,XDS.Q*):()X8H*CB193JQK]VKJ.B8AC_A&R49MC9&QLA#BR4P^1Q/+ M,42$D5 ;"0P_:S(EC!DEX/A5BEK5?YK$[?&+^EUN'LPLL")3P;[32,<3:VBA MB"QQQO2#V'PBI:&>T0L%4_DWVI2QCH7"3&F1E,E D%!>_.+GLA!;"6YW3X)7 M)GBG)OAE@I\;+,P?JHL:T!S_R)'98H-P6*MP?E"^8=Y+N7R'.\;D/Z]'#ZUU!7 MZ7X]W8:B5)7QJLIXN9Z_1V^NH2;0L!J));JC'.I!,4,SH6C>@#^N%TI+:,.? M358+[6ZSMMF;5RK%(9E8L/D4D6MB!>_?N7WG8Y/Q_R16*X-?E<$_I!Y<,]CI M>2_ ,P.%DD ;("94XP(74OUB%?F^+RG?*SRO^4R)K)OJ5B?Z;3%"ELN,& M^CM8K\$/1=2 !Q7PX"#P5"0);-ZW=,K@E$XY$E1C'E;,PS.8SVZ3X4X-1_T] M?7)2:,W#J/(P.M_#:5TRVH4:-N,W18X.T;O.O]>D?L& "-'@ & M 'AL+W=OBW6W/BJTTVME6)BE)NU\_RD[CQ*+4%NA+:SL4_9$4^9'6^5:J M'WK)N2&/95'IB][2F-798*"S)2^9_BQ7O()?%E*5S,"M>ACHE>(LKQ>5Q8!& MT6A0,E'UIN?ULULU/9=K4XB*WRJBUV7)U-,5+^3VHA?WGA_EL0\&T_,5 M>^#WW'Q?W2JX&^RUY*+DE1:R(HHO+GJ7\=DL&=L%M<1?@F_UP36QILRE_&%O MON87O<@BX@7/C%7!X-^&SWA16$V X]^=TM[^G7;AX?6S]B^U\6#,G&D^D\7? M(C?+B]YIC^1\P=:%N9/;W_C.H*'5E\E"UW_)=B<;]4BVUD:6N\6 H!15\Y\] M[AQQL #TX OH;@'M+D@]"Y+=@J0VM$%6FW7-#)N>*[DERDJ#-GM1^Z9>#=:( MRH;QWBCX5< Z,YW)2LM"Y,SPG,!-#A&"JWL##R!:1A.Y(#.FE^0+1%R3C]\K MMLX%2'\B??+]_II\_/")?""B(C>B*" R^GQ@ )A5/\AV(*X:$-0#(B$WLC)+ M37Z%]^?'ZP=@T-XJ^FS5%0TJ_)U5GTD2GQ :T13!,WO]\B0 )]D[.:GU)3XG M6_\M:O\ME"P))*%B1E0/S2X61G!]AKFM49OB:FV&G^D5R_A%#U)8<[7AO>G/ M/\6CZ!?,YG=2=N2!=.^!-*1]^@T*$F>J IO1_=&L'M6K;>793$>4G@\VA_A= MF70TVJ!L>Q(Q& MPTY<,1E/7,=[G.,@SGLCLQ]]6]YSDLD2.$\WF/FCO>88U+$#(QZ/.U 1F=$8 MAWJZAWH:A'K'M5'KS*Q5O9' I](LN2+9DJD'CB;+J8-BE'2 NB)Q&N- )WN@ MDQ=BO^!*@4,->^1 "U4PH2<.@'XW[HA(G$8XR#AJ^2P*POS#>N_$)BS*0Y'[ M4AIU@"%"J0?6 0&KRE79;]NQ9: MV(V+UY7=.]^IL+R7MF,/T=9#-!BXRRR3:UN(H<)PL6'S DW3G9:CX*2C;@1= M(9KZ8MBR>!RDR.G7:@-,(=43BBMQ=U;:K1^($$U\6[[EUCA,KGO/K=B3UVVI M"V]\X)(=/D0J'B>>RA&W-!L'6:FF?P'>:[C6)D'!H3CCK>+0Q3#J]@*84#SR MP&S9+0[3VY^OJ6RQRU?II L/X33JBW-+:G&8U3Q4@8)TF:I_ZNQ&1&A"/2A; M/HO#A%878$]I0Z&Z7 6)XV2T*T7'GBXA;BDM#G/:-ZRM^[BV;8.H/J$-'FJ" M2V4QC;L68'SGV;*TI3L:O6FT:++L%3TI#=+H6[GCO;0=>Z%E5QKDIKHRM[4% M@@F!,T\G9%4P>&0W(0\5Q?(:GG2BB4KZDH2WYT3#YW:X5-'R: MU^,VVS!1V$+>7TC5UPSF$%&0EM?U: E:0G"MH5>R7 M*(!MJ[,?-D; #G!$B/IZ8MK2+WV9?NLRMZML:)5 02,T2ZF3$XA4F@P]J%LV MIJ,WE;:%J!A,YZ\H;4&6?W-I>R=MQUYH29^&2?]6R8SS?.<#O81YNP_;L"1S MJ4!9_8%B*\R22"4>P$,%*=O\@\S3Q,#H0291@REG3]I? I'Y-G+VJ"M$(]\6 M;;L&&NX:CLW,^=SLQR"A]1H"SV&2UY[<: M= "EA=Q\$M%:VD\D]:<''V"D%W":2$QHF'AZGJ3M&)+P@'SX;81MFG4X-%?*A;AD^"3/\'5_M*-(Z.Y-E"6VZMJ:@0!&6'CH[&9.*?5LY M:;D\"7-Y7;=R8?O)*K=#F.,P<'!7LG50WW>J4G]N:&PO M=V]R:W-H965T&ULO5MK<],X%/TKFL"P=(802WX&VLQ 8L^R MLT"'PNYGUU8;#[:5M9VV_/N5'1-'CZAQ]RY?6CN]]USI'KWNB7I^SZKO]9K2 M!CT4>5E?3-9-LWDSF]7)FA9Q_9IM:,G_5JC>%D5<_7A/_OR(;V86&V+:$Z3IH6(^:\[NJ1YWB+Q=OS3@T[V,5O'P^>?Z%'7>=Z9Z[BF M2Y;_G:7-^F(23%!*;^)MWGQA][_3OD-NBY>PO.Y^HOO>UIJ@9%LWK.B=>0N* MK-S]CA_Z1!PX8/N( ^D=R*D.=N]@2P[$/^+@] Z.['"L#V[OX$H.CG?$P>L= MO"[WNV1UF5[%3;PXK]@]JEIKCM8^='1UWCS!6=F.K*NFXG_-N%^S6+*R9GF6 MQ@U-$7])^:#A3U<-_X /H*9&[(:_L>3[FN4IK>H7SP*"_;=H16^R)&O0RV]E MO$TS[GZ&INC;U0J]?'Z&ZG5OG_,\IP/J?I\UO#F MMXV8)7U3W^^:2HXT]2MKXESCMC2[+5E1L/+%,^Q9;[N.:"!69HAW*>\@;W2< MH\LX2Z>\&\MXD^F;$SZ"E23;8IMW^>YSJ &)3@?YW*QIQ:DK^,JR;J?\'44? MRH05%+W\D]7UF0@_XP-D/TK(?I20+IYS)-[[.(_+A /RGN^H/4-Q@SXGS6MD MXU>(6(3H"#6BMHOFFWH3)_1BPMM>T^J.3A8[HG0T[\#<#JQ=,.\6>//S MV=TAE9 Q0TBP" A,8-#>,VB?Q"!G[9K>9F69E;?MU-[0*F/I263N G@'^9_: M%G'%]"]5*VQ)#&E,L$]$HU 3S7'FDE6D6I%@:)&0*6>?*:=SLH]DBL\=OD77 M?+"OZ.[IK%VW#M? WU#XSS9K?NBRY$ .>4BP%218" D6 8$)=+M[NEWCQ/C$ M3V\TKMKYH-V37&75<>0E9VF,,)8F2+#PA-9'0 &%['O[['O&[.\VKT38O'*^ M:;U")>>%KT]-_$"UO'A*SZ:^@R5BC,''$@,)%D*"18_D0F#&WS/C&YD1#Q19 M?Z#(U0/%C@Y?;0*1U_2E,>)8.B#!0DBP" A,H"W8TQ88:?M0U]MNH^=S)^E. MOJAN=ZYV"TM86?8%W7W6K!$M-CG[06EOL>$GA!KQHSIBW:P\..SI&#>V8^Q& M%RC#)P@<1SHW0$8,(<$B(#"!\?F>\3DXX[O@6MIU5,_5LY@O[X'&1HZ=VW/- M@B8%#"$#1D!@ H'8&FIPRTCA%[K95LF:'S5KA<5'9F&/+*3*]BSIR+W4FQ%Y MAIG;.7:*@:)%4&@B1P,5%5@ZN) SBYD';\"10M/ZD$$ M%5,D8E /L%D^Z*K?:2OAIMUIG1\+XVY;H0_M,]528RL=PYXO,V.,.YJ9$T*& MH"$C*#21F$&LP,;B^)@R]T=<[L4<6TL.J$[1HPG:7.!:@:S-@48-0=$B*#21 MR$&&P&8=XD"@H^U9[%":>YQ-5Z/-!429;*J9(LYA53+ Q/7D.:1:31W/]N55 M2V=V ";F:A -L%DU.$&.UJ=)+93GP=Q2-V.=7> '1,X5J"0 BA9!H8D4#>H! M-LL'X_1F/5N^[N"DB&\:,W50J_($=BU7'M0Z$BC<KT$135Q-;_D[,''XL/Z!H(2A:]%@^1(*&XIN8B^^18C11 M2UL[D ]#YI"C28%$"T'1(B@TD;R#NP/F(O[72=+FAHR^;Z 6YH'G2\-H!1HS M!$6+H-!$X@?1@)A%@U^@3!/--0'?DV!XV!F#6& M_R!/$U48F&)?E3_U=I8G5USFEHZ>;: " A2:R-(@(!"S@/!D@9IHQ ,7.S)# MH)<V#%D',6L3C$C71?#WO.LH9$?2N BA:>%(/ M(JB8(A #,BL-3)&JBT0[D'7YICCN:&8T4(8<,04-&4&@B,8.P0JE@'E@J6J=WLZ>*R,&4BTZ.[@[W_XOQ<>XNLWXL3.G-]S->NWS M<57M_CUA]]*P37>=_IHU#2NZQS6-4UJU!OSO-XSOM?U+>T-__T\BBW\!4$L# M!!0 ( &V+7%@[M4_R@@( /@% 8 >&PO=V]R:W-H965T&ULK53?3]LP$/Y73F%B(&U-FI0?@C02+:!M$E(%8GN8]N#&E\8BB8/M MM/#?[^RDH:" ]K"7Q'>^[_-W9]_%&ZD>=(YHX*DL*CWUH;FO%XHLOV?AHL1*"UF!PFSJ78S/YA,;[P)^ M"MSHG3783)92/ECC.Y]Z@16$!:;&,C#ZK7&.16&)2,9CQ^GU1UK@[GK+?NUR MIUR63.-<%K\$-_G4._6 8\::PMS*S3?L\CFR?*DLM/O"IHL-/$@;;639@4E! M*:KVSYZZ.NP B&<8$': \"U@\@X@Z@"12[15YM*Z9(8EL9(;4#::V.S"U<:A M*1M1V5N\,XIV!>%,,I>5EH7@S" ',CA=$*WN##GHLHP&F9$ETX=<%AR5WM\[ M#<DCQQ>]P]?7^&V)/\/58R/,,_R^6&JCZ*7_&:I>RSX99K?=?Z9KEN+4 MH_;6J-;H)?M[X^/@?"CU_T3VJA"3OA"3C]B3.=,Y<+$6]/BXAAI5^V;@H-'\ MQ3P<*D++?.*8[<1:)\'HZ"CVU[O)#09%?5 KVM]IHA+5RLT6#:EL*M.^L=[; MCZ\+U[5O_#,::^T4>J%I9^(-4RM1:2@P(\I@=$)#0;5SIC6,K%VK+J6AQG?+ MG$8S*AM ^YF49FO8 _IAG_P%4$L#!!0 ( &V+7%C*$\#B\@8 (X1 8 M >&PO=V]R:W-H965T&ULO5AM;]LV$/XKA <4&^#:CO/2 MHDT".'U9LZ%=4#<;AF$?:.ELL95(E:3BY-_ON:,D*VT2M .V+XG$E^-S=\\] M1_EXZ_RG4!!%=5V5-IR,BACK9]-IR JJ=)BXFBQFULY7.N+5;Z:A]J1SV525 MT_EL=C2MM+&CTV,9N_"GQZZ)I;%TX55HJDK[FS,JW?9DM#?J!MZ;31%Y8'IZ M7.L-+2E>UA<>;]/>2FXJLL$XJSRM3T:+O6=G![Q>%OQN:!L&SXH]63GWB5_. M\Y/1C %125ED"QK_KN@%E24; HS/KCI2.6TUDT9W[OM&VK].61[F2N#_%7;M'8?)V9-B*YJ-^.],C;]U]=M' 8; MGL[NV3!O-\P%=SI(4+[449\>>[=5GE?#&C^(J[(;X(SEI"RCQZS!OGAZIH,) MRJW5A:= -FJ.U?$TPC0OF&:MF;-D9GZ/F7WUUME8!/7*YI3?WC\%I![7O,-U M-G_0X"_:3M3^WEC-9_.#!^SM]W[NB[W]>^PMLLPU-AJ[41>N-)FAH/Y:K$+T MX,7?=SF<[!W<;8]KY5FH=48GHYHCYZ]H=/KHA[VCV?,'T![T: \>LO[M6?D7 M9M3=HQ\*0HEDKJJUO>$PO7 V(%*YCI3S2XY*Q--K8[7-C"[5$CL)]1G%V)L+ MI6VN#-ZVA2O+F\=N:[$^-*M@@?2S4I35\ MFE@.ZL='/SR=SV?/+R?+B3SN/?]);Z?%XN+ M;O=$W#0VDC>56O>N&)ODC0.!V#16-[D@6361I85RJ=?T1M)N=C MH:-X9BFC$"!M*CH@<5;'QB:QDVBRZ5M9O#-W'8BU"1EF;DA[15S%ZK-?QS!6P@#&7B(F%1O9 M>YJ,I!3<0ZXS70(@J:7T(T;V%8:M#E!=#RG/U=J[2G6IVF6SCW68@.,](1#X MW;$=Y;^'Y;!4-DAI;$NE^9KZM]F.0;U&*(S0&=';%B8K>'T!+S1G+'K4"C-W M2$9DFP)"ZIF,?!IHS2T3V;:TAGCA>:(69;NV+5IT)XE>.AC"9H,6-@0<=T78 M3%91:=!%M'#K/66E#L' HD[K6F2^GT H,O(1S9TQ./]8Z*&KY#MHWE8P/S+0 MK/$>L4K+ZH&^3-1E( [6JQ#A"\?C0]&)04H')N_*(<>-H^USH4;2"2B"XL(& MU,^-P3GHB1:7"*DP8*GT)U+4'R69"+AXU,G/5++K-Y$\(;- MS#N+YZP]_=RJ)8NBE!SJ93X6_W9(!UL!VN;:0V_.'/[U@OEZL3SKY=8@:CAQ MTY@4?HD,58J=H39-;$C?:Z<5/DM?Z%[=^ Q4%@P;QZ**:N(V;;*V#[7,R9DN M.;2OY*@/%;;SA<<[U+P8F4(W!RP?[N4LEC7L7HA2B^RCCHV'=W(-Y8:7-YZS M(&!%]^$YPKH!/*%!&I16TDZSJ1IL0OIP6J4WZ);0HXD(4$N-R/VBSQ:"DZ0= M0-3G1H/;/F'>:3U?L,:*KKF9]LV@#0@0LXBS1O'4EFDR#%'2LZW!-!I1AP&G M?G' X9@'^7JRRQ!)^4''TSXVETNQLFQDWJRX_=XD^H*1$Q";U#NXKX[&JJ7J MDEDA(6=UW+'\?(=QW%)97-,Y>@4&L63@H:=2*ANA'A3] \SM"_(\5RL-640_+W8='V ).W ]E':53FP[#);1E2X;';LB,E"-3*Y7MR&P'2 81&C" M:7CGKKX]#4V=J)GZ@UZ5!"W92+.Y+[*I99N2&>Q=LRFZ7.:WDI5$)AC4,K=A M&.P,(X?<9D*;@%W1-:&-=\!LZ-[<\_5+Q M5ON-P2VBI#6VSB9/#D?*IZ__]!)=+5_<*Q?Q_2Z/!2[IY'D!YM<.,M:^\ '] M3S"G_P!02P,$% @ ;8M<6)5X!44+"@ #!H !D !X;"]W;W)K&ULS5G;;O FAW9F:U_VP30) HV^G#[=H,XWQCZXM5)> M/&5I[BX&:^^+MX>'+EZK3+J1*52.-TMC,^GQ:%>'KK!*)KPH2P^CHZ/I829U M/K@\Y[$[>WEN2I_J7-U9X'E>R)6Z5_X? MQ9W%TV$C)=&9RITVN;!J>3&X&K]]=TSS><(_M=JXSKT@2Q;&/-##I^1B<$0* MJ53%GB1(_'M4[U6:DB"H\;V2.6BVI(7=^UKZW]AVV+*03KTWZ3>=^/7%8#X0 MB5K*,O5?S.:CJNPY(7FQ21U?Q2;,C4X'(BZ=-UFU&!ID.@__Y5/EA\Z"^=$+ M"Z)J0<1ZAXU8RP_2R\MS:S;"TFQ(HQLVE5=#.9U34.Z]Q5N-=?[R7JW@8B\^ MY2' \-3YH8=@>GT85T+>!2'1"T(FXL;D?NW$=9ZH9'?](11JM(IJK=Y%KPK\ M+/.1F(R'(CJ*CE^1-VFLG+"\R4^L_*(*8[W.5^)?5POG+3#Q[SYS@[3C?FF4 M)V]=(6-U,4 B.&4?U>#RS2_CZ='9*[H>-[H>OR;]KT;DOQ8B/MZ]^64>C6=G M3B"G+0\Z(:T2R&F9ZS]5(G3NC?!KJQ0RCGPE%ZD2+DAS;\6=LL[D,A7W6^=5 MYH;BSF(-/#H4,D_$>V.Q2GJ%G1^5\[QL],,R899+#(G89)FRL<8;6AU#H1(# M2"OWX$WA>#0W7E%:8[-$>1FO22=7+WA4""@-##G_G0]V#6&%SD6<:M)@V-TI M,PN=:K^%M$<=TT(+L3H5A8$I!V9YX"2,WB-O14=G=[?W?#<^VQ>NMCK1KDCE M%G?K[<+JI'WCS-)OX%2Z2\O*QU"58$*[]3A#YW%:PF0P8T$^Y_F)*E*S)?^1 M\OE2K\HF9'BMGKRB9!/8R\H91Y#(-9(_&ACMVG M/!XURZYN/M2+>OR\LJ8$IK3';6H6>+,@(Z&1B&4A&15D>94$2BQ-BJ)%AC43 MRYR6;]8JKQ)DYRT= 9CG/\0A]V/>+K< J90NK'@R.W!,%XWA=0#N;]XU40O5"T$8@7KJC)<":%TILGX'L&VR MP/>=9&V$T/A:I04%)@.^<[0,'*14+U6\C5.6B0%M*0PA\A!4E)Y6-]G\WNW MJO$AF1<(NHED M0?,PC.V2BB!!=VG0H1<*'=D:KU)G@J^@ %SUFY4%/!S63#ZT<^FYSGW]9^ 5 MI UAY5F] :,!7I:+@K0/BDK5;6E?9X>-YBQLMT. D3.QU0L"#[6Y;>[?+I>P MJYU\W\ \42G:4?BK6Y;#[,I3KL]#PQ^S!3GGGBJ":]9K//*4: M>9TUKU4D]1]UP@1'E4_&#R'MJ@:%^0O%LER!$*C#QPK4#M07;8A,ZHC7==,A M6F(/K/E!.;W*/RLHB:??49N?^.Y3GNB5X>EXN@./?".AW]0"GN?E^ZTCNLGQ M1F;%V0_IT9#SCE8R231'*6L@P47^19\P/[>,[4I0(]-&Q55:GW/]:ZCSAXK(D&:(CT5. M)JL -:YX7>_4>_A$YX \0=^B4$H/%./2 JE,3D_A:4MMHJZ="Y8X//:%S\U5+! ?X MJM35RJ7J4:5#%8N5TX\A$DWS->U630DN=47(V%$=)3? BQ$E0)/F@/B??-I[]HAQ:JB" M_ A@CYV3PZ_BNGPZ/B$_T_FT4YG&@UG4T@; MSH\F/YY[YA@^%:?#\?RDS5',G4[H>C+KI:?Q,(IFN$[F\QZ^B"!J,IVU \?# MR>P$U^DX>B$O(C$67PVE805!D;>VBO$$ZDWIW^QT+FXYX'OC?>:6<716K>RN M^#6L.0DWM.HZ],P.31@R&J<#^:1ZOEE@P9+:/ MRV3_F0FJWI()J_-9!8Z#0%QW_$&@ZB9@: K,M%$I$'DX<3&E+;;'M M=R06G2\PN-0NQCY;;,1IQBV3#3*I'\&:G6J.!41AA/^VHF>D6IP:AQ-7Z"]H M7=W=5 >&&@CL(:;4>A_6/5!#TP()C_KFED')WZFJH;-KF[\.NBM _9AXX)^> M;!T% Y=I.*?A@.(HFG30KFA_U][.68]4@P9< 6O3 6-M$B<8(XCT@5[2J5C7 M9]KG9H$C4:.=1A/30.5_,2:XL=:F,F0MZ5.@T!FZ:Q\ZD0GC!9)7W4 M,MQEZYTW+Z5O0&[S%L[9><8\/C:W'PFO[YJ/A*.^;\"'G2_TL'?%OT-0HX1Z M&S[6-Z/-3QU7X0M_.SW\3G*#)*4/>ZE:8NG1:'8R$#;\]A >O"GX>__">$"5 M;]=*XG!"$_!^:8RO'VB#Y@>@R_\ 4$L#!!0 ( &V+7%BK$:? H@4 'H- M 9 >&PO=V]R:W-H965T4'3M+LF![B$)2Y_*= MRW=$GRR,_>XJ(B_NFEJ[TT'E?7LT&KFBHD:ZH6E)X\W,V$9Z;.U\Y%I+L@Q* M33W*DF1_U$BE!VS*GIV8SM=*TY45KFL::9<75)O%Z2 =K ZNU;SR?# Z M.VGEG&[(_])>6>Q&:RNE:D@[9;2P-#L=G*='%V.6#P*_*EJXC;7@2*;&?.?- MY_)TD# @JJGP;$'BWRU=4EVS(<#XJ[GIU8LQ"6I6&-%R'4H UP2G-1;KS%6P4]?W9-SMNN M\)U5>BZD+L577Y$5EY6TH,7T6#VA,%[.4OCOB::NFI%.?<(;5898>'#MP=,O2?38CX]4/Y'BZ%"WTQ((L M">G$S-28"^Y(?%2ND#47.0^6Q0W=DI6ZH(#IPX=K\;/1>[6<&MLC;*TR=F]) MT@:;3NRD;\4WXV'FLP99ZAJ\=RAK83MV+>MHSG$L7PMOIC#2=U8N7HO#0SQ2 M?F2\2 [7.1CG.,K%&"?25:*52\PE#X?[^5L\\,?_#[*W 6/!,@S:!)BR_!,\ MC@J9"-G*CL4.A%?KQQ&B\3M._*KW@>D@86"\6JD"];B/N3 .'I0N.FMAS!M1 MHJV?-C8>3_@9(M]_QX9W\\D!BCSCD0D+2HM+)-#4J@S\P*;$.,;JH@=ZPW/' M]>4(?K47M9)35:^A.5F/:MT+I^G#[8OJF6UIW:_R+#Y6E4TA M^6[]/LW3AQ6><&7'^,LF>!S^>XFYL#N034-CO*BTG)[]@^VJ+2A6 #O:Y#C-. M:J_P9HGN:=J:/ W!:%$:.-'&"[IKT0N(="EFG0U6\24D"YT5P9>(R9E"A18) MWB'F*+H=_I/77S4R>$L-%RL]C,7:W1PC%T;:DJ&^5Q;.C75"MJV%3AD"_]AA MPA#Z5);+:'*'CUD_2XX?^@O'Z?%;),\3?Y*8&*3EM"91JKEBYF#2:Q4A.*L M M39*$-?;#@N#++(E<-.A\D.-ND5XH'S&%^8#127M>WHFBIP&RO6WZ=3I,Q#2. MT(VVV99)A@=KF7:C2T6 M0!N565>OA[_<4(R-WD8 A]A;&S]K7;O^0#7QD7:"KY>X:[ M'4>O]+H[A*>BTJ8V\Z58=<*J0= 0Z)P^I*V>0GK,W,H&[-&XZW)#K%RS,-.Q M5"B8!MEFUC0"5#8,9[/?@L)0? OTBDFZS_I]IGRE;+G72@MJPNV,G(OZ?!51 M!6UF[I%D@+)(,E<$_4HDFGB=B]QY^!EAXMY_SXSQJPT[6/_<.OL;4$L#!!0 ( &V+ M7%C^%W-OL0< +(3 9 >&PO=V]R:W-H965TB'= N:+K=#Q?W RT=VT0I4B4I.^ZOWW-( M299=)QUPAR"V+/*\/^C#PV8H*Z?NV)(.5 MA76%#/CIE@-?.I)Y%"KT8#PNW?7E[8*6AFZ=\)712'=]I:T MW5SU1KWFQB>U7 6^,;B^+.62'BC\6=X[_!JT6G)5D/'*&N%H<=6[&;V^G?+^ MN.$O11O?N18^UCI[K4D6[%XW MVM_&V!'+7'IZ8_5_5!Y65[U7/9'30E8Z?+*;=U3',V-]F=4^?HI-VCN=]416 M^6"+6A@>%,JD;_E8YZ$C\&KXA,"X%AA'OY.AZ.5O,LCK2V@L.J@ERX_D1!.4*6@Y F%_?6AU\Z]V[)T$(%<:^E\9># (LL-\AJ M[;=)^_@)[1/QP9JP\N+.Y)3ORP_@:>ONN''W=ORLPM^EZ8O)Z$R,A^/I,_HF M;?B3J&_RX_#K4+WX[\WX_.]8P$G?]+@^;J'7OI097?70(Y[/./MM/5V^ISV_[M8_YYV\7E%(K-%:0W6O+ +\>[^YY]>C4LB"?3PK#DC\G1J_<&+:PU4N/% ["A,DKAGXB8N_'%WM6O M]?_W:^]-0, 0C-*SEV(V%:.Q& W%%']WCR4X#ZXC[94S I4HX1WRXPEY>W$^ M.L7'#!^C2?,QQ3^^;PKK@OHF0U,^$!PY)S52>I,%Y$])+;3U4+,$Y9\*V&[= M&B4]^+]WRH+ZNS&V!6]V-]]CEILD^Q\QADJ"<*ZR)Z R@>^G'.HK\>+E:?R! MT1%T*D=T[=#"SK_#.Y]M0#P_L'@"FR?1T G;345AV^GF75%JNR7'* U.S:L0 M"\S9>UN9'/@$:K3*MGLMDNXH+X(5"VP33#U-XY013-ZB$V3 "AC_"T$EXB,) MC[A!, Q4415P<6<5%?]: 9FYF&^1B@RQ+>V:G.',S@.F: R5:+[/'O#^[*]>-&.LBR=?528E:2WXF0Z M:^#.07)\IFFNO4#/#@71H0>"48BEOU92JX5"A!'2I73)+28$#NM04U=1QJEH M:YQIJ0HOD!+Z-D_8<#+Z+K:GDE)*A?WG3T=0 MRFUB0JS\XP0EK>-_/2]/T+]%HMR3LMQ>R2T[UVHI$Y)R@H:<:6L-OK&59^:J MBC*NH@)J 4XBDP&)F0B M6\BA"-2,,OBTJ. YU;2$B&^0DL _7"+F>D1R.T/88R16J?]2S1&/9O+W.)GR M7BD,81].\$+FH#6H0%0'W8LU5@SBPQF7I4RDXA\/\E3#8UZW"3P6?(RHB!-6 MUH0&RU6MG,=^JF6;HPA2WH/&,7].G3=OC8L*'-*!D!1C8JK'BDP1'DF9J519M9B+V[[SW:8" IUU>W!DZVT_@>,B1 MS,8X[M*7J /'P M^39>C2Y.8QOA&,Y63D;#W7A?U+T6CPRI+(>E32GA0ZNK0 QQB(*&W9(XN_"X MT[2U[QY7(M%1V ;^,)L7H_:3J&[R$EG8.0,FW?= MT>DKN'6LK_CYPL:YD\=%6Y8@ILJHL$TC%!DV<'1%4J.G,J:X.%?EDIKZUNS4 MF#TXN<5^X416)6N&OV="O2MH+O'WL< M'W3>HQ0$2_RVR(L85GJETMYM7TC=I/&ULE5=K M;]LV%/TKA)MU&^#Z(2=IVCR I \T PH$2;-]&/:!EJXEMA2IDE1L[]?O7%)6 MG*Q)FB^V)/*>>\Y]B3I:6O?-5T1!K&IM_/&@"J%Y.Q[[O*):^I%MR&!E85TM M VY=.?:-(UE$HUJ/L\ED?UQ+908G1_'9A3LYLFW0RM"%$[ZM:^G69Z3M\G@P M'6P>7*JR"OQ@?'+4R)*N*%PW%PYWXQZE4#49KZP1CA;'@]/IV[-=WA\W_*EH MZ;>N!2N96_N-;\Z+X\&$"9&F/#""Q-\-O2.M&0@TOG>8@]XE&VY?;] _1NW0 M,I>>WEG]ERI"=3PX&(B"%K+5X=(N/U&G9X_Q@)B)S]:$RHL/IJ#BKOT8 M='I.V8;36?8HX!_2C,1L.A39)-M]!&_6:YQ%O-D#>.'JOCG1Y(3XNZ/$;E3WOI&YG0\0"MXT&)!L4%$0)B<#"26THML.MK_ M14A3B.D^7[%MJ+"IP)#(1]GIT-1(+*LA)+7R0H0T6D#TENP"CQ.=Q[C_/'5G;Q]#0VM..U08#'F5FH&]S\G00D&@(QUE0'>!!G&$"*I =63+CIL[Q1.X M>&(>/0E9V]8$WIGK-OJ<3;9]/N$/I1%[8W%L#/-MGU:<'91[;;;YX>25CEY?Y?[_:QC0N??D."8PF'2@X1B.:VT M)EJ!)&H@OD11]*]D\16S'9L>V(\"00KPG@SDE-0C<6TVY<5C[,*F('AQ&LOS M?N\-H\:4&EXOG86.UG!AE$;]R]'<%L4ML#,=96*>@CADHV6E\DJT#0=^YR [ MZ".\M*TNA(S=\40?J@442LT>43 VH*V?XH*"@8G'X_E:[&2WQ?2,V3/:=$%T MP)B((R*]J<;8F;<][2D$33AJ=)GJM],*AQ\N\I@^(W507'%Y[EIX!:?'9#S4 M.9NE=\B?U:J(M82;@ET5X@ICK^.")&SF]^B!3&]-64BN9-&SVYE.]OK8Q29Y M/=O@%SN M-]F&RCH58^>HE*Z(78AHH;[A- +?8/PRZIV1F+ROFCB&D;E&\V@"2ZO;T#7[ MIB\8;XW9V_G>X/'C;0*\V"7 T"H(GARQE**O.6E%-RP5M<)LI;<&-;(6#:I6 MQ1= );$&/K12/K"2IRJZEFO< *QH\ZZL9V]NN^DA0L.NQ=C%,[H,*L#SAOG7-PH:7&)[!J\XJ]P9E,X??S&<75_%J>O@[ MLT"9(UDQ]-(DORQB*PW99'K0-=_TS;9TO#U;!W$_.@B.MP[JT%;&SQ&?PIS. M[/W3_HOG-!WT;[>GSZ7/>/LI-)JF!4PGH]=[ ^'2)TBZ";:)Q_ZY#?B(B)<5 MOMK(\0:L+ZP-FQMVT'\'GOP'4$L#!!0 ( &V+7%@[IU6+T P -&PO=V]R:W-H965TG+B\JVJI1N9G6KP2VEL+5M\M9L3M[-* M%KRIKD[2\7A^4DO=')T^YV?G]O2YZ=I*-^K<"M?5M;17+U5E+E\<38[B@_=Z MLVWIP\+M6EV[P M69 D:V,^T9>?BA='8V)(52IOB8+$[4*]4E5%A,#&7X'F47\D;1Q^CM1_9-DA MRUHZ]RR;6LQ$^-5SB0>W[2XB!:?I('HB\]T?0+1*?B MK6G:K1.OFT(5A_M/P&#/91JY?)G>2?!GV8S$=)*(=)QF=]";]E)/F=[T"_3> MV8UL]-\L7B)>F<:92A?2VTE3B'.K'$'"#TPYP.4#'C)<3OSW;.U:"[/ZWVT( M>0:RVQD@5WOJ=C)7+XYV=):]4$>GWW\WF8^?W2%>UHN7W47]H4K]UT3%*^FV MBJO3E_(BI$B2"%E:W7>JL+_?N8(6"BV(W)1M^)=WIJULO'!%.1A]E4% MZH[),[$;)SP2:9+.I[A/D\EX(=Y?.^WQY(F8S#(Q26>\-ILL>&TZ3?FWZ^NU M \.5I.^M$;(V'9T"9Z-H@H?$Q%95A8#0:[6554G22-%NM2W$3MKV2@ 6 ?LH M%$CE"JRN*^4$U'VA3>>J*P&C*T;B+,\]]??]*O%QJX2L$#"!L6)"N56%;D5E MG%.'O,7M^T,\1%O9;+#T4ED\<"!"]-Q3T+9*B=H[J"('O:F%(>@O9<5*D:58(]PN .MA_/GX@?5-%Q0':):!1O >?F M1H MQ?3)\$"P=W#4,A-OSD77ZDK_C=6YLBWRCD?]V*,NK27!O8OR;THT9* 5U-=9 MIXC@NG.P;N<(&-I&S]Z<.Z][0J_2,"YP?H58VTA/CG^0E3,$^\Z:"PW5[A?B M8>2'2#;*.GI6RAS<4M0@5K3E+$40YG*'QQ6D!P7K&1Z1YL%BZ;T+JX;B).)R MJ_,M215/RK7-N]JU!)@#KU<0LNEYT$S>BYV0!R)5T6Y)=MFX$G[&@G__W3*= M+)ZY T-EI]7N$PE!( Y 'I'WMLQI).3$7YVL='E%D+:V4\))HM+!P"SOEP@? M.O?VZ6V6Y-L /6(^X34'Y\-N"W5,_&\0JV&FI34U+]L';#S%EP)% CY%P_E MV1!'[^"O<*47=G+ *-&.[M"1P,\?U* M7//\W$@H7XEME!D>B4DVH>MR)C[>B.84PBF-K):XSA ]F M&Y.0YEP13 "Z/KLE67R;"?S47 !N U ?DL!1-6C4JH78&%,XSL#SL<_:J^E8 MG'<6:8N.)>:]!9=RC<0LO0T[5BG>,YZM@ MZV?8!%(/X98K'HU?]UH:ZAZ:0!VQXOLT6U'1N).Z&*R._B8]#UBVF-.F;"9^ MEU6GCF5!9MK*S^I ):M))I:SE'%9C%<>IVR.$]",(1 EXAQ:\0GI-;+'CEP@ M$;^J]D%R_@(Z"7*BKLB&/.P5(H[:DG7KFG)=B&)4.TVSI;\#^[!%N"^7*W8(;%OX>[H(BO_5-,?_!^7_H) UK-=.5*"O&,>^RIS- ML!Y^M]&,)X.+9Y E M&M,N]+^\QK@6^; -U0)"EJ^Z NWI:H:_:8!A.1OCCWQKD65>KA&H.5'E*4P*I!B0!7P '^ZOE"98#: M(;K$)!F#\]4J$Z_K766N$-]S4Q,D^U8M@C"'56(]O.0/S@O(%;,%S&L.D>$T MDEGSAE<-A,YF*Y%!I1^AY7U:3)Z*!"E7LN _EE) MZZ&7^7Q)URG"KM/R^!S=2JES7O.SW*%4I7YZA6L&"_IHJ&$AB0:6B07+F?^P M0!G$B8W@>Z]H)DA(G2O+(P*J(]X-JL;;?<,7PE"MKAG4BTAP4-PBQNCR6#T:A(U08)Q#%'8V2 MH)2*62IT/SFA;LE2*@4KA8$K4O%<:)>CJU:^.MZ@#=E0BQFX"4S^:\1T^90] M()T_8X+47!*;S#R, RZ%JCFPS)(4G>VG9J91X@HP"4[YSCVC#T-RT8KZ9NMV M/OPTIF\#:5;@FRU. 4A_Q]1<0;R"!K18?+E5OJ@-< _Q KT:*@Y"SAMWE:^ MF>-%WL!"E^M'KLK>X)6*Z('^;T+;;E&UX_ +B:8F%-:-;-&V<4?3 P^]@H6* M!P82K!KJ(SM.::[45/O>"D+LOKZF,FJ;7;?^$T+R2(+'0"%#7R%;"EF67E4( M.<2KZ1P-*1 >78*=^98[>&5K*#9*'/6.%;T)U*:@4"'WS:8L_@1Z?4L=FYP1 MM1-^SSTRXVT]8S*<4?0,#+/3VK)5D_I&B_/KY+.-+!*E&3:0H:%J(V MI&\_DP'LI?ZLBF-ON YM#HP[V(A&8FWX1)I*XW?H/,R2*FK'2]2:1.K1>#0; M!L7HRP-'98\@5H80?U50/TNX;@*C?3?F1\^*NB&J,X6C:+H?L\$#3=7Y*;6+ M>\JPIZ]-!R.\.$N+BWFT)0R#TC5AM.=4584!GJ6ZGIX-C#*.DH:>2$<0<+G> M^8JA[&?FND%Z:SM>-Q*_A9F&=I$_,G@_6PIDKGP,N@-+QA#X'/5_L 7U,D(RP*ACA$P4AL),[WK!EO:CTIKW0W M '\K+V@$1*TE64$X*V)(L2<$E##A*&*.>'/.J;//@DR(YFF0S]2H6W0L"WE, M%WGXCQM"1PDEG!@LB,[2GJ(,P_N0#E@'H=EJ+U5(*VXX&* '7](L:C1PUH0W MD#'C#*!(#L395:K8]+TB'-Z/$2C.,^0;N#DZ&[(*>(E3N5=)# WHC6K=MCP^ M"5":>]L- XM]-'SCZ$(O*'P$$*52/EL=#-J+FJ8Y<&0J);RS!Y=RARCUSHI739Y4PEB?F^P$G+)F+,'J+B2BGZFMO.NZ3IL7HMG>Q)X.7[2@4-_PO M!00XSO7OW?NG_7\MG/F7]?OE_E\>WDJ+Z.I@IB6V KW9D<\N\4MK=OSJ?FU: M5*7\<:LDU$@+\'MI3!N_T ']_W*<_@-02P,$% @ ;8M<6%=*IH'-"0 M9!P !D !X;"]W;W)K&ULK5E9<]LX$OXK*$UJ M*E,ER[H<'[%=E6.RR58RR8Z3F8>M?8!(2,*$)!@ M.+]]?MU R0A67*2VGF1 M2!R-/KZ^P,N-L9_=6BDOOI9%Y:X&:^_KB^-CEZU5*=W(U*K"S-+84GJ\VM6Q MJZV2.6\JB^/I>/SDN)2Z&EQ?\M@'>WUI&E_H2GVPPC5E*>W=KM:>!X^O+6J[4C?*?Z@\6;\<=E5R7JG+:5,*JY=7@V>3B^9S6\X(_M-JX MY%F0) MC/M/+F_QJ,":&5*$R3Q0D_F[5"U441 AL?(DT!]V1M#%];JF_8MDA MRT(Z]<(4?^K9PO&OV(2UL_E 9(WSIHR; MP4&IJ_ OOT8])!O.Q@CQUG<^SSLG1[8.Q/O3.773OQ:Y2K?WG\, M/CIFIBTSSZK!-NQO1FWQ1.O-0N*XQKK'+BW\\6 MSEO@X3_[9 XDY_M)DH]/X0]6]8 MXWOW"GZ\Y4?M"*-8F@OIA%\K45N=*3Q)#X=IBEPL%+PK4W".7'@CX#&%D/ 7 MYQ 3C!6UU#P!E55NJ:R0HM!RH0OM[\1CK%1?M0]D?Q&ZHKW&YLH6=V&+#/ZW M4'ZC5 7PVL\@7$OK=:9K67DGP NQ5BI)%H+/>Y%+KT8B$>JU5E;:;'TG7G\0 MC8,=24+)M+W*UI7^TB@7!)-6L:_FHJDQ;19D*+DH%)C#6)4,Z*IN$-;$^]TA M)I*K6\2MF@@Y7:U:YL&<1!S+UJ34NED4.H.T\E;J(E((X9+C#DY$I*$PQ$)" MKTU9TY3;JXM@% @X%)NU!K$][.[EC8@OE//;IW<\R05B\H]Q,!+/" 2.96AM MKE4X/BM 1R\USH?1B>ZRA]VZ,U8P@PDKD *(P8(X#Z($>P&E3J\J4,O 8-M MFUZ"C OQEK=/?O[I;#J9/OU78SQ.8/PY\;BI9/X7XJ;* Q@YZD*.,)X(-XKTIWOI$P&G2^C4[M]^_]"A^'*/1,_#]]!KN>^P71D?#QFV MB##0F*45U; MAXF/Q,=#,%E!EA"?ULBC!!*P;RQQ!#3L<0!"9$!3NG"O:_.AIL!R=A.>X^!- M8'_]@44Y?>I:_>^"O5-@!&%.X2H1@KR,(FAC+=$'X+6[@.<(LQ3(: UJG2ZI MQ>'WF3<+F"L.S](X]ZX]Y1-[]>&9Z 8M7%O+B(_& U/KP^]GYO?=_F%MEJQ#=B=[C MR2]B,AQ/S[MU[7\8G0S/Q^,][!M/[]@9.C!PC(+E)XQL>WW,0 MR+N#$@I[G@[]!XA$;WA$QC@EXYX^.=LRZ61X-A_S_SEDI?_)],G6BMEP?'(N MWO:^='%0"6\JKRQY,\.MUT!*;CY[Z/7D;/?U>Q0[/]O_O*/PPXK]UG^J^*#8 M-+:D'$_/)P^_GT[OO9,+[;J5KK*BR3ES]&AOBY5/HYL1RC*.)'>41Q3R$P^B M!2,=[6"\,M413Z_Z4Q8&@!]1\:_NV@(B.(%F%PP5P6J'+:(&[>=A=B)\VOC-&7B\A[/PRTW'L8\ MRAPGJD".P29=,(80WST%8 3RK(N0Q,(R BX1G37,DZRU(3]FI@0C LU=]ID' M5"_+B'CGQ.)$1G*J'3GI'=O1$->"L_5^$:S#G7D-@W,OD%JO M:Y>'$<:I;]Z';?2[U@E3749-^ZWN%VA!A$,O2?H'AVU_$TW+L"92:2\%HJ6+ MO3+=)09X^305<>0EY1(7U/%LJA0M(0@A&OO[EF']M)WF6N4KRC*N;->G>XU,-#9&=AVO?F#MOX-E7C2B_X:RL"DZF5;T*H>#VUKG]B="OJR)[.G MFMR]ZL@,7]DYF!3^I"VM&HKVEHVC>)(SPO5R#&&CW9-[#87V5_%S8B-(+YT5S!D@7\:AL(5"EVWOXP O9]7SA.OOR4"J+0]RT7 M*JKP$:@;[3ZA/0M?COKEX?L;L+4";&'I);:.1ZQ?"1.7T#ZFNG%]('IF5DL%ON!MNB8:%GTD)*3S*_?5T5*HFS+B;OWP'Z( M(TMDLEO5&9N M7QPE1]6-7_3-HJ ;YR^?K^2-^J**WU:?+;Z=UU12O52YTR875LU?'%TG3U^- M:#P/^%VK6Q=="Y)D:LQ7^O(^?7'4)X94IF8%49#XMU:O5981(;#Q1Z!Y5"]) M$^/KBOH[EAVR3*53KTWV-YT6BQ='DR.1JKDLL^(7<_N3"O*,B=[,9(X_Q:T? M.[HX$K/2%689)H.#I<[]?WD7]!!-F/0[)@S"A 'S[1=B+M_(0KY\;LVML#0: MU.B"1>798$[G9)0OA<53C7G%RW>S0.:5 M)S/H(#,4'TQ>+)QXFZ#O03_*O,S,4QZ8M ?C/;0&]9R M#IG>L(/>^WRM7,'2]<1UEHE/Q4)9$=T6_[B>0@-PDW_NDM^3'^TF3Z'SU*WD M3+TX0FPX9=?JZ.4/?TDN^L_V,#^JF1_MH_YX(WT#&?%:NH5X^T>IUS+C&S)/ MQ?5:ZDQ.,W6*N#_]@B8"-BH1R+69PNU/L\),H=MP>RA>&U>('ZUQ M3OR6 SDR_:=*Q8] C.V[/]/W=U);\;O,2O5=<]_GB)@L0_!O2_D4E.W*6%DH M!/&T$,=BW!_@\X>_3 ;)X%GKRC\93ZZZGN/)CV:M;$[J\?227G]P58^I_ON[ M2>^JW]_QC.[^:@H8:$;LJL@H26\\3'9,H;N#WFBRO92_N]^03T7C$QH^H8N2 ML5)'_C'>^#M%]504L)IV:EU856WIF695%B@7F9ITZ,^F(\J*==#>C& M<%+?N)P$#<@6XXX8UY$'CH8M,F.Z$9&9)%V*)(8>H'U,>KT5$I"H%3+*Q2 M8NF!U%B1*?BS+' ?/DJ.BC%R!I).^XQFE9C!N76J+-Q_4]2SKC E%6P&:8]7 MF4EK[W5^(^32E/!DS-Y6X&IES9T&ZUAS3M&VYFA+\5<8)N,6QA9BI:PV*0N& M-$[/@KCW9^)7C().MJFP&M1#%EK*>Y&;0DP5"@,&W+R0E-YI/A-R( /5W2+^ M_:B $< -HC^'2UIU!A#(&?+++6/$RV'2#H8XS"-7OX45A'1B;C*4.HBM+I1< M0CO,#(-;!V"]*4ED87(E[I6TY&W\]]'DI\LFU,@RQ7W,!B:M+*Q5*'C@0F5P M#+-8@B>F6L$LZI[S$I":HQYE,IVPE?$E1C>'JE

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end XML 102 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 103 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 105 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 341 379 1 false 108 0 false 13 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.hp.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Consolidated Condensed Statements of Earnings (Unaudited) Sheet http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited Consolidated Condensed Statements of Earnings (Unaudited) Statements 2 false false R3.htm 0000003 - Statement - Consolidated Condensed Statements of Comprehensive Income (Unaudited) Sheet http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited Consolidated Condensed Statements of Comprehensive Income (Unaudited) Statements 3 false false R4.htm 0000004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) Sheet http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited Consolidated Condensed Balance Sheets (Unaudited) Statements 4 false false R5.htm 0000005 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) Statements 5 false false R6.htm 0000006 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited) Sheet http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited Consolidated Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 0000007 - Statement - Consolidated Condensed Statements of Stockholders??? Deficit (Unaudited) Sheet http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited Consolidated Condensed Statements of Stockholders??? Deficit (Unaudited) Statements 7 false false R8.htm 0000008 - Statement - Consolidated Condensed Statements of Stockholders??? Deficit (Unaudited) (Parenthetical) Sheet http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnauditedParenthetical Consolidated Condensed Statements of Stockholders??? Deficit (Unaudited) (Parenthetical) Statements 8 false false R9.htm 0000009 - Disclosure - Basis of Presentation Sheet http://www.hp.com/role/BasisofPresentation Basis of Presentation Notes 9 false false R10.htm 0000010 - Disclosure - Segment Information Sheet http://www.hp.com/role/SegmentInformation Segment Information Notes 10 false false R11.htm 0000011 - Disclosure - Restructuring and Other Charges Sheet http://www.hp.com/role/RestructuringandOtherCharges Restructuring and Other Charges Notes 11 false false R12.htm 0000012 - Disclosure - Retirement and Post-Retirement Benefit Plans Sheet http://www.hp.com/role/RetirementandPostRetirementBenefitPlans Retirement and Post-Retirement Benefit Plans Notes 12 false false R13.htm 0000013 - Disclosure - Taxes on Earnings Sheet http://www.hp.com/role/TaxesonEarnings Taxes on Earnings Notes 13 false false R14.htm 0000014 - Disclosure - Supplementary Financial Information Sheet http://www.hp.com/role/SupplementaryFinancialInformation Supplementary Financial Information Notes 14 false false R15.htm 0000015 - Disclosure - Fair Value Sheet http://www.hp.com/role/FairValue Fair Value Notes 15 false false R16.htm 0000016 - Disclosure - Financial Instruments Sheet http://www.hp.com/role/FinancialInstruments Financial Instruments Notes 16 false false R17.htm 0000017 - Disclosure - Borrowings Sheet http://www.hp.com/role/Borrowings Borrowings Notes 17 false false R18.htm 0000018 - Disclosure - Stockholders' Deficit Sheet http://www.hp.com/role/StockholdersDeficit Stockholders' Deficit Notes 18 false false R19.htm 0000019 - Disclosure - Earnings Per Share Sheet http://www.hp.com/role/EarningsPerShare Earnings Per Share Notes 19 false false R20.htm 0000020 - Disclosure - Litigation and Contingencies Sheet http://www.hp.com/role/LitigationandContingencies Litigation and Contingencies Notes 20 false false R21.htm 0000021 - Disclosure - Guarantees, Indemnifications and Warranties Sheet http://www.hp.com/role/GuaranteesIndemnificationsandWarranties Guarantees, Indemnifications and Warranties Notes 21 false false R22.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9954471 - Disclosure - Basis of Presentation (Policies) Sheet http://www.hp.com/role/BasisofPresentationPolicies Basis of Presentation (Policies) Policies 24 false false R25.htm 9954472 - Disclosure - Segment Information (Tables) Sheet http://www.hp.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.hp.com/role/SegmentInformation 25 false false R26.htm 9954473 - Disclosure - Restructuring and Other Charges (Tables) Sheet http://www.hp.com/role/RestructuringandOtherChargesTables Restructuring and Other Charges (Tables) Tables http://www.hp.com/role/RestructuringandOtherCharges 26 false false R27.htm 9954474 - Disclosure - Retirement and Post-Retirement Benefit Plans (Tables) Sheet http://www.hp.com/role/RetirementandPostRetirementBenefitPlansTables Retirement and Post-Retirement Benefit Plans (Tables) Tables http://www.hp.com/role/RetirementandPostRetirementBenefitPlans 27 false false R28.htm 9954475 - Disclosure - Supplementary Financial Information (Tables) Sheet http://www.hp.com/role/SupplementaryFinancialInformationTables Supplementary Financial Information (Tables) Tables http://www.hp.com/role/SupplementaryFinancialInformation 28 false false R29.htm 9954476 - Disclosure - Fair Value (Tables) Sheet http://www.hp.com/role/FairValueTables Fair Value (Tables) Tables http://www.hp.com/role/FairValue 29 false false R30.htm 9954477 - Disclosure - Financial Instruments (Tables) Sheet http://www.hp.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.hp.com/role/FinancialInstruments 30 false false R31.htm 9954478 - Disclosure - Borrowings (Tables) Sheet http://www.hp.com/role/BorrowingsTables Borrowings (Tables) Tables http://www.hp.com/role/Borrowings 31 false false R32.htm 9954479 - Disclosure - Stockholders' Deficit (Tables) Sheet http://www.hp.com/role/StockholdersDeficitTables Stockholders' Deficit (Tables) Tables http://www.hp.com/role/StockholdersDeficit 32 false false R33.htm 9954480 - Disclosure - Earnings Per Share (Tables) Sheet http://www.hp.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.hp.com/role/EarningsPerShare 33 false false R34.htm 9954481 - Disclosure - Guarantees, Indemnifications and Warranties (Tables) Sheet http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesTables Guarantees, Indemnifications and Warranties (Tables) Tables http://www.hp.com/role/GuaranteesIndemnificationsandWarranties 34 false false R35.htm 9954482 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.hp.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 35 false false R36.htm 9954483 - Disclosure - Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details) Sheet http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details) Details 36 false false R37.htm 9954484 - Disclosure - Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details) Sheet http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details) Details 37 false false R38.htm 9954485 - Disclosure - Restructuring and Other Charges - Narrative (Details) Sheet http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails Restructuring and Other Charges - Narrative (Details) Details 38 false false R39.htm 9954486 - Disclosure - Retirement and Post-Retirement Benefit Plans - Schedule of Components of Pension and Post-Retirement Benefit (Credit) (Details) Sheet http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails Retirement and Post-Retirement Benefit Plans - Schedule of Components of Pension and Post-Retirement Benefit (Credit) (Details) Details 39 false false R40.htm 9954487 - Disclosure - Retirement and Post-Retirement Benefit Plans - Narrative (Details) Sheet http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails Retirement and Post-Retirement Benefit Plans - Narrative (Details) Details 40 false false R41.htm 9954488 - Disclosure - Taxes on Earnings (Details) Sheet http://www.hp.com/role/TaxesonEarningsDetails Taxes on Earnings (Details) Details http://www.hp.com/role/TaxesonEarnings 41 false false R42.htm 9954489 - Disclosure - Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Details 42 false false R43.htm 9954490 - Disclosure - Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofAllowanceforCreditLossesRelatedtoAccountsReceivableandChangesDetails Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details) Details 43 false false R44.htm 9954491 - Disclosure - Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofTradeReceivablesSoldandCashReceivedDetails Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details) Details 44 false false R45.htm 9954492 - Disclosure - Supplementary Financial Information - Schedule of Inventory (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails Supplementary Financial Information - Schedule of Inventory (Details) Details 45 false false R46.htm 9954493 - Disclosure - Supplementary Financial Information - Schedule of Other Current Assets (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails Supplementary Financial Information - Schedule of Other Current Assets (Details) Details 46 false false R47.htm 9954494 - Disclosure - Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details) Details 47 false false R48.htm 9954495 - Disclosure - Supplementary Financial Information - Schedule of Other Non-Current Assets (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails Supplementary Financial Information - Schedule of Other Non-Current Assets (Details) Details 48 false false R49.htm 9954496 - Disclosure - Supplementary Financial Information - Schedule of Other Current Liabilities (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails Supplementary Financial Information - Schedule of Other Current Liabilities (Details) Details 49 false false R50.htm 9954497 - Disclosure - Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details) Details 50 false false R51.htm 9954498 - Disclosure - Supplementary Financial Information - Schedule of Interest and Other, Net (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails Supplementary Financial Information - Schedule of Interest and Other, Net (Details) Details 51 false false R52.htm 9954499 - Disclosure - Supplementary Financial Information - Schedule of Net Revenue by Region (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails Supplementary Financial Information - Schedule of Net Revenue by Region (Details) Details 52 false false R53.htm 9954500 - Disclosure - Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationValueofRemainingPerformanceObligationsNarrativeDetails Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details) Details 53 false false R54.htm 9954501 - Disclosure - Supplementary Financial Information - Contract Liabilities (Narrative) (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationContractLiabilitiesNarrativeDetails Supplementary Financial Information - Contract Liabilities (Narrative) (Details) Details 54 false false R55.htm 9954502 - Disclosure - Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details) Sheet http://www.hp.com/role/SupplementaryFinancialInformationSupplierFinanceProgramsNarrativeDetails Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details) Details 55 false false R56.htm 9954503 - Disclosure - Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 56 false false R57.htm 9954504 - Disclosure - Fair Value - Narrative (Details) Sheet http://www.hp.com/role/FairValueNarrativeDetails Fair Value - Narrative (Details) Details 57 false false R58.htm 9954505 - Disclosure - Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) Sheet http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) Details 58 false false R59.htm 9954506 - Disclosure - Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details) Sheet http://www.hp.com/role/FinancialInstrumentsScheduleofContractualMaturitiesofInvestmentsinAvailableforSaleDebtSecuritiesDetails Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details) Details 59 false false R60.htm 9954507 - Disclosure - Financial Instruments - Narrative (Details) Sheet http://www.hp.com/role/FinancialInstrumentsNarrativeDetails Financial Instruments - Narrative (Details) Details 60 false false R61.htm 9954508 - Disclosure - Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details) Sheet http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details) Details 61 false false R62.htm 9954509 - Disclosure - Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details) Sheet http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details) Details 62 false false R63.htm 9954510 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details) Sheet http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details) Details 63 false false R64.htm 9954511 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details) Sheet http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details) Details 64 false false R65.htm 9954512 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details) Sheet http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details) Details 65 false false R66.htm 9954513 - Disclosure - Financial Instruments - Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details) Sheet http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails Financial Instruments - Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details) Details 66 false false R67.htm 9954514 - Disclosure - Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details) Notes http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details) Details 67 false false R68.htm 9954515 - Disclosure - Borrowings - Schedule of Long-Term Debt (Details) Sheet http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails Borrowings - Schedule of Long-Term Debt (Details) Details 68 false false R69.htm 9954516 - Disclosure - Borrowings - Narrative (Details) Sheet http://www.hp.com/role/BorrowingsNarrativeDetails Borrowings - Narrative (Details) Details 69 false false R70.htm 9954517 - Disclosure - Stockholders' Deficit - Narrative (Details) Sheet http://www.hp.com/role/StockholdersDeficitNarrativeDetails Stockholders' Deficit - Narrative (Details) Details 70 false false R71.htm 9954518 - Disclosure - Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details) Sheet http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details) Details 71 false false R72.htm 9954519 - Disclosure - Stockholders' Deficit - Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes (Details) Sheet http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails Stockholders' Deficit - Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes (Details) Details 72 false false R73.htm 9954520 - Disclosure - Stockholders' Deficit - Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes (Details) Sheet http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails Stockholders' Deficit - Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes (Details) Details 73 false false R74.htm 9954521 - Disclosure - Earnings Per Share (Details) Sheet http://www.hp.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.hp.com/role/EarningsPerShareTables 74 false false R75.htm 9954522 - Disclosure - Litigation and Contingencies (Details) Sheet http://www.hp.com/role/LitigationandContingenciesDetails Litigation and Contingencies (Details) Details http://www.hp.com/role/LitigationandContingencies 75 false false R76.htm 9954523 - Disclosure - Guarantees, Indemnifications and Warranties (Details) Sheet http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesDetails Guarantees, Indemnifications and Warranties (Details) Details http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesTables 76 false false All Reports Book All Reports hpq-20240131.htm hpq-20240131.xsd hpq-20240131_cal.xml hpq-20240131_def.xml hpq-20240131_lab.xml hpq-20240131_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 108 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "hpq-20240131.htm": { "nsprefix": "hpq", "nsuri": "http://www.hp.com/20240131", "dts": { "inline": { "local": [ "hpq-20240131.htm" ] }, "schema": { "local": [ "hpq-20240131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "hpq-20240131_cal.xml" ] }, "definitionLink": { "local": [ "hpq-20240131_def.xml" ] }, "labelLink": { "local": [ "hpq-20240131_lab.xml" ] }, "presentationLink": { "local": [ "hpq-20240131_pre.xml" ] } }, "keyStandard": 315, "keyCustom": 64, "axisStandard": 29, "axisCustom": 0, "memberStandard": 52, "memberCustom": 50, "hidden": { "total": 23, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 15, "http://www.hp.com/20240131": 3 }, "contextCount": 341, "entityCount": 1, "segmentCount": 108, "elementCount": 721, "unitCount": 13, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 992, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.hp.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "longName": "0000002 - Statement - Consolidated Condensed Statements of Earnings (Unaudited)", "shortName": "Consolidated Condensed Statements of Earnings (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GrossProfit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R3": { "role": "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited", "longName": "0000003 - Statement - Consolidated Condensed Statements of Comprehensive Income (Unaudited)", "shortName": "Consolidated Condensed Statements of Comprehensive Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R4": { "role": "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "longName": "0000004 - Statement - Consolidated Condensed Balance Sheets (Unaudited)", "shortName": "Consolidated Condensed Balance Sheets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R5": { "role": "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical", "longName": "0000005 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)", "shortName": "Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited", "longName": "0000006 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)", "shortName": "Consolidated Condensed Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R7": { "role": "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "longName": "0000007 - Statement - Consolidated Condensed Statements of Stockholders\u2019 Deficit (Unaudited)", "shortName": "Consolidated Condensed Statements of Stockholders\u2019 Deficit (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-23", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-23", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnauditedParenthetical", "longName": "0000008 - Statement - Consolidated Condensed Statements of Stockholders\u2019 Deficit (Unaudited) (Parenthetical)", "shortName": "Consolidated Condensed Statements of Stockholders\u2019 Deficit (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.hp.com/role/BasisofPresentation", "longName": "0000009 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.hp.com/role/SegmentInformation", "longName": "0000010 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.hp.com/role/RestructuringandOtherCharges", "longName": "0000011 - Disclosure - Restructuring and Other Charges", "shortName": "Restructuring and Other Charges", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.hp.com/role/RetirementandPostRetirementBenefitPlans", "longName": "0000012 - Disclosure - Retirement and Post-Retirement Benefit Plans", "shortName": "Retirement and Post-Retirement Benefit Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.hp.com/role/TaxesonEarnings", "longName": "0000013 - Disclosure - Taxes on Earnings", "shortName": "Taxes on Earnings", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.hp.com/role/SupplementaryFinancialInformation", "longName": "0000014 - Disclosure - Supplementary Financial Information", "shortName": "Supplementary Financial Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.hp.com/role/FairValue", "longName": "0000015 - Disclosure - Fair Value", "shortName": "Fair Value", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.hp.com/role/FinancialInstruments", "longName": "0000016 - Disclosure - Financial Instruments", "shortName": "Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.hp.com/role/Borrowings", "longName": "0000017 - Disclosure - Borrowings", "shortName": "Borrowings", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.hp.com/role/StockholdersDeficit", "longName": "0000018 - Disclosure - Stockholders' Deficit", "shortName": "Stockholders' Deficit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.hp.com/role/EarningsPerShare", "longName": "0000019 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.hp.com/role/LitigationandContingencies", "longName": "0000020 - Disclosure - Litigation and Contingencies", "shortName": "Litigation and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.hp.com/role/GuaranteesIndemnificationsandWarranties", "longName": "0000021 - Disclosure - Guarantees, Indemnifications and Warranties", "shortName": "Guarantees, Indemnifications and Warranties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GuaranteesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GuaranteesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R22": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.hp.com/role/BasisofPresentationPolicies", "longName": "9954471 - Disclosure - Basis of Presentation (Policies)", "shortName": "Basis of Presentation (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.hp.com/role/SegmentInformationTables", "longName": "9954472 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.hp.com/role/RestructuringandOtherChargesTables", "longName": "9954473 - Disclosure - Restructuring and Other Charges (Tables)", "shortName": "Restructuring and Other Charges (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansTables", "longName": "9954474 - Disclosure - Retirement and Post-Retirement Benefit Plans (Tables)", "shortName": "Retirement and Post-Retirement Benefit Plans (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationTables", "longName": "9954475 - Disclosure - Supplementary Financial Information (Tables)", "shortName": "Supplementary Financial Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.hp.com/role/FairValueTables", "longName": "9954476 - Disclosure - Fair Value (Tables)", "shortName": "Fair Value (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.hp.com/role/FinancialInstrumentsTables", "longName": "9954477 - Disclosure - Financial Instruments (Tables)", "shortName": "Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "hpq:ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "hpq:ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.hp.com/role/BorrowingsTables", "longName": "9954478 - Disclosure - Borrowings (Tables)", "shortName": "Borrowings (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.hp.com/role/StockholdersDeficitTables", "longName": "9954479 - Disclosure - Stockholders' Deficit (Tables)", "shortName": "Stockholders' Deficit (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.hp.com/role/EarningsPerShareTables", "longName": "9954480 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesTables", "longName": "9954481 - Disclosure - Guarantees, Indemnifications and Warranties (Tables)", "shortName": "Guarantees, Indemnifications and Warranties (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.hp.com/role/SegmentInformationNarrativeDetails", "longName": "9954482 - Disclosure - Segment Information - Narrative (Details)", "shortName": "Segment Information - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails", "longName": "9954483 - Disclosure - Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details)", "shortName": "Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-51", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R37": { "role": "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails", "longName": "9954484 - Disclosure - Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details)", "shortName": "Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-8", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PaymentsForRestructuring", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R38": { "role": "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "longName": "9954485 - Disclosure - Restructuring and Other Charges - Narrative (Details)", "shortName": "Restructuring and Other Charges - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherRestructuringCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-77", "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R39": { "role": "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails", "longName": "9954486 - Disclosure - Retirement and Post-Retirement Benefit Plans - Schedule of Components of Pension and Post-Retirement Benefit (Credit) (Details)", "shortName": "Retirement and Post-Retirement Benefit Plans - Schedule of Components of Pension and Post-Retirement Benefit (Credit) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-83", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-83", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "longName": "9954487 - Disclosure - Retirement and Post-Retirement Benefit Plans - Narrative (Details)", "shortName": "Retirement and Post-Retirement Benefit Plans - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-88", "name": "hpq:EligibleAgeWithTenYearsOfServiceForEnhancedEarlyRetirementProgram", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-88", "name": "hpq:EligibleAgeWithTenYearsOfServiceForEnhancedEarlyRetirementProgram", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.hp.com/role/TaxesonEarningsDetails", "longName": "9954488 - Disclosure - Taxes on Earnings (Details)", "shortName": "Taxes on Earnings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails", "longName": "9954489 - Disclosure - Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)", "shortName": "Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofAllowanceforCreditLossesRelatedtoAccountsReceivableandChangesDetails", "longName": "9954490 - Disclosure - Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details)", "shortName": "Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-8", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfAllowanceForDoubtfulAccountsReceivableCurrentRollforwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfAllowanceForDoubtfulAccountsReceivableCurrentRollforwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofTradeReceivablesSoldandCashReceivedDetails", "longName": "9954491 - Disclosure - Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details)", "shortName": "Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-8", "name": "hpq:ReceivablesSoldButNotCollectedFromThirdParty", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfTradeReceivablesSoldAndCashReceivedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "hpq:ReceivablesSoldButNotCollectedFromThirdParty", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfTradeReceivablesSoldAndCashReceivedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails", "longName": "9954492 - Disclosure - Supplementary Financial Information - Schedule of Inventory (Details)", "shortName": "Supplementary Financial Information - Schedule of Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails", "longName": "9954493 - Disclosure - Supplementary Financial Information - Schedule of Other Current Assets (Details)", "shortName": "Supplementary Financial Information - Schedule of Other Current Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:NontradeReceivablesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:NontradeReceivablesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails", "longName": "9954494 - Disclosure - Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details)", "shortName": "Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails", "longName": "9954495 - Disclosure - Supplementary Financial Information - Schedule of Other Non-Current Assets (Details)", "shortName": "Supplementary Financial Information - Schedule of Other Non-Current Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails", "longName": "9954496 - Disclosure - Supplementary Financial Information - Schedule of Other Current Liabilities (Details)", "shortName": "Supplementary Financial Information - Schedule of Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:AccruedMarketingCostsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AccruedMarketingCostsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails", "longName": "9954497 - Disclosure - Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details)", "shortName": "Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails", "longName": "9954498 - Disclosure - Supplementary Financial Information - Schedule of Interest and Other, Net (Details)", "shortName": "Supplementary Financial Information - Schedule of Interest and Other, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails", "longName": "9954499 - Disclosure - Supplementary Financial Information - Schedule of Net Revenue by Region (Details)", "shortName": "Supplementary Financial Information - Schedule of Net Revenue by Region (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-94", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R53": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationValueofRemainingPerformanceObligationsNarrativeDetails", "longName": "9954500 - Disclosure - Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details)", "shortName": "Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-100", "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R54": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationContractLiabilitiesNarrativeDetails", "longName": "9954501 - Disclosure - Supplementary Financial Information - Contract Liabilities (Narrative) (Details)", "shortName": "Supplementary Financial Information - Contract Liabilities (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.hp.com/role/SupplementaryFinancialInformationSupplierFinanceProgramsNarrativeDetails", "longName": "9954502 - Disclosure - Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details)", "shortName": "Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:SupplierFinanceProgramPaymentTimingPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:SupplierFinanceProgramPaymentTimingPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954503 - Disclosure - Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "shortName": "Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-153", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R57": { "role": "http://www.hp.com/role/FairValueNarrativeDetails", "longName": "9954504 - Disclosure - Fair Value - Narrative (Details)", "shortName": "Fair Value - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DebtInstrumentFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:DebtInstrumentFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails", "longName": "9954505 - Disclosure - Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details)", "shortName": "Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.hp.com/role/FinancialInstrumentsScheduleofContractualMaturitiesofInvestmentsinAvailableforSaleDebtSecuritiesDetails", "longName": "9954506 - Disclosure - Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details)", "shortName": "Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "longName": "9954507 - Disclosure - Financial Instruments - Narrative (Details)", "shortName": "Financial Instruments - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "longName": "9954508 - Disclosure - Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details)", "shortName": "Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails", "longName": "9954509 - Disclosure - Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details)", "shortName": "Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails", "longName": "9954510 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details)", "shortName": "Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-243", "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-243", "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails", "longName": "9954511 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details)", "shortName": "Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-245", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "hpq:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossPreTaxTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R65": { "role": "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails", "longName": "9954512 - Disclosure - Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details)", "shortName": "Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-176", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R66": { "role": "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "longName": "9954513 - Disclosure - Financial Instruments - Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details)", "shortName": "Financial Instruments - Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails", "longName": "9954514 - Disclosure - Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details)", "shortName": "Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails", "longName": "9954515 - Disclosure - Borrowings - Schedule of Long-Term Debt (Details)", "shortName": "Borrowings - Schedule of Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-2", "name": "hpq:DebtInstrumentChangeInFairValueOfHedgedDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "hpq:DebtInstrumentChangeInFairValueOfHedgedDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.hp.com/role/BorrowingsNarrativeDetails", "longName": "9954516 - Disclosure - Borrowings - Narrative (Details)", "shortName": "Borrowings - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-292", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-292", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.hp.com/role/StockholdersDeficitNarrativeDetails", "longName": "9954517 - Disclosure - Stockholders' Deficit - Narrative (Details)", "shortName": "Stockholders' Deficit - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "hpq:StockRepurchasesExecutedDuringPeriodSettlementInSubsequentPeriodShares", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R71": { "role": "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails", "longName": "9954518 - Disclosure - Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details)", "shortName": "Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-297", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R72": { "role": "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "longName": "9954519 - Disclosure - Stockholders' Deficit - Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes (Details)", "shortName": "Stockholders' Deficit - Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-299", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R73": { "role": "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "longName": "9954520 - Disclosure - Stockholders' Deficit - Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes (Details)", "shortName": "Stockholders' Deficit - Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-8", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-311", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "unique": true } }, "R74": { "role": "http://www.hp.com/role/EarningsPerShareDetails", "longName": "9954521 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.hp.com/role/LitigationandContingenciesDetails", "longName": "9954522 - Disclosure - Litigation and Contingencies (Details)", "shortName": "Litigation and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-326", "name": "us-gaap:LossContingencyPatentsAllegedlyInfringedNumber", "unitRef": "patent", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-326", "name": "us-gaap:LossContingencyPatentsAllegedlyInfringedNumber", "unitRef": "patent", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesDetails", "longName": "9954523 - Disclosure - Guarantees, Indemnifications and Warranties (Details)", "shortName": "Guarantees, Indemnifications and Warranties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-8", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "hpq-20240131.htm", "first": true, "unique": true } } }, "tag": { "hpq_A364DayRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "A364DayRevolvingCreditFacilityMember", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "364-Day Revolving Credit Facility", "label": "364-Day Revolving Credit Facility [Member]", "documentation": "364-Day Revolving Credit Facility" } } }, "auth_ref": [] }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Components of accumulated other comprehensive income, net of taxes", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "hpq_AccessAdvancePatentPoolUnifiedPatentCourtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AccessAdvancePatentPoolUnifiedPatentCourtMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Access Advance Patent Pool, Unified Patent Court", "label": "Access Advance Patent Pool, Unified Patent Court [Member]", "documentation": "Access Advance Patent Pool, Unified Patent Court" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r35", "r906" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for credit losses of $84 and $93, respectively", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r330", "r331" ] }, "us-gaap_AccruedMarketingCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedMarketingCostsCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing programs", "label": "Accrued Marketing Costs, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "hpq_AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossAndNetPriorServiceCostCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossAndNetPriorServiceCostCreditMember", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization of actuarial loss and prior service benefit", "label": "Accumulated Defined Benefit Plans Adjustment Actuarial Gain Loss And Net Prior Service Cost Credit [Member]", "documentation": "Accumulated other comprehensive income (loss) related to actuarial gain (loss) and prior period cost (credit) components of pension and other postretirement defined benefit plans." } } }, "auth_ref": [] }, "hpq_AccumulatedDefinedBenefitPlansAdjustmentCurtailmentsSettlementsAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AccumulatedDefinedBenefitPlansAdjustmentCurtailmentsSettlementsAndOtherMember", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Curtailments, settlements and other", "label": "Accumulated Defined Benefit Plans Adjustment Curtailments Settlements And Other [Member]", "documentation": "Accumulated other comprehensive income (loss) related to curtailment, settlement and other components of pension and other postretirement defined benefit plans." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized components of defined benefit plans", "netLabel": "Change in unrealized components of defined benefit plans", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r5", "r18", "r47", "r1013", "r1014", "r1015" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax benefit on losses arising during the period", "verboseLabel": "Losses arising during the period", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r4", "r18", "r47", "r237", "r238", "r1013" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r69", "r204", "r723" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gains (losses) on cash flow hedges", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r227", "r237", "r238", "r633", "r872", "r1013" ] }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax provision on unrealized gains arising during the period", "verboseLabel": "Unrealized gains arising during the period", "netLabel": "Net unrealized gains (losses) on available-for-sale debt securities", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r223", "r224", "r225", "r227", "r237", "r238", "r1013" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Components of accumulated other comprehensive income, net of taxes", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r236", "r237", "r662", "r663", "r664", "r665", "r666", "r667" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r46", "r47", "r143", "r212", "r720", "r755", "r756" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r236", "r237", "r662", "r663", "r664", "r665", "r666", "r667" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated Other Comprehensive Income (Loss)", "terseLabel": "Accumulated other comprehensive loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r18", "r47", "r642", "r645", "r672", "r751", "r752", "r1013", "r1014", "r1015", "r1022", "r1023", "r1024" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in cumulative translation adjustment", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r3", "r18", "r47", "r237", "r238", "r663", "r664", "r665", "r666", "r667", "r1013" ] }, "hpq_AcquisitionOfAutonomyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AcquisitionOfAutonomyMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Autonomy", "label": "Acquisition Of Autonomy [Member]", "documentation": "Represents the information pertaining to the acquisition of Autonomy Corporation by the entity." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r956" ] }, "hpq_AdditionalDepositAgainstPartsRelatedShowCauseNotice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AdditionalDepositAgainstPartsRelatedShowCauseNotice", "crdr": "debit", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional amount deposited against parts-related show cause notice", "label": "Additional Deposit Against Parts Related Show Cause Notice", "documentation": "The amount of additional deposit made with the Commissioner of Customs in connection with the parts-related show cause notice." } } }, "auth_ref": [] }, "hpq_AdditionalDepositAgainstProductOrder": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AdditionalDepositAgainstProductOrder", "crdr": "debit", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional amount deposited against product order", "label": "Additional Deposit Against Product Order", "documentation": "The amount of additional deposit made with the Customs Tribunal in connection with the product order." } } }, "auth_ref": [] }, "hpq_AdditionalDepositAgainstProductsRelatedShowCauseNotice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AdditionalDepositAgainstProductsRelatedShowCauseNotice", "crdr": "debit", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional amount deposited against products-related show cause notice", "label": "Additional Deposit Against Products Related Show Cause Notice", "documentation": "The amount of additional deposit made with the Commissioner of Customs in connection with the products-related show cause notice." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r132" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r602", "r603", "r604", "r764", "r1022", "r1023", "r1024", "r1066", "r1087" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r962" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r962" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r962" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r962" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r85", "r86", "r573" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r927", "r938", "r948", "r973" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r930", "r941", "r951", "r976" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r962" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r969" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r934", "r942", "r952", "r969", "r977", "r981", "r989" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r987" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r601", "r605" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit loss", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r213", "r332", "r367", "r370", "r372", "r1082" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofAllowanceforCreditLossesRelatedtoAccountsReceivableandChangesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r213", "r332", "r367" ] }, "hpq_AllowanceForDoubtfulAccountsReceivableDeductionsNetOfRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AllowanceForDoubtfulAccountsReceivableDeductionsNetOfRecoveries", "crdr": "debit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofAllowanceforCreditLossesRelatedtoAccountsReceivableandChangesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deductions, net of recoveries", "label": "Allowance for Doubtful Accounts Receivable, Deductions, Net of Recoveries", "documentation": "Amount of deductions of receivables doubtful of collection, net of recoveries that were previously charged off." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofAllowanceforCreditLossesRelatedtoAccountsReceivableandChangesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "srt_AmericasMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AmericasMember", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas", "label": "Americas [Member]" } } }, "auth_ref": [ "r1089", "r1090", "r1091", "r1092" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 }, "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "negatedTerseLabel": "Amortization of intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r11", "r67", "r68" ] }, "hpq_AmountDepositedUnderProductsShowCauseNotice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AmountDepositedUnderProductsShowCauseNotice", "crdr": "debit", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount deposited under show cause notice prior to order", "label": "Amount Deposited under Products Show Cause Notice", "documentation": "Represents amount deposited under the products and parts show cause notices." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive weighted-average stock-based compensation awards (shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r285" ] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia-Pacific and Japan", "label": "Asia Pacific [Member]" } } }, "auth_ref": [ "r1089", "r1090", "r1091", "r1092" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r177", "r207", "r249", "r294", "r315", "r321", "r364", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r631", "r634", "r661", "r718", "r795", "r906", "r918", "r1049", "r1050", "r1070" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r200", "r216", "r249", "r364", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r631", "r634", "r661", "r906", "r1049", "r1050", "r1070" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r116" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets:", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "hpq_AutonomyRelatedLegalMattersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "AutonomyRelatedLegalMattersMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Autonomy-Related Legal Matters", "label": "Autonomy Related Legal Matters [Member]", "documentation": "The risk of loss associated with the autonomy related legal matters." } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt securities, gross unrealized gain", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r337" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt securities, gross unrealized loss", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r338" ] }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-Sale Investments:", "label": "Debt Securities, Available-for-Sale [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofContractualMaturitiesofInvestmentsinAvailableforSaleDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofContractualMaturitiesofInvestmentsinAvailableforSaleDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair\u00a0Value", "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "crdr": "debit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofContractualMaturitiesofInvestmentsinAvailableforSaleDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in one year", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r1029" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "crdr": "debit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofContractualMaturitiesofInvestmentsinAvailableforSaleDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in one year", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r341", "r715" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r984" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r985" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r980" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r980" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r980" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r980" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r980" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r980" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r983" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r982" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r981" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r981" ] }, "country_BR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "BR", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Brazil", "label": "BRAZIL" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r99", "r104" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r630", "r898", "r901" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r90", "r91", "r630", "r898", "r901" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition and divestiture charges", "negatedTerseLabel": "Acquisition and divestiture charges", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r89" ] }, "hpq_CaltechPatentLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CaltechPatentLitigationMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Caltech Patent Litigation", "label": "Caltech Patent Litigation [Member]", "documentation": "Caltech Patent Litigation" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Equivalents:", "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r53", "r202", "r864" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Axis]", "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r202" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "hpq_CashEquivalentsAndAvailableForSaleSecuritiesFairValueExcludingAccruedInterest", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash Equivalents:", "terseLabel": "Fair Value", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "hpq_CashAndCashEquivalentsGrossUnrealizedGains": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CashAndCashEquivalentsGrossUnrealizedGains", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_CashEquivalentsAtCarryingValue", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gain", "label": "Cash And Cash Equivalents, Gross Unrealized Gains", "documentation": "Cash And Cash Equivalents, Gross Unrealized Gains" } } }, "auth_ref": [] }, "hpq_CashAndCashEquivalentsGrossUnrealizedLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CashAndCashEquivalentsGrossUnrealizedLosses", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_CashEquivalentsAtCarryingValue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross Unrealized Loss", "label": "Cash And Cash Equivalents, Gross Unrealized Losses", "documentation": "Cash And Cash Equivalents, Gross Unrealized Losses" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash Equivalents and Available-for-Sale Investments", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r54" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, cash equivalents and restricted cash", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "totalLabel": "Cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r53", "r153", "r246" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Decrease in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r153" ] }, "hpq_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCostBasisExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCostBasisExcludingAccruedInterest", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash equivalents and available-for-sale investments, cost", "label": "Cash Equivalents and Available For Sale Securities, Amortized Cost Basis, Excluding Accrued Interest", "documentation": "Cash Equivalents and Available For Sale Securities, Amortized Cost Basis, Excluding Accrued Interest" } } }, "auth_ref": [] }, "hpq_CashEquivalentsAndAvailableForSaleSecuritiesFairValueExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CashEquivalentsAndAvailableForSaleSecuritiesFairValueExcludingAccruedInterest", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails_1": { "parentTag": "hpq_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCostBasisExcludingAccruedInterest", "weight": 1.0, "order": 3.0 }, "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash equivalents and available-for-sale investments, fair value", "label": "Cash Equivalents and Available For Sale Securities, Fair Value, Excluding Accrued Interest", "documentation": "Cash Equivalents and Available For Sale Securities, Fair Value, Excluding Accrued Interest" } } }, "auth_ref": [] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "hpq_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCostBasisExcludingAccruedInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Cost", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r1006", "r1081" ] }, "hpq_CashEquivalentsandAvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainbeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CashEquivalentsandAvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainbeforeTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails_1": { "parentTag": "hpq_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCostBasisExcludingAccruedInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total cash equivalents and available-for-sale investments, gross unrealized gain", "label": "Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Gain, before Tax" } } }, "auth_ref": [] }, "hpq_CashEquivalentsandAvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossbeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CashEquivalentsandAvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossbeforeTax", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails_1": { "parentTag": "hpq_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCostBasisExcludingAccruedInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Total cash equivalents and available-for-sale investments, gross unrealized loss", "label": "Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Cash Equivalents and Available For Sale Securities, Accumulated Gross Unrealized Loss, before Tax" } } }, "auth_ref": [] }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss expected to be reclassified from AOCI into earnings in next 12 months", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r115" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedges", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r96" ] }, "hpq_CashReceipts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CashReceipts", "crdr": "debit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofTradeReceivablesSoldandCashReceivedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash receipts", "label": "Cash Receipts", "documentation": "The aggregate amount of cash receipts under revolving financing receivables arrangements facilities during the reporting period." } } }, "auth_ref": [] }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain/(loss) recognized in earnings on derivative instruments", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement." } } }, "auth_ref": [ "r175" ] }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gain/(loss) recognized in earnings on hedged\u00a0item", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement." } } }, "auth_ref": [ "r175" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r960" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r961" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r961" ] }, "hpq_CollateralPostedForDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CollateralPostedForDerivatives", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Collateral posted for derivative instruments", "label": "Collateral Posted For Derivatives", "documentation": "Collateral Posted For Derivatives" } } }, "auth_ref": [] }, "hpq_CommercialPSMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CommercialPSMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial PS", "label": "Commercial PS [Member]", "documentation": "Commercial PS" } } }, "auth_ref": [] }, "us-gaap_CommercialPaperMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommercialPaperMember", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails", "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial Paper", "label": "Commercial Paper [Member]", "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds." } } }, "auth_ref": [ "r164", "r913", "r914", "r915", "r916" ] }, "hpq_CommercialPrintingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CommercialPrintingMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial Printing", "label": "Commercial Printing [Member]", "documentation": "A business unit within the Printing group business segment that is classified as Commercial." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation and Contingencies", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies." } } }, "auth_ref": [ "r72", "r848" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Cash dividends per share (usd per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r168" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common\u00a0Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r909", "r910", "r911", "r913", "r914", "r915", "r916", "r1022", "r1023", "r1066", "r1085", "r1087" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (usd per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r131" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r131", "r783" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r131" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical", "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r19", "r131", "r783", "r801", "r1087", "r1088" ] }, "us-gaap_CommonStockValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValueOutstanding", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.01 par value (9,600 shares authorized; 980 and 989 shares issued and outstanding at January 31, 2024 and October\u00a031, 2023, respectively)", "label": "Common Stock, Value, Outstanding", "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares." } } }, "auth_ref": [ "r131", "r783" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r966" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r965" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r967" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r964" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Retirement Benefits [Abstract]", "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income (loss)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r48", "r232", "r234", "r240", "r711", "r729" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r254", "r296", "r313", "r314", "r315", "r316", "r317", "r319", "r323", "r431", "r432", "r433", "r434", "r436", "r437", "r439", "r441", "r442", "r1049", "r1050" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r254", "r296", "r313", "r314", "r315", "r316", "r317", "r319", "r323", "r431", "r432", "r433", "r434", "r436", "r437", "r439", "r441", "r442", "r1049", "r1050" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r92", "r873" ] }, "hpq_ConsumerPSMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ConsumerPSMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consumer PS", "label": "Consumer PS [Member]", "documentation": "Consumer PS" } } }, "auth_ref": [] }, "hpq_ConsumerPrintingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ConsumerPrintingMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consumer Printing", "label": "Consumer Printing [Member]", "documentation": "Consumer Printing" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationContractLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liability", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r489", "r490", "r492" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r489", "r490", "r492" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Contract with Customer, Liability, Noncurrent", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r489", "r490", "r492" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationContractLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r493" ] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate debt", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r894", "r896", "r1084" ] }, "hpq_CorporateInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "CorporateInvestmentsMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate Investments", "label": "Corporate Investments [Member]", "documentation": "Business reporting segment that includes HP Labs and certain business incubation projects." } } }, "auth_ref": [] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate and unallocated costs and other", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r25", "r314", "r315", "r316", "r317", "r323", "r1027" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total cost of net revenue", "negatedLabel": "Cost of revenue", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r148", "r249", "r364", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r661", "r1049" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "negatedTerseLabel": "Operating expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r146" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of net revenue:", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r251", "r252", "r448", "r476", "r673", "r868", "r871" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FairValueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value, short- and long-term debt", "label": "Debt and Lease Obligation", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r182" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails", "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable and short-term borrowings", "verboseLabel": "Notes payable to banks, lines of credit and other", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r210" ] }, "us-gaap_DebtCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrentAbstract", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount Outstanding", "label": "Debt, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.hp.com/role/Borrowings" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r163", "r247", "r444", "r450", "r451", "r452", "r453", "r454", "r455", "r460", "r467", "r468", "r470" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails", "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r33", "r127", "r128", "r178", "r180", "r254", "r445", "r446", "r447", "r448", "r449", "r451", "r456", "r457", "r458", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r668", "r881", "r882", "r883", "r884", "r885", "r1018" ] }, "hpq_DebtInstrumentChangeInFairValueOfHedgedDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtInstrumentChangeInFairValueOfHedgedDebt", "crdr": "credit", "calculation": { "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value adjustment related to hedged debt", "label": "Debt Instrument, Change In Fair Value Of Hedged Debt", "documentation": "Debt Instrument, Change In Fair Value Of Hedged Debt" } } }, "auth_ref": [] }, "hpq_DebtInstrumentDiscountRateAtIssuance": { "xbrltype": "percentItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtInstrumentDiscountRateAtIssuance", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount to par (percent)", "label": "Debt Instrument, Discount Rate at Issuance", "documentation": "The discount to par at which a debt instrument was issued." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Face amount of debt instrument", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r118", "r120", "r445", "r668", "r882", "r883" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FairValueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, short- and long-term debt", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r458", "r660", "r882", "r883" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate (percent)", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r42", "r446" ] }, "hpq_DebtInstrumentInterestRateWeightedAverageInterestRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtInstrumentInterestRateWeightedAverageInterestRateAbstract", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Interest Rate", "label": "Debt Instrument, Interest Rate, Weighted Average Interest Rate [Abstract]", "documentation": "Debt Instrument, Interest Rate, Weighted Average Interest Rate [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r254", "r445", "r446", "r447", "r448", "r449", "r451", "r456", "r457", "r458", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r668", "r881", "r882", "r883", "r884", "r885", "r1018" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails", "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r43", "r254", "r445", "r446", "r447", "r448", "r449", "r451", "r456", "r457", "r458", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r668", "r881", "r882", "r883", "r884", "r885", "r1018" ] }, "hpq_DebtInstrumentRateAtIssuance": { "xbrltype": "percentItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtInstrumentRateAtIssuance", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance rate (percent)", "label": "Debt Instrument, Rate At Issuance", "documentation": "Debt Instrument, Rate At Issuance" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r43", "r75", "r76", "r117", "r118", "r120", "r123", "r166", "r167", "r254", "r445", "r446", "r447", "r448", "r449", "r451", "r456", "r457", "r458", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r668", "r881", "r882", "r883", "r884", "r885", "r1018" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facility, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Debt securities, cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss", "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r1035" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt securities, fair value", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest", "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r1035" ] }, "hpq_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNI": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNI", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "hpq_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAmortizedCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI", "documentation": "Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI" } } }, "auth_ref": [] }, "hpq_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "hpq_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAmortizedCost", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gain", "label": "Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, Before Tax", "documentation": "Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, Before Tax" } } }, "auth_ref": [] }, "hpq_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "hpq_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAmortizedCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross Unrealized Loss", "label": "Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, Before Tax", "documentation": "Debt Securities, Available-for-sale, Excluding Accrued Interest And Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, Before Tax" } } }, "auth_ref": [] }, "hpq_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAndEquitySecuritiesFVNIAmortizedCost", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "hpq_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCostBasisExcludingAccruedInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Cost", "label": "Debt Securities, Available-For-Sale, Excluding Accrued Interest And Equity Securities, FV-NI, Amortized Cost", "documentation": "Debt Securities, Available-For-Sale, Excluding Accrued Interest And Equity Securities, FV-NI, Amortized Cost" } } }, "auth_ref": [] }, "us-gaap_DebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtWeightedAverageInterestRate", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "label": "Debt, Weighted Average Interest Rate", "documentation": "Weighted average interest rate of debt outstanding." } } }, "auth_ref": [] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reasonably possible decrease in existing unrecognized tax benefits within the next 12 months", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r88" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized debt issuance cost", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r119", "r1052" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred taxes on earnings", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r11", "r172", "r195", "r625", "r626", "r1020" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1060" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability", "label": "Deferred Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r87", "r1060" ] }, "hpq_DefinedBenefitPlanAmortizationAndDeferralsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DefinedBenefitPlanAmortizationAndDeferralsAbstract", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization and deferrals:", "label": "Defined Benefit Plan Amortization and Deferrals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": "hpq_DefinedBenefitPlanNetPeriodicBenefitCostBeforeSettlementsAndCurtailments", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Actuarial loss (gain)", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r497", "r535", "r560", "r896", "r897" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "crdr": "debit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": "hpq_DefinedBenefitPlanNetPeriodicBenefitCostBeforeSettlementsAndCurtailments", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior service cost (credit)", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r497", "r536", "r561", "r896", "r897" ] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contributions to benefit plans", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r512", "r522", "r564", "r894", "r895", "r896", "r897" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Anticipated contributions", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year", "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year." } } }, "auth_ref": [ "r897", "r1054" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": "hpq_DefinedBenefitPlanNetPeriodicBenefitCostBeforeSettlementsAndCurtailments", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r497", "r534", "r559", "r896", "r897" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": "hpq_DefinedBenefitPlanNetPeriodicBenefitCostBeforeSettlementsAndCurtailments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r497", "r501", "r533", "r558", "r896", "r897" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total periodic benefit (credit) cost", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r531", "r556", "r896", "r897" ] }, "hpq_DefinedBenefitPlanNetPeriodicBenefitCostBeforeSettlementsAndCurtailments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostBeforeSettlementsAndCurtailments", "crdr": "debit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net periodic benefit (credit) cost", "label": "Defined Benefit Plan Net Periodic Benefit Cost before Settlements and Curtailments", "documentation": "The total amount of net periodic benefit cost (credit) for defined benefit plans for the period, before gain or loss due to settlements or curtailments." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "crdr": "credit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Settlement loss", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement." } } }, "auth_ref": [ "r496", "r538", "r563" ] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails": { "parentTag": "hpq_DefinedBenefitPlanNetPeriodicBenefitCostBeforeSettlementsAndCurtailments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r499", "r532", "r557", "r896", "r897" ] }, "us-gaap_DepositsAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deposits and prepaid", "label": "Deposits Assets, Noncurrent", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r1007" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r11", "r299" ] }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetFairValueGrossLiability", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amount Offset", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r23", "r32", "r102", "r840", "r841" ] }, "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset." } } }, "auth_ref": [ "r24", "r30", "r193" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r636" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments:", "verboseLabel": "Derivative instruments, assets", "totalLabel": "Net Amount Presented", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r218", "r221", "r660", "r766", "r767", "r768", "r769", "r770", "r772", "r773", "r774", "r775", "r776", "r789", "r790", "r835", "r838", "r839", "r840", "r842", "r843", "r871", "r911", "r1086" ] }, "us-gaap_DerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Not Offset", "label": "Derivative Asset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeCollateralObligationToReturnCash", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Financial Collateral", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset", "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets." } } }, "auth_ref": [ "r30", "r112", "r219", "r869" ] }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeCollateralRightToReclaimCash", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "hpq_DerivativeLiabilityIncludingNotSubjectToMasterNettingArrangementAfterOffsetAndDeductionNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Collateral", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset", "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities." } } }, "auth_ref": [ "r30", "r112", "r219", "r869" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r774", "r776", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r809", "r810", "r811", "r812", "r815", "r816", "r817", "r818", "r835", "r836", "r839", "r842", "r909", "r911" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amount Recognized", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r28", "r102", "r141", "r217", "r871" ] }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Amount", "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction", "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement." } } }, "auth_ref": [ "r30", "r111" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gross Amount Recognized", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r28", "r102", "r141", "r217", "r871" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r100", "r103", "r105", "r108", "r774", "r776", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r809", "r810", "r811", "r812", "r815", "r816", "r817", "r818", "r835", "r836", "r839", "r842", "r871", "r909", "r911" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r20", "r100", "r105" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r20", "r100", "r105", "r108", "r113", "r114", "r639" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r639" ] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain/(loss) recognized in earnings on derivative instrument", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments." } } }, "auth_ref": [ "r107", "r995" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "hpq_DerivativeLiabilityIncludingNotSubjectToMasterNettingArrangementAfterOffsetAndDeductionNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments:", "verboseLabel": "Derivative instruments, liabilities", "totalLabel": "Net Amount Presented", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r218", "r221", "r660", "r766", "r767", "r768", "r769", "r772", "r773", "r774", "r775", "r776", "r796", "r798", "r799", "r836", "r837", "r838", "r839", "r840", "r842", "r843", "r871", "r1086" ] }, "us-gaap_DerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Not Offset", "label": "Derivative Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityFairValueGrossAsset", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amount Offset", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r23", "r32", "r102", "r840", "r841", "r869" ] }, "hpq_DerivativeLiabilityIncludingNotSubjectToMasterNettingArrangementAfterOffsetAndDeductionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DerivativeLiabilityIncludingNotSubjectToMasterNettingArrangementAfterOffsetAndDeductionNet", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Amount", "label": "Derivative Liability, Including Not Subject To Master Netting Arrangement, After Offset And Deduction, Net", "documentation": "Derivative Liability, Including Not Subject To Master Netting Arrangement, After Offset And Deduction, Net" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails": { "parentTag": "hpq_DerivativeLiabilityIncludingNotSubjectToMasterNettingArrangementAfterOffsetAndDeductionNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability." } } }, "auth_ref": [ "r24", "r30", "r193" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r636" ] }, "us-gaap_DerivativeNetLiabilityPositionAggregateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNetLiabilityPositionAggregateFairValue", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivatives with credit contingent features in a net liability position", "label": "Derivative, Net Liability Position, Aggregate Fair Value", "documentation": "The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument." } } }, "auth_ref": [ "r109" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Gross Notional", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1064", "r1065" ] }, "hpq_DerivativePeriodtoCollateralize": { "xbrltype": "durationItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DerivativePeriodtoCollateralize", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period to collateralize", "label": "Derivative, Period to Collateralize", "documentation": "Derivative, Period to Collateralize" } } }, "auth_ref": [] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives, Fair Value", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativesOffsettingFairValueAmountsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesOffsettingFairValueAmountsPolicy", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Offsetting of Derivatives Instruments", "label": "Derivatives, Offsetting Fair Value Amounts, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for offsetting or not offsetting fair value amounts recognized for derivative instruments against such amounts recognized for the right to reclaim cash collateral (a receivable) or the obligation to return cash collateral (a payable) arising from derivative instruments recognized at fair value." } } }, "auth_ref": [ "r110" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative Instruments", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r20", "r93", "r94", "r97", "r110", "r253" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives designated as hedging instruments", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r20" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r491", "r887", "r888", "r889", "r890", "r891", "r892", "r893" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r491", "r887", "r888", "r889", "r890", "r891", "r892", "r893" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash dividends", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r168" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r922" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r955" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DomesticPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticPlanMember", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Plan", "label": "Domestic Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r1055", "r1056", "r1057" ] }, "hpq_DusseldorfGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DusseldorfGermanyMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "D\u00fcsseldorf, Germany", "label": "D\u00fcsseldorf, Germany [Member]", "documentation": "D\u00fcsseldorf, Germany" } } }, "auth_ref": [] }, "hpq_DutiesPenaltiesAffirmedUnderShowCauseNotices": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DutiesPenaltiesAffirmedUnderShowCauseNotices", "crdr": "debit", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Duties and penalties under show cause notices", "label": "Duties, Penalties Affirmed under Show Cause Notices", "documentation": "The aggregate amount of duties and penalties that the Commissioner of Customs is seeking to have HP India and the other named individuals pay under the products and parts show cause notices." } } }, "auth_ref": [] }, "hpq_DynamicSecurityLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "DynamicSecurityLitigationMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dynamic Security Litigation", "label": "Dynamic Security Litigation [Member]", "documentation": "Dynamic Security Litigation" } } }, "auth_ref": [] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EMEAMember", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe, Middle East and Africa", "label": "EMEA [Member]", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r1089", "r1090", "r1091", "r1092" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (usd per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r241", "r260", "r261", "r262", "r263", "r264", "r269", "r272", "r282", "r283", "r284", "r288", "r650", "r651", "r712", "r730", "r874" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net earnings per share:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (usd per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r241", "r260", "r261", "r262", "r263", "r264", "r272", "r282", "r283", "r284", "r288", "r650", "r651", "r712", "r730", "r874" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Net Earnings Per Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r55", "r56" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.hp.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r268", "r285", "r286", "r287" ] }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-tax effect of derivative instruments in cash flow hedging relationships", "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective tax rate (percent)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r612" ] }, "hpq_EffectiveIncomeTaxRateReconciliationBusinessCombinationAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "EffectiveIncomeTaxRateReconciliationBusinessCombinationAmount", "crdr": "credit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax effects related to acquisition and divestiture charges", "label": "Effective Income Tax Rate Reconciliation, Business Combination, Amount", "documentation": "Effective Income Tax Rate Reconciliation, Business Combination, Amount" } } }, "auth_ref": [] }, "hpq_EffectiveIncomeTaxRateReconciliationOtherTaxBenefitsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "EffectiveIncomeTaxRateReconciliationOtherTaxBenefitsAmount", "crdr": "credit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax effects related to other tax benefits", "label": "Effective Income Tax Rate Reconciliation, Other Tax Benefits, Amount", "documentation": "Effective Income Tax Rate Reconciliation, Other Tax Benefits, Amount" } } }, "auth_ref": [] }, "hpq_EligibleAgeWithTenYearsOfServiceForEnhancedEarlyRetirementProgram": { "xbrltype": "durationItemType", "nsuri": "http://www.hp.com/20240131", "localname": "EligibleAgeWithTenYearsOfServiceForEnhancedEarlyRetirementProgram", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eligible age with twenty years of service for enhanced early retirement program", "label": "Eligible Age with Ten Years of Service for Enhanced Early Retirement Program", "documentation": "Eligible Age with Ten Years of Service for Enhanced Early Retirement Program" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee compensation and benefit", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40" ] }, "hpq_EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Severance and EER", "label": "Employee Severance And Enhanced Early Retirement Program [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r920" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r920" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r920" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r994" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r920" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r920" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r920" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r920" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r19", "r197", "r236", "r237", "r238", "r255", "r256", "r257", "r259", "r265", "r267", "r289", "r365", "r366", "r488", "r602", "r603", "r604", "r621", "r622", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r662", "r663", "r664", "r665", "r666", "r667", "r672", "r751", "r752", "r753", "r764", "r821" ] }, "hpq_EquitySecuritiesCostMethodandOtherEquityInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "EquitySecuritiesCostMethodandOtherEquityInvestments", "crdr": "debit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost method and other equity investments", "label": "Equity Securities, Cost Method and Other Equity Investments", "documentation": "Equity Securities, Cost Method and Other Equity Investments" } } }, "auth_ref": [] }, "hpq_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGainbeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "EquitySecuritiesFVNIAccumulatedGrossUnrealizedGainbeforeTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_EquitySecuritiesFvNiCost", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities, gross unrealized gain", "label": "Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax" } } }, "auth_ref": [] }, "hpq_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLossbeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "EquitySecuritiesFVNIAccumulatedGrossUnrealizedLossbeforeTax", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_EquitySecuritiesFvNiCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Equity securities, gross unrealized loss", "label": "Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": "us-gaap_EquitySecuritiesFvNiCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity securities, fair value", "label": "Equity Securities, FV-NI, Current", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r208", "r659", "r866" ] }, "us-gaap_EquitySecuritiesFvNiCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiCost", "crdr": "debit", "calculation": { "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Equity securities, cost", "label": "Equity Securities, FV-NI, Cost", "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r717" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r963" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r927", "r938", "r948", "r973" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r924", "r935", "r945", "r970" ] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe [Member]" } } }, "auth_ref": [ "r1089", "r1090", "r1091", "r1092" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r969" ] }, "hpq_FactoringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "FactoringCosts", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Factoring costs", "label": "Factoring Costs", "documentation": "Factoring Costs" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets and liabilities measured at fair value on a recurring basis", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r653", "r654", "r657" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r653", "r654", "r657" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r458", "r522", "r523", "r524", "r525", "r526", "r527", "r654", "r677", "r678", "r679", "r882", "r883", "r894", "r895", "r896" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r658" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.hp.com/role/FairValue" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r652" ] }, "us-gaap_FairValueHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueHedgingMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value hedges", "label": "Fair Value Hedging [Member]", "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk." } } }, "auth_ref": [ "r95" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a01", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r458", "r522", "r527", "r654", "r677", "r894", "r895", "r896" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a02", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r458", "r522", "r527", "r654", "r678", "r882", "r883", "r894", "r895", "r896" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a03", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r458", "r522", "r523", "r524", "r525", "r526", "r527", "r654", "r679", "r882", "r883", "r894", "r895", "r896" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r458", "r522", "r523", "r524", "r525", "r526", "r527", "r677", "r678", "r679", "r882", "r883", "r894", "r895", "r896" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measured on a Recurring Basis", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r652", "r658" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r99", "r101", "r113" ] }, "hpq_FinancialInstitutionInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "FinancialInstitutionInstrumentMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial institution instruments", "label": "Financial Institution Instrument [Member]", "documentation": "Financial Institution Instrument" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r368", "r369", "r373", "r374", "r375", "r376", "r377", "r378", "r469", "r486", "r647", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r684", "r685", "r686", "r687", "r688", "r690", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r728", "r878", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1030", "r1031", "r1032", "r1033" ] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments", "label": "Financial Instruments Disclosure [Text Block]", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r160", "r709" ] }, "hpq_Fiscal2023PlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "Fiscal2023PlanMember", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fiscal 2023 Plan", "label": "Fiscal 2023 Plan [Member]", "documentation": "Fiscal 2023 Plan" } } }, "auth_ref": [] }, "hpq_Fiscal2023RestructuringPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "Fiscal2023RestructuringPlanMember", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fiscal 2023 Plan", "label": "Fiscal 2023 Restructuring Plan [Member]", "documentation": "Fiscal 2020 Restructuring Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r871", "r894", "r905" ] }, "us-gaap_ForeignPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignPlanMember", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-U.S.", "label": "Foreign Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r1055", "r1056", "r1057" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r931", "r942", "r952", "r977" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r931", "r942", "r952", "r977" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r931", "r942", "r952", "r977" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r931", "r942", "r952", "r977" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r931", "r942", "r952", "r977" ] }, "hpq_Forsythetal.vs.HPInc.andHewlettPackardEnterpriseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "Forsythetal.vs.HPInc.andHewlettPackardEnterpriseMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise", "label": "Forsyth, et al. vs. HP Inc. and Hewlett Packard Enterprise [Member]", "documentation": "Forsyth, et al. vs. HP Inc. and Hewlett Packard Enterprise [Member]" } } }, "auth_ref": [] }, "hpq_FxAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "FxAndOther", "crdr": "debit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofTradeReceivablesSoldandCashReceivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency and other", "label": "Foreign currency and other", "documentation": "The aggregate amount of FX and other under revolving financing receivables arrangements facilities during the reporting period." } } }, "auth_ref": [] }, "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnFairValueHedgesRecognizedInEarnings", "crdr": "credit", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recorded", "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings", "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period." } } }, "auth_ref": [ "r106" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of debt", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r11", "r73", "r74" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r205", "r379", "r710", "r879", "r906", "r1036", "r1037" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r147", "r249", "r294", "r314", "r320", "r323", "r364", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r661", "r875", "r1049" ] }, "us-gaap_GuaranteesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Guarantees [Abstract]", "label": "Guarantees [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Guarantees, Indemnifications and Warranties", "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]", "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities." } } }, "auth_ref": [ "r415" ] }, "us-gaap_GuaranteesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteesTextBlock", "presentation": [ "http://www.hp.com/role/GuaranteesIndemnificationsandWarranties" ], "lang": { "en-us": { "role": { "terseLabel": "Guarantees, Indemnifications and Warranties", "label": "Guarantees [Text Block]", "documentation": "The entire disclosure for each guarantee obligation, or each group of similar guarantee obligations, including (a) the nature of the guarantee, including its term, how it arose, and the events or circumstances that would require the guarantor to perform under the guarantee; (b) the maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee; (c) the current carrying amount of the liability, if any, for the guarantor's obligations under the guarantee; and (d) the nature of any recourse provisions under the guarantee, and any assets held either as collateral or by third parties, and any relevant related party disclosure. Excludes disclosures about product warranties." } } }, "auth_ref": [ "r415", "r417", "r418", "r419", "r420", "r421", "r423", "r424" ] }, "hpq_HealthCareCoverageExtensionEnhancedEarlyRetirementProgramPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.hp.com/20240131", "localname": "HealthCareCoverageExtensionEnhancedEarlyRetirementProgramPeriod", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Health care coverage extension, enhanced early retirement program, period", "label": "Health Care Coverage Extension, Enhanced Early Retirement Program, Period", "documentation": "Health Care Coverage Extension, Enhanced Early Retirement Program, Period" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r20", "r639" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r20" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r20" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings before taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r144", "r183", "r294", "r314", "r320", "r323", "r713", "r725", "r875" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r389", "r401", "r806" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r401", "r806" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.hp.com/role/TaxesonEarnings" ], "lang": { "en-us": { "role": { "verboseLabel": "Taxes on Earnings", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r250", "r607", "r613", "r616", "r619", "r623", "r627", "r628", "r629", "r763" ] }, "hpq_IncomeTaxExaminationLikelihoodOfNoResolutionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.hp.com/20240131", "localname": "IncomeTaxExaminationLikelihoodOfNoResolutionPeriod", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Likelihood of no resolution period", "label": "Income Tax Examination Likelihood of No Resolution Period", "documentation": "The period of likelihood that the uncertain tax position will not be resolved." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Penalties and interest accrued", "label": "Income Tax Examination, Penalties and Interest Accrued", "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations." } } }, "auth_ref": [ "r1058" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Provision for taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r186", "r196", "r266", "r267", "r302", "r611", "r624", "r732" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes on Earnings", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r235", "r609", "r610", "r616", "r617", "r618", "r620", "r761" ] }, "hpq_IncomeTaxReconciliationOtherDiscreteItemsTaxChargesCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "IncomeTaxReconciliationOtherDiscreteItemsTaxChargesCredits", "crdr": "debit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax reconciliation other discrete items tax charges (credits)", "label": "Income Tax Reconciliation Other Discrete Items Tax Charges (Credits)", "documentation": "Income Tax Reconciliation Other Discrete Items Tax Charges (Credits)" } } }, "auth_ref": [] }, "hpq_IncomeTaxReconciliationRestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "IncomeTaxReconciliationRestructuringCharges", "crdr": "credit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax benefits related to restructuring charges", "label": "Income Tax Reconciliation Restructuring Charges", "documentation": "Income Tax Reconciliation Restructuring Charges" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableTrade", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable, Trade", "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services." } } }, "auth_ref": [ "r10" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r10" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes on earnings", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r10" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r10" ] }, "hpq_IncreaseDecreaseInNetInvestmentInLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "IncreaseDecreaseInNetInvestmentInLeases", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment in leases", "label": "Increase (Decrease) In Net Investment In Leases", "documentation": "Increase (Decrease) In Net Investment In Leases" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Changes in operating assets and liabilities, net of acquisitions:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets and liabilities", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r10" ] }, "hpq_IncreaseDecreaseInRestructuringAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "IncreaseDecreaseInRestructuringAndOther", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and other charges", "label": "Increase (Decrease) in Restructuring and Other", "documentation": "Increase (Decrease) in Restructuring and Other" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInRestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInRestructuringReserve", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and other", "label": "Increase (Decrease) in Restructuring Reserve", "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations." } } }, "auth_ref": [ "r1017" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.hp.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of employee stock plans (shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r273", "r274", "r275", "r284", "r574" ] }, "hpq_IndiaDirectorateOfRevenueIntelligenceProceedingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "IndiaDirectorateOfRevenueIntelligenceProceedingsMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "India Directorate of Revenue Intelligence Proceedings", "label": "India Directorate Of Revenue Intelligence Proceedings [Member]", "documentation": "Proceedings alleging the underpayment of customs duties to the India Directorate of Revenue." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r934", "r942", "r952", "r969", "r977", "r981", "r989" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r987" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r923", "r993" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r923", "r993" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r923", "r993" ] }, "hpq_InterestAndOtherExpenseNetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "InterestAndOtherExpenseNetMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and other, net", "label": "Interest And Other Expense, Net [Member]", "documentation": "Interest And Other Expense, Net" } } }, "auth_ref": [] }, "hpq_InterestAndOtherIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "InterestAndOtherIncomeExpenseMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and other, net", "label": "Interest And Other Income Expense [Member]", "documentation": "Primary financial statement caption encompassing interest and other income or expense, net." } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense on borrowings", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r151", "r464", "r472", "r884", "r885" ] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateContractMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsandRelatedHedgedItemsinaFairValueHedgingRelationshipDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate contracts", "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r860", "r871", "r894" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r159", "r867" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "totalLabel": "Inventory", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r214", "r865", "r906" ] }, "us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessAndRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchased parts and fabricated assemblies", "label": "Inventory, Work in Process and Raw Materials, Net of Reserves", "documentation": "The aggregate carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount." } } }, "auth_ref": [ "r159", "r1010" ] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Marketable Equity Securities Investments", "label": "Investment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r731", "r757", "r758", "r759", "r760", "r828", "r829" ] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAllOtherInvestmentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments, All Other Investments [Abstract]", "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments." } } }, "auth_ref": [] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-Sale Investments:", "label": "Investments, Fair Value Disclosure", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r653" ] }, "hpq_LaborAndNonLaborActionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LaborAndNonLaborActionsMember", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Labor and Non-Labor Actions", "label": "Labor And Non-Labor Actions [Member]", "documentation": "Labor And Non-Labor Actions" } } }, "auth_ref": [] }, "hpq_LaborCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LaborCostsMember", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Labor Costs", "label": "Labor Costs [Member]", "documentation": "Labor Costs" } } }, "auth_ref": [] }, "us-gaap_LandBuildingsAndImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandBuildingsAndImprovementsMember", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land, buildings and leasehold improvements", "label": "Land, Buildings and Improvements [Member]", "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business." } } }, "auth_ref": [] }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LegalMattersAndContingenciesTextBlock", "presentation": [ "http://www.hp.com/role/LitigationandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation and Contingencies", "label": "Legal Matters and Contingencies [Text Block]", "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies." } } }, "auth_ref": [ "r162" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 deficit", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r136", "r181", "r722", "r906", "r1019", "r1034", "r1067" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r41", "r201", "r249", "r364", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r632", "r634", "r635", "r661", "r906", "r1049", "r1070", "r1071" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r116" ] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities:", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Line Items]", "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1018" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity under credit facility", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r37" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available borrowing resources", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r37" ] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Table]", "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r37", "r1018" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facilities", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseAxis", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Axis]", "label": "Litigation Case [Axis]" } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Domain]", "label": "Litigation Case [Domain]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Long-term debt", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r33", "r180", "r457", "r471", "r882", "r883", "r1080" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "crdr": "credit", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "label": "Long-Term Debt and Lease Obligation, Current", "documentation": "Amount of long-term debt and lease obligation, classified as current." } } }, "auth_ref": [ "r40" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r209" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 }, "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails", "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt", "terseLabel": "Total long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r211" ] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Nature [Axis]", "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1043", "r1044" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation and Contingencies", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1043", "r1044" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1043", "r1044" ] }, "us-gaap_LossContingencyDamagesSoughtValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyDamagesSoughtValue", "crdr": "debit", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate damages sought", "label": "Loss Contingency, Damages Sought, Value", "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter." } } }, "auth_ref": [ "r1042", "r1043", "r1044" ] }, "hpq_LossContingencyDepositToPreventInterruptionOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LossContingencyDepositToPreventInterruptionOfBusiness", "crdr": "debit", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency deposit to prevent interruption of business", "label": "Loss Contingency, Deposit to Prevent Interruption of Business", "documentation": "The amount deposited by the entity to prevent interruption of business." } } }, "auth_ref": [] }, "hpq_LossContingencyMinimumAgeofPlaintiff": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LossContingencyMinimumAgeofPlaintiff", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum age of plaintiff", "label": "Loss Contingency, Minimum Age of Plaintiff", "documentation": "Loss Contingency, Minimum Age of Plaintiff" } } }, "auth_ref": [] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Nature [Domain]", "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1043", "r1044" ] }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNewClaimsFiledNumber", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New claims filed", "label": "Loss Contingency, New Claims Filed, Number", "documentation": "The total number of new claims filed pertaining to a loss contingency during the period." } } }, "auth_ref": [ "r1043", "r1044" ] }, "hpq_LossContingencyNumberOfPatentPoolMembers": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LossContingencyNumberOfPatentPoolMembers", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Number Of Patent Pool Members", "label": "Loss Contingency, Number Of Patent Pool Members", "documentation": "Loss Contingency, Number Of Patent Pool Members" } } }, "auth_ref": [] }, "hpq_LossContingencyNumberofDefendantsCurrentEmployee": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LossContingencyNumberofDefendantsCurrentEmployee", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of current employees", "label": "Loss Contingency, Number of Defendants, Current Employee", "documentation": "Loss Contingency, Number of Defendants, Current Employee" } } }, "auth_ref": [] }, "hpq_LossContingencyNumberofDefendantsFormerEmployee": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LossContingencyNumberofDefendantsFormerEmployee", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of former employee", "label": "Loss Contingency, Number of Defendants, Former Employee", "documentation": "Loss Contingency, Number of Defendants, Former Employee" } } }, "auth_ref": [] }, "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyPatentsAllegedlyInfringedNumber", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patents allegedly infringed", "label": "Loss Contingency, Patents Allegedly Infringed, Number", "documentation": "Number of another entity's patents that the entity has allegedly infringed." } } }, "auth_ref": [ "r1043", "r1044" ] }, "hpq_LossContingencyPatentsWithdrawn": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "LossContingencyPatentsWithdrawn", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patents withdrawn", "label": "Loss Contingency, Patents Withdrawn", "documentation": "Loss Contingency, Patents Withdrawn" } } }, "auth_ref": [] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Machinery and equipment, including equipment held for lease", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "hpq_MarketableEquitySecuritiesandMutualFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "MarketableEquitySecuritiesandMutualFundsMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities and mutual funds", "label": "Marketable Equity Securities and Mutual Funds [Member]", "documentation": "Marketable Equity Securities and Mutual Funds [Member]" } } }, "auth_ref": [] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Segment Reconciling Items [Member]", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r65" ] }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency maturity", "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments." } } }, "auth_ref": [ "r16" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails", "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r411", "r412", "r413", "r414", "r571", "r707", "r750", "r775", "r776", "r826", "r830", "r832", "r833", "r844", "r858", "r859", "r877", "r886", "r904", "r908", "r1051", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077" ] }, "hpq_MaximumRetirementMedicalSavingsAccountEmployerCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "MaximumRetirementMedicalSavingsAccountEmployerCredits", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum retirement medical savings account employer credits", "label": "Maximum Retirement Medical Savings Account Employer Credits", "documentation": "Maximum Retirement Medical Savings Account Employer Credits" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r961" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r961" ] }, "hpq_MessrsLynchMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "MessrsLynchMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mr. Lynch", "label": "Messrs Lynch [Member]", "documentation": "Represents information on Messrs Lynch" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails", "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r411", "r412", "r413", "r414", "r571", "r707", "r750", "r775", "r776", "r826", "r830", "r832", "r833", "r844", "r858", "r859", "r877", "r886", "r904", "r908", "r1051", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r980" ] }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "presentation": [ "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in aggregated product warranty liabilities", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r988" ] }, "hpq_MunichGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "MunichGermanyMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Munich, Germany", "label": "Munich, Germany [Member]", "documentation": "Munich, Germany" } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r962" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r245" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r245" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r153", "r154", "r155" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings", "terseLabel": "Net earnings", "verboseLabel": "Net earnings", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r145", "r155", "r184", "r199", "r230", "r233", "r238", "r249", "r258", "r260", "r261", "r262", "r263", "r266", "r267", "r280", "r294", "r314", "r320", "r323", "r364", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r651", "r661", "r726", "r803", "r819", "r820", "r875", "r917", "r1049" ] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings, basic", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r243", "r260", "r261", "r262", "r263", "r269", "r270", "r281", "r284", "r294", "r314", "r320", "r323", "r875" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "presentation": [ "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings, diluted", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r243", "r271", "r276", "r277", "r278", "r279", "r281", "r284" ] }, "hpq_NetPaymentsProceedsRelatedToStockBasedAwardActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NetPaymentsProceedsRelatedToStockBasedAwardActivities", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Stock-based award activities and others", "label": "Net (Payments) Proceeds Related To Stock Based Award Activities", "documentation": "Net (Payments) Proceeds Related To Stock Based Award Activities" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "hpq_NokiaPatentLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NokiaPatentLitigationMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nokia Patent Litigation", "label": "Nokia Patent Litigation [Member]", "documentation": "Nokia Patent Litigation" } } }, "auth_ref": [] }, "hpq_NokiaPatentLitigationU.S.InternationalTradeCommissionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NokiaPatentLitigationU.S.InternationalTradeCommissionMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nokia Patent Litigation, U.S. International Trade Commission", "label": "Nokia Patent Litigation, U.S. International Trade Commission [Member]", "documentation": "Nokia Patent Litigation, U.S. International Trade Commission" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r961" ] }, "hpq_NonLaborMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NonLaborMember", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-labor", "label": "Non-Labor [Member]", "documentation": "Non-Labor [Member]" } } }, "auth_ref": [] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r931", "r942", "r952", "r969", "r977" ] }, "hpq_NonOperatingRetirementRelatedCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NonOperatingRetirementRelatedCredits", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-operating retirement-related credits", "label": "Non-operating Retirement Related Credits", "documentation": "Non-operating Retirement Related Credits" } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r959" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r958" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r969" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r988" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r988" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives not designated as hedging instruments", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r20" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails", "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and other, net", "verboseLabel": "Interest and other, net", "totalLabel": "Interest and other, net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r150" ] }, "us-gaap_NontradeReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NontradeReceivablesCurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier and other receivables", "label": "Nontrade Receivables, Current", "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1009" ] }, "hpq_NotesPayableToBanksLinesOfCreditAndOtherNotesPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NotesPayableToBanksLinesOfCreditAndOtherNotesPayablesMember", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable to banks, lines of credit and other", "label": "Notes Payable To Banks Lines Of Credit And Other Notes Payables [Member]", "documentation": "Obligation related to notes payable to banks, lines of credit and other debt." } } }, "auth_ref": [] }, "hpq_NumberOfAffiliates": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NumberOfAffiliates", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of affiliates", "label": "Number Of Affiliates", "documentation": "Number Of Affiliates" } } }, "auth_ref": [] }, "hpq_NumberOfMembers": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NumberOfMembers", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of members", "label": "Number Of Members", "documentation": "Represents number of members." } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.hp.com/role/SegmentInformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r1026" ] }, "hpq_NumberOfSubsidiaries": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "NumberOfSubsidiaries", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of subsidiaries", "label": "Number Of Subsidiaries", "documentation": "Represents the number of subsidiaries." } } }, "auth_ref": [] }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "crdr": "credit", "calculation": { "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains (losses) arising during the period", "verboseLabel": "Other comprehensive gains (losses) before reclassifications", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent." } } }, "auth_ref": [ "r31", "r47" ] }, "us-gaap_OffsettingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAbstract", "lang": { "en-us": { "role": { "label": "Offsetting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Assets", "label": "Offsetting Assets [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r140", "r220" ] }, "us-gaap_OffsettingDerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingDerivativeAssetsAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets", "label": "Offsetting Derivative Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingDerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingDerivativeLiabilitiesAbstract", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofInformationRelatedtothePotentialEffectofEntitysMasterNettingAgreementsandCollateralSecurityAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Offsetting Derivative Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingLiabilitiesTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Liabilities", "label": "Offsetting Liabilities [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r140", "r220" ] }, "us-gaap_OperatingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenseMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses", "label": "Operating Expense [Member]", "documentation": "Primary financial statement caption encompassing expenses associated with normal operations." } } }, "auth_ref": [ "r27" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings from operations", "verboseLabel": "Total segment earnings from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r294", "r314", "r320", "r323", "r875" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r670" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r671" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r670" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability." } } }, "auth_ref": [ "r671" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r669" ] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r671" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r313", "r314", "r315", "r316", "r317", "r323" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r125", "r156", "r157", "r173" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r40" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "totalLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r215", "r906" ] }, "us-gaap_OtherAssetsMiscellaneousNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMiscellaneousNoncurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Assets, Miscellaneous, Noncurrent", "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "totalLabel": "Other non-current assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r206" ] }, "us-gaap_OtherBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherBorrowings", "crdr": "credit", "calculation": { "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030", "label": "Other Borrowings", "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity." } } }, "auth_ref": [ "r182" ] }, "us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentBeforeTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentBeforeTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in unrealized components of available-for-sale debt securities:", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of actuarial loss and prior service benefit", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax", "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)." } } }, "auth_ref": [ "r6", "r143", "r539" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Change in unrealized components of defined benefit plans:", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Change in unrealized components of defined benefit plans", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent", "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive (income) loss for defined benefit plan, attributable to parent entity." } } }, "auth_ref": [ "r9", "r17", "r174" ] }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in unrealized components of cash flow hedges:", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Change in cumulative translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent", "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r9", "r17", "r174" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in cumulative translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r9", "r17", "r174" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "crdr": "debit", "calculation": { "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax benefit (provision) on unrealized (losses) gains arising during the period", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r7", "r236", "r727" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss before taxes", "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent", "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r9", "r17", "r174" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive loss before taxes:", "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Change in unrealized components of cash flow hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent", "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r226" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinAccumulatedOtherComprehensiveLossIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Unrealized losses arising during the period", "terseLabel": "Gain/(loss) recognized in Accumulated other comprehensive loss on derivative", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r222", "r226", "r637", "r638", "r640" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gains reclassified into earnings", "verboseLabel": "Gain/(loss) reclassified\u00a0from\u00a0Accumulated\u00a0 other comprehensive (loss) income into\u00a0earnings", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r194", "r226", "r228" ] }, "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Curtailments, settlements and other", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax", "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan." } } }, "auth_ref": [ "r8", "r143", "r170" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss, net of taxes", "terseLabel": "Other comprehensive loss, net of taxes", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r9", "r17", "r174", "r231", "r234" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Losses arising during the period", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax", "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r4", "r143", "r170" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 }, "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Benefit from taxes", "negatedTotalLabel": "Tax benefit on other comprehensive loss", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r9", "r17", "r174" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains arising during the period", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax", "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r223", "r226", "r363" ] }, "us-gaap_OtherContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherContractMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsPreTaxEffectofDerivativeInstrumentsNotDesignatedasHedgingInstrumentsRecognizedinInterestandOtherNetintheConsolidatedCondensedStatementsofEarningsDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other derivatives", "label": "Other Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is classified as other." } } }, "auth_ref": [ "r861", "r871", "r894" ] }, "hpq_OtherCountriesWithIncomeTaxJurisdictionNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.hp.com/20240131", "localname": "OtherCountriesWithIncomeTaxJurisdictionNumber", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other countries with income tax jurisdiction", "label": "Other Countries with Income Tax Jurisdiction Number", "documentation": "Represents the number of other countries in which the entity is subject to income taxes." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Assets", "label": "Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r99", "r113" ] }, "us-gaap_OtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Other Current Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Current Liabilities", "label": "Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "totalLabel": "Other accrued liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r40", "r906" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "totalLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r44" ] }, "hpq_OtherLongTermDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "OtherLongTermDebtMember", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030", "label": "Other Long Term Debt [Member]", "documentation": "Other Long Term Debt [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other, net", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r155" ] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsNarrativeDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-Current Assets", "label": "Other Noncurrent Assets [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofGrossNotionalandFairValueofDerivativeFinancialInstrumentsintheConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-Current Liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Non-Current Liabilities", "label": "Other Noncurrent Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofInterestandOtherNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r152" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r961" ] }, "hpq_OtherPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "OtherPlanMember", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other prior-year plans", "label": "Other Plan [Member]", "documentation": "Other Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Post-Retirement Benefit Plans", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r495", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r543", "r544", "r546", "r549", "r552", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r569", "r570", "r896", "r897", "r898", "r899", "r900" ] }, "us-gaap_OtherRestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherRestructuringCosts", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other charges", "label": "Other Restructuring Costs", "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r11" ] }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSundryLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Sundry Liabilities, Noncurrent", "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date." } } }, "auth_ref": [ "r129", "r179" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r929", "r940", "r950", "r975" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r932", "r943", "r953", "r978" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r932", "r943", "r953", "r978" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r957" ] }, "hpq_PaymentForCollateralReturnedForDerivativeInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "PaymentForCollateralReturnedForDerivativeInstruments", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Collateral returned for derivative instruments", "label": "Payment For Collateral Returned For Derivative Instruments", "documentation": "Payment For Collateral Returned For Derivative Instruments" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited", "http://www.hp.com/role/StockholdersDeficitNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of common stock", "verboseLabel": "Payment in connection with repurchases of shares", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r51" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r400", "r1016" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash dividends paid", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r51" ] }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireMarketableSecurities", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of available-for-sale securities and other investments", "label": "Payments to Acquire Marketable Securities", "documentation": "Amount of cash outflow for purchase of marketable security." } } }, "auth_ref": [ "r1028" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Investment in property, plant and equipment, net", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r185", "r1061", "r1062", "r1063" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r960" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r960" ] }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension, post-retirement, and post-employment liabilities", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent." } } }, "auth_ref": [ "r77", "r78", "r129", "r169" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlans" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement and Post-Retirement Benefit Plans", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r494", "r519", "r521", "r527", "r545", "r547", "r548", "r549", "r550", "r551", "r566", "r567", "r568", "r896" ] }, "us-gaap_PensionAndOtherPostretirementPlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementPlansPolicy", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Employer Contributions and Funding Policy", "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived." } } }, "auth_ref": [ "r13", "r14", "r15", "r21", "r83" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plans", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r495", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r543", "r544", "r546", "r549", "r552", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r569", "r572", "r896", "r897", "r901", "r902", "r903" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r959" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r969" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r962" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r958" ] }, "hpq_PersonalSystemsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "PersonalSystemsMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Personal Systems", "label": "Personal Systems [Member]", "documentation": "Business reporting segment that provides commercial PCs, consumer PCs, workstations, handheld computing devices, calculators and other related accessories, software and services for the commercial and consumer markets." } } }, "auth_ref": [] }, "hpq_PhilipsPatentLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "PhilipsPatentLitigationMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Philips Patent Litigation", "label": "Philips Patent Litigation [Member]", "documentation": "Philips Patent Litigation" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (usd per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r130", "r474" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r130", "r783" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r130", "r474" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Preferred stock, $0.01 par value (300 shares authorized; none issued)", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r130", "r719", "r906" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1011" ] }, "hpq_PrepaidPensionAndPostRetirementBenefitAssetNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "PrepaidPensionAndPostRetirementBenefitAssetNonCurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid pension and post-retirement benefit assets", "label": "Prepaid Pension And Post-retirement Benefit Asset, Non Current", "documentation": "Prepaid Pension And Post-retirement Benefit Asset, Non Current" } } }, "auth_ref": [] }, "hpq_PrintingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "PrintingMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Printing", "label": "Printing [Member]", "documentation": "Business reporting segment that provides consumer and commercial printer hardware, printing supplies, printing media and scanning devices." } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassifications", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r1004" ] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from debt, net of issuance costs", "label": "Proceeds from Debt, Net of Issuance Costs", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r244" ] }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Maturities and sales of available-for-sale securities and other investments", "label": "Proceeds from Sale, Maturity and Collection of Investments", "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period." } } }, "auth_ref": [ "r49" ] }, "us-gaap_ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from short-term borrowings with original maturities less than 90\u00a0days, net", "label": "Proceeds from Short-Term Debt, Maturing in Three Months or Less", "documentation": "The cash inflow from a borrowing having initial term of repayment within three months." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ProductMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductMember", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Products", "label": "Product [Member]", "documentation": "Article or substance produced by nature, labor or machinery." } } }, "auth_ref": [ "r887" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r325", "r708", "r744", "r745", "r746", "r747", "r748", "r749", "r862", "r887", "r907", "r996", "r1045", "r1046", "r1053", "r1083" ] }, "us-gaap_ProductWarrantyAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrual", "crdr": "credit", "presentation": [ "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Standard and Extended Product Warranty Accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers." } } }, "auth_ref": [ "r122", "r422", "r426", "r430" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warranty", "label": "Product Warranty Accrual, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40", "r1047", "r1048" ] }, "us-gaap_ProductWarrantyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualPayments", "crdr": "debit", "presentation": [ "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Settlements made (in cash or in kind)", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty." } } }, "auth_ref": [ "r427" ] }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "crdr": "credit", "presentation": [ "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments related to pre-existing warranties (including changes in estimates)", "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties", "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties." } } }, "auth_ref": [ "r429" ] }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualWarrantiesIssued", "crdr": "credit", "presentation": [ "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accruals for warranties issued", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued." } } }, "auth_ref": [ "r428" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r325", "r708", "r744", "r745", "r746", "r747", "r748", "r749", "r862", "r887", "r907", "r996", "r1045", "r1046", "r1053", "r1083" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r161", "r203", "r724" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Net", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r12", "r716", "r724", "r906" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Property, Plant and Equipment, Net", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r161" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofAllowanceforCreditLossesRelatedtoAccountsReceivableandChangesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Benefit of allowance for credit losses", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r242", "r371" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r957" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r957" ] }, "hpq_R2SemiconductorLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "R2SemiconductorLitigationMember", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "R2 Semiconductor Litigation", "label": "R2 Semiconductor Litigation [Member]", "documentation": "R2 Semiconductor Litigation" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails", "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r411", "r412", "r413", "r414", "r519", "r571", "r597", "r598", "r599", "r680", "r707", "r750", "r775", "r776", "r826", "r830", "r832", "r833", "r844", "r858", "r859", "r877", "r886", "r904", "r908", "r911", "r1038", "r1051", "r1073", "r1074", "r1075", "r1076", "r1077" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails", "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r411", "r412", "r413", "r414", "r519", "r571", "r597", "r598", "r599", "r680", "r707", "r750", "r775", "r776", "r826", "r830", "r832", "r833", "r844", "r858", "r859", "r877", "r886", "r904", "r908", "r911", "r1038", "r1051", "r1073", "r1074", "r1075", "r1076", "r1077" ] }, "hpq_ReceivablesSoldButNotCollectedFromThirdParty": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ReceivablesSoldButNotCollectedFromThirdParty", "crdr": "debit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofTradeReceivablesSoldandCashReceivedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Receivables Sold but Not Collected from Third Party", "documentation": "Represents the amount of receivables sold to the third party, but not collected by the third party from customer under revolving financing receivables arrangements." } } }, "auth_ref": [] }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r238" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "crdr": "debit", "calculation": { "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gains (losses) reclassified into earnings", "negatedLabel": "Reclassifications of gain into earnings", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r31", "r47" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodTax", "crdr": "credit", "calculation": { "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax effects on reclassification into earnings", "label": "Reclassification from AOCI, Current Period, Tax", "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r7", "r229", "r236", "r727" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "presentation": [ "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r238" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.hp.com/role/StockholdersDeficitTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes and Reclassifications Related to Other Comprehensive Loss, Net of Taxes", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://www.hp.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Operating Profit (Loss) from Segment Operating Results to HP Consolidated Results", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r64", "r65" ] }, "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://www.hp.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Revenue from Segment Operating Results to HP Consolidated Results", "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues." } } }, "auth_ref": [ "r63", "r65" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r924", "r935", "r945", "r970" ] }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of debt and associated costs", "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security", "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation." } } }, "auth_ref": [ "r52" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r251", "r252", "r448", "r476", "r673", "r870", "r871" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r124", "r606", "r1078" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r925", "r936", "r946", "r971" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r926", "r937", "r947", "r972" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r933", "r944", "r954", "r979" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash and Cash Equivalents, Current", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r53", "r202", "r246" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Domain]", "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r202" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.hp.com/role/RestructuringandOtherCharges" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Other Charges", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r397", "r398", "r400", "r403", "r409" ] }, "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostCostIncurredToDate1", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total costs incurred to date", "label": "Restructuring and Related Cost, Cost Incurred to Date", "documentation": "Amount of costs incurred to date for the specified restructuring cost." } } }, "auth_ref": [ "r399", "r402", "r406", "r408" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated pre-tax charges", "label": "Restructuring and Related Cost, Expected Cost", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r399", "r402", "r406", "r408" ] }, "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected positions to be eliminated", "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated", "documentation": "The expected number of positions to be eliminated as a result of restructuring activities." } } }, "auth_ref": [] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Charges", "terseLabel": "Restructuring and other charges", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r11", "r404", "r406", "r1039" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r399", "r400", "r406", "r407" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r399", "r400", "r401", "r402", "r406", "r407", "r408" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Axis]", "label": "Restructuring Plan [Axis]", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Domain]", "label": "Restructuring Plan [Domain]", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accrued balance, beginning of the period", "periodEndLabel": "Accrued balance, end of the period", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r400", "r405" ] }, "us-gaap_RestructuringReserveAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveAbstract", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reflected in Consolidated Condensed Balance Sheets", "label": "Restructuring Reserve [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveAccrualAdjustment1", "crdr": "debit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash and other adjustments", "label": "Restructuring Reserve, Accrual Adjustment", "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability." } } }, "auth_ref": [ "r400", "r407" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveCurrent", "crdr": "credit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r1008", "r1040", "r1041" ] }, "us-gaap_RestructuringReserveNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveNoncurrent", "crdr": "credit", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Restructuring Reserve, Noncurrent", "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r1012", "r1040", "r1041" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "hpq_RestructuringandOtherCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "RestructuringandOtherCharges", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 }, "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and other charges", "negatedTerseLabel": "Restructuring and other charges", "label": "Restructuring and Other Charges", "documentation": "Restructuring and Other Charges" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r133", "r168", "r721", "r754", "r756", "r762", "r784", "r906" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r197", "r255", "r256", "r257", "r259", "r265", "r267", "r365", "r366", "r602", "r603", "r604", "r621", "r622", "r641", "r643", "r644", "r646", "r649", "r751", "r753", "r764", "r1087" ] }, "us-gaap_RetirementPlanSponsorLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationAxis", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Axis]", "label": "Retirement Plan Sponsor Location [Axis]", "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r546", "r549", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r1055", "r1056", "r1057" ] }, "us-gaap_RetirementPlanSponsorLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationDomain", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Domain]", "label": "Retirement Plan Sponsor Location [Domain]", "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r546", "r549", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r1055", "r1056", "r1057" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r495", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r543", "r544", "r546", "r549", "r552", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r569", "r570", "r572", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r495", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r543", "r544", "r546", "r549", "r552", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r569", "r570", "r572", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903" ] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Revenue by Region", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r26" ] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationValueofRemainingPerformanceObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining performance obligations", "label": "Revenue, Remaining Performance Obligation, Amount", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r191" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationValueofRemainingPerformanceObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationValueofRemainingPerformanceObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining performance obligations period", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r192" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationValueofRemainingPerformanceObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format." } } }, "auth_ref": [ "r192" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationValueofRemainingPerformanceObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation." } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails", "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total net revenue", "verboseLabel": "Net revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r239", "r249", "r295", "r296", "r313", "r318", "r319", "r325", "r327", "r329", "r364", "r431", "r432", "r434", "r435", "r436", "r438", "r440", "r442", "r443", "r661", "r713", "r1049" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.hp.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r988" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r988" ] }, "us-gaap_SalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesMember", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofPreTaxEffectofDerivativeInstrumentsinCashFlowHedgingRelationshipsIncludedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenue", "label": "Sales [Member]", "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.hp.com/role/StockholdersDeficitTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Accumulated Other Comprehensive Loss, Net of Taxes and Changes", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r47", "r1068", "r1069" ] }, "hpq_ScheduleOfAllowanceForDoubtfulAccountsReceivableCurrentRollforwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ScheduleOfAllowanceForDoubtfulAccountsReceivableCurrentRollforwardTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes", "label": "Schedule of Allowance for Doubtful Accounts Receivable Current Rollforward [Table Text Block]", "documentation": "Tabular disclosure of the change in allowance for doubtful accounts - accounts receivable during the period." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash and Cash Equivalents", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "hpq_ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsLineItems", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents and available-for-sale investments", "label": "Schedule of Cash Equivalents and Available For Sale Investments [Line Items]" } } }, "auth_ref": [] }, "hpq_ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsReconciliationTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash Equivalents and Available-for-Sale Investments", "label": "Schedule of Cash Equivalents and Available For Sale Investments Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation of cash equivalents and available-for-sale securities from cost basis to fair value." } } }, "auth_ref": [] }, "hpq_ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ScheduleOfCashEquivalentsAndAvailableForSaleInvestmentsTable", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash Equivalents and Available For Sale Investments [Table]", "label": "Schedule of Cash Equivalents and Available For Sale Investments [Table]", "documentation": "Schedule of the cash equivalents and available-for-sale investments." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.hp.com/role/StockholdersDeficitTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Taxes Related to Other Comprehensive Income (Loss)", "label": "Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r142" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.hp.com/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-Term Debt", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r43", "r75", "r76", "r117", "r118", "r120", "r123", "r166", "r167", "r882", "r884", "r1021" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r13", "r79", "r80", "r81", "r82" ] }, "hpq_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossPreTaxTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossPreTaxTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income", "label": "Schedule Of Derivative Instruments, Effect On Other Comprehensive Income (Loss), Pre-Tax [Table Text Block]", "documentation": "Schedule Of Derivative Instruments, Effect On Other Comprehensive Income (Loss), Pre-Tax" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r101" ] }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r98" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.hp.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of the Number of Shares Used for Basic and Diluted Net EPS Calculations", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1025" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.hp.com/role/FairValueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r653", "r654" ] }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship", "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r106" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Inventory", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r34", "r137", "r138", "r139" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Pension and Post-Retirement Benefit (Credit)", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r171" ] }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Other Non-Current Assets", "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "documentation": "Tabular disclosure of noncurrent assets." } } }, "auth_ref": [ "r1007" ] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Current Assets", "label": "Schedule of Other Current Assets [Table Text Block]", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.hp.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument." } } }, "auth_ref": [ "r107", "r995" ] }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest and Other, Net", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "presentation": [ "http://www.hp.com/role/GuaranteesIndemnificationsandWarrantiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Aggregate Product Warranty Liabilities and Changes", "label": "Schedule of Product Warranty Liability [Table Text Block]", "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability." } } }, "auth_ref": [ "r425" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofPropertyPlantandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Cash", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r29", "r176", "r1081" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r399", "r400", "r401", "r402", "r406", "r407", "r408" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring Activities by Plan", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r70", "r71" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r60", "r61", "r62", "r66" ] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Short-term Debt [Table]", "label": "Schedule of Short-Term Debt [Table]", "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTextBlock", "presentation": [ "http://www.hp.com/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Notes Payable and Short-Term Borrowings", "label": "Schedule of Short-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r38" ] }, "hpq_ScheduleOfTradeReceivablesSoldAndCashReceivedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.hp.com/20240131", "localname": "ScheduleOfTradeReceivablesSoldAndCashReceivedTableTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Trade Receivables Sold and Cash Received", "label": "Schedule Of Trade Receivables Sold And Cash Received [Table Text Block]", "documentation": "Schedule Of Trade Receivables Sold And Cash Received" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r919" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r921" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r291", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r329", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r402", "r408", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r879", "r996", "r1083" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r327", "r328", "r768", "r771", "r773", "r827", "r831", "r834", "r845", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r863", "r888", "r911", "r1053", "r1083" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.hp.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r290", "r291", "r292", "r293", "r294", "r306", "r317", "r321", "r322", "r323", "r324", "r325", "r326", "r329" ] }, "hpq_SegmentReportingInformationCorporateAndUnallocatedCostsGainsAndEliminations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "SegmentReportingInformationCorporateAndUnallocatedCostsGainsAndEliminations", "crdr": "debit", "calculation": { "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Corporate and unallocated costs and other", "label": "Segment Reporting Information Corporate and Unallocated Costs, Gains and Eliminations", "documentation": "Amount of reconciling item for corporate and unallocated costs, gains and eliminations." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationOperatingIncomeLossAbstract", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenue:", "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationRevenueAbstract", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]", "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment Information", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r307", "r308", "r309", "r310", "r311", "r312", "r327", "r876" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r149" ] }, "us-gaap_ServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ServiceMember", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Services", "label": "Service [Member]", "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service." } } }, "auth_ref": [ "r887" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600" ] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial Paper", "label": "Short-Term Debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r126", "r178", "r906", "r1079" ] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtLineItems", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes Payable and Short-Term Borrowings", "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Axis]", "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Domain]", "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r35" ] }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtWeightedAverageInterestRate", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofNotesPayableandShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial paper and notes payable to banks, lines of credit and other", "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time", "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time." } } }, "auth_ref": [ "r36" ] }, "us-gaap_SpecialTerminationBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SpecialTerminationBenefitsMember", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Special Termination Benefits", "label": "Special Termination Benefits [Member]", "documentation": "Special benefits offered to employees to terminate employment." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r198", "r291", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r329", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r390", "r402", "r408", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r879", "r996", "r1083" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "http://www.hp.com/role/StockholdersDeficitScheduleofChangesandReclassificationsRelatedtoOtherComprehensiveLossNetofTaxesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails", "http://www.hp.com/role/StockholdersDeficitScheduleofTaxesRelatedtoOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r19", "r45", "r197", "r236", "r237", "r238", "r255", "r256", "r257", "r259", "r265", "r267", "r289", "r365", "r366", "r488", "r602", "r603", "r604", "r621", "r622", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r662", "r663", "r664", "r665", "r666", "r667", "r672", "r751", "r752", "r753", "r764", "r821" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.hp.com/role/LitigationandContingenciesDetails", "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofNetRevenuebyRegionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r327", "r328", "r768", "r771", "r773", "r827", "r831", "r834", "r845", "r847", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r863", "r888", "r911", "r1053", "r1083" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r255", "r256", "r257", "r289", "r708", "r757", "r765", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r802", "r804", "r805", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r821", "r912" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r255", "r256", "r257", "r289", "r708", "r757", "r765", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r802", "r804", "r805", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r821", "r912" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r928", "r939", "r949", "r974" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock in connection with employee stock plans and other (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r19", "r130", "r131", "r168" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock in connection with employee\u00a0stock plans and other", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r84", "r130", "r131", "r168" ] }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "crdr": "credit", "presentation": [ "http://www.hp.com/role/StockholdersDeficitNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share repurchase authorization remaining", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "documentation": "Amount remaining of a stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "http://www.hp.com/role/StockholdersDeficitNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchases of common stock (in shares)", "terseLabel": "Repurchases of common stock (shares)", "label": "Stock Repurchased and Retired During Period, Shares", "documentation": "Number of shares that have been repurchased and retired during the period." } } }, "auth_ref": [ "r19", "r130", "r131", "r168" ] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchases of common stock (Note 10)", "label": "Stock Repurchased and Retired During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)." } } }, "auth_ref": [ "r19", "r130", "r131", "r168" ] }, "hpq_StockRepurchasesExecutedDuringPeriodSettlementInSubsequentPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.hp.com/20240131", "localname": "StockRepurchasesExecutedDuringPeriodSettlementInSubsequentPeriodShares", "presentation": [ "http://www.hp.com/role/StockholdersDeficitNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares settled (in shares)", "label": "Stock Repurchases Executed During Period Settlement In Subsequent Period, Shares", "documentation": "Stock Repurchases Executed During Period Settlement In Subsequent Period, Shares" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited", "http://www.hp.com/role/ConsolidatedCondensedStatementsofStockholdersDeficitUnaudited", "http://www.hp.com/role/StockholdersDeficitScheduleofComponentsofAccumulatedOtherComprehensiveLossNetofTaxesandChangesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 deficit", "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r131", "r134", "r135", "r158", "r785", "r801", "r822", "r823", "r906", "r918", "r1019", "r1034", "r1067", "r1087" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 deficit:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity Note [Abstract]", "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.hp.com/role/StockholdersDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Deficit", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r165", "r248", "r473", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r487", "r488", "r648", "r824", "r825", "r846" ] }, "us-gaap_SubsegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsAxis", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Axis]", "label": "Subsegments [Axis]", "documentation": "Information by business subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsDomain", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Domain]", "label": "Subsegments [Domain]", "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Supplementary Financial Information", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r1005" ] }, "us-gaap_SupplierFinanceProgramObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligation", "crdr": "credit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationSupplierFinanceProgramsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Obligations outstanding", "label": "Supplier Finance Program, Obligation", "documentation": "Amount of obligation for supplier finance program." } } }, "auth_ref": [ "r392", "r393", "r394", "r395", "r396", "r880" ] }, "us-gaap_SupplierFinanceProgramObligationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationCurrent", "crdr": "credit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationSupplierFinanceProgramsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts owed to participating financial institutions", "label": "Supplier Finance Program, Obligation, Current", "documentation": "Amount of obligation for supplier finance program, classified as current." } } }, "auth_ref": [ "r392", "r393", "r396" ] }, "us-gaap_SupplierFinanceProgramPaymentTimingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramPaymentTimingPeriod", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationSupplierFinanceProgramsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment terms offered by HP", "label": "Supplier Finance Program, Payment Timing, Period", "documentation": "Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r391" ] }, "hpq_SuppliesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "SuppliesMember", "presentation": [ "http://www.hp.com/role/SegmentInformationScheduleofReconciliationofSegmentOperatingResultstoHPConsolidatedResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplies", "label": "Supplies [Member]", "documentation": "A business unit within the Printing group business segment that provides supplies." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r968" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax liability", "label": "Taxes Payable, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r39" ] }, "hpq_TaxesPayableNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "TaxesPayableNoncurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherNonCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax liability", "label": "Taxes Payable Noncurrent", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes." } } }, "auth_ref": [] }, "hpq_TaxesPayableOtherThanIncomeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "TaxesPayableOtherThanIncomeCurrent", "crdr": "credit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued taxes", "label": "Taxes Payable Other than Income Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for taxes other than income tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r960" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r967" ] }, "hpq_TradeReceivablesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.hp.com/20240131", "localname": "TradeReceivablesSold", "crdr": "credit", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofTradeReceivablesSoldandCashReceivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables sold", "label": "Trade Receivables Sold", "documentation": "The aggregate face amount of accounts receivable that were sold to third party under revolving financing receivables arrangements during the reporting period." } } }, "auth_ref": [] }, "hpq_TradeReceivablesSoldAndCashReceivedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.hp.com/20240131", "localname": "TradeReceivablesSoldAndCashReceivedRollForward", "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofTradeReceivablesSoldandCashReceivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade Receivables Sold and Cash Received [Roll Forward]", "label": "Trade Receivables Sold and Cash Received [Roll Forward]", "documentation": "No definition available." } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r987" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r989" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.hp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialAssetsPolicyTextBlock", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Transfers and Servicing Trade Receivables Policy", "label": "Transfers and Servicing of Financial Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for transfers and servicing financial assets, including securitization transactions as well as repurchase and resale agreements. This disclosure may include how the entity (1) determines whether a transaction is accounted for as a sale; (2) accounts for a sale transaction, including the initial and subsequent accounting for any interests that the entity obtains or continues to hold in the transaction, how such interests are valued, and the significant assumptions used in the valuation; (3) accounts for a transaction that does not qualify for sale treatment (that is, a financing); and (4) accounts for its servicing assets and liabilities (\"servicing\"), including how such servicing is measured initially and subsequently, and the methodology and significant assumptions used to value such servicing." } } }, "auth_ref": [ "r22", "r121", "r683", "r689", "r691" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r469", "r486", "r647", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r684", "r685", "r686", "r687", "r688", "r690", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r728", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1030", "r1031", "r1032", "r1033" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r990" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r991" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r989" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r989" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r992" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r990" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.hp.com/role/RestructuringandOtherChargesNarrativeDetails", "http://www.hp.com/role/RestructuringandOtherChargesScheduleofRestructuringActivitiesbyPlanDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r399", "r400", "r406", "r407" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansNarrativeDetails", "http://www.hp.com/role/RetirementandPostRetirementBenefitPlansScheduleofComponentsofPensionandPostRetirementBenefitCreditDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S.", "label": "UNITED STATES" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueApril2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueApril2029Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029", "label": "U.S. Dollar Global Notes, Due April 2029 [Member]", "documentation": "U.S. Dollar Global Notes, Due April 2029" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueApril2032Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueApril2032Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032", "label": "U.S. Dollar Global Notes , Due April 2032 [Member]", "documentation": "U.S. Dollar Global Notes , Due April 2032" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueJanuary2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueJanuary2028Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028", "label": "U.S. Dollar Global Notes , Due January 2028 [Member]", "documentation": "U.S. Dollar Global Notes , Due January 2028" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueJanuary2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueJanuary2033Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033", "label": "U.S. Dollar Global Notes , Due January 2033 [Member]", "documentation": "U.S. Dollar Global Notes , Due January 2033" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueJune2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueJune2025Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025", "label": "U.S. Dollar Global Notes, Due June 2025 [Member]", "documentation": "U.S. Dollar Global Notes, Due June 2025" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueJune2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueJune2026Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026", "label": "U.S. Dollar Global Notes, Due June 2026 [Member]", "documentation": "U.S. Dollar Global Notes, Due June 2026" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueJune2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueJune2027Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027", "label": "U.S. Dollar Global Notes, Due June 2027 [Member]", "documentation": "U.S. Dollar Global Notes, Due June 2027" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueJune2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueJune2030Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030", "label": "U.S. Dollar Global Notes, Due June 2030 [Member]", "documentation": "U.S. Dollar Global Notes, Due June 2030" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueJune2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueJune2031Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031", "label": "U.S. Dollar Global Notes, Due June 2031 [Member]", "documentation": "U.S. Dollar Global Notes, Due June 2031" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueMarch2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueMarch2029Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$500 issued at par at a price of 100% at 4.75%, due March 2029", "label": "U.S. Dollar Global Notes , Due March 2029 [Member]", "documentation": "U.S. Dollar Global Notes , Due March 2029" } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesDueSeptember2041Member": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesDueSeptember2041Member", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041", "label": "U.S. Dollar Global Notes, Due September 2041 [Member]", "documentation": "Corporate debt securities issued at discount to par pursuant to a 2009 Shelf Registration which is denominated in U.S. dollars and due in September 2041." } } }, "auth_ref": [] }, "hpq_USDollarGlobalNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.hp.com/20240131", "localname": "USDollarGlobalNotesMember", "presentation": [ "http://www.hp.com/role/BorrowingsScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Dollar Global Notes", "label": "U S Dollar Global Notes [Member]", "documentation": "Corporate debt securities denominated in U.S. dollars." } } }, "auth_ref": [] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://www.hp.com/role/FairValueScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.hp.com/role/FinancialInstrumentsScheduleofCashEquivalentsandAvailableforSaleInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Government debt", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r714", "r894", "r1084" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r986" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r608", "r614" ] }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized increase in tax benefits change", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns." } } }, "auth_ref": [ "r1059" ] }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "crdr": "credit", "presentation": [ "http://www.hp.com/role/TaxesonEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits that would impact effective tax rate", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate." } } }, "auth_ref": [ "r615" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.hp.com/role/BasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r57", "r58", "r59", "r187", "r188", "r189", "r190" ] }, "us-gaap_ValueAddedTaxReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValueAddedTaxReceivableCurrent", "crdr": "debit", "calculation": { "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails": { "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/SupplementaryFinancialInformationScheduleofOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value-added taxes receivable", "label": "Value Added Tax Receivable, Current", "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1009" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.hp.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted-average shares used to compute diluted net EPS (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r271", "r284" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares used to compute net earnings per share:", "verboseLabel": "Denominator:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.hp.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.hp.com/role/ConsolidatedCondensedStatementsofEarningsUnaudited", "http://www.hp.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average shares used to compute basic net EPS (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r269", "r284" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481097/715-30-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "60", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "30", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "80", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "SubTopic": "50", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "a", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-13" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a),(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "70", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a),(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4H" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "860", "SubTopic": "50", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "45", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "25", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13,16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-4" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//460/tableOfContent" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-2" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "450", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r860": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r861": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(6)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r862": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r863": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r864": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r869": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20" }, "r870": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r871": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r872": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r873": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r874": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r875": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r876": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r877": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r878": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r879": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r880": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477128/405-50-55-5" }, "r881": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r882": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r883": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r884": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r885": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r886": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r887": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r888": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r889": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r890": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r891": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r892": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r893": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r894": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r895": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r896": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r897": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r898": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r899": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r900": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r901": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r902": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r903": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r904": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r905": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r906": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r907": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r908": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r909": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r911": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r912": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r913": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r915": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r916": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r927": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r928": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r929": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r930": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r932": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r933": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r934": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r935": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r936": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r937": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r938": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r939": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r940": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r941": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r942": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r943": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r944": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r945": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r946": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r947": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r948": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r949": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r950": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r951": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r952": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r953": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r954": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r955": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r956": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r957": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r958": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r959": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r960": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r961": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r962": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r963": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r964": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r965": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r966": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r967": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r968": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r969": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r970": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r971": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r972": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r973": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r974": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r975": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r976": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r977": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r978": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r979": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r980": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r981": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r982": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r983": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r984": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r985": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r986": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r987": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r988": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r989": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r990": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r991": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r992": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r993": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r994": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CC" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//210/tableOfContent" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 109 0000047217-24-000024-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000047217-24-000024-xbrl.zip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

(&"Y$9_D8E4W1X@G7"G_BJR<-(8%.TA_"7H$G4L=^Y$B,D M%,T-WRQCBQ-C('N]#C.+*A%GOA#"QJ3<$+DAC2@QLV0FCH.$3 MYV8$LZ0B:R8SV$#%X9J-6B2R5+"%4 ?U#9 "V\6:^'_"5^$"- 7'S&3?+O 5 M+GS(E_G*YQ, R#QEGH[ESV+CJ*[F& 96S37/FLC!6"?DEW\73,(,.GRR=S$+ M$(Q@8I-0ER\O?POMZI/(I,RD"TQ",(R8P!JZ3R7S,P9403GCE&=1TBQFOC[' M54."S2#6E@A%8F44$B. MYY]EFX)OQ19TVWH!(0N8/7\\$MRD1H2E1"-3-H^@^2IC"3[!%S/0Y&JH9$+W M!F8+%K"._G#DT0OS*_)E*$7P?!\&2&0?=H'!KH86_++NFF(36,MSX%TP8@N5 MLA9U!\JK]GA4'2[;Y5?+YO7>?DC\]%@[6^I2MNJS=H[PV7?5USVUP#4*%)I- M81CF@F5S25_0*&K+^$!>LH[1AV>E&&%U\Q1EDPO0E84@'2?%GP58^' HE',O%'K/\P MAF0"LWJ.\3)*%P658OL_#I22!'S3P*^94I\ $8]BP?2Y18=HGCL';+$/X#F7 M06J.4>C9[YFABOK,EYR87Z&P4G3>PQ'/AX6R/%_X0>298,\;*[M4'9L6:LOH MVKT@&<@A+H3^XN+"K'6P_5 U+G$J8'; G EJ&?C_4%9>B>$A"*QP\\"/'LWY M%LXH^MY M2W/\BJJRX/-EW6D$Q566^ ]1I)@^55QK4>SV\3 #O+6=^\"*6+J MJ!R)1V%:@"4)WRU>('[J. M>PY*FX>_0.,C>*4Z4PUZQ3CR8B_L E\JXY?]M![)56 ;+6Q%;S6(XKO^6WS[ MSU&N;EY$F;GI+SJ^]@"F19[, D!@!^H8XU_XN"LT"^?X>2Y$"Q=CV6W;,)FK M0+?#PJ7&/-^7 .HK"L0SQ548ID&7P1M_'QA%&(C3PO@FK.-LG=-#\PB^"44( M5"XNG?X(?M&9A-K:FE&\->KB@YJ*V/#LP<[,P9"UXY];G/EP - 3ET1GAOM6 MZAC%09T-\0DN47^Q<"$H@0F5WBCQ%X$P6A[1^Q'+$.PP9&BPO)4C,&1I#6A6 M8FS7G!"-,8[@R7?V*#"NX0,0!R1O;E@O>QKAF@F@&%$-/ 4.Q M_.;OZ#98KVA)HY$V#S8LS)\@& 6CUGT]%2HVA'G MC#"@9&NQ0]CPQWLIV' MPQ]P8%UMU-8+>Q[68Z8& B$(7 ##7P,M8-?K4AS-W[J'@5VM:1CF:J+IH%$' MK/PAT @N4AT62' ,WK +.W$B.Q::OSGC-V)GVRKUZ]#UC5:@"5W@^98+0SF, M]=HT4:#6=X?^@X5-61S#USXS"FZSWUWT 9Z)#;.#QJ)*H!J"H;/YO(&'$ID$ MJN>IOXOA2ZH^8K=EHS/H/6KX8 '1*+;"QRT%P.F*L M@0/T7F:_]R-JRY9]&"5?"-B2<3^AA!G/58Q\Q/X0A-3/F\'!.4[456 ^*2H9 M-G@33>_Y@@&/ F9A44B M[L<\CH3T1 E;IBF&!W_!LUF8/!PDVWMQ\8T8\@*S+XR\E!<^QV)S<>ZHQ]'( M#V\B"$S?RP@M.W#2@Q AC@)LO/D^B$'#X)#(F0EE3]F<,R/27\XH_87GG!'# M@B75KF!P/-1#&Q4KZB'*3$IT)-#WMG&)ML.-2B>R<1E8YZMZS8\Z^+K-PF[; MOC6PM$#XVR(N]>.*P=NKT85L*0W$\M5.9"*KN[,P8/]1'TQLGFK"$;&N%^(K._+?:U*_E;3,S=9U9C M@)W-(]J1F%G]Q4C8DNA\5Q?'9FM%.P]*&EL(K$O]QJG9" MW+=*:T\\]M3[SW<_I'ITUEN;F29-<.>8X<%!NX^G@8,.CEHR],^U->L%#T,U MR-2AE^$?5QC0,;%!7VHZMEDL#C5L_L,)+XEQ?:JUKS-5AP]BMXJ2&&.%"6Q8&R+NNZM,B_QB1W?[=AL)0*=A0?WE.*\3 MG\"+QDX0[\WU3/Z=F!ZLD[F>@Z3D>OCU7(^>[7'D>@:-7(^>V;QY9T&^!5CZ M]-,DGH;!J,^I#M4'ECG:[6#"2&PME4)+*]NC]-N\%V'ZI.-Y2U3 R"/K9#FA MU8K'YVTZQI3P5XH'(*P)+8H%BT0HA@6+,\F[!8MSR+$%B\//KP6+H\^W!8LS MR*\%R\"?=PL6)Y%O =[9@A5&*L]L;0LC-9>L:VXT4K\2@Z7\#L:4'?ACMFI^ M54^S .9;,]_F6S/7YELS]^9;,]?F6S,PWU9RWG,]H7P+LS#E"FD/=(IORA4Q M$TWN)(TW8KFK;UCN:AYE/+H:RG+2+$2:ZQE(IPV19CF54]G8F;+C^,MREL,_ MOHV=Y>A/8]1E.8/CV]B9@O]4(=(L)Y%O 19V-3?&669V-;"U>[)V9=MRSP6/ ML^"Q4D]H@ ]<2_TUM@QXA1,<)I-N*9Y5=A$BR^(O1+\ L*A_V VC&#YU(7G7 M*/7N+=>OTK)!MF-/!XD5O'!0:(,8'[_CJ.!=1KQ#,0Z:\UQ*7TG0..'1+RT2 MG&,4@EH09@M!S2?O&K6HH,J7TH"^L ()?'3P%F*:+:OKHKEC/GFG1,54N<0^ M0RO]1QY8J:\;O_^($-G"L+W>$"*;2]ZUHB+;0)%U=9O.JP\]6HY;B7SW->B# MA 4)A?P6!P/UII#?7/*N&Y7?YJ7TC)W(L#):6/1 "&EA&%T71SYSR;NF'!72 MUN5*@:@-U;.$V!:$]75Q"":?O.M$Q;9]*7TCNBW]$QM[".DL#(=E$1/.)>]: M]:AT=BZ7EE$,.[$=5R&HA6&VK A!S27O&E%![5Y*7RW;MMZ$;UHH#LMG<#RH MD+Q;SH&H76Y+0Q3R6@B>*R+U,)>\:R^E0M3KEXOJMH_4E@;8UU2(:6%8K8A4 MB'SR;BD5HBY?2M]U-]I*!9M" (,H>*PB$:) 3!<"FU/>+6VDUI5+Z7>/V 2$ M ULF8O.+B3GOT>>W^?@O8N,-0GZ+A %EQ\V:L).):<$K+Y+>)1Z*_V#7EZP; MF<@)3N:&C4S6_TW8KJ>SZ9UW1\^SX8\F\YUE\UZB/ M6EW%25-^&VEAITC6-^W^IBI=W]]*@Y]?!_W;_O53_VZ0_SYAJ3KRY'^Z&P]E M[]AQ=CZ9XS90ZW:KC7HS;?^TMEQMMEO;^J=E9BYD?%>B*=;KU5:WD:I%W.;O MFTHSDV9S;% ?/RJ=NRGA?]O5=G.[/^+#YOAV1+K&<_M#IYO/)G;/K#'$4N&P MH/:6I-0/V-WN7&!QF+MV;<,3C[_#\"(9_N2:W$C B$03KN%TMQ(M6.;6'U,H MHBI"=KF2W6X!9;=O2O!0PV]'3]]5"M.94G"U<5-1(A/+8QEUR7$X).JO%QM^ MIE6"*:@JI>#'\MGL-AZ@]]25;/I*38]>Y@ZF*7BQ3=L>[?>I035B_\NB75WP MB K>CY[9B2#W:%N:I[I.XCT%+D"7AC\U*0]KT]]7Y3W5%*-3L_&I7,WMB_Z. MS/MF$Y5M2GNF[CYAI,]SM!)PW,31LR_4"K!=HZH^(8;S6ZG2*DDFF5"\L_)" MR/3RR=>.3DGRCR_]5M+?W4O3FU0TBT45\9> ')@Y_ I^CO'>445AI1[*C7KW MR\7R8#88!2D5@)2*"RD4U\KKHHI/R$!19:!Q&!G *H!*N=9H<"(#&5ET?D") M<\MN0.U77:5.[JPZ.1T_8A5-OJ6QF50:UP0.FY*U6OM*VP>H/\2*D\34%J!H M[0P*!4#1W%L%9P2*C/P?G[\*YSKXV7*)(9D+'[M0RCC@S,804=$ELGX8HZG! MC*9ZIYF1T92,/R=R*030$@"M?1B@-1G0VMT.]T [ATCLC>6XF#UB%CPBNQTE MIXK5IA@9-U%IURYUVG9/(SY%- ME8(#9TNX<"_@8"7S6KG9X25NGFG,,%$2F@@;BK#A <*&*U*Y)GC8Q4\6L<,B M(F-+[' ;,KJ(#)D39&0;0.1?(?LQ1'7=.RR4AC[W$,^66.(^%A5K.E$KR]TV M]W$>$5#D(J"X%]IPS[]>KM6S\ORXCRKZ\.!_(?G=MAQ'\H]/%6KM2!R^2R?- M)V56AFL'X_NC;8UT-ZTLRZ6>7.YT]MX@2,6AY*(<<.CX[L+90FW+PK$'U!2$ M6KNSMXUR<*AEZ7_D(![T1!U*;'7,BL)H8!(8UA1/.A=J!3EW>W!K)H./@6M3 MNUT@X.Y]BJ??8V2Y4>HIW:SBM\+;R#NZMJ8OI$-7L]1KU!3NT75V^P8&?/E2 MEEZH26UBL/6":!/=U!W79K5_"K5DG$?@>,O"$##]=Y_E(,#72PR?RW Z4Q [ MMI65SMXB+K8B.$34EL7@,(AJ,T0I>X>D.-S"R,'2L-XHUV*-+C$;>,UZ(@:0#5X2 MR<[,K+]6__1TOR"G'P&"1=AQ=6 =+:3^/@\C;(M9_]5SX/&.3% A-F M^A&5>FJD*("4K$ZN\F2KYR=5U)I2#):9+Q+UHV7%4N#;-OC/( LC0;*H;6<7?TY20S&WBSQF@+D'2Z#ZH:V("4 :EHHZ!NF,?_ST% M-.:=%T>V-0D7%3_)D-4N]=J-@V?[B(2?U$CH8X%OZKB+#=TRGDXKU/*0W[CNI[V6 M ?&#W^M2NR]95K+0KLQ2Z_9P4V[]3.CG\460*ZALJ;3,X *[N_&1!>/#I6S MLNJ'%-PS*KGDO6#Q(6%X;3/I%_;6-W#M_%[='I#C8>[C?67@\.][1H3A]5*OV=J[ MO(5P,0Y18.Y5=Q!+P.P"+E5G8C,F6HY B ,+\2LU*3M NB:H,AB*,17EA$^1 M;WPD6@R2X$/!*.3IX9%IA:(NYSH:&XC1U8;'G"OG Y[4Y(X_J3O<))S\V6R M , _"E"W&J5>:__B: L5#B(DF%]].TN#D+.U,LV\(@Q0@,2:Y6$2,6^UW5>&%CNZ+:=+35=PQX, MHW.G4](MI@%\8[1*ARVG6072*"&R)P)8(;)U53M+&%=Q7$RFW?4-E<^WKFGMO,J3VPXBMY,Z#YSHN M,9%"RT[R?&>K72OUNMV]3\2)A"4^P;-EVW-?\-0!//LWP.0PG2D'*CUG 99$ MA: Q FL';W;L&: M$7R8WK]PR="@1^>.S,H9C:E$5/3JB#G#>D:FY<+3@8P2#$8'SKQ@HX$IL5EK M3'=,'2K=6"9+_,%B@_A!PY1A3?JFF\14=;A]X,(E[##A5)<;U\,_X0S])FD5 MGQ:7'1AM\ WFCW18(,3_Y=!&0FUX2C 9I06_GUI^&<1+&^L@ZJ_TZDW7W'&( MP\BO@I?6%C\A0Y@10&CC3R(\52F>AK[?[]356ZOK^5!C^_#OJW_>NG_MT@H>+A>'H;U.Q"N?KPF$QM.H9+H/ D M/Q$T_U/_]-,DGJ;#Q#\G@7P0-V-]EKV8^N ME@F#[M/*DLT(XU]>J+QJS5=[@>,6O#FX7(5+%^O?M^5J6XF_5*O6_\_I?9PD M6\T?3[%>K[;JW6U33/A] HMLW)7BH ML5:G,Z-M64[LBC,XB2Q2KG.6(Y;MJ>)V-J>*Q=D" 72^3P"WLSD!S.%9@KI< ME7G?ZW[P^W NA>D,X--2= R[7+">[F9FS$Q7ZBDHTZR M*0SH+ZHQ ,,@J@S>26Z@9'3"F"XXH"^ 04U!#)2U;-U5R\:H@N>DLQPJ=3X M5Z8_%X!\(;J)&]6Z@]O6FM_X&'0M9B/KEL@MXH-A679)8!ULH^NH;_0L,/&' M92!]?@=DH"7T8 [FZNC:Q\DM@\DC0XA?WO*9O,=83"VPF#@Y*I*+#*/<8&Q; MOX0C8JS-#\:V+"-\*4J>[MIPCJLASG'EUVCBE<"GO^NLBFXF\()4XHRED6&] M26.JO13-YSF'XV\Y\WDP;D3/Q>G9ZZ#323EVD,9 FTQ3M$)O0!%] SWT!ZJA MT#3U;<\GJAK$UBS>U>',4FPG%E(8X4F7GDW4;+3J\DC83.C2\NKC9 M=K+"X8?9?LC#ZO$["Y/9IF^MEU3B"IHA: M+D7?90'G_6["',6;MW*PJ1ZQ"]8C(G= M]6@YKDU=W6:GH8.6=8^HS>ZI^Q,>:P&M0/_-5[A4^_.=!GBZM=,'K$0\E#O[ MZ;@X; (.3P_#BW2KT"%6L7D-LWW)H9 MTJ(U]T;Z.]4J?U';BD%@&X\>=^2Z?,4)#L_-%[KQ;)?H!JOW4X;%QG6-H/@/ M+D$6 J502TY^S= C[>!AE3TC,$P>1@M3]-XR@P_+]BAJB7\2PUO=ADFL CJ9 MJ0#A$7$(Q3UV_K*"XAKDNG$N3SZ/JQ9F4S!-Y#)'HG*,Q(MUL\VYUO[E.:X? M+PBW6-#A!/EQ75L?>JPNW;.U:=^E6ROU.OMOF1^@G?/)7(:B(?,D_D1J8"8U M([KUK#V)@V)7'.S)8A.>@T[DVT9V;N4H%AO$JC?Q_#K9DFO#$PT_UDGF"J!0 M?N5YQ)5V-%"^@:*'>=YX-BAU=?:,A<>R9%6P^$"9C- M:G%/W8=1:@NP4^K)BO!&!!2S7&AV@V(7C)?&(0^25)^'^[*+9H*19'G;H2]UXJ&C-"K(G$-_*,<,=K!AM&&K"=74';R_U ME,[ZZ>2]$@XRX->)?#TAL4)B3VC.I)3=.IC-[7T*TG$AMDL=WM,U08]MR.M_ MHV,S8/=2EJO->:?T(V+DQ*WCSZ[I>SN3IN]-T?3]^&,13=]%T_<,FKY_)08H M2"H-QI2Z3OZG>>X-WA,]2C12/Z(AO%/?W9PV/[_&0E#GWBDYVX[$IYSRHG%] M6>*DL7CR>FXG'\XX6,Z7*E;?)1"WCFG5Q9'D%I5]N\Y_MBQ>.RWZ^+ M_NGIL([/2^C8U'%M7<5P"U[?J^-\P7:]XJ;(-]+3;%O)6W:: 0SX_W<+O#S- MH8(7KDUM^8O(G48XM*?YR.) U2CU.NM' MMIBYD&J 6R1E]P'BH;+U,P-E-&:F5,5M<&,6$RH0YSW2P&>-$_?4#3RNU&JJ MA6JJ4^.EX;%COLLIIY.3 4%[\R+[Y"DRS[-G&V(,H*+E% MK]RZR8)X"15HWL!!]O/ECLQ_8US[2;D16T&1RZ7 MHM4[:=#SL">V:%!&S6M&Q!VMB#J>BRBW:[P41!+FZ!'U: ;PP8ZMY5:CQ0E\ M,JVGQ7N'OV?+)486NK2@)W&SC #L)21RJ5<'FZ.9E;'*Q>FR-&,19\.S#R7L MA4@%$-DN=]M9[3*)4^![(N/1MJ8PG%F9-6%U68 9]Z>G> "*A0X%J'ZW+.U--PP10]Y5?8<43"T*K5*O4V[%M/45\>/\@V:+3MT9-&T$3;-; ME(Y4>5"1?L 8:%T10>/,@\;WEJGNZ$%V2KUVN=G>6Q1$W)A#!"6/&^^!(*Q M5VYQL_-P#O:F'S&.5Z"'C<5Q1XK4*;Q%*>B4>50\K>#+N.78+'?VWS0J0CA< MB)T0NYU"_ZG%#K=JV^7:_IFG.8WY_^Y?S?P"Q@]/]S\QQ\/ MWV_OG@:L16;[2KJ]^]:_Z3_O<\0QPJF8HG=Y/\!X$&+L>AJTV*0^!QLY/$EM MZ&2H&[JKTQV/4Q?D]+PH-G"*8@-YR>>\9Y4^IV3&"K+AKK4SMFRW BOM1 )E M:%MO,*ODSF;2^ IWA$A=0;B@MNL6E_&6#A<'7M9M5!E=0UXB0D>HLRUPSM/< M,O31MN <>] JO/0..[.36_,SR<&J)3;?]ST7^^@3\]E6NXFC--LV;@;RP1I_E M3C,7YVO$B2\^8+E%EV< RR[ LE%N=')Q$/$[ZB4BOUNF6EEE7&*QC34<4-!]J)I"J\LPD3WD=@/-FOMK/T3>V@MGAJHU]I"O38^UON;!M0YV(":I5ZM M&N,!KA<(G_<(DS8W4'?P-4[J>A#1P;.1.M>>.[9L8+P6MTBU/J!B_!"VEDQ) M.X1VJ:?4UM-=ULGFCTR)[@J?,&'M'R!,^/6).)9>YE46U;*_Q7I+5>&O)NYM2V%77'T2BG MMZ4B(U^W8M*% AH?V:H[65E9#@Z;Q)1;I[# $LSKP7,=EY@HOG%CS]Q\71M M:&:MOQOLUFXG"=7PX,N!L;F%3'M:I'N1J8MD6C^UL1%22*)1<*IKD_1ENSAOE@G.2"B83"(YJL*7%2 MYP@GYW;,!4:-U"8&&%"Z5M%-2253W26BVN3N!U[F-'T$DO;-&Y^@$:%(:YHU ML39\N=G>^\RC\/\YA-.VLR_9PTEA<*KQCM"9)5'= M1*G<-X'H]#N0^IZZ#Z-G\AXG(ZU2KQ'3!RFYA @[ET<$)=6Z&2"H#5I67C_, M>G0$96G:YN0(HK,Y]TX<73FP[HWF/6(/&'>6VC[IH&_8:JS'XU+;)^+LRCE M,ZE2SP":781FK;4>!>,+FN=P>,57]9$#*WY5O^2J/^&AT:'ENM8DKDJJ*'F= M&8'XUD:'.;-_;6K[:Z36@8K49\#4XQWQWW.P.Y2Y%TI!*(6#5$S(1BDW7Z8.E2ZL4Q&7Q9& MA \P#0?^^J:;Q%1UN)TE-F+K3:>ZG&X4H5HP#*4%XYQ:#MO>N[2I03!/Z>I- MU]QQB//(KP(BUQ8_(4,8B^=N_LD:]4]$ZLY*YE7D7QPM2H[>DF72U+J-EMIH M-+0&);5NHT%IN]E11JW.2/U?K)<3_&AL+U)Z7VAE:%/RJT)&,,%+8KR1F8/( MC<(4$!D2O8Z06Z/81KJ,1@>CBR\*H$DLFS!^@NQ3&^^",1%NQB*-;52D?]O. MH38(%2OQ#>)R@SH8"ZA^N2"]C9*P35L$>.U]&=H7O3@0;=1%2@)==/R&'DP: M_GCT%X+^_4W5[^CQ\^N@?]N_?NK?#;:1BO_I;5"1"\7(X$&)KNKIV42CJ9SH;)L%5WH?[9*@^3,LC4H9?A'U>:[DP-,KO4338T]J.K MY?>AQEM9X=G[_,L+95BM^0HQB%X$;PXN5^'2Q?KW;;G:5N(OU:KUV.\W/:I> MK[;JW52/VOQ],\-!R1^_?$O$A\_ 3GRSH2V'QKM))G7,'DJ=1+-ZAB6,2A.X M;^Q(%#22%DDB3W/DFPM6)IMS\N/_*=P'OMF,AP&RFO"VF@=+3MGZ8PI%5&47 M$8DE8+> J.N;$CS4 */924.G0NP#,#-NA&:<-+*MB61-*?H/>$X'#]V(QEBB M,=9A*Z[D.Q7XGKH2#7(+1?>K<^D*5/\X( V@6"0YQ068Y5*O)?-29%WTOQ)( MWXCT]IY(Q])Y,?D>XFC@48X&_LMS7#]@YUJ238&UJFY0R8PL6G@%/ZMH!TYM MZU5'WWHX$X:@, 2Y,03E)O_2=DNG(&$ZVWMAN51D8L'H_F)?G-GQL QMJ2A9 MX6^#XA_7IG8=H6[*ZK5D13)0_:DV7M5(8$ M]QDQH8.:CJ])Z3O^+;IW[JQ 656?KTC8FPA=XP0 6\BULVIE)$YN\821+2HS M.4:P0UR+%XR\ MPU/1M-RP;U-PNR'5X< UQ;GA<&!(73\:_$S>[WR[_2LUZ0B+;*Q)0[M6ZJW[ MYZ)"0+[QLJ8XL\,+%AG,NQIE9P/MI M\IAV6=@CBSAC7R@#B8P311E#9:>O?R1LWH/:O!M4=RJDX/ZO,'A/D]DW)N8+ MEN$VHWNYCD-=_ZQ_Y.P_4YYXJ(.H?WJZ?S9-;/:*S=Z3;/8JM:K,NVQ=JRK, M!@3)IBK57_' SIG9'H=P(M=#*R&=G^9DCEMD&K#([%_!01@E'$(GJ5&R*W1P MT[=11 LE#UJT;[Y2T[7LF8C [>RWK0,_I*I.XS(RVUB:'.[WYD$_SJW,*9F=H8EYD(V*S8;"HT_D9YMHL:9"I]1KQY@* M(NJ5;^#L;V$N R==K:DV*XG95@I633X/VA6/[NFP^OE')#!,9B!?Q7;P'EHV M/D&"G1(*"=TWOS,RQPA#IX;GXH1M6C#0;-.P>X(&]X77@S^\;0L7SCA]SB2- M)K]&QD%]># M;"^2'4%#(R-. &3PZ'DYMR",TR.F;>^)&P5;;!2Q;6<>U.>& M7&YA?!["Q5\B-GR@]FNL1#1*O8Z(C18--[M[^$EQTRSUNASX+>=F@K),I TI M+6=FC1YV2XD1^B%,(@KZUX*#%B<+;']I'W],6*)YL$03Z] TV,'=IOU[9/-E MD2;6H!_5,#]X('2M_,LG#X]BZ^;GV$(P*X6\=S!6B]9R*]OR85B5\3'@QM?9 M3P==NKD,7<_9$"=#V/Y-WON065HNY<#,+1KB#F(#[X>];C:A6+Z:N\4O)UP; MQJM%7?UMKBQJ>07$V+7V+W]2M$?N=Q++\=QI>68E]_I+^\E@3X'>=&=E:6H0 M^ I=5/JGIT_QAMT/K)U)V&:+E?1(9JRTX;-UC8=6; IKEN:A>J/7+"(0LT!U M:[! B;[DA8/*EGV2G:""V\HY".H5Z[AQ#E3\HV>K8\Q%8.?E7HENX/Y:9639 M%8=@LQ^J>O:BHZY?H6>19W1N@DP9SHRPEX(_V=:I6_J&W% MB;B,)DM'KLM7G(2<1,SRI,M"/)[6<1-[J#G7^9HYT+L_B!O5JZAKCZJ"\VM* M9:F";0O(H#G?;&LR %('3)E=F]J-91B4O&&#*>H9Q.M%'D-!8+=G'D-"V'5+O8:207%:D) MJ8I$!I'((!(9#KO+%<1B?+%SQI;M5L!OF$C 9-MZP_.>TIONCB4+N =":4B3 M17S6H(XCN6,8=;?FDU(C,^<<$QX.%7I%?CP#.V[IT/7#9.9+WWP>VY3^@(>. MG0?[.XWKR"G7, 6BQDM%'Q%?/55\=0\$U;'Z,R\(*I[;G?/TB*6%0P-TS8L+ MZX[C@?5&@0R.R(/(9B5 \05?YV'4#XA[@[2-DUHY]HRBR'/(/UQ2J/WD<%%* MO28O<"F>CL^Y<^ GSJ!.1P7O=SMV' N;KK+^G;NJ]_R::5EF-C_1:9"9]##Z M;IDOH9F&^^#^\5;OS>A#!"C[#+KNF8*6%JV&U MUX3!N;>:?!C=AB3]&/;U&I8]VB?=1)B7/.(DH8I,CA/<>&L6QY@LS+$&F[J> M;1[J8$-^#8J,O/A 4,"46-#\*2#Y4@)[?T'OY*?.Y'IVQX"%J9HC/;P[M-8A MI,2G1/!FN.9PI^R#)2N7AQ#B,ECW,;;/.AM\ST,(WT)>?!C"JS?PE-P^AQ!V MR(_EW78_:]CM>0@A(>Q84?$,O$*^#B'LZ0J< AMA+6-4WZC+R[Y&QTINK\ T M,R@^;F.Q>%UE&1!P79PL.[!21]'"_[];\.%IS@*\<&UJRU]$[GR$B5C:>K5J MU?"0N'?OZIB8+_0)3,*[T8BJ,>6JY7JKU.O4>3\FE%(P$XU%'%T[X*IQ;%RG M:E@IU]O8L%+9:S= M[B6DJ66N4^HI95GA)1]7[!-DB;0N3TCK(M+JC76CALO,[T*X%^FT.,6,$J78!VPEZ%]T8M#T49UI"101P<7AW:L./SQZ-LC M_?N;JG1]?RL-?GX=]&_[UT_]N\$V4O$_O0U:?ZE6 MK<=^O^E1G6I#2?>DS=\W%263,;6KK6Y;C&GKF+K5>BO=DPX_IGJMVN(.4-UJ MJ];Y\$F!4[!B+M9E9BK'F^U<1+';VU1CDNJ3W21S"GP)CF;EG\?PYS;X\/3H M.M,V5=&TK;>UG:^E@$2JVIG\T>P:QHJ6)C&8/:KJ33QVT)[!YP'+7["_0!:G-AV#T8E':[Y;#KH@@IZ)@/=LN2R*L=TV MCY2Z75FIY%J"E6I;Z> =*P3S1]=[;S*D-G@\P>(P)O8'>?PI*9",BAL!6APJ M/Q);^B'CXP(>.W6[\2@Q6[ M):[TH+H6KA:24B]+/@:@K.U +X[*^XOO@^6 M[F2DDO (609BT<0\6Z6UWDDYCX7[A$0452(:>TC$.NA;V&Y2$9 7D.<7\FL' M$P^W!K"COK68O&O>ZAKEIB!G,CQ@T2!*;#RK>X+*[ZXU/IT@*IS JCSBK0O'RK1&1.+4A13A" $ M=P1W!'<$=P1W!'=.R9V-IX-RR+<,@^(Q!G1H/,=9R'*IIW3VKON9BB4B>+X- M#GW'\=@QIY4VVZQ7BF6:U$?)F^Z.)3J9&M:,TN#$&+MM:L"[6:UCBYWT/JLH M>]HC4>V/CT2QC"]D"-5N/1M(X3>#\(]'L7]9TWH4.Y Y5@XL[4DI12GU.N56 M.ZORNR+\P>4R*[C#8W J5>;GNAY@!^DWJ8'UY1:[WF70Y$5@2$BXX,Y9<*=( M;LY!M@VR4JU->84.[:S67CV M<&P6=-983:O4J[?+M=9Z\EWJ3JLY"TOE#UCG%#3,'W?V]&9V MD7FV=,8MDNU23UX/4@B)SC=FMIR.V!,SG5*O$1-@%J#A#31B&>"9._NY3IE* M=+?4:]8;IY?HZ$2?0=_Q:G,T2D0W!'<"?K3.4MNQ'7VK\\QV5=+I^M:RWL M<(7-K?IFT-J*!2"&JSOX3_1/3W=TEPZH_:JKU(]8/5'5>C'94S8%KQI8HGO_ M1$N!-J$+!'<$=WCF3H8&_BD4=8,G1;W%6PB["L- /\"FN(N?N\YE[RC2+^G? MB>D1>Q:V2VKLOQ^SW,Y- ;G2+ ^[<+.$QR(EKJ9-O>L>K\U2HXEMEFIEI9O5 M\:$LV'JBF-W)$,M;P"=U7?=,*)-/&8ZSA[H9M(-JM#)L!R6$4@CEF0NE7#MT MVZH&Z\W0;*_W9A!"*X16".TN>X=RJG-<^XEO!]MKM=L9M-<2DBLD]^PE=ZU- MY#YMP!K=4J_1[ C1%*(I1'-OT3S:FMJLH4G<:JS[L;D17!&\+]A=@J$%NTLP MM&!W"886["[!T(+=)1A:L+L$0PMVEV!HP>X2#"W878*A!;M+,+1@=PF&%NPN MP=""W2486K"[!$,+=I=@:,'N$@PMV%V"H06[2S"T8'\M3X#?L=>'5(+T&QFJ0J4,OPS^N MPJ'J)LM)8C^Z"IX5I.K@H%:R:]@8_=/@QU6O5%G> ZE9;MJ@9GQ,^0\TZ2[*] MH>1$W#F<^9RZ2>;D*U6>9N6?!_;GQE(V-TYPG6FQ!2W@-MMZ\_^.'.1>2L!< MSK*,2;3DFV:+,A1L6<1:%!7=E()J%!D0,(] VB(> CUS]*BJ-_$,XE*-P>>! M]4G%OY;ZYTI^ UWITW?+<3Y+@K )$?AL@0Q*T>QS5BNH?27=TI&NZNX2)>.7 M++F68,G:(KP;D\IS1]=[;S*DMF2-@E6"E8U(@,=$%$A&Q8T +0Z5'XDML8I$ MV:\?>](X5V2,:-=8@<^6H%NB)<6Q;I4B*K9^8/?"DPTPYYRR_Y&^JW3J^G^; M3/?Y?X<*T"^\X_^M!X]PQY8'(]&55:6)'!QN+?XAU?P<-DUUUE3)H!924\ZP%I( NP#[ MH<#>.'2-H296H"[7V^N=<84P\(*8 @M#NC(#:WU[#E=GH%'J-]!X[0_[Q HL!H3Z7_UZJ@'D[]MTH]I5R316>H(^/A MGKH2);8)(]^\G7"P_@A^N/MLNE<$TTVA=4_:O4)P1W!'<*= D>\XB[;]L44+ MZX.? X$9$'$+=QO\MOW#V.?4%$@(+L_L5TTF[1@CN".X([@CN".Z?; M#UMK:+PA(,I6^*5,\H4Q!I;9P^B9O#]:-K[PVG5M?>BQG&V6O= M4J_=R*"SQ5D@*C<1]C4K_FB :M5."JASC;??K%G](NHN A"".X([@CN".X([ M@CO[YI9R*+R)^O@T3?#=$C$UR6+'OL\JT)[V M6-265O8L]0L90K5;SP92/,*H+,T_(L7^_4H MS<*SAV.SH+-V;6I/U-7M.#\GM4?3Q-,N+7G=HTD=4\A9:"I_N#JGP&'^N+.G M,[.+R+.5,VZ-;)5Z0J +!IEMQR/VA$R[U.NV!&:XQXQ8!(KK-V4JT!TL<[1> MY^A($IWYAE":HG?ALX-'5/#^RQ9SI4Z4:D6\?P03XRFSY M#^'2O__V05FXV_!5X;-NJ6K ?[0Y4&H+H'1+/:P*OX84:>H?#6'^'#XD4G7X MR,7[\J=P\QG"$MP1W!'<.1?N9.I^S)>D=LKG&/$"&_ MY^)LI!'?^DG%]UPW6AA+*D/T!-F![7"/3*+O^/?F/@$B#'*681#!'<&=_6M[ M;-NHN-;^Y3GNA)JN\VQ=:V$C+.R!U3>##E@L C%LBFRU<8"WJWV2>N%"+0)72"XL6=A,R5E__V8Y69O"LB59GG8K)NE0A8II35E M4IY2/UX3IG:CU.MVFN5:)ZLF3%FP]9!5+_;BGK48-=3W@)R162>[Z2N]9$,H7DK@LG5FJ/65F%: K1%**94C3K MJ>I9[+>H=O&09T?.\:(JHO<%NTLPM&!W"886["[!T(+=)1A:L+L$0PMVEV!H MP>X2#"W878*A!;M+,+1@=PF&%NPNP=""W2486K"[!$,+=I=@:,'N$@PMV%V" MH06[2S"T8'<)AA;L+L'0@MW%&'K!NE.'1R@CQ4,GQ'[139;+M%(92*6F2^VL M4\SJM6TY9C+FF#V/J414+ !$S)ENODBFY<+3B0U?FY(.(WNQB2%-B>UB/P9W M3!TJW5@FR\4B+M7P@X8%@S3IFVX24]7A]H$+E]CA\.KRF=+T!.E]&=I(W U/ M"2;3P$=,+8<=(+^TJ4%<_95>O>F:.P[/E41^%>2;U18_(4.8D>=N_@DO#,/C M8U%:1/_%X6*.GMZ29=+4NHV6VF@TM 8EM6ZC06F[V5%&KN#2 ZC:>!<,AW S%FEL8P[GW[:S#;CVC/H%1?$&TS]!PJ0O%V2S M?"QSX01JIQV+XC\>_>-3_?N;JG1]?RL-?GX=]&_[UT_]NT'>)G//5*;[_[/W M[DUJ(\G>\%=1<,Z^CR>"9D#1BUARCB-CW%9WUN^\6\74# MIOI+FD3:.J7!^I0&Y1?1+K!L'(6=6T6$6G_Q%_ P3=F(K=Z,H?[JO!#+^ ]C MY&C1X8\[2W]T8(NT//;GUUFX]M'2?S19I!W6<8P@?3UGZ$H=>C-H_[-BR?ZG>>^ X'2%V-+'&?#*O QB^$9X^*48>]O:OLXT)K?B_*9-*#+\(>CA#&,AL MWJVJMHY0E3T"%'OB+1:W,;0(8PBU=.G0)=:>%SV1,77!\%:\)_)W M"^41?[*KO,-J5&K[_??64XM][+S_17FA%@6-UESA:.D2+R\%#7R M<$!+5DK)11(AVJB.XX7Q!+_'A^G.;=^$ 5)X&@F(^6_?BG68QD>OK6+JV@6# MF!F8***L*'$4"JNM*U\USYY2A\O8H,8,OND/1M#.\+VKW%D@;TSE&UW::&%8 MRF<8H9#*[9O_MPF/->%1\,-'H,XB?%QGQ!_'5V0+UH)2-T]S2CTVT/0AO1%7 M 64,+ 9=F3GV0@F6+UIA=YM%LRE3"PG*M;UCJWA4ZRH>'R-NXPIM1(SZ"LDB M.$X=$!Z8JR+BZ^ M0#Y0%_C/0?&%;P-!N$!)- 5Q">H)/'\%BKHIKA5B7IER!N,O]AR@#$\$<^%U MKQ1NII9"30-,1IQMF9P#T+&=L'2<25R7:5%,!PMEZT=@&\=8\M:? 3=U#^>F M\Z&K((-MDB:OV7%F,;)S3@++3C@U+&!-'8\ VI>(BANV!9$%YQ;82H66@!\1 MVIKO.# +?MDRIIB5B<_O+OTZ^P0 62 G1NCKU566PX11,H53KJ\ YPHHUZ)@ MQFDZ DI>E->.SO0/KILR+13U#M0H ;]_^P: 3X$QD1>NV@% %^0'!80((G*! M[KK^8LG%*M<59S/0)_FF(%#N,/V)*\4Q[:K(7L->E? $@]#7/-30 IUS05:* M;L (' 6'Z!A,EV9:DS>WW=C@RV0G6+Z8->G8%GS4^, S;,M^71D.9#N,"FA_ MI]O,C(D(I*Q3J)ZL^& I3VB_H4V :KS:9!P183M&CR>LI$@<,(T^V/"?T+;[ M?/?T(;0,#=9*7'GQ#H-><:#CZ;:3AH?%H:F(]3V^=,Z'/1Y_K+I6G M8+A$0$%AOSAD 3ST'7V][%H+)A^\H:EP;C.H8&Q\$-GZ'&&C@96X;J(%'?UP M#"\VVG^@QKF\N"XWF86LT5' Z-S[1->,P6 N^'TP:KP8>-M^PV$Y[E91!YFK;A:@%QN!4* U'^]@E(0X>/.3)+ 26]ID)_HMT? MVJUZZ(Y#*Q.58_SI#6$2)Q%7I-\,^!ELYF ,\-:-%_2;^"7"-5HAR@0VF)?\ M/GR83RAVB,30%E M-C42UF2.SY"=C'$@Q+:)[P-?D9PQV+J*;_ESR IH47 M@.33F%W+Y!4:O^&;D)&(H3/A8+AKTH[QVX:D0.XPF,+#AB&$#^5C$PZBH"3R MH*5\(@XZ"P/&A2?!'0O#8^XU_D9A4 %1?0R#? MXMSHN"5\L&AXY I412+?=P6(7/C5#:^'Y6?7B(4D5H D?C]WM4[1\W\,1/:Y MHAYX8F)>7Z"L0]G!_9E FSA>VCA2*FD#R1D1,FY=3TQ(IXR8D%[[5#$A6P^W M993(L:)$\@2)5#_FX*"PD>I/;Y] $N7=?1 /\,OE4V!K4$EQ(9*V35Q2:(JB M%HU*>>(*"C]+A=T\"C1)\8L-4@))!LE $O',N)FY7Q@)>W;*&]7+.H#).)H( M36H;]"U^Y,(\,#8/&&(> ^#O[MMB/,2\/ZCF^VH[O4:@2E'=L1+&#O #6:TD1IQQ25W+U5'JGC,A_#T\H% M@>0V%3S31?!Q'\Z][2QM9L$]6*]41#RTE(LU=HH><&^0)YCW.< )VL ,_7A@ M-0/?LET$5PB YB(C \#<'T!E;@:A[W]JVS]@077J$6V.Z^X&-["RFOA%4P$H M_7#Y\9F+QAWZ*$T#5[D9?]/"GH+QCJY RMR238"31PRP=6R RXT]NW$!B:%? M]O'K4^B6=0-DB7A[^#1?31U#CWYQ[9GW1M#ER!1VSG4PU, )VDK@-#A9Y[XO M##W!ZW6Z-.T58K3)#@V-%S]D8O@9<,8#6^!=#EB0JYB7%7Y>$)@*_-]5%K[I M&3="!(!5Q0?*+V(_$4>;PR:GH9\4<( ,\H)>8-_%R_\R-,?&.2G_ EC;;_SQ MO]OV"Y#H'HSMS/#SN?N7(PJLAWA:WT N6*&?(G")R Z M^R4D.S[M3G_EAC0;D?)1K)W0P2RM%=Y[]]?',$9*,O<9F!NKZP+OHH'^8MI3 M&-44P81^"]C.">,^@X6$"+?:S$;?/@(HO!!W(8R^HY80]FN_QMP>M_LOL2C< M>X/EIV^[.1;]IM,]XX[.0#UX?^2E+02\=1+B0QJ3^TC2/CZ=%8>XG1@NCU(2 MLCXX6692R$#9SX4OHFO7]K&Y9[#G;(I^=)VAF$,',]HM2\=P81]8^E.@)'>X<=Z[:Q(\I"%L2P O#*7$AIRMC>8UDHTKPL9"%ZL> M$S?C'+RF7(F346;E+#UCP3@'V3+4+'T7P(RLJG']!G2.%Q@WV@@F)8[%SX1T M)@SPLT,7H'Z:JZ9X!'[']2;D3L(>SI@=M2VNK3&&80'< 6\@WP0GT$SH8%]& MO"+FX1?<[Q$6[R+.UFEP"("1X6R>&FAIUZ/5"/NM&J:*0!"W.T*IB5'Z>+P/ M*ZH+O9^?8.,RIXK=5FB7XM$'F-$VAR,/+?_=(4L ,;^G^S&Z%O\.U#R1[A,$ M&FR84;"8L+8.CU9P?E"T).*3Y2P3YN&MLTD^H**#WNID:%%YD -QK3 MN@#Q#Q[GK5#3^NH8 $E@ .PTLF2>Q+^(Y<\(,WV=4&_Y^NFO4&\)N'J#@^O$ M"'6 _1_HAJ@JZ W+LE_9>2]'.\_MLD'O]U)AOX'Z(#9LCG-D9@=^"(1XK:!8 M3YD<[N@A+I5S C/$)9.9-UP!;>[0(3;\F *O/"_08+$K#+=!EJ##KUL2[0=7 M@X63EAF6(BJ&@+JAPQVVX\ULT[!1N0]V@L!WB($NRCLP9S]2C)3Y)X5!PE]_ M$H D^_1@Z<:+S2Z'OQY!K_\7/O1?=,I27.'V0_Q_DCM.PQUQ%??_(8OE^X22 M>TYF"5TI:U#E\:P@SQ>A_L"\WUL9A7E3(O^*ZV/+,5VH[X83/9!Y_D%-\9CN M'G_XOVW?L>@J[N!!EXM)/1I[,0O+-DTR#1SJ+.X7Z$8U6WC^D=6(XUGH+9*& MI'2+2\E7 4=Y%? 9][3%K;,UT=8$& MU9EW<@1Q?QET5RW4ISE(=A*,]D(S2 MYULY1'(?UUEA6"4B563GB',FL_[2^#*%OY 1)8]5B\>>Q.*<&5 +[B;#%#_* MXNOG\+NYBCLKN,>;!5E%[@H\4F0%&S!^P[!^".\;# 24& <,1OV%J[SL>"2^ M6P3J<-IFD:[R1JX1]($X>/;!OO=9QN!6CWS@L[L:[38UL.VL^ I]KD$QA%!% MA5_\:3QQ*A@P8NS?6)IH8]D.BCK-R,<>77+YC:S"%+H-C[-LCR7.:HB.8#&B M>*T@W:@I#DX-3QSW YMZXF@IP)9)7ZG91-9FI5Y$V"6K>03\Z%O!:_2P$$!0 M,29,:@*[%XS1"!71PU_L5^KP?$\P5+TP_\DA+JP,CTV+L(+.4NP)E&-07W!I(&1NSDC#;UWGAA\A_^P9/KQ%"")]OL'>)BWBXR +!])^P MR )&UH$01+F(V5B959AVIAY=7\U8=7M^D$SUD:D^5 M[;DG:M$2IM_6$LXQL^*5 N$_@PH>I%8\V_&U2ZHZXW9"U3EH"%\#%>+1L6>& M]Z?MND6&,QK75O,*DI1""BG?1+6BH"3)1OT 5OZ"&3,AZP7UC=XH1AZXPA'L MYO7I;C#:B-%"9,L$^H,#\OV&'14L77H;?'@?]!$P+#8S=M/[]:>CIL*2+C1B MBD5@Q.<_1WMPJ\WW8=%60KQ9_-R"GWY-?C_LM<9J-_6G=JOSCRIW7,@[Q4Z[ MU1_WLZ:8\_ONJ%?HCIV#&NU\5$:+$.'IN%67/Y5>JSM,$^Z;L%D8NF[2LOET ME"7QV]Q;M!9T[.G'P\SX8HGTC-EWR@*NF[NBCNX_"6QHSDKI=M9H)]%1K7XP M0L"C^.\L/85M+4I MDM;#2R5E6,MM19:L.MG]A4$U8__;!)6"_QU6'%RIZ8M51U>1 MA6@KE\#C_[U)^D)3C$_-P:=6:FY;*V[XKKY9;:/;CY?;N!DD'3-,#J[7UL"Z M&C>ZS3RZ>&=87&,0.80ZC[U$\4UTG7??5@]]S(4$%$;KXN+.,D$M66" MP9&80$4FZ([4BC!!2RSB?SBJN^RX55JL25)%387SI'#(W%D%\S2YG#0 M.Y0C=W#&,;:E/)JW1$UW="34]! UHW:W(J@ITU[J=%O#?L5E^;;J0[40Z&)M MTA>U_6%LVWW2&P[;DPZ354]F&VK<\@A41.AIG<4U'3;;41- M=S2J"&JNR1"(3@7J*,VOP\O;RWUDG62]#NA9AYOGTOE?15CD/L1-PD)M3+J# MLI3O*NG7%^'=KZ,HEE[6F]YQSG"[[6YCTFMVAQ?A995>_=/A[3BGO]UV#_$V MZ)05Q5,MY\R.3>L2-H^=M4EJL9-(M^M-+_?Y<))Y^Z#Q7X)757KQ3P:G?N[C MWR2Y%:7OU&HCD"K>3?\XY[W=]A#8NMOL MC :7H.-)F^)T@#O.@6^W/6* &X[+.@2HUF9RX4;%5RSD5JN]HZ9:W[M"O)PX M!<:^#_"IB/XW3M/_?JF4ZBVYI]_?<37D:RI3D=84]=R0B-Y2_+6)F\= MZ?"SHUZ3X7A1E:!RS"M&["Z04[=]+)I9M(;8L>KR%!Q=2:I?I47=)]ZRVU6F M%/B4*A[Y2=U;Y5*4OM+X_YKB4B\UP_G@F,/*K41^Y29MBO717[)RLL/Z MTP^69B\H5NA.4U>ZC4F_6Y7(RA+V4PGXN@(^*RD\)^ Q6.SPT,0*AA)7?@NM M<1AQS=WH69'".5D/JWT,JU)K3>;BG3*V-R="!HB0=D40I5/QV6T"LGUK8$ MZ*F\],95I?)5>I.)[ +L7AAO\ARU:;;K&HU[@?Q<3 O<4JACOOP[T4G]P>*< M#,\,,7%GZ=\C1-PC('XGAN7"]Y],8V%87 5)X_,.&/K)JJ_2K+AP0&TI\7$" M0*F-R3BY:URJ!5+I/>')L[4?-U/BLEU@L:26RSO9TI_X^6(B;FONOCTP]V)= MM[L+F/)I3ASZ =?^/K;TG_C*IS%F%S2ZX2$>).GOKR1@,C(K]@=,#P"34NOI MY("Y!O7^&W4]Q]<\WX$11\J\HL&BO=2S''?M&7.+)$<=;&VY8;59'N4]7^LT M5NPW)BDEMJ66?N$(V2*Z]T$(EMOHE9!P*?7N[$6^T_[V#==@ZXNB6C?PI-: MM:*U%-C7HDEEJ-X??!=>X+J@/DV%!1Q#PC=JAK9R&H-BHX0**%-2^SZI]GT8 M9D:-R2C9@$\JX,>0Z0OTAOV'^T_LF6)8'K%>#,SK(:Y+90Q.1=:I7&=*;-&_ MSA[");]C*Y[&D6/@R IH65(1/ZT/I2A.NFW 23*VO6K:>+4$5I6NN@8S!G!, M'3!<(G=3$^MUU&JCNQ8U-&_%IB^V9:]'AVQW '>Q.D7OD+,\:;-4$BR)W:X, ML&"YA8-4HVH9*Z+.4L5%. \]I6FY]YJV@*5\O3)+E07JI)IIN]1<*6^&-V?W:4 > M&QM, @5_4"_(GV*\V%*>87A.M"#PV?5-C'8W+#9TX$S+G?%!_DF (/^$1RRQ ML %UW'C549&'E6AGJ7BVDM*SN,4G.#.!4O V;VZX>*1KO5"\(3E?(PJ>Q:'! M"&PG-G40+H:MNPH[*%:(>V/,E"EQX:%O_]):9T,4,AJ7V^S9:XPI@-Y# M@VUI\].U6P>/UP#O[]\,W9L'>TKL+L''[>@6,H4)^M[V6V(,KE%$VYF8N=/= MH$[L7QPN;D3&0%5)7Q_W!EJOU]-[E+3'O1ZEP_ZH.QN,9MK_]D S%3?-G6 * M2_)";Z; ?3]NR QF>$O,-[)R<2^(BT*0>F)$0Q6&O$FPK629S8Y&%BYK00VP M.?QN82^E#EX%8R*5&8LR=U!G^:_L]1F"B8\;+\H!U%FP&(#RVZ]DDG.'ZJ[O M4!N9M"<"OMRWE+LO'Y6G[Q^>'CX^W'U[^/1T^=/[8GOP,":7 M8S(3_M#1@:8KG\.-\@GV/+I>YN%B9_WNNT5\W8"I_I(FG@IH4F=<-H[+[JWR MVYI:F_0P;!:JC47LW5FZ".ZX0Y4+-A?J?@1E"K0@WZ'/\)@/IJW]B R&/K=G M8'.#6SSQ';Z$@@:VQ(W'\6E:G# +#%3N@["S3E*60+5 ME3>PDT'[569@.-MO[NW>]A5,FQFBD0+'#%^8ODF6+KT-/KP/',V&Q2;!;GJ_ M_G14%3>,7D9G_G.DS[3:7*<19PKBS>+G%OST:_+[WJC5&W12?VJWTK_?]J@. MW- ?%GK4]E>,QZH<5*[O1VJWM$%E("'CQ&KG<>8X<5F*QY.K!*?Q[(VRMEG& M3)^Y7T%MJUTFEW,<5N6LFGSDRPY9JYB[?)N_;E?\2/56\0FL?P>T6%Z3X-.G M;SF6,7OJ^6@GA'C2W5D3VGZQK1N3P&3*8XTLRNT;NW1*[T@^XG&=F#GC;ICO M,M?TG+B?V6\H:=RGG? .&Y/1P:V%JI,.( %?6\!G5(3."WALQ"P! M+P%??CGSO8<7/=E4$?*G]6'(U2^86\;FJ M>V94C:AGUDH1D \RF@ZMH7Q[G91>IS'I'1R)+?.:JHB0S";-^1"BEK#M2X!4 M$2 99;/S J3;F$@)4D> E"1 L+%=64VGJY0-F4^/.F^5=.+.E259[>Z:)"M> M9*I3CX*&GVUG#?9I>)?%"6N)D QI6 0A T"(!$C= )*A3A4!R#!-I9( N6R ME"A 1HU)2A>DJI53.H)7ZJRKC3%(&FI443UJHF-:X_[JU748$H6<5<(ER^(4 MB'D7$KB3Q@AEG$E(V[.*D"EB?.Z 3+S-U\SX2?6;_U#'3H%2O]V8L&!^];T$ MU(4 ZD#];$N9I[VE4;^3)HUD>;#*X>983K!2Y)!:-3ETO5&1_R26C[ES(BJR MMV>ADFLOS'-5=7<&&366J\?(1=NY(] M R0?23ZZ$C[:TDMW-Q_E5U?[I:FKDLDDDU5HXD68K$@DS8Z]:I#:WZ:";'0- M[0!X+6G>3=ZP--]QL ">K>BLZ?QA]J$@1VR-4JI8UEE6%"= ?81%(0LQ*IR$ ME73P_P\"B\_V1_@ZU0\Y;$QZO62[E?W<1_G7Z$S.2LEEDLL.M!_WXK)1B:'S MDLDDDU5DYDP18%C; M:CQ_$(?K3W.:KX'P?C$K\O[3WW]E>56\H![;5RU/,0TR-4Q6[5?6S;J6*A/[ MQ'G<<\"D:5F=$L,]+N"03.*^2G,[=ES&#MRK)22/2]A+V%?*T[4)^]S1%+"I ME!Q-(9E",D4E'%/96T$/5*"J[ 57EMG([1D+\QL/L&GR)H14;OJ%W= UY>=] M;!KL 5M\GRLO:K Z25.2+VK+%WO8/'&^2.)_T)AT.A+Z$OJ5A_X>=L]^6\)0 M;@F2+RZ&+_8P?7;O"*,*[0@9UD_03! &NH-1KO&J+>$'G7.$'\C[*W;_-80! MY.HNI$J/PK5LDV#H'#/[<#"62J/DALOAAKUZ;>7FAF$=2UA);J@M-Y33J&78 M:4RZ-2H"* %?5\"7TX=KJ%8([U<6]WE(7Z++K7)<2*@7 ?GVIA'#;F/246O4 M;DY")(3(L)S65<->8W)P8J $2!4!LE?CF?QF4NDEBR1\*@6?J8T)+A.37MHH@!"N>2(#4 M#2#E]:498CN.9-TIB9 +1TAI !FU&Y-1!5HD7)G;Z@B-BR[7E#A0ORJ[:XJ3YNCN;Y*H06]*=7Q)_43C)!^7T_-L-&Q,1I)3):=*3CU: M5^ ].MJG<>JH,1F6W*CE3*PJ+TANO]#V.^T9MC98)+$V)2_$!CE#?#FXO#-I.^$&W%?G2;\+.) M7IVWN:'-%>)0Q?6GKD>),JD\]XYRZ^6 M\L5^I0M,J>Z,>$IU$]#";+3A>U?Y8!-'1XQ]-!Q C>VX"EDN';A'9XC][,/& M1)5OE.@K1B?E'7Z-]ZOM]YM$9%]WWO\"J/;P?YB*_;2,Q;&?]CW_/QY21WV%]Q&9S-#,Z@%S,'9 2#/D>X" M@H%/IE0QD!W0-\T&#QO?RSQ@N14E#HZSWXK?"*-SJ.YK5'DQ[2E<-H=Y:K!A M>LITQ0GQTT#F 6;;NN=3>*N]HC2AHJ_7P^D6:,;QB8V/ZL!TL')?9X]"-KJ? M3*"0A9?E:\[1CO2'<6/2:P+:$BH$4J'XY 95FMRXW9@,TB<73,#E"P_\B>N) MXIAXBN%Q[+"FC^:EH/-(7N6(= O]=R$);/VT9[4$A_)RS"\LXHD6G M,>FTMA4(G\)T<>31KG+ #$=GFJ':F+1;VQS%P0R7L2U8,0EHM*)#I\.'@;!_ MLYT?\&[@?R8&& J9Y$$9Y] %,2P8NKB/(87?C/=B"4S^6!*[D>_B D&M S>5 M:NZ<7^-3K.FV&9]BH,*Q%8=-TG><$!1-\2-^X,IEAA5N= MXE%M;L$,7E9*L*T%NQWL;K -"NRM;9" 8_O%(0O0X2SRPG:WX-5X,2J%8"9X M, Q/F3GV0@&%TL;AQ#=/=D-+>69*'D=SQ!X1I+VYX>@W2^* @@BOG5'7Y?>C M46IH- [Q%&*TE,_ #<@ZL/E2JBR SG-7X8J .)GD/!ITP455).J86TCX9(0_ ML!5VJ1)2_#-T+UYX'N)W26D2SNZA4Q=V_2][;?$Q(Z&FJ)S M)A'3Z6U0)_8O#A<);PQ4E?3U<6^@]7H]O4=)>]SK43KLC[JSP6BF_6]OT AN MFH>UQ)8@)VZF#B4_;L@,9GA+S#>RWV&CUN'LL]@J5@:^E2>//AI/3SZ8F?][KM%0)N!J?Z2)IX*Z'=G7#:E=QL8 MM,)KE=0=-O(28$V!Q<%&8?LE6*2>0SW#8K_^]'[2^\[6C_\LM(;QN-7K]%%Q$,-6X-NOU"3]K^?;_@D^28Y)A.-:;QSB<=Y6#UJDYK MKVJRUW"59 EYE5S0J[M*+FC-KI(+6K.KY(+6["JYH#6[2BYHS:Z2"UJSJ^2" MUNPJN: UNTHN:,VND@M:LZLR%K1@21A^*GKZV <6M96>"QA-*IK5>OY?9H9? M,CSE--F8F[E6Z=-^WAIDJ6!1[A@U+F&M\\TY8ZG'T4IGI(#FRO#,7O]STN)[ MZZFE?*0S^$%?CZ#9S@J;G+";#*GUQ*Z*QE]LZT;2^?AT9@%ARK:(L.L49@5! M=!'KC,D/1^6:_'M]K8B:*'BW@S,DW208)1@K2#<)QJ.#\7J4A^XUJ8\/EB*2 M\0KIBGD+\5:Z6M43SU%5,!3_D(+#=:O-E3;%^E37&F9TM1+VJC"CT(H2.,'\ ME@*%+U:BPL@5]; MX&=4Z"\(?!B0!+X$_B4 OWL21:C7[DA%2++%Y;!%1OGXTMA"K1I;7$-OJ ?T M2U+72_6%A9.N9[O:XSJ/ LIN4XNZC4F_K Y&%>B((+%R@$1,TA]ETAU'2P0TFR MD+Q$S86CIK"E5PPUV,NE*U%3-]04MOF*H4:5J*DC:@I;?\50TTU3\"5H+APT MA>W 8J#I-285D#37<*AWM[!A,+'NB#J=4<>!=;W-DR^SEQ]%WB_O/_7])3EW MF P9MH;]JK.UYOF$]>8U;==5WKT0PTK(SYKO:(=Y=UP8/WS*WMGB$O3K['<@ MM/LGT)RF;FS]QN3@@WRI$E400$E'SW$ -&A,MC4.E "Z: 5]OGLP$WN2+I. M'1/0)*IV^(2.(Y9&C4GR\$("J)H .K)_J!!PQM(]5$/,%'8/%<&,VJX$9DKR M#EV*1?GH&+83M.QF(>!AGT(9"UYBU, Z)S"JQY(D[AG%"RAX:GD91#(BJX( M*QY@4#; RLO%D0"K(L .M$NW 2P)I&YC2:K0N[>6?J] M[WC$,-F?:;PS3..=_?S*1>IQ5MV!6#;8]8A8,8\GI-!0]:;O 2KKM3TV:W93V&KIQE$6=^NPFQ?U$Z6[RM%UB7'I( MSZ$+=Z:3&\FTDFE/&QA5 OOVVF6>8DG.E9Q;4\X]KD,S/[]VR@\3DUPKN59R M[1YI;?FY5BVO$:ID6LFT]6;:4R42YF??;IFAAY)S)>=*SCTH=3,_Y_8NW;R5 M9QXUNXHMZ*\> ?C ?W7C=1+@\XN_ %!K@=(J_MS@FLXF=SQ2RP50WUGZ5V]. MG4=@!(=ZAL,._)!9W$= H[:*>*+?4"APRA(>XCD^R@H813##"N ^@#8 M7GR#V!X$8MFP='CZK:JV^K!!'$W8L"?>&AXPA;9;_*BL&]9B:=HKZBCW<*EC M3'WD=I>50?\,3 ULJ'!:A/S/R%]X]IQ'_^V[GC%;G90@.Z?_QR,[KAV^=Y4E MFZ9BN(IG*S.8NV)X\"V'"FL1YH*04KPY\> 794%^P##@LTF)Z\'75%D8EK'P M%PQ] 2D5A_[M [)T9;I23!O$E?)B@^2R$&I-]AZD,=+;(S_91]^;VX[A&=1M MK1-]$_-U682/OH,3GQFX%RDK2AQ%;:N]IO+'(Q &9+RQ)!Z\#DB.UVEK2+5G M"EDN'?LG;(H>-5?*?Q?:4/O[=G'X['N^0P/V6>.>>]]Q@*B?V7S^+TQG/8+ M\AF;<&#QJ27K'$, #--G!$ %+$)O]U\;SVUUD':/(@>@TK2 W/@ MDW%AF_1@M$"B_.T#TF<&,!WK[+1Y7')=@B!AI4DT"CM1#%.'PV%3GB2 MKIG$6+@P4=# E#49Z'HWT5887L^ U5($HZ*L\^8.!8D'LYB["H7GZ,H_B>43 M9\5=--U.,V+BD&/AJF+4+NP57J/KAU5 [L($Q=3B;9&(.=EP28R"TRU^YES2 M=/NI1UK;\;,D*Q8;A;_DYKKB]"@>-%@6/3IIA=A*YZ?ZZU2"(W#Y;52UMU($ M0WHX3.PI3(OPS5VG\ 0=6[2^$K!=?1>[M/J+)?L5Y)$QFU&0G!H,?DJ]-THM MA0;M79F@QQX@INCTZN)S#.N5NAX'+UZAS8GU K<;E@)6AP:&K*AJOOA/&$"G8;@19(@UO]L7#=5@,OI8AC1CKX75P"3P/MZ2@*"\((,JG!RS[2H7: M;O/+V8\<'\0"51_HE)14>//,L?]#A1QO'@CMASVQI?Q/>'<(KCB_QA_Y!J+#-!:&)[@_?&AH6^YT;HQ&\>3M M3T!\8VK2NQ?Z+\.;/U,+U4GWZTR4:?ML.Y\L$'DPQT_$,5<1#L3BK^V40&OM M5O>=%5-)@[U1;4SZ_4UCE)EMP&D@;M[@Q4JGC5P'+$N#7V8AD\+$_GAL*9^B MF6H:7>+\#$:J??Y&L)]W_5/'L* M$D*HH+ :S_!$MF(Z5QBB?3BFL;&% $(R20J/@=>_&CKE!G\PIN!&O!:NF5*N MU;"1X#7L00@2*A8"/H"XP=&R*<4D#1]63(P:(2/&WP(HU7R3B#V&*"9L0+"1 M+)0I2&>V-:;3-Y"E'C 1_AB]J+E.0+6-,^FK"FR?/]AS0+L#F8TO$SL'XQG# M31TL8YS8QD<4%P0LRGHNU3GNPQ!>5 W4]ONGYP_L4^?]+TPB6RX;9#'M,$-; M_@8;O>/#UH-&R_T<1-5F7Y@VM1L*],&9V&"8ZX(#:!.$?/&<^)!0 M]X Q(0Z M@$5T/^$0()+DY/W1/JZJ(!PI$XC,F>('6:8(75$>@+&J0.OO17BY!Q4#(K;B*#P"W@/IS M2DP0:1HJ*TSO)R\T8"^A9P2OW?#],7&%Z/"7^,0"@OP/]LY[>.6]>..GGQY? MR=T"G!_RI(IQ9JU'T,8.HX.$'! M(W+P\9A/Y!5UZ3N-J?:A]X4E$N24!NV(9'V0!FH34)RT#0%@-/"E\SR%P!Y$ MF,3T+3$P18Q,$4,+8-G:E*=6G.U!;AY-7K*SD'6AB0I]89&)Q5Z3S4G6)29Q M-V1A9&UQJ>CF$JK!-7$.#7>F-/>YX&FV*3'!QR75Y+>I@^=,6Z2BD#(];% " MQ@];C%N'PJX,KWG_9NC>/ B>BMTEA&@[NH5,7= +O>VWQ*0K3H(Z9Y*DG?X& MZ6+_XG!QJ8V!JI*^/NX-M%ZOI_X$4UB" MT+B9@FWYXX;,8(:WQ'PC*Q>/^>+[$&PY8D1#%8:\C6#K^U5W?;_J[MJ)9K.C MT8_OB, APDJ_97( KX+AD,J,19D[*!C^*WLAAXW),XIS%#GH84/OR6^_DNT, MD[4L[T\/].%67Q7*I8'NV\.GI\N?WA<;%1#89V'5 M6( %LR/@#QUW$!VL8 M4"536GSSX:<$7]M)G_>Z[17P=#>I?TL18 77WC,NF M]&]WZXN)J(8'2[,7])G\_&BXFFFC!^T9+O]@VMJ/:'<>-D+%5K_SQ'?XL/7X M!G@,90[33\(;F3A]%I3=V%2C]^ S4]ZDGFE+BYSM"36 PV+[1-3ZA'L\HOKM M!C8K6^1ZVH*Q0P@*)AZWTCSRD]EDS+&R574&%7>*1T8)=HN4Y^XF[WT*WA$R MX3=XSSW'$[#/UR7E^V]4%A%@%6)LU)BHG5;R!.X?3"\N.-+A,4>*YZ*#U)$& MNGC>DV$V-=3BFV@*+/F@S!5WB^GAR4YXL.,%3KP9!0T&MBQVVN'9SBI:5]!/ MU XGVFX %!QLER%FZ0!1'<"JHOL4=U5\''\X\YO-R"MH6:@G!>]AYU4V;+"X M[3*_J$:Q0J85'?(P/\T?C_\'GA!2'HU)L+XQ.A(>]&^PD%RP&?E/,&+;?YG; M/O<_O-F.J=?4GU,\W* ;>B,=O6BL02*P(Z4V:L0S\ I0G$R#MT)!PQ5W78=Z M] 'T*!M!N3?I+-UJUHP!R>S1EL5 QTH5N06:?BX[C?0M=I*GF?[A=,PD7QF.VD&G,>EN2_*+T2N#5FD. M6K=9&@'2A>\Z-3[X+G""Z][;BZEPG]^Q!2E,$M!;.EF.F-CB$ M04EZRLDS3H)?1$B'N^?,T6N_K9%># S.M'RO];F&@#L(ZRMO9LA3XX->BU M]O6K\$2(I$]E,-STGL2/<)#L()A!= ?*!U/Y(V/!C6K-,=$?7AX<]/#]P"(F MY@1@L 2\@YW\[UKI;4I>\-,6CV#D!T1N"YP_K<0QX0YQ%#/L@ YSHH=#+I-A MPU7Y]),$80:/ 9'N+$ =I^(=?W=AT(W2#_Y#3BVL&74RJD(?>T)@N0^WQXBO M&^%-'N@4 '$-@)>K7F0XC$!9$M8)J D>W 0Q[IFU+,S7QZ8Z,*K%TL3S34@/9X6"ETU4'7P M>3SBA[T[>!Y^'1\ _B@XW0(2YQ1Y:T9:#(=_&C^H:6.]A@ MV(YKY!O!!FSZ4W@!?47J>PH+-2*N;8%\7&&XJW87<"J&:88L]\^85/@BG+N)*)0A=M%)B4 1X1/!@[DNL39KQP:N MM3!(R5G:?.DC.K C,R:C@-PK$2<+VL>&I-H,Z%E_@X6G$0,^FJ[,Q+*26< MB@SUN(#I%;+GE'?WP% /B)AT6PVXR-&/830:!Q![NK&+!0@\6UV%!RFP+"]D334)9[(S" MM4@+S=P2JL&GD#(QM5&P0,B3-@>3P:1?9_?$G6-C0_C/I[]]XQ5T,> E)B-3 MZ)HL$[+G:[^%GOXM TB^NU?7$B4X]::BP;\*C2C %+G8@0C^'J#$XWZU0.=B M=89@_"99NO0V^/ ^J#)C6.R=[*;WZX1"[6ZCS! C%/\Y4D%:;:Z&B*)#XLWB MYQ;\]&OR^Z':&O>'J3^U6YW4[[<]JM-I]=NC0H_:_GU?[94VJ,[NEV<4:JIF MRX*$"&=+GUZ8,IS4.,^D^"9ZFFF-7G7)G4)2Y9O;ADK%BOY5Z#=;+67 M<_,DI*S)IS8D2CQ#R-3D8^I#X,T$E>MDG7$-6>?!"CRN;I%%K44['E3 >+&, M#1VL:$W(*RA:>D&51TL\"4DW4NZ\>^(X*R#'_V 6<^&3#SSW;ZJ#LEKE7$!! M8,D@59I;H>3:V%ZC\/<>-_E]#\J,+ZENQU*'T)EZZ;;2G%=8,40?C;QKK/I*=W4X60[T8PM+\M#E^#M)/MBB%%_ M6X"V[$5[R>#)V Y* \F8JG;"M-4K,ML19HF;!J=-=6P2B10?1@RAP&SP8,) M'EW_(G9E4;UMU$;#IM/(B?5XO4WR'?BJ'KM]/KF.,?7.>PQ]1![C*]D\M^C&)>;/N]M16+7 MS%P>EAVEBXHL83Q/CRHNSZG)4E.F=$[,&2]%[,T-1V?U^%8\#\4A.@9E:Q08 M E" F?7T%@_\ U6$M;GC3CZE@ 7[/=X(4$F.TF-\<4D( W# M)"_9%Y2E7LN*%JL2X76M<#A+OB5!P43W=N\ ^L:%Q*V,!BUU7"RH9&?*^7J>=13J2IM1'"*L.9C" M$6D,<&#_V8H<:5P"]#]2EC'):A%A%236)H)5N#?V1'S>W:V>B$?;.Y_\CRC_ MA7J8[A%0/8TA^FG-_0HW9)9[02$=C_4=*ZS=B3G+(X?3$:C:8J7$,\J#-7 M'RJ@+]4T_O8-'=ONP( )?QPOP6%BQ^VH%U=T(?;G$>/!1UI87@?[=A,L))-F.)J_<+%[ M(.7%91!7P1@,]G@^[>9:TT5/P&NC'D7\!(1E,QKN#T4T0(L1F?7BXK4X@@>Y M"F^VND*2(N04E^!3HH8S9+D$L')O-9<1K%X.4 \'WQ3M$V/O9XT8;V*%=,(& M4ELRRX.]DJ4;PZN7V!A5C*\I2C"+5^#S@YZQ8:6V^-O#=\6Q)2K;$&7A8Q=/ M$R;[XE#6.@A?A7W-^.[<4CYCQ\=U*+[:YJNH!4)Y#G.@WO+U$4,0( U[CN(A MEV@_"2]R\0G KC\H:T1)^$!= SB-.'RV1-1EYNFHV$ JZ-2F<4D,H"53!.4J MH_3:.D&#]G")$3(VVEE[360A;5:PQH,*;-ZTI4[H7@)T_;3I&0_VHJW(?;)- M702W\6_IUH.E46U%*"YCU$T+NV-A^[X%.LA%+TK60PSQ$;(O%OV+P;G^ATKY MDJ%3S(Y@W #5'=%(1[Y*)FEGYH >O@(7FD*]\WSLXD[&RC[JK 3['OW(CDO( M\^"OS#SOG- [SG1S&MQ%3V5/E)5^9@A<:29Z507-L3+DSXFRJL0&G"TK,%^ M0)V2!"O&7D>)N3CK9G;DF(NSSJV$F OT/FRX&S[XWA?;NP]BDC\[]N(9?4J/ MZ%)*:;[MH'M>8YW&-DPV =G+:<7:5G!G\ M-5_Q'?WJ2EEQ%5=\,$PV<#CJBE]#\!JK2L9$ZS)9B>R"1&K)071GY;RR@NC" M$\-E\639<7=;LNR)0N9*5>K[6?1VX5$0VHI% M)K 6-1 M:$CVE>R[AZZ[I1US&?R+A5U3NKQ?(O_*8EUI^D\%BW7=B7)PR75O[I^YL!S?>0$E&.[BK;LLZW-Z65798 ME1U63Q3U?0T=5K%+)TLRW"(4M:V7A\,?4*V1/S%XL,"2![7M8RG:I:1SRRYV75ETR6+)0]+V7/2]GS MLHX9/6<)7S LPP5M4WFQ;5TVNKR:ZIX9-9A"M3O Q^\(#U'##8;W2HN&'_7; M;18BVJY*S<^JYJ!(]J@ >V04OST&>["8^7&W71'VN(8RB(^^H\T)^K3PV(#7 M-IJ1J0/CX]6-7+J8FOO6"+W="O3(W!/?I$-)@\2Q,>#5Q>;V(T/[TE5D7K-%8\XN2SM1Y9W/6!' +8L MS(Q8,[TYONB8DY-:()*#)0?T<^5^>U#7IIME+&;ZD+W#Q M1O6BL"]00;MTV)ATFKU.P0)&52ZI(KFBKER1X9\ID2LPPZ_9[56%*TYT*'U6 M(#PZ=$E 9XEVOJ#!#EGW4ISL+/IB^")CMQ"4_?1SB8DL08$0[OO9ET'&C$&& MR4:NISP=++YMG/7P^6+PE"%GCX"G3INI(;WS!C.)[PZ9L#7PQS9 A;1M4[).HS^9FC;6>_TVE,QIV#^W961_^66,DK2(MC M16U,1OVRSA"/+"3/7QOJ4+4YEU5YOI;0%V*3GJ$E],4(B(S-I 3%BE7+';8/ MMF3/V!>Z5#5?\K'DXY-O]"7P,2MB/.B597!7KNI4D?BALB*#'AU["4-[HX'B*"I:M*!)8<=@I MU64C[J3"2VTW)L/FJ%U6_:JJ5UZ0("PIAK)4$'80A,/.P:>#IP#A-:BE=YKF M+WR3E5/3Z=*!E6,U\Z],YRS4_C=#;,=(^C%&4?AL4OP 3'2WL&'N_V'?;V6P MPKRE-B:]YGA\2/M@J9A6$7 9(OIL@.LBX$:C9,C6R0$GBZY5R$RX)H,J*Q>B)$,J+S.J# 94"D#*F5 I0RHK$9 Y5F3 MO#[2&075C%5 V%)HYBCA81>2\U?O>E(9SJ, &\_D)]?;_S3(U# -SZ#N/M;F M$%/XU#-W.I*EUB1K'.Z%*9LU1L@:G?[!Y7]DO;7<:'BP/&*]&.A-D 76#MLH ML!N>1_\T7JD>454XOO9@!E9;K7]X24Y96ZV"4,H0K.5"J4>M6UR23O8E:F/R#9]X8\]N?#ZZ=."/ M=&F[ANB N^1E3:4:O+^_A%-S\\@W#>S]QJ37.6_"C]1PS^0ZR(^2 :#D\.@, MJ;P6+L*.E9UQG9EX;#* LJ46G1F'%26_3JTARWB$+:+/N6Q5#[K")\MRS3-9SSED*:^O!=?CD=9[5B'K$>RVKN#SNG",_/N805#;20C"L9M^P- M\P#&59%Q!X:93 \8_UA!HQFG9T"YD"S7QO^RV)Z-73XYSE MTW1&Z[2(_SMWHF#C%WHS=2CY<4-F,-A;8KZ1E8L+&E\;6!CQ\*$*;]^<^]89 MSF9'FR&' O"5[3 PW0(K4 >O@C&1RHQ%F3LH2_[+&*@JZ>OCWD#K]7IZCY+V MN->C=-@?=6>#T4S[WV%C\LSRE>R9GRI_?%]N!AGHW+QB0J*V4" M?^C8\T]7/AL6L32#F,J3!S^QDK/*NWLN":G^R^53X-UWB_BZX24F$^9$QN6^ MV/IZP^Y-EV^YC YW7O!MKU$PCY+MQ,)U%XNN9/R43*+L=>N=1!DD4,8H(;,H M919E%?**9!;E=::"R2Q*F44ILRAE%J7,HIP\$9/R(#K0CGY0#(E4EH[]XI"% M3*>\FIRQ[ *.8)CH?P4(N;?=O=LA]E@MKK$J+[+K3);'%WU,I&P? M?G@M0WJ*EQ!PZ"NU_#/TE;@83LC8(=!]B(_YE^'-[WT7YD2=P.&SVI!5##:@'J&NP+[@,F?*/$4BU4QIWO%7?^C*1[)"OT9#.B M/L^)]6!IP!C[LL,(V:%=6I!.!31Q":4\,>AYH)1$R[@Q&8\/%IU2.\V]VI\6 M2]->40H37&!6#S^M1%>-R..1ZNJ^ZFI VF^4-0F('4UN9X!^NS$9'-X\4RJC M%81+AC*: R[%MMY^AVV]O8.[_DA--#<>_D42JJ?![1DT'TPR00AF?>+ MF/:ZJ__N"I@N@&905B2PUSAS+'G]ILKI1 MOY=]21],_J"V"F_6JY@I@5_K_Y'ZZT&%D))^L20O83V&OJQ+5T>L%"IUE [6?R<]02DK]=&^I&/=K[8#WJ#%11U(7K2- ,D1A3H", 2"= MLCI+2;TSYR&1U 8/2]GF1VR'^Z8&;=9:;5"5XEU263QY$G%I4.H@E'K#JM@= MLB!')8(%95Y_8>E> B^JC4FGW51[9048RIHOGG?S;*K M7Y;C%(UNV;)$15*R<[0'O7KG:,<;WO)PP^N8Z3LYRY>3OKTP^&C"B5@4N MUZ![BC9HSL?6&:5)5Z:M$DOK#S'#OZP_9S$=U%/[J(YJ(? MW:,)@X\=#.YF(\S;JDQJJU1R3YGL=WQP]:H$KFO0D$,WN2>S5,KIM*@+(X3QTADMEH.R]$,*U3.DNKEZE2<_SF"5E^@I5V5KGW]6%C,N@6 MS#F1NF&50)$G%K8@*$8 BE%52B[)[)%*'+C*"/1#LD?V/YL=CD'7:';5@]E1 MYH]([I7>15,)67/T[)[C*'_YEJ+,C)Y+T/^+ M)G"=*/_HS!"XTMZ0514TQTK<.B?*KCEQ*[0Q*#>R%#"R864=^PUFL#TTJ&+P ME+DSE^34>5?$J]/9[=4)\"M\!!_I-.WP8X0%>SK)2)=?+O#H7V*]ME@?EH)U M+'"34IGJY%B_AAB&ST!.U7F/2 M2U;WSL]J,C"WBI#8(H?S00(C#9.UQ4X.B6LP7OZT71<-%A@B#-DWW#G+;;!G ML'S3[2W=+E$87TH$J"9]B8)&-WI(9]A#7'DZEV1Y2I)\X95#[-.OX5K+GI&WO,53^/+$>CC%0EQE3IY MF5C9H9+OBY4Q^@0K I9KT-9%!)-%I69>C04I43/?';F7PGWC-I;AEIKWA4#E M*)IW<=!T&I-D_Y.+4[LSRLM60O1ES:6T&)2Z'5&53I\:"8;$)K)%,!22"7BT MVRO!X5IF5-4YC 7)L9)CS[:5%^)8/* >)2VOR^+8',DS^#>2T[!\PF:X,YTF MGJR!?XH!WB!GBB:-$7>C-U*/EQ0V8PV%MB MOI&5BZL;7RA8$_'PH0IOWYS[UAG.9D>;(0<"<*;M,&3= G-0!Z^",9'*C$69 M.RA&_LL8J"KIZ^/>0.OU>GJ/DO:XUZ-TV!]U9X/13/O?(=;.Q=0D>Z9@/60 MCZO\]BO9CNE,_CD]%A/1I0R+?SQRH_;ARWU+N?OR47GZ_N'IX>/#W;>'3T^7 M/[TOM@_M!1_.O*9\,BEF804WGRX*<%6]EW]UPL4OV7RZ? MN^\6\77#2TPFS(6,;P)B%^P-NS>]1L%,R6^\N<)GQUY\^@D3MH@9% QW/ZQ^ MI_:+0Y9S0[L#F;:M_=:XMNVWOE!/$112IBOX^ +DELF2E^!FN.IDR:.[@V3Z M806R@L9US@J2Z8\C%1&\=?+1;.;%? MY^2K(IYNM(MW13@(R](M6BQJW&],^LU>NZQ2;Q6(=9!,4%LFZ!^)"0;(!,-> MP9JTE8W@N(2M]9/OV$O:5/YB@U ^$5%([&Z&.^ZE;+@R!#9BSL&1F'.(Y0P' M@ZK4!I:!TZ6B)B.I?&_4C!AJNE?6/N2\UI)KD)M'HADS0V.R_)\$1E$K47ZY M(;*%F#*C5NW>3#EN3+K-3CL9)'NQQH9$382:\5%0,VBW$36]RC1W+$D[9^\= MMH;]BDOU9]LC)J;%* Y?P$L1Z,7B\V3I]K))4Q_)EI%=M+=@ZS0F'=@/1P=+ MMA*7[2+"PR6S2F;=LTK9WLRJ,F8=CLOR0UQB6X7+BKC['V+Z+&3W&UT0P\(" M#8_48'.J4!CP@@7$O@:D\AQXH>"R)8"!*L0T;8U=Y-F@ @:47,8H:4>45-Z( MJ_SW_EV-1EOX-5S"V I&"YB/F<<1,W?!I&AMX^0I/^YN*7\\LKJSFN?RN6OV MBP7T5\ARZ=@_&>G,5;'9@CP[QWQ[(+Q:VXXWQ'S9\@,J?(L2QX+U)@L06YYB M6*#]__24W<' .*\]9O*)T9?J 'RXY.OL";YU9WQX<(-AZYVUR0(O:+>Z[["X MNVA^?9B?NBG'@N \=$457*3..19IT)BHK6TE'X)%PJ1DRO)!6O646L!T3G7J%<$Z9.H@5'!./X1UN^AP]R#<^]AL*M MI,P<>\'9/97E%,.-MF!=L4'!54!]827A83+$!3*_VL#)NC(E+ES\-J<6EP&< M\T%4.-1=VI;N@HR 1WD@-=X,;\XNXAH0L#Z#E4A;D0"I D"6MN/%]).DZ/;F MQ$-XO!+'8$DQJ+(0SWR]KG"!#1]:?_!G9!LFES8KU0MODNR$J9PL?9C$O:Z8HM@.V[RHR5H76; M<*C6!D1K2"?086 V%=Q_05@8 MKR"$FR"E-=/'O"D0UZS8DF#Q]44,NTN"=> MKO#(E.5 3DRLI0$]=K$$$ZAL,]V:Q;;I,$+'#FRW0!0#K2T'%M%"F>\"%!C[ M\GK&?$=V_27NVF*?,#!CGKT6IO<*OX/<7Q+8U ENP/9LYE(/'U7,2#\ WJ'] M'JB3A?$^;DS:K>2YC1+SI01Z;4QI98H*$C(._L*T5C=8@YE8@R5? M ^8=A<^OA@Y(IHX'#!]>[#)\VTP<(#LSY=NEIHG?&X["3BOPN]AFOB0K7BD_ MIH?B*U!D:,:2UUJ>A94;# LHZ/GLNI;R'>M[P,,--Q@?*@H*>0%!)QZSXF9F MCL>Q"UV/;2F1 PFX=68X"\:^S.1TN?%J>&!94JQ!Q&Z(2,#]=I%W8H'&"=)" M9R06ADWPL);R& W-YD(V?!07&&Z,^'/R2F%O5(S%$B6(>%= 0]2\A3K-Q@\C M#&SM/QZ9BSMTG+$' =Y 7EGVPM 4(^B^!B\EX1C^CQLG'1KFXHU\0.Q=!G\B M85>N K.:K0$;U91Z;U28YR&L\$;\8MO*/EA(>8ORO2&PW&.D:*Y-9VE2'4T5 M%W87%UT^-M,B4- SDK_ +D=@AJACN !)C2])L#-J]F)A>+B.(2GMW+AAA(7[ MX-%\'")N#9!67:/:NAD%6H8'8QZ:R>.-'3$%* ; M@-12]C:;@-4+&A,9]E#ZO/<_"^ET&I-^*]DE[+@F4>FS4!N306M;"'HPBTVC M:&W;LWT/MA\+'6/*.Z-%6TV8X)(8T=;SB] JT<2--B:"WC",&?#%=IC&4D)L MMI2OLYBCU-W]F+B8CXVNN?8$^XV?H^1BQM*M\ZQUO.=&9.'E[*+2GW6*>FI0 M[CN9'DYF6R1V.)G])$P:QO$#6R=SY.)> 6H5 M7> P8AIB'EO_'-OHACV66F)1UD1,HYS:WEX3$8>+L,TNU-=:0H[1X6U&-->F$O*9& X+I_S(@VM\V.$3Q1L'G0'7;=B* MWWGB.WS:>DE'?)K"'II12M6AM/Z"VP]GW?F>01P:RO^ M;\H4AREO'B:G6!MO(%LK'AQAH'<+='AN%W!;(#Q^?[-]4\?S8(=J%'04/?3S ML> ,]/#;CL(L%_2CX!G^#'T^H<=[I;Q#W]-/P^./_85YG3"D![>9U=JQ?^ ^ M CK^@ >'5@:+"_/8T!;1BC(OV]5XRB/F4OX LX$XVGQUL7//"FF2R0(HY\TOZBV7@ MCDKBF#,43+"IO,T-DZ8--W5L^/ I]]K&WAZ.B4S!:B\V O0T,2@@3DU@=-@ M\;*1\SNV;'E%89&J_VO4/#_IU%32(6U< ]Y,G'3*).G95/Y./"(B;Y[G!0L3 M"B1V,,)>T@S8F)],P!76QNO"FV*L'QQ0A)MJM(/RXW9\WPU&.]I3M-488S+A M5GN.Z8IE_YXB*K>3K:9T>=XFBE\ >EQ_F\/E*(@!;;8CSF93-AF4^EQBQR], MVSZ3[J^#\LJ.*U74G(&QB*SDO\%4"QD<3]J6'HOR$^:( M_M7ZAL>2#HC<#QC3G%XT?] 9I1@EHQ2CY&PPM$T $%-.&%J68#XR!T',I4O2 M58Q0 HJM7T<%/P9KU&W0YN!4XJ'?D6JP:5WN-"N18K4LPM\=M50ULPA_KD?U M6^-.L2?MJ'7?37]'\3$-AT7??9UCJN+:57%,55R[*HYIK.[N>W$)!)G&E5,PK%:]&@^W5T5JZ MCH9MVQPX>(ATFT>,[C'=U,J:9RW.G=]"VZNHO227))B8D!2?MICMD3OX@%+[.SG227))=)4NT470Z]3:!4V32N3M4G76^1VY'?]:Y%6L3HN[N-876Q9VE MXW]B-D9*+OUZ\1Y>2/4_U+%3^E!UQKQ6>T=]?]9^F&*5RNFB*GFDOCS2+8U' M$KR@MAN3?EN5?"#YH/I\T#O]7J%VY%XA>>2">*1_Q+U"E7N%Y(,+X8/!&?:* MKMPK)(]<$(]D]'D^:*_HP5XQVE8;5_)!!; B^2#@@]$9]HJ^W"LDCUP0CXR/ MN%<,JK179)R\!'5H8* [V$9>):_*NNK4P6&QJDQK-0@'['CP3$+H=VQ";/$2 ML[&3OU*',F U%K/&DM(C #-9;KJME+I26(J3UY!_U]DL99VH:U)L25,WQ@O? M/3KMHVA8VUITQ+:686/2:;;5@S>7=-X[FI*5)PI"XJK3Z9Q!L,ZZ. U<=Q-6XW9:XJB6NRCM' MSKT)=E6Y"=8;5&L5W&2=&37\)]\N#.'G5)1W$74JNW>>T%O+LL^.S M;71[A7ZI;78R8H5BVLB!=DMY 4+2;JDDDC(B:K*0E$3,H#'I2JS4$2MJQOEY M>5)G**5.O9&4<6)>7.J,I-2I*U8R#L++DSKR]+OF2,HX_2XL=7IM*77JBI6, M$^W2I$ZOO-1NB:1*(BGC#+NXU%&K(W6D=U1>54WOZ(''BEO3%,Z1H]!10>C\ M19P?5'2IQB[9O*LV=ME>^)Y/3&4&LWF5TF;IT.X*\O[K[$XAR27))R73W(MYEE&M%.D_-^Y M+O7< J9]OXZM*R1V8MC)B&]*8B>)$;4Q 8!(?-02'QGQ%H?(ECJV.I#8B6$G M(_PBCVSI2=E27WQD1%P<(EMDC$7-L9,18Y%'M@P:DUYE2L9+?)2*CUY&6,4A MLJ6\_%:)G4IB)R/*(H]L&55)MEQ9<9*OWIPZL(+!*LEB)+O GA$EJXY M=@H[I?-CIR>Q4V_L',]A/9"E&FN.G<(.Z_S8&50-.V6&+77&%7,17" M5JVH9V]J.SIU;K!)),[7M4U#5X(A9[)$Y4A1N-5Q_OG72!3T,\XFN HH;O$ M@'>N')9U?IY[M0VR6T5FG@Q M;LLXKBR/VWC7V])J]$ANJQ3H)+?EXK:, ][RN$U%;NNH \EMDMNNEMLR#LS+ M,-J&I:=S25:K%.(DJ^5BM8SX@O(VMEYCTFVV^V4%F1^5V^I58VN8"I,_#3(U M3%;8_:#"6K&%Z *I==O'JO%;5J+:G'/^2C.2F)*8DIB2F)*8DIB2F)*852;F MJ;LDG6/:91:BS9[^12Q[F=G;DER27))S#=?Y$BSCDEYDA_JRP^YXZ?WMN >45^Y/\(/GA^/R0NW9AQA8PDEN A/QE M0#YW!<,]MX ZEC&4_%!??LA=E7'W%C!J-R;]@W.=)>0EY(\/^=RE)O?; D9U MK#^'MN1/(IE4U!U!9HA,[5_6JTN-> M@J1MZLD9:XLF%;VS#M*S[S]1.:XCL<-$D#[ M-,[;$T"J!%"] 71D-_=8ML&J.8#VYZ]2"L: M)8OTED:@&@F.K!9],7%Q6-7L\;%:'96PH-4NJRU96K)TF7T LUAZDW6';3RO M&GW$PW9YAVZ2I25+2Y;>NZ]A\9U8E3NQ9%O)MD=FVXPS MY_)VXF-UDI(L+5E:LC3-WX6Q^$Z,66_#LF(X)=M*MI5L6[R=8WD[<>EYB)*E M)4M+EB[>-K+X3CRHST[,CKQ_]0B\$/ZK&Z^3W^"?8- +XKP85C"V :R-^ 8' M@W^*U]\@[]RJ:BO,Q3 LG5K>[0W_KFR8]%MJ%D[4]C_>+VW7P)6Y=:C)0A'> MX[AOU-9HF2#)E+@4']"8O.O\PEB'K]**ZOS17B*M];3RW%P8>'3/(?H M_%=DC%0H'8VZ!7[=^X$HUG" M2M], 0(_;L@,!GM+S#>R/D26VIS[UAG.9D>;(1<@(+%MAZWV M+8"..IPW?R.5&8LR=W"#^2]CH*JDKX][ ZW7Z^D]2MKC7H_287_4G0U&,^U_ MAXW),PI8Q9XI][@W(:O^]BN9K*_C5KG;79>[W76UY4183#3F95C\XY$+QHG[AZ>'CP]WWQX^/5W^]+Z@Y%0\&Y>-[;L$Q1[\ 9N;"Y\^&Q:Q M-(.8RI,'/W$A_.Z>BRJJ_W+Y%'CWW2*^;GAID^$CFOPV=7Z=I(FD#:D=Q.5T MAC>=QO9?!S=JXV EY'C48D^\-3Q8&RV'L$9MDL_OF6ISR_C;CP7:%5:W8JCX MM^]ZQFRUIFT=>^X[9WI/W+GRZ6_?> 5U&?D 58$'IBKP1H3*'X_*W#9!@?#@ MO: NL*T7%)-%0L6 [WS/![82?]DBA184C)CFLG1 IW=@)JCQNP;0PWI!&0O" M>FFSSC4XA)DH]A;35)A"Q'YD2DZ3?=3L!0P$J&9K/]@7-)I+"\?^BH:!JV@X M3[HQ3_S;6PG-B(L!W\7A_.W;*#+$Y&#$&JIBQ 2.MGBO1OP.KW1MWV$_<@T) MO[+@%H)-[?F[@0X.$$NG)CS= Y/E/WB1>+0]A75[9=N,82U]'//SG"HSL&CX MW4@9H3E&@S1_&=Y\R]M;]63)+1U!$. MGD)J6UDP,R(.I9;R+^!'(/UR"5(0B=F$-:$N#>Y:.O:_J8;,[.&=C&5FIOW& MF44'XQH,80_O"2XA"_R&O6_IP),L@7F!,KY6-P*KFU"/\XRQWKK*=UX10C!C MSN,^_KPD#C"KYE#8V!3'<'\T0RE!?VIS8KU0=KN0#/#;&Q('/[M+.^2-&:*; MEY ,#*FUMP,+/E&JH!+!M:114T&7G]I^'RD.L85AOW7>L^<2((S#I1Y0RW== M7!/@8%2X1FIG^![Y3_!TN,@Q4_!01)\(O@5W4UY* ;TT"G/3*)&?IJ:[ZM/< M=KP;AJT_;=!QGJFS4#Z"&&=<#$@#L(HCR); GL-(Z MKWF!BM(4DC2^/20EIQ#]P3X01[[@"P]>2EZ)8;+;@+=ADP4B(K? "%T#"$:< M@!&9$,)'(?Z#W^"A"\Y:#EW OL"%@1=W7K#-'[D 1P'CL=^L.&_S?1 4 B_) M0HP^;#>!F-3,Y?6 C0LIN4?\_$!.W*.5I3IE[ \&U6=KQ+;D!>A!8O.W8(^TM#DN9T)R)96'&-W<")4FHA)7B;_V#8CP MWT7RIW=GZ?=DB3+P3]AIZ==HX0K/Z-1^=9LW'CDP%D=<9<1;>%-/WFK%MGF@:5Z8=JE'C ME>OGX9=+LF*[,=-LPT?%\@#77/1\G&(W7[O*+H0/O'1#EKIH/SCV3Z;!Q-=> M]ZG8..$K!JS8EE\>9+G%PET+J31-A2[(BW7H.O&_NU<(Y2^V=?,7TP@9KCYQ M5TC,\\.@AE=%<+]#KP:S1$-8XQG4(GI,BD<%CX_B*Z_9H*Z8U 7$@@ W'+RJ M*;0GRLRVN-+*C+9 AVIMOCD" '.XH$039VF@&,$M!F,9\=.+;>MO(%K9Q #" M2PKV)' @X,L+W4%+,1P8M(/G!_HVN,+=AHW696P:.$X'K%"FC&KVBP7KH9<% M?8%\CNX7:@$\31 ;ZSA';\FZF"Z"[8)G>%GN\,9V5_-5GP2JVT\"<;BH(V0? M3PW0&R^/#R_J^#!^>G@.Y"F7?[(ECRZO^.CRX,EL/_4LH-:=$1K"(7VK",OV M"ZB\H"!MQLYM&J\A:F+V2N2#?88[/YBV]B,R3SO<.F:8NO/$=_A<"J;L$O=2 M!RS[2:HA%!BU8FP;U$X_/Q9/3WFG&H8-9LQUOOS[]DF;4]TWZ=<9'FO&3C7! MI@&F$DX)":U4VBB;LZ^+N[YU"/@D%PWH)#?(,'B MMD$I)E'(F=QT"!4[%C<)Y##)TJ6WP8?WNN&"JKZZ-2PV!7;3^_7W]9,!@NQ] M_.=(SVFUN:XCB@:)-XN?6_#3K\GOU6YKT!ZF_M1N=5*_W_:H86LP3+]CVY.V M?]_OIK]#CDF.28[I(L8T&NQ\4D9YLXU0\HJD1B14&"9PTT/MH_I\G3RSXMO& M:>:U&>2=/JT[=BXJ3F>4X&!FZS23:Y=>K?"BJ2$.+@)J=->H<0F0SC?9#$3' M4JH*I(-4>WWO;=J# M=;J-2;]=E:96)?0]D^"_.O!C$!P"GV6JK>&?^>8BUQSZ/PLT!AQVZMB]5C*( M9)!M#(*NZR*M,X>=.K;GE1QR=1P2UY^27)*OU&IG(%4IR0<7P@<9=8:+VQ%# M /]H+,$OP7^QX#^>'3&26I)DD"MBD.)V1'G]CR6'2 ZIA/ZTKQVAMJND2F6< MK 3YB3#0'6PCKY)795U54M#7I1SA;?3(V)X>5HP"J?O(I0O;T6'&:IXJ=3'Q MVVE,.LVV>K WH'/$S>KDF#*!M/1C#]5+;MYFD14O1!5V%I22^^,*R%U$9#: MP[PHN/GUY.979UR-3ZI)]1%,XW9;@NF:P'0\36H@MSV)J'(UJ:&$U%5"ZOB: MU*A:F]^51<@_VQXQ$_W/]O*R"4+LRK7>GFA==P933ZI0CI&G^MU.26 M]/2XVVU,U&:OM/ =";^:PN]XBF;I28L2@]>.P>+J8NEY@1*$-07A\37"P:5L MR:D^VLZH7H7O=O=8*:4,WKY%<'*O;+69\OS5A"0A)2$E(24A+XJ0,M-%7E7- M3)>+/8KO]/\1[Y>(_G^@.6 P>]^PY[)M^9IOV&?;?ASGN'ZH:' M-G^:-35L3+H5R4T\L>5^[5C;1-<&]C3-7_@FMNY-\6!^H&#MT6?RLX@3J8YE M$R3@C@\X%%U[ :Z.50@DX,K:3;=MH"E(ZK7E+EE7#'4JII'U.A)K5XJU4VMD MO?)RF27@K@EP^VIDO?(RG27@+A%PY6EDO>KLDM+3+*^JIJ?YP'@"W7@-GBT> M<8/7WPY ]IW>^:R",/J+.#^HAR)#<4,QHA!+5Q:^YQ-3F<'L(P\T3$#68$J5 MTQGQW!BRXZTB2?WY]8N!)DZ:).XW)KVJI$7*=-N3P 0C#1,0^9\O#[M-E&FD M,291A-76#RZV+E%4;Q2AW3'=Q^Z0=0&N$V*[]K,TG(P:D[&40O6$2+<\E6?KE97A+B%T2Q JJ/'VU,1E610I=3RAEK*H1 M6/_].8JPN*8EG'%#)E4L(R M)RSS1@HD =LKPPTG 2L!6Q)@]XTTZ,N,=8GF,Z$Y#8Z#QF3Q@ARW9;=ZILA:7JCGE?;D! 4D09!%A8)+-__3OG9&(' M%Y @"9+9$>T222R9)\^^MJ[&P_KWV+RPH9+%7>\IW;&SL (<,) M,,DRW.,.-%D[J&X^];ABZ)P/IUK3KSK9?]4VLMPJP<>2YLD'S3.]Y14 Y9K$ M]6GJ9V_0K2BP51$*'"EL*LE?DO]QR%];2?Y;I\[TU0JSA25M2]J6M'TPVMXV MH:E?^91<2?B2\"7A5ZS31QV>*U/E:89Q7^U+JI=4+ZG^<#['FECR/6SWWNM( M;5^2OR3_XY'_OBSY?H5%,)*V)6U+VCX8;6]MR5=>C2T)7Q*^)/R*=?KJ+?DA MJ?*#JBJGCTCUE(CP*S4BBMH,\3U]#69PPGJJ>=),(+[/EB._B/& MB-&5P@!/YO $'U#K:GQK6D?@4 _[O._08;PI6MC*'Y3@&;1G.&7\3@%@T ME2>X"J"5?PH!B*U)&X$'+13;\95GIKAL#C0.WVJ^^4KWTX,\> P ]86/H-%Z5)\;I+T!FBN:!SP;.Q$G)K/1 M&94 #\!"=& 3_)ES68")IZ7>+/XN0D__9K_?J V!YWBGUK-=N'WRQ[5;C?[[5&I1RW_ MOE?AHM35+U^3+[>N+V"2#JX':OZLCCIY<,WPK-$FV]09ZC*'V=9PLWF*22FC MA *FS&2K6DR/W&RSF\\_6Z;)%2AS-3_?T%.NH*N\JJVO&_^6TI3SCSD?\*+1 MPK&*3)?+I)O1&=+-O=86A@RJ&D-2G;Y0D#DD< MFQ-'Y/@L(@RU/H11^[D#Y"9?YEK$_7MH'^-6QKV?Q %&I9%) M%QFH5W/7?-5\9BV4*;/PB&8 "IHQX*+ZA8$0[NW\YD^9J\""K^%V%]:A:)[' MN#<./:%WH*.BMDV.6/@ /;@KP^:A4/ E,O2%M$=V*'Y:AKH)!<_+A2+ 3B;"H:3$J.ILT&?V(NNO+B:P9K*5TXR'0UN ]&+EI8*2C$;?RK$CUTB)A\9 M\2S GZ5QMD&?4Y1I!\RX]<5W^*@3B9+0$V],'_!;WP#?8I H]P6#R<^-M@)$ M0"/>O0JE&3.9 (24GD./&0#0 \_ MYPX\DT*8F$4$X%6X,-47])#TZES3^X'< FX#=HE$1L%&SCTF&-/B;X:'@,:L MF7BEZ=&ZA&C&GRU3>S8MXA]-!6"'(4^#>?!N?(?IIP 9+Q\#9W$T=;+H35K$$]9 ])V!62B]2,B.<,CHO?A;\ M3"-!G*1F01U=C"T"@A&L;HAQPP+CD.+?T^Q.$'\KOD5[AH4&_O);N+A%/#+[GWI#B>3 MO>V0\UH#92N=]@TG#;@*UJ359BT*R'J0T'\S^ZJJ]8Q1MZ]WNUVCR[36J-ME M;- ;=B;]X43_G\'5F!(74%W$$#\73MIX0P'520NH3I'K_O Q62&,N%YS__4. M&-77C\KC'Q\>[S_>WWZ___1X^MO[ZOB,1-D2+O;9M(&+F2 ]'WWXB;/!=W>A MYO7+Z4/@W1^V%H#\*=H,7]'X'\_NK^,BCI1AVJ%RVFZC%R^KGL*WG:NE]W#E MM4"E5;=18FNJV=V""$7K,+ H8PQU$]#T\,]ENAZ(9E/H52Q2)$AO(B4#GZ"3 M9\&=H\:&9@LFH% M#!R1/ 9B\P65*&'?)=6[S%N?%YC%!C?0,V#5< D\4?@]/,IYF[C.3/R4N!L4 MPQ<-]YRZ%JZ!*^D.RI,#^RA]$W'I2"^$S7$5"O;S!+IGX)*68YFPHG#U"#4" MZ%1#H%EH][E)"S.QO(>; )\5-'?(F18_!M390 M@731[@4@\9T"Q/SD9;[3R)W8E'%-"@&6SO";1.PGJ89-K #/$3D702AQM& 4 M@'H-HLCTIH@P(,$\7*D7V:/5XKVZ$=XK^WGY9D3W1#HJ>OT6H;_/4UZP\"%Y M+GA.J%V#N@ZZ, -")*<@UY8S#D$R2E(_)&R04FIQQE=$V9YI#$A: F1K"&SF MG/(%7SYA&/7@;]8(B<+E+)10]U7> .E+>>C6Q&%B@_PK\W\+W_<@7G?[ K2$ MK",1>2GIH!N@@VY4M=]Q22;]P7:%X^AV]3KRWS?P/3;(EH-KWZ:F/N4.K4F M/")&?$I<>J-@F9(B3R W_=K\>3TU#4#=&US\Z&KLOSF"EF.KWP"CXTS=G'^0 ME$F(@")7@L@(3THG'64$>4=1?-(I!#[P91O#@XJ/GLDP;Y=D+MS]RI/6IQH0 M-:63X^,=2V&OQ'DF$SQ5(5M1.G$U(F(W()=?S5>\ "Y'RG]F^,$E]O/,4)*! M806H0>G7D4S4\)G(=TRO@+/,7>?5]! G#=,@1P1?1Q(BL8B*>$W2B^)MYT3? M%9_JZ<5$OJ$0XU"^D$/F/*D&4)0L&D1.] 1FW6P-P%;@1YJWS%L)R&T$.B/$ MCI1.H3!3R&#NN#Z0C^F0,DDT0Y20>!6G#Z0!KB/%%STS6Y]BV##]>@I<)!&; M.R.C:^;:8B;J2,[QT#ZGW(XI?9-KPRY+N2&!$.7\WIHD9)1H;58,IG,H_.FX]1("8?9KE88RH;!2J, M(Q&)+0DEI2,9N6 +6LRNXZ..$;H%B+RSP23V4]!_<50)*10H''48(%44&_@$ M72,;#ZG>1;4J8&B+>^2+B;YP@*A)*Z*PE.V)"!")'=/S K3>FBDYD5U;;E-4 MZ 7< J2:@RJA[8,*'NK<*R/#@YR%\KOVTYP%L]^8_>)/OTWP<#_S!=R)]R-M M(FD29:8,%%3I;XS ?7-$LTGE62%"]-]'T(W1?.#)!R"EB.5V/> RX"[ 0&9@PY_N "QV:\ MP/71!^)&9Q)H=@+[X6434S?72=&TTX,V[07/'OLK8$0+L*]4@#5*F!(:)"N6 MNX#*2*?< :87:R'DT0F?)<*>J$DFM1-ON4:Q%+"1AS*VA;Q0 M;U 014@+H?-=]XZ$UG*Z!%)2F>")=XFDEY/=^ ;;+!W9Y]E-:']$:1_H&,ZJ M)*BI$#LF#,H)I6O8O\/=$8;R+,C10W*,#"Q.$9KE.5SKR2>-Q(\WB:DS/2!J M "; 7/)> +L BN>!G3F\)/9$9A, SN545_#[S1,W$G92>=8NC:2:\C52P)1/ MW','VB7SO'P2S-*DE[H#8VWJ]Y(HK\IIIL#SDR&68I?"C*P-Y@E&Q)+0Q2AD M OG7N1P2R!^G<6WFHV@JN(>72+=;%N3:*-=4U:[&VV:JWGDI%ZW M_VB)"1"4N#WD'8"FTSC2@$KNLX:L 8X^W#7YV)IYI#]3P? QB,YCTYQA0A(> MQK$=\G&2-ST&=T9VA$HX&LK4( <5> STL9^BK"$*H&/DTO-F0I-/XP\F'":. ME_(=,TAX,3P[X:$'.!5G'9F?.Z M,N>U*W->:[ 6F?,J:H/9!K6KNF?K/5[\@U;8#C:J=N:ZHCG.2:-E[3&IYY,WGS0T1/)H"(U."AH7@]&GU59SL_/]EDB8IC$5RE?AO)$M M-BL&]9J\_Z$:!J_O1+G++=7!1.<@C^.@Q]$)CP/;'\DCJ<.1=+,4\EM<$";/ MY#AGTBLBDZW.18)>RN:Z8GE?RN8Z'<= RN:Z'6F,D??+^RN\_U0YC@27!)<$EP37*8*K M(K<33?@:- >]FBM.]ZEJVZ@J58ZNUA9^/.IR*4>TL=6 J:F(Y:5^-! MKU63F7D5F(D2[<\7[9=,3\NC/0_2IAOZ3LR?S+C^#W.=(C)HHV09JFWUO20% M20KU)X4E$_>J( 55DH(DA1,BA?ZFI)#(22A##QU)#Y(>3H@>!EO10Q[ONU?C M;EV&:4N4ERB_ N4WGP2RUA[N27M8HOV)H/UH?T9 7RH]DA1.AQ1&K?V1PD"2 M@B2%$R*%]I[MX:&D!TD/)T0/&P\_7&,/CZ[&O6%-4/X2$@3O,GUK97Z@O%_> M+^\_C_LO+&GIPUUJ-9$ MOZFR7D3B47M4.G,FCR)M0)'!&<6#)'XD\*-T.DD>/]2KL5H7\TBB1[7HL5V* M11Y'.L!#I(PY4R2I)N]@V.I>C7LCB2-GB2-;!^I+ZK,]KL\.I$ Z3SPJ'?G. MHTC_:MQMGU&BA\2/"#_45NEP1P9@ICI#B22G"62 M5!,W'+8P;E@7FV>-USD<*P0+78%2\BIYU:E>=0F!\R<:]IX<3K]]H\)5@D" M9FE?R_,7$0<*S[0Q/--OM#H[BY%21[9/)623L*K$O56XMWM(IUU-2$?BU-G@ MU.YAH'8E82")4F>#4A6%CMK5A(XD8IT-8E44;FIW ;%:$K$D8H6(=: 85;O' ME7HI+27N1;BW>URK74U<2^+4N>!4>_=86+N26)A$J;-!J8KB9^UJXF<2L>[T.UNI[O$G=JB3L5I6&HG:MQ5?Y:B2+U0I'M$BHVYS%=R6/. M&X$.E#BA]J[&W4:W*[7@\T2CW7,@U/[5>.<. A([ZH@=ZMX:/0_5ZAH]2]RI M)>Y4E+:@8MI"5643$D?JA2/;92!LSF1&=6,R%]:(\IL_96ZR.%+VGUQ!#5L[ MMG.(W\$:QHYLJ'&>>+*[Y[K3OAK7I4N"Q(YJL6-_CNO..0XKE;B3P)W]3O<< M=LYQNJ=$H 0"[=FMW:G.K2T1J)8(5-EPR6$'2_[4GL23L\23O4UC'';.<1JC MQ)T8=SK[\VIWSG%\H<2=!.Y4Y-7N#*4!?JXHLF>G=JY3"'@N"+A[!GVWP@QZB5=G@E?=_44INI7GWDNL.Q>LJRB^T<6L_9UC[Q*[ MS@R[]AP:Z5:>[[]7U+N$AH2YN$G9X)0X@6?']YW930? ;#C!L\6B4]B-HFH' ML/\Z(H#.B-4YA!/=C8P[C4RNYA M-&ZXGHT*FYG[[6D M5DFMDEJ74^O&0:8UU%K-_#U)K9):);4NH]8#923T>N1[ZHVD\)7D+,EY?\)W MN/M,OQ[-B92$*@E5$NH>M>32F?5Y0JUD^*:D4TFGDDZ7"]2*DHQZF&34E]:L MI%9)K7NDUHK&Q/:J&1-;"VJES*U??0U>"/\US-A:JRZ'H?9M,0#N!![U\UDSW7YH5,.XA\!Y@$_HB@FB_Q0\+7LF,6U]\A\]F M /TY/-UW \0Q6& (T)GFOIAV"+<^H(OX!@'53U/TGX'GFY,%_\JT#6;[-ZK: M[ ''V1O>TA-O3!]6H*_&9)4:S$:P4IR)$@-1N2^HP8_.*3Z6DX+-2DC\(X-_ M,9( 0HR_/"@NTYT7&Y[H*9J53,E+]BM0X$9- 8KS/.59\TP/?E3\*5/N')M( MB'H=P ?8L =_?= LS=:9\CAEH% W%7B/X8CF" Z=#=T] 4167A&3\9A,>,^2 MUVLO&GXLN$G7O"F*2 M6X&J6,G<\7 IP!N;2$Q._>4P/7--?P.-4*N/VR[.7M@I>W\R^_]1"N M_ZT!/-P%Y\*==D-16VI7T6Q#^:;[SC-S4[]T&G!VQ,X"KGS;O) MT7'N33(BD%Y=!M+.YQV["/]X;IC>WM,6-:1,A MTTWOTT_'UMX9^4.\AO_\_LTT_"F*\V:+BW211RS>+'YNPD^_YK]7N\WV2"W\ MJ=5L%WZ_[%%MN*$W*/6HY=_W.L4OV6)1W>Y(+FK]HD;-WJ <(ISWFI:O=="J M" W49J>W&@W6U 74,_U_4&AIK)F6C/UBU^]*!P' W,/L:[C1MNY+*$4;C(I> M652TT<'7#T0;S\FN!3IOO2=!J^%"PLNY'7".&U[BJ"IA;=<;;]^9OZS:KPO* MYS9[7S?L_8S@)P&X*P#-7SCA_1_E'?X)YE/[_3JX2E@6PO*U!-"$Y97?\U* ME(1HX0M*>2IK#NZ-H%U2V[D<9'U-TKV9H/S7Z,\,@'?0/K8%Z\Y,Y& /6'G9 MJ,1[3@)[_DD^6Q$H4+XZOL+=A0G#8J-Z>JLP/"5^4D@/+C,PS5N@@X5*$GGI2 !E^L M 9J92X'K&TJ&P*LRP7TEC.MOP@*V@%3],MPVYWA;C;F1X)+@DN"2X+H\<-4N MR[LZ:)TJX8MDMO\R?G._,"U[S1O6D0&@ZMQMXY4T"]MXJ_#9=^95WW8 M_8W.^ET[ES@HB?7BB76Y%<_#NER@W?*2X9BRBVAX"#1<$Q*N*%)Y@NXZ*ZZ; M+MONX9RIO6B+DMK3+446140] EMMM/- SA7D5;,&/I((ZK2WO1!!A.]IWYUP M76_LMQNT*O/;2?*0Y%$[\BCN,#5H2X$@,?X\,7ZQA0-OH%;BP)/T(.FA-O00 MF_G?\57HN],MS9PM<=X-<#Q-JZK&VX?RWFV7AG4\[YVZN?=.4NIY4NIT_E>1 MU+JW=2M ,(#X>@R>_P2A]>3\3GW@OHI6=JZKV2_4Y.UV E\+IYYM1)+M:V'6 MS@!'V535^_?@/KWM_/,G5GT@&@B&U0>=K9(TUT.J?O2T0T[J)F/F);@DN"2X M)+@N#UP'4GL/#JI3Q8S+C666+#V09D\-$7HO0_U*E1X,>E?C;F73=R>X5L4WP@2XTNFMQ7%1\,,==T ML'/^@2R.E410&R*HJ/A@J,JF(9(\SI<\BHL/AATI$"3&GR?&;U-\,.Q6XL*3 M]"#IH3;T4++X8-B[&N\>T-D#!9Q3YY 2M0>24,^34 ]>>S#L7XU[-:%K\NC] M2A/DPVGW)2;6AZ^_1IR_4=5FQJ/W9^#YYF3!OS)QP+%_<\TOJQI?>DUU'<*H MK;^_GSN>2>4&+K/HO-_C5J[5)LZ/R$#I6?,8+TA(./DK771V:$7QDI,P;O>; MW2Y"[SN;\QE*'LV2UD&&((<6 D:!?>)4Z><%?!G@%(ZYYJ+IH6A46X&WP.US M5,1>\<^YXR)**SB,&FUUY&#]QY/5E1"R#44&S[!,XQ$.J.8&^=/-1]? M:,&;&5R#]-#@KVPH+\S&I5F+AI*"(D!%OS9_7D\!*9E]@P0RN!K[;XX N?(< M> 3SX/%+3QE[IJP/-]9O8>FHD2D)+%Z"5:KM(AN25Q?Y$AB"\P/O?Z+K;%_"^0?[H[\:=1'28.2T+0#"AL7?5.&/-:0PGXH M89LR,Q4UA$^3"0 )CRP1SKFW/=\-9H1HIDW0O'-L&FRD(9K!!]B+!W\]^O % MOQ >\4ES;8"REP8PE^1?X7FNJ6>4CG;6'GC4IZ >6.S;)/*3?F$&P/_!,<*G"3:U_[J; ("1)T:R:00+,-A9@G'#F< MSPO\QX03(.S0E F39[^8OQ8 M0WUB"UV4.7FV_F8:_C14?1-WB1-JQ;=HSX#-@;_\EL31\3E=1SHFM9>!5N+? M:33V=:Z]L.MGEVD_KC74M6\TZPT8(JJP27P%U!0/'Z#@S.Y]Z0XGD[WM<%6A MZS^TVJQ%F;K(L/YF]E55ZQFC;E_O=KM&EVFM4;?+V* W[$SZPXG^/Z"<$8M! M:KI#7F=C)8LVWE#?ZJ2Y2"?-10Z$BKGI<(2**/G1"+O_>M=4;K]^5![_^/!X M__'^]OO]I\?3WQX8LO P4!Z6B+I(HB2%WKN[4&;\/>'K8'>Z!=MAJ]H MG)ZHFN!%&:8MQ.J@W;[NY@0K?MN[6G8/%[N["EJ3.!7LA_CMEHL\59J4@!$F\6/S?AIU\+OA\T MN_U!X4^M9KOD]YUAM]0=2Q>E-CN]XI_*+ZK7*?>D%9 :]$8U6U0? -6OV9K: MO>:P,D -U4XEBQHV^Z->[=8T&JTFF.W'V18/=^4Z_?_'-/="M_[D^.CN$UXYL%),6W=F[-=W[.<<-=U?%+PG MMN_1^^.%&B]>/XD4X7GLYOC)SS90N=J&1P-[5S;L5^T5>57CLHY,;%+]Y8'E-_]*GJ&\M^: M'6CN0NFTJY@U7[HWGKQ?WE]T_YET'EZ9(GJ/2B[S?,7%#!^,QV#*Y0FUJ#PJ M]#Y3K1Z!SF#/$FQED0X32QQ_RES*')/@VPQ\:DOM5@VK,O"1B?W'WMN[4E,% MNIUL;K\'.X"_LMEWZ"K[S?&\;W8J^XYYWR._V;T=9OD5Y.Z/6E?C=C=?I[E3 M&8DL29,$46FE2P$]I,G@;HJ5*_?V'[;+8&^ ]4L((YV6VBZBB#901%W*6215 M7!A5[$E,K*(/'EK'R/I]1H@4DH=:2!X'EQ>[]EJOC? J/9>DJ/;'VY M\1;/BAUW#Z6UXQR_8;X3YDZM&V4O6$D0%6OM.7K8G]:._56Z-6DK*:GBPJAB M3V*B0JV]5T@>!Y<7!>T9\M6#&Y6?8I>+N/0T3I5.\ E>*?O-_H;NZCMG-G?9 ME-D>780)E C(!Y<]:3^7E)B.^K*85%044_'YQ'+>"@M&/5'!SI/T;G4]F 6\ M]I1"!7"&"> K(K./9[$J;YJWO-3T,DJ*!NWF:+2V_N/PJ1++5I+YOK(RF':S MWZY;O1 N2E6KJ#E98S%O=DHK'S;*7;9QDN1^Q.>&^>T;IY<<$M)57E5%!G>% M&;''/.Q-(Z&[)AI?""P[)TP?;?4TZW%V2>H^"[_H\OJ,A.K'8;1>_TM5QB3T MO^6\X?#\N_;>=)E 5R8%S''A(]@T@>LR6U]$.72;%&/5 ?EDM/V)SW,UC:Y"H*W4D?V 1H@MKW>IXY,7FE\:UM/&D_B[Q)@ZMQNR^3AB3! MU)Q@^G4AF.'5N(^Z^K$)1A8T[5(2E'=<)]O@;=DU,79=>_MMF#@:26_V%M[L MJ.1\=5/$R_!4=]O-;G=M+Y]:4O#&#M].LU<_+[3:[(ZJ:ENU0=.QTS[!*H%5 MX0GV6O6)(QSJJD35[-FT)SEP/YZTL-I;.QZ)-_O&FXS;5)@.H:=TXCHS_E?. MB4H]/-=[4DW;=_@-+-O6NT[!@=S1GGH89M?R> EY&3G>T45\'LE4)^#?__7)D__1L[F%T;#K47PSOS$;)1"_M0=!KM MXO#\ MC\)DCU$+.V2,=AYT7A\"EH1ROH0R.B:A=*[&G6&_)H1R"9G/=XY' <@3LR=C MST:YXRAD1O6CV%))C6LM,#SC;Q.A@);6/[&-0JNAC@;'SU6L(+E7(DX)FV4W MQ,$& ^U&J[U+4YH:(H[DA/5%Z%YK7^G=I;28_M6XVSHOK)?8!=C5K@5V#:[& MO5T:M]2DW>*&VK'OS(^$'-_F# =?V"^*R.*K9S'@MC)A4U/]Q*EV(^W8N[6- M3^*02^LY0]!S&J/>+K4\]?'L2-0IJ1_OA#JCJ['::'5KT(;KC+WZ$J63.HQ: M!QVFW;H:2WYY?LC5J05R8<3T^,AU"=[C[6< G8YDV,FZW4^*W('TY"7$^]6Q MG= TXF0K])\B6E2/.DQ&@/]4?"&G@RT%JG$5V+)S$_,:8HOD>;6-=??6="/? MKYK2+=*!#SE42'+'?>%5KBW3(?&J5Q^\JLA'3.\=- >]FJO#5 9^32IL..BC#VR?F0 MZ++)C'^;_M2TG]Z8]Y6(K*FPY M1*\+GP1G_6HZ@0=/VGZ@S[/FX74<1CJ-L,)M 2G]P%)F>$J#(@CX(&) 8FE3 M[36Y.',VU["/8]R!L9GNN)@?')4@94$:730BYZ(_Y@UO\OC*XAZ(?T\WP124 MWXIOT9Z!&P7^\EMR=?-'(G^UGX%.XM^I&ZYFKKVPZV>7:3^NM0DL]D:SWK2% MAZPRR0>!Y8F'#U1X>W;O2WQMAYS1&MCVC$[[!H0,<_$J6)-6F[4H4Q?9 MWM_,OJIJ/6/4[>O=;M?H,JTUZG89&_2&G4E_.-'_!^0K-6I%VKA#CFEC_WEM MO&%;T4Y:.G6*6CCL'15SW1H(%;\\<&YZ__6NJ=Q^_:@\_O'A\?[C_>WW^T^/ MI[^]KX[/2(S"J9&J0GP1/A@8Z#"4J"^O$C?Q5=[=<4[%C%].'P+O_K"UP##] MHLWP%8VI95T11]JR2S+INHE6R7 ('QEJ$@C\6R\_)+3Z!LJC=KZ!Z?1ZO@5?U]>Y7U]QU4UW2XPD6M[F6]2P.L M=F^SYF$GU2)L^7"KR)1*C:Q*L+5M.HO5RY-7#))BGT^1IW37'G2';8JY9HCF MF?2\J[Q)ZDGL>F.=*^A&N=)G7"/Z'!VDOV<)]GI10-VJT>=1 MQ7'%G&TK^76RNZT7OSO=V;:7VVEUI[F@9P&!JOS"\(-:NMHM(TV0:P-AATSM11LI9STP*?O=!)^VI\'D G=JW%5 MTW.J.].:.BLD54NJWL)1VEU1DI0LY-J[16ITD'6=N M+LM)ONB*D<'RBA%<+J+=^C*&/DB=/969;'KDR^$GZU%VJT=19$'*"6RO7'I\ MHA)%.?V]+RU%*;VE(VU P7(BCIZC&Z5<>K5UO4^CU/']9^8.\,]%NQL MD"O%*8V]!ZJLH2?>F#X0B[Z!5.;590_:@G@Q!BL(%-<("R5Y4-M0+M_H87+FQ;[*E^ M:>NIWA1*V):B1'+^FDJ-$P3&-]UWGID; D,F*Y] ZOF&YTO--,C9\"WP/1]D M.*Q=9OA7#.9_TP=F7-_"HK071@"/LCR^@^VS*W^Y1*A*Y*TC\EZ,/%#;9R@0 MCEQ3<=1.RG?.#"Q_ZH;R -:ZNU/&[::1MJ/N>,])Q:?3%[N?&\^9X:=4N#7$P=0Q.AQ!-SHN!-I9*7+_IC\2A:_A8[>Z:".OO/EXWK)S7]:[&_>;.KJQSX7674#?(L[GF M(IO+=Y1GS?[A-12\DM( =)<99J(H?2O-]70GCI=S4:S179$D5W#K/E#?SC6S M]6G'P6B.NMJO?=*,PF;A'%A\?#D#UQL$*/;>KY42W=37N M[#Z?M?+S.;:G8[?(2/T0:O-\:\G0)$.KM7MV#4-K7XW53E7.-,G0ZHI0!>>Y MP5#?+:M.$>42_3CR=:==]5SK3C$8PHM,/R8#Z$O*2T^LF'2@-@=G7R*Y^N6G M4$)0S3BJ4RX+/+FJCX--$"N0L_4^SRVJ764-51D GWP%;=7L[GR.MBY3:%;- M.M^KUOM'\[&I?$3MR57^:3G/FD5]8B)H5+JF/BJB:Q=5T!0-,>VZTRS0W)XU MC_%>6._:V<8\U7;//0F+I8 MGA?@Q&]? 7-/QX=CQLL<6!A\I2ES,,6INUSI(%AJ;[UP9]/Y7YE=?12OQ9#7 MK7\/R\%)[T7!KV[W:CP:-8?]?*;RWW&UNRUQ+?B3L3EJTV8\,!?%L/92O%R> M.9:'^=\;BA$PY9'-?88+ T6HVR[FMSLG])UP[5;1%NM=U+$#\:].="U-[WVD M]_;HN&FNY>NV=HAF2$JHT][*44)OCY0PJ!L?2HT; M$C+W#JG&]:M7XT:DQ@WZ>9K<3HTK!_ZR:ERO=356F^I2->Z_ YNA*ZNWQF*^ ML'KC]812+:/OM8DVNCLS>EFJ7DO4R0UQJ!!UU'JACO2DE!?!PP.)X!YY4EH' M]:0,*Q?!/>Y)&;3SDTFV$\'EP%]:!.,0E16>E% $9V=C'*R1P GQT1+EM47H MWT?$J8LQ=1+5LR>$&VMF8J[#C4&=<$/:L:6%Z*"UM1#-(P.8JL-#&JKIQ5MP8U GW)"F9GDA>JC, MM_[P\$*T^LRW/K=$>X.*,M]*@K^L$!U0R+2_3HAVVB>8&:VNRXR6)E(&O4IS M=["P -L'-3&1I/E<+6Z42O;*XX9:)]R0YG-YR7^H9*G!$=RE%*>4\I0[1GC1JETJ#QNR%#MB4O1 M0^4[#8Y@/U>?[S3@]O.HH)7P=E)TO_E.PQ9*T>4IQZ$4[:C2%BU'*:4YY1!L MT?[@N!VHI2VZ+]S8+>%IJ-8)-Z0M6EJ*#BM,>!J"N3DZI)@<5I_P-!2QVFX^ MLK*5F"P)W])BDHS-P7(WLVCF ^;F4)J;Y8BA/#,$AKS"]:!RM/J71 4>X MKA:S%8C690O."]?U0G6$@SN+(HM;2=3])D"-UEBFOVNN/I5AT"VPOK3M,0*[ M]+B3K:55NB_,V"V5:#2H#V;L:I-NJU$M[3Y\5G/:"I%GC[UH1F#%CAJM;E73 M)S<[I1,8_G?!Z+;'_C6CT:F@VX&4_N.W O^&8Z$5 *3KO,'"O:UTU+TF&< Z M6UCJUBNHR[LNO=31GI?:OAH/FP6#HX0^;=K*Q,3[E 737(]&-USO6.J^DQ)U M.HQIM";L0YC\(4+D//N!=V))\^[=LW92I?8SETOBASI:$_K9!#_(U[!SGD1% M^''H<13'..'/FNDJKYH%K%$S_@P\'[FN0H5.S,"PR909+_"7D9P:=C!?_E%! M\VZGZ:T>K!_^6N['NIMJ-HYQQA/X%Q[ M\D7@G6Q$0IKZEZ-NWDS])?#^&/E M&/ ]84XNZW /F-,#MIK7W@Z..8=6ZH]Q]G_ J3FPG/\(IDENH/N['0K&$P8:[+C,^FC>"\ VAZ7UDQOF-#B.X.^"X5S#HBR-J!PILC"':% MR,J'M)[!Y2L46O&^.3XFK6&%Z[;>G6#[3>>A'14 MF)6>A%0A@.K-./8D5;XZMAZRCE*QIG:KW<)@4Z=55?.MZH[R2+J\)&9)S-43 M&$;]$UN=,NYC-EV41MRDNU%XH/ MB\7@KZ;K@%CDCWLS_2D]!K4O#_]RF3-I*D_358]SF>(QVX2%!+;'@)R$GZ^9 M#B!?/#JI=40GP!U'I\@6+$FCC&>%_17 Z?H.H8+-?&7N.F#/&!Y^-^&^),0[ MEXD/#<2CMZECT=?P]UQS_8;"[%?3=6QTT,-K%O &X(*.;M('EWESQ_9,Y' MH1?Z U[T)]-]#Y]!Z SX1K%1A?:"N*9Y-W"OS=XTNM-F[LOBO?+B,F8KSX%I MX3:]]^('!8PP4S>9K<,UNL5@C[X+0$3/BX9'^%Z9PRL"$BESE[W"4O%/7"G* M%->QX%&Z+X&\,1MP6EK+XP"C^@<,E\1!+;F!RX<#$#."5Q=/-'" M?P*/O8_ Z_ EF;JB&:]X/#.Q;H7-YLX;D#9\SA"G$&%?@QE@EUZ.6!-"!L.E MYF21HM44J8[_\>RBM-F6,91YUP%5%!55E%N/JNLLQP-J @1&]LA5@6%#^5]_ M&ZIJZSWWQ (%*''PRFO0C^WW"M CG"1B/\_Q48B1>V_:G$AO!ESGA;XAQL\Y M/OL)[ AX+GXV@7(HPH+X#;1C.GB;3L$QHJE)'-N&YP>6CW@U<9U9\J)G()AU>4[E/?5:\J?-FAZ1*JD/>E:E,M5=@(HX/CP4*Y1%U'D<']F$!L=/= MYFP.RA/>CJ*I8/\[")-#(@@]\<8$BC;U#5#FSID!P1$^/&ASYIXM8<#!BDI( M3A&==H,2S1H*J31PX/!_%$)7JBT;KRDQ_ M@_U]F]R!!HKH%H\]%T@:DY M;I9CX:-QSR90 3T[2=YYZMU,7@HRZZ)^G-=*WTS#GX;V<^(NP45:\2W:,UB3 M@;_\EL0",=>4N4=B);EF)(E_IVY:]:8M/+1SDSP5 MV*=X^ #U_NS>E^YP,MG;#CG3!DQU7,*2&R)+;D#\0ZO-6I2IBW3[-[.OJEK/ M&'7[>K?;-;I,:XVZ7<8&O6%GTA].]/\97(V?0LW@#DD>]!WE'[]JX[W80AMB M4;M5B: ]$"4,"O> O >9T_W7NZ9R^_6C\OC'A\?[C_>WW^\_/9[^]KAO <0U M( UYNDBDPP>0\*A?QXHT)<&3'JV\N^,,EAF_G#X$WOUA:P$(NPTV(Y:^0F;P M?S,B**R!4?O7ZM5)J9MEU6S2&A2A-H MOB%V]-,;[Q]_X]7IV275L\Y1U;,N M-EE9IYY%#A1Z^37 YP?L-.>:1+/ ])&;N.S5L!UX$>O#O&O5$ ["B=EP:C.M*Y_<+1IK/M1:,RP'VCY27*+>YWNK*)8RY MI-8,>*[?&('[YK@&O#6Q4*P[[W>O#6V1]4QM>6BB94"GJ=S1;KB\"&T>=EK4 M,-B$&I;"27F#*Y1GIFBOFFF1;@:VH&EQU.X3O^@+#V@%H#HNQ@\WP?B#H?5H M"[1><5R(U.T19_!)Q%8FC'F-C/>.3M2ATDH>W0%1$5GRB>-=MA#T8+]B)RN, M:,"3[*3U"^!BK@W*F+@'#0;R#]A&(_+9G!*-J:U-:"QF/9&;)"6#E!GSX72] MIO(9 .P)> /T-@,WAOK@X .$-P+Q!8,:"&3'G3OD&IT'\)?'-O:.GIE"\Z:1 MPQKXU-PRTQ%,W7EE8"'$H20!7@TC19REO< EKHV@7W,0IPO=DGKR;<1B(@I2 MOH?1II,%PDXH-M6,!.>-&68X<45L+9VL4Q4(JZ& M\:# CM4^A!KM4U &)@T8ALDCG#Q*/ E 2.EB26%H:G.26ND]I MMF56XE]<+J+(>I<>#A"5+M?3V^.JG+X_3CI.PD&P'F3SQ9FIO*181*6GTM62@&^V,<=OJ3HW5OYONNIP#]. M,1OS.P.[4)^"G:X\\%#^>>:5)!P0'FWY3"(F#U#ZQML0V?.; 63FY@O M$O+,5[2D$[=2AB!7BL%R_QBXH8GH@PAFR@S6-?44!@ P5A@.["?3 V2AV:5Y M*[O!TM5>UF9(]Y').:2(6.)3-VYMXSOS35"Z^>H? +Z.\2@>73+/7<59H(-F MOF9%F84>8WHPSS]DOF]1>A=6PR>/?97 '_OAAH]A%J^BC:+&2%6@.'XF3V[X6"9[C;4U:F> MN@;'I"X,=33S_9WV1UR#PQ/7 -&D@(%$Q'6>\@ES[L0IQ0BZ(;M(2Q0Z?D1^ MY8T!NE/!1T*0+15>&WFWYB K?\+9^\\I#:D$/X]#YA7.I&2JWR&3Y\LI[/J4&8'%R7GN MLBF8=N8KNT=?'_O-\3SR&Q2I[:.L?GXN&O.3]I/(,^KNQKN/IN"C< I[Q!$ M6QJZ?,\\23YR)%(]GXZ9RW./W81_O#=,;VYIBQO3IO723>_33^_E*XT(R/SG MV*_6;''?FN@A(-XL?F["3[_FOQ^H3774+OP)N/C?EY?^ANL&A%Q1(+SU5UK([EH&AW6[VVZ-2CSK(HCIK'K6F9T0]&^7DG!.$ML6%M%OCU,KF M*:--(,3]4X>!4;:NKQA$3ZL,CA3D3@$O-MMSQ6A1Y54K42S1)"%5ZYVOYBY3 MZEUO_$15\&PGW$PFP'RW@Y="%X95#F+!GN@ MU&/E-Q:7@NG'2UO1^138+H/E_8%N;#MN9)-BV<%#O16^J@T"L6-.KS?V7,$&BM#VG:]Y4F5C. M&Q_6S(PC0IOO1,1'Y<[C6I'\9$F\RP1?W:=V:VCFV(2"\^C74;879 3.P_I MKH]+2>+-*CE1(=[TKL:#_*#'TQR?>R9NE@U4H]WF>IPV/52CA@,]//#Y^ M[YK/ :61/CD/&M),NY!6^E?C_LZT4O8$3T!1OV1LK$:+WP8;!Z#*#W>>KG(( M=)0^V (?K('3(;!X0CB60)S8E^J(/0FNL$,:C027]!O;TEE\6=Z]]N&]>\.K M\8#,I5%EF4N'<1\?GE>>RE42T4^V:7V MY/ESZLYQ_ '=5@7"O]3IG4!HX(+1L+N]PK 6^S;7&KKMJO.=]X>;,O.S5IF; M>\[\/+XV4=>K+L5=FW#-\,;_>JJK";IK3L0ELT-MQO9CU2^AK*,JZ)R/8E&% M5VL;[5:]&@^6S9LXTJG6M-I*4K2DZ.T;'AZ.HC$5=9AOCGER)$WJTJ^TX67C MXDO.;TCU@VM1G$M.;"AL3]?)3"J5\V[E\(722"2'+]1]>W+XPL&FW48M_TMU M3LT&%[\%_K?)K:X'LX ZAR[3'98U5.UVS[6AZAUEAO&&U6XV)+NNT2JJ6@W% M9CZ-D,+6K.'!GD;GU'9S-%K;,O3P/I9E*\E\?^Z=4T%XR\ZI6^&4[)Q:=[PX MT>Z*LG.J[)QZ8*#*SJFRX[\EZI?'30' M=2\SN+ND!KXU:^%4V?V5UL:,:HZQ?YQ;.]D5G*S, 9Y;S+5HB^<3.%W?3E8W ME]1>?&7^M\F3]K,H6EH8+.U=C:LJ]:U!98^DB?.EB77]8JNC"1P-61.:D+FF MN^6:9A(82N95S2G>7Z46>QZ6UZFVVJVK;5\GW\ IV5EGTGR@HKJP$ZS^ M*MFV?^,>6=7I8]B02,WW%CUX!W^)2Y7B4HD.5]7ATO!JW&L/CH]+%^66^^=Y MM*.]W)8BN\J(+?J*EJ;L$4J)72B[/FXLB4U5=ZDMBTT];'K0VT7GJ$DK\S/Q M6>S2DB&;+'..5%)-[]J02E:47!422QN))>\R+:U4U:)WK43'@ZKV>T!'+.D= MU!T=I4/2=TZ3;4]6')VHEI3/.(:K[]I#_=9B[D256YGJ)_^AQ>[8DZL[@<@ M0C2+8F-4D#D'Z>$J\/Q74V>A@K.7TO0^%J6N771!$P?4(BF<\00S>AJ7$%PO1;Q0HF,QQTJL!$*;JXI]%M5FPF' M""/*.I=ZU*G4I,ZEWI9@% H6;?RPV87OPA,M[D/5C#\#ST?C\$0L0ND.VHS+ MK\D+7<;E/SLNO-/F&KJ^>$)4X>^[M8VG&'%N([S94BWI8R+3SLW@I2^RCLC7 M7I-&>GSD4P'Y1C5!ODL8U;)9SZ43$4$K%)(-T]RV:'&_D6E2NW,_X&B''(#J MS5!+.1"J&-BR+:OL *OL]"K+\*S@9(_D I:T+6E[#[1=Q>B6;6F[>S4>="O( M;#HN;1<,;RG3:#Z5V\0[S2=?CJJF.5FD^M%?[ZSF>?^TRWW0IQ!UEM+_376:8_B^*/H7CAGW XW $!=?QNPT%'8]J MZ_WW^%9\W ,^+O'=!_&X!TR0IUO:[YN9Q*S,H*!*AAP4C7PH-^M?ODI=$*O9OJ%.MAD5_5K M7K]R8D5#R0T,.(43K;BW_?E,*@"S)5&B2!H/;R7\CG>Z^D5Q;/IV2>MK^BUN M?[T+[.08B=6'H^0.AKKBT0DD.N/)(ZCR"/Y(TT:LO=+'N(R7/J9*>>4Y5'D. M15%T@GDBDL[Y5)EHNCR C0\@8:EQU*<4]I FTA:;Y_^ M"DQ_4>CK[U^-\QW;3C;=1N+[^>)[KL!_*WP?8-SZC!+,),:?$L:7JP]I;UH? MLB'N#Z_&W4:'_&:)\K1=D-[4?(\B762ZRO,]97C/0#[)Y;!ZR_U#3F MC&/\F5I.)1JPBYY3RQTW%U]0?L 9?(-V!3/X9%>".O+58XQ+&:AR7,HYXE*) M@OWJ<$FVJSP-3*JV#K,Z_.E645 IL:B._.CPS7,'/9!L[3PZG7W3TV/@0NZT M,,Z'=L6&HYMDR?%:$^*@'= &M6M_* O<]VUK'*#SV6 @QVZ="#;MQ]C8#U8- M94_@)?AR^;+DTC-[-BFT#UL(T>I8K\DU4>:$63*!*C?T8Z=7:OQI(X)7%*XJPBP+;ID-<-:;,'HK-707;5L:BSH,5AMNT< M?D8@FG9 _M4U+,Z[4RWO\2_N%Q$,;.OJEK/&'7[>K?;-;I,:XVZ7<8&O6%G MTA].]/_!+'UQTS0:(#+77MCUL\NT']?:!'9XHUEOVL+#\TX>'9R;6-$ VT,N M ]BZ3GS+X3>9[ U^',6!DAV7D/(&2(JYO"'E/[3:K$69NLAW_K;!05Z-J5$B M.E[OD&5A+\%__*HMIYC-.B0>%--SS18(T[\\<%_<_=>[IG+[]:/R^,>'Q_N/ M][??[S\]GO[VX+2((5.[1_A@,-N#OQY]^&(6MH3\)%*ME'=WG)4RXQ?E]/?^ M[@];"PP3=IX=*KUZ2_WTEOH':-Y9O(&X# MS3NVYD]X7>_CHS9Q_?*@@'JD4RL@3WG6/ ;-FC]]/"H!!YV2,%/8<(DM6O% M'L+\FV*\5T+Q< ?L2B,329,I[ZQ\' ?#A=O\5!7);47I_+2!V=. M^9X-?#RE4M@ZJ 0:,B;M37,-O@6QQGG@ZE/ZC207+5!MJ6V%S>:6LV!,/#2\ MCEJ!K6E6O&5/X2PN?L"3N+4- 9UEO82'P]TQLPYH>(OU?8ZMFY89-:;&T\BA M58"G!0KMW%.X=H:$PJ*/-%E=)RW04'JC-06=M']E: MYAILW)6VW>RWJ^MT7*[I[JI%J?MJE7M,U\..K55W1YC1&;;=K:BA7OUV?4"\ MV--LJDT=3O4^AUQ7YR,TS-S<>5=[6'8NLP-F77Z4B1FT!STZHY=";?& MJ>!7F:,XT[CN"<5G*RSU &2-YTK=AK,;GIP[9P8F1C)D2WZCPHCMZ$@K$AZL MHC6-6E?COIJOE3N?G@N28L^58M>4QU= L:/VD5:TBF+5JW&WGQ_T71.*O02U M^".SG9EIGZUBG+#I"N:>'EMM+KFZ"U.J_YT-"R:C-KZC\-&C+!UG/#DD/L_^ M24M%#3_#DOIAB FW'!&^4ASOVX1BF]ZW.#:\7/IUKL:C4;X0^61508D^)925 MW=&G"^@SS"LJ)ZV7G(H8^)C/VLAF5&PX4^UT&/_I]J2HEO&#C<$G?6N6L"SH M*>G^$V&*"S,>M 5>?.NZ.!&.T@8+R;EW5L-V)$:5D 5[PJ@:C6^25D*AE9!) M[#HK<9$N?UD_6? \*7\[(T+XIW+*8+IYEAW,K@V'ZA/P!84\ /O_-5JMG;NU ME3W-$S!!+APSM[-/EF-F ?(-T<#-M[JO(>I=@ELU&0^.DR^DAU5Z6&N%IN3P M.!6DE-'/D&[*,2%ZTZSH,(<-\"[!+UK9UN6 MU%SIV=)KG>TE=OX^ZS71%$3T$,\?F1ZX@#S,^_23VFT8.#WBC@)OA-[YCA2W M5(96X,ENMSI7XSWXL5<=X&D%4"X/%=>$3_:'BMT*HOK[1\6"[H.)9B2I3H*\ M+4NJ4\OU?EJU])KJ)DW?ED@=M3G<4.I4NNAL@6WQDI, ;?>;W2Y"[\L#UMKR M7D,30#EJ.)-H'H-I:]G>,JDF0]1]IK@=D?(V92ZC)VJ>%\S@U[GK@-YF>%3@ MRW@;I5#)F&GN#WC#'![$&LHST[7 H[M--\RA>W,"RX"?X*4)?:6I/!6] E:N MI=8:=E6BM\+%> 4ND_UDKFYB9R/^:MQ1N*C QIX\+S: .:/ZZ([GKWIS(4RP M]1/\ B\[LFK&RQMTI8SW:%Q60?.#3M-=JX*:+3^;=W4LFW=?F,OFO6[YOO, M]6YM@_?K>V&V#JPYWWJJW>KE6[S!E_D6;[\!NW@1.K--G0+CYV[5[$V\I>CE M:MD><)A19OJ4)9;=\[)V<.U6_YS;P9D>,(M7QWH%VC1MQ=+>O( :K.F69L[@ MO_ KT+I! T1-HP'D\C3B%^9C:;(/?"5S/[U70=F^<' B,E](4W:[ZB MN@S-KACGM=48-N:KL-1PC,5R]2>3"QD;N[3/,<&YZU4!#(,VRN2>N+W@VOQ8"#=*P?9X7Z-,()O#B!C9#@S?&K8@:V/"NV\"GOL%OMN,GEP"RWC,3 M^\+EN'!(?,E3S%DN#W< TV1AVJ[<%[6"D M]@VE_;KLU61O"&J0&?$>?,6"Y?D*;-F%;V"-)+(,I"2/1!H=).B=F$GHLHF% MPA.78L[F&L]%M]F+X_,^<]@WD/F^Q5_<4-S XDBL&:\@$.ETD"TBUMB@RW ) M"4?.7-@(3S<+&1N<#FYU#BJ09MJ$_P[ ;*ZA2@0ZA0MG[('$?@#\"T"*X\\D MCAE<$C\&+&">V$I?O+B,XQXU+2'PP6UO)B#=%_9FP=J5!U!@-==0/N$5<\)Y MU)[Q_-\AG-76^^67T@7M][\T$.8B#Q/^/T<*#:E@S-%#5QQ,9.D]H,E9X088G9<6RE,X*WX*#%"!'AE/3 \\+- M*=BH!8D':(1I>/B3P HAX% #PP32SQULF 9X[+!/\ K-"3(GF-:EC7UI?TQ!L3!)2I;R"$8TQH M* ^Q9"7ZN4\)WPW[6=9/"2D%D54]S^^<^8*,;>4W%!C[\<=N?9+-/2]GY&5SP"W)6> CPZ?C-S#&B(;5!-R.1X3H-6G6]6"(F8$ M.G!*8&ZQO@><[UK\$DD9H27QQS= QIFP[U?0S)K*HS-C!?"F-: P(_Z*&Z( 'JT]N(IP(!X7!3]E.HW?!&T [U*<,#@(L-\P61.H0(:F - MH>;HI$O0J^$)L#C3"4BX ]L %5+S/$<7RA3')6<."" <'/1>+WWN0NT)7QG! M!)X>XIF+N."*+O+4[3<\%$\#T81NBUG"!T.O!8W-X>J&9@&RV.2;0MQC%@$Z MY6= W1!)!9;,>UXTE;QH6>IEN+R9'>KRF1UR_(8<8H M2MP?.LV\_ 0!'ICA;J"<'RZGBX'B2PX)<@L:T56AYR^RO*E#:^B"0X>/8;@( M&_(Y"BT;DQI S&?-UQ/"F65G'WWMMYYJ:?+(%6BXX3P7#:!:0#E>B'0N=GJC]BF#]Q+0X4=\&+X \2GN(;M]V M/_1N_6$C$^5RPE,^FMRX ED2N'Y#^>J@1\BUXQ]05P! @6)NFUHC=O$3_+?7@.V$ M7DS'CI'C/;WPG9HZGN\!:+EJ1Q *?T>,Q813)P7W8>5P!S G ++N%-2F$B;L MQ.D3$;233,B.N!/Z+B(8XI+>:;_0(%*4L,J_-;CO_R;TLRG>&X1X&A!3& M0;1XR>0@A26]>XX?8BQ'\&R2^G,U/JK4LQT1108(OU!44I!GC%(< MQH#@W"4,".#,?1XR0]AGX(R^/9"B<,DU!I5X9$*W'*$!?V;/+D5)D=&H+5"Q ME(>,.)@Y-O/Q$AX]PK%CR GP>*-OXH AH@:;-!64.O\=V#1KK-/@6($1$O*) M:C@2#/$X#OWAXEQ0IX M,.,/HY] #(E4$\RQX?H3,'G@\B\"WXF5_R2O"##V_RK34CP#]'PB=P;N'[G0 M>W0"H-)_:5; RO9D@O]=C3N# L563,A!FRR@Y 7-\LW(_83),9B4"F2',4(N M[Y%X<0!HY OBI-N(SP/L!W17H9#< Y0*,/,C?^&3\^!2OA R(=<-YCS1_8/P MK)6'FGHU;N=K,$*@<>L700"\C6=,18DV<[1\M3A[#,3VLV.'N5Q3;*)'\EO< M'7OJDGHVIKYX#'AW#-JE&$PY/&+7L2_Q>1'=>KJZP6;BJDU9=VV5RZ@/ &'- MPIP7RD7U\ RXP_).L @A@S2TO] F$][9$,#7%'G$)'5";\R^,=% >HG"J8+' M4*9F3#>QUR9F)T0E&D]\ KB;!F72[*CK 2X;+R:*!.^-!]P@*:"1K%NCAQB+!':K;,*]=^1@^F3;Z M($XRL^'R^\6FQTMWVU0 S\RG9%#/$;":.NOC@5+X_I_@C':Z-,FESZPAI* M4%< (GJH ,8M1\@0&-\Y5N\,DQYPQN7BA+);'-MF?#<1GUQ"7-SN,< "I.P\ MC*X!<2&X9B2'/-3E_A3I=K%4BDA?;25)/T7PRZ@<>6:5)![>$X4:7V$2EC2,'%$ M?9O04AKH#<88#_*81^92^OR3]A.=06!FHRWRA&GMB&=)8SM452!O$ M[0O7EEC61TS.I_H@'@ZV %4XM'07-/OK$&9Y@$0[(O8O*BYX1@H67( 4$+Z_ M[/4=4K';UNJ@*"NQ5(\1++]0"TLBV 8'R".B?/$TT MMT_,KV2>S[T&LU#QYZ[DT'A.6R,V3[HP I?@A^72&4J)=X$FMV4E=R&\$S98 MO%20Q8-W%(+&EX?E2/#%*$DM0EU2VTO@-6687ZN\FJX?T$=.S+!(_ _'(+SQ MS\!X(9>,\\92V2+9\P:K=;KPL( Y>I@X )&$@JYN!S$7DU 0G75,G@NQ]0WP M&DLA,+'6"! "5$&6?295V 0SAK$L\KUO61/4V+Z:!IE:0V0P1\D^OC#F^6:P M<".N8Z-:ND2=]'+K?K)B51'@0[.?Y1)O3TBV5A8)>)@"D.<> (R.(*[_.*9W MG<>I'MGD6/) 5.:L2Z2H? M0=][HU0M6&;R-9K-R\[#%T9ZXA_-QR:%"%P>J(7'/[F:D>2+D4___NDNVL,\ M0Y>%F69 MD0DH\NK CF/.M:[-*:\WK''@F4$S>"3C>6R@8F 3 '*Y0YY#O.\,M%?XHY? MXAKFN.W=TL(-:W$O7FQP7WU9C[S:NAI/X+CSR@5L*H%7&)[G.^#9/E$@D["9 M8D1/=PJ>@^D'PB)*%3@W4IB->JQ+2&*X0&:E@3;8/(8A /9O>I?V9I>&4/MJ M[+\YA0#"?9_:@:O+#CPZWF]V&&3N\(!]?, NL[E.K?&X..PDD47"Z2U(O2U-%YE7,SP@;#-'C1)^EEO C8BBISA)"WXKI.8BZH1F A<(YQQ<_% MH ZF*(FJ4WB3.C1&#:-2(PJ"D*X:U9];YH1*R;_%68!< MN>J08R#DB8E4%EC]#)4PU)Z(TQ*[,!@ $!1QOC:8F/OWZ"Q9VL4GMA/+:D6 MMD>A-RD$ME@':%'P!B-,9J"\2@^^BM?'75V)Y7K\%JHV1@772Z\5WEY:OQX> M5[_N@'X-&E>AO9 X/][ A+^[P:UD@;)?'0#VH-%N]QN#=NL]_-D%6+3TZXEUQ**8G[0PE#UD;=VJ4& M 7 6;XR44%"P76I=$G4,$!8RGMLBMNWO/WWZI Q;:K/=!ON._Z'II#__"O@D MOOBIT/@N[/+;C#!FM6J>SO.]CU3MV(?)L195 MAZGP(M#C7+.$]+>IHS@$2Z6$H7%1#3\_9D< MK-A=+->I1C1.Y$:%P+9TOG+"EYWL(L+S@J#MZH:A+;+U1=N^-2-+%A3&\$D;WTW['I!G_ M$7_Z-S,]"P-AU#-10T*"%2N_,>]/[4?>Z2F$XYI:O5",X1W:?.Z8% 8#Z;BP M\#6?T'GA4JCB/BSH?1 !,#I*(.#?@/CC.HAFYG-"LB?TZ$1!G8@M1-%&8,LH MY8B+)XK_/MFN^5< VW5KD1 M3Z#(1?ITVSUD-;P2@V=#]1NA-S9.C=%Y:C3W'/-T7V4J[ MA=5(>*W:PN(F@2:?PDQ*=/P^+SA#TK#77-Q3+]M/;J919N\$] &6Z(ZG:,]. MX*?:B:&PXZP4XUG,2W0VS%:L1%U0G+AJI4!TY: 0;3GC**)Z;@\=XH(UAR>" M''0"9Q6X5+/":_,T[B#B37,X*O WANT/160VH;2E7'GI0BS>6RB[#!(E><0$%5)B$U5 ^T*&&#@QL3E=VPH8\1\I6T$(Z4 M%L[8,:2@1?8F4!Q%(!I[!,-J< M0U"!VPNE/0C-$6J2S!L1*8\Z*!,*:-\89;,C3)IH3H>87 MY'7,U46RI&J62D;CQOS$UA3FTO 0R)%U.%;"Y M0E4E?L\SC@8,<3*5DD$_\^O)YN5]TKRBUT3%0'!FHL(Y*C<%9$J@390UE\0: M#E?QJ ,>/,6U$\>H"36*,FEX(E^X%%XA5<"=0^Y/R5(BG6ES 2 C52LB55T9 MJ9*1JA,+9,A(E8Q451NIZA9'JGH7&JFB.2&IQM1@XM\&(&9M/]'LY%$X(XX; MOWHT4=..7#MHB/ <5G@-J<7X7TJ0B90XW7PUK43:#O68H4M()Q/U7;!#KLJ+ MV%2R+7^@/]XKL:LQL6Z/,@0H*@$.CP!+K?H MY022X+5Q^);_#S13^)N;=^M/C[II@]J#JF=L;0&:?5P 1H%B+^:;12Y+EZ4, M6&XUT 2FA >$O&0S] !KANC3#7P];#,8A;]X2YRP,H87_[DB.S4[B0*W'O#! M)]FE<1L K1_-BHT$K,VCG-E@;G D$K'6>'P!K$GDAV.#93 H7--X"0GF-&&(R),5P],="EC: A-A0RNTTUYJ"7\=V@&3,J-F3K#NL$4D M'W4 OSKN>GH)[(EF\D[7S#LT@ Z]R!B6TCQAIH?&%?HS [+LPY2WVX3G MF9M>C>3::#^!A$J7^O+'2=)@W7@ ,H MFL]0=-I\E@/=ROML4_0+SX!N"^=1W$\4/@V(:OL#'<>Z\*$6E,(HADPD!C70 M>@E1,[S0CX=$)*ICXY9)895=@[IX$4+;?K)G$:_CX@B8WS^Y]Q$^SXSFAUF+ M$&!@YE&3@7A<15.Y2Y6_9N@.OA>,,L$4S"#_*\4#Z*U._O[#6,A7[ I/QWL%3^"$]I MJYU[^X?_2S+5XBLZ2FB#='W4E?-=8NN_1!57(B 6DQ*ELL9$PTFA(>SV:/W" MRD\UIPH]\10D#Z-!*]K>T)/S*1/+&NLM29F T^)MX#XCX#;)DXBR([I+DJD+ MXWI> A>$KRJ&>9%_*NF#,Q-%^AS@8>DX^L16]LXIAE)G6>.O6$Z.%YW:!>A-2$ MZ!.V1A&59L7-Y.[MV&/+/9) DC-*:]8H[V2/;.6V;GDL@D\&([JTN29IDW&0*J," MYNL\H^I%-)M(=:!TAE#KU70:=4/L8P:J&7 OQG7#F%C"O +.),#U,?P@D6K75;L,J0"\.AQA-HH. MQXY:^^7E>SS!: M&MV*IQC^+,X!L\Q0835QOB,&S4AESJCXO+SS_S:5+X#*HHDI#L5$ZL+F.EQ$ MKSG8I7T*-SK6WTF:EC_10;$:RM#S,M*'\CAE5S%)^6]A4 M[FTHCX$W=5Z!AK\$G@= :&1"Y%P6I0+E)E>YL#4FTFQT6M@B8)Z8'85#NNP7 M[$F-]B-1-MG6P'Q"G9ETH)C\(ZU'.$ZXB2_L9FJU 0LMUP"CDVY'-=I3-\-1 MXL"&5^/>DN-ZCAO5"-6GJ?P.^A[VI8_/1!R%T-BBT8[4[]1M\B?QJ^/4NP!I MD_N0POZ0)0&UI*?1_MH^@BDWAJTL[17"-QJ#*BP])"4:/5YQL ,[7[IDGQ)< MFM@O@@R/>+I=TMYH91-RU((L:90,O' TK(;$U,XP:9MW^"0?"3-X^#Z=PH*Q M[[#A.*58P!W%1\VP[2(1"JUSXFJ!X'0B9HUOA(/GMT7DG3SS9)*G$?HDR64C M0"="^32=E@J:&V&_"187>V*"#XLRGZB55$&N5ICC\PPPM]--L]5PM# ZW.)9 ML+3WR.4%IAL"3'AOTD"S^!@5C>:ABGFLV3&IJ=FH4?Z*R\)\0MNA$?4NY=N$ M!R62"WBWU' IB$[$IK#3+_:^H+51KQ=Q!=U&' V>'R>F\3'.T?J>XN_0<2]: MJ(F-@D6(.M("P!9ZQ*(YSD(PB3;D.(H"3!IXX%='C#>.FA )'U/ZOJ)!RE$) M@-FQ$LG;T!T&/!@SCH$*:JVP4[QP0XL0K.!K.X\Z)2B>J3N$KS1>/+ZL87Q5U6]TEC$I/49DH6\7=Z1ZPBCM$WD[K M:NP7#=](5LYRL)6-'?8.%3OL+&M75="ES3M.F[;&+GA1$I#5X(6Z="S+EDW MCH/>G77H'5:*%[:(P'!:IEXTW4"/DI!$OP'Z ED 76MJ80U:&)^@YGKP(_?\ MQ)TNHE8!R?R(6^-5HW:N_Z*[[OA=[[XTU7[W%_0XD /Z4QP>S%_7^R7]:-&M MCSAAMAT#&=!1B6LA@3C\KV^&T$(+9#OHY&:K*-%KK1DQ[BH]33YL>DA M"IJCS<*C22;M)-L^8C=I#@]TAE%9&79#X, U,X>9;1BY5(/FS?2$!K(79@@\D\ -_G*RLJLDHT*BV56 M/O@"+'RLYKS!XH/X9M.3@0SP\&F4>;,[P =(-% M *+(209[DDD;$>%&V2>)%Q Y?W USZ2J___U-[77>H\ZD::0%(4O.IWWKFYB M$W+ETU^!.,.U$#+Q@X(@,R:K$&[X^+#A\Q'1%1Q'!>%=,?ETF,9>U_-RKQ.PO2<0">DSS)PY=D'.I M-IH1YG1#S!&!YP/W#M MI+>V(7K-9\G'9:_.#QZ_ #1'3@I0\*-<;=YIU(M24C?-Z^5YNW%<)IYI$^Z- MTG&I[))W=\<85_(/B19[A3@,X3 MT;HX[YB?<$ J$/Z(=?74E"#4BQ14 6=B0F ZJ=]R/$(GEQJ6P,_X19@=@AA! MO>"C5O!>.#C@A*>D5.9+^:Z"-3DS1:TV +$N_I2,9: VE.Q2&WS&>2B\OZNY M;GVA@A%J]AC/L@S'Q9&J+]SVSBIO$0G1L%60*X'OZ5-*E__G[/D+(6KVR_24 M*N(<_&X^,A,1#1?/C;XM!/(A^^Q% GFP1"!'6G#HOXH;"1I\)F)>Q1$][;B> M$P**@X@8C.PM50<4VJPBG,_P]3@*/@,3?-ER.30%#"P"CF&"DHHFT+UY^C-BV: M02UK$JVK$YD)@S"N^#05(ZPC$$?7FY0[O IT'DWY#>&6;5N8-%^BO&AJ@^3, M*1N$XW4"SEHH5$6+[^@6VA5W=\Y0\8^B^8F>B!%E"$$L52I0=J)*L^18]-10]-3,'Y&5WDUV,K>37=G#?'/>FB?L;(AOB$X\ M6VRS4MHW1&>LA+@G81]W4 G3+KPIV!]D71#Y[%,RT\C[E&PVO8AG1TD!//$$ M=3],[Q&4;-*+@=W0(J4<'_^6:=I_2VIRZ- +714/CF,ETLTBWR#3CUSUG%DN M36 1=U!D-"X"ZK4#G7#+#2,$R"GC.>8V,D/7):*!J5O$MNP@<1 M<%OZFM=L)N$4\ATS?"&A,S4ZC6LYHY7, >#[:A*Y8?7R4^+=X3B& Z24]DV=Q]%S#.AMF@#P10ZAM_]\7!'):D?T5.IO@_51BYZ$V>7'-N3@'6E$-DD MU3\)D4W0M=M:$@C- >EBNSA0RDML:V;\X3O'^A#_2D7FXK@#2KRBT?*2N7IS?F_R4<$IG41'/ O1CI M<:Z/:=>-E)_G+ M11)GO'>]1^K2*KZ_B^;,'R,BNXP#T(2,>GX)6YQ9'">SVO5]=!/7PXZ&W/DBS_DM$W:B7+'A].?;W M4V12O@H+OL%5/X!>)01E61T4:&[>!(O3CJP*Q(Z M1X[-71E)Y#')\Y&V0EIQY7:U<&K$C[9DR7/\5F_H).KT.&M\-+0[3T*,()Y3 M:H3"^S T1_<\;DZNF2$6D9,-3,6I6"G.P1T2@.**; M0_PP,D&&"&GU(-H%./8]_#KU/*I+GYH/HAA6#HX;9V;24B@U, RBSH SGDEP M[\VG2]\+@OH*^^69GFOKU$]V=9[K]),T\13 17(1ZG(1+JG0AJ?%PA?B<*8 M #:B *U]WC($#4LP 5*YN.A!-<&NC48\OAYXXQ#+!FHRQ506,9'F1S"NG(-) M?)BM@ K0-8+11^YU'!&%B!@X<:PA"Q\17.%Y.(,QI2]R5P2E.CCH TGA+V?\ MONB9F:^#6: ,UE1BPX^$$A2 M$6^J_(_#;R)GQ] _G@WK6&8:A78E%#A4I[KTAU!0F 1#IZPG-_2EO]TG9SBW M_[CPB_4,\HCCH>*A")&QACEDJ%+4I;=4G+[D0=R!CGQ0^-=M5V#'I5N;_QQX;5KO:L3E2#&'7.$V*2T0!FQY0N=+:8"R'9E MXQX3%J"#,73<+5XK%2ZR<>X9%FN2ZI-V,V?6"9=!O#'.'DR_6'XH,&)3*9-2 MBJ3Z";M65J)D$TUER(1KFBM+@"LN4J=2@:Z9^63/HAF/T,#D(Q)*/X,$\GP9 ME!>Y<@&?K^R#Q"DIR'E3 B!LSZ0Z=[K\=R,3 ,KC8$9 8N;3\E*(6A-TY(G6 M#3(#(DLQ)-#%7N)CTL)9!E01LA5[GCH+00?DG$>H*9X -\8L:*S7PH?%>4FI MC%=;JNEH?E!WKKSH"'N"K:<(+<4"$Y<\G3(Y5S-WMD G,CB8/T_^"DXU:6<_ M8B$EZ'YINP'+EV@60X+A]KTA?P-%O^-U6B304C''D\F,$N.*8VK%T"+?/+Z06DZ60F,#=C?/85(\M<\&;?:($]$,(@DWF9HO&8%X4C803*W8Y< M&6"E%8VUG(1)BB,;7T9):2(RLV#FV50NO/F4=CR=Z(R?XR7F:.1'PF".Z9,: M R#1"$&@/<8+D8$OM4,ZGQ,7WAE0YU,WXL*1@_)1Z@-,5D0MY=,0T R/$/P^ M\4V!\B=R\;,50*9 %\?>#S;*!_P,>^4]F$YDQDGY\H'2W8)8UBZ>:]&0Q \^ M(E =TG MHQ*)>2UD);,/9A&UM@C06R/'2[D8/F_J8>(YF/#6":@2T)>U.&(I M\.CDG9C//(LQ)23DEOQ6-OR5CP:^!/(?_Q6>D%$R! +ICI%\X5QC$[\E^8WY M*[C)L.0X#K!&,,6:YZ5G]S>>=^) R@ERIAVM.SE/[T1SUZ_C&SY^<9 6<3B: M0DUY3N/6R7A/GSE9\:Z8DPDF/8=L^30MLB8Q:E?4]3K@L'N8SD2-3(,/^\6H M^.P)ZS&),V,(O ZKX)CS@'V0/WS$(+IC+C[8+LV%;OJ8?3I&M+'X '4TP=!H MN?G72:RVT>3QVM"'_RWY9O%U [YZO_IYO]O0^_E?-1MZ[N?K'J7KC:ZQ^5'O M:6A\>-B5"-;VO]\ X<6Q:@N9SP=C_J3I60[NL/'*(LQLRW+8\:,WS23M)::/ MT-IC4CQT=YQI];>:U3?,/T:>'TZQFAAQ.Y?K5C-3/H4-W6[F6^^G.,EXSF%* M&L5]-3F\D]KL:U>B%@>[;"H&+Q VV[7J8J"()SP>;YI\@<=W14S0W'_ 7D@C MPH0?,N"UU'T,]2Y2(Y;)8)>9-[53F/]W+YIB>FH^/K54<]L%0KR_&4!\28NZ M0)T]'QB\W7[SJ=?LKL%0?\EJ(Y?9:=6?%[2K[QW3?R=UA,5F<)=*RD[BY;5K M.;FQVRKD'N?3IGE]'YI/+/)K6M_<,]!Y\TGOMUYZ!O)I\?7/P F*L8L8<3U( M.VOG/JO'WKW4T7B; C43%@_Z"81U&KS;Z]!L*P//\-#<@#8MMN':':%#DETQ M_F_N^>G"^1DH$7(T KB+>W>*@,=;WM!TRCMX:O>V:^UW*$Y7DKQ]_5,A8DRY M1Z#WYI-AK)Z!E5U0TN.@1A BB.UM_@B3.'&&:987H?-+3F%KF[FBQM,!%ZC< MS&,7WF$VK[> MH-^/ZPT.77&E2JN.5UKU3'2G7Y:*$>WZV^=?.5FD:SJ+P Z2+E,VP96YO'<577-+/5'IDJ])^_G3K\VJ>.G93IM_^M/=B7I7 MIKN5"-QE+4J73X)935:R_[ <29^]46;%_&3%O"@N[Z:\2 0LZ&O,"=@CM:BD9<<1>:.(,O_WK.-^2YSWCL?>$+" C?%+.ZHE!F@/$$9,N>V(34 MP)%Y+$:9RC4-2'\BK\0C$J:Q66N" PD_M:RJ(9AMLAL29%&9^]S0?L<,=L0D MI_1X&X87<:86H$$$E]_]^@,G: ?[.Z;J=C();4GZMTA83P!%:MJ4F4XH&G8R M&"IG=P$C=K'(?B@A&WK>/;S88J$) M[)G2J\4-9$0/B0,_>OY]((!\49(@CXQ+/Y,WS3R10QS3JP^/M1WMYNN=%L@Y MBI0L^&FZ&/I@W,??I*J]UI$KS5T2OIQS+$WC:?(IQ .CHP(?3TW?$B_@"93I MD['TIMS%EX46LJM MTJ="L6[L&CK^$+(+AK=0.L[J>4/![GAP(=7Q$J .F]@CT%F H6&R/%C&!]JV M]@!WI.P;-^@UC=)LW* Q( T%3M#8YLQSXGN/A,W'L6%MU_4>3 Z=!XM_ST+) M%)*C&-@(ZQ>75@C-'-DQ:..VI[:WZ.UE[I3W1TMV$[4(:A!=3P%DR4/+OT#8 M44ZJ]/\S>"^@TV%[,E'"M M.19F94OS8@%-RBKJU<2=.:*EO#*MBUZ1]L%1,N_X]V1RHEHJF<34'O-^_8 MME5:]RFP3O(DI'DGG5]I>F>LYEPA2K *V/%R.V]2K-,C=5R[Z.C&?E'W4H03 M!L3_S^'=*3IC<8J*OT_>K/2ZPHF'NV0(NENX,G-(9TQI@%84\(9.I,#;HR"K MN)OHJ)%X""F'8\J[$PT=Q/I'U@+BFSD8,T 8G$GL2Y4L9)B-(J3C&&+L@ M":X>A\D1*L D07-7>$Q,3(OFAT&H;+RQMDAIQZM$U7E &8LF56]K8S,("6@" M>Y&1,@=WQF\DS0TK[1E)![Z6<0@ 13S>"T*>.VZ7AQ-W74 !@ F2AV+L\Y$)O!_)>FFUK=_+8%TLVTN:(79-OZ@_0P MET+]R_2F"*M PKI.[-R?A)U;+%7]0@Z8'RG[4$M&5]-N$ ;J=T1ANO%1R7][ M\_O-.T*PMR<>[Z<77Y&:56QQ+V=4B$R+]>1W?M41_>.UEE&%#J4I=%",]348 M:^M*^[LYFW^,LWOL__"-+I2[WJ0#53AHX2!)>[#6\,G$Q\E<"RBESM)!\#C< M//,-9]%/F MS+4HT!"/&)8+7KK9HS?'6&0D$./AW1AI MQOPDAC"]&,J,?-IE@1X92&_F2N8F253A\FQH7V%&.<8/[.G$= 5I\W<1$C:; M2+1[_G01<)6N\20](G:&\"Q'&!TA54HRI=P*V=6&&E9&ML,S+$+?HY[;XDJQ M8ND(C? ?QFGR*PITJB/GM:OEJ$(UZ924\7I"UL8D#0G$;3H>059+K=9VDS ! M#8A[_GGX7:HB]#I@$+3$6?80OQ'Q(L*UITW&N"7!(?CMR)Q3T] 9^D(1L),E M(6S+'I/'"ANLII.P*YP.D*::!* 3BST2N1PXJ MRH%$@^RHO61JPJ,=3.$4U+E#^ZN+3('09%,W<=]C(,'A)7SJ#(\GZ""N-[-' MZ6Z,";BR]< 0]-Z>S;'%+QYRZGF;0;26N8LBX;^A7>!1]NA$;QA)JNPG%#V1 M94*&@VUU$9:4-]V,B;YUZ)K%L&/&*2?J)\%>P]34_>E:YCH.?&FSSS+(KUR=V'J=NBQ;T? MNJ(6(4"8Z*1+B'@%@<3 &YQ%DMR3SE7Q^,UD;-,R<_#JC:N<'5>\Z')T$P^Y MB\@_@_4<13+1T43L?\]YX-'2=,,27E"&V/E^LE,USFV220"Q$#HNO6F&3;!- MUV6.QL\:HOI?6+Q$S7328W]DO,VR0#Z6V?0.\#F'U@FG.T9E MF?]WAV*33K M>N_FII++U4PO,(7'ELZ,/5IJ(,L;U?##CE*:Y*1:ZF2IX[RAG"4F[6#YY(IU M'YL/8/0)1'^&[8@Y.QXM5I;?]=RZYX-J@5L::^)O!?@_K_D CC"S0Z$\@.5H M.[S7L<\2M1X9H ,LSR4!%[SC*:O84,,;$@?'SO1) 4L,Z"TF0BP)SAU,:,02 MD&^939=H$XC7;=J.4'UK1%; & 1>>*JO,WH#L>)LM\+S$U-"OF%'9(N<5VJ. ..-YQ]#BQE CL;#R4=;B8M G434HNP MS5ZR9_Z=-B]R/D\W[$>T8\?+UF,9L"K+4CQMT:>,,WTWZ$Z^^ ].V0XQEERGVF<*)2!Q%O M^96PH+3/9A"^JZ7LS86\(+920"4W0^Y:HFX?7*&732UL>!FQ.#274A9LHLDO M7-CR45(0S5<11H_KG5!FP@E3QG/ F^O(EY-Z;G+_<]H S,JCI-/-D F3F3TR2 ^'7D3U'/RI7IP1Y\Q:SA$R2XP_Y1I>*]9*N@8"[UQ " S:6 M=^04#C*Y?/$YX>0K_"# H+@GA"6]V7P0FS3Z^(BF_3G:Y1287^-UO/[&=E[_ M(D,.5RP L<]X>RQ!H>M8-K*O56)XI+Y:0G"(OJ]B/VV.-4B;Y."G0#+POT"? MH.)(EJ1@V.4CH?L4M1T(FYO6[2>&AF/W%/E7"K M(\8AKD60.K-8=^!XC\ 8_XIXN19Z^\@2"C!TQU5#HE\^;OY23N2Q0Q >-!7H M'=1Q$J]'W)N*.>_=8%!EA)4L;\Z\U!XBM@ 6$%$_I3>Y$V/']L(^4ERL**DC9V436T< M^0):)XWCQ4]];2GPD&B0&4PKWI%0>N@3HYNB?#+$P)CPIG*S$1E0Z UB0;+ MMW9PK_W(GRH:*N,N7 ,'UO0+'-(-4*IV+0W'"]?%JJI;PH]!OHD9.YK>K/]+ M &LQN8,$SL45G*_P>&SR+12[/*L@IR6GSSX>;$ M)OAMCAASVBLIDUMJLOA?-:7!M:M] ?UXAOP1>*/!$P%^V-$\?U; M4/\6VHT#8WR+?%9P\!]C@=FB+P47?TR02X #A$D%4U[4 M9*ES"EG*<]/U4=GTDI1C=;$D>,@9RLNKE@>&E=2Q+@N#\R,W+K(5@/1IT0'W M=?B#N,F,HV&R?8/0TU9>82;31-=&BHYKZ6)]KMN+STFZ2GR;(THM,4?3.-=G0K:LR64BS*=.16I@1J 6Y).[":S3P$0/3"""TB0GER;: M3D-0IBTF=!%CYV9:VY75J>:)^)UI,00/SV'A^[GLQ\Y+2Y+5W['EY3#AI;^X M)H; 0^:RL9WP4C 9Q.8370,W358U^QVE0,5^L50RE"33XQD2>!<7;FDW MIG#G+$L';@U]\8!%MVKQ0F:FAA/^2I;6Y12Y=5"30[#I8["TQ?=LGA.E[ M>7O][?KRXA?MXO+RZV]?OEU_^4F[^?K+]>7UYSO"B/]\]^WZUXMO6P/$GQBW M^/6*$M$OD+JP9;DES\5..-V<0&-_%+K/YJ9/Z'@$D.U;%-,C7]IOC;N&]M/% MQ0W7V_BE<>!=>(CRT+Q]]E=DHWL^"3?C@9N9]TDW=1C+GY&51N((@F@V3^7% MIEJP\^.%Z2\S%#S$Y.!Z\M*GNH'7,IX^BI<)49G B:.#QO$HL1!S[4A(32@Q M+7E.NCV#S,T5@PH)53M9/]?+Y&W+M#QKFP@1ST&282+)DCA?$H/A1,8H;2FP?H^;SX)7<"R6E%][%R$N509! M\['>\(,I6JW8)J1&WG^]^^^7; MG?;U1^WKS>?;BV_77[]4]&S="D$89[$23+DK'2.IG+XI HS: 5@?(MH=EU(P M:[F2@8J?TL9=?&T-/5/FGYXOS..TT9@2S#G!M;38%G8@#HDDK R8+8_#SAG* MD*4NWR? =@UB$AO$\3Z\A/N.P1W?G#'*'D3YB(I'0(9^.@L*GI1*/Y)1G/'F M0!TY(,B+()0D$06NX[+52?K".Y AHL]##!7FD5ZO.-R\ZXV8=4AQ:ZJTBL->+"9,PYQ)Q>N867&@)8R)BF@G.? <[L*0E2L\0)I4L44!]SJ" MLN0L[PZG8UEB0IHH)J7P)W!E3VX!ID%/F445(&(K0*YXH*?]AZNZZ>H9_@1! M7K"87A0B F_$@8-IQUU^(GCZB^?+Y!+^:#&P5!G,LV1&36+2)JX=-^U!9Q77 M_C)1:XHU4Q:Q3 E.#W=I=W:C^I3T683D:;<7RH9417]*R1=#3 MS.C_E@>WH3,C@^_*71A$8Y;0?+D_;NR(M%7D(R+S;R4>RNV251*>,9.G!^&S MXG6UDZQG.-XUV:."(SDCTD5HAY@] LM5V_] H;W$SU!#N!ZX5]XFK@O?2587Y'P([@X MHQ*@C\(,9#^X;=&.EVR&?E:]C0^JZ#,D#S_UTR5H\WG /L@?/HH^/!]LJAZL MTTT?L^]#-K/42Y?>Q[\6!V@P:/0[+3Q#HI^W>+$X7@U8L_>KG[>;C8&1_U6S MHH0@^IN/CG4YEJ< MQAS"6>JB74PS^/YSSH F+P_-:S+^*@?+T./+LDW*GVU#OLJ$R[2$WS850&16 M5I%-P5<-EBD0I?R)DQ]&3K;8B*TFW,3IGLFBM5[Q:'+&IHYFI:ZJ#O5?<4/J M5;G&RC/6"OOJK"N5VWP!,U3$';988+6&BC:+ITVEF*JKMK39#G04BM20!(NA M'JBVXZ![<9?3@" E$]^+7*LN!CP:,38>;UJ$XQV3YYVLM 9?$F?I!W5:#J\K M/DRKVD$&2.T8^4#XKN!%U(DL!),4,7A(AV(IN MFMHIB(KOEN7#3E-,3\W'IY9J;KI1:^N#?*5Q1PZ@[33='3C7TNMR.9^Q&\/* M);SR[JVIEXND%(MX:6S@T E( MI\\BSB%-Y2=J?ODKX3\KE?%X7KI*<0^CUN_O6>!4O#@XD(^@6ANJ-W:-!;[N M?I9!'"B">@F'Z/5WM2D5ARCSAC9WCDA7GT,2D>WF\ M)_K4]"<*:?283KP3Y!'=/4WQ$S.X3W!G=E>[JE(GJ&CC6;6KK4KSR[HU^SK+ M3_[8GI//ZV+T5V3S.EH>-;4?0 VS00EC2O%2/J]MO.9%V&;*;-Y*\2JB%+(, M'%S1QG/KU5< [R7=F>;9%K>?D[/K8N;!8/YCDN+EC37;#4UW8@\=IIE!P$*E M=2EWUV;T)64WEW-G=N??5;&;%6T\>VJ+\(2J4ZM.[;&\7:?25<>;,TSHYHS-U!>KF-ZN2J5-:K7!IT]<[Z*3P-6961Y,:E].R-6. ]8$=1+"DUW[U>M M.$2)-U1QB-?SWI5:>?QL^BZ,-=#&OC>32J3G*N7QB,ZZ2G&20>O0/1E/S5=0 MJ>WL*5"[HKV"U:*GMBHPK=!V=AJ[F@'59P_GE&QW[8;,9T&8%#?4$!Y9:8\J MP6X#U;S5VZF>)2I/IS3;TM"/NRUE8->*+IZGB_Z1Z4(=U^V.:^O\CNM!^TZ4 M/[@;^^>&;.SY3 O-)Q79+85S[D0MMM[@T :XLL$+KA-6&'"E==&=*$EUNGLV M0E5,HJ0[VE9^_+-VU-WXWH,=8&D&J)%*BU1.NBW,RYZR^LNX+>=H]2NZ>)8N M!DGO7:(!2HWR^GNW!;]X"MT.DZ,/29[BN*VO3.LZF&7 MZ22E]0$H4G%MQ;6W/*'=EW6D4%R[>ER[]<(DTK/DVL_86*50YM55%;B*".U] M:,*Y.C3=&\_1O8%TSWG#ZM_Q<;#LAT__@+_DP&;49SO%%CZ*3Y /X*_B\-=1 M;_A@&(W8P6"[%G/##W7^V:'/>:>QS80_SCV.7OK!9PZUZ/F(XZX;C?Y\A2$- MS8#A ] O'/N9#CKH_E9#3B^HWFVTV[AZ-[YG1:,P "H+0H0$R!N1%B M@FFF-F?^"!;)-'-DD3W\%N](N1[NTX%RU2!$GCC$*_2'" $Q,!I:'7U\PT\?C87M60_NM<==8\\Y>H_D]WOD=O%P;VHX#2UFC*:>O MI]6QL=3'I>KP!&X(%SYY6JNA\Z?U&WWYM(;V;9J\$9Z2>?(CS !&#/0+E*99 M/O V5QO"3VPF]]-E =\$G"D+;>1_>,\(L8[@<4(0 #W .H2VZ<"#8/<"> L\ M:&P^>#[J+ICW '3H)FMHP\(A(3Y.;?@ZYAY &V(ZKC>S77Q>0ZOF6;R =0Y- MF#VBI >C* @$=B<2TA@6Q_.1P-S0MX<184L)(AM-37=":P7K-L&&U,NL6IPP M"R_Y^]_ZAM'\>">NO'9A*V9$//2-_E$;,L=[7,^KQ:#;*)579>&C;85382.E M[Q)[TDQN,8=@ 4;A^EM2FX6"A?D%;4Q;SZY%^N^I+T9O=MMU^JUQMS\>_=%[\^D;<1DX M/)?P0B"> )B&^2EO'U_&/@I23'[R/>##O]+HJLD-=Y?C$UH3/L64W "QHS=Z M:>UT[ME($'F23HJO[,,LX*+ :X$K8KLP;S;S+#M?H'('Y@,J-?FR,D_ +@G'-3-.)&4U2>.0@C*]A$%&5!+C>;FT/!V>\C7& MK/R\C%EY:N1#3_Q@AS""T18$=7O3G9=-J\"GZ1$+$U9$CK:)>.=&7**P:89Z -\1@R2.)P;F*GF0,'(GN/( M!(.$.0'#QJW(YY%3&#X\48X<+W'A]S&<7:1CGXT8L$]2>V-K3!IB)[N).Q)W MW'7\IU37\8M,U_&8SN]^HI6\J#:ARUG&E)Z(SA9:^;M2^BJA"[J<>+ >*%SN M@5QAO8%^<;G7"/P7G XAM9#F?XRHM]8M,ZV%!OOK!K'$DOK&D4E_;<"P4(:_ MU KV*[6"O5SJ2%8ILG^F_^U+R)ZL?R;5K!^!4('/P#4M[<8Q7>Z4FV'!M)WH M3S70P9CVQ0N9>&Q-*EO/#%0PIYI\'5AX%$HF3S3\8N&9MF 4KNF.X)!I=R%\ M-2,C$ 3!-?S,WZBCSG@#)Y'_>LU52!O]D.A?K*&Z#4H!5PH]?XXF*3P8AL)L MLA; 'F6HVK_ L5TTQ>QX<);;^5VEVOGM=GARPCYE/CQ;]#%,G0=A1,!5H(*$ M2%2^54>>3Q;FF)'%(D2QPR;PTYBA6$"O[L0W\]Y2YV?,DG:FZ[GUD1F SFKA M8G'R%B=B;-HH2)R(/" CYH.U! _$*?@4K<$&0.BQ1Y47J1NL7S":%MS7+*_/ M"" Y1SD*>!.]'9X4.EP&P:L0? I,5;P@"+W1/1A1MC!X0>NBHP^GI3XD6;OF M8G)OF\ER!PUMF\7?F7LEZBV2KTIR6E/,T\N3#[89VX\$%YM+ MT.BTW8C[PI.MA#V?P&R/+7@+9!-+W:>ND^Y3%]GN4Z>V$#M->Z7IUF%D[.IC M@;@BATQW.CWH;)_KS#6KA>N\C MT,EX##H.>A%"\TE#%9GBR/^PGS!I[4??'!$[1.%^B_$;-YH-F?^&9"5,ASX; MU?4W2)M 54Y Z6^N.8/I1$%]8IKS#Y_E.ZY!$9\Q6-A;>,]E+&V_QO'O-QK* M:;BU;KS1;.N_WXSKNMX>O/EDZ(WN/]YG!_5I'Z\6-PHL&_WL:(,#R7-+WK(Q M2R%)EJ! _YA9Y'0)P :)4,=*5@D$A*%_?[IGXQE&I%VQ$<.MQG6#U<,E^>I/ M3%<*2%SZST %WLP>@=T6YS"L]<)^_7P9NV!ACTQ2'6>>Q1S-CQRA YK [QZU MB>,-8=71R36+9K3F8Q](ZM'S[^/G_?#YYDZ[ 1X(.MVW1T\^FFO!Z(?QHD"; M> _,=[EZ;9(7@V8"#W+ %#2![,5(:AJ^G6Q#AC?>,P6E,]@!F U#?%* MH/89>LF.='H^_6/HO_^D,B+BC AC?48$#A<9[_-A>KW9>J/R*%0>18$QSYRX M;C7E\15WIG)7A@\J.C!H'TX7;NV2;P-TG)]OD-OB3#!X!IL^C$ ,H51"-0YN MD*Y5[BG%)Y-[=^1X 7+R1SNJRY$#X!'%/F-B97,*" $F[8"V*A!5A>^0?YAOD! M+<+=(H M>-;LHB(T?ARIF"81RE2C!A-QS'G /L@?/LI"'-NEE]--'[/+TUG- M_Z?SS[\6(FHP: P&!DHI42XF7BP$6 ,F\W[U\TZWT6WW<[]J-O3ORURQ]#J0 M%)N72S<:[4'WN>7:\O-.*_\EZ^XXM4%UFIL?]4QM8SG[JZUPB692O'845!B] ML\T*<2W^.&NT7"F4OT3?UCI"M):>6;E3H(OMYGQ$LBC_5;M4[I>;E%&7W09; M8YL)YV('K#Q#* *KCZG4HK;4HAYX4;_'Y G0T15_+2=//*@Z<%BRY:>CF'V] M0N/()[M7A!*#72AX6\C%DJB4Z^$&_:42X3,B\%VVAZ7W1HK:""LJ9 M;F]K()M"Y]NO]9N#0\/[*K(X=;(8U/1^Y_10GPM=L[?MH[7L*W2>KX(O7&HI M'S?^XM 4<;J)$OF;][7*O#UGNB?"VSNMWK$Q1Q51E)THVKW]Q/V!0#9/4-SK MK7W;.)V?S#]!RWZ=S.=I56D94@5ER>V9Z!(97Y M]G0+RR(A\L0VS)7+9@$^,I\ 3,>>XWB/P8=MDL$*R@7K#@9[Y()UC+;*!=LA MPZEUN+2KUL'2KLHYJ,U)AJ<0DU:Y8(7E@LGQR:<(IEI>6JET_L*@@CE=>8C< MKY2%Y(/JL&S![+F.&PGZF/5=VRWR[U+9PO]2*[Z4I730D:V"[^>-[>7M&$3) MDF):)65:*EU5958>/UUU9=U.0=&M-!^HHO+R7+[DEK19=49XDT!UWQ!4]]F% MGBZ]V0P6 6J5HK6 M6OVCAMX.2FNO'Q4M-@&VU>@=-P'V>56]$OFGB$(1(8[&>:H#%4\D,VJ][IY- MEX_%T\XWR\^H]9LMM3GEW)RWS49[>X%SH&TYD 5*[^TU>IV2RYYO7HAVZ#J MG3,20\]M<-:MVH(MMKP($TIV]JMN;6<42AD[VQD'7*!RI\Q14>5^5LKAUFCG M],+CV-/JE*A3DJHQ/=-3LHLGX)5/3 G5NGT*:8L@B26E<,L\WQSL4/'Z.G*O M#ZT8350DZ-;U_N'STZ1+A/ M6*Y1Q+OH8&]U^\&V)#2K2&BVW?C6_!?&&/,K_>7QD2$I[,N#D$CWJRWI3PG] M2U=JL.!E6R^3=)^T$ $F_;WV-OW[ MX'M$M3?QS!"N>]+[&#B#';S;N=U"0\/R@+S74Y.)E3XD)GZ/$R*$>CR.$P2\ MI0Z8U$4YZ75Y<7<3Q-T$X-3T&IWO:ZEVC*;6P?G)WI :[X@EP[*BVQ-WRL(; M\:3=7(KC^> Y\#E6(#S""8Y"T?N*\5*&N!^D:'C%FSIC:QYLN\4'ZHV!]H>V M8X<+O@2I:>' D8^L3#ZO8S2.,W*3IM0S^TD+IO8X7-.$,KERN6UU@Z"0V5\1 M3-59U+1,C'H-A70:K>_S-HE6=FE*^>,Q-1VI*KT+24^QE%=\S0#T1CMW 'H3 MO]AR!(-&/V<$%6WLV/9&[RXK[5H2Y0[=#'LAO93?E/U-2V/"NP&W]"^[C*SU%RVZU)+ M(]NKPS(J%Z7M<7M^S3J6M)1]FW5T#]&L8]!&WJ;:=92P78>H#"T-I+]VX]O8 MX&NR%99_LX#Z3:#?1I/3\(X%G(/VL_#M90V"[!0J.7=L_1(."E3BWC&+/(_D M2#Q*\OM&1^[95'F6FC J711Q4'HMJARHR'VO;(U5P8M:S98 12[J$5H"* ;\ M6G@/_?TU 87GK_#\CU8[77B93+D2<_:MSM@>X;70^;9KK3TQ7A595)HLNKIQ M:+*H>J%31R']5[/2ZFR1_HN'>S]!KO\BN/=B,]1[^_%\1125)HJFZ@&PTXHU M=\:!5BT 3E\9.-,6 "6S HE#7W0V+/ 2R' 5Y\X^HHX#D (/3F)>T- M<-@Q;5/:(\>T^K=J*W#*;07V3TOKMC=G!I5%$2E)7X$29G>5=%"=YN9'G0+< MJNHKH/H*J"2(BD+SJKX"Q^PKH'H**(95XJNJP]8JF^^J>@HH/J 4%]530/44 MV-;_>!?-YX[-JI_(V]J+$M-W96J$Y@P5O3JO? M5YM3SLUYVVITCM11X 7RY@3M3PG6IZ1-Y?0T8U\4;Z5"O_;6M+K*NBGIUKS5 MC]8L;6M)4RYNJ:YZ_JH#F:HGUHQH&1GPC'2)YS9V_S8(E79-'GAURBU:".EA M/POS0 MT!./T "/=I7I5G2MUK@@J0YVKG<[5+OZB\VMTM!..R,%7Z;4;'>44 M"&5Z\_ *H6RKH]>I&CJ79D?=1ELU.ZILLZ/F&34[6LO^CL";>2<4862N[6VS MW/VH__W^W8]>A7]L.=%<&LD;4.%;$O="BIN[I/<&&\@D;6/2_8GD3F:;!BTY M$8I8^AKO_E3*Q=9DQF"\R$6N5+:#C>O-;!=[RS3X-L)VICMOI1I =1N=G Y0 M%ILA+03>."1!@[_0@[0I"#<0<(RWV4H>9.#Q?F'+K8JVC$I!IA*+RSMYR4+" MT2PEN>MZH_M]D12>VZ>LCQW4T@QOGD?NN42]OJ%:,]O.#"E]J1>7;#.WKB?7 MA@$2:9KNB1R1O/6.:-VWZ4BL M*@IYYR:WA62>: B7'K;Q;.30_G.]%BLO(F*Z.T@WP5*>+6"KQ4J/I?:*N4=Z MMT:*HOG?C@T4EP7))--0,>?$\:: .0>TMEV31>JSZCCX;[J1XO[]$5=&N*Y% M8OF:'&[9S*_=&;PY#1](?F^X2\^?HP.$:=\D'66VAF!A\K!<[3, M-^%,;5R,0GC1KFV>49:6DJFOLH(4)PD\L'%"Z47S(A]/;S3D1W3N>W\RV=_5 M3O8%-\RR)TCIL"+((/!CU:XT7O)V.[L6^[8K31C<"]J5]C!JH)J5EJ]9:0$B M:J- ^N7ZW[]=7UU_^S_MXLN5=GEQ<_WMXA?M]O/=U]]N+S_?55.K_YUI$>AX M(S.8:A/FHDSB"GI6KT?.R/GH LRJ"'0OW'3'_BNR+6IP#\\9,L<&/0PDABG] MYB$]N,8?/P:E*B/[T-$V AX(W WU,!=F-/1\WWOD/;3-!]-VI/HEO5%S$^[5 MS"B<>K[]GT0AHVB4SRP,-IDCVZ%G E<'G7+(M" :C\&*PP&A$LA R?OYYN]_ MZQMZ[V.0&@Z-TVBG$L7-YP!CO8DY*:4.[L"P2*ZCYPD3&L$@V!SDT1_!V M+G-@;4 O"5&AQ_4$,1J 2H^/O,3XD[L Q1=H91B:-I\IO!"4<[A%1!_Q4C$; M2QO;KNF.>/ 05(+)5#/C0:36"*@)/>I$=.9HA!8\^FG%!G 5/J 7#QF/U/@F M:>*X%G@3:>3P\OB1='%LT!"OTT;,IU'+2&5-&@?X%&",Z)\>X>/Y".'[['A, M,@]8B&9#O''\; 0QE>$M\2D!"F=6@/:3Q0+@!C!BN$Z0*^I^&+JUP8ZQS8=/<=MH-$V-$*RES.O@14$T1!4&'X2C]:) @RV\#U)&"NT0_PS9D3VV MDU[P =R+&XF?APY\CF?&:'Z\A>NU'^'P>GY '^D?\9;KD,TT_0(7Y :,*NT: M/\0EN. $>LN0,O!0_ AVD*8WZ_]*2!0L*KB$XKQ'7A1JO_*WX%27I]A*S9!H'%;:I[E5 MU/=S,0,%'L[[M\:=PT-N1(7'VA'1R%0]'\X>0<1<1#-]=PZ M7;I\'' G\'CR' $8-=Y%_\+I!CN;)S/PA\7O THRX0LAH& D9MX(X\N3H9%$ M<+T0'QZ:3YPCXIM-?N6867@E?H<^AF".Q 3T 4.0'"=UI@(ZMG"6/!@N$#+R M6=A LB:FGL//%SPIFGN8(I&,&=@O>CPT]F Z$3Z#C@!W%Y 0XFL#$\/CD\CB M&MZ$X_#9 [!BNHU/G;B0>'WLH4/F" OA\]6#L<.#@!B GAQ\!+=I^,G!]\C[ M889PFXWLC>_/%"0W/$#L*^<[R/)( DI& F^)B+GCH[C'R&+#4'- *7!JN#Q> MB+XHT#<.ZR,MC4OC%TG:U>0"*%U2^AQ*=2!?4C202% /\NU12,H2?$_LFE)[ MB R6H9=?"%-]*I#,/:/1.US?]ZX^*!LR, S*V/SR4VAYJQ\"-&VPS9S*US/V M @7-R34I/LB.O19.6I';F> P9]/ *@4>6>0"+QLFYWETJHC$>.WR29]MZ^Q+ MJ;@M:W@OP@_;MEZJT#J.5X9(*W1N1LTX+AQ?4FM25C@^16NO!5=1TYM'!:Q8 MJFNJ..;;;=;*?@G,4=7.2MX4RWU6]$Z[@-:C)>X?K2CMM2C-V!-,X.@\^02U MYF^QEU.IR:>LN@QJW6Y3JTHRAUAWLW$ T?_Y]%;\ZV_A5F3M;OB" =5+-*$N]E0?N MWU0=[WQE@UFEZH1V-D>DF@&L_!9BQ[;"-Y58O*I:C;74]FJ0W]VR(7Z70B3ORI\% M2Q9UE6LX\K+(-G+G?"I@\8;17TNL-NT*I]X5H[:6H MEUP39HV]<1=KO'%5"2A?2K1N4<0\\GR0I7./HP8(*'12PY,J>/3,UPA!;\6A MF>?&S.+K?1OX]!]+@J 4V3'NT M#F%4UFQCJ)N14D&UQE3![6I#-C6=,=5V8X6];]$S%GP>OFDAKL2(@7H"[T5$ M.O: \ 8.XI,XXDE\N/DH;G-S@57^ C- PI6(GU6\8G6[)LJG*.*9NHW6P,0VZA]H[7=]M=J6:=3J(& M_" )@WJG*I 7>T30SGKR&RX[!?)729:E1 ^IP )N1 =1"_C\ O(6AX?C3UMW M92WWLBP=S,+IZK16;^E4&D6OWLDMX*%/Y4E-_O_>_Y^6LP#GD"ET92X(AS0P MT]I7>UJU/7UK[)QTIK:SO-NICJC:4[6GY=]3:LIB?%0;6[6- M+9L\/0>LP-AVPR[P"UEMY8:>OTC,M*]W+S+3MD5[*Q]%=GJ_M]B6GMJ6TFW+Z>(M57QC MX+PTU7DIX[:TU;:4;EN."L&M-F:'\U(ZF+6=#)(>(;J4VD:XS"O6>TD,X)51 M,\J'X?_6&&Q/I =?I.U)_*!]?Q1%;**(U@YA3D419T 1>WH?RT@4:N]WE@^* M&RB*4!J#HHCU%+%GV% 1196)XNT.'N]2$,0N&'7E@]6A)VZ+++0)'"H72 TA M;T8I_+>\BY)JSE-;NXV01-\06BT?$R@@W+4@FF&8TA+ARJN[KX0C=/7U3G-8 M$&A7-U\;VG7(9H'V.+5'4VUF8E>V*& 28O@1U@Z6W[/&8 M^=K8]V;:U Y"ST=JUD*?N18!Z#F1Q6K:, HUV"W-]4+-L6=V2!M7TT94 H@7 MPB4!S!9&.+.?,E_,S05!,(7,GW%0I!">X$YJXE_Z"/8'KX$9IS'LQN8(1X37 M!LP,/#<9&CT'P?OX,^C&!^9&!(+G35P"D*.KD@S/)/;[:(=3 73'UV(]EEU) MJ:G9PZ V4,<,%B;R&:<>$_8=$:O<:(:UO3$A17YF77$K4^'O!I$9$"!L/1)( MR!$381%LBHXS'B3/J6WD:(R(2(@ 5J8[8H04.(*#;0.E> $L=HV0#;5!LPYC M248(]XD=:VAX*M* RSB<1S-(XRWZ-ER+3TJ@%>6&X[K 5>&";_<,<2&9)4$4 ML?//^MT]:6:"3&&;[:?3#:LR@@OY4?2H>A4O0-* KZQH%#:(RSQ+!LEYRMO7 MD1<004P\#TXI(D_R[958G+2]_#4K:)I!" *$3>P1,),%\8X;8&-TZN\6 ?&\ M%(HE;I(/JP>$!LQ!"Z;V'"<'])8 :B9C!8J,B!CHL 9S6, -[LP@/AY^Q+ S3;G.RLXD&5K<(WE^8<]SR71HK!5F6S\LC/X[XDQ MK@. _ZYVRY$"1*+]&MH!@7Y!NL'A0I$"A\.',:UD7I-%J.J.IGF; M3)-;=RAHT:RIYE&ZBM"&VY&F?[Y):!&HIA]3C3B/1#!34"] 1904B."]2)UT M^BRYJ()>6QF27Z$W<55'7M70"!5PP_"FIJ69G^#TA0PH_3L]N1^>/3-M MA(37R!^2##KU5LV,PBE8N/\AQTG '_? ><+/-U3ZV_L8:#]XIF^1.\ &VRM$ M#4BK)JG\"!QDYOE9)&;\ ^KLRI:A5X!I7[R0:7JSIHE\[;O0&]T+PA KJ%VQ ML3VR0Y''79,T= EKCEX_4GCA%Y@_,F0AY-#L".$KSO2 Q-#MPNE Q\VX 0[' M?[W&7\.IC:;QW//#FO#-V.1"\?PY>L88(OG[S"8MUV=C^!ET\6JR.0DO?LL" MV+G1876$TBA#5RA/?T$@\(HR[M^!50,/"^%_KCP0ZCG:G6:H/3(--&^PU&Q@ MML#7O6A"KL< N*XO#BZVJD@,4^[.@V/+_8H<,QUN'H.VHK&G.; VS@=%LRT? MNVWYXORA/B*Z?- 57/$GU68.5FV@O4V>:H[@1MY#(GA7R^&ZL1I6(\XB;5:) MX$[.1=@FQOMZ\0]1_QF!0"+$]D?F..3&YIXNT7LD,WO@T5=L+DQGCP04O#I> M@T=0B^!VP_B>]AI.S'3=.&![DTFK$TY3OV"+^![-1, M)&GB#9$;VH[V*PA_HTL3Z#: I. #4&R$K(7YF$[@:21\R/\$]&6B:9H\_@73 MT%K=-OG[X3A$&'2#8Q*AD@0JAM*GMX!XW&Q0Z)Y(AZ9GYI^>3C8N6-1K_LNTG") 1 M"I8AF;71'#M:1D-866>1XBII:D^9\9F^;U,&?&'(G1Y'-X>5&9MH)E?@Z^3)Q,[)'^&;'*7\4Z@R(U# M+CRDQ=T>":OELMM+-D%*_QI/H,"A^?<4WQ(,E-PRY$*9S9A/YWMN@KY=D]X; MKH![W#F!\TG<&JFP$W]QX,U8,KTX]C0"LO&I81YJ\#@-OKJ:BQH51:>HH9[D M7XX-;[9D0I#TWT@;GC[D0^:/C>#+.'N-;S+,ZM'TK9IF+7EP4HEJ003,*%Y\ MH 7,OB,<$7R.Z<#$7#ZZE/@:1_2TM O,\LU'?$RP=O7)3V6/8;KX:!">Q&M% M6&WNX8!L"MV)%)W*.WP./:R)?OWR[O;C\]MO%+]K% MEROMZ[>?/]]J7W_XY?JGBV_77[_<55+_NF6AB$:0"+D!F59/??8#6+!C8-HW M#@P6]]VWAQ&QXVJJ:L^9X#7#<6&B0R9 M +^A)^"C_@*MP![;H$JFGR>2Z&%6KM!&OM.?>?K(,>U9$(M>U(3J?D(U\2!P MM+R?\!RLI]&""@(\4ACXC>EI@4H1!^%F#$0\27O;M6?1++/,4@LCY=GQ<&TG M.#P77UZ3ZH@(>#W1CSPC@4S?C1Y0/WL<-DYLV8YLQW;D#H>JE);F0?,P2L/J M+M$RN#,?R*>.:U]9%F:B>RER8JLJSL!!YSX/^%*^'Z=BC'E3G)IW![]'=Q*% MA"E>'3.25:;5; BN%6<7_;[UHS#7+G-S3MIAF[MGDYRC[%-D>'[IKLYS)SR] M!*G<16(]&%-'=BA7CJQ)47TA$O'C])Q6ZKQGGHF1W!"S^2^G&&\_Q!'7XM.M M*1?2$L'_!C/SR;/QS7Q"9LMS)"J:3+:5PSE[3@?M5E:>\XHTK!1%[S(/!]DB M;9.L51YBX;% DH/,!=L?+YGSI:8@I(=N:K'T(&AC9T1 C "/4N22S2"9 ?(E MJGC##S'#'4>(KBJXX''*7'[ Q:&#I>4=/XIQ1(>GQ+BH!; BFC>"'-*1#8[ M7A:/ARZ24^%?!OPI\$J8& SQ)L6-^-?>$+9<)"UR%Y9@H^2#2H8EZC9VU2W6 M+-:R&M&)V0J0,SI87.VSZ;ME]4I74U?X.A[716&1%DQ1&35]'ZL_:3$KRUG2 MHD_ZAJ4747"7!UXP&]L,G%=H5+5F"D\=B5(>_"1#2;AZN2,,+IC: M^7SA8\^VF=#LSSTQ.?]L'&O&YX2]<\.F$SLT"(#W- &1&6,ZBKO^VEYWPMRM2>*:*NA_3M"IVK( MHXK(HO^-7DKQ^Q78]H['"\,OAEX48EH8AO]N[>#^I1*R#.(0Y<5?RROP5VH% MK-0*F+0"(@!*J00FSQT%V?'S#9<80E+LOZI"@&0-AM[%DL5P+=7$"]>-J"@& MQ0-*.IB1M#*:]7_%:E/:2\-KY/*SWDXC.:,__!#F3B2>RF2:Q"L5;((1(-/)TA MPC%:X'>XVH$#ST81\28PHVS0P[G;*?X^,0;%]V2-@BF%V2&8XNS*E"KQXDQB M/2\QXA]:+(#5Y?DR\U1-%Z7G)#L[2N_L/-[9&EH<%A8H<;/W-G+0OTO'@KI7MK;_$2P=]3 M)'EEHNN(-_-I:#]0JA@E]B1Y9G!9[:4KCDM"R%D6V?>UU R6!E/;+PV<$(]\>XE(RQWL\>2;U MYM.O;"\*G(784>%I(J-V!F-:Q+7DN4J(MIW^H24E?+#QLF=A(WI(5-)8NRT=2%?9XL4A4,X@3+ M!F+7WWZZE/YHK$9%Q]H88?8P,Y60*[$,PH\S!S%GD3._1!PTTGZ+Y>EQEWS. MY("K18%,G(U].TFS,Y'JF)YZ6NZ(L /^^&#"9J!5E2EQK?'!BM6-@P-YR^RS M& Z%8X5X.-DL=%\]CD*D/*05]>U]0Y&S2N26;1&7%]$4W"IWH3'?)\P'GFX< M;GUK\ M-UWGAH0R&R#?(T!+.8'./YI%331QSP"%*5 (M=C M+B),4+X4E3?(-H*EL\T1AY!GDK\6XZR@,J%SF!ABS ?EB'@.-Q;9K;"/5*(] MD5MHWC-<138GOS/<*8*@/&MAQBR;,TI,VZBMF2]5UPDBDER-\C[X[53)AM5V M7.^L1[SWBG5T OEL!;G980< MPZS&"95GQ7%6F.B#?DI+YS)2'"4^DYGGVJ$0X"O:O$VHG=EUD>6P0"YKO@_2 MNU8!A? R :6]EMK(95H;23S]MU(;J29'N A2^KXX^(\\#R'DN9KQX8K/PX$, MC89(^ %*IT0FN-[E,*V);9PA1<%-5L;K>E)-VMG6>9MCF6K"*!UGC-+Q.J/T M'<^H0(Z1*C3_*P*KGOE99"LM!JZ@TXTL(.6,XPHH,@,4A$$B=!>:8]^CXDF. MO:7K:SLN^G-A((I'G$<8:'"0,)"AJS!0]<- Z]S<1Z7C?$_SS<7M-^WZNB&* M+ZZ__/CU]E>JOE@YZP=QPQOMDW3#ZPWM%S8!7D@N9X;FP8O5_#)(\+0[X'%% MOT=E'+,3!,K"F)P,(.F2U#G=B#,E?@$./C'CTD@\+;!*O)Q61KA>G$7'_SEV M@?<1PU1&;Y_S49Z:KM1>730HNJG]R+'**FH58_ T 90CTD]K3NC0X%97$ W_ M%"<+W6!>%%"$E=^22:--.\_"*6:^)5HKPLY3FE!-) Y=)#GQJ<5.A937AHRW M]-8NH[#QT\6]-J:%!CV+]4F.^Q"G+R8+@7$CF_OZY)J@^R@%Q!=#^ 6UI"N' M;W*89-\>Q17=6'4L 8=C3#UO=$_&K,]2N81NHO&F.XF0=8]K)4#T1"#[L.OT M&JRE>$#.K7+!SL<(Z#0/8@2TFLH(.&DCH C:T_"_%S*9G".4=\1/3UTW&MIO MKL\F=L#1R^Y,AP-G?/XKPMC#'0*6)14XO_$<9Z';[Y],4M"\;QEN83+)[-3C MJ5; 7.$27B0Q@-*4FF<@9\_X%@?)%J]"..:G>Y31-[V9X(,@8KYVDP:?7Z'P M:FR[%G(X-TPJD:4$6< EQ$7T+;G1R_D*JT#]UN[M!%Y$('P"L=)#32,)NF@> ML _RAX^6'Z='K?^\T]KM2:9YFM% M[HD;T[;H5] Q^$JJI5M/?=H7V<^!UHQ37JS)6)HIR%"4&MX(#$;Z\,)UO8CR M* C/A5.OC^K[Q#=G@5KV?(I-( JT*U0W^+'_'].)R/I)'7X*,",\]/\QQ,[) M,H0DDLT_)R"A=DN/Q MI2UWY+N7[,+6JZ^H;1]J4\R@U-NCF,$I,0.CUFRU:YUNNQAZVUFS&=-_)Z79 M7+'1"S6;G$F?"#-KU;K=WHZDE;_%K\;*EEZW%2O;=D-.F)7E3;'DM-9LM)HG M2VN*$91XN YJDPPVZMUQ[LIW$?;K&*-MY?YKHLWZX^$Z _@J]#'21U MD*IYD$BDOJ=DY*K5;W[;(ED<$\XQMTD6/UH>"U+M>1,,(O8TMP7 I46PC*)5 MR7^H-TJ2>RX@CKPYK.F_7P3 M#_@'S_0MCI3J,U[4*%OT6NGKDL9.*U.4(S5EE_/O]$ZJ1SJ.&!6-AG;A.#G9 M]+Q72PS,-K;]((QQ3/(Z\E$11WH!LE/>V'3GYYN\ICMZHQ,/-YEH@KNR> MV7A:W&YCX8;,I&.SN>,M&-8&>*-[T<*O?)7IK=9)(C>T&MH5&YM4Y(TTVYHOR*>V9TY9N$B#=Y>#5H)D74ZP+A MGI>1:@95P<#H2)BR%,Y*A7$PK%C[(+!OCF(=+..D94"Y$31-T[MF77\[?O>. MI.U8BF&"B\%_*3$:8@D?=7/8(95WY:_AU79>]1 M??-G;KCUH(Q=YK__:T GX^BTYA;3+R&K;QLGJ2!T&W!8I_;0#BNA$7PCYD/S M 4EEL2=MR&"@9#\A=J8Y85FGP)I!*E"1[4%%]';GS:<.H8B<[/"-PD%0LM!O MZ(4@-2"<@O!UP#@G0(A7/*D*$6D)$4D_"")2^_6ZX\GK8(:C.JP:-@;]$$0S MV/$-]D+AG"TS7$'1'PL?H,)0VAM#*8_^/JZ^LBPXL>A$)K3-+Y<-[>++E7;W MVP]WUU?7%[?7G^]V6,*RS.?S__Y\_]Q.;'@I. DA+V81I'9D'JQ8;;/Q-2K M Q&Q)?Q("DGBI CB.@VV/5QHMQ)E.P\?8JLC!X- =" M%BERF1!7>9M4K6TF?#Z+ALVKOG@-M7#['RY M;C8/_^\?&Q M <-L3+R']Q?^:&H_L. ]LR:F_]XR0_-]NV?HO?;,@X/W,WMT6!C6;\S1/>;XB53%FOQ"DU]\1LXQ]^T@:>@GVRCP% 2$ MTD,T9,)0#KW&?_U73A^CPFB\9 >_7_]7\>>^9&L"AZ#>;+O&+LEY,%+$D,4A>A_.U \%"ENQ,&&^'!U00E YPHCJ P76 ;YC"3A%;[8[Y M#_8(YK)&]LOC(7IE+* ;S4ZO"4_O=0?=]Z;1;#?U;N<_[*G>^F/8")_"7%E\ 2:O M1;7$6#"->#8;A'/CO,U4)2#/4T 6SD:+F/:O)K ;3>^BF=K45R7D6D2OH]4M MYE9!E::8T5CBDZF_55EBH?)7E26^4EEB*6K0=,/8IP;M@.5>O<.4>\$-@]T> M=81!-7J#LBW4H-'M[E:E]?ICZC6Z3:-D8\(:M.[F0:D:M->K07O)9:JLZZ7F M0PDH395UJ;(N5=95EH5395VJK&M/=] AT\A46=?INMR3'+-.L]\:O+?Z;;W7 MM-A32Z1T/Q_Z+M[[7I%3J6JN5,W5+DS\D'G>U:BY$HFNHD=$=1/3K**#.4I M'SDQ3>_BC]W^>Y#,=?V/-E!W]W0$].F<+97%?8[1\4-6+Y^,L+R8^[:C]4A2 M=JLJ*9F2E*G>5>#Q> M&267C% M@G,^[Y= ?S0#P/[9\1-1 D M/*V1/84=='.&&GV_0M#QSN:D,RG,4FV=I4"8M>IN\16\U MI6:[^&(S)34+<;\..F!3MH6TQ%0?+A9)&EY3>8N\WGIO&:"(]!$9M2V04=N(RU@L"%M->^;MBB:. M1!,=21.=HFF"!)PBBW*015>21??(MFNY%+Y8%]/T >GS.3@YU=#G"\^:+YT^ MW^WD*.?2ON.Z^2"ES2N57*GD2B57B!JK9:4M2VE@BG2R)!&OL5V=FI8XE4UJJV%G65"\48MK)FGA>5[50VEARD] M3.EA2M@^)VQ!@O0ZG18(6Z/>;;?:?W11UAI2UAI*#5.4D::,? 7][+0P 1C- M53"CJBJ8JOHYZ5._3U%L$Q.Z]*:."5UU_0_X5;B_[^9L!!-PM5&J^F?L^004 MD:.NCKS9S,-]\T;W54WZ&FRI;5Z\OU#ZYODE?9UCKC.U&C):U$BAL@E?$R47 M3UDN[I/GW,[[Z;S>;C7U_I.86/M/D?5L^T&HW47SN4.-=4TGR7G.-MGE MJJ-!O4:P;%Q@+:VYFK?NHN/47.G$FQ6]]-4W^.@'TZ6Z6ES2__/\>^U7YC@@ MB[_Y$8Q1].&M:5\:%U45S*K'D1+,&_CWGT7S[\(D,\_$KF@/P/;;:=$;JP1S M82A.()GU9DLW6B":VU,NE5-="%) $[&-"N^)?#NTF0)M4A&1=+_(% M1V.IQ?:ED)?[&)8U?'*(G[-SK_E5V0;G*%O/U_LK^4A5Q>I9>@]D8IK1,+!0 MU_5">#;FG\%.=U2RF6+_*ME,::=[:Z=)OEF1/:6);E6^6=F(([\L]^Q2SLY" MM[H_9]VJQ4%0,KI53^E62K=2NI42GWN+3U52J8A#Z59*MWKKG+=NU5[6K5I- MI5LIW4KI5DI\[BT^RX,BIW2KTA&'TJW.1[>:%:=;#;TP]&8JV^:8N:?R[.M- M0^\T!^^'_A1/O]$9&/UT0&/[JA!^2KH<1*UVP H/2L3YQA-QBA92#94$I+3I MLTH".D?+D%D<4:!<3GY'TWRSQ>6FG M.?/<29[8_\ES+%@7[I0NI;2M=IO@S([ MM5[K7(&B5>Z#OWF +S_X+:/;[,NT[[;>;??2)O@=O!2X\C:%7G&_9DV$EOGKI'3\%31PH)W6$J-, M_3WU$X*8L/K09^9]W1S#8#^8SJ.Y")""4A.=V6X]O:J[+,CQ#3VC[*K\Y@$* MB?XWNVL89L<:M+NC=KMMM9G9'+3;C/4Z_=:XVQ^/_NB]^?0-SP!*TDMX(9!; M4"3*+-&=AO]E22]-2:8_ 6(2AZT%3Q2? *NA7]<=GT__&/KOEV7_\M/S;B8N MD1QR'Y:Y#FOAF/. ?9 _?+3L8.Z8BP^V2S.BFSYF!]N9K_)'?!__.CD3E.[_ M)K8)Q)O%UPWXZGW.Y\U&9]#)_:K9T'?\O-/*?\FZ.]8-JM5O]-$-6:I!=1IZ MOUNR,0T:1G^W)[W^F$I)47H'5FHS10ES>DF6ZP9H-2M*C>\]\I^-%[OX#\HI M^TN,LI>KXGSF H?XVI<(=9U->MZ&N;Y2U*. )?G[W_1N\^-+U5U#WU_/+W+V M8"%[_AP5 C"IAPOMEHV9S]P1R_,W;75 3H\"Q*'04NT-#V?]".F/J@9RY+9CM8V[\-W*5:MI7CN)UG6"UMOH M'#!R4(V5.6@/QVHLR<7;6BV#Q3A+]<,02P/SS'"?YZ25]>;[6YGT.PV MNT9K8+PWF]TZD':G^X?.GO2F9:P5OY^?1BP(M!^8R\9@BM^RT/8I]$\RN*:9 M\+.%47_*/PW"-/*;Z4:FO^!^',H":'9?1VB?S*D[5M"^7+,N2PIJ,7SVS$/V MACCY596B(R5%STV*=IJ=7JO3 BG: 2G:[>@H10<#2R1/_\P>'1:&]1MS=&_Z MELQ@TR[-8*I=C$9>Y*(@#4(QL+TD:4=)TC-DJ^#LP0&_>(]"$':X@>_ MJH+44H+TW 1IO]ELM_I=$*3]>JLS6+)&9<%C#"R.6.$@4#&6 MJ24J=&?-:)/X[%=5?#(E/L]&?#;;O7:7Q*?1;G?>FX;>;S4-XS_LJ:XW__"\ M5Y.?W]B3&9R[Z-2;]7^?(2,];]GYUGM7?/N"(J;.(?ST9K6EY[CHK572LR32 M>O25LH]3HA0DIE9\MM()'3$E,\]L[L!5Y^^*!*)7,O-U=W=2]-8J MF5F S.P9O1[)S,Y ;PF9&459F7GIS68@+;D8^2F$IBGMW< M@:=&[^#/&4Z=(+6ZU9:7TZ(W5LG+8\O+ =J8K1;*2_C%T(6\' Z'0F#:?@"2 M$3-_2#*&'O4=7I=!M#D95PE,)3#/:^Y4Q,#_G.'L,U;FH*I2TRYZ:Q4.Y4MP M*/>0FCK]U&Z#U#2:NMYO"JEIVW:>:_:+)\#-9?CRXA%E9M;<-/$SRJ5U/;?^ M5X1Y0#9#V!E\A$?>W4 )4)43=%YS)_[*_YSA[*_82$#4=E"&ZLVJRM _B]Y= M97D>V?)<)T/__///(R37DDO7^.C"$DW!0E490TJRGMOOR/V3K*/(]_');#9WO 53$E9)V+.;.W%?_N<,9W\V$E8O>G>5 MA#TR/J#>PA]UXST6@]:-/YHMHPD4WLKT(+I(H27<2K2$=7'3M5FYU$]( B^P M\9B-Z*L?V=!/ !>,/IVPUIF+6%4Q>FYS/].*41Y7Y;A%>JNJ)9$>)JF>0#I.6<^Y1ZY(U8?P12!'O B)5254%5"-6&[YCO^YPQG M?QYR]:^BMU;)U9+(U02206B4DCVUEKI&1X_%X%QFIS$DE*96D3!CI^!W_2^51-^;3";%9HZ4_KA4C\TIQ:[L,U**W4G,""3IY!W_4Z5I56^C5A6[H?_^ MTZIV]SXTAPZ3T@O^D@--S0QQOIDO)O(I^Z#EV\0@6ET8Y=P+;!+I/G-,A /_ M^&A;X52,,'W7T M#;_:AF=QB#@//B<+UMV14EB":S4Q_\7'=H(^X^@8.M--> MT@I2?T_]A)@FK#[TF7E?-\4 M7>7ZHW6Y;;68V!^TV8[U.OS7N]L>C/WIO/GW#HX,Z MXB6\D/K+I/7!(NA.P__6GDV@B D0DSAL+7BB^ 38%/VZRYG?BF$0U<,QYP#[('SY:=C!WS,4'VZ49T4T?LX/MS%=Y*[Z/?RW.Q�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�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ȟ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

"@RZ)BB M+#*V'C-U'*4C#^,8T^-HHKP.+.]FN=ROW]]-JQ,U(8=((_H")@0272*I14L< M9:OJ6[VDX]?:.7B*EG'G/0\,LR8*&#E]_HB'_W[WVVY/)=Y:=DS:6>2J%G]0 MS%O+/EW("$XQGE!D;1[A;%L>] 02QAWP/!"\SJF6D;/NA[%9_8H[-J,0-B(Y M$CXD#RHJ#[Z( %XQYY12ALY=<_0](&'<8<_=H.]XM?3C[FTSY9.2B@_>&D#/ M YEQQR!8<@I8SEYI[1Q7K6=1;*-C+YBY9P:S9H(?=11H/2S'.9NO9GGK*;N? M#9LPP4*M*0:GZP PE1C.(L&R'I6EQLG0 ?@ZGOO5HX6XSVFVTQPX.^87:3LW_[\S $D9V M9,\DGX>9-5$46L\8H#)T38J2R.DJ'HPDJZ)B"-'NT[$X!NW[G93G]N+U+) P MOM/=7$P3S6TL7@9 5(Z4)0M$+VOPRX,2GL)ALT]%5E.B]H/X6^T[?:K#OTWGG4K@JC(,.@8'*M8;)%@[9"^0FRQP?=2 ]54_8GKIG MUP9R6DU.)VKNH*CZB>EFCR6P9UHR&6ZY0PY<95FMC0;O4@%;BDWHC&8A'8[R M%J2-\Q;6$\3/KN"^#/F1[#],?%K&?:+_!(4J4K12]]W[R_O(VD4_H)42+='\EDR#6T3^12UUT M\<:7?08F-B5JG ? GJ!]1J5V.%V]^8S6R48=_TC#:XF,[L;7;HKF=H#M_VJN MN)N5L5?AXH]P>8/E>;E'TG2V2>_#H'2P0<3-*!M6O<,(\+PCBU,PGJ,6X*3( MH!RS$)@-0'=P(A?3&Y4WTYM]CRS^>6JFZN!.80]BRUNQN(1,(DDD9$MBX[+[#^FEU^FL_80!GMP3.,().SUG!O+1^Z\^8PBI^')3X15BVL\'$Z?A[[ M:5IL4]OGUPX0I9UEQ]J>!A8],FZ#!%N"J$]2=1N61/#6*+121\6>9XAUB_WE MW<[*Y2_AHK8/__D%\?+W^BM(D[_\N/N!==1<9UW_\N._,'^>SCZ_P>7T\VSU ML]<#Y@Q:[1E=2L:H0)<2&CI640(JCS:&$NVC*4+--M0UY^99!&>'H/31$I ^ M@-"!G["-Z=7@8A(EZNB(>A5CG9@8:@%& 5VR8RB]H BA,:"?HJ63980C8V4^ M@.(Z!>#-[@ C=,P,-12N=&T:B765GH"\N%[R^67Z;74,G=0IB4C> MA_!DR4L*$+QT((I)THA@N&R=O3R.TDY6L?9UEYY!Z1U >PL;-V>?YV(%]X;. M:*:S'U@ S\BS3D$I))GJ9%H'?$\2,ZZ!/ <2YD.HI0-\U>J!7R_F_[IA:#W] M/Z 0"CEHJR4H'CV%:8H"MA!RX&AB;+YB=BLAX^*JD9*WC*H\3>(=P.;>37![ M/?Q^6P_%4O*ICKP2@62D-"=F)+=TO# $YK1%V7H$ZDZ"QAWMU/W]>:H*.YL\ M45\J_\#++_,<9GGEY5[_Q+U\U*3XP'QPEDYL(?:$85 [><$5C-EK:Z3>1.@^ M$R?V^.A>KLJ3E;YCR$1K#71E\-[1@9V&.+T@AC[,E].5ZCY_7JRJ?>\>:H1( M+F7! 67E+V@&ON3:&N4D71\EAMQ^L.EA-(X;5K2'XEET-7IW\IJW#_35/%_. M7\\O:L'[8E7G/O'1.)(- UNWUJE"_JSG)0/#K%EB*L6R7\O]SH\9]T(=QHBU ME&P'!NN/\-?TZ]77WW'V^?++^_)I^K6^."/Y#Z]7"9_TX[XCBA,T04@?%?&3 M%"A)]CCFPH S8WD]'8JU+AXXD,1QYQP.9ZZ&U%0'0'Q _#HJ_S3_!3]BN@C+ MY;1,,5]7.WSZ%UY\QS_(]?VRG.223=+:D!666)LJ. 0D7GDL*EN9Z^:: 6/0 M T@==S+B<, \A^9:=U>=J1]EU5WV;EY_?0WD\JWDY^5.']M^Q90D5(.[Y?QB MFBL#]'7&V1+S_8APL*:'<]$]:$O$*,(_<\,$&F.D]9"LCA38*UTG+2M($K-- MEK[+6[^B/OMJGL*SLBXK$(GB2,5SA.B*!:&R2KPP9*EUTO+?O)KG$)2>L9KG M$"!TX" ]9F/U/&'0.(8A@\U)$!?&@XLR58C?#V\+;;0 M\T^AH/4,?I_E/-LJXP.\/6N.N=KKM8L(*<#IT3=.QI U4XX%R,Y(-Y9;2)% MNJ5UEFH+&>,FS@?!SZG"[@ O1Y:!:&0YL?J,KY@D)S9*\#9QX%JAY(D.B&@] M&OP_56#-_+ S*+T#:#]=B1)*1!FY!I\+A6 "R1%Q24,BQC37+(<@AG'47D@5 MV$%(V+L*[!"U=("OV\/]L"C)9ZR3/ 48AG6*)^/@F"2F?$PI%8/8/ K83DD7 M#MNI:GXJ 7*\S#M SO9J-O(5?"Q<0-0&*2@B'\)YAB"%TXS,/2?7HIOZP:$= MM<:X.5WB';'5@ZW]KJ,4V!48[\OMYJA:;@DL=#:ED!0$14&\1#JOP3(?G??9N-:O"KOH MZ<_'.D[K3\+I1!5T *?U0,:/%$JON;FQTA%YX"HZ0%?78!01(3!A@7DT1AJ, MJ;3VUI^FIA14)2OCV\"?")' M,:JL=0Q.R=PZ%;:3H%ZJ21O#J9T2.D#4ZB5W@P6A(QH;2!I%,?( K"C=.O^UA8Q>*DH;H^=4@7> F2>[V(U71><4P4992\L$G0)I*7 EFQI# MTMZ&UD'>2<,F!BL-[=1%;Z*X3@%XM4!SQ2U ITUUO# M9(S>M0[K=A(TKF-^!J-TF@IZP=/=T7C,3Z1HQ?@L@&N=Z7QD#8$%!B7I[+*, M&=4@5]P.FL9UV,]CHTY31 ? VMU9Y&J[&?5U?C6[G 3C8HJ2 0_148@C$8*HA6]2!FLT MBZ9Y[^I3M/225#]9W4_WU!\O^ZXPM'(A_R3=8'W%>E]N&\;6@P+>UHZOY92. MX-O9U5=@HO8S:,R>'>YP^CN9>,O/#8?(, MNNP/N\N)<"+YB'3BDM6@#"?A"900@HZ.3B$G*H;%XLC%$6?#UF&R/AHKWW$1 MY\W1N!TBWH[GE41!M4GDFG M75F]>P'5)!9%Y--Q]#F0%(6(X*I0O0E,A<2B;MX@O960GF<_M$7:H5)O: 3/ M--3AMUF9+[ZN?OVJ9A/SY9Q"^@]S.D67])?>EH+ITG]=_EC^$9:$\G=X M>5F7L7Y>X.H8U@6<=X.#;F:B_;C[]E"3'MTW+GF?'POI3EM3HVO:@[WD.6DN4,WM4TFZ%_!.D" M"&E$REX(W7PAZ,^I>A8S%PY!S:,$95O%=.442W#OG$:!3* M>V*C[O1022F(K$BP3GHFLS.F>6'F?I2-FPOX_"->7BUFM2%V4C PYY@ O6KC+ZL-N4I#YEF6[&/. MS:?%[D]=+P]P@R"OJ6HZ>SEY.G:Y?OV^/FVO/H?I;'EY)XB)DQB4+1YR;8!4 M6GH@P2)D9A/7+!3TK0J) M$C%";1P'79B-2?B89/N)@/O1UE]"[F1@'&80C]-29W?V+1,/4T#7&! 1DV2*%\Z&*UK=15E_N;GAL-=,0UW9O?OOY!*+4SPKD#PY M4+4WW%E=0)D@A-<>M>BG.N&LJ;KA476H_#MPVW:+1\HD8BD6D%E++#@23](. M>%T^Z4EDY!.? TS]IN_. JJC]-&EA?KQTSR18SS0;U)07#TUQ1"+@=>Y8L)& M9V+PV'I.S1%D]I+0.QDD/[\IFVJL*U#>!=L?IY^_7-;,4;H(TZ^KU)%1QGN7 M$DBM%+FA6H-3-J_ZLCQYH88/6.6WB[)>,GK#0:^97KI9F'A[F'Z;I8NK3#<( MG:H_K^+_I;/T:?ZPC&RQJ,-^:M3_JM ?WZ2'9OGVP-$/3E26S#-1@!5'O ?N M(&CFP"(/)A:6,&]F47;O6FQ-82\IO58H[4B?(WJ-^RRK=#(JAIS<7I-60S\\ MA,PM2"E09I&PL,.@V>$:T &3=:U%W,P&GJD2^L,"/X6_UH6V=Y*X]\-AEF^J M98XP?3;P>J?1Z8W$&KG<\IZO/6-P>,1D4F@4+N.@\T6?!* M:L@RUQEY*DK?>C[8>>J;MRIIYZ3Y7^H=-?^*M\TZV[K!'XY4O>[]]CK2+2P0I$^0A F,*VU$\XF4N^CI)6:: \H4,= M+)0@.:@7-ZB_=!:#JX,M9,";3< <6 M:*?-__UV) ;SH3A7&R"("2 )90@Z*-">!59*\,(/]["]B[)>GFJZOC$'4'(' MT%TS\'[V(*&+RX^8YI]GT_^'^;?9V["8D0J6$]3)6VTRU'Y5.O,\@U-:@=.< M9&?0>-6Z=/L@ GN)(MHA9'XN=76 Q=>K)3>_S?X^6^#JF2L_P>Z#_>)+/DDR MC+49#[3$DW!UBF\(TGMV"L8'JJM5/C\!I'M\28\G6WL M@;WOG"VO*V(P3V>O4KKZ>K5Z/+[91?65J/]2QP)^QRKG:S=NQ)?Y@3@9^]'^ M' HZ[WN^%,J9* 1([BG:Q#H5(26*-EF*0GHO9'J>\\K.&/W$E#/)C %%0:XN M?B9;*86'5")/Q21=TG"U_/]YSS\0Q2.^YQ\"E Y\YQ^BT*[ N>5I4>J2.5,!(C)+O* CW47 MF5*RN+J3TPUGD9_5>_Y!6C_D/?\0%70 I]T;@0/+6A4KP;/"0#$7P$>=@&/B M];69>&E=O'3Z6N9Q7O4/TOM!:YD/44('B#K\3KA^+512*28T20WK8J!(DO31 M@K0^)*:+#G:XF4>'4-IQQJWO&[G%: Z'A/D0:ND 7QM)EYO[0%K%)45]X!#)=:F59#YF M8B+H$.A;Q:OFKQ/;"!D75XV4O)G"/5GB'YR2.X#NXZSQM6@K4_?/)MXJ! LYSZMV[N5R6J8W]6>S M_"G\-4$17 @B@N%)D.=,3K,K/ -GU7,6T@K=VE(V9:#CF_M(A&U=73R&NE]@ M$^N^CS3KIS>0?;*>+S/G1%;E*T NDH!+ICE#'@4I:04UUU&FQR M[#^-JS^YIXV66ELR;-E8\BBMHWO::[)X(=E"-W4H T[ _<]#UX$H'O&AZQ"@ M=.!M'1F;0.(^.R-+]#*/?AS^K1['#L)=FU3=(2#H M .I/IPM4#MK71CG.+0=5N ?/K0.TT5BMO?2Y]5BNEY6J.P@)>Z?J#E%+!_C: MGCC"8A4IWX'&NF_'*(2@+(,DT&015"FE>7'FI_: NV$-TT &@_@P7N+RQTKPPK+OF MZG "5L]8H3.&'ARR;)*4RC??FW#OX[L$RS%*G;>1< ?@>#U?7KXO]QD0VBAA MA0$RQJYZE1$"'1?(,22#(=@26L^ >$3$V/M;A@+*:=+N "[OO^$BU%FH#]N\ MB_*I%(H_7*V$5LR13+P00!XF4[$P+IN'OF._+ M@T?TY?O91UQ>$;+>EQM+3H*_?6/).O',(IEM1J)4SD>HBQB Q"FSP.CH=S;& M\1%D=IPB/1(M\_.JK@-T?L3O.+O"Y23&6'2Q C*B 24,AT!\ (LL2\N3S;'U MP^KZL\?%T>!*GC>0>!>[\*YCE1OZ)SQHRXR.D'WP=:@#ARBC!JE32*Q(ED7K MMMT'!(P;$9X;-/Z9&, Z&@-G(JA3\WNJW?SV7P=^3X8+S?Q1'5R M@@.3G,Y$5!XB3XK.A. 8?/2"MQY@]20QXX:4YX96&YUTX P=7 .[6?UZ71-; M"V"#BU(FK,18'ES?C'-]7?0U[D: MD'R;?UC.RS#%TMVR-T"!=;>\CEB4G6,R5B<&=2HM*,T1HG8,1 B1&73,R,V) MO_\IRMY(^KD2G:T-]\5I@FQ?%!2I#"A6"H3H'1B?"X]1"%589R5A'56KG@=!!Y2$':+. M?I&Y?C5,7*6<,MA:1Z X,^!"HDA?\F1U2*Z8UJ'P,RT).TCMAY6$':"#SA[B MMXWM%RIX[W*&D 5%-BD)<"XSX&@M'3SN\)&;] (7(QRDU ,7(QPBX0XLT,Z1 M7J(^N2G#0$DO0=45WJZD JAS4LP:&]4YVI(.FLSW$@JF3[D=FRFT*W!N&0_& MHO>!%PE&AE)?A"UX'TEFIA3)E14LM$[-/=/)? =I_9#)?(>HH ,X[1X*Y[-Q MQDH&R7$%*E@!0:("BRF;J$.PS4=;/-?)? ?I_:#)?(2<'[)@K6)H M+#D =:$\)^J=B0F83\HE53"$UE[[%C)ZN2L;H^=4@7> F3T+GK1$EG-Q=5Q; MJ&\0 9S0$J(T/#DGA#&M$YK_J8$6D.*FT MILA+: K/52ET]H44@$4'&:,2!L^RL/X0HGNYB-LA:1^P#J;6_N9$_3)?+.;_ MJ@]9=Z.+B'UNH&N<1?"B,>RN$2.WCNVV4G-RF>2/G M]^56L/6#;@86AB(CB@!T>.M45J;!>:F@UM5HGX/#YH.0=M$SMJT[&0F/.CA; M";^#Z_U_NA#^(:+FX@[96-"(H-LBN&@5##@I!-@C9="E%QT\V*; MK81T!IIC5/RHO/M4>8_\"'G?E?PT_R7,_KD*4I;ORVLB9'K[=';_Y]8M\RBR MQ201I+=U[JTM$$O,D'BQT;O ,M^LQ=CV.'D"">-FS5H"ZIRZZ,!./1#=752< M0K;2$Q580(\T0U1%+*5/-C@!K,S=V2,'[R?I-JG;,N1L"<]8DD%7*=-Z[-.^M(WC6IT9*KN"NU9ZZP"/ M/V,G)\UD';8G7.%U6)L$ATJ!(49*\"9Z8P>X,$]%7W/;-R[Z6FKI>90BA]ON "N2M>U-$]=8QAIR%9*U;^88I&'AX MZ*ZS=#:E4%8[-VOE9%U]#3XS"TZP9*K+F4/[A4F/R!@_PW"BWK=9F5-$WKZ>2XW!9.4%V,@3W\,/"US+6 +Y^K6'WQ=- MV&<>"O/68HQ,/5H$=S!6[)B[)T; RC&R[1@KDMWPH]&65(-#'2+929DY>(82 MG#%6&:V-#Z?:E?5GC3,R]/Q8.4JV'6-%F/6=J@W#8@L8KUD-$A$<2E=W/6DC M$A,>3[8KY@"L-)_/.8)=.4:V'6-%KOTOH0.W2G$HGFM012:(&34= !V5#%PR M_K-T[;Z?M1=6S//'RE&R[1(KK[XMIA>D:W_#D.0\%%'W5BCOR5!JNE2UJPWK M$;44,?D3G-N-#]L++?8YH^44Z?8,%RG6ME*D[.DZ!>MC)'_=E6HK!6!6! D; MD=O-UIR#X;+^L+W@XEX 7(Z2;I=P^=]A=A46/TC?[H8EEYVPJ78)Y)A!&8L0 MR$:"3,99P[VR8I\BG3T_;B_(^.<,F=,DW#=HI%R++&?-O/'@1%!D+$,!7QSY M\59EGYE)T9_@[6Y^W'Y9.O8B4'.4B+M$S1]$SY=[5ZW71+KV%N)JQ;P4 D*D M^S9G25_;S*+9W%2]/V8V/FP_Q#SKQ.XIXAT9+ZONL?M5'[>KDJ,267!(*DM0 M*!&B2PY.+#(Z780^* M7R>-2\Q)<@$:A2/&N818L*XLEA3&%^OHVZU4/^:CWPG*VE3W$9(;6>%_3&?3 MKU=?UPXQQJBY<5!"%J"").:%(A-ER$$V6*Q7>TWS^HG*'WSHR$H_1F7S%O(; M6_'AKWN$H^,"90@@;32@(EU0T14-5EN/.=@L\EZEEC]3_/T/'N,1?GT&[TS-UMJ28\B*RR$J;K>0,GZ;V7#%AL?)NP/8 MW'=J)T9HJ5@1@%%0\+O:KH9<@;=:.&UKT--ZS^S]S^^IG.Q(A>YH8#U(NL5%*DT$5*8 K&;-E%$NYTA@<&R3T%$BTP<SYKJ^W?LNN_?H$U$L .. M53HU%@A69$!?2A9%V]Q\,M 6,L;=[3NT/W.,K/M$S;OY+*UGB'C/..<9!/EG M)!Q$"%$9B%)(&8/E(K;N*]Y.R3BU1.?"SI$2[^*^NB^97T/"5U_G5\1'"$HS MECV4P@T93R?!,24@DU>?Z1;.X='\C;9Q]ATMXU06#7MC-9!Z5PYS[9&M'*QZ M\2]_6RZOZE4\R0*-Q\*!,T;\&$V^/W<*=#0L%%,V?-4Y!T7E< MY ;2[0HMFWQ(GTJ0!:2N^POM:L1:("$EU&1/G?=[]57L^HQQ:H?.@XX3I-G= M#71_WL9J>T[^@(M4=?49)T9I$8PO$(7FH+BUX*25P)@UFO$HLAEB0.9^U(U4 M:'2^:ZJ9:GH>C?(N+!:KM30MIJ$\^F7-!J#L)G/8F2>>'!*9, :Y0E'*H.C M>!J2]M(&YSCCK;/JP\P\J8=D/9>:?+#IQ?3RQ_5#BLC*9.L0,$@&2M?ZN6I, MR?_B/L4;S]%S/BO""=BX%'@U$3L'=Q<#UE8E68H%%[6) 3&723>7$R^M:'91L>XB#E5MSNAP#+UIT<(Y .5V_>RU .438'2#F(WZ?7WPGW_"A>-:%O4Q+)XR"P!%! M*><@UM=8*Y6-(OJ I?5C]TZ"QGWZ;HZ@=L+O $GW+_!UT:!$)K*-1'RB?U! M!U$J ]:4$FPQ,NG6\'E,Q;AOX,TQ"5-.I-^+'[?LT8%-$<0:HZDJR.? [& M>T!F12)W3=JRF9#:]GRPSV?U!)!C-3H?4+P=V)EM]O:O#&*B@^2"E]5DF= UU/T==?8O!(6.P!N"8ZZ@!_&WT>N/@Z,2)$ M0587?! D*IL+Q&P1N)48"DJ+:M@6F$I%?TYV&RR=*.\.$+---A^Q^@ET#!Z? MA\ 2YLJ3C+X&LM*",\&!**7$& R%I,U7P!U$87]7Y'!6JY&>^GMA__-RGO[Y M97Y!REJ^P3(EEAH\M>_S6T]\#VNPK1?H2EIA?S?)'O)P2<-]< M+>@<1^NYAE)2!]?FA_"CWOC+7^>+.P[)/L^_?IW/5HQ//!/>IKJGVBX'6U MW9]7<8G_*FQM%X^G=MS^Q_-=SD,I\%G$%G<+ C^%OW#Y$2]JO?+E?-6@ M3C<(?>@7G"W)A_]M1K\'?Y\OETW#D%,(:!^Q-!/'>8*;G'WQT23 D$Q]#)<0 MO'>0")YUZ*GC^XWUZB:X>972U=>KE=!WB?QFBHL466CREDUV#E2B&\0SBO8E M'5*&.116-F==GLK](?1U'=P<@IQ-^SF8DKJXW(FMZJU'1AMU)*!PC;X&$]H-2' M[)1"J.X%*"9X75M?RQELSB0C%4OK^N:MA(QMM)HI>MY:ZAU Y]Z!>X>7?Y\M M,%Q4/_6WV7=<7E:Y_8VXJF=N/:XXQ,SI]X"(BM6AZ *\*KF6W>DLBXY)M*Z# M/I3&<0'7 !9/7X[M==07!M>,$)^OP_++KQ?S?ZWF$7U8B?Z&O4A<"$^R-#'D M6OF9R=&( ;2+)J)1^?$(J(80W(?$^SA>7]?AM'#J2HI/.*"@E(UTE'"'Z[(&[(IR1F8O8.A'3 M@NYQLXB#0O4\NGQ&^%UWUVA1-UL;"-D64!29U2FE'H2.AKN$VKC6XV4.HW#< M-.%XF#Q"/WVA;U?,]OMMX0:QH'B=B& H>B/W1%GP4N>ZFC9*)W.R>4#\[47C MN!?XV:+@0577 31W,?4+EOD"/V*Z",OEM$S32KTDU+\F1D7)R'4!ZU-=^!(E M1/21^$TE%>U"2JTCY^,H?1;)FB/1LVV\[;"J[&>BX"8KOY+L7\W3]&9.XO53 M9V4O8%)>I +&E-K>Z.E6V9V%"VV!S$'5U;CZ)G0_5 M>29U7EXNIO'JLMY&G^;7<2"?2.-Y\DZ!TO4?@?PEI[V Q%6111JI8NN\]@GD MCAL%=6-(6RKU9&NZ,7W^/$_6UP.QEZ$6UVU<)SM>;F\2(C=/O ,]9K)X'YB< MZ_ "L68^*++P*:TV37CP==BE,9)E*XIFMO44XY,('ONUJ1FV?N9D#*?&#CR/ MW:]VEFX>M$Y#L*7NT125?;)MO7J'3[9GY&8!STB'Z(ECJ W/:T M'W.2RU3J[E==0-G:B88D+5:,+S(ZAK+U6].S>T0_2-%[/:(?(O4.H'/P VW* M)AN7 SC!5[MCB3^OR(_VF 1/6HCF,WU>PB/Z0; X]1']$!V-VM]P[",MI^"Q M*))FK92O\^[IV$:E0)I,O@CC/CV:#_^?9_16&&RNH;[,X E/KTKZ;#&0B\PE M*!(G1&$*A/_?WK)+_1\(9M*3C;"7LS"%^6ZJ>KFJVV^5:LI6,^:RZ&"$D<5!1"5S"-! M,.!80Q]D%X8;)ITR7=Z-CE*_F (!!(A@^'EMD3Y_W8]\Q C[L14VK%H:CW43M5IZN*=OM#7#AC&2$*:"<#T%(&:)JBSEPEN/2B;+@(G8*/"+[ M:0_VZ1+FJ2P@ ^._TM6!,BT?W?@^C E'J]W3H\BTQ Y)QY#\H MQA4*%L;AZ)/BS^(TKSN@5S.LW>*2\5'.P)8[U7L=%;B$%$-*#2AT$4)T!@$O M&0(.*J=MB;BCL7.O@YG.RVFGLO#7Q3Z?DM1#6OWH-WMU-UN)KQ^7X9K42X1F M^X.WC7*.5)K=6DJ$#Q )X-@&-V"A/[UZF)S2"!%(68EBM]A[50'3IHMSV4OY MVE0&'YEC=9I=Q$5.(&4@!JP(8[Q@N+\LPT-,CDF!C*"&QZY<&,ARVAQT[IMB M#-S/-_,TQ;E/=2?U<3R>%Y/*F5G7I(Y5F1N+KU'+&?C-KA0&G!&*JL35Z MQ)8;;[LI51_+&=24J@](&407QROZ2L4,=ZX C@LK"7_3EF@)WL&N5(H&5@CR^3]+>FM"71!0*V#)/-:5$"H3@$%G)&$()6 M\=C.\"47B:UK+,#W#2R[O#,_X>.=G]-]POMH?^ G_,/L1QN*5NOU039A.&+KM\MR M;.?YU5F'* VLI^K$8*0*J-VUMF/5'"PT\;&9),R':E@YH#@J 34DM((G&);1 M.U =X&6H#_&[8GMHV@K(M=;$2B ,"0W,@ZB<8>\/:0&1_]-2QD[-[64D\7UM M#/QWW<9PA6=P>'PNQ#>_ U>>]G([C'KM&=_)MM*WR!)!?%#HQ<,H#)\)+9S\ M0;RPL.3K*8UM(B&,51,XN+T)LRP/?5) RK]GN6*H%"#38V_ML, M#?>'%:+"HS:KE-48H]CU<[V93'O:3&F$YZ"4@1G^RU9W]Y[O"W]*E7?V\R)< MFERYU<3SJ\6\GO??+*MJY63M])>"/3^?+W_/"VC-M7Q<=@%KFO"\ M9=E#R1^J_2?!%@9P2BT@7 @@?#SBC^R40UY@S6#LE-MPKM,ZT5>UX%>&.-^O M_CJ&>:'EV\+APH9VH0IKY6-KRX#0*HSHH,YHSA&&L6M3>[*8-D6<@\.- EZT MMYOQ6L_@,_DB5;\^XT/JN(;+KWV8^EK%TTUKVS[X1\]61AKP@5O*/Y:K!"[ MA&M=)0L4KO>T*?VNL2X4]CL%,$)"64M*_WF/74P7@_'$[9_'^#:^/J#1K#C: M#>OO7N:[Y;\/;1QJKQ%_#)KI:D@GC-,T!]ZZ]F0ZTOUK.$Y6\TTGY>?+5JV> MU.WB!\/D6(C2FC"86Q;>+)3_,#IOIX@[9Z B3C$3>9_W8G"H-PPY]&=+K&JN M.5%":R]LR:Q9-966HJ#^ "T$@074J(R='MG/2=I8;#Q;V75B$7#(X-OZ0HIW MCY_EW.OHRFU_^W'Y]IT6W$M2%,!JY",17EK 5>@$R4K)$$4&1G\QUIV[M%87 MPQ9.F5<<8+(SN;54ZT?PAGC]*/\1%Z&K J$$ E7XT"+<-U(F><&*<;W8,W8R M,ZI(%G#4T,Z'(Z%EA1$-'^NF?9S?^S!D\LNW]I??KC_-]"\^2OG-?I_8^?Q: MZK]E8S[,_&H/3=5NWLY)3)14F"^O3L+H>7_0(H[ZJ%90Q!BV&.UV>]TW.>.\ MU7.RKP' UZ^*0F([^S0SE7Q?-5;[OR/G?C-^L=_L;&$_>:$FDRKHTEXWM;8V MY(V?^AMPP1 A FA_\ :$%!HH6VH@E(,^ +$2XRX36LY;/6U^8PP[>P44$MO9 MQ6)>S^KIXWHN]^_V3D[^D/- ?"T,5$YBJKWN2+@M\T%%R!&%@1YA_CP7B/+= M.0-[A_Z<6BAM 3%9F46-_Y?K#=- 961A)8 M">(-FF'A?: 0P%(&E856J[)3Z5DOX]BNGR;FB8'G0=,X4[F)/S#77E/50WOM M/>!LOA5HXP"%<8)!"*BDU)\HI 9<%]8':$QJ:53I7CP@VO=Q.;I(+J9P+G[U M&,I,;!67,A-;Q?O'F9Q6>GU7\_A"%&X@HEA%3H8EMXW/]=R4/F'@A+2/:'[!T> U)D/#?5\D)()@A6&@$>=DE MNW)DB32WHZ/81"Q%YF@/?_[R]9=P-&]FJ]O#R4TCC5U>UK3M5DQ*'6/>_86' M1P@0+[4_@&$-G(_3A!?=^\4N?F0 "VFFUKZ>/8T 1&)[^U)\M=Z5UC.S",F@ M%UO'%(63I3) LE"XR7RT+V"H&K"P+$QI.'DQM7Z?39U8)LU(V5'L)J9"4R?1 MM+9M>V&^R9 .7&Z%Z[J>_#FK7!5*T,-O7-:+YJG-7>F5QG1H8L)#28DL@3"4 M (X0PI)@R%Y4:!^8H]UGV30C8D>QG3$5GL'5Y;M%6\V"@/K?BZJMEA"%/ )3 MI2TU00!!+P&1" %>4@@(])]K VV)9>QKRP.LY)2LC7(/'D/EF5I.^&EC-UNN M+!"W7&F >'"KFA @(=,A26!9F(/&2>R:_)-,I;V@C )]!W,Z'X?DG[$$&;I7HQ)HXI!35%JNNQR]CBR1GW$, +*.K]7$%P"7 MH4C6-EZ;\\?/!-A7"&Y!=B%L>Q:*B"$0@"6&*/">,FZ];D]D?S?MW;: M.N;(=T.#E9O8.+[8AT6C[\,]R)W?,=-56/9,I/4N(IIIPCD"1FL>ZKP)4$4) M >,^U)<^:E.DTRN-$Q;3F:%TEP;#,:_'!B#Q]^@/[X^;]O?'F;[?Y!&PP5AP M'5J3AZ$V5 #)PW8K2N$@% :K+C4*+PBGLX*1@*MC:3&Q8WD:G_6KK>\:^7!? M:3E9W;5"A9'E!(3T07BLR_U'U.M$2%>45LG2LD[O;TXXDH,,I,GLC?3]B:/F MU+9B[W9%V*0?D ^J#*, (2T $>&M(\<.,$.$*B1AJEL9\"E;.<1 .O<2"=@Z MMI83FHH.[K5YO'WWY=99K0SW/I SIP$IL 7<%:%/F8-$>GD4/O:VI[7ZE[OZ MVW^M*:Y,8_V+K65LUTMH!G% JP=I,+%[^+!HZH=-A;!3SB+)';"%"!>BS,=9 M5'JQH9&40:&-CE'2]N.:Z0H1XJ(_2)>I"P\6;6LGIF[N$B(06@0!)SF1L#2A6667@\5+TNDJ"N*#/U1S&23.7P3.OS]-=!$% ML>7O)U/J;UB K.RV!6?<%J]]YS,C-R-F_7@R0^3!\F]:.UM\(JB*G?8PR6#! M M')"2<6"<+K%#6!=T]ZS:P7A.KIO94XOHAA17\;D;U<>ZF=KF231)-!:V#(4U M17BG5@H@*<4^./-'?5PRKHHNU?<]E\VL=N 53&J VK,+C1[?RZF\L^W7>G%W M/_]+3A;VEC')E*068(Q\K(=M:-IMP\P[IYA%18E,[$EN)YG*[!YPF)6- T5> MWNJ]?:C;:GY37S?AC>U\63[:+!Y6%^2;>_A;5FKM#*9 64, <:@ "E,""J*\ MXI0I$>]29WG6XIGE]J-[KA$@2)[8"2V_KNU,3L)/+IRKO"LV?\Y,:/)5?[^4 MB]9^KN>5MNTMAIP):"5PQOB]PT@!A#0L/,EUG&*O9+2;]MV?[>F^9F;'N>$6 M-9K"4]= +9O!K3?(6I[KI@ZUR^V.7+<*2U1J P$L0\K;"0M$42@ "48%Y[C@ MG4+U'DNF*>T=T8S&4G=J*S*F6KV'6(MV<>?/KNU\(]JZ4\"NA-K[6XHT!LXQ MXX\@/FI4)65 .LZHEP+[@V\7@SIK]4ZVQ=^2;8T/0JYF)IN#XA%KF6%&A^\Y M#?E:$7H[68 <):KP!UX%.[7YZ+]T)P,3_PD&%DG]N5K7:O]5#RMW*CPYY MA=UENEG-&\ZG#])K?F[JL_U^.9'5M/U83;96SU%AK:% ,"W]!QLONY,;4&J+ M,!&:0Q%[JEX'MKJ9UEO)JX^%1^JN!9MA0PO55J:2C5?4K9#4'U(=!J:$X=H2 M(2"<\_Q['RJPUF5I=SL>[VU'L(=V-Z-X*VGP*!K,Q )693+M+9&6<1_O@X*$ MZ%]Z"^;:,F#]NM1":ZGI\MW9(=L-][>4JAZBM[Q"CXTDVW?K&YE$:7F!C0^G M##=A,!T#*@Q)]M%4FL--=#DU=U^MF)&\I^SR*IC-Q&"&5/JF\).TM-46) MG S/0]6R^S;S83?QW'NU$4WT.77A6SD;&YM M^VEF[#1TO-!+!G84"!NE77CU M4H:G__Z\PH5Q@'H;A(893FCL(4XON1AZE/FC_K9\XO-I]C5,EY2-N9B9#VN= MK5-):PT_+J>JRM:^MZL?O]23R<>Z^>[_T:VVI6+M@AQH5[LGH11P9G @WY'L0NMF(2>WNJ3CE3X^,(OVDE$$A;@(52 NI"ESAV=KH;9VG+=?.UQD$(9NL%KQMK M_ZG:$"_OJO,6*HUA.!J+HB1A5@\+PS>%UZ'F"A($J8P=PO1F,FTE<+[6&@O7 M? U7/BYGYWG=,5MX28"S1 'BN)?+80NT9LA:1DMG8W M4N^9ECF+Z8'Y%[_,[1>KO>TUCU?NQ5I/N;^SM=)Y@3.=2Z"_IKI99C6:=@C# M>PDF.6/VQ6>SHT^I)6%4LA*IW32_>>]_7/9L&F9A+^DEP^NHWNM.2D@,3QBY M]ZTRBW4WK2'([)!*@LDVS &=U]T4D!B; MS_7LLZUC@/*<4C(TCNJZ/B%X1M\5ZTE.J]7LB^!?HWU@7A!.YM3.C0RZJ"FU MR[N[FZ^%NIC.ASF[YZ22Y+N&H+5?%8GQV3 TDY/'MFIO_#GDG?^SOV/$W2^) M)DD(18B]#ZHG,7I?YW]?-_JJN6F;#^V\FJYGOLSO:Q,'R4X+),FW#$&UC]H2 M(WRUF+F8WDOJ@.W04'X3I 9))7@\/0?&X:O+"[?W"WM0?_GFPL]9Z M.6>N;O0RM![J;/NLD^3Y;D2$NR@Q0]C_JNJ)7'5F^:V>VLM5\^7?Y?1VE?TQWU[;UY\(O=CD^\.DV,(I3[K%, MFI>AL:X,NNDP_;.M_04UU]_&J@!Z3CE*]<\19B-4_ES+Q[_::]OXT]8T3'&. M7?C3A?Z ?>V5,[S6YXE(L@O7'BC\N"-WI4]](?2/U8MY]>C=Q5S>/@TM' M]E-,!].NONN.PJ=.)$\FN^Q5-E(1R6'"Z:JOCD)1]]-+8NBN;1T!IRV5E#4E MIW5='Q$\?9&/9^ES%#AV:26K'ND+R@$E_*Q5?,TOS<_ZQ)_UB?VP,?]S4R_/ MXT.WQW-*R6(KSM;8)9?NL[Y7W747V1.#\H>5X8 U>$_\ M2"=9D=JQ';%'T-1![9K;.$FWE]32?;:'G>-SN[^XK+_:B=5S:]8V-/CJ8C_% M=!^2\_ ZJI?4YQ3/BGD*ZJ^UE%JCWHO0]_N)T9CH7B,;K*ZW'.]ZVD=)=^+]4T] MEY,8]\"[M)*5VYZ]Y_;J(CU"%WKN3^*3QVM9F4A [2.9K+#V?+R.:";U03F< M%#V'@:M8KO$0S63ULF<"=T(WJ4E8,K?6(UND,]2#E=A>D0OWI*4:DK*_Z]J.:/8;3P M2I7^>#-=CH-]7SG/C/72QD*WYU+I"D[/A/L\5:8^-NZXF;_:Y4?DZ[W7TGT] M\5K^,H]UDNRW5+I:U;-S=^>H,CO\/]OYIYFNIY%RZ)T62%>R&@WKPVK+#N$7 M2>:QD#ZR4)K))%$1/ZW&Q,CO<3]!\G7R*P[H7==(,W=D -X]E9?=)K^:W]MF MY/V]?XU.4.>4N.JIO-2[6JK%1#:_5^T\XE7W8:J=X,PIG7520:D!?.E9AF9" M#I#L5*V04S+KN&J29_XWSC\^@*=H=T(RIU161V5ET,#^*7 /P\F.@'A.+_#G MM#N!F$L"ZZAZDD<[.Y'WT.VWEV GN')*0!U32^JGSB&@"A)% FP?O4YXY90P M.J*4'%+\4=IC_DBH$T Y97GVJ2%Y$%(/+I7[0336M9GZ@"T4C[]2#5=(_6CF'Q;&.>TDAJ3[OA+V+? M[D,TTSU2[XU6ENVX-]Q=^V7GS71F/D[D712DGE-,]IBJ-TY[-9$)2F''7\Y: MT\2#:8=DLH=29WF_E[K(!*C?ZN];_N)ZP .DD[V*Z@W<<=VD/IAOOJG5U)J/ M];(3W5]R,GB[':.;["E49^@Z:"6'C==>^C#9WM1/[,:[X^Y"/]DCJ7Y;L)N6 MLL5S)!C3/9F*@%XFH*5M>33>H>RXSG\V0?K9!&E($<%J__N_?&+3G%-$\)QV MVL-RIUUT5"D9@+6L1GDG6[M\HVIG[5I_37@='IH0M^\>MW_G6CXN9X4$8;82 MSBJK663,1V$QR?8^;@SUZR&3@>%]F#Y,ZD=KO\Y]D';UL!KP M=L*5GV,]A]=)XCU>!=VZIZHS,([[Y:O6BJ>64' M#VPZ3#5=YX)^J!U320Z0??BGT==-I2/LKRVI=*T(^H'S0O@<$/G5?P'F87SX M1UDUX7UU!&CVT$S77Z ?1H?5D1BLYSO[\8^_YTM3NKR?W5WK86[O!.ETO0(Z M0]=-.;F6X7R:M977XDTCES.-?XC)HM;B'%DF2D%.5S$B5.6\6.J%=9R94SU( M=LB3M"=R[\*,M.$Y^KT$$Z873V'Q[!':$66D?CKXQ-K@Y/P.J638'-7V7E0R MR2:NL])[?$F<]/QAPAE@=21-?U(A_Z'U,U+)"C[/!.69 A*C\F4QL0@JBD)48^J'N1U>EWN(9K+ZSGXXG5!)^O=] M8V!VA&RRVLY^L)U63!8.<,E7Z(HIYS&5Q? M^ /)9)6:Y[O"EPK)RQ-& NPPU637PH/\8':P;0X,S;2:R8B><)=BN@OA<[SA M 7UD@=7[1;-D+ )(3Z32W0B?@\ZN!K* Y8<2@KN[BV^RF@SNHW>$;KKKX7, M.ZJ;MW'+>%U/*NT%N&YJ/>(MX[-E1KAE/"Q&]%O&'Y=Z82,1KAOWTQ^4BU^3 M-S^2CG6D.TT]DQO)H[@]3^!WU%?R.Y9]?'ZNYVM6XZ21NZ^2259Y(,Y']#>^ M1U__0?B?DJW]___O?P%02P,$% @ ;HM<6(&9^^=O10 0<SB]/JU5425^.7@^WM_WKF M75JIZVHK3).+["4-&#Y-)A=!F%;P]$EXH?Z]/>S_-;UX%I1%U/@3WT,>M?]\ M>OUJ$A87\/1A7E7YY.4^//E2%542A:D\A1[('\N@#K:GU_#840ZS*G>,\C0O M7OZP3?^\PD^V1N$D2>J<)@J?^9+.]V.YO\^Q7,-(JU@\6_="GCWZNXN9G.]O]P8N#SH_AT\[/%MUV M;Z^_<]C]\9?>=K#7/]C[!K<]Z.^]V%OJMC_3!/,DPS*6TS#[^[/=9S5A>+DS MO0X&4S@HX+^[_<-#?U>BJ-07=9+$<:KN:Z_U MO49I_.\/1^^/_WWT^M&^6?N*'4^F:3Y7*GC[YGM=N./W)^_>OO%>3+97?C6VP%?M<0$=5YZL/C21S"ZG^E<<8ZNVQ]K^_T7#W"L/=_O/]_=_9)C M;?>@?WBPG$:_S6T/X,/=Y4[+&PX*F3N:W6VTVH(R3Y,XT%M+/J_R:>O'M6U] MTUZ&VSSK7MV=_F'3E.0_WMX"NOEF]Z(J_RA">-(;<.9\3&DWGG8:\7 MYNZ5O+J>DK'^[S='Y\BGL6T.4/\AL% &P_R44_2O6S=ZS6@>+#*: M94K$?%QP,M\H*4N8W4L_[.856L(<;SVN![LM\3WY8U> [Q;6P)?<_GY">2>J M&.7%),PBM744_S4K,1Y_JLJJ2"+\\:S*H\_!IRRIRLY7==X ;Y",YG?T"O4 M=+O04X1WF<'=?WB6 Z5GG]Z_/SK]5V.(]^[@'?0'@\&7.'C[@_[>\[N/!.X= M]'=WEKOMO3IXI.#W^K2%5DO!>[;,\D?;3?.R&@[8;G_04)+TMWLUEX*S<5BH M,KA[;^E[$4+GS C@YR2/5T\25W?V!C9#ANFQX,?NMVM.8K<^=GI6N!6P8;[BHC;]S*Y(I+_^.-H>9'\^FE;"VVG MT':&4+\L,KK^5G><^+DO-7<:3EU.2G[\87"P_:KY[UM$?_D-DBR&6:!7NNWT MK>A][OCQ]Q,P_//M67!R?/K[Q]/W1Q]>'V\=O?F_G\[.C]\$I\=GYZ=O7^./ M9^%4@B\I[\.7FWV@K ,\E%0 MC55@H2!!EF,&(1R"U@F&JKI2*@O^/ G>9E$?OA&\46EX%18J>)T7T[P(JR3/ M@@UYTNM\ II^[CPAB^G^2J/RLG!B[JZ_I2%[]FLP=MJ+<&F253D.=)2G:7Y5 MMB!5OKO5_^>?QZ?'1V<]FKD(+D^R&@0PA4.X9 (+5N%"(_3;^?RGTGG,19%?56.8YQ>OO,>9G !GAST26XF$K]F)5\OEUZ0#5B I"J# MH]$H21/8=K 3B^!L-H0%3,(B427L A3\*%)@G819E*1I6,R#4._B,HA5"5,& M*P;730O8M5%%STC515(E$]S+0ZS1466)NPCDHJS*^D"J<0BWA^T\"6-X&1Q^ MG%@! ZFZ(-5 &SEW9-"\8#@:A4E1OS$+[Y^G]$7\F\I*%ESX99)4%4R=?..W M/"QB_.5-4L [Y(U[!3)9L8)7H[ER] W?2ZN.8!SB=?"RDX2F!E_/6Z]R'*8I M[@9Z+]Q63BXUU+G4PN922\JESC"7:IY[H57?A1JE,*,E/5RNRV9D2\*(^"5XBB;AW)T36&DS8>ZX M:J <'A\/HW'?,!HGZA)N=I7PA#O+@F\T#<$OI26##1F.85EG97]IS4SN%E1LHQM MUIR1($S+7 M8/JQ"W+3?<* =)8KW/C5@-5T5>)[@B0][-E73<9XE$4S1?V:P M[;4*T.?2F8H*!7IUW@\^92F>LZCYBZND1&TW(E5'IR0D#4#>YF,JJ6=C+N?MT51!,\3V;IO5V1P6^7XM8]\Y<\)A>XT M$!QMB^6!;]V"+X_;V^V_0"4]S4LZD%^2(H0CL[-D7,E__@EBMMO>.P*1[#.?"NKVV!J48ZA M8SJ"RNMY2AH4L@+%3J9MJ6^OK=LG<*AI,S\'RQWF@FVB%G>"71P*"I6*0@1P M'1FV-Q\A2PC1G<53'[M*W5D-E>KZ6*_!Z($;A[21FL[7 E7Z$ )P;U;R10YV M,.R',H\2LI"-.R=[RL02X *AVE2CKW0FX0Y<%*URXK^)NRSB&Y7*C! X*=T M7E=+M?A=7Z,;8Y7"^80!OF6<9AXO?&_J*%89.@T(5.*%\#]L_Q=>L OOKN_G M^?J.7[^AKJ-TAHO%(QB-\.[P>5N(8C,8AB5RQ4S%0ZT[Y$[T!;&P M0 .7+A"7WH2+3\ZL5ZS/;!A]I>,MXSS%$(RG8=(8; M[CY_=1+L;V^[(^+X]6;,!YQR'%>#83R:S29#"8].GN!K.#YO1%N/NC,'O:W=_"-\80:)1DHO6DXQSBJ5=$M$5=6 MP[)3P@I#.F0ZDU(QD4A'_41B$_0DW(@:&%5FD="-1L%&LHF(-T?CF>@Y*+R- M)-GT=Z2^#C0J? B?@MHTJE0^Y$?IX8?3:9JHSI@J/XYS(92]D!.N<7!Q[+YI MU^*-SY1$;7O2K-N)];KMFK=C]//QP;T$\Z6T69!@H+15E4*INH0&C2<%R=!I8O> V M9E5SV6Y]2JVF;AVNAFX]:EE 2C;!5GR^P$1F36/TE]Z:M!]UI-;N1=G-FUHG M;HJ[O: N\A:[\A:RL+^W@K*0/*PH#':U+#C'S&_Z%$75_0>>67Q2+!($L-XK M&%@Z]T3"<8NZ7* 0/+WPPJ0R$5X)-_&/W&XGP\O;-H\W/ADYA'B M):IREE8ZI\ A#FZD%TN#"G&,=P(73.V.7K!SG[;%\2Q;5R]WW9[ MUL+R%7D4+X5\"]=UP4.\:W<67LNI6?\;=(IV?BLO])6R>N'_P.'[K? M()MB!%)28B(?)S,J5A618B[8PMW"D-(ICG[5-X0&@/L!T?+A"<42AZH%SS@4+DVA-"=(:M4 M8_+9)9HIKYO),2G[ -,YH*J-_>OMI_J=-1BJ.4+/(*6G.-.TV-IL/)V>2H9Z M/_AM'ER%M+[J.IQ,4]5#";)U1D, M<&=N.#8N_,Z;B1_&/SG+LPM*YXCL>= BJ2"%6HQB\P1S]-*C%IZ]=V+//OJ3 M\Z&/3F2 ZSPZT1>4H_,(4UUU12&%!&V[L4M01#4T/*@E#EGMF2[4 HL/VEK> M&+>RY_C6MIB?[2RUA(PV*M1-; MN_U!"TT%SBS>X=FOU?C>,UKZ\()IV^SIP(4^S1##04K[!F$Q0J+_4*AX%O'Z MDD8;@I++D?VQR5C:NEA8 M48!Y=N1@#&^J!>%P+0CW+PA)A@SWI2,*$9SYG',Q_CN?/L[6ODDH_F:%8J=; M*-IU1:DP"4Z8I'%2Q(ZP4.YFK2Z6E1(T(M9[ZA9[*LO1X*:APQEI/3ZS6=S M:UM@LW-/+-J1%>V8VP0G;V^YK6;\*WKH^-?^C?&OG=O'OXQ'B3'J4PGY?Z$- M&'Z+H2TT$5OR%%\0>3'A>2\)[1F.ZP#*.H!RNR3_7G\I_W-/&FY\%RHR?F@5 MR6'A,U5<)B!XIYB6*0B'V \^Y!6F)\L*A C/O8UP$^4KGUV,P8K?!_69 MP*Q2E(/_8)*T:0A__]0_Z]LJKCB<+PBG].*@@I(5HD MA_T=A\QM=4%T>RL"HK.9]^6!R:1AWNBLWO&BK-X3@/9P?:-;.2$@G]C+6K\P M^VBPPP=5STE%>.?O3^9PCJ0Z&4X7TLT1,B)L+H>=,Y6#-Z( J2ACB+I\HJ10 M4G^W%<5L40A=Q1[VCJ-9.H+3!9ZZH:O+8$>C,5+1.!*,$:!>,-5DI#86*HI- M'Q_-($9!%M:!B#^5!+U &VI# F1NM39%ZA45P>%I/529@EE/L% 5?L5JS32X M &=!@^C:UO;@5Y;A).X2^98?8*%-%:?EY5:KG3C;O?1;@/N]0"8 MI"Z(0LO,17F!H-">ZXR7;5"8'7E"F MRPF-R*;!+ *E-2F[A7HP"DNGW,)5O%/2VAF5MLO.Q$V$M["!RT)AH@P4.FK8 M*(*]YWD.7)Q/GVJ_A7YQCB<$[L&14\$ATO,0@7/V.N] QRW>A#[G]8NZ?;F2 M*;2-P6IX&9-96B73=*Z-'(N&]^6*,(4[*R&E- T:Q$1(@A_P4">-:4/R\'O85($[\/B M,QBC_Y^H$%"?L;!H#]21+M:#K%KJR 8K08X^O!KG*>ND41%&OI*L.:HUDY-E MY=%X,-I;Z07C_ ILVZ+'.PA]C@SY6L"JOR"_8<$)4[J;"D&!.YN&PD.#KT*S M#+12SK32HO6X_KO^9UNC5"!1!,4ZCLQ&SG@U44.O_FN MTB2<$QT0JM42YRQ.2F0 @/GNR1GKGKQU:X%UMEY%601X=ZKOIV_3!R@*I+/Y M?$: */B((&=4!8,KF&%Y4YHCP4P:7O&&(?PH0V8*#DEYN\I_D1!5\M[A*XRP M(H^!YATBM\UP$A&C"K$_L&*9HJR'5"V W[H ^2PH:AFF[AUAZK#R)H>[84]O M/0V.2TD.93$W W=&;J0]AIN7&"^^)EXK)& %[8T1TO[BRU^(7X@_&4CN:1) M#6,LKL(P+7H#"-&<%;!%2W!W^L%1"EHNDT_N4A#TB3RK6I>*N!P4;%K:T')Q M,IF NN1BP;S0OG\88&T?IR&F'+? TSB9J%IPI.&TLP(W5&(7XV(YJG#;K0BZ[(R\4A4/9UT+LYV1QV(]RP-GQ9R$+#6QC(11A6A MX@"K80I^V84B<(=])"BDK!RI DRDI:L!ON_M<; :V^,US 6>:ILIE_FP%1Z#MXU$%4*NRMI#MGC@8UC]0*:/>F'$U S/3'721 M?V;X_!)CEAAOAV<$C@RGT?%KKHUCAE+.0/-EL?"_NG[/>7B]=2I\96\KQ517 M]>)0_8J#/9U-F#$[EV.I=)MOELL!>=","8BO$ZEX5C@VJ#,P)M\*KQ5"6NPJ MH*J_]4K [4>*+'V"][7G8U9DPSWLJ7"X&J?"AYRUO1!/G-+AOR(+=*\MQE@; M&CI4GPN5MP12Y55):B+>Q..@64WJ-"CN=K'YU X:J!JN@K>3V%H(:,0(.''J M6F20F&DF=8DF&_Q04+D>JQ7AUK/+6Z+JD%+='BD__'AO_=T46Z3Z7Y.VH?L8XX0"#=C 'Y^(8"Y&WZ^@" ML8HFN8$5W!K3-)*'(2 ?5ZHRI1&Q"JLQ\O]4@K["49SG$HO"[\.-\,]ODC(< MPM@J&#IJA%DF60W15DT?K>4@EJBY#3HI=A3](%X8E&CGT L0JZ_->S=5FZ:R M,5Y?@VGX-AQX3U!L"0(Z*Z9YJ98\$WS)AJ^7 N*S]%R&0=\189OCH@3(F+ N M8!^BI&=Y@$S#6'4620R15Q8C;W)[PSJX7)222\HMG+A&_4H\$25:I-9J]9,R M5V/5"+6UO[>_54=+3"B&!S5/!3Q']J,+9X3]#*+0G$_F1JG/#88:4\HXA0'X M'Y>OF7J#+ M$%SG5434,0 =7C<2#-50SW2(^U."2):"2"1,^85+7NZY2+-6'7JK0> M26S)5UH5ZEC_+7O,-\"=:Z2-+)Y#@ZMPD:WSW8FL#[C-O\ MEF^C2?O!B1ZO;%N[QSMTT6@&'],PP09,PVGI1A6'ZB+),B%GK!\54U-58BS? M1IBW97$:*V/,68_W-1^"A(76=A7TN<$ON>K3CP(Y>G.PC;)0\YIL!R.Z \(G M6N)"9$ZK:Q7-R,(/(@HYNX;NJ;H(B:($QIZ-4,LBC5/P-J,9H@>0HUGDX.)2 M%PBPA^ HS:>L?34[[-'IZ[FWHGY\&P^:U^&L7&"F"$'B:AJC M=:\Z&\',#K'M>^T9N6T8U\5G"ZR/12EA4S2UI)+[)BGD?G!&14 \R)DI_R&# M PLSX*C@/I6C]NP=*E96^5A20*K,/I_0?UEL4G>%I3YA3)P;]%FCEE%)/' 7 M%E$2QK3;?G&T(LK[OH&ZMAR&=DU)QR'*]KRV >O'K&NVA=<2@.:M3D"6X$2; MFT2%US "G5:[;9T+"^:%R@1G1B?ZG$]SV%!(<0&3)3 8- 0G4U;U&,)UE]4: M,+%M3.5>8 G?74,7S0/8S5+%0Y&L7LN$&+-((>0V4Q'H$($MA/$E>G*IZ@34 MPNUF64*6(N/J)HK)+"=YC"^G]:];0]8Z6?2T'$%UI+@HBI](U;R#SG40"O0H M6IU>Y^72)*TJN-37()J_"S8L @/9)K*\NZ)V8?0V,48XO[Q-3JVA@; M&'--%"Z: 1Z"VT+3R!BDCI[!96TYQ"-E'*6_+EBM!^:WU/&IK)P50I.&)\*R M/A3>EP2;4.S@CF9L[UAHW6 MLY:Z(Q93!1]3RUY=+M-=*&CZVO,NYVGU=X2+4J^!U-UIGH 0$-+'.*2AL\)^ MX0^9 "T=6VS3>IHEWL!4,8>8=;RU MT-FT*^<(=RC^GR_==($&+[)"(%V2U4D:_!:-7#\",WQD>-OP1JT"Q5NY\$!6 M69YMZ7T9HXU+)60T4E ?'@Y!YHG#OK0^/#_WKPV80 A%6&2%*=&F>Q'=!01 M00;'Q@4]'MY-;B*M+*H*_6+BF3:YVHM5'!A=Y$QR2#^+P=U39SJP35 MA <7WK#(Z-(6"0S 915.N@X>FFCG8!MO/Q@$49&7)8=;\/9Q6% _CWIA9.M MS/(0C8E/>NW=[4$D*]7^L18MA!^%9F"I[ M].!AFZ;6RM!F*_R$G&YD:1&S(3:J A.1V]Z.,#"HM&W*5X%&*/(T-;_P.9#I M>K2>5LH%/\Q::/#K5B$U>PG5[.G?&LPONBDPTMM'R=3SMHPC1;2"Z;P6&?'J MIY&+2)?<-6KHZD>P-;BH#0_X)'!L-K#CM9 2O)=+\RQ7%>;@U-$5F.=9(0V; MJ=*@IS,./>)(Z-D0N8;TX-)5CMU"= ZFBW&] -+QZUH2=#[HW'D?&#Z=1;UV MU+R);+'H*&2>R8L)?%_/ Q%I2"@HIMP=&-+DWTW1.:EDH?'$)Y9EE@XD M!=1ND9QOS&4&WS,387M.6\%M.T V]P,5#31#O%&&/%@/6>= M$D_\.#+>,'U)M. ME5RMGI)SN)6MI6BFJA6#?+,1$F7B#6SBS.'A@3M,R/7T M.6/09Z(_Q\A^B8Y303V\)=^U(%?C^=:.%+@K8VM8FYO&B/]5>.%N;AJ>9U_2 M&;ZXGWGG:#3(+E61&]:]L697MBX)7%DFUJ W)#D-_A:F6,&]5D@;=!E,35AH M'YGW$-$A^;7N-@5N,#&(R]PL4;YQ*V+4U5V(O+#6O=9VBU7:!JT=$LHW-+?A MNR4]PO$')R4D86O9:(00O%V]- [>UDS'BVJF:9 BR_W@3^UPU]O46]+J+F>E MY\\?[R\JP>0E-#O-64>62-U,O4&*ZBDK>?$;GB-TESFLP+-%/M!M[[R=%/'I'E+IV,3.;XJS5W'CH["3#.YF(P)C>,F M%5F/L%K1 S5Y9*V:=^'5UUG<7TC8^51PE'N/ $>Y IVWSY@$+H5>:02GY']HN_&87P.UMF@K_V&>UV!2L7UG=Z#9F\81I_)GDCGEE*%!XW? /6KX2G-N4#SO.9#D'RR M$=$5,>MT++]M8&DUXQ@KTFO]U$,EN/'R!19S19F.-L,Q[[#"ZP;*HI0$7HG$ MRQ-TL6QV8=1U;Z*2S&*#E6J5/:;$;\;YFCE9=K+O1)LP^E2RP+Q1YHLF M0S*ZYM5,&U3W%1L^2(BM6B'LSM#4MEI/A%S+ M,K&>39\:=^\FI0X'C&X('GML++IG)[D"I.%Z-K30P4V'B"8(# MG;LQ!3N==!10Z,!_B!-AT$O8$J-PD+TWQ2E$YDQX@E+".@31\3(F7F$IN0E> M6=??)@"TVPOBG"8U(D8"WFCL!F5Y#2;+G)\SH345SIYBF35V9K$]YY5+ MFU:\G\)5SC3;?6._^?NV*84<= NC<:(DC\BGPRP-^?SDDP73G;RA*,300$M) MO69&4,3O=BU31LON4=,?08+#B>OQ@L0&V<'AU?<+> M-3I#BS2R3:JV\[3=& 2YQ0NU! ]O$4/NZF/C["07PM[FYHE"QM0E,C.KRR2? M(2MNK,JH2(;(VNE:S?AJ:$:6JHXBUW$:\T67"'RO(7"C,$G+.DZH]67LCFS5 MMZU&U8(:\&_=.&>5[*(5Z<'YEE(K:FJJ'[2I[4D$05ZRJFG#)'XR8"F,2E.7 M(:S'2>L$NBQ 1R6]J-G0)%[:J L)O22;W&M#3>IP%1T*= +O!NA# MV7#&IBPY11W;?#'2"S:].=X(J7.CQ-4-Y64.*M@\&-*OOVQK:LZAYV/]VNR7 M9K-3_0[3U\3PI';&2:>9'4,FA,8QN,<.'C4([2EY J5IXQ0&.ZT0?,59(3#; MRJJ6H7B0<-TCP#!\$P@#W>9E4L&+1E](:O0&J11."M@+T1SKI\KEF=0>/99$-@2)6?!>M_6IBI*@K#%*&*'3' .O'68H%9!\>PP]X/R5 MK!)C[FI<:Z;G)34YN>)F4SQ6N;)GL%U&->N@FZ64<\)O"=:C3KCZLF) M6[\Z1(9=WY:\(>B#K.3(.XXF5QQCSQ+$)X'WI'_EL<#&GH[1_^4X=<_@+8=) M@1#/.C+*7#<%>PXI@TR 6ZL%+L UK6?U]668AL42J!TQ 3''=,#2K/*B'"?3TA#,>\L UC7YB1@2,E!_T%53 MR?B[H.A:AJ+^0"%'[:$7C/EO;%@Q*Z(Q5GYC!9LJHH1^Y'1 SQ;.X8PX=:RU M)D!&3XS"2[A2HYOP/#80JEMH)Z.+2%-ZJFJM=Q["V_TJO;._A-XARTW\)*=; M"LKP>_@)7:YW\RP:FV,5SMPBYF.)X#MEPK%@$4PC3Y*A=SM#20D]"9G'TX9R M9>M%&'>83!.I!J.Q(0#)Z1S: D^@5ECLC)3J"NT7K2A%O9J;-KY$ZC,D)EC! M++*],16+-@VO3+E3I6Q9TN*QU"K$R >>6"]?WTM7CLNSD X4GYUD[.%A7K4. MK6BL(B>"*T3"!$-02 L]!(1(J<+PDIS@3'R(;;=XU1K%J<2.- S92JJ*!U>5FW!B9]* M,\?,6\<@V/#*CS$R4!^)]CDL@\IX9$,AO)*P&9MR,@S)1.&4(QJZNJ[.2U"-46NS%$TXZ-#JMC?D@R=* MET[189=G:-.7Q+J,_TUJ0#RSD5V;U=F_MS57@V#94N8G=W3$JW=T+&.R)B.' MPIMM,*:W@!]HW;&A$35P8JO5"U!1YS_!U&$@$"R?1%V1G/9,4,@I96RW8\&X M*G0U/6'LX#ABP+.]$;8%I%HX(]U.F2D(.FT-*KJGQ$+.30'C(KP2IU:<7#Q1 MDJQG.%(0[Z*[5D0Y5AR*%@XC?2!>%0G]B&XJW'=L@+3C&6PBG#,"X)5>;OA2 MN:FR:N$2C%T*=TF6240BHU M5M(?&;],ZLVI8T69H!66O+5>XT['6\9.A7GU$"T7(^MG2^$$YV"]";*I G$2 M0!H1LG 5%IQ8OB/->HYKC+U6;Y*7KAEHKAD7R=*TMH_'*16U0U.U@?U.U>E4 MFV^WKT!2O"+CKO@/#1@KF7,S,&?HW$.U5^C!G M&#\&IL:-=2U2:0XM&Y9HIM@,3F#?CZ@UT3,MF4#_ M8*3$H#X,FS+!P)#ZH2EW=:."&+'.,P;\DG]3 [Z[KR&7/$72@P?NABZD!Z17 M'";5)\J=UF)2Z?*8*)\FU@W2\7#1R+"#".X[XZ@@'X2LJ^V<^J0$UML"GP4T M?9,5S:^/6QBX,?"B=SG,*"+.8#$CW(%(>";:Z)9R=IX@V.N#N@I.N$TH DF.0"OZT M;*WF_LDL01UPW 1$MXE93<1Z#;#2[ 2F/T)70Z,>E6*\<&2&$XB MZ]_X9AD<+06Q*=+*25#>'X>S=CJ)4>1' H.\($WF:NT1 YD1TFV<=IU-U"=I&%O5!:X^!MN'(J-NLI.$JGCKA7CD4V,QE(RA,KV1.=\J8^V&''+682V2 MJU,+BV)%>?=1B+8N^,6:J1C%$BE"IVAU.)V@W4;!?B&FX?G,.SH]FF!?',_X0F@F!5I,W0S&K$ M M@*4F\7P=:"-2YH28O"9$2XUMR<'&)H9J,HU-O^AZ&,1FQ>].9NYE8;]NI \L ME-\&A?$%IZEJ6$XHG]3D@+ 0/2=_3_& * I+1DE0<9))W5/CED :NA X#-U/ MDXVFE(CK6(G31$\O_7)NH0NAQ#7W>-)TVR#\::)F]O(>U=HO;HK)-$>-+2$S[HG@&928BX5F98BUVLU]RL^>AA MU_R%H@:<:]I=;6/5BD8CMA6,.N7NL7,3,LTPR6ZO;&]NQ[VP]!':GDWS MFC=)#&V<3-WS5=P45K#H%6!9$_DCL=0[D5>*EB3%SYQ;)J8+#>7;6=I)^#%[ MQQD["N6L9=S(^,5JZ+6Z*^G:>XZH6U [BOK:%+L_.1FOAIPX<2L&:#-5!@J& M,7^(A.P:C*L1CCTL:8[$Q5JFH:1$.6H#&TK/C)+W0M#TUNN%]TL^E^/<-'Q),&]GF&N MC-PN,#$XCNAQJ2+2AJH:#8V%)1Q<6)UI>\E*^R33\8Y+(B]T@SRO6Q[R/F58 MGH(%CDF)/,_H4BJF9M0@;,UN!<_-LQF-99RG"7;:F")R'ZM&MO3%VBW4XIR[ M'>P(KZO2$<7']!SA.\-[($.4SZ.UEG:0]L\/??RQ*R#DU;8;@!C&]9 864BW MV!C:]P]+PUYJV#I[@G"K$; (%BGLZD;*)NWN\(6)<2]]- MTC=Y6.G;Z^_O:H=0PEF783HS)CJY_]S6S5+NSC),3A/,1]-O&K2M%UWAVEM&.YV3ZLY26\0)+BJFD,F1BE5[G0547 Y+.IPCK_!??R:8V4DHS9R<6I(H2YRYB;ROD9DS-*$"+F3L#J!/1K:%E1CWV!CS:@* MMA%$>_+50 ?K:J!EILD'/S>[L@GAOKM3-?F^."=$6YDST[-RI3G4[!'VVEI9 MB^X&8U%*7EV/!K :I[E9B6H?MW9G[3F?K\8Y_Y5JVG4&:LT!487"=&..?DPM ML K2Q"F2=_.9-535%::]%U0;,W@YLE4P'@@?A#(E/FW3O]B69GLFJTW9N]UY MD;ZDWDK,[["N:B3K_KWH\^4XUFN$[;0/EI/>_;WO>AM,5V,;)/7B >&X(9:9 M!+F+X<@W[;U2,(!2ZM+69(]M=%4'2_J&!K6TB2ZE&3E>+]*C00."PV]K:;FT M&'WGVO0_JRA&EHC:J:+WZ/U5=@'6#9GS<'IB1V)L-^;TA6NT[#(ZS/Y5>)OJ MW0Q#;NW&&I']+&K1EPNSC,]5Y;;9Q&NH/X>P3L];J)09Y]DR-DL9)712<3[5 MD7FGT,H9/_,&R,,GIB6&WZ*%F'&ZF@3Z#<^(\-Y,/#RHR*<%E_!CYQ%YJ99W MJC1A@8J%/5HVKI .SJ;\I );(NYN4L_HTG98;3W&:KZM[^49P 758I)UV^.& M&4R(V'Y+E_A0@\NDTP9\LZ(.GN;@EFXW-">4@\K9^CGK2,$0YCU5&)U@_ $@5O@JG;<3^U5*OA;70_X<;< M@96:?28:=JOY,$*=J4IKQ+<8U,;?L7J0O^36H"7999Y>LM)N)P/M-1Y+O\N2 M!9=)Z(Z;>&,-F+2\\?5P$1*W3X@N@:O5.3)-BV!8M:XS:&IXF2D11TQ;9,H: M'/5*?,RV$J]76P]>A^;+.UDLY5<+$:"NHM\9;*2;EG,+:UPF='"TS4%MQ$S( MT-888:BL#/*Y4WMQFF]]GW[;#';0=YE#IWUX=C)S:5+ 3E#M*QYIL G4>8/B M%"'K;;LP&VW=@LRKAEG70S8]H!\L&CAOH&GK:Z9GAE\_=CELL!]-Z:^+]Q9+ MK+$WRU*UY!H?MYSB[KK"25A<)-E6E4_!1*-0VNH7<1ZN1!'GASPXBBD$?6KJ M?NALN./)?JA6HR)UEAV0]D1XW1-S%*NEP6[+B)PTI)GH47.ZI*S9I9_UM]&P MG&!52ZB;?K@%4\O#AXUIWF27PW "!W8%(-.=E&O99E(]CF]3VHV&;:YHESHZ MSA"E.S.B2[;LE)3([6K?TOU^=X4Y,?(%E9TVL5!;[)CO:U\_7XE]?63)0X]A M6!-@>5:B2VM='S=E3EO(F)4\1_-!:%9:S"_"!)PX@;43 M8I4FECZR-AH3P+:/,0TZF)&:_*S\2OCAA(8% SW<#^)P;GP5]G/>4$,&L;H- MCR!!IN ZFS753^24BUY+"4=XD0@;(#;I&=OA!6K8=C;JHS4]09][!K"!;Y$LENYEH* MPP+\B^(GC^5/=RYAVFF#L' V(>56"DPY<5^0!O9QZ/493&2-*EDC^'I5)-*Q MP%%R8%9\!K\_'"(=&V$^6 7<@O67-4]/9WYL0Y,>:+?4.OH$NP#-H3N.F*K0 MGM[^E3\7K38-H33IHTT1'167, 08?C*8ZR M$6Z2SD_S4D]<\\[:>' C1QL.B09QY\KR9))VQTVD%X9H=#6+;+#FY><]H+.D3O#MZ[IQZTPEF.2*L_O:O<.M0] (J*\RE<\61*2>4JOC%6%B.F\8\ )8 M<4..%19JD]U_E3'':HV?*RRI71LE977M!NYPJW\T0:M2',D%I4::P6;_S1<= MNY^(']P>4Z $+Y,\-2E#IV,MN9NEI>=Y>,]@-05O1?B64/!,2[ +D0OM[I-H M:(\/$;.%]G@9DD=Y7.&49N>^E$ "PIT)Y 41PPMD\Q$6FG@J1,)D;LJU60C%&#&3I M\?1\$CHW&N:6>:(CD+G&8#U322:>1.Y*;L1"?2+I8H1ZP%OT@^##8E@XMIVH MD2%PW+YEA:0RP@,G)C'Q=Q0UXC63VIQANG56C?,"I"TV]+%V65WT9'URGSRR M_'"-+%]FFFIP+HYVX.Y!] CND2DFE6HH$FHK5H/),NV-*BZI^R77:TNE-SGS M?D7KK,B84ZZV-5U>\T0$/ M&-.(^^G6&ZEQVS30;$3!',2(]LRGTEH0%'++#LXKG]8IPS]6[P"'20H UDCO@% MB(!1]V*R;5CE5G)5K^V/#)6A2MT\_;H.7G6)Z0_VC= \>GE<$0*Z\Z4\00FQ MH5&DZW 3<2:9F)T,'^<^>+W!S9K:R-3 (6PX<98I5)>1PCL3*A>' M,(VA'R?NX,INS[98"Z">%<^62(=G)@^NR1E1\B638 MZ"@:_H*-&++Y7A4S9J<)]1-U;)($Z\:;$ZI-^^JV:$Z&**,W\NY95(1E5T^F MM^BC8 &LZWU/P,KN:CA<8JP47VGL!X) M40;7?#*T2/BH2T&W-AD,-OB!360"'1[&W-[49PFXA^_!K$)/L-=H# W^0!Y1 MV2KV0\R4=8[Q_DZ"-:Z_CA ]+9H*0W^A1TOJ'Z-@\Z:7[==+N6JCK6)-0FDZ M.F5(-AIC2-S:<.KC#.)@:H+)D.SI/&E>8+UQ>.WV>RXH!"5GG.2F[13HT]J& M.TLGQO#%Q]13M!U7A2W2S@3Y9!*O.7(U# M)/%9>[5VK5IJJ?W"H(&;-D"WO/=TYL="1=V@=1X@=R&'P"R&UXVSU\+P+EC" M2Q-A=0:"-LNQ']->"FX]:*"M5U/$5X4;\PCQH@SH,@Q_UADQ_%GES!&[+F?> MGHP1!@>'8?39$=5ZW>W"\M^U+;5"E)*(GL(RK,B!).14A,$P? =G4,]E&;/I M(J'V$K;4SE+(6X88E@:X$F/Z] 7R-$U15?WNV@#0]6GH8F+\/DE5@SYP+5&K M1!SIB!2'%F2YC;9P:,A:U$VM#L!TKV!!8 ,U"IG7[:BJ,FX_]T>:#[&N!$2X MHEK1/T^P)6J_%PSVMP?!"4:YW\.M>O!CF@=':97W@M>P?' $94D8O-C;W=[K M!9_.CM;"M$(\D#> )0GGJ T-870TY#]AB3Z:&WZ+R$&1TG$&8SM670-O[8 P M/90UFTCX29[&-QAPC(PMQS9K0^=A9U.#8,.F(0USG&9NZ:)Q,93-FUQ:P\!V M2NP4<%1GG\VKN]SW#@&@.&YM9=PUK!K/G08'T??0>L2I9EXB3 Z%&C,K,5)V MM804@G$% NKUBYM;!Q&F9=XQDK BY@@N1C3L&>91HQE.F9EXBA\Q_6,+!V)W MV2 "VANC#$S'6:\Q+,YUKBL+=/E/:$23.YQ07IB&-:UN[A"\!""8PF1<"U6U MPX);ZG^03+!9C=E6B"DUF (&UN'@&,DETV7AIJCEOA?0[V E0+^_&X93]B=/ M%8CF=!TD7S$$L%T679Y%&]YK7&EL[)X;$A#/K %W\;'!1NTQYA^/C/9X9BPY MT7J4,]&-XWUR773SR,NCZ@GS#JV$3\1M))6>Z=SZ?D(H).A1,N*8D*F6,%C MSP2^IE<)"F? +%7-&AX-=C'E)9;[3^/6"]Y-FH(3EZXNMSRK M5WCA]_$K6.OE=']HPPBY2Z63D8/M-^:TT2,ZPJDYA?? 3[<&O'06X*2_NKN] M>]0?[.FO?U!7P;_RXG-PALPU]F[O>)AZ,M^'V--^$X?-K$S+3/\HC/ TT9V[ MFFG3O]AY\SA_%+Y[QB8,24D\B]AN"6.>HJI.?(*H:7>#&*'W>5)I+U<7E M$E*GU4_2 MC,4=L0'55=2:63$)NLW9L50ND[A\.1X&VE-C#X':,PTG9&:P ' M NR9%GE9 _.:]%ZKF/L!IC( MSM?8RUX]/F*NX#,=EOD2C.[F'EYF6SX5_/7S1X"_WMGI[WXKE7?8.BL2#UM. M:7O#NX6RWSG4REXT^XLO35S>*Q(]*Y+_@#9\!^JU7,TAOC[^2#KC1% U;+# MW*XMR-:7.>)W>*/'(!'_*-"FSH)WL_@";*?5'.3K<:)&P8G*I^!(?!R-P+HM M[FD1[O);]Z@#3X_/C]Y^",[_?'L6_'%Z].$\./KC]/CX_3'\]/O'T^!?'S^= M!J?'KS^>OCG[HB/VOBIJVE_O[01CLVAH?,B)3_?YJV]AY=)M7H*S"(;)$F(: M!/=L:C_[]5_YK!"D%]A>3KS#6E"+UP)LIS!Y!K=P,XF?PM9 MC2_#M&1.T7D^8S LM:NH\?/-S5A[P91ZSF@NT^""W.,JOO\T^F'8./\['0S>'WT[O6G=T?G;S]^^)[>^N087O2/TX^? M3NZZ*N^&(,U]QVBHU$@I5([Y;,JQNM+6=$>DCA/E-/:N0UC/$"",%8X__K#[ M_!5XTGEAG/@-"=B=T6BF1]WF()A+M*W.-BDAL$ DH"Y\5.ET] MW"$W0RK:Q20.IK*GLR%88"F1O\32PUJW4LHT(-L!T4CZ1S:'+V=W"UA^FL'< MMSRQZE("@R'! 8K9M,+.WFD"9EQLRY\49I=$3=1$Q65)7R@0/7^5-4,H+7/] MGAGQR84E8A40#$$"@,W0U05#@;$J8#S+8HJWJB*B&H0M?%U0+6_, 9G)J\!#LSHTIXI-F?,1G]1"G6M7I, M/CA;R@06/8R;M]N2(\TN9U>E931V+!2#WYH6R:7F<)6$DH-^>=0[:D78:EJU MJ$D*4,J00_A&];F]130^!W8,6/O,6S*;;V'.#);,7T-GX2Q4IOYD*I8DAICB M,J&D(R;.A4G%;VD:I#F(6='8!HS],57TH=.GD^&N^N6\9VL,9., \96XJ3#J MI#MF=D#-'-T+QOF5HGHA1AJ-%HQAJ*(0NS:(2N/J//H3;QK4&KH;4:)S-\(7 MGU06DT!D9XS&,@S67+D=@A<\'1/E9#B$]WS4.VAU^"-J.ZB<)A3OP \(!LF5 M5;AD0R3PU&TT<-MDAI>%-:'A76T<+5PC!OXRWE@?"$/8$;#D5(3O[X->\RXW MFBB]S@<9HY[[+NK=4G<'ZD8S?06?$85I)$ 2UOMB9>NB-XVXU-2GC#V!PXE; MM2"O"+$$TU!%C55-@^!5OV-0;4DFQD#I561+Z>>B6K[5K)K-',+ M _UC%HX5(8)XZZ'1+&J)@:K=&Q,T28J*;P,/\)&@R:FT@+%'8M65LR&J@))1 M$AB(R--$=UI!?#?9E*6!\]35$C^+@.!3"ILSR&.SUWXYBH[; M160."B2\,' M$E_[#D&9H^H2.@0T32!<(D'W>$W\.'2E-FVD_T_TLJ8^U:V]B:^$)[XS3_$>.;'>EW+837X67 MPBT^LV?/R2DMLW=PK'Z38.CSP_YS_B(WLS&I,VP6L!5AJ_!IJ5[J'UYA]X4T MG+],,EHC^M(K*766?-L^+"@256'[0QDOC9,_EDS4 ;C*G(RJ8*A5K!\L>:H^ M??1S%3<_V]OK[Q^^Z/QXNS_H_&S1;?=W^V C+W7;GVG(/&R8F!*$X._/=I^9 MN0NCSQCZS^(MV1+#$?[OE4PJS?LVUD($=!X'>LO(YU@QWO:QK-O+G>EU,/"- M*L[F-&8]G]YG@J>^'4[U%F#9MX)^"GO$2*=,]C>81TK@?H\3?<(:\'T>8TM3 M HX>F5/2F]B;)/6;"23>LCY+O/^?=>NBG?[AOD.4P.LG?WPXRE?<]S_^<+#] M:FR;;<9VPV1K M?_N_]"'/!LKN%O8X#\)+1IP?GYRY7M%Z?WX#6=[9OT-W?K__?'^)I[8 D7 A MMG:)]:@QN6 ZXAVP,_F]AAYP>E ^#]=3M'"*K&+OAB,\DMVPUNQWHMD_Y&YH MX]NJ> U5[)[.]2&PA)&V\^IP;:1] ^'Z_C?[W[[:C/N98B%W'(![P&@;RIS3 MCI=#KIS_'N78R[#L<9]1#Z^_;#+HRS(_Y]3($^O)3W-8AJ]Z1TJ*'GR30H/E MJ:?VR)"2P6R_^LU@,+E4_J1((J6SMQZ 21G!U"TU.:DRQ6_HI$>$)#MQ6##Z MT\(<. ?CM!II@>QM?(RJ''&>"/+<7"_O72SOL="]W\7:IHCMK2WP*-YKCK6,S8\6-,03L=Z]RXDD+C>TA=Q-W4"-N51-"M*!YIM %1T MC>EHW*HW,&,!(RAGQ#LEJ#)&6<6+1 7N2CE4T!4:.&:&)GQ=_'@9G=MI>4KW M0/X(0M_4N11UBV7JW]A$HA"32#I/J-'09()$)U3Z_F5U0_=4X]B=G0.#%$3A M&\ILVZ-YQ\8JRID=Y"5/*OG53?U#B*$!C+)=@OX6M GY:LZXV] WZ.KTNVK_ M#AK_M"[$NFYNP=DPV.XNG/MYF,=S^,^XFJ2__@]02P,$% @ ;HM<6&'5 MH&\8+P 12 ! !X !H<'$MMSVT:6[_?[5^ ZNXE413%Z6)9L9UREL97$-;;C*VMV:CZEFD!3[!@$,'B( MYO[U]SRZ&]T-@*)L2Z)L;6U-+!($&J=/G_?YG5]F]3Q]\PB^E+$MU,:NC_=W]Q]&_\O*C MNA3\?:WJ5+XP]_GE9_[[EY_I(;],\F3YXI=$748J^=LC=9#$CP]WQ?'AP73W M\<'Q=+(OXR>/Q<'Q;B(/'Q\=_[GW"'X*E_-OJGJ9RK\]FJML9R;Q^<_VGXX/ M]XOZ^4(E]>S9WN[N?S_R+JWEIWI'I.HB>T8+AF^G.;R>_CK.T[Q\]L,N_=]S M_&9G*N8J73[[Z5S-916]DXOH+)^+[*=1);)JIY*EFO*%E?I?"4^$A].?"U[0 M$=PG59DT"^0EG7Z:J8FJH[W=+;5M__^7G_&7Y@7M:[[X1LZGS\[A/5=RK)6L4@U(8@F M_+6FVY/=XE,?H1WJQ;"9LER??">E$ND0T?;7(MK9Z?GIN_/7?[R+?CL[>7<> MG?QV=GKZ%CZ*IGD)C"FC:9G/HW?YI9Q/9!GMC9 =#WRJKO$VP)7EB\%?%2)) MX CLI'):/SMX,GY:(!/58I)*<\DD+Q-9[@ U4E%4\IGYQ_-$544JEL]41F]' M/_J<_3E^.MY[\@19NX:5UHEYL.;Z,7']SW72\]WC\='QT>#7N^.]X9^NN.WA MWGC_X,E7O^W>X?AH?__KW_9@?'QXN-9M?R8",Y%A&ZM"9'][=/ H8(9G^\6G M: ]VSF$IY(_.3N;%HV%FVA\?X>Z;ST@^/=LYV(7%%O7U>7.=VWWAP7VZUKE] M)^;RQQ\.CY]'412(.$W^.Z$L?_B5Z.K=["M3]7$O57]-DS_?G;P]_?/DY=T0 M]>#X:U)UC]CR%JDZH)CG19HOI8Q>OR*6O>>DO4OF/'W[_LWK5ST$U#(UL%70 M?I>I7?W?X]/-^N6JQ3P['QP?KW7: A?8Z+/3D4;!+M(^P_@*. M;)ZJ)#)G57\/(J3WZVMPH+X32XFO]:@K3*:KWBX0I!'^=W]\?+2N3+TU5?%; M*>!)K\ K]C5%C[Q9E]RW;/3_^?O;=,\O[4L4/PF45O_S75'M!>_UNT/?"+R?SO,GJ!U99P2J[7\<369=E M5KD?U]V&+_5)-F7-W_PQ?)^*[.$07J'?7YU^>/GYNEU[HRN^I_^S6]G:'W_8>[+[O/N_Y[^_ M_A!F"4>1J*)\&M4S&;6^>Y3EF-86D_Q21A-9+Z3,HM_?1Z^S> R_B%[)5"Q$ M*>&\E45>"J1AM/7C#\?[^[O/7^9S.()+^FOO^39IOFBZ@FS?ZM<^:_?3T$$?1@1 M"\9P&Y4U0)!"H$Q5!?.6YE";B #*P:652HAXDR5]JQDO DI.X)(Y<&:-'(V) M<.?[GRKG,1=EOJAG0.ZGSUT^78-VK 54EL 6/ML[7C,'L?Y];F53+/$5T!BU M(!+O0@'7>N06&5R $IN^R2W]\&A4()7BFIZ1 MR@M5JSG*J@E6W\BJPC,$[%#55;B0>B;@]B"NYB*!E\'E)ZKE*V"F"Q)]P #T M',MZ]@7%="I4&=Z8>?;W,_HA?B:SBOD5_IBKN@;2Z5_\/1=E@G^\4B6\0]ZY M5Z2)E4AX-:*5(T_Y7D9P1#.!U\'+SA61!E_/VZ]J)M(4#P&]%THBD.C9SG^L M\JM(^>6D_.B5FS*&N_*V9PU5BL#ZX#Y 4+A:M.H /L9U_M?N>'X /=QBZ_*7*F*KY!1<2S.P(/DW1BZUDT@]T$^N/W^)\8 ME$T"3"*CA8)O!V^@Z8INARN'1[3Q!7'I8J;B613#!4"C:=[ #?22WN1@D^%M M4=MW;)_ _LQ1%=PZT*!<*!% BIT1 $KP@F=DH/3$: :W) M)9"\4#7(LO]%Z48_1\W_ZQ]GIZS$2.C?<=KY:K5XY]7[GOM7=N^[WW M;E)N]3TRH G%%TPN X2KZX96XVB]0H8!RMXJ_^!I\XT*]U4B8U1A=72&AB5* M4# SJ@9?7$L_*UKAZJJ9_$7671Y) 2<2/\:SJQ40"-Q+59&"1UDA\^GP";V' M;+F_26Q)*;9A\FX>*YK8!2T!"T.!F.4@WO2K4 6:#EQ8OZTU@\"GR\B( M5"@".7Z1B@5Y-^ 3HVM"$C)12*E)@X\8&5$J/\DR5A4](L_29>1^ MAM[9WM'S*@)A+L&SEN,HZK[$7"SI+<#4-2]2R@2#B.RFCZ(BE3;(-!0 I\@J67?75#,.<9BPN<^'EX[A)?IMR&<3&>=SZ1TSCDX01[-I MD]DO#"<+]K1E_8:>Z^QC=UV@XWX[2=?BJ4EH^8P;GW MATWB^T@3EMO;_8I$/N2NBJOIG%?$U,\HZ*,NY7/DRYV#\5Y/V?=$5!+O@(F@ M6X^BP$G+8'UEA='S3C;O*RYG8^-(H73=^O&'@\?/@T-!GVV/P"&EH%.5YQEF M/"B.3D8*& 8QRKA4#H:<'3]T+5&'5I0C>^=PP(SBD/P+E_='D9I&F*Q(TQ'R MOH@2P8831OC^G96GGV*P$"_(V0'+*.,D5RE(!0F.9\,G$PF?ZV1.(""" MA=F4096G$DS&4E8%9MA0@>"]]9K99ENU:G"[NK)9NBIMV#0YY0).]6GX!ZK MJE%@A:E:!Q\RLO\P]40&F[431^1!3:SM2-F[,F\N,-\R*?./((\XY>DZ34Z* M$#ZA?Y%7-&=:ZDMTPA&3@V#\@9B2">>UC54YBF;Y JW$$:<,,QW[MN+(R@"2 M=B@!M$DXE0L4E.B3U@MXT>7.%#/!6_N'VQQKQ!+=NE8%D\;> $W%H1)3'Q'O1H**@+] MSL6GG3.=RGE=2S!C\95G>8K\!H]_KV^K=PMT02RJ&:6O[>MB@FP^04'PS0Q!8LEZJ MW57XB,,J'6L>+R!/&+QRD48E^"OPS JKOU0U\QB1N6SXS!K(B>,QGM>N"36$ M06'J\]J?B FHHJ8>_LGGPU:L$@5'ZZ41^F I^']G92N_+N3.I)3BXXZ8@IGQ M3*0+L:S\MU@#IV-0(WT+>NEH,_32N;8"=8");8[5SNJFJ:?351$%M.&&H@KF M*VW+HFSS4[*VU"102/ KM/+09,1()*:P.=8&\J3)M H,Q1"L9"I57TRP+45, ML/8&_^WLBDG!M[8T"&?'E)8K53,)R(Y^'I'\HY?'O.<<:#P#+8&'U5]'7TS$ M7=S6I"&9"SH5!#(\#W6+49E=ZQNB#+A\@A3A".JG%T]6[3@G@X3+8?O,0[.+,CE M3;HF,KL46-C.!QXU$]P%;NX0A)(,6AK\U92J2C@/@S@1NLTS M*C:)UV!'.;ZX]=#'N,/?FB#^QKJ;D5OGX.VRC:.H"V7G33^*V-3FA7*B@> HF= M-A4Z/JVNPX-E]2.N.5OOZ:IRACI0X!ETX\J*]MZ MSJVV,'.0#TL)8M&Q+@U'N/?D5+:UEB>DODVTHS?X#'+K=49KC04($"\JL"JW M@C;+2BOUFY("3S=$"F @$$R\>AF%._\@#U;[6$E#3M![^$AD)AM^GH-M%K54 M[6/Z-41(UYGL+&7MD\Z^))[UBL$W!SS:\4T=6S?)8I?OIU>(&)V K/-NA2C! M0A+%+*C-K+E+2_?/D%>]I;9]6CIRE0MPJ ,E;LI2>O0Z(P^'VT:RJ4*Y )P) M5 %[:-ZZ->_+O"@55<='KX!":5YP_GZ_2O;7\*N/JP:;E%-!7;; M+,-Z^RX1:8/4?"X3=+_(?].)K&L% CRC>P2T"8F#\7DTO65V(2YTGI&M[Z2) M=9R"<84K;E6:IABRQ;8;W=]D3DY>J,Q12N;55E56L7/JVJ0VL6E^KD/D.V", MUNZ%VIK7=^<.F@X#B>)Y=N-:!^=]YR]UWU M^E1VC;6M*7'W]\9/;C9DBN8^90?_26UMOBCH/80. M:]O7C+:HI\_I?6';;IN<^VSDE(NY16)&S>X=;8GMSX^[WDADU:D]&"I>B%/V M>+-KR=B;B9U&T0>,J6DJ-:518WD,BBOR@W&]_C<*=E8Y2G*6T5D B'JVZ[7S MC6U@H,Q9CTTYF*'_WI H[AV+I#ONTS$B27R2*XJ# W31#:0CB(6A0A]0NZ:X MQ^I]^*;&5QY%;; )_H75KO#Y**KR&"TT4*,-';01&+@*3S*[U35?58AEF?.M M1FV&GNNI&K2*=!2O- \SI=SX]XYIL524ES=_#16F^C@!;AH+7X@" NDR$ 5N MY3@\@$H4F!;&6K?4"A)><,\??WA\]#PO*6J8J.E4EIT40R#IX;VV\&L?!Z*T M]JJ1)D!H-)$3+*6BWJF1J2(>66D,6R"PC,0:IZ;.&'>Q=FI#L'[>&LB=<@?S M; X=M&Z8;25W2DZ<-X,7(>-JU!^QM-IH;Z39S,:7\0=S2X]M5!9:!":DML#U MH3@N%4S4>L--30:S">H^@<9@DUI_T2=3U-:I647B]=<1IX$S4V$3+IY D=*% MICHDYA5Y?6IY)RV<^ M^5VB< J(*$-\V^&^!2B=JCU;M+3812DHA.HB^42F>L]#9(2AU+ ^ M.5<7QKB+H-"VU,$XIJ%%]0CVD#BXM6QX1XEW,HF='H*)36>>Y)TC&@Q'NL5 M/:5"%D["2)?5(D13B@ZDIA+LFO<,.GRV+G4M.J*UX5;HB!0LI(PCGJ:41U9M MKE#S).8XNM8;%6.2>YXP\$-;Y>046)D2J-Y'=9[$#E[53#':VA&1D6CJ65Z" M(@O?UP<,02'N(H:,M'>'Y&\[3RD)P^XS4%8@?E=3HG9JO^CLB]?:8(\$\ MRR;:.9/M.[47C\:[^]RYZ/H))$!C4Q\XJ%1K4!)5I^A27]G+D>%ABC]F^8(Z M[W2-H^90H\Y!93)8#AI]''V>#MT;#R[>P\1+^H.AICR<;X;7L],82\G.I"#T MU8@3RNF2Y9U,^XI:76*$9VW:E'1$O%?LF"D#6HH'K&!\DO1PEGNY(0PG93@D M":4>[ %L9J4=/1-4JC$09^1?_T&G(%:6:35H@EB@<&@??8"AL-_?,;/!7VYJ M+MM0<\4&T*C'QADY%@ZFD^LZE6X%;(^EXA@\H'(;):H0HK?$S89-=Q#,%&E^7 MZZ+[TF"Y!*HNMF[A#/S*;$^V4B?*H/L/W:@\_!88<<8I7 6/Q8I:BUI6DTL)5OICD*4V-&(FO3D%$M\)Q=@N@ET_XU"PM' @Z<,S=2.?$) M:1L'V,E'R6(<_4"(*(Q8RSD?ZO^L&K"\UOA59D]RU MK&&KNB> 68B59B0K>#Y4L*T#_MFJ&UQ#D?4$IJX1I_0?[)K89!&-AK7>=])K ML[^9O3;7L#ENY; .!$$[=GN/S6[5B6.S Y>V0>>^Z/)H.,:A73Q$V\-\I;Q4 M>5.!P$7D&L+="QJ!\:RA=JPD1VQ2;&:G6YB\@OVE004-[>*I4&G%D3WX:-G6 M-73.5:L=>YVW?M$_? B_74-3;H;P?YUIA&"CF(-DM,L%:#)2<#T,@B@_RQ&4 MAK!#Y=4Y@6!VXC.?;%&1B?EZB8J)32.9 )^[*O*1M#H9[J5:'6A794^75;?E MXZIZ@[YJG]ZG*@N23=:W$\(V:0=+-"?Z'>P&6; "S,$Y.[M!\(F"SC:'0036 M5 +E[N)C7;G8_E/L;K'K4F/WR+H,%0;2KEH*O@ .D$0N"EZP-[E((G7J2,L6 MR,)TZ[59M<'8F(U'ZW([1U+;$T'1"ZFKJ%RKAKNJ,8W <3O"SRA@L44-?$[A M( -:ZR=YOBPO_JT4*MPQ#;"%81S.0^5Q++ /07"5?Y)++KCFHNI.JZ,-&=KV'Q.QFS;$7/3BO^JMMPF4%)+F6!ZTO2I3%6"U'5#YRX86%OC#TE M,M:=+AV@')=E3&/IR+:6:R,RL.0#LXHS7@][OCGAQVL&]#A Z8J<5K88D[W/ M)W-BEXES$VK[P#+#]DKC1OG!1FY6,?KM2E^0PX3 Q3-5N,J/H71K!A+&;#E& M;LB@8C@K;6OEN9X\X]RR[6JFFN=:YX48Q5TJ>G.D&]4U5?E44.QT17'+USL+ MMX/#^&5+?8CWA* P%N=)<"NM M\22HJY$E'=GI9(05J8AUD83,*NK@X@Y,K%1Q:N4>3"2S\Q>;<8 _8^?QC*.. MR+#Q,^44!MI4B('GEF=B^D+0C#@306QSTRM+J:)8I%AF4W-'XK+M%1KAN@@= M@(,,;I\1%OYD" +"@OL-:Q8%BF8])S%-[T\NN 5EC#)LX;6@EA .Q9I9"'* M!#XT;.QU^^!?"YE.D1*6+"Z(BK[YF@K33$NS.%35C,!>?$@0$52]3K$JFY:E M*:2;4A>89,U'Y(FT*$;!/,61;X/H?1F -7J0T_:TSC;CM#;A!"YMZH6I@E&W MO- V#II60[^0(W"$S<6ZGPC_Y-&!>)0$YA.--+!3"]LIGSZ?=@/^NM)1GSC/ MA,# D.[WXTQ]HD M(W#,'$_%1(!:J:<=H2[;(Z-JMPV+$P?A&:[_[*[G]R \U^3(OS:&(VV!<.F9R0.SHXPC-&P9!? .UA<:$1QC;3HPU4-M.MG% 2,K3H6:D[WJ%VB&5FLBYM3RPV$=<%\KW2KF])OW5?!'6 Z-&?:F M<-L0PF*=%EJ/(E"MI4W/(("6/GS;_L#0Z@:-:,N8WAJ.#F\2Z18K11?CFK7RLRP)BAR^7$9V$51]0'_#9BRH MOM-<4K=-OII0\&XI=A=J,]DW+]RFTO[=P") BR[B!BG:1S&V"S%#TE],0(4: M.1KT<)7)UC,CB0MLN5E=F,C=$JE$T*"P)L&_DC;?5B'0$UB(J&E?-2WU\,F+ MG%PH_V?4$Z2[=+%J 0C7L,=&C$X]:IUV@XQ*+?SPC1.RZ6VCI1(9JBE692DO MH!WNZU05&$Z7)/\KAAO\IK"S6%#M;9(_<,R)24 MX,6EMAF&'E<]2&0KD=,-T<X!F-C(VHW707Z;8Y?@,V">AG(C7S&P$G8HQ1-4^QL M%+J"M5Y(.="SQ+S,^'MQ:R?\,Z/@Z(>:&IZ2/*4N1%.&*:93BN7, L^F4T_> M=EI4!J+18_1PZ/,5/:O7;"T-VE5MN^A#P1<NUNMO M=: 1P0HSR(A%F<_41/6'O0T?MI\:'R# )1%4JR.9N;DD%W/>R)O4T^#'MEV< M&KR&VLBMR]&MZ.V#,F$$87-#O2R1Y(7)3#@-"\[Z#99QBQ/&1K6W/#BHPQ A MG=E4#N%I0E11*JZ(2H)KVP1#/S8+HDII*O00@6J7$!=$)KKJV3_@;8-?4_"# M6[Q4#W1S?:!-L_^\E]@B0A8/K'2RK4?Z#32#.$"503S1-^(,JAUUHL?;A-G@ ME%EKE ?+*QZ441>SXP'B[=&+O9L9-CXXL>%HW5KJ5Z(6.#[L4L!!?P M8]])-]_!_>WFN_'SO;&"[B\X0;T-NRB.)X@-@R)085,)EY&)^41=--P9 M:-M4K#.>ZF:5481M@:2C],1YTGC4RU+FF8K;"E[,M8R&.W!E65%5<(+GF^!6 M34_AJG';SKA%!(P&^E7LNE+3/H7*7 2,D6]NH&)V\:L\<]])BK8Q.VV M"ZE MTYVNX"I:&8?H$C@!."BP-##+X#V+BT'PY\&*Q>\&0NJZY^MFJM^_X'P]T:[F M>#31)68Z0]!2.UUA:@JG-1A(2&,8&!H M^:G)*9CKN90(UT4M)3P^ *N!$DDE/X0T FO\*Y]$%-#787$+,5&1Q8CI'5U2 M@"GDBH$F5.;O0X+3BE*&!2-8$ 8U!]+P71KPQN%9O>XUOT608@J7H:LF1G:$ M]0A%1PP.%?[3&MTC:\I:I&BDDV,'#T&?3,4E9FET2 VM) MA>@VI964425!/ MA'V.//IVA<_--#Q\;>7>$3YD/>MF+*.QM??\%OZ% :XWRRR>6>4*FK=,6#D1 M4"?.OG78T'*/KLDS+%.V R*(I;R(DLDOL3!DE%]5*+(P]-HP*%:W8.L]L)!- M5G-\3J:5I'%D1EAJ&6MOVOD1B5!!\6"-$,Q61Z&]"IIZAO<"/[DV3;GM/(^! MM02H"=2C/6^[T,V][$ 6?A:0A/8$Q_\V&J>H VG9V<9)VR45@8VK@J9%Z9L0@^$UJOFS%\<$XSJ0!"! MB$'EEF8R(M ]274BT9 *>3C+= ,U2JB>[OG6LM*D-L$=1)Y&9$YONSC) #I( MPP>@*N6(:0(4NL"Y:WPF0(/6!(J/_]$O3DN*X[Q,VED9%]B"@1R DEW@!&>, M0N@YDQ*UH]25M[$HN&7$Z/]P[$8]0UG-W$2QIJ%6\_[C;L+6I/CR#"W\BE(; M%&X+N+XW)8L-G)4P15 Q0 =9J7 MP+I1H&3':9'5S&KQG9N3^(&H=7XEKBO*I'1O2*V*C!1:GJ0:^.DSNS M9LYU/P1\7 4S\%STBVZ\.G0=O.8;.S:RYR5X>"18>IBY;)MP)P($9HM&9V_7 M=N+R;;B4-[B(IS)54G[4T)N7^<L.NQWQ8EB>!@ZVU]PFA^B M-;?8O_@5'*9KR%X?$0U$"XG8UHO@K"!)V!:^LM58KBVM?2_7_J_;:F7G2J,F MN^QJVR8R%BF>#Z/Y?XQRWIUTE"6K0(,X&SI0_S OI0["VDG"O8MAI$9?2B< M+2^(8E38*+R.1:0)_5;;X4B.5>ON[I_K' W^"C<9JQU]^SB?4-"M+>GM>HY7 M^JQ^<9>N2X&WU/?ET[*A&UFXBQF&?[?L2E"_37DR_RY2&ECXP,[+(/_=V1 ME?JN;M0(XY=YQL#&9/P&Z,'N:^A+'M+\F.9_O!$ :>_RZ"0A#Z"=.DOIOON# MCQ;$_JAOVKIGY #CO#6V$!"I7V4BH\"0H!?GZD/E]PS,:>R%[:28HTLK#$:@ M.PEC?1=A-.A24=$>URCH3N[A?JDP *4JDT?&MZE,Z51&H,LKP%X73OK*H0\U M]7D$JC#*]KGO;(==MN2T%4'>_#IR4![$ HB%PXT0"[1YSL#I^R4->BQETQ40 MYX6259@/T=P*8H,@JQJ.!K-ES)9;2PI_!F3K1X,K"N>@6[M(ENF*N)TM%'R# MX A8R@>$CU&M7J*9P";&-7GB7"$"+8Z7/@ M,^RL,RJFC[4"MAIUN"E:\;*4C1&7X"208T'>(\8\:\GH^+H@0,6MJ^K[9F N MEC0?/ER\5AFNM6CG<6 ELNT"<\2TF5./*I1]Y15BW[6J#7#YTH,@'?:2ZEF9 M-Q>8 .K>P?9PX+T\OVJ)?@\<' M#YH(-=&3C=!$)VV2XA2(8R:KG;F#HM^;DN+[HZ80O5V_F1UJQ^%IYR7!;:+2 MNG:V^;0-5+2ZRP^.<4JFZQK:& .(.N!_/'7FG/.A)/..!8AN#9QB1ZL^]J*< M*%M]%#0_73=@1/9E9J9]C MY(5)6J'F+-MQ.3J_3.$X"JUTWI[AEMQ6Z#Y?N)NNX??!+^>T)ECET2&X\TNK M [AN\A4^K,4O9R#Q7$\%M0%$ F&A&>JFC]JL@)OJS,;JK@:OH:$#O&&;ADW- M4_/11HC&M\ #,@4Q(//FOD]CWXB&K/-9B\"- M<$PEV))D'NC0UH3&L6#&(=818CM1O>^LN,8JR:N"1L.!LXV&EP8Y<$26$^-E M^6&*OT(X7CZ7M28.HUL -(QZ('D2Y?A*GZJ&,0(#6TH1T*J\6I& 3?YN-=8$FJP!. 3'D'I*\C6 BM>5!S"0-)D7,6/+$>J"MM'*;K =E!IL4>DIYQN47>*0+C&]::#N^BNJ- M@O9HAI"6Y25/K3=#8HVL"@#QFC)CQS XP^0(]QP?Q$_#MDWGW'+<1D]/K'6I M_2LX&0M1MJ5)'!FE^KV:JC6F(,-H58C.0"*+(-%OVV[:3#V_(6,3P@HL;*[6 M\0^MR;WH+6G"-+=

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�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hpq-20240131_htm.xml IDEA: XBRL DOCUMENT 0000047217 2023-11-01 2024-01-31 0000047217 2024-01-31 0000047217 us-gaap:ProductMember 2023-11-01 2024-01-31 0000047217 us-gaap:ProductMember 2022-11-01 2023-01-31 0000047217 us-gaap:ServiceMember 2023-11-01 2024-01-31 0000047217 us-gaap:ServiceMember 2022-11-01 2023-01-31 0000047217 2022-11-01 2023-01-31 0000047217 2023-10-31 0000047217 2022-10-31 0000047217 2023-01-31 0000047217 us-gaap:CommonStockMember 2023-10-31 0000047217 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0000047217 us-gaap:RetainedEarningsMember 2023-10-31 0000047217 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-31 0000047217 us-gaap:RetainedEarningsMember 2023-11-01 2024-01-31 0000047217 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-11-01 2024-01-31 0000047217 us-gaap:CommonStockMember 2023-11-01 2024-01-31 0000047217 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-01-31 0000047217 us-gaap:CommonStockMember 2024-01-31 0000047217 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0000047217 us-gaap:RetainedEarningsMember 2024-01-31 0000047217 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-31 0000047217 us-gaap:CommonStockMember 2022-10-31 0000047217 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0000047217 us-gaap:RetainedEarningsMember 2022-10-31 0000047217 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-31 0000047217 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0000047217 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-11-01 2023-01-31 0000047217 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0000047217 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0000047217 us-gaap:CommonStockMember 2023-01-31 0000047217 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0000047217 us-gaap:RetainedEarningsMember 2023-01-31 0000047217 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PersonalSystemsMember hpq:CommercialPSMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PersonalSystemsMember hpq:CommercialPSMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PersonalSystemsMember hpq:ConsumerPSMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PersonalSystemsMember hpq:ConsumerPSMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PersonalSystemsMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PersonalSystemsMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember hpq:SuppliesMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember hpq:SuppliesMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember hpq:CommercialPrintingMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember hpq:CommercialPrintingMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember hpq:ConsumerPrintingMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember hpq:ConsumerPrintingMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:PrintingMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:CorporateInvestmentsMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember hpq:CorporateInvestmentsMember 2022-11-01 2023-01-31 0000047217 us-gaap:OperatingSegmentsMember 2023-11-01 2024-01-31 0000047217 us-gaap:OperatingSegmentsMember 2022-11-01 2023-01-31 0000047217 us-gaap:MaterialReconcilingItemsMember 2023-11-01 2024-01-31 0000047217 us-gaap:MaterialReconcilingItemsMember 2022-11-01 2023-01-31 0000047217 us-gaap:CorporateNonSegmentMember 2023-11-01 2024-01-31 0000047217 us-gaap:CorporateNonSegmentMember 2022-11-01 2023-01-31 0000047217 hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember hpq:Fiscal2023RestructuringPlanMember 2023-10-31 0000047217 hpq:NonLaborMember hpq:Fiscal2023RestructuringPlanMember 2023-10-31 0000047217 hpq:OtherPlanMember 2023-10-31 0000047217 hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember hpq:Fiscal2023RestructuringPlanMember 2023-11-01 2024-01-31 0000047217 hpq:NonLaborMember hpq:Fiscal2023RestructuringPlanMember 2023-11-01 2024-01-31 0000047217 hpq:OtherPlanMember 2023-11-01 2024-01-31 0000047217 hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember hpq:Fiscal2023RestructuringPlanMember 2024-01-31 0000047217 hpq:NonLaborMember hpq:Fiscal2023RestructuringPlanMember 2024-01-31 0000047217 hpq:OtherPlanMember 2024-01-31 0000047217 hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember hpq:Fiscal2023RestructuringPlanMember 2022-10-31 0000047217 hpq:NonLaborMember hpq:Fiscal2023RestructuringPlanMember 2022-10-31 0000047217 hpq:OtherPlanMember 2022-10-31 0000047217 hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember hpq:Fiscal2023RestructuringPlanMember 2022-11-01 2023-01-31 0000047217 hpq:NonLaborMember hpq:Fiscal2023RestructuringPlanMember 2022-11-01 2023-01-31 0000047217 hpq:OtherPlanMember 2022-11-01 2023-01-31 0000047217 hpq:EmployeeSeveranceAndEnhancedEarlyRetirementProgramMember hpq:Fiscal2023RestructuringPlanMember 2023-01-31 0000047217 hpq:NonLaborMember hpq:Fiscal2023RestructuringPlanMember 2023-01-31 0000047217 hpq:OtherPlanMember 2023-01-31 0000047217 srt:MinimumMember hpq:Fiscal2023PlanMember 2022-11-18 2022-11-18 0000047217 srt:MaximumMember hpq:Fiscal2023PlanMember 2022-11-18 2022-11-18 0000047217 hpq:LaborAndNonLaborActionsMember hpq:Fiscal2023PlanMember 2022-11-18 0000047217 hpq:LaborCostsMember hpq:Fiscal2023PlanMember 2022-11-18 0000047217 country:US us-gaap:PensionPlansDefinedBenefitMember 2023-11-01 2024-01-31 0000047217 country:US us-gaap:PensionPlansDefinedBenefitMember 2022-11-01 2023-01-31 0000047217 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2023-11-01 2024-01-31 0000047217 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2022-11-01 2023-01-31 0000047217 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-11-01 2024-01-31 0000047217 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-11-01 2023-01-31 0000047217 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2024-01-31 0000047217 country:US us-gaap:PensionPlansDefinedBenefitMember 2024-01-31 0000047217 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-01-31 0000047217 2023-01-01 2023-01-31 0000047217 us-gaap:SpecialTerminationBenefitsMember hpq:Fiscal2023RestructuringPlanMember 2022-11-01 2023-10-31 0000047217 us-gaap:LandBuildingsAndImprovementsMember 2024-01-31 0000047217 us-gaap:LandBuildingsAndImprovementsMember 2023-10-31 0000047217 us-gaap:MachineryAndEquipmentMember 2024-01-31 0000047217 us-gaap:MachineryAndEquipmentMember 2023-10-31 0000047217 srt:AmericasMember 2023-11-01 2024-01-31 0000047217 srt:AmericasMember 2022-11-01 2023-01-31 0000047217 us-gaap:EMEAMember 2023-11-01 2024-01-31 0000047217 us-gaap:EMEAMember 2022-11-01 2023-01-31 0000047217 srt:AsiaPacificMember 2023-11-01 2024-01-31 0000047217 srt:AsiaPacificMember 2022-11-01 2023-01-31 0000047217 2024-02-01 2024-01-31 0000047217 2025-02-01 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember hpq:FinancialInstitutionInstrumentMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember hpq:MarketableEquitySecuritiesandMutualFundsMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2024-01-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2024-01-31 0000047217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2023-10-31 0000047217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2023-10-31 0000047217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember 2023-10-31 0000047217 us-gaap:CorporateDebtSecuritiesMember 2024-01-31 0000047217 us-gaap:CorporateDebtSecuritiesMember 2023-10-31 0000047217 us-gaap:USTreasuryAndGovernmentMember 2024-01-31 0000047217 us-gaap:USTreasuryAndGovernmentMember 2023-10-31 0000047217 hpq:FinancialInstitutionInstrumentMember 2024-01-31 0000047217 hpq:FinancialInstitutionInstrumentMember 2023-10-31 0000047217 hpq:MarketableEquitySecuritiesandMutualFundsMember 2024-01-31 0000047217 hpq:MarketableEquitySecuritiesandMutualFundsMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentAssetsMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentAssetsMember 2023-10-31 0000047217 us-gaap:CashFlowHedgingMember 2023-11-01 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember 2024-01-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember 2023-10-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember 2023-10-31 0000047217 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-31 0000047217 us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-31 0000047217 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:OtherContractMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2024-01-31 0000047217 us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherCurrentLiabilitiesMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2023-10-31 0000047217 us-gaap:InterestRateContractMember hpq:InterestAndOtherIncomeExpenseMember 2023-11-01 2024-01-31 0000047217 us-gaap:InterestRateContractMember hpq:InterestAndOtherIncomeExpenseMember 2022-11-01 2023-01-31 0000047217 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-11-01 2024-01-31 0000047217 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2022-11-01 2023-01-31 0000047217 us-gaap:CashFlowHedgingMember 2022-11-01 2023-01-31 0000047217 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2023-11-01 2024-01-31 0000047217 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2022-11-01 2023-01-31 0000047217 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2023-11-01 2024-01-31 0000047217 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2022-11-01 2023-01-31 0000047217 us-gaap:CashFlowHedgingMember us-gaap:OperatingExpenseMember 2023-11-01 2024-01-31 0000047217 us-gaap:CashFlowHedgingMember us-gaap:OperatingExpenseMember 2022-11-01 2023-01-31 0000047217 us-gaap:CashFlowHedgingMember hpq:InterestAndOtherExpenseNetMember 2023-11-01 2024-01-31 0000047217 us-gaap:CashFlowHedgingMember hpq:InterestAndOtherExpenseNetMember 2022-11-01 2023-01-31 0000047217 us-gaap:ForeignExchangeContractMember hpq:InterestAndOtherIncomeExpenseMember 2023-11-01 2024-01-31 0000047217 us-gaap:ForeignExchangeContractMember hpq:InterestAndOtherIncomeExpenseMember 2022-11-01 2023-01-31 0000047217 us-gaap:OtherContractMember hpq:InterestAndOtherIncomeExpenseMember 2023-11-01 2024-01-31 0000047217 us-gaap:OtherContractMember hpq:InterestAndOtherIncomeExpenseMember 2022-11-01 2023-01-31 0000047217 us-gaap:CommercialPaperMember 2024-01-31 0000047217 us-gaap:CommercialPaperMember 2023-10-31 0000047217 hpq:NotesPayableToBanksLinesOfCreditAndOtherNotesPayablesMember 2024-01-31 0000047217 hpq:NotesPayableToBanksLinesOfCreditAndOtherNotesPayablesMember 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueSeptember2041Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueSeptember2041Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueJune2025Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueJune2025Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueJune2027Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueJune2027Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueJune2030Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueJune2030Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueJune2026Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueJune2026Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueJune2031Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueJune2031Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueApril2029Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueApril2029Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueApril2032Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueApril2032Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueJanuary2028Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueJanuary2028Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueJanuary2033Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueJanuary2033Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesDueMarch2029Member 2024-01-31 0000047217 hpq:USDollarGlobalNotesDueMarch2029Member 2023-10-31 0000047217 hpq:USDollarGlobalNotesMember 2024-01-31 0000047217 hpq:USDollarGlobalNotesMember 2023-10-31 0000047217 srt:MinimumMember hpq:OtherLongTermDebtMember 2024-01-31 0000047217 srt:MaximumMember hpq:OtherLongTermDebtMember 2024-01-31 0000047217 hpq:OtherLongTermDebtMember 2024-01-31 0000047217 hpq:OtherLongTermDebtMember 2023-10-31 0000047217 us-gaap:CommercialPaperMember 2024-01-31 0000047217 us-gaap:RevolvingCreditFacilityMember 2024-01-31 0000047217 us-gaap:RevolvingCreditFacilityMember hpq:A364DayRevolvingCreditFacilityMember 2023-03-31 0000047217 us-gaap:RevolvingCreditFacilityMember hpq:A364DayRevolvingCreditFacilityMember 2023-03-31 2023-03-31 0000047217 us-gaap:LineOfCreditMember 2024-01-31 0000047217 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-11-01 2024-01-31 0000047217 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-11-01 2023-01-31 0000047217 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-11-01 2024-01-31 0000047217 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-11-01 2023-01-31 0000047217 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2023-11-01 2024-01-31 0000047217 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2022-11-01 2023-01-31 0000047217 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-11-01 2024-01-31 0000047217 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-11-01 2023-01-31 0000047217 hpq:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossAndNetPriorServiceCostCreditMember 2023-11-01 2024-01-31 0000047217 hpq:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossAndNetPriorServiceCostCreditMember 2022-11-01 2023-01-31 0000047217 hpq:AccumulatedDefinedBenefitPlansAdjustmentCurtailmentsSettlementsAndOtherMember 2023-11-01 2024-01-31 0000047217 hpq:AccumulatedDefinedBenefitPlansAdjustmentCurtailmentsSettlementsAndOtherMember 2022-11-01 2023-01-31 0000047217 us-gaap:AccumulatedTranslationAdjustmentMember 2023-11-01 2024-01-31 0000047217 us-gaap:AccumulatedTranslationAdjustmentMember 2022-11-01 2023-01-31 0000047217 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-10-31 0000047217 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-10-31 0000047217 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-10-31 0000047217 us-gaap:AccumulatedTranslationAdjustmentMember 2023-10-31 0000047217 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-31 0000047217 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-31 0000047217 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-31 0000047217 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-31 0000047217 hpq:Forsythetal.vs.HPInc.andHewlettPackardEnterpriseMember 2016-08-18 2016-08-18 0000047217 hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember 2010-04-30 2010-05-10 0000047217 hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember 2012-04-11 0000047217 hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember 2012-12-11 2012-12-11 0000047217 hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember 2012-04-20 0000047217 hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember 2012-04-21 2012-04-21 0000047217 hpq:IndiaDirectorateOfRevenueIntelligenceProceedingsMember 2013-01-24 2013-01-24 0000047217 hpq:PhilipsPatentLitigationMember 2020-09-01 2020-09-30 0000047217 hpq:PhilipsPatentLitigationMember 2020-10-01 2020-10-31 0000047217 hpq:CaltechPatentLitigationMember 2021-03-19 2021-03-19 0000047217 hpq:DynamicSecurityLitigationMember 2020-12-01 2022-04-30 0000047217 hpq:DynamicSecurityLitigationMember 2024-01-01 2024-01-31 0000047217 hpq:AcquisitionOfAutonomyMember hpq:AutonomyRelatedLegalMattersMember 2015-04-17 2015-04-17 0000047217 hpq:AcquisitionOfAutonomyMember hpq:AutonomyRelatedLegalMattersMember 2015-10-01 2015-10-01 0000047217 hpq:MessrsLynchMember hpq:AcquisitionOfAutonomyMember hpq:AutonomyRelatedLegalMattersMember 2015-10-01 2015-10-01 0000047217 hpq:NokiaPatentLitigationMember 2023-10-31 2023-10-31 0000047217 hpq:NokiaPatentLitigationU.S.InternationalTradeCommissionMember 2023-10-31 2023-10-31 0000047217 hpq:NokiaPatentLitigationMember 2023-11-01 2023-11-30 0000047217 hpq:NokiaPatentLitigationMember country:BR 2023-11-01 2023-11-30 0000047217 hpq:R2SemiconductorLitigationMember srt:EuropeMember 2022-11-01 2022-11-30 0000047217 hpq:AccessAdvancePatentPoolUnifiedPatentCourtMember 2024-01-31 0000047217 hpq:AccessAdvancePatentPoolUnifiedPatentCourtMember hpq:DusseldorfGermanyMember 2023-11-01 2024-01-31 0000047217 hpq:AccessAdvancePatentPoolUnifiedPatentCourtMember hpq:MunichGermanyMember 2023-11-01 2024-01-31 shares iso4217:USD iso4217:USD shares hpq:segment hpq:employee pure hpq:country hpq:age hpq:patent hpq:claim hpq:subsidiary hpq:member hpq:affiliate 0000047217 false --10-31 2024 Q1 http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent P2D http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent P2D P2D 10-Q true 2024-01-31 false 1-4423 HP INC. DE 94-1081436 1501 Page Mill Road 94304 Palo Alto, CA 650 857-1501 Common stock, par value $0.01 per share HPQ NYSE Yes Yes Large Accelerated Filer false false false 980731959 12419000000 13044000000 766000000 754000000 13185000000 13798000000 9871000000 10589000000 426000000 422000000 10297000000 11011000000 2888000000 2787000000 399000000 403000000 1383000000 1331000000 63000000 141000000 27000000 84000000 81000000 85000000 1953000000 2044000000 935000000 743000000 -142000000 -181000000 793000000 562000000 171000000 93000000 622000000 469000000 0.63 0.47 0.62 0.47 995000000 989000000 1002000000 996000000 622000000 469000000 4000000 4000000 -162000000 -623000000 159000000 334000000 -321000000 -957000000 -10000000 -1000000 -2000000 0 0 1000000 8000000 0 20000000 29000000 -305000000 -924000000 -70000000 -183000000 -235000000 -741000000 387000000 -272000000 2417000000 3232000000 84000000 93000000 3804000000 4237000000 6928000000 6862000000 3709000000 3646000000 16858000000 17977000000 2807000000 2827000000 8610000000 8591000000 7571000000 7609000000 35846000000 37004000000 359000000 230000000 13255000000 14046000000 10243000000 10212000000 23857000000 24488000000 9301000000 9254000000 4328000000 4331000000 0.01 0.01 300000000 300000000 0 0 0 0 0.01 0.01 9600000000 9600000000 980000000 980000000 989000000 989000000 10000000 10000000 1579000000 1505000000 -2771000000 -2361000000 -458000000 -223000000 -1640000000 -1069000000 35846000000 37004000000 622000000 469000000 205000000 209000000 177000000 167000000 63000000 141000000 -5000000 -140000000 20000000 -4000000 -446000000 -244000000 47000000 -230000000 -744000000 -1731000000 -62000000 -16000000 49000000 220000000 -87000000 -92000000 476000000 -279000000 121000000 -16000000 158000000 192000000 0 4000000 0 1000000 70000000 240000000 -228000000 -435000000 100000000 200000000 92000000 52000000 49000000 539000000 76000000 79000000 500000000 100000000 275000000 259000000 0 200000000 -708000000 -925000000 -815000000 -1376000000 3232000000 3145000000 2417000000 1769000000 988782000 10000000 1505000000 -2361000000 -223000000 -1069000000 622000000 622000000 -235000000 -235000000 387000000 8677000 -76000000 -76000000 17062000 27000000 487000000 514000000 0.55 545000000 545000000 177000000 177000000 980397000 10000000 1579000000 -2771000000 -458000000 -1640000000 979869000 10000000 1172000000 -4492000000 285000000 -3025000000 469000000 469000000 -741000000 -741000000 -272000000 8844000 -79000000 -79000000 3624000 4000000 96000000 100000000 0.53 518000000 518000000 167000000 167000000 985089000 10000000 1256000000 -4637000000 -456000000 -3827000000 Basis of Presentation<div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Condensed Financial Statements of HP and its wholly-owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2023 in HP’s Annual Report on Form 10-K, filed on December 18, 2023. The Consolidated Condensed Balance Sheet for October 31, 2023 was derived from audited financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Condensed Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP has reclassified certain prior-year amounts to conform to the current-year presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (“FASB”) issued guidance that enhances the transparency about the use of supplier finance programs. Under the new guidance, companies that use a supplier finance program in connection with the purchase of goods or services are required to disclose information about those programs to allow users of financial statements to understand the nature, activity during the period, changes from period to period, and potential magnitude. HP adopted this guidance in the first quarter of fiscal year 2024, except for the disclosure on roll forward information which will be adopted in fiscal year 2025, in line with the effective adoption dates prescribed by the FASB. See Note 6, “Supplementary Financial Information,” for additional disclosure related to HP’s supplier finance programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued guidance that updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2025 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Condensed Financial Statements of HP and its wholly-owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2023 in HP’s Annual Report on Form 10-K, filed on December 18, 2023. The Consolidated Condensed Balance Sheet for October 31, 2023 was derived from audited financial statements.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Condensed Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP has reclassified certain prior-year amounts to conform to the current-year presentation.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (“FASB”) issued guidance that enhances the transparency about the use of supplier finance programs. Under the new guidance, companies that use a supplier finance program in connection with the purchase of goods or services are required to disclose information about those programs to allow users of financial statements to understand the nature, activity during the period, changes from period to period, and potential magnitude. HP adopted this guidance in the first quarter of fiscal year 2024, except for the disclosure on roll forward information which will be adopted in fiscal year 2025, in line with the effective adoption dates prescribed by the FASB. See Note 6, “Supplementary Financial Information,” for additional disclosure related to HP’s supplier finance programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued guidance that updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2025 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.</span></div> Segment Information<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s operations are organized into three reportable segments: Personal Systems, Printing, and Corporate Investments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Personal Systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offers commercial and consumer desktops and notebooks, detachables and convertibles, workstations, thin clients, commercial mobility devices, retail point-of-sale (“POS”) systems, displays, hybrid systems, software, solutions and services. Personal Systems includes support and deployment, configurations and extended warranty services and maintains multi-operating system and multi-architecture strategies using Microsoft Windows and Google Chrome operating systems, and predominantly use processors from Intel Corporation (“Intel”) and Advanced Micro Devices, Inc. (“AMD”).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Personal Systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> groups its global business capabilities into the following business units when reporting business performance:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Commercial PS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of devices and accessories, including workstations, thin clients, mobility devices and hybrid systems, for use by enterprise, public sector (which includes education), and small- and medium-sized business (“SMB”) customers. HP offers a range of services and solutions to commercial customers to help them manage the lifecycle of their personal computers (“PCs”) and mobility installed base. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Consumer PS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of devices, accessories and services which are optimized for consumer usage, focusing on gaming, learning and working remotely, consuming multi-media for entertainment, managing personal life activities, sharing information, and staying connected informed and secure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Printing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offers consumer and commercial printer hardware, supplies, services and solutions. Printing is also focused on Graphics and 3D Printing and Personalization in the commercial and industrial markets. Our global business capabilities within Printing are described below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Office Printing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> delivers HP’s office printers, supplies, services, and solutions to SMBs, public sector and large enterprises. It also includes Original Equipment Manufacturer (“OEM”) hardware and solutions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Home Printing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> delivers innovative printing products, supplies, services and solutions for the home and home business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Graphics Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delivers large-format, commercial and industrial solutions and supplies to print service providers and packaging converters through a wide portfolio of printers and presses (HP DesignJet, HP Latex, HP Indigo and HP PageWide Web Presses).</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">3D Printing &amp; Personalization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offers a portfolio of additive manufacturing solutions and supplies to help customers succeed in their additive and digital manufacturing journey. HP offers complete solutions in collaboration with an ecosystem of partners.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Printing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> groups its global business capabilities into the following business units when reporting business performance:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Commercial Printing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of office printing solutions, graphics solutions and 3D printing and personalization, excluding supplies;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Consumer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Printing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of home printing solutions, excluding supplies; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Supplies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises a set of highly innovative consumable products, ranging from ink and laser cartridges to media, graphics supplies and 3D printing and digital manufacturing supplies, for recurring use in consumer and commercial hardware.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes certain business incubation and investment projects.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges and amortization of intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment Operating Results and the reconciliation to HP consolidated results were as follows:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial PS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer PS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Systems</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,186 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before taxes: </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Systems</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment earnings from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated costs and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total earnings before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Realignment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective at the beginning of its first quarter of fiscal year 2024, HP realigned its business unit financial reporting more closely with its customer market segmentation. The realignment resulted in the transfer of LaserJet printers net revenues from Consumer Printing to Commercial Printing. HP reflected this change to its business unit information in prior reporting periods on an as-if basis which resulted in the reclassification of net revenues from Consumer Printing to Commercial Printing. The reporting change had no impact to previously reported segment net revenue, consolidated net revenue, earnings from operations, net earnings or net earnings per share (“EPS”).</span></div> 3 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges and amortization of intangible assets.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment Operating Results and the reconciliation to HP consolidated results were as follows:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial PS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer PS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Systems</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,186 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before taxes: </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Systems</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment earnings from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated costs and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total earnings before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment Operating Results and the reconciliation to HP consolidated results were as follows:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial PS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer PS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Systems</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,186 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before taxes: </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Systems</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment earnings from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated costs and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total earnings before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 6045000000 6382000000 2764000000 2803000000 8809000000 9185000000 2863000000 2857000000 1227000000 1388000000 285000000 367000000 4375000000 4612000000 2000000 1000000 13186000000 13798000000 -1000000 0 13185000000 13798000000 537000000 475000000 872000000 870000000 -37000000 -33000000 1372000000 1312000000 89000000 92000000 177000000 167000000 63000000 141000000 27000000 84000000 81000000 85000000 -142000000 -181000000 793000000 562000000 Restructuring and Other Charges<div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Restructuring Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s restructuring activities summarized by plan were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2023 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Severance and EER</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-labor</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other prior-year plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of October 31, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of January 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs incurred to date as of January 31, 2024</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reflected in Consolidated Condensed Balance Sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of October 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of January 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Primarily includes the fiscal 2020 plan along with other legacy plans, all of which are substantially complete. HP does not expect any further material activity associated with these plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2023 Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2022, HP’s Board of Directors approved the Future Ready Plan (the “Fiscal 2023 Plan”) intended to enable digital transformation, portfolio optimization and operational efficiency which HP expects will be implemented through fiscal year 2025. HP expects to reduce global headcount by approximately 4,000 to 6,000 employees. HP estimates that it will incur pre-tax charges of approximately $1.0 billion of which approximately $0.7 billion primarily in labor costs related to workforce reductions and the remaining costs will relate to non-labor actions and other charges.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other charges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other charges include non-recurring costs, including those as a result of information technology rationalization efforts and transformation program management costs, and are distinct from ongoing operational costs. These costs primarily relate to third-party professional services and other non-recurring costs. For the three months ended January 31, 2024, HP incurred $15 million of other charges. For the three months ended January 31, 2023, HP incurred $10 million of other charges.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s restructuring activities summarized by plan were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2023 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Severance and EER</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-labor</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other prior-year plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of October 31, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of January 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs incurred to date as of January 31, 2024</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reflected in Consolidated Condensed Balance Sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of October 31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of January 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Primarily includes the fiscal 2020 plan along with other legacy plans, all of which are substantially complete. HP does not expect any further material activity associated with these plans.</span></div> 88000000 18000000 2000000 108000000 43000000 2000000 3000000 48000000 63000000 6000000 3000000 72000000 2000000 0 -2000000 0 70000000 14000000 0 84000000 445000000 43000000 869000000 1357000000 70000000 3000000 0 73000000 0 11000000 0 11000000 0 0 32000000 32000000 122000000 9000000 0 131000000 53000000 4000000 25000000 82000000 -2000000 -5000000 1000000 -6000000 67000000 0 8000000 75000000 4000 6000 1000000000 700000000 15000000 10000000 Retirement and Post-Retirement Benefit Plans <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of HP’s pension and post-retirement benefit (credit) cost recognized in the Consolidated Condensed Statements of Earnings were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:30.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. Defined Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Defined Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post- Retirement Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and deferrals:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total periodic benefit (credit) cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions and Funding Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s policy is to fund its pension plans so that it makes at least the minimum contribution required by local government, funding and taxing authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2024, HP anticipates making contributions of approximately $45 million to its non-U.S. pension plans, approximately $31 million to its U.S. non-qualified plan participants and approximately $3 million to cover benefit claims under HP’s post-retirement benefit plans. During the three months ended January 31, 2024, HP contributed $11 million to its non-U.S. pension plans, paid $6 million to cover benefit payments to U.S. non-qualified plan participants and paid $2 million to cover benefit claims under HP’s post-retirement benefit plans. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s pension and other post-retirement benefit costs and obligations depend on various assumptions. Differences between expected and actual returns on investments and changes in discount rates and other actuarial assumptions are reflected as unrecognized gains or losses, and such gains or losses are amortized to earnings in future periods. A deterioration in the funded status of a plan could result in a need for additional contributions or an increase in net pension and post-retirement benefit costs in future periods. Actuarial gains or losses are determined at the measurement date and amortized over the remaining service life for active plans or the life expectancy of plan participants for frozen plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retirement Incentive Program</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Fiscal 2023 Plan, HP announced a voluntary EER program for its U.S. employees in January 2023. Voluntary participation in the EER program was limited to employees at least 55 years old with 10 or more years of service at HP. Employees accepted into the EER program left HP on dates ranging from March 15, 2023 to October 31, 2023. The U.S. defined benefit pension plan was amended to provide that the EER benefit was to be paid from the plan for eligible electing EER participants. The retirement incentive benefit was calculated as a lump sum based on years of service at HP at the time of retirement, ranging from 20 to 52 weeks of pay. As a result of this retirement incentive, HP recognized a special termination benefit (“STB”) expense of $105 million for the year ended October 31, 2023 as a restructuring charge. This expense is the present value of all additional benefits that HP will distribute from the pension plan assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All employees participating in the EER program were offered the opportunity to continue health care coverage at the active employee contribution rates for up to 36 months following retirement, but not beyond age 65 when Medicare is available. In addition, HP provided up to $12,000 in employer credits under the Retirement Medical Savings Account program. HP recognized an additional STB expense of $34 million as restructuring and other charges for the year ended October 31, 2023 for the health care incentives.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of HP’s pension and post-retirement benefit (credit) cost recognized in the Consolidated Condensed Statements of Earnings were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:30.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. Defined Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Defined Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post- Retirement Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and deferrals:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total periodic benefit (credit) cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 0 0 9000000 9000000 0 0 57000000 54000000 12000000 10000000 4000000 4000000 61000000 65000000 13000000 13000000 4000000 3000000 -7000000 -5000000 0 -1000000 4000000 4000000 0 0 2000000 1000000 -3000000 -3000000 3000000 -6000000 10000000 8000000 -7000000 -6000000 0 0 0 -1000000 0 0 3000000 -6000000 10000000 9000000 -7000000 -6000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions and Funding Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s policy is to fund its pension plans so that it makes at least the minimum contribution required by local government, funding and taxing authorities.</span></div> 45000000 31000000 3000000 11000000 6000000 2000000 P55Y 105000000 P36M 12000 34000000 Taxes on Earnings<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s effective tax rate was 21.6% and 16.6% for the three months ended January 31, 2024 and 2023, respectively. The difference between the U.S. federal statutory tax rate of 21% and HP’s effective tax rate for the three months ended January 31, 2023 was primarily due to tax effects of favorable tax rates associated with certain earnings from HP's operations in lower-tax jurisdictions throughout the world.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January 31, 2023, HP recorded $56 million of net income tax benefits related to discrete items in the provision for taxes. These amounts included $30 million of income tax benefits related to restructuring charges, $14 million related to acquisition charges and $12 million of other net tax benefits. During the three months ended January 31, 2023, excess tax benefits associated with stock options, restricted stock units and performance-adjusted restricted stock units were immaterial.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Uncertain Tax Positions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, the amount of gross unrecognized tax benefits was $1.2 billion, of which up to $828 million would affect HP’s effective tax rate if realized. Total gross unrecognized tax benefits increased by $20 million for the three months ended January 31, 2024. HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Consolidated Condensed Statements of Earnings. As of January 31, 2024 and 2023, HP had accrued $105 million and $73 million, respectively, for interest and penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP engages in continuous discussions and negotiations with taxing authorities regarding tax matters in various jurisdictions. HP expects complete resolution of certain tax years with various tax authorities within the next 12 months. HP believes it is reasonably possible that its existing gross unrecognized tax benefits may be reduced by $39 million within the next 12 months, affecting HP’s effective tax rate if realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP is subject to income tax in the United States and approximately 60 other countries and is subject to routine corporate income tax audits in many of these jurisdictions. In addition, HP is subject to numerous ongoing audits by federal, state and foreign tax authorities. The Internal Revenue Service (“IRS”) is conducting an audit of HP’s 2018 and 2019 income tax returns.</span></div> 0.216 0.166 -56000000 30000000 14000000 12000000 1200000000 828000000 20000000 HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Consolidated Condensed Statements of Earnings. 105000000 73000000 P12M 39000000 60 Supplementary Financial Information<div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses related to accounts receivable and changes were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit of allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions, net of recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Condensed Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Condensed Balance Sheets. The recourse obligations as of January 31, 2024 and October 31, 2023 were not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the activity under these arrangements:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables sold</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amounts outstanding from third parties reported in Accounts receivable in the Consolidated Condensed Balance Sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,928 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,862 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-indent:-22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier and other receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,646 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and leasehold improvements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment, including equipment held for lease</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,384 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,716 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Non-Current Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-531"><span style="-sec-ix-hidden:f-532">Right-of-use assets</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and prepaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension and post-retirement benefit assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,571 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Current Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing programs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-554"><span style="-sec-ix-hidden:f-555">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,243 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,212 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Non-Current Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-569"><span style="-sec-ix-hidden:f-570">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension, post-retirement, and post-employment liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,328 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,331 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and Other, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense on borrowings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Factoring costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating retirement-related credits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue by Region</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific and Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,185 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Value of Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, the estimated value of transaction price allocated to remaining performance obligations was $3.8 billion. HP expects to recognize approximately $1.7 billion of the unearned amount in next 12 months and $2.1 billion thereafter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP has elected the practical expedients and accordingly does not disclose the aggregate amount of the transaction price allocated to remaining performance obligations if: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the contract has an original expected duration of one year or less; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the revenue from the performance obligation is recognized over time on an as-invoiced basis when the amount corresponds directly with the value to the customer; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the portion of the transaction price that is variable in nature is allocated entirely to a wholly unsatisfied performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining performance obligations are subject to change and may be affected by various factors, such as termination of contracts, contract modifications and adjustment for currency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024 and October 31, 2023, HP’s contract liabilities balances were $2.8 billion and $2.7 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Consolidated Condensed Balance Sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the contract liabilities balance for the three months ended January 31, 2024, was primarily driven by sales of fixed-price support and maintenance services, partially offset by $0.5 billion of revenue recognized that was included in the contract liabilities balance as of October 31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Finance Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP facilitates voluntary supplier finance programs to provide certain suppliers the opportunity to sell their right to HP’s payment obligations to participating financial institutions. Under this program, HP agrees to pay the participating financial institutions the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Participation by suppliers in these programs have no impact on the payment terms and amounts due from HP. HP does not have an economic interest in a supplier's participation in the program and is not a party to the agreement between the supplier and the financial institutions. In connection with these programs, HP does not pledge assets or other forms of guarantees as security for the committed payment to the participating financial institutions. HP pays a monthly service fee to a third-party administrato</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that provides the supplier finance platform and related support. HP and the participating financial institutions may terminate the agreement upon at least 30 days notice. As of January 31, 2024 and October 31, 2023, HP had $5.3 billion and $6.6 billion respectively, in obligations outstanding (i.e., unpaid invoices) that were confirmed as valid under the supplier finance programs. Of the amounts confirmed as valid under the program and outstanding, the amounts owed to participating financial institutions were $0.7 billion and $0.9 billion as of January 31, 2024 and October 31, 2023, respectively. These obligations are included within the Accounts payable line item of HP’s Consolidated Condensed Balance Sheet</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.</span></div> 2263000000 3107000000 154000000 125000000 2417000000 3232000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses related to accounts receivable and changes were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit of allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions, net of recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 93000000 6000000 3000000 84000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Condensed Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Condensed Balance Sheets. The recourse obligations as of January 31, 2024 and October 31, 2023 were not material.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the activity under these arrangements:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables sold</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amounts outstanding from third parties reported in Accounts receivable in the Consolidated Condensed Balance Sheets.</span></div> 141000000 185000000 3298000000 3679000000 3232000000 3753000000 5000000 17000000 212000000 128000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,928 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,862 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 3603000000 3930000000 3325000000 2932000000 6928000000 6862000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier and other receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,646 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1419000000 1349000000 1376000000 1445000000 914000000 852000000 3709000000 3646000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and leasehold improvements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment, including equipment held for lease</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,384 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,716 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 2348000000 2332000000 5452000000 5384000000 7800000000 7716000000 4993000000 4889000000 2807000000 2827000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Non-Current Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-531"><span style="-sec-ix-hidden:f-532">Right-of-use assets</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and prepaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension and post-retirement benefit assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,571 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3230000000 3155000000 1519000000 1593000000 1165000000 1188000000 412000000 427000000 395000000 393000000 850000000 853000000 7571000000 7609000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Current Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing programs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-554"><span style="-sec-ix-hidden:f-555">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,243 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,212 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2920000000 3053000000 1424000000 1424000000 1071000000 994000000 648000000 1046000000 572000000 569000000 459000000 430000000 282000000 217000000 2867000000 2479000000 10243000000 10212000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Non-Current Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-569"><span style="-sec-ix-hidden:f-570">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension, post-retirement, and post-employment liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,328 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,331 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1373000000 1324000000 926000000 904000000 815000000 825000000 546000000 546000000 31000000 44000000 637000000 688000000 4328000000 4331000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and Other, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense on borrowings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Factoring costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating retirement-related credits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 116000000 143000000 40000000 32000000 0 -8000000 4000000 11000000 10000000 -9000000 -142000000 -181000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue by Region</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific and Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,185 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5408000000 5747000000 4668000000 4636000000 3109000000 3415000000 13185000000 13798000000 3800000000 1700000000 P12M 2100000000 2800000000 2700000000 500000000 P30D 5300000000 6600000000 700000000 900000000 Fair Value<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hierarchy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—Unobservable inputs for the asset or liability.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measured Using</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measured Using</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-Sale Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial institution instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Marketable securities and mutual funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,059 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds. Money market funds invested in government debt and traded in active markets are included in Level 1.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation Techniques</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash Equivalents and Investments: HP holds time deposits, money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 8, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Consolidated Condensed Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $9.3 billion as compared to its carrying amount of $9.7 billion at January 31, 2024. The fair value of HP’s short- and long-term debt was $8.5 billion as compared to its carrying value of $9.5 billion at October 31, 2023. If measured at fair value in the Consolidated Condensed Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Consolidated Condensed Balance Sheets, the carrying amounts approximate fair value due to their short maturities. If measured at fair value in the Consolidated Condensed Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Consolidated Condensed Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hierarchy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—Unobservable inputs for the asset or liability.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation Techniques</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash Equivalents and Investments: HP holds time deposits, money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 8, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Consolidated Condensed Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $9.3 billion as compared to its carrying amount of $9.7 billion at January 31, 2024. The fair value of HP’s short- and long-term debt was $8.5 billion as compared to its carrying value of $9.5 billion at October 31, 2023. If measured at fair value in the Consolidated Condensed Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Consolidated Condensed Balance Sheets, the carrying amounts approximate fair value due to their short maturities. If measured at fair value in the Consolidated Condensed Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Consolidated Condensed Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:</span><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measured Using</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measured Using</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-Sale Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial institution instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Marketable securities and mutual funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,059 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds. Money market funds invested in government debt and traded in active markets are included in Level 1.</span></div> 0 502000000 0 502000000 0 589000000 0 589000000 1029000000 0 0 1029000000 1900000000 0 0 1900000000 0 3000000 0 3000000 0 3000000 0 3000000 43000000 49000000 0 92000000 33000000 45000000 0 78000000 0 212000000 0 212000000 0 489000000 0 489000000 0 2000000 0 2000000 0 0 0 0 1072000000 768000000 0 1840000000 1933000000 1126000000 0 3059000000 0 43000000 0 43000000 0 58000000 0 58000000 0 248000000 0 248000000 0 212000000 0 212000000 0 0 0 0 0 2000000 0 2000000 0 291000000 0 291000000 0 272000000 0 272000000 9300000000 9700000000 8500000000 9500000000 Financial Instruments<div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-Sale Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available-for-Sale Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial institution instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Marketable securities and mutual funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and available-for-sale investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of January 31, 2024 and October 31, 2023, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of investments in available-for-sale debt securities were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:-72pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities in privately held companies are included in Other non-current assets in the Consolidated Condensed Balance Sheets. These amounted to $108 million and $111 million as of January 31, 2024 and October 31, 2023, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP determines credit losses on cash equivalents and available-for-sale debt securities at the individual security level. All instruments are considered investment grade. No credit-related or noncredit-related impairment losses were recorded for the three months ended January 31, 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates from contractually established thresholds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes gross collateral posted and received in other current assets and other current liabilities in the Consolidated Condensed Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $119 million and $91 million as of January 31, 2024 and as of October 31, 2023, respectively, all of which were fully collateralized within <span style="-sec-ix-hidden:f-779">two</span> business days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of January 31, 2024 and October 31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP uses forward contracts,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted net revenue, cost of revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements extend several years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Derivatives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Effectiveness</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January 31, 2024 and 2023, no portion of the hedging instruments’ gain or loss was excluded from the assessment of effectiveness for fair value and cash flow hedges.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-782">Other Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-783">Other Non-Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-784">Other Current Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-785">Other Non-Current Liabilities</span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-786">Other Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-787">Other Non-Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-788">Other Current Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-789">Other Non-Current Liabilities</span></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,032 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,028 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,446 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,056 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,571 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,088 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,599 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offsetting of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of January 31, 2024 and October 31, 2023, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In the Consolidated Condensed Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(i)</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ii)</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(iii) = (i)–(ii)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(iv)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(v)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(vi) = (iii)–(iv)–(v)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount<br/>Recognized</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount<br/>Offset</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount<br/>Presented</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Collateral</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">As of January 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">As of October 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, <span style="-sec-ix-hidden:f-887">two</span> business days prior to the respective reporting date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, <span style="-sec-ix-hidden:f-888">two</span> business days prior to the respective reporting date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of Derivative Instruments in the Consolidated Condensed Statements of Earnings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) recognized in earnings on derivative instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) recognized in earnings on hedged item</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Three months ended January 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total amounts of income/(expense) line items in the statement of financial performance in which the effects of cash flow hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) reclassified from Accumulated <br/>other comprehensive (loss) income into earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,011)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, HP expects to reclassify an estimated accumulated other comprehensive loss of $33 million, net of taxes, to earnings within the next twelve months associated with cash flow hedges along with the earnings effects of the related forecasted transactions. The amounts ultimately reclassified into earnings could be different from the amounts previously included in Accumulated other comprehensive (loss) income based on the change of market rate, and therefore could have different impact on earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Condensed Statements of Earnings as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) recognized in earnings on derivative instrument</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-Sale Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available-for-Sale Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial institution instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Marketable securities and mutual funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and available-for-sale investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 502000000 0 0 502000000 589000000 0 0 589000000 1029000000 0 0 1029000000 1900000000 0 0 1900000000 1531000000 0 0 1531000000 2489000000 0 0 2489000000 3000000 0 0 3000000 3000000 0 0 3000000 40000000 52000000 0 92000000 40000000 38000000 0 78000000 43000000 52000000 0 95000000 43000000 38000000 0 81000000 1574000000 52000000 0 1626000000 2532000000 38000000 0 2570000000 All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of investments in available-for-sale debt securities were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:-72pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 3000000 3000000 Non-marketable equity securities in privately held companies are included in Other non-current assets in the Consolidated Condensed Balance Sheets. 108000000 111000000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates from contractually established thresholds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes gross collateral posted and received in other current assets and other current liabilities in the Consolidated Condensed Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $119 million and $91 million as of January 31, 2024 and as of October 31, 2023, respectively, all of which were fully collateralized within <span style="-sec-ix-hidden:f-779">two</span> business days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of January 31, 2024 and October 31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP uses forward contracts,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted net revenue, cost of revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements extend several years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Derivatives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Effectiveness</span></div>For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates. 119000000 91000000 P12M <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-782">Other Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-783">Other Non-Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-784">Other Current Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-785">Other Non-Current Liabilities</span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-786">Other Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-787">Other Non-Current Assets</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-788">Other Current Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-789">Other Non-Current Liabilities</span></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,032 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,028 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,446 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,056 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,571 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,088 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,599 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 750000000 0 0 0 43000000 750000000 0 0 0 58000000 15282000000 173000000 28000000 182000000 59000000 15278000000 410000000 70000000 147000000 52000000 16032000000 173000000 28000000 182000000 102000000 16028000000 410000000 70000000 147000000 110000000 3926000000 11000000 0 7000000 0 4446000000 9000000 0 13000000 0 130000000 2000000 0 0 0 125000000 0 0 2000000 0 4056000000 13000000 0 7000000 0 4571000000 9000000 0 15000000 0 20088000000 186000000 28000000 189000000 102000000 20599000000 419000000 70000000 162000000 110000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offsetting of Derivative Instruments</span></div>HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of January 31, 2024 and October 31, 2023, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In the Consolidated Condensed Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(i)</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ii)</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(iii) = (i)–(ii)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(iv)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(v)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(vi) = (iii)–(iv)–(v)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount<br/>Recognized</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount<br/>Offset</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount<br/>Presented</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Collateral</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">As of January 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">As of October 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, <span style="-sec-ix-hidden:f-887">two</span> business days prior to the respective reporting date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, <span style="-sec-ix-hidden:f-888">two</span> business days prior to the respective reporting date.</span></div> As of January 31, 2024 and October 31, 2023, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In the Consolidated Condensed Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(i)</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ii)</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(iii) = (i)–(ii)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(iv)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(v)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(vi) = (iii)–(iv)–(v)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount<br/>Recognized</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount<br/>Offset</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount<br/>Presented</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Collateral</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">As of January 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">As of October 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, <span style="-sec-ix-hidden:f-887">two</span> business days prior to the respective reporting date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, <span style="-sec-ix-hidden:f-888">two</span> business days prior to the respective reporting date.</span></div> 214000000 0 214000000 170000000 40000000 4000000 291000000 0 291000000 170000000 109000000 12000000 489000000 0 489000000 178000000 291000000 20000000 272000000 0 272000000 178000000 89000000 5000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) recognized in earnings on derivative instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) recognized in earnings on hedged item</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Three months ended January 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> -142000000 15000000 -15000000 -181000000 14000000 -14000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> -162000000 -623000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total amounts of income/(expense) line items in the statement of financial performance in which the effects of cash flow hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) reclassified from Accumulated <br/>other comprehensive (loss) income into earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,011)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 13185000000 13798000000 199000000 386000000 10297000000 11011000000 -40000000 -54000000 1953000000 2044000000 -3000000 -1000000 -142000000 -181000000 3000000 3000000 159000000 334000000 -33000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Condensed Statements of Earnings as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain/(loss) recognized in earnings on derivative instrument</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 1000000 -44000000 4000000 6000000 5000000 -38000000 Borrowings<div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes Payable and Short-Term Borrowings</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable to banks, lines of credit and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Dollar Global Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 issued at par at a price of 100% at 4.75%, due March 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,042 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,042 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment related to hedged debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,301 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,254 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">HP allocated an amount equal to the net proceeds to finance or refinance, in whole or in part, environmentally and socially responsible eligible projects in the following eight areas: renewable energy; green buildings; energy efficiency; clean transportation; pollution prevention and control; eco-efficient and/or circular economy products, production technologies and processes; environmentally sustainable management of living natural resources and land use; and socioeconomic advancement and empowerment.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Note 8, “Financial Instruments,” HP uses interest rate swaps to mitigate some of the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates. Interest rates shown in the table of long-term debt have not been adjusted to reflect the impact of any interest rate swaps.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, HP maintained a U.S. commercial paper program for the issuance of U.S. dollar-denominated commercial paper up to a maximum aggregate principal amount of $6.0 billion. The principal amount outstanding under this program and certain short-term borrowings at any time cannot exceed a $6.0 billion authorization by HP’s Board of Directors.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, HP maintained a $5.0 billion sustainability-linked senior unsecured committed revolving credit facility, which HP entered into in May 2021, and a $1.0 billion senior unsecured committed 364-day revolving credit facility, which HP entered into in March 2023. Commitments under the $5.0 billion revolving credit facility will be available until May 26, 2026 and commitments under the $1.0 billion 364-day revolving credit facility will be available until March 19, 2024. Commitment fees, interest rates and other terms of borrowing under the revolving credit facilities vary based on HP’s external credit ratings and, for the $5.0 billion facility, certain sustainability metrics. Funds borrowed under the revolving credit facilities may be used for general corporate purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, HP was in compliance with the covenants in the credit agreements governing the revolving credit facilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available Borrowing Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, HP had available borrowing resources of $1.0 billion from uncommitted lines of credit in addition to the full capacity of the revolving credit facilities.</span></div> <div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes Payable and Short-Term Borrowings</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable to banks, lines of credit and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 100000000 0.055 0 0 193000000 0.059 179000000 0.060 66000000 0.012 51000000 0.010 359000000 230000000 <div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Dollar Global Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 issued at par at a price of 100% at 4.75%, due March 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,042 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,042 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other borrowings at 1.58%-8.30%, due in fiscal years 2024-2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment related to hedged debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,301 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,254 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">HP allocated an amount equal to the net proceeds to finance or refinance, in whole or in part, environmentally and socially responsible eligible projects in the following eight areas: renewable energy; green buildings; energy efficiency; clean transportation; pollution prevention and control; eco-efficient and/or circular economy products, production technologies and processes; environmentally sustainable management of living natural resources and land use; and socioeconomic advancement and empowerment.</span></div> 1200000000 0.99863 0.0600 1199000000 1199000000 1150000000 0.99769 0.0220 1149000000 1149000000 1000000000 0.99718 0.0300 999000000 999000000 850000000 0.99790 0.0340 503000000 503000000 1000000000 0.99808 0.0145 521000000 521000000 1000000000 0.99573 0.0265 997000000 997000000 1000000000 0.99767 0.0400 999000000 999000000 1000000000 0.99966 0.0420 676000000 676000000 900000000 0.99841 0.0475 899000000 899000000 1100000000 0.99725 0.0550 1097000000 1097000000 500000000 1 0.0475 3000000 3000000 9042000000 9042000000 0.0158 0.0830 549000000 506000000 -43000000 -58000000 54000000 57000000 193000000 179000000 9301000000 9254000000 6000000000 6000000000 5000000000 1000000000 P364D 5000000000 1000000000 P364D 5000000000 1000000000 Stockholders’ Deficit<div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s share repurchase program authorizes both open market and private repurchase transactions. During the three months ended January 31, 2024, HP executed share repurchases of 17.1 million shares and settled total shares for $0.5 billion. Share repurchases executed during the three months ended January 31, 2024 included 0.3 million shares settled in February 2024. During the three months ended January 31, 2023, HP executed share repurchases of 3.6 million shares and settled total shares for $0.1 billion. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares repurchased during the three months ended January 31, 2024 and 2023 were all open market repurchase transactions. As of January 31, 2024, HP had approximately $1.5 billion remaining under the share repurchase authorizations approved by HP’s Board of Directors.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxes related to Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect on change in unrealized components of available-for-sale debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision on unrealized gains arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect on change in unrealized components of cash flow hedges:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit on unrealized losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision on gains reclassified into earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect on change in unrealized components of defined benefit plans:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit on losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit on other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes and reclassifications related to Other Comprehensive Loss, net of taxes</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized components of available-for-sale debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized components of cash flow hedges:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains reclassified into earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(773)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized components of defined benefit plans:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss and prior service benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments, settlements and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cumulative translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">These components are included in the computation of net pension and post-retirement benefit (credit) charges in Note 4, “Retirement and Post-Retirement Benefit Plans”.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Accumulated other comprehensive loss, net of taxes and changes were as follows:</span></div><div style="margin-bottom:3pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:26.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net unrealized<br/>gains (losses) on<br/>available-for-sale debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on cash<br/>flow hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>components<br/>of defined<br/>benefit plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in cumulative<br/>translation<br/>adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive loss </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gains (losses) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications of gain into earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 17100000 500000000 300000 3600000 100000000 1500000000 <div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxes related to Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect on change in unrealized components of available-for-sale debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision on unrealized gains arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect on change in unrealized components of cash flow hedges:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit on unrealized losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision on gains reclassified into earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect on change in unrealized components of defined benefit plans:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit on losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit on other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 0 1000000 -36000000 -106000000 32000000 78000000 -68000000 -184000000 -2000000 0 -2000000 0 -70000000 -183000000 <div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes and reclassifications related to Other Comprehensive Loss, net of taxes</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized components of available-for-sale debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized components of cash flow hedges:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains reclassified into earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(773)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized components of defined benefit plans:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses arising during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss and prior service benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments, settlements and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cumulative translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">These components are included in the computation of net pension and post-retirement benefit (credit) charges in Note 4, “Retirement and Post-Retirement Benefit Plans”.</span></div> 4000000 3000000 -126000000 -517000000 127000000 256000000 -253000000 -773000000 -8000000 -1000000 -2000000 0 0 -1000000 -6000000 0 20000000 29000000 -235000000 -741000000 <div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Accumulated other comprehensive loss, net of taxes and changes were as follows:</span></div><div style="margin-bottom:3pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:26.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net unrealized<br/>gains (losses) on<br/>available-for-sale debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on cash<br/>flow hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>components<br/>of defined<br/>benefit plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in cumulative<br/>translation<br/>adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive loss </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gains (losses) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications of gain into earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 7000000 230000000 -437000000 -23000000 -223000000 4000000 -126000000 -8000000 20000000 -110000000 0 127000000 -2000000 0 125000000 11000000 -23000000 -443000000 -3000000 -458000000 Earnings Per Share<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions, except per share amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic net EPS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of employee stock plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute diluted net EPS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive weighted-average stock-based compensation awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent unrecognized compensation cost.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions, except per share amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic net EPS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of employee stock plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute diluted net EPS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive weighted-average stock-based compensation awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.44pt">HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent unrecognized compensation cost.</span></div> 622000000 622000000 469000000 469000000 995000000 989000000 7000000 7000000 1002000000 996000000 0.63 0.47 0.62 0.47 6000000 7000000 Litigation and Contingencies<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP is involved in lawsuits, claims, investigations and proceedings, including those identified below, consisting of IP, commercial, securities, employment, employee benefits and environmental matters that arise in the ordinary course of business. HP accrues a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. HP believes it has recorded adequate provisions for any such matters and, as of January 31, 2024, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation, Proceedings and Investigations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Copyright Levies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Proceedings are ongoing or have been concluded involving HP in certain European countries, challenging the imposition or the modification of levies regimes upon IT equipment (such as PCs or printers) or the restrictions to exonerate the application of private copying levies on devices purchased by business users. The levies are generally based upon the number of products sold and the per-product amounts of the levies, which vary. Some European countries are expected to implement legislation to introduce or extend existing levy schemes to digital devices. HP, other companies and various industry associations have opposed the extension of levies to the digital product and certain requirements for business sales exemptions and have advocated alternative models of compensation to rights holders. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the exemption of levies on business sales and industry opposition to increasing levies to digital products, HP’s assessments of the merits of various proceedings and HP’s estimates of the number of units impacted and the amounts of the levies, HP has accrued amounts that it believes are adequate to address the ongoing disputes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This is a purported class and collective action filed on August 18, 2016 in the United States District Court, Northern District of California, against HP and Hewlett Packard Enterprise (“HPE”) alleging the defendants violated federal and state law by terminating older workers and replacing them with younger workers. In their most recent complaint, plaintiffs seek to represent (1) a putative nationwide federal Age Discrimination in Employment Act (ADEA) collective comprised of all former HP Inc. employees 40 years of age and older who had their employment terminated under a WFR plan in or after 2014 or 2015, depending on state law; and (2) a putative Rule 23 class under California law comprised of all former HP Inc. employees 40 years of age and older who had their employment terminated in California under a WFR plan in or after 2012. Excluded from the putative collective and class are employees who (a) signed a Waiver and General Release Agreement at termination, or (b) signed an Agreement to Arbitrate Claims. Similar claims are pending against HPE. Because the court granted plaintiffs’ motion for preliminary certification of the putative nationwide ADEA collectives, a third-party administrator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">notified eligible former employees of their right to opt into the ADEA collective. This opt-in period closed on February 15, 2022. Plaintiffs seek monetary damages, punitive damages, and other relief. In June 2023, the parties reached an agreement in principle to resolve this matter. The parties have finalized a settlement agreement, and the court preliminarily approved it on October 26, 2023. The Court has set the Final Approval Hearing for March 28, 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">India Directorate of Revenue Intelligence Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30 and May 10, 2010, the India Directorate of Revenue Intelligence (the “DRI”) issued show cause notices to Hewlett-Packard India Sales Private Limited (“HP India”), a subsidiary of HP, seven HP India employees and one former HP India employee alleging that HP India underpaid customs duties while importing products and spare parts into India and seeking to recover an aggregate of approximately $370 million, plus penalties and interest. Prior to the issuance of the notices, HP India deposited approximately $16 million with the DRI and agreed to post a provisional bond in exchange for the DRI’s agreement to not seize HP India products and spare parts or interrupt business by HP India.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2012, the Bangalore Commissioner of Customs issued an order on the products-related notice affirming certain duties and penalties against HP India and the named individuals of approximately $386 million, of which HP India had already deposited $9 million. On December 11, 2012, HP India voluntarily deposited an additional $10 million in connection with the products-related notice. The differential duty demand is subject to interest. On April 20, 2012, the Commissioner issued an order on the parts-related notice affirming certain duties and penalties against HP India and certain of the named individuals of approximately $17 million, of which HP India had already deposited $7 million. After the order, HP India deposited an additional $3 million in connection with the parts-related notice so as to avoid certain penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP India filed appeals of the Commissioner’s orders before the Customs, Excise and Service Tax Appellate Tribunal (the “Customs Tribunal”) along with applications for waiver of the pre-deposit of remaining demand amounts as a condition for hearing the appeals. The Customs Department has also filed cross-appeals before the Customs Tribunal. On January 24, 2013, the Customs Tribunal ordered HP India to deposit an additional $24 million against the products order, which HP India deposited in March 2013. On February 7, 2014, the Customs Tribunal granted HP India’s application for extension of the stay of deposit until disposal of the appeals. On October 27, 2014, the Customs Tribunal commenced hearings on the cross-appeals of the Commissioner’s orders and rejected HP India’s request to remand the matter to the Commissioner on procedural grounds. The Customs Tribunal cancelled hearings to reconvene in 2015, 2016 and January 2019. On January 20, 2021, the Customs Tribunal held a virtual hearing during which the judge allowed HP’s application for a physical hearing on the merits as soon as practicable, which will be scheduled when physical hearings resume at court. Pursuant to the separation and distribution agreement, Hewlett Packard Enterprise has agreed to indemnify HP in part, based on the extent to which any liability arises from the products and spare parts of Hewlett Packard Enterprise’s businesses. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Philips Patent Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In September 2020, Koninklijke Philips N.V. and Philips North America LLC (collectively, “Philips”) filed a complaint against HP for patent infringement in federal court for the District of Delaware and filed a companion complaint with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP and 8 other sets of respondents. Both complaints allege that certain digital video-capable devices and components thereof infringe four of Philips’ patents. In October 2020, the ITC instituted an investigation, and Philips later withdrew two of the four patents. On March 23, 2022, the ITC rendered a final determination that no violation of Section 337 has occurred. Philips did not appeal and elected to resume litigation with its case in federal court. Philips seeks unspecified damages and an injunction against HP, and the prior stay has been lifted. On August 10, 2023, HP filed a motion for summary judgment of indefiniteness for all asserted claims. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Caltech Patent Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On November 11, 2020, the California Institute of Technology (“Caltech”) filed a complaint against HP for patent infringement in the federal court for the Western District of Texas. On March 19, 2021, Caltech filed an amendment to this same complaint. The complaint as amended alleges infringement of five of Caltech’s patents, U.S. Patent Nos. 7,116,710; 7,421,032; 7,716,552; 7,916,781; and 8,284,833. The accused products are HP commercial and consumer PCs as well as wireless printers that comply with the IEEE 802.11n, 802.11ac, and/or 802.11ax standards. Caltech seeks unspecified damages and other relief. In August 2021, the court stayed the case pending the decision in related cases brought by Caltech against Apple and Broadcom. On November 6, 2023, the court issued an order maintaining the stay of all discovery and deadlines pending discovery relating to whether Caltech has standing to bring suit with respect to the asserted patents and the court’s resolution of that issue. A hearing concerning Caltech’s standing is scheduled for May 2024. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">York County on behalf of the County of York Retirement Fund v. HP Inc., et al., and related proceedings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On November 5, 2020, York County, on behalf of the County of York Retirement Fund, filed a putative class action complaint against HP, Dion Weisler, and Catherine Lesjak in federal court in the Northern District of California. The court appointed Maryland Electrical Industry Pension Fund as Lead Plaintiff. Lead Plaintiff filed a consolidated complaint, which additionally names as defendants Enrique Lores and Richard Bailey. The complaint alleges, among other things, that from November 5, 2015 to June 21, 2016, HP and the named current and former officers violated Sections 10(b) and 20(a) of the Exchange Act by concealing material information and making false statements about HP’s printing supplies business. Plaintiffs seek compensatory damages and other relief. HP and the named officers filed a motion to dismiss the complaint for failure to state a claim upon which relief can be granted. On March 3, 2022, the court granted the motion to dismiss with prejudice. Plaintiffs appealed the decision.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2023, the appellate court reversed the district court’s decision and remanded the case to the district court for further proceedings consistent with the appellate opinion, including consideration of HP’s other arguments for dismissal. On June 27, 2023, the district court issued an order setting the briefing schedule for a renewed motion to dismiss. On May 17, 2021, stockholder Scott Franklin filed a derivative complaint against certain current and former officers and directors in federal court in the District of Delaware. Plaintiff purports to bring the action on behalf of HP, which he has named as a nominal defendant, and he makes substantially the same factual allegations as in the York County securities complaint, bringing claims for breach of fiduciary duty and violations of securities laws. The derivative plaintiff seeks compensatory damages, governance reforms, and other relief. By court order following stipulations by the parties, the case was transferred to the Northern District of California, and the case was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. On January 13, 2022, stockholder Gerald Lovoi filed a derivative complaint in federal court in the Northern District of California against the same current and former officers and directors named in the Franklin action. The complaint alleges the same basic claims based on the same alleged conduct as the Franklin action and seeks similar relief. By stipulation of the parties, the Lovoi action was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. Both derivative actions will remain stayed while the district court considers on remand HP’s other arguments for dismissal. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceedings re Authentication of Supplies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Since 2016, HP has from time to time been named in civil litigation, or been the subject of government investigations, involving supplies authentication protocols used in certain HP printers in multiple geographies, including but not limited to the United States, Italy, Israel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Netherlands, Australia and New Zealand. The supplies authentication protocols are often referred to as Dynamic Security. The core allegations in these proceedings claim misleading or inadequate consumer notifications and permissions pertaining to the use of Dynamic Security, the installation of firmware updates, or the potential inability of cartridges with clone chips or circuitry to work in HP printers with Dynamic Security. Plaintiffs base or have based their claims on various legal theories, including but not limited to unfair competition, computer trespass, and similar statutory claims. Among other relief, Plaintiffs have sought or seek money damages and in certain cases have or may seek injunctive relief against the use or operation of Dynamic Security or relief requiring interoperability. If HP is not successful in its defense of these cases or investigations, it could be subject to damages, penalties, significant settlement demands, or injunctive relief that may be costly or may disrupt operations. Certain of these proceedings in Italy, the Netherlands, Israel, Australia and New Zealand have been resolved, have concluded, or have concluded subject only to HP’s pending appeal. Civil litigation filed by Digital Revolution B.V. (trading as 123Inkt) against HP Nederlands B.V., et al. (Netherlands) in March 2020, including its competition claim, remains pending. Both parties have appealed. In addition, two putative class actions have been filed against HP in federal court in California, in December 2020, April 2022, and one in federal court in Illinois, in January 2024, arising out of the use of Dynamic Security firmware updates in HP Laserjet printers, in HP Inkjet printers, and in both, respectively. Plaintiffs in these cases seek compensatory damages, restitution, injunctive relief against alleged unfair and anticompetitive business practices, and other relief. In the case directed to Laserjet printers, plaintiffs filed a motion for class certification, and, on December 8, 2023, the court entered an order denying in full plaintiffs’ request to certify a damages class and granting certification of a narrowed injunctive relief class composed of those who did not see HP’s disclosures. In its order, the court declined at this juncture to resolve the merits of the sufficiency of HP’s disclosures. The other cases are in their early stages. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Autonomy-Related Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the result of an internal investigation, HP obtained information about certain accounting improprieties, disclosure failures and misrepresentations at Autonomy that occurred before and in connection with its 2011 acquisition of Autonomy. On April 17, 2015, four former HP subsidiaries that became subsidiaries of Hewlett Packard Enterprise at the time of the Separation (Autonomy Corporation Limited, Hewlett Packard Vision BV, Autonomy Systems, Limited, and Autonomy, Inc.) initiated civil proceedings in the U.K. High Court of Justice against two members of Autonomy’s former management, Michael Lynch and Sushovan Hussain, for breach of their fiduciary duties in causing Autonomy group companies to engage in improper transactions and accounting practices. The claims seek more than $5 billion in damages. Messrs. Lynch and Hussain filed defenses and Mr. Lynch filed a counterclaim seeking $160 million in damages for alleged misstatements regarding Lynch. Trial concluded in January 2020. On May 17, 2022, the court issued its final judgment, finding that HP succeeded on substantially all claims and that Messrs. Lynch and Hussein engaged in fraud, and dismissing Mr. Lynch’s counterclaim. The court deferred its damages ruling to a later, separate judgment to be issued after further proceedings, which began on February 12, 2024, but indicated that damages awarded may be substantially less than is claimed. Litigation is unpredictable, and there can be no assurance that HP will recover damages or as to how any award of damages will compare with the amount claimed. The amount ultimately awarded, if any, would be recorded in the period received. No adjustment has been recorded in the financial statements in relation to this potential award. Pursuant to the terms of the separation and distribution agreement, HP and Hewlett Packard Enterprise will share equally in any recovery. In addition, Messrs. Hussein and Lynch, and Stephen Chamberlain, former VP of Finance of Autonomy, were each indicted on federal criminal charges in the Northern District of California. On April 30, 2018, a jury found Mr. Hussein guilty of conspiracy to commit wire fraud, securities fraud, and multiple counts of wire fraud, and that judgment was affirmed on appeal in August 2020. Messrs. Lynch and Chamberlain are set to face trial on charges of conspiracy to commit wire fraud, and multiple counts of wire fraud on March 18, 2024. HP is continuing to cooperate with the ongoing enforcement actions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nokia Patent Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 31, 2023, Nokia filed a complaint for patent infringement against HP in federal court for the District of Delaware asserting ten patents and filed two companion complaints with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP, asserting seven of the ten patents asserted in the federal court case. The complaints allege that HP products that are compliant with certain video coding technology standards, including Advanced Video Coding (H.264) or High Efficiency Video Coding (H.265) standards, infringe Nokia’s patents. In November 2023, the ITC instituted investigations on Nokia’s complaints. On December 11, 2023, HP filed counterclaims against Nokia in the Delaware action, including claims that Nokia violated its commitments to license standard-essential patents on fair, reasonable, and non-discriminatory (“FRAND”) terms, and seeking a court determination of the proper FRAND rate. Nokia’s patent litigation against HP also includes a lawsuit filed in November 2023 against HP and six of its subsidiaries in the European Unified Patent Court in Germany, 2 lawsuits filed in November 2023 but served in January 2024 against HP and its German subsidiary in state court in Munich, Germany, and a lawsuit filed on December 1, 2023, against a subsidiary, HP Brasil Indústria e Comércio de Equipamentos Eletrônicos Ltda. (“HP Brazil”), in the state court in Rio de Janeiro in Brazil. In Brazil, Nokia alleged that HP’s products contain “skip mode” technology compatible with H.264 video standards that infringes one of Nokia’s Brazilian patents. On December 4, 2023, before HP had received service of the lawsuit, the court granted Nokia an ex parte preliminary injunction against HP Brazil’s commercialization of such products in Brazil. HP has appealed the injunction and asked the appellate court to suspend its enforcement. If the court does not do so, the injunction in Brazil will take effect and remain in place unless overturned on appeal, until the state court revokes or modifies it, or the case is resolved. If HP is not successful in its defenses, it may be subject to injunctions, orders to recall products in Germany and other EU countries, or licensing demands to avoid potential disruptions to its business. On January 31, 2024, HP Brazil filed the non-infringement defense and a patent nullity action against Nokia. Given the procedural posture and nature of these cases, including proceedings that are in their early stages and have significant factual and legal issues to be resolved, HP is unable to make a reasonable estimate of the potential loss or range of losses that may arise from these matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">R2 Semiconductor Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In November 2022, R2 Semiconductor, Inc. (“R2”) filed a lawsuit in the Dusseldorf Regional Court in Germany against Intel Deutschland GmbH, HP Deutschland GmbH and certain other Intel customers. R2 asserts one European patent is infringed by HP’s products that contain certain Intel processors. R2 seeks an injunction prohibiting the sale of the alleged infringing products. Intel is indemnifying HP subject to certain limitations in the parties’ agreement. The Dusseldorf Regional Court conducted a trial on December 7, 2023 and issued an adverse judgment on February 7, 2024. The Court’s judgment imposes an injunction prohibiting sales of the accused products in Germany, an order to stop all other infringing actions, and an order to issue a communication to commercial customers recalling the relevant products sold since March 5, 2020, which could take effect upon notice of R2’s payment of the required sureties and remain in place unless stayed or overturned on appeal or the parties reach an agreement. On February 8, 2024, HP filed an appeal and request for a stay of the judgment pending appeal. Given the procedural posture, the nature of the case, and the relationship with Intel, HP is unable to make a reasonable estimate of the potential loss or range of losses that might arise from this lawsuit and that would not be indemnifiable by Intel.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Litigation with Access Advance Patent Pool regarding video codecs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Access Advance LLC (“Access Advance”) is an independent licensing administrator formed to license allegedly essential patents for standards-based video codecs, which it licenses through various licensing pools.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In late 2023, members of Access Advance’s HEVC Advance patent pool launched a patent litigation campaign against HP in Germany and Europe. To date, three pool members, Dolby, Mitsubishi Electric (“Mitsubishi”) and Konikijke Philips N.V. (“Philips”) have each filed patent infringement lawsuits against HP and various affiliates. Specifically, Dolby filed a lawsuit against HP and 14 affiliates in the new Unified Patent Court (UPC) in Düsseldorf, and Mitsubishi and Philips each filed a lawsuit against HP and two affiliates in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Court in Munich, Germany. The complaints allege that HP products that are compliant with the High Efficiency Video Coding (H.265) standard infringe the pool members' respective patents, seek an injunction, and allege that HP has failed to act as a willing licensee of HEVC essential patents based on HP's negotiations with Access Advance. If HP is not successful in its defenses in these suits, it may be subject to injunctions, recall orders, and claims for damages or face licensing demands to avoid potential disruptions to its business. Given the procedural posture and nature of these cases, which are in their early stages and have significant factual and legal issues to be resolved, HP is unable to make a reasonable estimate of the potential loss or range of losses that may arise from these matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    HP is, and may become a party to, proceedings brought by U.S., state, or other governmental entities or private third parties under federal, state, local, or foreign environmental laws, including the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), known as “Superfund,” or state laws similar to CERCLA. HP is also conducting environmental investigations or remediation at several current or former operating sites and former disposal sites pursuant to administrative orders or consent agreements with environmental agencies.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP is involved in lawsuits, claims, investigations and proceedings, including those identified below, consisting of IP, commercial, securities, employment, employee benefits and environmental matters that arise in the ordinary course of business. HP accrues a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. HP believes it has recorded adequate provisions for any such matters and, as of January 31, 2024, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.</span></div> 40 40 7 1 370000000 16000000 386000000 9000000 10000000 17000000 7000000 3000000 24000000 4 2 4 5 2 1 4 2 5000000000 160000000 10 2 7 10 6 2 1 1 3 14 2 Guarantees, Indemnifications and Warranties<div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-Indemnifications with Hewlett Packard Enterprise</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 12, “Litigation and Contingencies”.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s aggregate product warranty liabilities and changes were as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments related to pre-existing warranties (including changes in estimates)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made (in cash or in kind)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-Indemnifications with Hewlett Packard Enterprise</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 12, “Litigation and Contingencies”.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP’s aggregate product warranty liabilities and changes were as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended January 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In millions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments related to pre-existing warranties (including changes in estimates)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made (in cash or in kind)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 706000000 183000000 19000000 229000000 679000000 0.216 false false false false